Citrus Sinensis ID: 031828

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150--
Protein Sequence
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHcccccEEcEEEEEEcccEEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccccccccccccHHHHHcccccccccccccc
Secondary Structure Prediction (SSPRO)
ccEEEcHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccEcccccEEEccccccEEccccccEccccccHHHccHHHHHHHcccccEEEEcc
Coil and Loop (DISEMBL)
MLKKLNKHLKSCLDCELNflssvnhpniiRLFDAFQAENCIFLVVEFCaggnlssyirlhgrvPEQTARKFLQQLGLEIlnshhiihrdlkpenillsgldddvMLKIADFglsctlypgnyaekvcgsplymapevlqfqrydekvnffvs
Flexible Loop (DISEMBL)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Low Complexity Region (SEG)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Disordered region (IsUnstruct)
*******HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDL***************LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF**
Disordered Region (DISOPRED)
************LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Disordered Region (DISEMBL)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Disordered Region (DISPRO)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	152	2.2.26 [Sep-21-2011]
Q9QY01	1037	Serine/threonine-protein	yes	no	0.888	0.130	0.433	4e-29
Q8IYT8	1036	Serine/threonine-protein	yes	no	0.888	0.130	0.433	7e-29
Q5ZJH6	468	Serine/threonine-protein	no	no	0.967	0.314	0.433	4e-28
Q86CS2	668	Serine/threonine-protein	yes	no	0.953	0.217	0.406	9e-28
O94168	619	Carbon catabolite-derepre	N/A	no	0.815	0.200	0.461	2e-27
A7KAL2	960	Serine/threonine-protein	yes	no	0.980	0.155	0.351	3e-27
O70405	1051	Serine/threonine-protein	no	no	0.927	0.134	0.409	4e-27
O75385	1050	Serine/threonine-protein	no	no	0.927	0.134	0.409	6e-27
Q0CLX3	964	Serine/threonine-protein	N/A	no	0.980	0.154	0.356	6e-27
D3ZHP7	472	Serine/threonine-protein	no	no	0.960	0.309	0.443	7e-27

>sp|Q9QY01|ULK2_MOUSE Serine/threonine-protein kinase ULK2 OS=Mus musculus GN=Ulk2 PE=1 SV=1

 Score =  127 bits (318), Expect = 4e-29,   Method: Composition-based stats.
 Identities = 62/143 (43%), Positives = 89/143 (62%), Gaps = 8/143 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y++  G + E T R FL Q+
Sbjct: 56  EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 127
              + IL+S  IIHRDLKP+NILLS  +        + +KIADFG +  L+    A  +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIADFGFARYLHSNTMAATLC 175

Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
           GSP+YMAPEV+  Q YD K + +
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLW 198

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens GN=ULK2 PE=1 SV=3

 Score =  125 bits (315), Expect = 7e-29,   Method: Composition-based stats.
 Identities = 62/143 (43%), Positives = 89/143 (62%), Gaps = 8/143 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y++  G + E T R FL Q+
Sbjct: 56  EIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYLQAKGTLSEDTIRVFLHQI 115

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGNYAEKVC 127
              + IL+S  IIHRDLKP+NILLS  +        + +KIADFG +  L+    A  +C
Sbjct: 116 AAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIADFGFARYLHSNMMAATLC 175

Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
           GSP+YMAPEV+  Q YD K + +
Sbjct: 176 GSPMYMAPEVIMSQHYDAKADLW 198

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652, FRS2, FRS3 and RPTOR; however such data need additional evidences. Not involved in ammonia-induced autophagy or in autophagic response of cerebellar granule neurons (CGN) to low potassium concentration. Plays a role early in neuronal differentiation and is required for granule cell axon formation: may govern axon formation via Ras-like GTPase signaling and through regulation of the Rab5-mediated endocytic pathways within developing axons.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1

 Score =  123 bits (309), Expect = 4e-28,   Method: Composition-based stats.
 Identities = 65/150 (43%), Positives = 98/150 (65%), Gaps = 3/150 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           + LN+     L  E+  L ++ HP+I+ L D     + I+L++EFCAGG+LS +IR+   
Sbjct: 49  RSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLSRFIRMRRI 108

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE+ AR FLQQL   L+ L+ H+I H DLKP+NILLS   ++  LK+ADFG +  + P 
Sbjct: 109 LPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSPW 167

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +    + GSPLYMAPE++  Q+YD +V+ +
Sbjct: 168 DEKHVLRGSPLYMAPEMVCRQQYDARVDLW 197

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86CS2|ATG1_DICDI Serine/threonine-protein kinase atg1 OS=Dictyostelium discoideum GN=atg1 PE=3 SV=1

 Score =  122 bits (306), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 61/150 (40%), Positives = 92/150 (61%), Gaps = 5/150 (3%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGR 62
           N  L   L+ E+  L  ++H NI+RL+D    E     I++++E C GG+ S YIR H +
Sbjct: 47  NSKLTENLNYEIRILKELSHTNIVRLYDVLNEETDPTFIYMIMECCEGGDFSKYIRTHKK 106

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E+ A  F++QL  GL+ L    I+HRDLKP+N+LLS   +  +LKI DFG +  + P 
Sbjct: 107 LTEEKALYFMKQLANGLKFLRQKQIVHRDLKPQNLLLSDDSEHPILKIGDFGFAKFIDPF 166

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           + ++  CGSPLYMAPE+L  + Y  K + +
Sbjct: 167 SLSDTFCGSPLYMAPEILHRKNYTVKADLW 196

Serine/threonine protein kinase involved in autophagy. Involved in the control of autophagic vacuolar cell death.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O94168|SNF1_CANTR Carbon catabolite-derepressing protein kinase OS=Candida tropicalis GN=SNF1 PE=3 SV=1

 Score =  121 bits (304), Expect = 2e-27,   Method: Composition-based stats.
 Identities = 60/130 (46%), Positives = 88/130 (67%), Gaps = 6/130 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+++L  + HP+II+L+D  ++++ I +V+EF AG  L  YI   G++PE  AR+F QQ+
Sbjct: 100 EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEF-AGKELFDYIVQRGKMPEDEARRFFQQI 158

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +E  + H I+HRDLKPEN+LL   DD + +KIADFGLS  +  GN+ +  CGSP Y 
Sbjct: 159 IAAVEYCHRHKIVHRDLKPENLLL---DDQLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 215

Query: 134 APEVLQFQRY 143
           APEV+  + Y
Sbjct: 216 APEVISGKLY 225

Essential for release from glucose repression. It interacts and has functional relationship to the regulatory protein SNF4. Could phosphorylates CAT8.

Candida tropicalis (taxid: 5482)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A7KAL2|ATG1_PENCW Serine/threonine-protein kinase ATG1 OS=Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) GN=atg1 PE=3 SV=1

 Score =  120 bits (301), Expect = 3e-27,   Method: Composition-based stats.
 Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 50/199 (25%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L KLNK LK  L  E++ L  ++HP+I+ L D  ++ + I LV+E+CA G+LS +I+   
Sbjct: 55  LSKLNKKLKENLSSEIDILKGLHHPHIVALIDCHESTSHIHLVMEYCALGDLSLFIKRRD 114

Query: 61  --------------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL- 97
                               G + E   R FL+QL   L+ L   ++IHRD+KP+N+LL 
Sbjct: 115 TLGSHKYTRDMIAKYPNPPGGSLNEVVTRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLC 174

Query: 98  --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
                                     +GL+   MLKIADFG + +L   + AE +CGSPL
Sbjct: 175 PSPSSYRSGHAQVMPYKGSDDSYEPTTGLESLPMLKIADFGFARSLPATSLAETLCGSPL 234

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPE+L++++YD K + +
Sbjct: 235 YMAPEILRYEKYDAKADLW 253

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) (taxid: 500485)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O70405|ULK1_MOUSE Serine/threonine-protein kinase ULK1 OS=Mus musculus GN=Ulk1 PE=1 SV=1

 Score =  120 bits (300), Expect = 4e-27,   Method: Composition-based stats.
 Identities = 61/149 (40%), Positives = 90/149 (60%), Gaps = 8/149 (5%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           ++ L  E+  L  + H NI+ L+D  +  N ++LV+E+C GG+L+ Y+     + E T R
Sbjct: 57  QTLLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHTMRTLSEDTVR 116

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIADFGLSCTLYPGN 121
            FLQQ+   + +L+S  IIHRDLKP+NILLS          ++ +KIADFG +  L    
Sbjct: 117 LFLQQIAGAMRLLHSKGIIHRDLKPQNILLSNPGGRRANPSNIRVKIADFGFARYLQSNM 176

Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            A  +CGSP+YMAPEV+  Q YD K + +
Sbjct: 177 MAATLCGSPMYMAPEVIMSQHYDGKADLW 205

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652 and RPTOR; however such data need additional evidences. Plays a role early in neuronal differentiation and is required for granule cell axon formation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O75385|ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2

 Score =  119 bits (299), Expect = 6e-27,   Method: Composition-based stats.
 Identities = 61/149 (40%), Positives = 90/149 (60%), Gaps = 8/149 (5%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           ++ L  E+  L  + H NI+ L+D  +  N ++LV+E+C GG+L+ Y+     + E T R
Sbjct: 57  QTLLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYCNGGDLADYLHAMRTLSEDTIR 116

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLS------GLDDDVMLKIADFGLSCTLYPGN 121
            FLQQ+   + +L+S  IIHRDLKP+NILLS         + + +KIADFG +  L    
Sbjct: 117 LFLQQIAGAMRLLHSKGIIHRDLKPQNILLSNPAGRRANPNSIRVKIADFGFARYLQSNM 176

Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            A  +CGSP+YMAPEV+  Q YD K + +
Sbjct: 177 MAATLCGSPMYMAPEVIMSQHYDGKADLW 205

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652 and RPTOR; however such data need additional evidences. Plays a role early in neuronal differentiation and is required for granule cell axon formation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0CLX3|ATG1_ASPTN Serine/threonine-protein kinase atg1 OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=atg1 PE=3 SV=1

 Score =  119 bits (298), Expect = 6e-27,   Method: Composition-based stats.
 Identities = 71/199 (35%), Positives = 103/199 (51%), Gaps = 50/199 (25%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L +LNK LK  L  E++ L  + HP+I+ L D  +  + I LV+E+CA G+LS +IR   
Sbjct: 59  LSQLNKKLKENLFSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSQFIRHRN 118

Query: 61  --------------------GRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILL- 97
                               G + E   R FL+QL   L+ L   ++IHRD+KP+N+LL 
Sbjct: 119 TLGEHRYTRDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 178

Query: 98  --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
                                     +GLD   MLKIADFG + +L   + AE +CGSPL
Sbjct: 179 PSPTSYRAGVAQIVPFKGSEDSFSPATGLDSLPMLKIADFGFARSLPATSLAETLCGSPL 238

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPE+L++++YD K + +
Sbjct: 239 YMAPEILRYEKYDAKADLW 257

Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes.

Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1

 Score =  119 bits (298), Expect = 7e-27,   Method: Composition-based stats.
 Identities = 67/151 (44%), Positives = 98/151 (64%), Gaps = 5/151 (3%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
           K LNK     L  E+  L  + HP+I++L D FQ +N  I+L++EFCAGG+LS +I    
Sbjct: 49  KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            +PE+ AR F+QQL   L+ L+  +I H DLKP+NILLS L+    LK+ADFG +  + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            +    + GSPLYMAPE++  ++YD +V+ +
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLW 197

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	152
255581995	321	serine/threonine-protein kinase, putativ	0.980	0.464	0.774	2e-60
225431573	275	PREDICTED: serine/threonine-protein kina	0.980	0.541	0.715	8e-58
359476946	260	PREDICTED: serine/threonine-protein kina	0.980	0.573	0.715	8e-58
224116060	266	predicted protein [Populus trichocarpa]	0.980	0.560	0.692	1e-55
357464547	290	Serine/threonine protein kinase GE16371	0.980	0.513	0.668	3e-52
297852566	266	hypothetical protein ARALYDRAFT_314341 [	0.980	0.560	0.622	1e-48
356518738	278	PREDICTED: serine/threonine-protein kina	0.980	0.535	0.644	1e-48
7770326	392	F27J15.5 [Arabidopsis thaliana]	0.980	0.380	0.596	2e-47
334183174	376	protein kinase-like protein [Arabidopsis	0.980	0.396	0.596	2e-47
30694500	408	protein kinase-like protein [Arabidopsis	0.980	0.365	0.596	3e-47

>gi|255581995|ref|XP_002531795.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223528561|gb|EEF30583.1| serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  236 bits (602), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 117/151 (77%), Positives = 130/151 (86%), Gaps = 2/151 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLNKHLK+CLDCELNFLSSVNHPNIIRLF  FQAE+ IFLV+EFCAGG+LSSYIR HG
Sbjct: 53  LSKLNKHLKNCLDCELNFLSSVNHPNIIRLFHVFQAESSIFLVLEFCAGGSLSSYIRHHG 112

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E+ AR+ +QQL  GLEIL+SHHIIHRDLKPENILLSG   DV+LKIADFGLS  + P
Sbjct: 113 RVQEEIARRLMQQLGAGLEILHSHHIIHRDLKPENILLSGQFADVVLKIADFGLSRRVQP 172

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           G YAE VCGSPLYMAPEVLQFQ YD+K + +
Sbjct: 173 GKYAETVCGSPLYMAPEVLQFQSYDDKADMW 203

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431573|ref|XP_002282420.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 1 [Vitis vinifera] gi|296088603|emb|CBI37594.3| unnamed protein product [Vitis vinifera]

 Score =  228 bits (580), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 108/151 (71%), Positives = 131/151 (86%), Gaps = 2/151 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++LK+ LDCE+NFLSSV+HPNIIRL   FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43  LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  AR+F+QQLG  LE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           G +AE VCG+PLYMAPEVL+F++YDEKV+ +
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMW 193

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359476946|ref|XP_003631917.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 2 [Vitis vinifera]

 Score =  228 bits (580), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 108/151 (71%), Positives = 131/151 (86%), Gaps = 2/151 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++LK+ LDCE+NFLSSV+HPNIIRL   FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43  LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  AR+F+QQLG  LE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           G +AE VCG+PLYMAPEVL+F++YDEKV+ +
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMW 193

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116060|ref|XP_002332038.1| predicted protein [Populus trichocarpa] gi|222875263|gb|EEF12394.1| predicted protein [Populus trichocarpa]

 Score =  220 bits (561), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 106/153 (69%), Positives = 127/153 (83%), Gaps = 4/153 (2%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLNK+L++CLDCELNFLSSVNH NIIRL D F+ + C+FLV+EFC+GGNL+SY++ HG
Sbjct: 38  LSKLNKNLRNCLDCELNFLSSVNHTNIIRLLDVFEDDCCMFLVLEFCSGGNLASYLQQHG 97

Query: 62  RVPEQTARKFLQQLG----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           RV E+ A++F QQ+G    L+IL SHHIIHRDLKPENILLSG + DV+LKIADFGLS  +
Sbjct: 98  RVQEKIAKRFTQQMGSGDGLKILQSHHIIHRDLKPENILLSGKESDVVLKIADFGLSRRV 157

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            P NY E VCGSP YMAPEVLQFQRYD KV+ +
Sbjct: 158 LPDNYVETVCGSPFYMAPEVLQFQRYDYKVDMW 190

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357464547|ref|XP_003602555.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] gi|355491603|gb|AES72806.1| Serine/threonine protein kinase GE16371 [Medicago truncatula]

 Score =  209 bits (533), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 101/151 (66%), Positives = 120/151 (79%), Gaps = 2/151 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN HL++ LDCE+NFLSSVNHPNI+ L   FQ   C++LV+EFCAGGNL+SYIR H 
Sbjct: 58  LSKLNSHLRASLDCEINFLSSVNHPNIVHLLHFFQGNGCVYLVLEFCAGGNLASYIRCHE 117

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV + TA+KF+QQL  GL++L+SH IIHRDLKPENILLS    D +LKIADFGLS T+ P
Sbjct: 118 RVHQLTAKKFIQQLGSGLKVLHSHGIIHRDLKPENILLSSHGADAVLKIADFGLSRTVRP 177

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           G Y E VCG+P YMAPEVLQFQRYD K + +
Sbjct: 178 GEYVETVCGTPSYMAPEVLQFQRYDHKADMW 208

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297852566|ref|XP_002894164.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] gi|297340006|gb|EFH70423.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata]

 Score =  197 bits (500), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 94/151 (62%), Positives = 119/151 (78%), Gaps = 2/151 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L++CL+ EL FLSSV+HPNIIRL   FQ E  + +V+E+C GG LSSYI+ HG
Sbjct: 39  LSKLNRNLRTCLNNELEFLSSVDHPNIIRLLHVFQDEEFLVMVMEYCDGGTLSSYIQRHG 98

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  A++FL+Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L P
Sbjct: 99  RVEEDIAKRFLKQIGAGLEIIHDNHIIHRDLKPENILIVGSGDDLVLKIADFSLARKLLP 158

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 159 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 189

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356518738|ref|XP_003528035.1| PREDICTED: serine/threonine-protein kinase ULK3-like [Glycine max]

 Score =  197 bits (500), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 98/152 (64%), Positives = 117/152 (76%), Gaps = 3/152 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN  LK+CLDCE+NFLSSVNHPNIIRL   FQ + C++LV+EFCAGGNL+SYI+ HG
Sbjct: 53  LSKLNPRLKACLDCEINFLSSVNHPNIIRLLHFFQYDGCVYLVLEFCAGGNLASYIQNHG 112

Query: 62  RVPEQTARKFLQQLG---LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           RV +Q ARKF+QQLG      L +   + RDLKPENILLS    D +LK+ADFGLS T+ 
Sbjct: 113 RVHQQIARKFMQQLGNFYFFFLYTLTALFRDLKPENILLSSHGVDAVLKLADFGLSRTIC 172

Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           PG YA  VCGSPLYMAPE L+FQRYD+K + +
Sbjct: 173 PGEYAGTVCGSPLYMAPEALKFQRYDDKADMW 204

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7770326|gb|AAF69696.1|AC016041_1 F27J15.5 [Arabidopsis thaliana]

 Score =  193 bits (490), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 90/151 (59%), Positives = 119/151 (78%), Gaps = 2/151 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 38  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 97

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  A++F++Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 98  RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 157

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 158 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 188

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334183174|ref|NP_001185178.1| protein kinase-like protein [Arabidopsis thaliana] gi|332194280|gb|AEE32401.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  193 bits (490), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 90/151 (59%), Positives = 119/151 (78%), Gaps = 2/151 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  A++F++Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 190

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30694500|ref|NP_175344.2| protein kinase-like protein [Arabidopsis thaliana] gi|332194279|gb|AEE32400.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  192 bits (489), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 90/151 (59%), Positives = 119/151 (78%), Gaps = 2/151 (1%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40  LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           RV E  A++F++Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 190

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	152
TAIR|locus:2028496	408	AT1G49180 [Arabidopsis thalian	0.980	0.365	0.596	1.6e-45
TAIR|locus:2084440	712	AT3G53930 [Arabidopsis thalian	0.980	0.209	0.529	9.5e-38
TAIR|locus:2065680	733	AT2G37840 [Arabidopsis thalian	0.980	0.203	0.516	1.4e-37
TAIR|locus:2079527	626	AT3G61960 [Arabidopsis thalian	0.973	0.236	0.48	2.8e-35
UNIPROTKB|Q5ZJH6	468	ULK3 "Serine/threonine-protein	0.960	0.311	0.443	1.3e-26
MGI|MGI:1352758	1037	Ulk2 "unc-51 like kinase 2" [M	0.980	0.143	0.428	1.9e-26
RGD|1310181	1037	Ulk2 "Unc-51 like kinase 2 (C.	0.980	0.143	0.428	2.5e-26
UNIPROTKB|Q8IYT8	1036	ULK2 "Serine/threonine-protein	0.980	0.143	0.428	3.1e-26
UNIPROTKB|E2RF62	1037	ULK2 "Uncharacterized protein"	0.980	0.143	0.428	3.2e-26
UNIPROTKB|E1BH35	1037	ULK2 "Uncharacterized protein"	0.980	0.143	0.428	4e-26

TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)]

 Score = 478 (173.3 bits), Expect = 1.6e-45, P = 1.6e-45
 Identities = 90/151 (59%), Positives = 119/151 (78%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             L KLN++L+ CL+ EL FLSSV+HPNIIRL    Q ++ + +V+E+C GG LSSYI+ +G
Sbjct:    40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99

Query:    62 RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
             RV E  A++F++Q+G  LEI++ +HIIHRDLKPENIL+ G  DD++LKIADF L+  L+P
Sbjct:   100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             G Y E VCGSP YMAPEVLQFQRY+EK + +
Sbjct:   160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMW 190

GO:0003676 "nucleic acid binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)]

 Score = 411 (149.7 bits), Expect = 9.5e-38, P = 9.5e-38
 Identities = 80/151 (52%), Positives = 106/151 (70%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             + +LNK L+  L  E+  L  +NHPNIIR  D  +A   I LV+E+C GG+LS YI  HG
Sbjct:    53 MARLNKKLQESLMSEIIILRKINHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHG 112

Query:    62 RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              VPE TA+ F+ QL  GL++L  ++IIHRDLKP+N+LLS  D+D  LKIADFG + +L P
Sbjct:   113 SVPEATAKHFMLQLAAGLQVLRDNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQP 172

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                AE +CGSPLYMAPE++Q Q+YD K + +
Sbjct:   173 RGLAETLCGSPLYMAPEIMQLQKYDAKADLW 203

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)]

 Score = 410 (149.4 bits), Expect = 1.4e-37, P = 1.4e-37
 Identities = 78/151 (51%), Positives = 109/151 (72%)

Query:     2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
             + +LNK L+  L  E+  L  +NHPNIIRL D  ++   + LV+E+C GG+LS Y++ HG
Sbjct:    45 MDRLNKKLQESLMSEIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHG 104

Query:    62 RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              VPE TA+ F+QQL  GL++L  ++IIHRDLKP+N+LLS  ++D  LKIADFG + +L P
Sbjct:   105 IVPEATAKHFMQQLAAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQP 164

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                AE +CGSPLYMAPE++Q Q+YD K + +
Sbjct:   165 RGLAETLCGSPLYMAPEIMQLQKYDAKADLW 195

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 2.8e-35, P = 2.8e-35
 Identities = 72/150 (48%), Positives = 108/150 (72%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             K L+  ++  L  E++ LS+++HPNIIR ++A +  + IFLV+E+C+GG+L+ YI  HG+
Sbjct:    44 KLLSPKVRDNLLKEISILSTIDHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGK 103

Query:    63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             VPE  A+ F++QL  GL++L   H IHRDLKP+N+LLS  +   +LKI DFG + +L P 
Sbjct:   104 VPEAVAKHFMRQLALGLQVLQEKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPE 163

Query:   121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             + AE  CGSPLYMAPE+++ Q+YD K + +
Sbjct:   164 SMAETFCGSPLYMAPEIIRNQKYDAKADLW 193

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)]

 Score = 302 (111.4 bits), Expect = 1.3e-26, P = 1.3e-26
 Identities = 67/151 (44%), Positives = 101/151 (66%)

Query:     3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
             + LN+     L  E+  L ++ HP+I+ L D FQ ++  I+L++EFCAGG+LS +IR+  
Sbjct:    49 RSLNRASVENLLTEIEILKTIRHPHIVELKD-FQWDSDHIYLIMEFCAGGDLSRFIRMRR 107

Query:    62 RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              +PE+ AR FLQQL   L+ L+ H+I H DLKP+NILLS   ++  LK+ADFG +  + P
Sbjct:   108 ILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSP 166

Query:   120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
              +    + GSPLYMAPE++  Q+YD +V+ +
Sbjct:   167 WDEKHVLRGSPLYMAPEMVCRQQYDARVDLW 197

GO:0005524 "ATP binding" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=ISS

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

MGI|MGI:1352758 Ulk2 "unc-51 like kinase 2" [Mus musculus (taxid:10090)]

 Score = 310 (114.2 bits), Expect = 1.9e-26, P = 1.9e-26
 Identities = 69/161 (42%), Positives = 99/161 (61%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 109
             +  G + E T R FL Q+   + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIA 157

Query:   110 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNTMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0007399 "nervous system development" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0010506 "regulation of autophagy" evidence=ISO;IMP

GO:0016020 "membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0031410 "cytoplasmic vesicle" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=ISO;IDA

GO:0042594 "response to starvation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0048671 "negative regulation of collateral sprouting" evidence=IMP

GO:0048675 "axon extension" evidence=IMP

RGD|1310181 Ulk2 "Unc-51 like kinase 2 (C. elegans)" [Rattus norvegicus (taxid:10116)]

 Score = 309 (113.8 bits), Expect = 2.5e-26, P = 2.5e-26
 Identities = 69/161 (42%), Positives = 98/161 (60%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 109
             +  G + E T R FL Q+   + IL+S  IIHRDLKP+NILLS           + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYASRRKSNVSGIRIKIA 157

Query:   110 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNTMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0003674 "molecular_function" evidence=ND

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0008150 "biological_process" evidence=ND

GO:0010506 "regulation of autophagy" evidence=IEA;ISO

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA;ISO

GO:0042594 "response to starvation" evidence=IEA;ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA;ISO

GO:0048675 "axon extension" evidence=IEA;ISO

UNIPROTKB|Q8IYT8 ULK2 "Serine/threonine-protein kinase ULK2" [Homo sapiens (taxid:9606)]

 Score = 308 (113.5 bits), Expect = 3.1e-26, P = 3.1e-26
 Identities = 69/161 (42%), Positives = 99/161 (61%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 109
             +  G + E T R FL Q+   + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSSVSGIRIKIA 157

Query:   110 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0007165 "signal transduction" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0048675 "axon extension" evidence=IEA

GO:0030659 "cytoplasmic vesicle membrane" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0010506 "regulation of autophagy" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042594 "response to starvation" evidence=ISS

UNIPROTKB|E2RF62 ULK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 308 (113.5 bits), Expect = 3.2e-26, P = 3.2e-26
 Identities = 69/161 (42%), Positives = 99/161 (61%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 109
             +  G + E T R FL Q+   + IL+S  IIHRDLKP+NILLS  +        + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYANRRKSNVSGIRIKIA 157

Query:   110 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E1BH35 ULK2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 307 (113.1 bits), Expect = 4.0e-26, P = 4.0e-26
 Identities = 69/161 (42%), Positives = 98/161 (60%)

Query:     2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
             +K +NK +L KS   L  E+  L  + H NI+ L+D  +  N +FLV+E+C GG+L+ Y+
Sbjct:    38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97

Query:    58 RLHGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 109
             +  G + E T R FL Q+   + IL+S  IIHRDLKP+NILLS           + +KIA
Sbjct:    98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYASRKKSSVSGIRIKIA 157

Query:   110 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             DFG +  L+    A  +CGSP+YMAPEV+  Q YD K + +
Sbjct:   158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLW 198

GO:0048675 "axon extension" evidence=IEA

GO:0048671 "negative regulation of collateral sprouting" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0042594 "response to starvation" evidence=IEA

GO:0034045 "pre-autophagosomal structure membrane" evidence=IEA

GO:0010506 "regulation of autophagy" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00034887001 SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (275 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	152
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-44
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-39
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-37
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-35
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-34
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-33
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-29
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-29
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-28
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-27
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-27
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-26
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-26
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-24
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-24
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-23
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-23
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-23
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-22
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-22
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-22
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-22
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-21
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-20
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-20
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-20
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-20
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-20
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-19
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-18
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-18
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-17
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-17
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-17
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	9e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-16
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-16
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-16
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-16
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-16
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-16
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-16
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	9e-16
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-15
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-13
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-12
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-11
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-10
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.004
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  171 bits (437), Expect = 1e-54
 Identities = 65/152 (42%), Positives = 93/152 (61%), Gaps = 9/152 (5%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K            E+  L  + HPNI+RL+D F+ E+ ++LV+E+C GG+L   +
Sbjct: 29  IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88

Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           +  GR+ E  AR +L+Q+   LE L+S  I+HRDLKPENIL   LD+D  +K+ADFGL+ 
Sbjct: 89  KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENIL---LDEDGHVKLADFGLAR 145

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
            L PG       G+P YMAPEVL  + Y + V
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  144 bits (366), Expect = 2e-44
 Identities = 65/155 (41%), Positives = 93/155 (60%), Gaps = 11/155 (7%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K   S L      E+  L  +NHPNI++L+  F+ EN ++LV+E+C GG+L   +
Sbjct: 23  IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82

Query: 58  -RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
               G++ E    + L Q+  GLE L+S+ IIHRDLKPENILL    D+  +K+ADFGLS
Sbjct: 83  KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD--SDNGKVKLADFGLS 140

Query: 115 CTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKV 147
             L    +  + + G+P YMAPEVL  +  Y EK 
Sbjct: 141 KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  145 bits (369), Expect = 2e-44
 Identities = 66/155 (42%), Positives = 93/155 (60%), Gaps = 12/155 (7%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           +K L K  +          E+  L  ++HPNI+RL DAF+ ++ ++LV+E+C GG+L  Y
Sbjct: 29  VKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY 88

Query: 57  IRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           +   G + E  A+K   Q+  GLE L+S+ IIHRDLKPENIL   LD++ ++KIADFGL+
Sbjct: 89  LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL---LDENGVVKIADFGLA 145

Query: 115 CTLY-PGNYAEKVCGSPLYMAPEVLQFQR-YDEKV 147
             L    +      G+P YMAPEVL     Y  KV
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 5e-40
 Identities = 61/137 (44%), Positives = 84/137 (61%), Gaps = 6/137 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E N LS +NHP I++L  AFQ E  ++LV+E+  GG L S++   GR  E+ AR +  + 
Sbjct: 43  ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLY 132
            L LE L+S  II+RDLKPENIL   LD D  +K+ DFGL+  L          CG+P Y
Sbjct: 103 VLALEYLHSLGIIYRDLKPENIL---LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159

Query: 133 MAPEVLQFQRYDEKVNF 149
           +APEVL  + Y + V++
Sbjct: 160 LAPEVLLGKGYGKAVDW 176

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  133 bits (337), Expect = 1e-39
 Identities = 53/144 (36%), Positives = 87/144 (60%), Gaps = 10/144 (6%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
             L+ E+  LSS+ HPNI+R + + + E  N + + +E+ +GG+LSS ++  G++PE   
Sbjct: 44  EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI 103

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYA 123
           RK+ +Q+  GL  L+S+ I+HRD+K  NIL+     D ++K+ADFG +  L     G   
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGT 160

Query: 124 EKVCGSPLYMAPEVLQFQRYDEKV 147
             V G+P +MAPEV++ + Y    
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAA 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  129 bits (326), Expect = 8e-38
 Identities = 48/138 (34%), Positives = 83/138 (60%), Gaps = 10/138 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARKF 71
           E+  L  +NHPNII+ +++F+ +  + +V+E+  GG+LS  I+   +     PE+    +
Sbjct: 49  EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCG 128
             Q  L L+ L+S  I+HRD+KP+NI    L  + ++K+ DFG+S  L    + A+ V G
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIF---LTSNGLVKLGDFGISKVLSSTVDLAKTVVG 165

Query: 129 SPLYMAPEVLQFQRYDEK 146
           +P Y++PE+ Q + Y+ K
Sbjct: 166 TPYYLSPELCQNKPYNYK 183

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  127 bits (322), Expect = 2e-37
 Identities = 48/135 (35%), Positives = 78/135 (57%), Gaps = 6/135 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L    HPNI++ + ++  ++ +++V+EFC+GG+L   ++   +   E       ++
Sbjct: 47  EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           L  GLE L+S+ IIHRD+K  NILL+    D  +K+ DFGLS  L        + G+P +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKARNTMVGTPYW 163

Query: 133 MAPEVLQFQRYDEKV 147
           MAPEV+  + YD K 
Sbjct: 164 MAPEVINGKPYDYKA 178

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  121 bits (307), Expect = 5e-35
 Identities = 53/159 (33%), Positives = 91/159 (57%), Gaps = 14/159 (8%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             + K+    +  E + LS    P +++L+ +FQ +  ++LV+E+  GG+L+S +   G 
Sbjct: 30  DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89

Query: 63  VPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------ 114
           + E  AR ++ +  L LE L+S+ IIHRDLKP+NIL   +D +  LK+ DFGLS      
Sbjct: 90  LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL---IDSNGHLKLTDFGLSKVGLVR 146

Query: 115 --CTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFF 150
               L      + ++ G+P Y+APEV+  Q + + V+++
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  121 bits (307), Expect = 1e-34
 Identities = 55/136 (40%), Positives = 85/136 (62%), Gaps = 7/136 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L S+ HP ++ L+ +FQ ++ ++LV+E+  GG L S++R  GR PE  AR +  Q 
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L LE L+S  I++RDLKPEN+L   LD D  +KI DFG +  +    Y   +CG+P Y+
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLL---LDSDGYIKITDFGFAKRVKGRTYT--LCGTPEYL 165

Query: 134 APEVLQFQRYDEKVNF 149
           APE++  + Y + V++
Sbjct: 166 APEIILSKGYGKAVDW 181

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  116 bits (293), Expect = 5e-33
 Identities = 54/156 (34%), Positives = 86/156 (55%), Gaps = 11/156 (7%)

Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK + K        +  +  E   L   NHP I++L+  F+ +  I++++E+C GG L +
Sbjct: 23  LKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82

Query: 56  YIRLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            +R  G   E TAR ++    L  E L++  II+RDLKPEN+L   LD +  +K+ DFG 
Sbjct: 83  ILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL---LDSNGYVKLVDFGF 139

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNF 149
           +  L  G      CG+P Y+APE++  + YD  V++
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDY 175

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  116 bits (292), Expect = 7e-33
 Identities = 49/137 (35%), Positives = 78/137 (56%), Gaps = 5/137 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L  +NHP ++ L+ +FQ E  ++LVV+   GG+L  ++    +  E+  + ++ + 
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L LE L+S  IIHRD+KP+NILL   D+   + I DF ++  + P        G+P YM
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166

Query: 134 APEVLQFQRYDEKVNFF 150
           APEVL  Q Y   V+++
Sbjct: 167 APEVLCRQGYSVAVDWW 183

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  110 bits (278), Expect = 1e-30
 Identities = 46/137 (33%), Positives = 79/137 (57%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
           E   +  ++HPN+++L     + E  +++V+E+  GG+L SY+R +  ++       F  
Sbjct: 51  EARIMRKLDHPNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFAL 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SP 130
           Q+  G+E L S + IHRDL   N L   + +++++KI+DFGLS  LY  +Y  K  G  P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL---VGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166

Query: 131 L-YMAPEVLQFQRYDEK 146
           + +MAPE L+  ++  K
Sbjct: 167 IRWMAPESLKEGKFTSK 183

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  110 bits (276), Expect = 2e-30
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 17/157 (10%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI---- 57
            + +  K  L  E+N L  + HPNI+R +D    ++   +++V+E+C GG+L+  I    
Sbjct: 37  NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96

Query: 58  RLHGRVPEQTARKFLQQLGL-------EILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           +    + E+   + L QL L            + ++HRDLKP NI    LD +  +K+ D
Sbjct: 97  KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIF---LDANNNVKLGD 153

Query: 111 FGLSCTLYPGNYAEKVC-GSPLYMAPEVLQFQRYDEK 146
           FGL+  L   +   K   G+P YM+PE L    YDEK
Sbjct: 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (273), Expect = 1e-29
 Identities = 51/145 (35%), Positives = 72/145 (49%), Gaps = 28/145 (19%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL- 75
           L  L+   HP II+L+  FQ E  ++ V+E+   G L  YIR +G + E+  R +  ++ 
Sbjct: 55  LTRLN--GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112

Query: 76  -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----------------- 117
             LE L+S  IIHRDLKPENIL   LD D+ +KI DFG +  L                 
Sbjct: 113 LALEYLHSKGIIHRDLKPENIL---LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 118 --YPGNYAEK--VCGSPLYMAPEVL 138
                N        G+  Y++PE+L
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELL 194

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 2e-29
 Identities = 47/137 (34%), Positives = 70/137 (51%), Gaps = 28/137 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E++ L  + HPNI++L D    E  ++LV E+C   +L  Y+      +     +  + Q
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  GL   +SH I+HRDLKP+NIL   ++ D +LK+ADFGL+          +  G PL 
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNIL---INRDGVLKLADFGLA----------RAFGIPLR 153

Query: 132 ----------YMAPEVL 138
                     Y APE+L
Sbjct: 154 TYTHEVVTLWYRAPEIL 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (269), Expect = 2e-29
 Identities = 44/135 (32%), Positives = 76/135 (56%), Gaps = 7/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L   + P I++ + ++     +++V+E+C  G++S  +++  +   E+     L Q
Sbjct: 48  EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107

Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 131
              GLE L+S+  IHRD+K  NIL   L+++   K+ADFG+S  L         V G+P 
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNIL---LNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164

Query: 132 YMAPEVLQFQRYDEK 146
           +MAPEV+Q   Y+ K
Sbjct: 165 WMAPEVIQEIGYNNK 179

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  107 bits (269), Expect = 2e-29
 Identities = 45/138 (32%), Positives = 76/138 (55%), Gaps = 11/138 (7%)

Query: 16  ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E   +  ++HPNI++L     + E  + +V+E+  GG+L  Y+R +    +       F 
Sbjct: 51  EARIMRKLDHPNIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA 109

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-S 129
            Q+  G+E L S + IHRDL   N L+    +++++KI+DFGLS  LY  +Y +   G  
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 130 PL-YMAPEVLQFQRYDEK 146
           P+ +MAPE L+  ++  K
Sbjct: 167 PIRWMAPESLKEGKFTSK 184

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  106 bits (266), Expect = 6e-29
 Identities = 44/137 (32%), Positives = 76/137 (55%), Gaps = 9/137 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E + +  ++HPNI+RL         +++V E+  GG+L  ++R HG  +  +   +   Q
Sbjct: 51  EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+E L S + +HRDL   N L   + +++++KI+DFGLS  +Y  +Y  K  G  L 
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCL---VTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167

Query: 132 --YMAPEVLQFQRYDEK 146
             +MAPE L+  ++  K
Sbjct: 168 IKWMAPESLKDGKFTSK 184

Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  104 bits (261), Expect = 3e-28
 Identities = 55/137 (40%), Positives = 75/137 (54%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E+  L+SVNHPNII   +AF   N + +V+E+   G+LS  I         +PEQ   + 
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
             QL  GL+ L+   I+HRDLK  NILL   D    +KI D G+S  +   N A+   G+
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGIS-KVLKKNMAKTQIGT 164

Query: 130 PLYMAPEVLQFQRYDEK 146
           P YMAPEV + + Y  K
Sbjct: 165 PHYMAPEVWKGRPYSYK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 6e-28
 Identities = 51/137 (37%), Positives = 82/137 (59%), Gaps = 7/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L  V+HP IIRLF     +  +++++E+  GG L SY+R  GR    T   +  ++
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              LE L+S  I++RDLKPENIL   LD +  +K+ DFG +  L    +   +CG+P Y+
Sbjct: 111 VCALEYLHSKEIVYRDLKPENIL---LDKEGHIKLTDFGFAKKLRDRTWT--LCGTPEYL 165

Query: 134 APEVLQFQRYDEKVNFF 150
           APEV+Q + +++ V+++
Sbjct: 166 APEVIQSKGHNKAVDWW 182

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  102 bits (257), Expect = 1e-27
 Identities = 48/142 (33%), Positives = 76/142 (53%), Gaps = 16/142 (11%)

Query: 16  ELNFLSSVNHPNIIRLF--DAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFL 72
           E+  L  + HPN+++ +  +  + +  IF+  E+C+GG L   +  HGR+  E   R + 
Sbjct: 49  EMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTLEELLE-HGRILDEHVIRVYT 105

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-----TLYPGNYAEK 125
            QL  GL  L+SH I+HRD+KP NI    LD + ++K+ DFG +      T   G   + 
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIF---LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162

Query: 126 VCGSPLYMAPEVLQFQRYDEKV 147
           + G+P YMAPEV+   +     
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHG 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (257), Expect = 2e-27
 Identities = 52/144 (36%), Positives = 84/144 (58%), Gaps = 14/144 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFL 72
           E+  +S  NHPN+++ + +F   + ++LV+ + +GG+L   ++     G + E      L
Sbjct: 49  EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV--- 126
           +++  GLE L+S+  IHRD+K  NIL   L +D  +KIADFG+S +L   G+   KV   
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNIL---LGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 127 -CGSPLYMAPEVL-QFQRYDEKVN 148
             G+P +MAPEV+ Q   YD K +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKAD 189

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 2e-27
 Identities = 44/150 (29%), Positives = 82/150 (54%), Gaps = 10/150 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
            +  K + + L+CE+  L ++ H  I++ +   + +  + + +E+  GG++   ++ +G 
Sbjct: 42  PETKKEVNA-LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA 100

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 119
           + E   RK+ +Q+  G+E L+S+ I+HRD+K  NIL    D    +K+ DFG S  L   
Sbjct: 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTI 157

Query: 120 ---GNYAEKVCGSPLYMAPEVLQFQRYDEK 146
              G   + V G+P +M+PEV+  + Y  K
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  102 bits (257), Expect = 3e-27
 Identities = 53/142 (37%), Positives = 80/142 (56%), Gaps = 9/142 (6%)

Query: 12  CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           C   E   L+    HP + +L   FQ ++ +F V+E+  GG+L  +I+  GR  E  AR 
Sbjct: 41  CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF 100

Query: 71  FLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 126
           +  +  LGL+ L+   II+RDLK +N+L   LD +  +KIADFG+ C   +  G      
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVL---LDSEGHIKIADFGM-CKEGILGGVTTSTF 156

Query: 127 CGSPLYMAPEVLQFQRYDEKVN 148
           CG+P Y+APE+L +Q Y   V+
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVD 178

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 6e-27
 Identities = 48/145 (33%), Positives = 71/145 (48%), Gaps = 17/145 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL--Q 73
           E   +  + HPN++RL      E  ++LV+E+  GG+L  Y+R    V     +  L  +
Sbjct: 46  EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105

Query: 74  QL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            L         G+E L S   +HRDL   N L+   +D V+ KI+DFGLS  +Y  +Y  
Sbjct: 106 DLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG--EDLVV-KISDFGLSRDVYDDDYYR 162

Query: 125 KVCGSPL---YMAPEVLQFQRYDEK 146
           K  G  L   +MAPE L+   +  K
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSK 187

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  100 bits (251), Expect = 1e-26
 Identities = 48/139 (34%), Positives = 76/139 (54%), Gaps = 12/139 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L +  HP +++L D F   +   LV+E+     LS  +R   R +PE   + +++ 
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM 107

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGS 129
           L  G+  ++++ I+HRDLKP N+L+S    D +LKIADFGL+          Y+ +V  +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163

Query: 130 PLYMAPEVLQFQR-YDEKV 147
             Y APE+L   R YD  V
Sbjct: 164 RWYRAPELLYGARKYDPGV 182

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 99.2 bits (248), Expect = 5e-26
 Identities = 50/128 (39%), Positives = 77/128 (60%), Gaps = 7/128 (5%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPE-QTARKFLQQL-GLEIL 80
            HPNI+  +D++   + +++V+E+  GG+L+  I  +  R+ E Q A    + L GLE L
Sbjct: 73  KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLYMAPEVLQ 139
           +S ++IHRD+K +NILLS  D  V  K+ADFG +  L         V G+P +MAPEV++
Sbjct: 133 HSQNVIHRDIKSDNILLS-KDGSV--KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 140 FQRYDEKV 147
            + Y  KV
Sbjct: 190 RKDYGPKV 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 7e-26
 Identities = 44/140 (31%), Positives = 78/140 (55%), Gaps = 7/140 (5%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K   + LKS +  E++ L ++ HPNI++   + +  + +++++E+   G+L   I+  G 
Sbjct: 37  KIKEEALKSIMQ-EIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP 95

Query: 63  VPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 119
            PE     ++ Q   GL  L+   +IHRD+K  NIL +    D ++K+ADFG++  L   
Sbjct: 96  FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDV 152

Query: 120 GNYAEKVCGSPLYMAPEVLQ 139
                 V G+P +MAPEV++
Sbjct: 153 SKDDASVVGTPYWMAPEVIE 172

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 8e-26
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 31/154 (20%)

Query: 3   KKLNKHLKSCLDC----ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           KK+ K   S  +C    E+  L  +N HPNI++L + F+  + ++ V E+  G NL   +
Sbjct: 30  KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLM 88

Query: 58  RLHGRVP--EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +     P  E   R  + Q+  GL  ++ H   HRDLKPEN+L+SG +   ++KIADFGL
Sbjct: 89  KDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGL 145

Query: 114 SCTLYPGNYAEKVCGSP---------LYMAPEVL 138
                    A ++   P          Y APE+L
Sbjct: 146 ---------AREIRSRPPYTDYVSTRWYRAPEIL 170

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 98.2 bits (245), Expect = 2e-25
 Identities = 54/157 (34%), Positives = 87/157 (55%), Gaps = 15/157 (9%)

Query: 2   LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK++ K L   L+       E + L++     +++L  AFQ +  ++L +E+  GG+  +
Sbjct: 31  LKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT 90

Query: 56  YIRLHGRVPEQTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFG 112
            +   G + E  AR ++ ++  E +++ H    IHRDLKPEN L+   D    +K+ DFG
Sbjct: 91  LLNNLGVLSEDHARFYMAEM-FEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFG 146

Query: 113 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNF 149
           LS  +    YA  V GSP YMAPEVL+ + YD  V++
Sbjct: 147 LSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.5 bits (241), Expect = 3e-25
 Identities = 51/137 (37%), Positives = 76/137 (55%), Gaps = 17/137 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT----ARKF 71
           EL  L S   P +++ + AF  E  I +V+E+  GG+L+  ++  G++PE      AR+ 
Sbjct: 49  ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI 108

Query: 72  LQQLGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKV 126
           L+  GL+ L    HIIHRD+KP N+L++    +V  KIADFG    L  TL   N     
Sbjct: 109 LK--GLDYLHTKRHIIHRDIKPSNLLIN-SKGEV--KIADFGISKVLENTLDQCNTF--- 160

Query: 127 CGSPLYMAPEVLQFQRY 143
            G+  YM+PE +Q + Y
Sbjct: 161 VGTVTYMSPERIQGESY 177

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.9 bits (236), Expect = 1e-24
 Identities = 46/151 (30%), Positives = 84/151 (55%), Gaps = 10/151 (6%)

Query: 2   LKKLNKHLKS-CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           L K+N+  +   +D E   L+ ++   IIR +++F  +  + +V+E+   G+L   +++ 
Sbjct: 35  LSKMNRREREEAID-EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ 93

Query: 61  G--RVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
               +PE    +F  Q  LGL  L+S  I+HRD+K  N+ L   D+   +KI D G++  
Sbjct: 94  RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKL 150

Query: 117 LYPG-NYAEKVCGSPLYMAPEVLQFQRYDEK 146
           L    N+A  + G+P Y++PE+ + + Y+EK
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEK 181

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.8 bits (236), Expect = 1e-24
 Identities = 44/128 (34%), Positives = 80/128 (62%), Gaps = 5/128 (3%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L+ E+  LS + HPNI++     + E+ +++ +E   GG+L+  ++ +G  PE   R + 
Sbjct: 49  LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           +Q+  GLE L+  + +HRD+K  NIL   +D + ++K+ADFG++  +   ++A+   GSP
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANIL---VDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165

Query: 131 LYMAPEVL 138
            +MAPEV+
Sbjct: 166 YWMAPEVI 173

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 94.2 bits (234), Expect = 2e-24
 Identities = 47/135 (34%), Positives = 77/135 (57%), Gaps = 6/135 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  ++HPNII  ++ F  +  + +V+E+  GG L+ YI+      + E T   F  
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q  L L  +++  I+HRDLK +NILL      +++KI DFG+S  L   + A  V G+P 
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166

Query: 132 YMAPEVLQFQRYDEK 146
           Y++PE+ + + Y++K
Sbjct: 167 YISPELCEGKPYNQK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 96.3 bits (238), Expect = 2e-24
 Identities = 57/140 (40%), Positives = 80/140 (57%), Gaps = 15/140 (10%)

Query: 16  ELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF 71
           E+  L+S+NHP NI++L+D FQ E  ++LV+E+  GG+L   ++  GR   + E  A   
Sbjct: 47  EIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFI 106

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--- 126
           L Q+   LE L+S  IIHRD+KPENILL    D  ++K+ DFGL+  L        +   
Sbjct: 107 LAQILSALEYLHSKGIIHRDIKPENILLD--RDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164

Query: 127 ----CGSPLYMAPEVLQFQR 142
                G+P YMAPEVL    
Sbjct: 165 PSTSVGTPGYMAPEVLLGLS 184

Length = 384

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 94.5 bits (235), Expect = 3e-24
 Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 10/153 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
               K +   L  E+  L  ++H NI++       E  + + +E+  GG++ S +R +GR
Sbjct: 45  DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR 104

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL---SCTL 117
             EQ  R F +Q+  GL  L+S  I+HRDLK +N+L   +D D + KI+DFG+   S  +
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL---VDADGICKISDFGISKKSDDI 161

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQR--YDEKVN 148
           Y  +    + GS  +MAPEV+      Y  KV+
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVD 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 95.3 bits (237), Expect = 3e-24
 Identities = 52/144 (36%), Positives = 85/144 (59%), Gaps = 21/144 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + L  ++HP I+ +  +FQ EN ++ ++EF  GG L +++R  GR P   A+ +  + 
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------- 126
            L  E L+S  II+RDLKPEN+L   LD+   +K+ DFG         +A+KV       
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLL---LDNKGHVKVTDFG---------FAKKVPDRTFTL 175

Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
           CG+P Y+APEV+Q + + + V+++
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWW 199

Length = 329

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 93.7 bits (233), Expect = 3e-24
 Identities = 45/115 (39%), Positives = 75/115 (65%), Gaps = 8/115 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P + +L+ +FQ+++ ++LV+E+  GG+ +S I+  G +PE  A++++ +  LG+E L+  
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 138
            IIHRD+KPEN+L   +D    LK+ DFGLS     G   +K  G+P Y+APE +
Sbjct: 117 GIIHRDIKPENLL---IDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETI 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 5e-24
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 35/166 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + L+  + P I++L+ +FQ E  ++LV+E+  GG+L + +      PE+TAR ++ +L
Sbjct: 51  ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110

Query: 76  GLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-----------------CT 116
            L +  ++    IHRD+KP+NIL   +D D  +K+ADFGL                    
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNIL---IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 117 LYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVNF 149
           L+  N              A    G+P Y+APEVL+   Y  + ++
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW 213

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 1e-23
 Identities = 52/143 (36%), Positives = 77/143 (53%), Gaps = 18/143 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPE-QTA---RK 70
           E++ L    HPNI+  F ++   + +++V+E+C GG+L   Y    G + E Q A   R+
Sbjct: 50  EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109

Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VC 127
            L+  GL  L+    IHRD+K  NILL+   +D  +K+ADFG+S  L       K     
Sbjct: 110 TLK--GLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQL--TATIAKRKSFI 162

Query: 128 GSPLYMAPEVLQFQR---YDEKV 147
           G+P +MAPEV   +R   YD K 
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKC 185

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 93.3 bits (232), Expect = 1e-23
 Identities = 51/129 (39%), Positives = 78/129 (60%), Gaps = 6/129 (4%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNS 82
           HP +  LF  FQ +  +F V+E+  GG+L  +I+  GR  E  AR +  +   GL+ L+ 
Sbjct: 55  HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114

Query: 83  HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQ 141
             II+RDLK +N+LL   D D  +KIADFG+    +     A   CG+P Y+APE+L+ Q
Sbjct: 115 KGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 142 RYDEKVNFF 150
           +Y+E V+++
Sbjct: 172 KYNESVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 2e-23
 Identities = 53/139 (38%), Positives = 77/139 (55%), Gaps = 11/139 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  +NHPNII+L D F+ +  ++LV EF    +L   I+   R +PE   + +L Q
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 130
           L  GL   +SH I+HRDLKPEN+L++       LK+ADFGL+ +       Y   V  + 
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRPYTHYVV-TR 162

Query: 131 LYMAPEVLQFQR-YDEKVN 148
            Y APE+L   + Y   V+
Sbjct: 163 WYRAPELLLGDKGYSTPVD 181

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 92.2 bits (229), Expect = 4e-23
 Identities = 54/140 (38%), Positives = 86/140 (61%), Gaps = 10/140 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E + L+ VNHP I++L  AFQ E  ++L+++F  GG+L  + RL   V   E+  + +L 
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 105

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
           +  L L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+ 
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162

Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            YMAPEV+  + + +  +++
Sbjct: 163 EYMAPEVVNRRGHTQSADWW 182

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 91.7 bits (228), Expect = 5e-23
 Identities = 50/133 (37%), Positives = 75/133 (56%), Gaps = 11/133 (8%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ---LGL 77
           +S  HP ++ LF  FQ E+ +  V+E+ AGG+L  +I  H  V  +    F      LGL
Sbjct: 57  NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGL 114

Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAP 135
           + L+ + I++RDLK +N+L   LD +  +KIADFGL C   +  G+     CG+P ++AP
Sbjct: 115 QYLHENKIVYRDLKLDNLL---LDTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAP 170

Query: 136 EVLQFQRYDEKVN 148
           EVL    Y   V+
Sbjct: 171 EVLTETSYTRAVD 183

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 89.5 bits (222), Expect = 3e-22
 Identities = 48/136 (35%), Positives = 84/136 (61%), Gaps = 8/136 (5%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F ++ NHP ++ L   FQ E+ +F V+EF +GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 49  FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 134
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+ C   + PG+     CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDAEGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIA 164

Query: 135 PEVLQFQRYDEKVNFF 150
           PE+L+ + Y   V+++
Sbjct: 165 PEILRGEDYGFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.7 bits (220), Expect = 4e-22
 Identities = 54/139 (38%), Positives = 77/139 (55%), Gaps = 7/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  V+   I+ L  AF+ ++ + LV+    GG+L  +I   G    PE  A  +  
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q   GLE L+   I++RDLKPEN+LL   DD   ++I+D GL+  L  G   +   G+P 
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPEVLQ + YD  V++F
Sbjct: 160 YMAPEVLQGEVYDFSVDWF 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 4e-22
 Identities = 54/131 (41%), Positives = 77/131 (58%), Gaps = 15/131 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ LS   HPNI+ L++A+  EN +++++EFC GG L S +    R   E   R   +Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-----VC 127
           +   L  L+SH +IHRDLK  NILL+ LD DV  K+ADFG+S      N +         
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLT-LDGDV--KLADFGVSAK----NKSTLQKRDTFI 164

Query: 128 GSPLYMAPEVL 138
           G+P +MAPEV+
Sbjct: 165 GTPYWMAPEVV 175

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 89.1 bits (221), Expect = 5e-22
 Identities = 49/144 (34%), Positives = 77/144 (53%), Gaps = 9/144 (6%)

Query: 12  CLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           C   E   L+ +  HP +  L   FQ ++ +F V+E+  GG+L   I+   +  E  +R 
Sbjct: 41  CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100

Query: 71  FLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 126
           +  +  L L  L+ H +I+RDLK +NILL   D +   K+ADFG+ C   +  G      
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGM-CKEGILNGVTTTTF 156

Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
           CG+P Y+APE+LQ   Y   V+++
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 88.5 bits (219), Expect = 5e-22
 Identities = 51/127 (40%), Positives = 77/127 (60%), Gaps = 7/127 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + +    R   +   + + + 
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 76  GLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
            LE LN  H   IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P 
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTPY 168

Query: 132 YMAPEVL 138
           +MAPEV+
Sbjct: 169 WMAPEVV 175

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 87.9 bits (218), Expect = 6e-22
 Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 24/148 (16%)

Query: 14  DC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGR-VPEQT 67
           DC  E++ L  ++HPN+I+   +F   N + +V+E    G+LS  I   +   R +PE+T
Sbjct: 48  DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107

Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--- 122
             K+  QL   LE ++S  I+HRD+KP N+ ++      ++K+ D GL      G +   
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGL------GRFFSS 158

Query: 123 ----AEKVCGSPLYMAPEVLQFQRYDEK 146
               A  + G+P YM+PE +    Y+ K
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 88.3 bits (219), Expect = 9e-22
 Identities = 53/128 (41%), Positives = 74/128 (57%), Gaps = 8/128 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E N L +V HP I+ L  AFQ    ++L++E+ +GG L  ++   G   E TA  +L + 
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPL 131
            L LE L+   II+RDLKPENIL   LD    +K+ DFGL C  +++ G      CG+  
Sbjct: 110 SLALEHLHQQGIIYRDLKPENIL---LDAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIE 165

Query: 132 YMAPEVLQ 139
           YMAPE+L 
Sbjct: 166 YMAPEILM 173

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 87.4 bits (216), Expect = 3e-21
 Identities = 48/136 (35%), Positives = 82/136 (60%), Gaps = 8/136 (5%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 49  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 134
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+ C   L PG+     CG+P Y+A
Sbjct: 109 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIA 164

Query: 135 PEVLQFQRYDEKVNFF 150
           PE+L+ + Y   V+++
Sbjct: 165 PEILRGEDYGFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.0 bits (213), Expect = 3e-21
 Identities = 45/138 (32%), Positives = 73/138 (52%), Gaps = 12/138 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQ 73
           E+  LS + HPNII  ++ F  +N + + +E+  GG L   I  +      E+    +L 
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVCG 128
           Q+   +  ++   I+HRD+K  NI L+      ++K+ DFG+S  L   Y    AE V G
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSM--AETVVG 163

Query: 129 SPLYMAPEVLQFQRYDEK 146
           +P YM+PE+ Q  +Y+ K
Sbjct: 164 TPYYMSPELCQGVKYNFK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 86.0 bits (213), Expect = 5e-21
 Identities = 52/173 (30%), Positives = 99/173 (57%), Gaps = 27/173 (15%)

Query: 2   LKKLNKH---LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +KK+NK    L++ +     E + L+   +P ++ +F +F+ +  + +V+E+  GG+ ++
Sbjct: 31  MKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT 90

Query: 56  YIRLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            ++  G +P   AR +  +  L LE L+++ I+HRDLKP+N+L++ +     +K+ DFGL
Sbjct: 91  LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGL 147

Query: 114 S--------CTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           S          LY G+          ++VCG+P Y+APEV+  Q Y + V+++
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 6e-21
 Identities = 49/129 (37%), Positives = 73/129 (56%), Gaps = 15/129 (11%)

Query: 20  LSSVNHPNIIRLFDAF---QAENC--IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           L S  HPNI+RL D     + +    + LV E     +L++Y+    +  +P +T +  +
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           +QL  G++ L+SH I+HRDLKP+NIL++    D  +KIADFGL+  +Y    A       
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLA-RIYSFEMALTSVVVT 169

Query: 131 L-YMAPEVL 138
           L Y APEVL
Sbjct: 170 LWYRAPEVL 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 1e-20
 Identities = 48/143 (33%), Positives = 72/143 (50%), Gaps = 29/143 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E++ L  +NHPNI+RL D   +EN ++LV EF    +L  Y+             + +L 
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           QL  G+   +SH ++HRDLKP+N+L   +D +  LK+ADFGL+          +  G P+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLL---IDREGALKLADFGLA----------RAFGVPV 153

Query: 132 -----------YMAPEVLQFQRY 143
                      Y APE+L   R 
Sbjct: 154 RTYTHEVVTLWYRAPEILLGSRQ 176

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 1e-20
 Identities = 47/137 (34%), Positives = 78/137 (56%), Gaps = 11/137 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FLS    P I + + +F   + +++++E+C GG+    ++  G++ E      L+++
Sbjct: 49  EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREV 107

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 130
             GLE L+    IHRD+K  NILLS   ++  +K+ADFG+S  L   +   K     G+P
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQL--TSTMSKRNTFVGTP 162

Query: 131 LYMAPEVLQFQRYDEKV 147
            +MAPEV++   YDEK 
Sbjct: 163 FWMAPEVIKQSGYDEKA 179

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-20
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 7/102 (6%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQ--L 75
           L++++HP +  L+ +FQ E  + LV+++C GG L   ++      + E+ AR +  +  L
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
            LE L+   I++RDLKPENILL      +ML  +DF LS   
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHE-SGHIML--SDFDLSKQS 153

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 2e-20
 Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 18/139 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---K 70
           EL    S   P I++ + AF  ++ + I + +E+C GG+L S   ++ +V ++  R   K
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEK 105

Query: 71  FLQQL------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            L ++      GL  L+S  IIHRD+KP NIL   L     +K+ DFG+S  L   + A 
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL---LTRKGQVKLCDFGVSGELV-NSLAG 161

Query: 125 KVCGSPLYMAPEVLQFQRY 143
              G+  YMAPE +Q + Y
Sbjct: 162 TFTGTSFYMAPERIQGKPY 180

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 85.0 bits (210), Expect = 2e-20
 Identities = 47/125 (37%), Positives = 75/125 (60%), Gaps = 7/125 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L+ +NHP  + L+ +F+ E+ ++LV+EF  GG   +++R + R P      +  Q+
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 76  GL--EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L S +I++RDLKPEN+L   LD D  +K+ DFG +  +    Y   +CG+P Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLL---LDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYI 195

Query: 134 APEVL 138
           APE+L
Sbjct: 196 APEIL 200

Length = 340

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.5 bits (206), Expect = 2e-20
 Identities = 48/140 (34%), Positives = 81/140 (57%), Gaps = 7/140 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV--PEQTARKFL 72
           E+  L+ + HPNI+  F +FQ    +F+V+E+C GG+L   I R  G +   +Q    F+
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 73  Q-QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 130
           Q  LGL+ ++   I+HRD+K +NI LS   + ++ K+ DFG++  L         C G+P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166

Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y++PE+ Q + Y+ K + +
Sbjct: 167 YYLSPEICQNRPYNNKTDIW 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.7 bits (205), Expect = 5e-20
 Identities = 48/135 (35%), Positives = 70/135 (51%), Gaps = 8/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
           EL+ L   N P I+  + AF     I + +E+  GG+L   ++   GR+PE+   K    
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108

Query: 75  L--GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           +  GL  L   H IIHRD+KP NIL++       +K+ DFG+S  L   + A+   G+  
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV-NSLAKTFVGTSS 164

Query: 132 YMAPEVLQFQRYDEK 146
           YMAPE +Q   Y  K
Sbjct: 165 YMAPERIQGNDYSVK 179

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 83.9 bits (207), Expect = 5e-20
 Identities = 46/136 (33%), Positives = 82/136 (60%), Gaps = 8/136 (5%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + ++P ++ L   FQ  + +FLV+E+  GG+L  +++   ++PE+ AR +  +  + 
Sbjct: 49  FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA 108

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 134
           L  L+   II+RDLK +N+L   LD D  +K+ D+G+ C   L PG+     CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIA 164

Query: 135 PEVLQFQRYDEKVNFF 150
           PE+L+ + Y   V+++
Sbjct: 165 PEILRGEEYGFSVDWW 180

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 83.3 bits (206), Expect = 8e-20
 Identities = 54/153 (35%), Positives = 85/153 (55%), Gaps = 13/153 (8%)

Query: 3   KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           KK  KH+ +    E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  +++   
Sbjct: 36  KKEQKHIMA----ERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER 91

Query: 62  RVPEQTARKFLQQLGLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--L 117
             PE  AR +  ++   +  L+S +II+RDLKPENIL   LD    + + DFGL C   +
Sbjct: 92  SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL---LDSQGHVVLTDFGL-CKEGI 147

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                    CG+P Y+APEVL+ Q YD  V+++
Sbjct: 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 83.7 bits (207), Expect = 1e-19
 Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 13/144 (9%)

Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVP-E 65
           H ++    E    + + HPNI+ L D+ +A    +F V E+  G  L   +   G +P  
Sbjct: 20  HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79

Query: 66  QTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---- 120
           +T R  LQ L  L   ++  I+HRDLKP+NI++S        K+ DFG+  TL PG    
Sbjct: 80  ETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRDA 138

Query: 121 -----NYAEKVCGSPLYMAPEVLQ 139
                    +V G+P Y APE L+
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLR 162

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 82.3 bits (203), Expect = 2e-19
 Identities = 49/131 (37%), Positives = 78/131 (59%), Gaps = 8/131 (6%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
            +P +  L+  FQ +  +F V+EF  GG+L  +I+  GR     A  +  ++  GL+ L+
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQ 139
           S  II+RDLK +N++L   D D  +KIADFG+ C   ++  N A   CG+P Y+APE+LQ
Sbjct: 114 SKGIIYRDLKLDNVML---DRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 140 FQRYDEKVNFF 150
             +Y   V+++
Sbjct: 170 GLKYTFSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.4 bits (201), Expect = 2e-19
 Identities = 46/135 (34%), Positives = 76/135 (56%), Gaps = 9/135 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  ++ +NHP+IIR+  A   ++   L VE+ AGG++S  +  +G   E     + +QL
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-----GNYAEKVCG 128
             GL  L+ + IIHRD+K  N+L+        L+IADFG +  L       G +  ++ G
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLG 170

Query: 129 SPLYMAPEVLQFQRY 143
           +  +MAPEVL+ ++Y
Sbjct: 171 TIAFMAPEVLRGEQY 185

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 81.9 bits (203), Expect = 2e-19
 Identities = 47/129 (36%), Positives = 69/129 (53%), Gaps = 12/129 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQ 73
           E+  L  + HPNII L D F  ++ I LV EF    +L   I+    +    A  + ++ 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYML 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPG-NYAEKVCGS 129
               GLE L+S+ I+HRDLKP N+L   +  D +LK+ADFGL+ +   P      +V  +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLL---IASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165

Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 166 RWYRAPELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.1 bits (200), Expect = 3e-19
 Identities = 47/128 (36%), Positives = 75/128 (58%), Gaps = 9/128 (7%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFLQQLGLEILN 81
           HPNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ LQ   LE L+
Sbjct: 75  HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ--ALEFLH 132

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQF 140
           S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+P +MAPEV+  
Sbjct: 133 SNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 141 QRYDEKVN 148
           + Y  KV+
Sbjct: 190 KAYGPKVD 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 81.2 bits (200), Expect = 3e-19
 Identities = 46/127 (36%), Positives = 76/127 (59%), Gaps = 7/127 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
           E+  L++ NHP I++L  AF  +  +++++EFC GG + +  + L   + E   +   +Q
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
           +   L+ L+S  IIHRDLK  N+LL+ LD D+  K+ADFG+S   +      +   G+P 
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLT-LDGDI--KLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 132 YMAPEVL 138
           +MAPEV+
Sbjct: 176 WMAPEVV 182

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 81.5 bits (201), Expect = 4e-19
 Identities = 47/129 (36%), Positives = 76/129 (58%), Gaps = 7/129 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P I+ L  +FQ ++ ++LV ++ +GG L  +++  GR  E  A+ ++ +L   LE L+ +
Sbjct: 56  PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAPEVLQFQR 142
            I++RDLKPENIL   LD    + + DFGLS   L         CG+  Y+APEVL  ++
Sbjct: 116 DIVYRDLKPENIL---LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 143 -YDEKVNFF 150
            Y + V+F+
Sbjct: 173 GYTKHVDFW 181

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 80.7 bits (199), Expect = 5e-19
 Identities = 54/142 (38%), Positives = 79/142 (55%), Gaps = 10/142 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AFQ +  + LV+    GG+L  +I      +   PE  A  +
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+   II+RDLKPEN+L   LD+D  ++I+D GL+  L  G    K   G
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVL---LDNDGNVRISDLGLAVELKDGQSKTKGYAG 159

Query: 129 SPLYMAPEVLQFQRYDEKVNFF 150
           +P +MAPE+LQ + YD  V++F
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYF 181

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 80.8 bits (199), Expect = 5e-19
 Identities = 52/151 (34%), Positives = 83/151 (54%), Gaps = 9/151 (5%)

Query: 5   LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
           LN+  +  +  E N  L +V HP ++ L  +FQ    ++ V++F  GG L  +++     
Sbjct: 34  LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSF 93

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYP 119
           PE  AR +  ++   L  L+S +I++RDLKPENILL      V+    DFGL C   +  
Sbjct: 94  PEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL---TDFGL-CKEGIAQ 149

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            +     CG+P Y+APEV++ Q YD  V+++
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.6 bits (199), Expect = 6e-19
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 29/147 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H        +K LQ++
Sbjct: 65  EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVH--------KKPLQEV 115

Query: 76  -----------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      GL  L+SH  IHRD+K  NILL+   +   +K+ADFG +  + P N   
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPAN--- 169

Query: 125 KVCGSPLYMAPEVLQFQ---RYDEKVN 148
              G+P +MAPEV+      +YD KV+
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVD 196

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 80.2 bits (198), Expect = 6e-19
 Identities = 37/102 (36%), Positives = 62/102 (60%), Gaps = 7/102 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  L  + H NI+RL+D   ++  + LV E+C   +L  Y    +G +  +  + F+ Q
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ 107

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           L  GL   +SH+++HRDLKP+N+L++   +   LK+ADFGL+
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 80.8 bits (199), Expect = 7e-19
 Identities = 47/136 (34%), Positives = 76/136 (55%), Gaps = 8/136 (5%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLE 78
            L ++ HP ++ L  +FQ    ++ V+++  GG L  +++      E  AR +  ++   
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108

Query: 79  I--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 134
           I  L+S +II+RDLKPENILL   D    + + DFGL C   + P       CG+P Y+A
Sbjct: 109 IGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLA 164

Query: 135 PEVLQFQRYDEKVNFF 150
           PEVL+ + YD  V+++
Sbjct: 165 PEVLRKEPYDRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.8 bits (197), Expect = 1e-18
 Identities = 43/129 (33%), Positives = 67/129 (51%), Gaps = 10/129 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E++ +  + H NI+RL D    EN + LV E+    +L  Y+  HG    +   T + F 
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFT 106

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  G+   + + ++HRDLKP+N+L++       LK+ADFGL+     P N       +
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVT 163

Query: 130 PLYMAPEVL 138
             Y AP+VL
Sbjct: 164 LWYRAPDVL 172

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 79.3 bits (195), Expect = 1e-18
 Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 11/146 (7%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           S L+CE+  L ++ H  I++ +   +  AE  + + +E+  GG++   ++ +G + E   
Sbjct: 49  SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT 108

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 122
           RK+ +Q+  G+  L+S+ I+HRD+K  NIL    D    +K+ DFG S  L      G  
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTG 165

Query: 123 AEKVCGSPLYMAPEVLQFQRYDEKVN 148
              V G+P +M+PEV+  + Y  K +
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKAD 191

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 1e-18
 Identities = 48/136 (35%), Positives = 71/136 (52%), Gaps = 17/136 (12%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENC------IFLVVEFCAGG---NLSSYIRLHG-RVP 64
           E N L    NHPNI   + AF  +N       ++LV+E C GG   +L   +R  G R+ 
Sbjct: 52  EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111

Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           E+     L++   GL  L+ + +IHRD+K +NILL+    +  +K+ DFG+S  L     
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168

Query: 123 AEKVC-GSPLYMAPEV 137
                 G+P +MAPEV
Sbjct: 169 RRNTFIGTPYWMAPEV 184

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 79.9 bits (197), Expect = 1e-18
 Identities = 48/131 (36%), Positives = 75/131 (57%), Gaps = 8/131 (6%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           NHP + +L+  FQ  + +F V+EF  GG+L  +I+   R  E  AR +  ++   L  L+
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPEVLQ 139
              II+RDLK +N+L   LD +   K+ADFG+ C   ++ G      CG+P Y+APE+LQ
Sbjct: 114 DKGIIYRDLKLDNVL---LDHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 140 FQRYDEKVNFF 150
              Y   V+++
Sbjct: 170 EMLYGPSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.8 bits (197), Expect = 1e-18
 Identities = 44/129 (34%), Positives = 77/129 (59%), Gaps = 8/129 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A  +  ++  GL  L+S 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 141
            II+RDLK +N++L   D +  +KIADFG+ C   ++ G      CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DAEGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176

Query: 142 RYDEKVNFF 150
            Y + V+++
Sbjct: 177 PYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 80.7 bits (199), Expect = 1e-18
 Identities = 40/112 (35%), Positives = 72/112 (64%), Gaps = 5/112 (4%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           +NK++   +  E + L+    P I+ L+ + Q+ N ++LV+E+  GG++ S + ++G   
Sbjct: 43  INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD 102

Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           E+ A K++ +  L L+ L+ H IIHRDLKP+N+L+S   ++  +K+ DFGLS
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 78.5 bits (193), Expect = 2e-18
 Identities = 46/136 (33%), Positives = 82/136 (60%), Gaps = 8/136 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV-PEQTARKFLQ 73
           E   L+ + HPNI+   ++F+A+  +++V+E+C GG+L   I+L  G++ PE T  ++  
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
           Q  LG++ ++   ++HRD+K +NI L+    +  +K+ DFG +  L  PG YA    G+P
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTP 164

Query: 131 LYMAPEVLQFQRYDEK 146
            Y+ PE+ +   Y+ K
Sbjct: 165 YYVPPEIWENMPYNNK 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 2e-18
 Identities = 43/129 (33%), Positives = 68/129 (52%), Gaps = 11/129 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  L  + H NI+ L +AF+ +  ++LV E+     L   +    G +P    R ++ Q
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQ 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGS 129
           L   +   +SH+IIHRD+KPENIL+S   +  +LK+ DFG +  L         + V  +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYV-AT 164

Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 165 RWYRAPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 79.1 bits (196), Expect = 3e-18
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 29/166 (17%)

Query: 3   KKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGN 52
           KK++      +D      E+  L  + H NII L D  +       N +++V E     +
Sbjct: 31  KKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METD 89

Query: 53  LSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           L   I+    + +   + FL Q+  GL+ L+S ++IHRDLKP NIL   ++ +  LKI D
Sbjct: 90  LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL---VNSNCDLKICD 146

Query: 111 FGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 147
           FGL+  + P    ++     L        Y APE+ L   RY + +
Sbjct: 147 FGLARGVDP----DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAI 188

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 78.9 bits (194), Expect = 3e-18
 Identities = 54/153 (35%), Positives = 83/153 (54%), Gaps = 13/153 (8%)

Query: 3   KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           KK  KH+ S    E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  +++   
Sbjct: 36  KKEEKHIMS----ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 91

Query: 62  RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TL 117
              E  AR +  ++   L  L+S +I++RDLKPENILL   D    + + DFGL C   +
Sbjct: 92  CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGL-CKENI 147

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                    CG+P Y+APEVL  Q YD  V+++
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 79.8 bits (196), Expect = 3e-18
 Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 33/180 (18%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI--- 57
           + L +  KS L  E+N +  + H NI+R  D F  +A   +++++EFC  G+LS  I   
Sbjct: 49  RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108

Query: 58  -RLHGRVPEQTARKFLQQLGLEIL----------NSHHIIHRDLKPENILLS-------- 98
            ++ G++ E       +QL L  L          N   ++HRDLKP+NI LS        
Sbjct: 109 YKMFGKIEEHAIVDITRQL-LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167

Query: 99  ------GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL--QFQRYDEKVNFF 150
                  L+   + KI DFGLS  +   + A    G+P Y +PE+L  + + YD+K + +
Sbjct: 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227

Length = 1021

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.0 bits (192), Expect = 3e-18
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 12/155 (7%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K   + +   L  E+  L  + H NI++   +    + + + +E+  GG++++ +  +G 
Sbjct: 43  KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA 102

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 119
             E   R F++Q+  GL  L++  IIHRD+K  NIL   +D+   +KI+DFG+S  L   
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL---VDNKGGIKISDFGISKKLEAN 159

Query: 120 ------GNYAEKVCGSPLYMAPEVLQFQRYDEKVN 148
                       + GS  +MAPEV++   Y  K +
Sbjct: 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKAD 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (193), Expect = 4e-18
 Identities = 51/139 (36%), Positives = 77/139 (55%), Gaps = 8/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L+ VN P I+ L  +FQ+   ++LV+ F  GG L  +++  GR     AR +  +L
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 131
              LE L+  ++I+RDLKPENIL   LD    + + DFGL C L   +       CG+P 
Sbjct: 103 LCALENLHKFNVIYRDLKPENIL---LDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPE 158

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APE+L    Y + V+++
Sbjct: 159 YLAPELLLGHGYTKAVDWW 177

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.8 bits (191), Expect = 4e-18
 Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 12/146 (8%)

Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+  D+F  +N + +V+E    G+LS  I+   +    +
Sbjct: 44  KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE+T  K+  QL   +E ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160

Query: 122 Y-AEKVCGSPLYMAPEVLQFQRYDEK 146
             A  + G+P YM+PE +    Y+ K
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFK 186

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 77.7 bits (191), Expect = 5e-18
 Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 11/138 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E   LS ++HP I++   +F   +   ++ E+C G +L   +         + E    ++
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG 128
             Q  LG+  ++   I+HRDLK +NI L     + +LKI DFG+S  L    + A    G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTG 167

Query: 129 SPLYMAPEVLQFQRYDEK 146
           +P YM+PE L+ Q YD K
Sbjct: 168 TPYYMSPEALKHQGYDSK 185

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 78.2 bits (193), Expect = 5e-18
 Identities = 53/163 (32%), Positives = 75/163 (46%), Gaps = 30/163 (18%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           MLK  +   K   D   E+  +  +  H NII L      E  +++VVE+ A GNL  ++
Sbjct: 49  MLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL 107

Query: 58  RLHGRVPEQTARKFL-----QQL--------------GLEILNSHHIIHRDLKPENILLS 98
           R   R P + A         + L              G+E L S   IHRDL   N+L++
Sbjct: 108 RAR-RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166

Query: 99  GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVL 138
             +D VM KIADFGL+  ++  +Y  K     L   +MAPE L
Sbjct: 167 --EDHVM-KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.8 bits (191), Expect = 5e-18
 Identities = 46/150 (30%), Positives = 82/150 (54%), Gaps = 12/150 (8%)

Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +
Sbjct: 44  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE+T  K+  QL   LE ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160

Query: 122 Y-AEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             A  + G+P YM+PE +    Y+ K + +
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIW 190

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 78.3 bits (193), Expect = 5e-18
 Identities = 46/139 (33%), Positives = 73/139 (52%), Gaps = 8/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
              L  L+S  +++RDLK EN++L   D D  +KI DFGL C   +  G   +  CG+P 
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 161 YLAPEVLEDNDYGRAVDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.9 bits (189), Expect = 7e-18
 Identities = 49/159 (30%), Positives = 89/159 (55%), Gaps = 18/159 (11%)

Query: 1   MLKKLN-----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLS 54
           ++KKLN     +  +   + E   LS + HPNI+   ++++ E+  +++V+ FC GG+L 
Sbjct: 29  VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL- 87

Query: 55  SYIRLHGR----VPE-QTARKFLQ-QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            Y +L  +    +PE Q    F+Q  + L+ L+  HI+HRDLK +N+ L+  +   ++K+
Sbjct: 88  -YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKV 143

Query: 109 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEK 146
            D G++  L      A  + G+P YM+PE+   + Y+ K
Sbjct: 144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.2 bits (190), Expect = 8e-18
 Identities = 46/143 (32%), Positives = 74/143 (51%), Gaps = 29/143 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++       +P    + +L 
Sbjct: 49  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLF 107

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+          +  G P+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 154

Query: 132 -----------YMAPEVLQFQRY 143
                      Y APE+L   +Y
Sbjct: 155 RTYTHEVVTLWYRAPEILLGCKY 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.8 bits (189), Expect = 1e-17
 Identities = 45/134 (33%), Positives = 68/134 (50%), Gaps = 7/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +     P I+  + AF  EN I + +EF   G+L    +  G +P +   K    +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112

Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L N H I+HRD+KP NIL++       +K+ DFG+S  L   + A+   G+  Y
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELI-NSIADTFVGTSTY 168

Query: 133 MAPEVLQFQRYDEK 146
           M+PE +Q  +Y  K
Sbjct: 169 MSPERIQGGKYTVK 182

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 76.5 bits (189), Expect = 2e-17
 Identities = 53/150 (35%), Positives = 77/150 (51%), Gaps = 23/150 (15%)

Query: 3   KKLNKHLKSCLDCELNF-----LSSVN-HPNIIRL----FDAFQAENCIFLVVEFCAGGN 52
           K + KH KS L+   N      L  ++ HPNI+RL    FD  +    + LV E     N
Sbjct: 30  KCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFD--RKTGRLALVFEL-MDMN 85

Query: 53  LSSYIRLHGR-VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           L   I+   R +PE+  + ++ QL   L+ ++ + I HRD+KPENIL+     D +LK+A
Sbjct: 86  LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLA 141

Query: 110 DFGLSCTLYP-GNYAEKVCGSPLYMAPEVL 138
           DFG    +Y    Y E +  +  Y APE L
Sbjct: 142 DFGSCRGIYSKPPYTEYI-STRWYRAPECL 170

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (186), Expect = 2e-17
 Identities = 43/144 (29%), Positives = 79/144 (54%), Gaps = 11/144 (7%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           L+CE+  L ++ H  I++ +   +   E  + + VE+  GG++   ++ +G + E   R+
Sbjct: 51  LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLY-PGNYAE 124
           + +Q+  G+  L+S+ I+HRD+K  NIL    D    +K+ DFG S    T+   G   +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 125 KVCGSPLYMAPEVLQFQRYDEKVN 148
            V G+P +M+PEV+  + Y  K +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKAD 191

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 76.7 bits (189), Expect = 3e-17
 Identities = 48/138 (34%), Positives = 78/138 (56%), Gaps = 18/138 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARKF 71
           E + ++  N   I++L  AFQ +  +++V+E+  GG+L    S+Y      +PE+ AR +
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFY 147

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKV 126
             +  L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG +C     N     +  
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFG-TCMKMDANGMVRCDTA 203

Query: 127 CGSPLYMAPEVLQFQRYD 144
            G+P Y++PEVL+ Q  D
Sbjct: 204 VGTPDYISPEVLKSQGGD 221

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 76.2 bits (187), Expect = 3e-17
 Identities = 45/129 (34%), Positives = 77/129 (59%), Gaps = 8/129 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L   I+  GR  E  A  +  ++  GL  L+S 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 141
            II+RDLK +N++L   D +  +KIADFG+ C   ++ G   +  CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176

Query: 142 RYDEKVNFF 150
            Y + V+++
Sbjct: 177 PYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 75.6 bits (186), Expect = 5e-17
 Identities = 48/129 (37%), Positives = 75/129 (58%), Gaps = 8/129 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E + LS  N P I +L  AFQ ++ ++LV+E+  GG+L S + R   +  E  A+ +L +
Sbjct: 51  ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110

Query: 75  LGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 130
           L L I + H +  +HRD+KPEN+L   +D    +K+ADFG +  L       ++   G+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVL---IDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167

Query: 131 LYMAPEVLQ 139
            Y+APEVL 
Sbjct: 168 DYIAPEVLT 176

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.5 bits (183), Expect = 6e-17
 Identities = 42/136 (30%), Positives = 78/136 (57%), Gaps = 8/136 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---EQTARKFL 72
           E+  LS++ HPNI++  ++F+    +++V+++C GG+L   I     V    +Q    F+
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 73  QQ-LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 130
           Q  L L+ ++   I+HRD+K +NI L+    D  +K+ DFG++  L       + C G+P
Sbjct: 109 QICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIGTP 165

Query: 131 LYMAPEVLQFQRYDEK 146
            Y++PE+ + + Y+ K
Sbjct: 166 YYLSPEICENRPYNNK 181

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.4 bits (185), Expect = 6e-17
 Identities = 47/130 (36%), Positives = 74/130 (56%), Gaps = 6/130 (4%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGLEILN 81
            HP +  L+  FQ +  +F V+E+  GG+L  +I+   +  +P  T        GL+ L+
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF 140
           S  I++RDLK +NILL   D D  +KIADFG+      G+      CG+P Y+APE+L  
Sbjct: 114 SKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 141 QRYDEKVNFF 150
           Q+Y+  V+++
Sbjct: 171 QKYNTSVDWW 180

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.8 bits (183), Expect = 7e-17
 Identities = 47/139 (33%), Positives = 79/139 (56%), Gaps = 9/139 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +  + +PNI+   D+F   + +F+V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL 125

Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   LE L+++ +IHRD+K +N+LL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 126 Q--ALEFLHANQVIHRDIKSDNVLL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MAPEV+  + Y  KV+ +
Sbjct: 181 WMAPEVVTRKAYGPKVDIW 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 75.4 bits (185), Expect = 9e-17
 Identities = 47/146 (32%), Positives = 83/146 (56%), Gaps = 16/146 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVP--EQTARKF 71
           EL+ L++ +H  I++ FD F++++ + L++E+ +GG+L+  I  RL   +P  E      
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLYPG---NYAE 124
             Q  L L+ ++S  ++HRDLK  NI L  +G+     +K+ DFG S         + A 
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-----IKLGDFGFSKQYSDSVSLDVAS 229

Query: 125 KVCGSPLYMAPEVLQFQRYDEKVNFF 150
             CG+P Y+APE+ + +RY +K + +
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMW 255

Length = 478

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.1 bits (182), Expect = 1e-16
 Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 11/139 (7%)

Query: 16  ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARK 70
           E+  +   + HPNI+R +  F   + +++V++   G  L    +S      R  E+    
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 71  FLQQLGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
              Q+ L +   H    I+HRDL P NI+L G DD V   I DFGL+    P +    V 
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVT--ITDFGLAKQKQPESKLTSVV 174

Query: 128 GSPLYMAPEVLQFQRYDEK 146
           G+ LY  PE+++ + Y EK
Sbjct: 175 GTILYSCPEIVKNEPYGEK 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 74.5 bits (183), Expect = 1e-16
 Identities = 42/138 (30%), Positives = 72/138 (52%), Gaps = 19/138 (13%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR-----VP 64
           E++ L  ++    I+RL D    E       ++LV E+    +L  ++  +GR     +P
Sbjct: 50  EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108

Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPG 120
            +T + F+ QL  G+   + H ++HRDLKP+N+L+       +LKIAD GL    ++   
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVK 166

Query: 121 NYAEKVCGSPLYMAPEVL 138
           +Y  ++  +  Y APEVL
Sbjct: 167 SYTHEIV-TLWYRAPEVL 183

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.4 bits (182), Expect = 1e-16
 Identities = 47/139 (33%), Positives = 79/139 (56%), Gaps = 9/139 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126

Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +    + G+P 
Sbjct: 127 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MAPEV+  + Y  KV+ +
Sbjct: 182 WMAPEVVTRKAYGPKVDIW 200

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 1e-16
 Identities = 46/132 (34%), Positives = 71/132 (53%), Gaps = 7/132 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E+ A  +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           +   GLE L+   I++RDLKPENIL   LDD   ++I+D GL+  +  G       G+  
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENIL---LDDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166

Query: 132 YMAPEVLQFQRY 143
           YMAPEV++ +RY
Sbjct: 167 YMAPEVVKNERY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.5 bits (184), Expect = 1e-16
 Identities = 48/137 (35%), Positives = 75/137 (54%), Gaps = 22/137 (16%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E+ FL  + +HPNI++L +  +AEN   I+LV E+    +L + IR    + +   R  +
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-ANILEDVHKRYIM 113

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            QL   L+ ++S ++IHRDLKP NIL   L+ D  +K+ADFGL+ +L           +P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNIL---LNSDCRVKLADFGLARSLSELEENP---ENP 167

Query: 131 L---------YMAPEVL 138
           +         Y APE+L
Sbjct: 168 VLTDYVATRWYRAPEIL 184

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 74.7 bits (183), Expect = 2e-16
 Identities = 45/133 (33%), Positives = 79/133 (59%), Gaps = 8/133 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ A+ +  + 
Sbjct: 93  ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 151

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 131
            L L+ ++S  +IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208

Query: 132 YMAPEVLQFQRYD 144
           Y++PEVL+ Q  D
Sbjct: 209 YISPEVLKSQGGD 221

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.1 bits (182), Expect = 2e-16
 Identities = 39/118 (33%), Positives = 63/118 (53%), Gaps = 7/118 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P ++ L  AFQ +  + L++++  GG L +++       E   R ++ +  L L+ L+  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQ 139
            II+RD+K ENIL   LD +  + + DFGLS          A   CG+  YMAPEV++
Sbjct: 125 GIIYRDIKLENIL---LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 74.3 bits (182), Expect = 2e-16
 Identities = 52/145 (35%), Positives = 83/145 (57%), Gaps = 13/145 (8%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
           MLK+      +C   E N L + +   I  L  AFQ EN ++LV+++  GG+L + + + 
Sbjct: 39  MLKRAET---ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF 95

Query: 60  HGRVPEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSC-- 115
             R+PE  AR ++ ++ L I + H  H +HRD+KP+N+L   LD +  +++ADFG SC  
Sbjct: 96  EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL---LDMNGHIRLADFG-SCLK 151

Query: 116 TLYPGNYAEKVC-GSPLYMAPEVLQ 139
               G     V  G+P Y++PE+LQ
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQ 176

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.5 bits (180), Expect = 2e-16
 Identities = 42/148 (28%), Positives = 80/148 (54%), Gaps = 11/148 (7%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           + L+CE+  L ++ H  I++ +   +   E  + + +E   GG++   ++ +G + E   
Sbjct: 49  NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT 108

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 122
           RK+ +Q+  G+  L+S+ I+HRD+K  NIL   + +   +K+ DFG S  L      G  
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTG 165

Query: 123 AEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            + V G+P +M+PEV+  + Y  K + +
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIW 193

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 73.6 bits (181), Expect = 2e-16
 Identities = 45/141 (31%), Positives = 77/141 (54%), Gaps = 17/141 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E+  +    HPNI+ ++ ++   + +++V+EF  GG L+  I  H R+ E Q A   L  
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124

Query: 75  LG-LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------C 127
           L  L  L++  +IHRD+K ++ILL+    D  +K++DFG  C       +++V       
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGF-C----AQVSKEVPRRKSLV 176

Query: 128 GSPLYMAPEVLQFQRYDEKVN 148
           G+P +MAPEV+    Y  +V+
Sbjct: 177 GTPYWMAPEVISRLPYGTEVD 197

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 73.9 bits (181), Expect = 2e-16
 Identities = 49/141 (34%), Positives = 83/141 (58%), Gaps = 10/141 (7%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + ++  I  L  AFQ EN ++LV+++  GG+L + + +   R+
Sbjct: 40  LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99

Query: 64  PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYP 119
           PE  AR +L ++ + I + H  H +HRD+KP+NIL   +D +  +++ADFG SC   +  
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG-SCLKLMED 155

Query: 120 GNYAEKVC-GSPLYMAPEVLQ 139
           G     V  G+P Y++PE+LQ
Sbjct: 156 GTVQSSVAVGTPDYISPEILQ 176

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 2e-16
 Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 21/140 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTA 68
           E+  L  + H N++ L + F   A+  ++L+ ++ A  +L   I+ H +     +P    
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLS-------CTLY 118
           +  L Q+  G+  L+S+ ++HRDLKP NIL+ G   +  ++KI D GL+         L 
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 119 PGNYAEKVCGSPLYMAPEVL 138
             +    V  +  Y APE+L
Sbjct: 171 DLD---PVVVTIWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 73.9 bits (181), Expect = 2e-16
 Identities = 46/133 (34%), Positives = 78/133 (58%), Gaps = 8/133 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  + 
Sbjct: 93  ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 151

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 131
            L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 132 YMAPEVLQFQRYD 144
           Y++PEVL+ Q  D
Sbjct: 209 YISPEVLKSQGGD 221

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 73.5 bits (180), Expect = 3e-16
 Identities = 43/129 (33%), Positives = 75/129 (58%), Gaps = 8/129 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A  +  ++  GL  L+  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 141
            II+RDLK +N++L   D +  +KIADFG+ C   +  G      CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176

Query: 142 RYDEKVNFF 150
            Y + V+++
Sbjct: 177 PYGKSVDWW 185

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.2 bits (180), Expect = 3e-16
 Identities = 44/135 (32%), Positives = 69/135 (51%), Gaps = 15/135 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PE      L ++
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----NILGKI 104

Query: 76  GLEIL-------NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 128
            + +L         H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G
Sbjct: 105 SIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVG 160

Query: 129 SPLYMAPEVLQFQRY 143
           +  YM+PE LQ   Y
Sbjct: 161 TRSYMSPERLQGTHY 175

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 72.8 bits (179), Expect = 3e-16
 Identities = 42/137 (30%), Positives = 69/137 (50%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++ ++HP I+RL    + E  + LV+E    G L  Y++    +P    ++   Q 
Sbjct: 46  EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV 104

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS-P 130
            +G+  L S H +HRDL   N+LL    +    KI+DFG+S  L  G+  Y     G  P
Sbjct: 105 AMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161

Query: 131 L-YMAPEVLQFQRYDEK 146
           L + APE + + ++  K
Sbjct: 162 LKWYAPECINYGKFSSK 178

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.1 bits (179), Expect = 3e-16
 Identities = 49/146 (33%), Positives = 80/146 (54%), Gaps = 17/146 (11%)

Query: 13  LDCELNFLSSV-NHPNIIRLFDAF-QAENCI----FLVVEFCAGGNLSSYI----RLHGR 62
           ++ E N L S+ NHPN+++ +  F +A+  +    +LV+E C GG+++  +        R
Sbjct: 65  IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124

Query: 63  VPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E      L    LGL+ L+++ IIHRD+K  NILL+    +  +K+ DFG+S  L   
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 181

Query: 121 NYAEKV-CGSPLYMAPEVLQF-QRYD 144
                   G+P +MAPEV+   Q+YD
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYD 207

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 72.7 bits (178), Expect = 5e-16
 Identities = 47/132 (35%), Positives = 71/132 (53%), Gaps = 7/132 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E+ A  +  
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++  GLE L+  + ++RDLKPENILL   DD   ++I+D GL+  +  G       G+  
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166

Query: 132 YMAPEVLQFQRY 143
           YMAPEVL  QRY
Sbjct: 167 YMAPEVLNNQRY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.8 bits (178), Expect = 5e-16
 Identities = 47/139 (33%), Positives = 75/139 (53%), Gaps = 13/139 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H +  ++     +   
Sbjct: 75  EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHG 133

Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
              GL  L+SH++IHRD+K  NILL+   +   +K+ADFG +    P N      G+P +
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPAN---SFVGTPYW 187

Query: 133 MAPEVLQFQ---RYDEKVN 148
           MAPEV+      +YD KV+
Sbjct: 188 MAPEVILAMDEGQYDGKVD 206

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 5e-16
 Identities = 46/118 (38%), Positives = 72/118 (61%), Gaps = 10/118 (8%)

Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQLGLEILNSH--H 84
           I  L  AFQ EN ++LV+++  GG+L + + +   R+PE  AR +L ++ L I + H   
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 85  IIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVC-GSPLYMAPEVLQ 139
            +HRD+KP+N+L   LD +  +++ADFG SC   L  G     V  G+P Y++PE+LQ
Sbjct: 123 YVHRDIKPDNVL---LDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.4 bits (177), Expect = 5e-16
 Identities = 46/132 (34%), Positives = 72/132 (54%), Gaps = 7/132 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     E  A  +  
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++  GLE L+   I++RDLKPENILL   DD   ++I+D GL+  +  G   +   G+  
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166

Query: 132 YMAPEVLQFQRY 143
           YMAPEV++ +RY
Sbjct: 167 YMAPEVVKNERY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.4 bits (177), Expect = 5e-16
 Identities = 46/139 (33%), Positives = 78/139 (56%), Gaps = 9/139 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125

Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   L+ L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 126 Q--ALDFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MAPEV+  + Y  KV+ +
Sbjct: 181 WMAPEVVTRKAYGPKVDIW 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 72.7 bits (178), Expect = 6e-16
 Identities = 47/139 (33%), Positives = 75/139 (53%), Gaps = 8/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
              LE L+S  +++RD+K EN++L   D D  +KI DFGL C   +  G   +  CG+P 
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 161 YLAPEVLEDNDYGRAVDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 71.6 bits (175), Expect = 7e-16
 Identities = 48/143 (33%), Positives = 74/143 (51%), Gaps = 13/143 (9%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G  P    
Sbjct: 36  LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKV 93

Query: 69  RKFLQQL-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           ++ +Q +     G+E L S H IHRDL   N L++   +  +LKI+DFG+S     G YA
Sbjct: 94  KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYA 150

Query: 124 EK--VCGSPL-YMAPEVLQFQRY 143
               +   P+ + APE L + RY
Sbjct: 151 STGGMKQIPVKWTAPEALNYGRY 173

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.4 bits (177), Expect = 7e-16
 Identities = 50/149 (33%), Positives = 78/149 (52%), Gaps = 29/149 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I     +  E+  +LV+E+C G + S  + +H        +K LQ++
Sbjct: 71  EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVH--------KKPLQEV 121

Query: 76  -----------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      GL  L+SH++IHRD+K  NILL+   +   +K+ADFG +    P N   
Sbjct: 122 EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPAN--- 175

Query: 125 KVCGSPLYMAPEVLQFQ---RYDEKVNFF 150
              G+P +MAPEV+      +YD KV+ +
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVW 204

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 72.4 bits (178), Expect = 7e-16
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 34/154 (22%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           EL  L    H NII + D  +        +++V++     +L   I     + E+  R F
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
           L QL  GL+ ++S ++IHRDLKP N+L++    D  L+I DFG+         A  +  S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGM---------ARGLSSS 160

Query: 130 PL--------------YMAPEVL-QFQRYDEKVN 148
           P               Y APE+L     Y   ++
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAID 194

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.5 bits (178), Expect = 8e-16
 Identities = 44/125 (35%), Positives = 67/125 (53%), Gaps = 12/125 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  VNHPN+++  D F     I +++EF  GG+L        +     AR+ L   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-- 179

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCGSPL 131
           G+  L+  HI+HRD+KP N+L   ++    +KIADFG    L+ T+ P N +    G+  
Sbjct: 180 GIAYLHRRHIVHRDIKPSNLL---INSAKNVKIADFGVSRILAQTMDPCNSS---VGTIA 233

Query: 132 YMAPE 136
           YM+PE
Sbjct: 234 YMSPE 238

Length = 353

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.0 bits (176), Expect = 9e-16
 Identities = 50/147 (34%), Positives = 79/147 (53%), Gaps = 29/147 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H        +K LQ++
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVH--------KKPLQEV 115

Query: 76  -----------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                      GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N   
Sbjct: 116 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN--- 169

Query: 125 KVCGSPLYMAPEVLQFQ---RYDEKVN 148
              G+P +MAPEV+      +YD KV+
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVD 196

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 71.8 bits (177), Expect = 9e-16
 Identities = 42/132 (31%), Positives = 73/132 (55%), Gaps = 15/132 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
           E+  L  + HPNI+RL +    + +  I++V E+    +L+  +     +  E   + ++
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVC 127
           +QL  GL+ L+S+ I+HRD+K  NIL   +++D +LK+ADFGL+         +Y  +V 
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNIL---INNDGVLKLADFGLARPYTKRNSADYTNRVI 163

Query: 128 GSPL-YMAPEVL 138
              L Y  PE+L
Sbjct: 164 --TLWYRPPELL 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 72.5 bits (178), Expect = 9e-16
 Identities = 36/111 (32%), Positives = 67/111 (60%), Gaps = 10/111 (9%)

Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           H+K+    E + L+  ++  +++L+ +FQ ++ ++ V+++  GG++ S +   G   E  
Sbjct: 47  HVKA----ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL 102

Query: 68  ARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           AR ++ +L   I + H +  IHRD+KP+NIL   +D D  +K+ DFGL CT
Sbjct: 103 ARFYIAELTCAIESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CT 149

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 1e-15
 Identities = 35/118 (29%), Positives = 65/118 (55%), Gaps = 8/118 (6%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK  +   ++ L  E + ++++ HPN+++L       N +++V E+ A G+L  Y+R  
Sbjct: 36  CLKDDSTAAQAFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR 94

Query: 61  GR--VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           GR  +       F   +  G+E L   + +HRDL   N+L+S   +D++ K++DFGL+
Sbjct: 95  GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLA 149

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 71.2 bits (174), Expect = 1e-15
 Identities = 44/132 (33%), Positives = 71/132 (53%), Gaps = 10/132 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ----TARKF 71
           E+  +    H NI+  F ++   + +++ +EFC GG+L     + G + E      +R+ 
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSP 130
           LQ  GL  L+S   +HRD+K  NILL+   D+  +K+ADFG+S  +       K   G+P
Sbjct: 116 LQ--GLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTP 170

Query: 131 LYMAPEVLQFQR 142
            +MAPEV   +R
Sbjct: 171 YWMAPEVAAVER 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.4 bits (175), Expect = 1e-15
 Identities = 41/127 (32%), Positives = 65/127 (51%), Gaps = 10/127 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           EL+ L     P I+  + AF  E  +++ +E+   G+L            +PE   R+  
Sbjct: 49  ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108

Query: 73  QQL--GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
             +  GL+ L   H+IIHRD+KP N+L++G   +  +K+ DFG+S  L   + A+   G 
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV-ASLAKTNIGC 164

Query: 130 PLYMAPE 136
             YMAPE
Sbjct: 165 QSYMAPE 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.3 bits (175), Expect = 1e-15
 Identities = 47/136 (34%), Positives = 73/136 (53%), Gaps = 6/136 (4%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +K +K     E+  L  + H N++ L + F+ +  ++LV EF     L    +    + E
Sbjct: 40  DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDE 99

Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNY 122
              RK+L Q+  G+E  +SH+IIHRD+KPENIL+S      ++K+ DFG + TL  PG  
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 156

Query: 123 AEKVCGSPLYMAPEVL 138
                 +  Y APE+L
Sbjct: 157 YTDYVATRWYRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.4 bits (172), Expect = 3e-15
 Identities = 51/144 (35%), Positives = 75/144 (52%), Gaps = 15/144 (10%)

Query: 17  LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 55  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIK 113

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A    
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA-RIYSFQMALTSV 169

Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
              L Y APEVL    Y   V+ +
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLW 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.9 bits (171), Expect = 3e-15
 Identities = 41/140 (29%), Positives = 75/140 (53%), Gaps = 12/140 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S+ H NI++       +N I + +EF  GG++SS +   G +PE    K+ +Q+
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------LSCTLYPGNYAEKV 126
             G+  L+++ ++HRD+K  N++L     + ++K+ DFG       +       N  + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168

Query: 127 CGSPLYMAPEVLQFQRYDEK 146
            G+P +MAPEV+    Y  K
Sbjct: 169 HGTPYWMAPEVINESGYGRK 188

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.4 bits (172), Expect = 4e-15
 Identities = 47/131 (35%), Positives = 69/131 (52%), Gaps = 7/131 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112

Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168

Query: 133 MAPEVLQFQRY 143
           M+PE LQ   Y
Sbjct: 169 MSPERLQGTHY 179

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.5 bits (170), Expect = 4e-15
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 22/143 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  ++H  +++L+     +  I++V E+ + G L +Y+R HG+  +        QL
Sbjct: 49  EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQ------PSQL 102

Query: 76  ---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
                    G+  L S   IHRDL   N L   +DD   +K++DFGLS  +    Y   V
Sbjct: 103 LEMCKDVCEGMAYLESKQFIHRDLAARNCL---VDDQGCVKVSDFGLSRYVLDDEYTSSV 159

Query: 127 CGSPL---YMAPEVLQFQRYDEK 146
            GS     +  PEVL + ++  K
Sbjct: 160 -GSKFPVRWSPPEVLLYSKFSSK 181

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.3 bits (169), Expect = 7e-15
 Identities = 47/132 (35%), Positives = 70/132 (53%), Gaps = 7/132 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G     EQ A  +  
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           +L  GLE L    I++RDLKPENIL   LDD   ++I+D GL+  +  G       G+  
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENIL---LDDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166

Query: 132 YMAPEVLQFQRY 143
           YMAPEV+  ++Y
Sbjct: 167 YMAPEVINNEKY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 69.4 bits (170), Expect = 7e-15
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 30/139 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFL 72
           E++ L  + HPNI+ L D    E+ ++L+ EF +  +L  Y   +     +  +  + +L
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYL 107

Query: 73  QQLGLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q+   IL  +S  ++HRDLKP+N+L   +D+  ++K+ADFGL+          +  G P
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLL---IDNKGVIKLADFGLA----------RAFGIP 154

Query: 131 L-----------YMAPEVL 138
           +           Y APEVL
Sbjct: 155 VRVYTHEVVTLWYRAPEVL 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.9 bits (168), Expect = 8e-15
 Identities = 42/138 (30%), Positives = 74/138 (53%), Gaps = 7/138 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P I R + ++     +++++E+  GG+    ++  G + E      L+++
Sbjct: 52  EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 110

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV++   YD K + +
Sbjct: 168 MAPEVIKQSAYDFKADIW 185

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 69.4 bits (170), Expect = 9e-15
 Identities = 50/144 (34%), Positives = 69/144 (47%), Gaps = 20/144 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRL---HGRVPEQ 66
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   H R+   
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQMDLDHERM--- 120

Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
                L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T        
Sbjct: 121 --SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMT 175

Query: 125 KVCGSPLYMAPEVLQFQRYDEKVN 148
               +  Y APEV+    Y E V+
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVD 199

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.8 bits (168), Expect = 1e-14
 Identities = 44/137 (32%), Positives = 75/137 (54%), Gaps = 7/137 (5%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107

Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163

Query: 135 PEVLQFQ-RYDEKVNFF 150
           PEVLQ    YD   ++F
Sbjct: 164 PEVLQKGVAYDSSADWF 180

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 68.3 bits (167), Expect = 1e-14
 Identities = 45/136 (33%), Positives = 71/136 (52%), Gaps = 13/136 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L   +HPNI++L      +  I++V+E   GG+L +++R   +    T +K LQ  
Sbjct: 42  EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLR--KKKNRLTVKKLLQMS 99

Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCG 128
                G+E L S + IHRDL   N L   + ++ +LKI+DFG+S     G Y   + +  
Sbjct: 100 LDAAAGMEYLESKNCIHRDLAARNCL---VGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156

Query: 129 SPL-YMAPEVLQFQRY 143
            P+ + APE L + RY
Sbjct: 157 IPIKWTAPEALNYGRY 172

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.8 bits (168), Expect = 1e-14
 Identities = 47/139 (33%), Positives = 74/139 (53%), Gaps = 7/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   L  VN P I+ L  AF+++  + LV+    GG+L  +I   G    +  R   +  
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 74  QLGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q+   IL+ H   I++RD+KPEN+LL   DD    +++D GL+  L  G    +  G+  
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPE+L+ + Y   V++F
Sbjct: 160 YMAPEILKEEPYSYPVDWF 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.1 bits (169), Expect = 1e-14
 Identities = 48/137 (35%), Positives = 72/137 (52%), Gaps = 11/137 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           EL  L  + H NII L D F      I+ V E   G +L   +     + +Q  + FL Q
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTEL-LGTDLHRLLT-SRPLEKQFIQYFLYQ 116

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  GL+ ++S  ++HRDLKP NIL   ++++  LKI DFGL+    P         +  Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNIL---INENCDLKICDFGLARIQDP--QMTGYVSTRYY 171

Query: 133 MAPEV-LQFQRYDEKVN 148
            APE+ L +Q+YD +V+
Sbjct: 172 RAPEIMLTWQKYDVEVD 188

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 68.3 bits (168), Expect = 1e-14
 Identities = 35/131 (26%), Positives = 64/131 (48%), Gaps = 21/131 (16%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           ++PN I+L+ +        L++++   G+L   ++  G++ E   +K ++QL   L  L+
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-------YMA 134
            H+IIH D+K EN+L     D +   + D+GL           K+ G+P        Y +
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRI--YLCDYGLC----------KIIGTPSCYDGTLDYFS 174

Query: 135 PEVLQFQRYDE 145
           PE ++   YD 
Sbjct: 175 PEKIKGHNYDV 185

Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.5 bits (167), Expect = 1e-14
 Identities = 42/138 (30%), Positives = 73/138 (52%), Gaps = 7/138 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++     +++++E+  GG+    +R  G   E      L+++
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 110

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV+Q   YD K + +
Sbjct: 168 MAPEVIQQSAYDSKADIW 185

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.2 bits (167), Expect = 2e-14
 Identities = 40/127 (31%), Positives = 66/127 (51%), Gaps = 8/127 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + HPN++ L + F+ +  + LV E+C    L+   +    VPE   +K + Q 
Sbjct: 50  EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPL 131
              +   + H+ IHRD+KPENIL++       +K+ DFG +  L     +Y + V  +  
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165

Query: 132 YMAPEVL 138
           Y APE+L
Sbjct: 166 YRAPELL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 67.8 bits (166), Expect = 2e-14
 Identities = 47/149 (31%), Positives = 65/149 (43%), Gaps = 21/149 (14%)

Query: 9   LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRV 63
           L   +D    E   + S++H N+IRL+        + +V E    G+L   +R    G  
Sbjct: 36  LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHF 94

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---- 117
              T   +  Q+  G+  L S   IHRDL   NILL+  DD V  KI DFGL   L    
Sbjct: 95  LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKV--KIGDFGLMRALPQNE 151

Query: 118 --YPGNYAEKVCGSPL-YMAPEVLQFQRY 143
             Y      KV   P  + APE L+ + +
Sbjct: 152 DHYVMEEHLKV---PFAWCAPESLRTRTF 177

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.5 bits (167), Expect = 2e-14
 Identities = 45/131 (34%), Positives = 68/131 (51%), Gaps = 7/131 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++   R+PE+   K    +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168

Query: 133 MAPEVLQFQRY 143
           M+PE LQ   Y
Sbjct: 169 MSPERLQGTHY 179

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 68.5 bits (167), Expect = 2e-14
 Identities = 37/114 (32%), Positives = 70/114 (61%), Gaps = 6/114 (5%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           LN++  + +  E + L+  ++  +++L+ +FQ ++ ++ V+++  GG++ S +      P
Sbjct: 40  LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP 99

Query: 65  EQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           E  AR ++ +L L I + H +  IHRD+KP+NIL   +D D  +K+ DFGL CT
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL---IDLDGHIKLTDFGL-CT 149

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.7 bits (165), Expect = 2e-14
 Identities = 44/137 (32%), Positives = 76/137 (55%), Gaps = 7/137 (5%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E+  R +  +  
Sbjct: 48  LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107

Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163

Query: 135 PEVLQF-QRYDEKVNFF 150
           PEVLQ    YD   ++F
Sbjct: 164 PEVLQKGTAYDSSADWF 180

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 4e-14
 Identities = 45/130 (34%), Positives = 67/130 (51%), Gaps = 10/130 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   + P II  + AF  EN I +  EF  GG+L  Y     ++PE    +    +
Sbjct: 49  ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAV 104

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             GL  L S  I+HRD+KP N+L++       +K+ DFG+S  L   + A+   G+  YM
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYM 160

Query: 134 APEVLQFQRY 143
           APE +  ++Y
Sbjct: 161 APERISGEQY 170

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.4 bits (164), Expect = 4e-14
 Identities = 45/139 (32%), Positives = 73/139 (52%), Gaps = 8/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ ++ +  V+E+  GG L  ++       E   R +  ++
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
              L+ L+S  I++RDLK EN++L   D D  +KI DFGL C   +      +  CG+P 
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGL-CKEGITDAATMKTFCGTPE 160

Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 161 YLAPEVLEDNDYGRAVDWW 179

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.1 bits (164), Expect = 4e-14
 Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 24/149 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK----- 70
           E   +S + HPNI+ L      E    ++ E+ A G+L  ++  +    +  A       
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 71  --------FLQ---QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
                   FL    Q+  G+E L+SHH +HRDL   N L+    + + +KI+DFGLS  +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLSRDI 174

Query: 118 YPGNYAEKVCGSPL---YMAPEVLQFQRY 143
           Y  +Y      S L   +M PE + + ++
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKF 203

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 67.4 bits (165), Expect = 5e-14
 Identities = 49/130 (37%), Positives = 72/130 (55%), Gaps = 12/130 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E+  L ++ HPNI+ L +    +  + IFLV+E+C   +L+S +  +     E   +  +
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCG 128
            QL  GL+ L+ + IIHRDLK  N+LL+   D   LKIADFGL+ T  L       KV  
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVV- 170

Query: 129 SPLYMAPEVL 138
           +  Y APE+L
Sbjct: 171 TLWYRAPELL 180

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.3 bits (165), Expect = 5e-14
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 13/107 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAF----QAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  ++H N+I L D F      E+   ++LV     G +L++ ++   ++ +   +
Sbjct: 64  ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVK-CQKLSDDHIQ 121

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
             + Q+  GL+ ++S  IIHRDLKP NI    +++D  LKI DFGL+
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLA 165

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.3 bits (164), Expect = 5e-14
 Identities = 50/145 (34%), Positives = 70/145 (48%), Gaps = 37/145 (25%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPE-------- 65
           H NII L      E  ++++VE+ A GNL  ++R              +VPE        
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 66  -----QTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
                Q AR      G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  
Sbjct: 137 VSCAYQVAR------GMEYLESRRCIHRDLAARNVLVT--EDNVM-KIADFGLARGVHDI 187

Query: 121 NYAEKVCGSPL---YMAPEVLQFQR 142
           +Y +K     L   +MAPE L F R
Sbjct: 188 DYYKKTSNGRLPVKWMAPEAL-FDR 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 7e-14
 Identities = 41/140 (29%), Positives = 68/140 (48%), Gaps = 22/140 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +V+E  A G+L SY+R   R PE          
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR--SRRPEAENNPGLGPP 116

Query: 67  TARKFLQ---QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           T +KF+Q   ++  G+  L +   +HRDL   N +++   +D+ +KI DFG++  +Y  +
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETD 173

Query: 122 YAEKVCGSPL---YMAPEVL 138
           Y  K     L   +MAPE L
Sbjct: 174 YYRKGGKGLLPVRWMAPESL 193

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 66.3 bits (162), Expect = 9e-14
 Identities = 40/126 (31%), Positives = 58/126 (46%), Gaps = 17/126 (13%)

Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PE 65
           E +FL      S  NH NI+RL          F+++E  AGG+L S++R   R     P 
Sbjct: 53  ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPS 111

Query: 66  QTARKFLQQLGLEI------LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
               K L     ++      L  +H IHRD+   N LL+      + KIADFG++  +Y 
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171

Query: 120 GNYAEK 125
            +Y  K
Sbjct: 172 ASYYRK 177

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 66.2 bits (162), Expect = 1e-13
 Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 28/143 (19%)

Query: 16  ELNFLSSVNHPNIIRLFD-----AFQAENC---IFLVVEFC----AGGNLSSYIRLHGRV 63
           E+  L  + H N++ L +     A          +LV EFC    AG  L S   +   +
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTL 118

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--- 118
            E   +K ++ L  GL  ++ + I+HRD+K  NIL++    D +LK+ADFGL+       
Sbjct: 119 SE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSK 173

Query: 119 ---PGNYAEKVCGSPLYMAPEVL 138
              P  Y  +V  +  Y  PE+L
Sbjct: 174 NSKPNRYTNRVV-TLWYRPPELL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 1e-13
 Identities = 38/142 (26%), Positives = 74/142 (52%), Gaps = 15/142 (10%)

Query: 16  ELNFLSSVNH---PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---- 68
           E+  LS +     PNI + + ++     +++++E+  GG++ + ++  G + E+      
Sbjct: 49  EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVII 107

Query: 69  RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-C 127
           R+ L    L+ ++   +IHRD+K  NIL++    +V L   DFG++  L   +       
Sbjct: 108 REVLV--ALKYIHKVGVIHRDIKAANILVT-NTGNVKL--CDFGVAALLNQNSSKRSTFV 162

Query: 128 GSPLYMAPEVLQ-FQRYDEKVN 148
           G+P +MAPEV+   + YD K +
Sbjct: 163 GTPYWMAPEVITEGKYYDTKAD 184

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 66.6 bits (162), Expect = 1e-13
 Identities = 50/143 (34%), Positives = 68/143 (47%), Gaps = 14/143 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVI--HMELDHERMS 126

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTACTNFMMTPYV 183

Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIW 206

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 1e-13
 Identities = 36/119 (30%), Positives = 72/119 (60%), Gaps = 11/119 (9%)

Query: 1   MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           ML+K    H+++    E + L+  ++P +++L+ +FQ EN ++L++E+  GG++ + +  
Sbjct: 39  MLEKEQVAHVRA----ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK 94

Query: 60  HGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                E+  R ++ +  L ++ ++    IHRD+KP+N+L   LD    +K++DFGL CT
Sbjct: 95  KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLL---LDAKGHIKLSDFGL-CT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 2e-13
 Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 7/102 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  + LV E+    +L  Y+   G  +     R FL Q
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           L  GL   +   ++HRDLKP+N+L+S   +   LK+ADFGL+
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.8 bits (160), Expect = 2e-13
 Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 25/139 (17%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQT------ 67
           H NII L  A   +  ++++VE+ + GNL  Y+R              ++PE+       
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136

Query: 68  -ARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
            +  +    G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVM-KIADFGLARDVHNIDYYKKT 193

Query: 127 CGSPL---YMAPEVLQFQR 142
               L   +MAPE L F R
Sbjct: 194 TNGRLPVKWMAPEAL-FDR 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.4 bits (159), Expect = 2e-13
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 9/150 (6%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           N+ +K     EL  L ++   NI+ L +AF+    ++LV E+     L     +   VP 
Sbjct: 40  NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP 99

Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 120
           +  R ++ QL   +   + + I+HRD+KPEN+L+S  D   +LK+ DFG +  L  G   
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNA 156

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           NY E V  +  Y +PE+L    Y + V+ +
Sbjct: 157 NYTEYV-ATRWYRSPELLLGAPYGKAVDMW 185

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 2e-13
 Identities = 42/154 (27%), Positives = 82/154 (53%), Gaps = 21/154 (13%)

Query: 13  LDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSS----YIRLHGR 62
           ++ E N L ++ +HPN+++ +  +  ++      ++LV+E C GG+++     +++   R
Sbjct: 61  IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120

Query: 63  VPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E      L +  +GL+ L+ +  IHRD+K  NILL+    +  +K+ DFG+S  L   
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSAQLTST 177

Query: 121 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVN 148
                   G+P +MAPEV+  ++     YD + +
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 65.2 bits (159), Expect = 2e-13
 Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 24/148 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-------VPEQTA 68
           E   L++  H NI++ +      +   +V E+   G+L+ ++R HG              
Sbjct: 58  EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 69  RKFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              L QL         G+  L S H +HRDL   N L+     D+++KI DFG+S  +Y 
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMSRDVYT 174

Query: 120 GNYAEKVCGSPL----YMAPEVLQFQRY 143
            +Y  +V G  +    +M PE + ++++
Sbjct: 175 TDYY-RVGGHTMLPIRWMPPESIMYRKF 201

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.4 bits (159), Expect = 2e-13
 Identities = 46/140 (32%), Positives = 75/140 (53%), Gaps = 9/140 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  ++
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 76  --GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSP 130
              L+ L+S  ++++RDLK EN++L   D D  +KI DFGL C   +  G   +  CG+P
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 160

Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+APEVL+   Y   V+++
Sbjct: 161 EYLAPEVLEDNDYGRAVDWW 180

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.1 bits (158), Expect = 2e-13
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 7/138 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 52  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 110

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167

Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV++   YD K + +
Sbjct: 168 MAPEVIKQSAYDSKADIW 185

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 64.5 bits (157), Expect = 3e-13
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 9/137 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  V          
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+   +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y A      P
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE L + ++  K
Sbjct: 169 IKWTAPESLAYNKFSIK 185

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 65.0 bits (158), Expect = 3e-13
 Identities = 38/118 (32%), Positives = 71/118 (60%), Gaps = 10/118 (8%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+    H+K+    E + L+  ++  ++RL+ +FQ ++ ++ V+++  GG++ S +   
Sbjct: 40  LLRNQVAHVKA----ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM 95

Query: 61  GRVPEQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           G  PE  AR ++ +L   + + H +  IHRD+KP+NIL   +D D  +K+ DFGL CT
Sbjct: 96  GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CT 149

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 65.2 bits (159), Expect = 3e-13
 Identities = 33/115 (28%), Positives = 65/115 (56%), Gaps = 20/115 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++++                   N +++V E     +L++ +   G
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLE-QG 109

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLA 162

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.6 bits (157), Expect = 4e-13
 Identities = 47/139 (33%), Positives = 71/139 (51%), Gaps = 25/139 (17%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ------- 66
           H NII L  A   +  ++++VE+ + GNL  Y+R              +VPE+       
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 67  TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
            +  +    G+E L S   IHRDL   N+L++  +D+VM KIADFGL+  ++  +Y +K 
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNVM-KIADFGLARDIHHIDYYKKT 199

Query: 127 CGSPL---YMAPEVLQFQR 142
               L   +MAPE L F R
Sbjct: 200 TNGRLPVKWMAPEAL-FDR 217

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 5e-13
 Identities = 48/139 (34%), Positives = 73/139 (52%), Gaps = 25/139 (17%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
           H NII L  A   +  ++++VE+ + GNL  Y+R              RVP++  T +  
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 72  LQ---QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           +    Q+  G+E L S   IHRDL   N+L++  +++VM KIADFGL+  +   +Y +K 
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARDVNNIDYYKKT 196

Query: 127 CGSPL---YMAPEVLQFQR 142
               L   +MAPE L F R
Sbjct: 197 TNGRLPVKWMAPEAL-FDR 214

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 64.2 bits (156), Expect = 5e-13
 Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 32/152 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------------ 63
           E N L  VNHP++I+L+ A   +  + L+VE+   G+L S++R   +V            
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 64  ------PEQTAR------KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                 P++ A        F  Q+  G++ L    ++HRDL   N+L++   +   +KI+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKIS 169

Query: 110 DFGLSCTLYPGN-YAEKVCGS-PL-YMAPEVL 138
           DFGLS  +Y  + Y ++  G  P+ +MA E L
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.9 bits (155), Expect = 6e-13
 Identities = 44/137 (32%), Positives = 74/137 (54%), Gaps = 10/137 (7%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTA- 68
           S +  E+  +    H NI+  F ++ +   +++ +E+C GG+L     + G + E Q A 
Sbjct: 51  SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110

Query: 69  --RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 125
             R+ LQ  GL  L+S   +HRD+K  NILL+   D+  +K+ADFG++  +       K 
Sbjct: 111 VCRETLQ--GLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKS 165

Query: 126 VCGSPLYMAPEVLQFQR 142
             G+P +MAPEV   ++
Sbjct: 166 FIGTPYWMAPEVAAVEK 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.1 bits (156), Expect = 6e-13
 Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 21/110 (19%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFC---------AGGNLSSYIRLHGRVPEQ 66
           E++ L  + H NI+RL D   +E  ++LV E+          +  + +   RL       
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL------- 103

Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
             + +L Q+  G+   +SH ++HRDLKP+N+L+    +   LK+ADFGL+
Sbjct: 104 -IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA 150

Length = 294

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.3 bits (154), Expect = 1e-12
 Identities = 46/137 (33%), Positives = 66/137 (48%), Gaps = 14/137 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S+ NHPNI++L          ++++E   GG+L SY+R             L++L
Sbjct: 49  EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108

Query: 76  ---------GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAE 124
                    G   L   H IHRDL   N L+S  G D D ++KI DFGL+  +Y  +Y  
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 125 KVCGSPL---YMAPEVL 138
           K     L   +MAPE L
Sbjct: 169 KEGEGLLPVRWMAPESL 185

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.4 bits (154), Expect = 1e-12
 Identities = 38/102 (37%), Positives = 58/102 (56%), Gaps = 7/102 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  +  V E+    +L+ Y+  H G +     R F+ Q
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           L  GL  ++  HI+HRDLKP+N+L+S L +   LK+ADFGL+
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 1e-12
 Identities = 38/121 (31%), Positives = 66/121 (54%), Gaps = 10/121 (8%)

Query: 1   MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           M KK    H+K+    E + L+  + P ++ L+ +FQ    ++L++EF  GG+L + +  
Sbjct: 39  MFKKDQLAHVKA----ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK 94

Query: 60  HGRVPEQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           +    E   R ++ +  L I   H +  IHRD+KP+NIL   +D    +K++DFGLS   
Sbjct: 95  YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL---IDRGGHIKLSDFGLSTGF 151

Query: 118 Y 118
           +
Sbjct: 152 H 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 62.5 bits (152), Expect = 2e-12
 Identities = 42/132 (31%), Positives = 73/132 (55%), Gaps = 20/132 (15%)

Query: 24  NHPNIIRLFD-AFQAENC-----IFLVVEFCAGGNLSSYI---RLHG---RVPEQTARKF 71
           +HPN+++L    F+A +        +++ F   G+L S++   RL G   ++P QT  KF
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
           +    LG+E L++ + IHRDL   N +L    +D+ + +ADFGLS  +Y G+Y  +   +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 130 PL---YMAPEVL 138
            +   ++A E L
Sbjct: 176 KMPVKWIAIESL 187

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.7 bits (152), Expect = 2e-12
 Identities = 39/118 (33%), Positives = 65/118 (55%), Gaps = 7/118 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P ++ L  AFQ +  + L++++  GG L +++    R  EQ  + +  +  L LE L+  
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ 139
            II+RD+K ENIL   LD +  + + DFGLS   +      A   CG+  YMAP++++
Sbjct: 125 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.9 bits (150), Expect = 2e-12
 Identities = 41/136 (30%), Positives = 72/136 (52%), Gaps = 12/136 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   ++ ++H N++RL       N +++V+E  + GNL +++R  GR      +     L
Sbjct: 49  ETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107

Query: 76  ----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
               G+E L S  ++HRDL   NIL+S   +D + K++DFGL+     G    K+   P+
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL---PV 161

Query: 132 -YMAPEVLQFQRYDEK 146
            + APE L+ +++  K
Sbjct: 162 KWTAPEALKHKKFSSK 177

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 4e-12
 Identities = 38/139 (27%), Positives = 71/139 (51%), Gaps = 15/139 (10%)

Query: 17  LNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTAR 69
           L+FL+        +HPNIIRL         + ++ E+   G+L  ++R + G+       
Sbjct: 50  LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP--GNYAEK 125
             L+ +  G++ L+  + +HRDL   NIL++    +++ K++DFGLS  L      Y  K
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTK 166

Query: 126 VCGSPL-YMAPEVLQFQRY 143
               P+ + APE + ++++
Sbjct: 167 GGKIPIRWTAPEAIAYRKF 185

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.9 bits (150), Expect = 4e-12
 Identities = 49/144 (34%), Positives = 75/144 (52%), Gaps = 15/144 (10%)

Query: 17  LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L + +HPNI+RL D         E  + LV E     +L +Y+       +P +T +
Sbjct: 53  LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK 111

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 126
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+  +Y    A   V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLA-RIYSCQMALTPV 167

Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
             +  Y APEVL    Y   V+ +
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMW 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 61.6 bits (149), Expect = 4e-12
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 9/131 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ E+ A G+L  +++    G+V       F  
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 131 L-YMAPEVLQF 140
           + + APE + F
Sbjct: 168 IKWTAPEAINF 178

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 61.6 bits (149), Expect = 4e-12
 Identities = 42/138 (30%), Positives = 77/138 (55%), Gaps = 7/138 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +   +H N++ +++++   + +++V+EF  GG L+  I  H R+  EQ A   L  
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127

Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L  L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184

Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV+    Y  +V+ +
Sbjct: 185 MAPEVISRLPYGTEVDIW 202

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.6 bits (149), Expect = 5e-12
 Identities = 42/137 (30%), Positives = 74/137 (54%), Gaps = 19/137 (13%)

Query: 16  ELNFLSSVNH-PNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQ- 66
           E+N L   +H  NI   + AF        ++ ++LV+EFC  G+++  ++   G   ++ 
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121

Query: 67  ----TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
                 R+ L+  GL  L++H +IHRD+K +N+LL+   ++  +K+ DFG+S  L     
Sbjct: 122 WIAYICREILR--GLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVG 176

Query: 122 YAEKVCGSPLYMAPEVL 138
                 G+P +MAPEV+
Sbjct: 177 RRNTFIGTPYWMAPEVI 193

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.6 bits (149), Expect = 5e-12
 Identities = 41/138 (29%), Positives = 77/138 (55%), Gaps = 7/138 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  I  H R+  EQ A   L  
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125

Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182

Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE++    Y  +V+ +
Sbjct: 183 MAPELISRLPYGPEVDIW 200

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 60.6 bits (147), Expect = 6e-12
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 9/135 (6%)

Query: 7   KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           K L+   +     L+ + H  PN++ L     +E+ +FLV++   GG L S+I     +P
Sbjct: 24  KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83

Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           E+  +++  ++   L+ L+   I+ RDL P NIL   LDD   +++  F     +     
Sbjct: 84  EECVKRWAAEMVVALDALHREGIVCRDLNPNNIL---LDDRGHIQLTYFSRWSEVEDSCD 140

Query: 123 AEKVCGSPLYMAPEV 137
            E V    +Y APEV
Sbjct: 141 GEAV--ENMYCAPEV 153

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 61.3 bits (148), Expect = 6e-12
 Identities = 44/137 (32%), Positives = 71/137 (51%), Gaps = 19/137 (13%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR------LHGR 62
           E+N L   +H  NI   + AF  +N       ++LV+EFC  G+++  I+      L   
Sbjct: 52  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111

Query: 63  VPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
                 R+ L+  GL  L+ H +IHRD+K +N+LL+   ++  +K+ DFG+S  L     
Sbjct: 112 WIAYICREILR--GLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVG 166

Query: 122 YAEKVCGSPLYMAPEVL 138
                 G+P +MAPEV+
Sbjct: 167 RRNTFIGTPYWMAPEVI 183

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 61.2 bits (149), Expect = 6e-12
 Identities = 35/118 (29%), Positives = 56/118 (47%), Gaps = 14/118 (11%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNS--- 82
           P I++ +  F  ++ +F+ +E  +        R+ G +PE    K    + + I+ +   
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK----MTVAIVKALHY 129

Query: 83  ----HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 136
               H +IHRD+KP NIL   LD    +K+ DFG+S  L       +  G   YMAPE
Sbjct: 130 LKEKHGVIHRDVKPSNIL---LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.3 bits (149), Expect = 6e-12
 Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 17/146 (11%)

Query: 16  ELNFLSSV-NHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           EL  L     H NI  L+D         N ++L  E     +L   IR    + +   + 
Sbjct: 51  ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYA 123
           F+ Q+  GL+ ++S +++HRDLKP N+L++    D  LKI DFGL+            + 
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFM 166

Query: 124 EKVCGSPLYMAPEV-LQFQRYDEKVN 148
            +   +  Y APE+ L FQ Y + ++
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAID 192

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 61.3 bits (149), Expect = 7e-12
 Identities = 36/129 (27%), Positives = 60/129 (46%), Gaps = 11/129 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  ++ + H NI+ L D +   + I LV++  A  +L   +    R+ E   +  L Q+
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS----CTLYPGNYAEKVCGS 129
             GL +L+  + +HRDL P NI    ++   + KIADFGL+       Y    ++     
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIF---INSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 130 P-LYMAPEV 137
               M  +V
Sbjct: 186 RREEMTSKV 194

Length = 335

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 7e-12
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 15/140 (10%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E   L +VNHP++IR+ D     A  C+ L        +L +Y+ +    +P   A    
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS---DLYTYLTKRSRPLPIDQALIIE 163

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLY-PGNYAEKVCG 128
           +Q+  GL  L++  IIHRD+K ENI    ++D   + I D G +   +  P      + G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIF---INDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218

Query: 129 SPLYMAPEVLQFQRYDEKVN 148
           +    APEVL   +Y+ K +
Sbjct: 219 TVETNAPEVLARDKYNSKAD 238

Length = 357

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.5 bits (147), Expect = 9e-12
 Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HPN+++L+     +  IF+V E+ A G L +Y+R   G++  +        
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 130
           +   +E L S+  IHRDL   N L+    +D ++K++DFGL+  +    Y     G+  P
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSSQ-GTKFP 164

Query: 131 L-YMAPEVLQFQRYDEK 146
           + +  PEV  + R+  K
Sbjct: 165 VKWAPPEVFDYSRFSSK 181

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 61.2 bits (148), Expect = 9e-12
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 186

Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 60.5 bits (147), Expect = 9e-12
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 10/133 (7%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           ++SV+HP+++RL     +   + L+ +    G L  Y+R H   +  Q    +  Q+  G
Sbjct: 63  MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--PL-YM 133
           +  L    ++HRDL   N+L+        +KI DFGL+  L          G   P+ +M
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 134 APEVLQFQRYDEK 146
           A E +  + Y  K
Sbjct: 179 ALESILHRIYTHK 191

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.4 bits (146), Expect = 9e-12
 Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 14/147 (9%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L + LK     E   L   +HPNI++L         I++V+E   GG+  S++R   +  
Sbjct: 31  LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLR---KKK 87

Query: 65  EQTARKFLQQL------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           ++   K L +       G+  L S + IHRDL   N L+    ++ +LKI+DFG+S    
Sbjct: 88  DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQED 144

Query: 119 PGNYAEKVCGS-PL-YMAPEVLQFQRY 143
            G Y+       P+ + APE L + RY
Sbjct: 145 DGIYSSSGLKQIPIKWTAPEALNYGRY 171

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 60.6 bits (147), Expect = 9e-12
 Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 14/132 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+   S + H NI++   +        + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114

Query: 73  QQL--GLEILNSHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKV 126
           +Q+  GL+ L+ + I+HRD+K +N+L+   SG+     +KI+DFG S  L   N   E  
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAGINPCTETF 169

Query: 127 CGSPLYMAPEVL 138
            G+  YMAPEV+
Sbjct: 170 TGTLQYMAPEVI 181

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.9 bits (147), Expect = 1e-11
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMS 122

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 179

Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIW 202

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.9 bits (145), Expect = 2e-11
 Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 26/126 (20%)

Query: 41  IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ----------LGLEILNSHHIIHRDL 90
           I LV+++   G+L   I+   +    T R F +           L +  ++S H+IHRD+
Sbjct: 114 IALVLDYANAGDLRQEIKSRAK----TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDI 169

Query: 91  KPENILL--SGLDDDVMLKIADFGLSCTLYPGNYAEKV----CGSPLYMAPEVLQFQRYD 144
           K  NILL  +GL     +K+ DFG S  +Y    ++ V    CG+P Y+APE+ + + Y 
Sbjct: 170 KSANILLCSNGL-----VKLGDFGFS-KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 145 EKVNFF 150
           +K + F
Sbjct: 224 KKADMF 229

Length = 496

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 59.6 bits (144), Expect = 2e-11
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 30/154 (19%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
           EL  L  + +HPNII L  A +    +++ +E+   GNL  ++R              HG
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 62  RVPEQTARKFLQ-----QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                T+++ LQ       G++ L+    IHRDL   N+L+    +++  KIADFGLS  
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS-- 166

Query: 117 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEK 146
              G   Y +K  G  P+ +MA E L +  Y  K
Sbjct: 167 --RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK 198

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 59.1 bits (143), Expect = 3e-11
 Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 36/158 (22%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT-------- 67
           E   ++  +HPNI++L         + L+ E+ A G+L+ ++R   R P           
Sbjct: 58  EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTS 115

Query: 68  -ARKFLQ---------QL--------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            ARK            QL        G+  L+    +HRDL   N L+     ++++KIA
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE---NMVVKIA 172

Query: 110 DFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRY 143
           DFGLS  +Y  +Y  K   +      +M PE + + RY
Sbjct: 173 DFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRY 209

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.9 bits (143), Expect = 4e-11
 Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 21/158 (13%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + + +     E+  LS ++ PNI RL      +  + +++E+   G+L+ +++ H     
Sbjct: 59  SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 66  QTA--RKFLQQ-----LGLEI------LNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
             A   K L       +  +I      L S + +HRDL   N L+        +KIADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFG 175

Query: 113 LSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEK 146
           +S  LY  +Y  +V G       +MA E +   ++  K
Sbjct: 176 MSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTK 212

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 4e-11
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 27/166 (16%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +      +  +LV+ F  G
Sbjct: 45  IKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF-MG 103

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   ++ H ++ E   +  + Q+  GL+ +++  IIHRDLKP N+    +++D  LKI
Sbjct: 104 TDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKI 159

Query: 109 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
            DFGL+          ++ G   +  Y APEV L +  Y + V+ +
Sbjct: 160 LDFGLA-----RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIW 200

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 4e-11
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 15/107 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + H  +++L+     E  I++V E+ + G+L  ++    +  E    +  Q +
Sbjct: 51  EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL----KSGEGKKLRLPQLV 106

Query: 76  --------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                   G+  L S + IHRDL   NIL+    ++++ KIADFGL+
Sbjct: 107 DMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLA 150

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.6 bits (142), Expect = 5e-11
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 8/104 (7%)

Query: 16  ELNFLSSVNHPNIIRL--FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
           E+  L +++H NI++            + L++E+   G+L  Y++ H  ++  +    F 
Sbjct: 56  EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
            Q+  G++ L S   IHRDL   NIL   ++ + ++KI+DFGL+
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLA 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 58.2 bits (141), Expect = 6e-11
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 20/156 (12%)

Query: 4   KLNKHLKSC-LDCEL----NFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGN 52
           K+   +K+C           FL         +HP+I++L      EN +++V+E    G 
Sbjct: 34  KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGE 92

Query: 53  LSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           L SY++++   +   +   +  QL   L  L S   +HRD+   N+L+S  D    +K+ 
Sbjct: 93  LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLG 149

Query: 110 DFGLSCTL-YPGNYAEKVCGSPL-YMAPEVLQFQRY 143
           DFGLS  L     Y       P+ +MAPE + F+R+
Sbjct: 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.4 bits (141), Expect = 6e-11
 Identities = 43/147 (29%), Positives = 75/147 (51%), Gaps = 10/147 (6%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +  LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ +++ +  V E
Sbjct: 36  DPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTE 94

Query: 66  QTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-- 121
           +   + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      
Sbjct: 95  KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENY 151

Query: 122 YAEKVCGS-PL-YMAPEVLQFQRYDEK 146
           Y  K  G  P+ + APE + + ++  K
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSK 178

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.6 bits (141), Expect = 6e-11
 Identities = 38/102 (37%), Positives = 58/102 (56%), Gaps = 7/102 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + L  + H NI+ L D    +  + LV E+    +L  Y+  H G +  +  + FL Q
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           L  GL  ++  +I+HRDLKP+N+L+S   D   LK+ADFGL+
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 58.5 bits (141), Expect = 6e-11
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 24/144 (16%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTARKFLQ 73
           S + HPNI+ L      E  + ++  +C+  +L  ++ +   H  V     ++T +  L+
Sbjct: 63  SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 74  -----------QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
                        G+E L+SHH++H+DL   N+L+    D + +KI+D GL   +Y  +Y
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADY 179

Query: 123 AEKVCGSPL---YMAPEVLQFQRY 143
            + +  S L   +M+PE + + ++
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKF 203

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.0 bits (141), Expect = 8e-11
 Identities = 46/141 (32%), Positives = 69/141 (48%), Gaps = 34/141 (24%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL- 72
           E+N L  + HPNI+ + +     N   I++V+E+    +L S +    +   Q+  K L 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCG 128
            QL  G+  L+ + I+HRDLK  N+LL+  G+     LKI DFGL+          +  G
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-----LKICDFGLA----------REYG 157

Query: 129 SPL-----------YMAPEVL 138
           SPL           Y APE+L
Sbjct: 158 SPLKPYTQLVVTLWYRAPELL 178

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 9e-11
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 25/165 (15%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 47  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 105

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 106 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 162

Query: 110 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+      +  +++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 163 DFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 202

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 57.7 bits (139), Expect = 9e-11
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+      + I LV EF   G LS Y+R   G+  ++T       
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L S ++IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSST-GTKFP 164

Query: 132 --YMAPEVLQFQRYDEK 146
             + +PEV  F +Y  K
Sbjct: 165 VKWSSPEVFSFSKYSSK 181

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 57.8 bits (140), Expect = 9e-11
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 8/150 (5%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           LK  +   +     E+  L  + H ++I LF        ++++ E    G+L +++R   
Sbjct: 38  LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97

Query: 61  GRV-PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           G+V P  +      Q+  G+  L   + IHRDL   NIL   + +D++ K+ADFGL+  +
Sbjct: 98  GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL---VGEDLVCKVADFGLARLI 154

Query: 118 YPGNYAEKVCGSPL-YMAPEVLQFQRYDEK 146
               Y       P  + APE      +  K
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 58.1 bits (140), Expect = 9e-11
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 25/163 (15%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R +        + +V E+   G+L+ ++R HG
Sbjct: 43  LKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 102

Query: 62  ---RVPEQTARKFLQQLGLE--------------ILNSHHIIHRDLKPENILLSGLDDDV 104
              ++          QL L                L S H +HRDL   N L+      +
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159

Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRY 143
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++
Sbjct: 160 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKF 201

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.0 bits (140), Expect = 9e-11
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 19/131 (14%)

Query: 16  ELNFLSSVNHPNIIRLFD------AFQAENCIFLVVEFCAGGNLSSYIRLHGR------- 62
           E   +   +HPN+I+L        A        +++ F   G+L +++ L  R       
Sbjct: 51  EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFT 109

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +P QT  +F+  +  G+E L+S + IHRDL   N +L   ++++ + +ADFGLS  +Y G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSG 166

Query: 121 NYAEKVCGSPL 131
           +Y  + C S L
Sbjct: 167 DYYRQGCASKL 177

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.7 bits (139), Expect = 1e-10
 Identities = 37/120 (30%), Positives = 63/120 (52%), Gaps = 7/120 (5%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P ++ L  AFQ E  + L++++ +GG + +++       E   R +  +  L LE L+  
Sbjct: 65  PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124

Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQ 141
            I++RD+K ENIL   LD +  + + DFGLS              CG+  YMAPE+++ +
Sbjct: 125 GIVYRDIKLENIL---LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 1e-10
 Identities = 44/132 (33%), Positives = 70/132 (53%), Gaps = 12/132 (9%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+N L ++ H NI++     + Q    + L++E+   G+L  Y+  H     Q    F Q
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-FAQ 114

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---G 128
           Q+  G+  L+S H IHRDL   N+L   LD+D ++KI DFGL+  +  G+   +V     
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 129 SPLY-MAPEVLQ 139
           SP++  A E L+
Sbjct: 172 SPVFWYAVECLK 183

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.3 bits (138), Expect = 1e-10
 Identities = 41/140 (29%), Positives = 74/140 (52%), Gaps = 11/140 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS---SYIRLHGRVPEQTARKFL 72
           E+  +    H N++ ++ ++     +++++EF  GG L+   S  RL+           L
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL 127

Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSP 130
           Q   L  L+S  +IHRD+K ++ILL+ LD  V  K++DFG  C     +  ++  + G+P
Sbjct: 128 Q--ALCYLHSQGVIHRDIKSDSILLT-LDGRV--KLSDFGF-CAQISKDVPKRKSLVGTP 181

Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            +MAPEV+    Y  +V+ +
Sbjct: 182 YWMAPEVISRTPYGTEVDIW 201

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.0 bits (137), Expect = 2e-10
 Identities = 36/147 (24%), Positives = 73/147 (49%), Gaps = 23/147 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------R 62
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG              
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + +       QQ+  G+  L S H +HRDL   N L+    +++++KI DFG+S  +Y  
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYST 173

Query: 121 NYAEKVCGSPL----YMAPEVLQFQRY 143
           +Y  +V G  +    +M PE + ++++
Sbjct: 174 DYY-RVGGHTMLPIRWMPPESIMYRKF 199

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.0 bits (137), Expect = 2e-10
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 7/102 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L ++ H NI+ L D    E C+ LV E+    +L  Y+   G +      + F+ Q
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           L  GL   +   I+HRDLKP+N+L   +++   LK+ADFGL+
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLL---INEKGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 56.1 bits (135), Expect = 3e-10
 Identities = 38/137 (27%), Positives = 72/137 (52%), Gaps = 12/137 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E + ++ + H N+++L      E   +++V E+ A G+L  Y+R  GR  +      KF 
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
             +   +E L +++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 162

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE L+ +++  K
Sbjct: 163 VKWTAPEALREKKFSTK 179

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.4 bits (136), Expect = 3e-10
 Identities = 37/140 (26%), Positives = 70/140 (50%), Gaps = 18/140 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ EF   G L S++R + G+         L+ 
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--------YPGNYAE 124
           +  G++ L+  + +HRDL   NIL   ++ +++ K++DFGLS  L        Y  +   
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 125 KVCGSPL-YMAPEVLQFQRY 143
           K+   P+ + APE + ++++
Sbjct: 172 KI---PIRWTAPEAIAYRKF 188

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 56.2 bits (135), Expect = 3e-10
 Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 25/150 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV-----PEQT 67
           E + ++ ++HPNI+ L      E  + ++ E+   G+L  ++ +   H  V      + T
Sbjct: 57  EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116

Query: 68  ARKFLQQ-----------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            +  L              G+E L+SH  +H+DL   NIL+    + + +KI+D GLS  
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSRE 173

Query: 117 LYPGNYAEKVCGSPL---YMAPEVLQFQRY 143
           +Y  +Y      S L   +M PE + + ++
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKF 203

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.1 bits (135), Expect = 4e-10
 Identities = 40/140 (28%), Positives = 72/140 (51%), Gaps = 15/140 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
           E   +  +++P I+R+    +AE  + LV+E  +GG L+ +  L G+   +      + +
Sbjct: 45  EAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKF--LSGKKDEITVSNVVELM 101

Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCG 128
            Q  +G++ L   + +HRDL   N+LL    +    KI+DFGLS  L   +  Y  +  G
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYKARSAG 158

Query: 129 S-PL-YMAPEVLQFQRYDEK 146
             PL + APE + F+++  +
Sbjct: 159 KWPLKWYAPECINFRKFSSR 178

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.0 bits (135), Expect = 4e-10
 Identities = 38/127 (29%), Positives = 63/127 (49%), Gaps = 13/127 (10%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-------L 75
           +NHPN+++            LV+EFC  G+L +Y+R +  +  Q A+K + Q        
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLY 132
           GL  L+    IH DL   N  L+    D+ +KI D+GL+   YP +Y    +       +
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 133 MAPEVLQ 139
           +APE+++
Sbjct: 169 LAPELVE 175

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 5e-10
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 27/166 (16%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 45  VKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MG 103

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L++ ++   ++ ++  +  + QL  GL+ ++S  IIHRDLKP N+    +++D  L+I
Sbjct: 104 ADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRI 159

Query: 109 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
            DFGL+         +++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 160 LDFGLA-----RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 200

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.0 bits (135), Expect = 5e-10
 Identities = 34/108 (31%), Positives = 58/108 (53%), Gaps = 14/108 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTA----R 69
           E++ L +++H  II L  A++ ++  C+ +    C   +L +Y+   G +P + A    R
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192

Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           + L+   L  L+   IIHRD+K ENI L   ++ V+    DFG +C L
Sbjct: 193 RLLE--ALAYLHGRGIIHRDVKTENIFLDEPENAVL---GDFGAACKL 235

Length = 392

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.7 bits (134), Expect = 6e-10
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 24/138 (17%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----G 61
           NK+ ++    E+  LS +  PNIIRL      E+ + ++ E+   G+L+ ++  H     
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118

Query: 62  RVPEQTARKFLQQL-----------------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
                 A      L                 G++ L+S + +HRDL   N L+     ++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE---NL 175

Query: 105 MLKIADFGLSCTLYPGNY 122
            +KIADFG+S  LY G+Y
Sbjct: 176 TIKIADFGMSRNLYAGDY 193

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.8 bits (134), Expect = 6e-10
 Identities = 33/114 (28%), Positives = 64/114 (56%), Gaps = 6/114 (5%)

Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L K   + +  E + L   +   ++++F +FQ +  ++L++EF  GG++ + +     + 
Sbjct: 40  LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99

Query: 65  EQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           E+  + ++ +  L I   H +  IHRD+KP+N+L   LD    +K++DFGL CT
Sbjct: 100 EEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL---LDAKGHVKLSDFGL-CT 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 6e-10
 Identities = 33/121 (27%), Positives = 59/121 (48%), Gaps = 17/121 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
           E+  +S + +PNIIRL     +++ + ++ E+   G+L+ ++              +P  
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 67  TARKFLQQL-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +    L        G++ L S + +HRDL   N L   + +   +KIADFG+S  LY G+
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL---VGNHYTIKIADFGMSRNLYSGD 183

Query: 122 Y 122
           Y
Sbjct: 184 Y 184

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.5 bits (133), Expect = 6e-10
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 30/154 (19%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
           EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R              + 
Sbjct: 45  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104

Query: 62  RVPEQTARKFLQ-----QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                ++++ L        G++ L+    IHRDL   NIL+    ++ + KIADFGLS  
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-- 159

Query: 117 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEK 146
              G   Y +K  G  P+ +MA E L +  Y   
Sbjct: 160 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 191

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.9 bits (135), Expect = 6e-10
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 22/153 (14%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           LKK+    ++ + C     EL  L    H N++   D  Q  +      I++V E     
Sbjct: 30  LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS- 88

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L   I     +     + FL Q+  GL+ L+S  I+HRD+KP N+L   ++ + +LKI 
Sbjct: 89  DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL---VNSNCVLKIC 145

Query: 110 DFGLSCTLYPGN----YAEKVCGSPLYMAPEVL 138
           DFGL+    P        E V  +  Y APE+L
Sbjct: 146 DFGLARVEEPDESKHMTQEVV--TQYYRAPEIL 176

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 7e-10
 Identities = 44/141 (31%), Positives = 67/141 (47%), Gaps = 19/141 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII + D  +       N +++V E     +L   I+    +     + 
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQY 110

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYA 123
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL         + G   
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167

Query: 124 EKVCGSPLYMAPEV-LQFQRY 143
           E V  +  Y APE+ L  + Y
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGY 187

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 54.9 bits (132), Expect = 9e-10
 Identities = 36/136 (26%), Positives = 68/136 (50%), Gaps = 10/136 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNII L         + +V E+   G+L +++R H G+         L+
Sbjct: 54  SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 128
            +  G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +   
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNIL---VNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170

Query: 129 SPL-YMAPEVLQFQRY 143
            P+ + APE + ++++
Sbjct: 171 IPIRWTAPEAIAYRKF 186

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.0 bits (132), Expect = 9e-10
 Identities = 38/150 (25%), Positives = 73/150 (48%), Gaps = 26/150 (17%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--------VPEQT 67
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG          P Q 
Sbjct: 57  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116

Query: 68  ARKF-LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
             +  L Q+         G+  L S H +HRDL   N L+     ++++KI DFG+S  +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDV 173

Query: 118 YPGNYAEKVCGSPL----YMAPEVLQFQRY 143
           Y  +Y  +V G  +    +M PE + ++++
Sbjct: 174 YSTDYY-RVGGHTMLPIRWMPPESIMYRKF 202

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.1 bits (132), Expect = 1e-09
 Identities = 29/91 (31%), Positives = 57/91 (62%), Gaps = 6/91 (6%)

Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHI-- 85
           ++++F +FQ +  ++L++EF  GG++ + +     + E+  + ++ +  L I + H +  
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           IHRD+KP+N+L   LD    +K++DFGL CT
Sbjct: 123 IHRDIKPDNLL---LDSKGHVKLSDFGL-CT 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 1e-09
 Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 12/125 (9%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEI--- 79
           + HPNI++            LV E+C  G+L SY+         +    LQ++  EI   
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 80  ---LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYM 133
              ++ H+ +H DL   N  L+    D+ +K+ D+G+  + Y  +Y E     C    ++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168

Query: 134 APEVL 138
           APE++
Sbjct: 169 APELV 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.0 bits (132), Expect = 1e-09
 Identities = 37/118 (31%), Positives = 64/118 (54%), Gaps = 19/118 (16%)

Query: 20  LSSVNHPNIIRLFDA-FQ-AENCIF----LVVEFCAGGNLSSYIRLHGRV-------PEQ 66
           +   +HPN++RL     Q  E+  +    +++ F   G+L S++ L+ R+       P Q
Sbjct: 54  MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQ 112

Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
              KF+  +  G+E L+S   IHRDL   N +   L++++ + +ADFGLS  +Y G+Y
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCM---LNENMNVCVADFGLSKKIYNGDY 167

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 54.6 bits (131), Expect = 1e-09
 Identities = 39/137 (28%), Positives = 69/137 (50%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F  
Sbjct: 51  EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    P
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE + F  +  K
Sbjct: 167 IKWTAPEAINFGSFTIK 183

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 54.5 bits (131), Expect = 1e-09
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  +++V EF   G L +Y+R   G++ +       Q 
Sbjct: 49  EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+E L  +  IHRDL   N L+S      ++K++DFG++  +    Y     G+   
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFP 164

Query: 132 --YMAPEVLQFQRYDEK 146
             +  PEV  F +Y  K
Sbjct: 165 VKWSPPEVFNFSKYSSK 181

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.4 bits (131), Expect = 1e-09
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 30/154 (19%)

Query: 1   MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           MLK   +   +  L  EL  +S + NH NI+ L  A      I ++ E+C  G+L +++R
Sbjct: 72  MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131

Query: 59  LHGRVPEQTARKFLQ---------QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLK 107
                  +    FL          Q+  G+  L S + IHRDL   N+LL+      ++K
Sbjct: 132 -------RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVK 181

Query: 108 IADFGLSC-TLYPGNYAEKVCGS---PL-YMAPE 136
           I DFGL+   +   NY  K  G+   P+ +MAPE
Sbjct: 182 ICDFGLARDIMNDSNYVVK--GNARLPVKWMAPE 213

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 2e-09
 Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 19/142 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HP +I+L+     E  I++V E    G+L  Y  L G      A K  Q +
Sbjct: 51  EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY--LQGG--AGRALKLPQLI 106

Query: 76  --------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
                   G+  L + + IHRDL   N+L+    ++ + K+ADFGL+  +    Y  +  
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEARE- 162

Query: 128 GSPL---YMAPEVLQFQRYDEK 146
           G+     + APE   + R+  K
Sbjct: 163 GAKFPIKWTAPEAALYNRFSIK 184

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 53.9 bits (130), Expect = 2e-09
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 17/110 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLHG---RVPE 65
           E+  L  + HPN++ L D         + +     +V      +LS    L     ++ E
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGL--LENPSVKLTE 114

Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
              + ++ QL  G+  L+ +HI+HRD+K  NIL   +D+  +LKIADFGL
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANIL---IDNQGILKIADFGL 161

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 53.8 bits (129), Expect = 3e-09
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 10/130 (7%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           + S++H  I+RL       + + LV +    G+L  ++R H   +  Q    +  Q+  G
Sbjct: 63  MGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL-YM 133
           +  L  H ++HR+L   NILL     D +++IADFG++  LYP +  Y      +P+ +M
Sbjct: 122 MYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 134 APEVLQFQRY 143
           A E + F RY
Sbjct: 179 ALESILFGRY 188

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.5 bits (128), Expect = 4e-09
 Identities = 49/142 (34%), Positives = 67/142 (47%), Gaps = 31/142 (21%)

Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTARKF-LQQ 74
           HPNII L  A +    ++L +E+   GNL  ++R   RV E          TA     QQ
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQ 125

Query: 75  L---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YA 123
           L         G++ L+    IHRDL   NIL+    ++ + KIADFGLS     G   Y 
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYV 178

Query: 124 EKVCGS-PL-YMAPEVLQFQRY 143
           +K  G  P+ +MA E L +  Y
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVY 200

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 52.9 bits (127), Expect = 4e-09
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 10/131 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
           E N +  + HP ++RL+ A   +  I+++ E+   G+L  +++     ++          
Sbjct: 51  EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  NIL+S   + +  KIADFGL+  +    Y A +    P
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAREGAKFP 166

Query: 131 L-YMAPEVLQF 140
           + + APE + +
Sbjct: 167 IKWTAPEAINY 177

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.7 bits (126), Expect = 6e-09
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 7/102 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G  +     + FL Q
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           L  GL   +   ++HRDLKP+N+L   +++   LK+ADFGL+
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLL---INERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 53.0 bits (127), Expect = 6e-09
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 18/131 (13%)

Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           NK+ ++    E+  +S +  PNIIRL       + + ++ E+   G+L+ ++  H    E
Sbjct: 59  NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQE 117

Query: 66  Q------------TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
                        T      Q+  G++ L+S + +HRDL   N L+     +  +KIADF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADF 174

Query: 112 GLSCTLYPGNY 122
           G+S  LY G+Y
Sbjct: 175 GMSRNLYSGDY 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.4 bits (126), Expect = 9e-09
 Identities = 38/108 (35%), Positives = 60/108 (55%), Gaps = 11/108 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L  ++H N+I + D       +A N +++V E     +L   IR    + +   + 
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQY 112

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           FL QL  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+ T
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLART 157

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 2e-08
 Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 19/149 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTA 68
           E+  L  + HPN+I L   F   A+  ++L+ ++ A  +L   I+ H      + P Q  
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106

Query: 69  RKFLQQLGLEILNSHH------IIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 117
           R  ++ L  +IL+  H      ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEK 146
            P    + V  +  Y APE+L   R+  K
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTK 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 51.3 bits (123), Expect = 2e-08
 Identities = 39/167 (23%), Positives = 76/167 (45%), Gaps = 20/167 (11%)

Query: 1   MLKKLNK----HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           ++K L K    +L+S    EL+    ++H N++RL    +     ++++E+   G+L  +
Sbjct: 39  LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98

Query: 57  IRLHGRVPEQTARKFLQQ-----------LGLEILNSHHIIHRDLKPENILLSGLDDDVM 105
           +R      E+     L             LG++ L++   +HRDL   N L+S       
Sbjct: 99  LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QRE 155

Query: 106 LKIADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +K++   LS  +Y   Y + +    PL ++APE +Q   +  K + +
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVW 202

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 50.8 bits (121), Expect = 2e-08
 Identities = 37/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  ++ L+ A  +E  I++V EF   G+L  +++     + ++P+      
Sbjct: 51  EAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + IHRDL+  NIL+    D+++ KIADFGL+  +    Y A +    P
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNEYTARQGAKFP 166

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE   + R+  K
Sbjct: 167 IKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.2 bits (122), Expect = 2e-08
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 19/149 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTA 68
           E+  L  + HPN+I L   F   ++  ++L+ ++ A  +L   I+ H      + P Q  
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106

Query: 69  RKFLQQLGLEILNSHH------IIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 117
           R  ++ L  +IL+  H      ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEK 146
            P    + V  +  Y APE+L   R+  K
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTK 195

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 4e-08
 Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 17/145 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+     + HPNI+    +F  ++ +++V    A G+    ++ H     PE      L+
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108

Query: 74  Q--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSP 130
                L+ ++S   IHR +K  +ILLSG D  V+L  +    S ++   G     V   P
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVL--SGLRYSVSMIKHGKRQRVVHDFP 165

Query: 131 LY-------MAPEVLQ--FQRYDEK 146
                    ++PEVLQ   Q Y+EK
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEK 190

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.4 bits (120), Expect = 4e-08
 Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 20/140 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQT 67
           E + +      +++RL           +V+E  A G+L SY+R          GR P  T
Sbjct: 59  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPT 117

Query: 68  ARKFLQQL-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
            ++ +Q       G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDY 174

Query: 123 AEKVCGSPL---YMAPEVLQ 139
             K     L   +MAPE L+
Sbjct: 175 YRKGGKGLLPVRWMAPESLK 194

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 5e-08
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 7/102 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L  + H NI+ L D    +  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           +  GL   +   ++HRDLKP+N+L++   +   LK+ADFGL+
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 5e-08
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 23/147 (15%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  + H N+I L D F +          +LV+ +    +L   I  H    ++   
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKVQY 121

Query: 70  KFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVC 127
              Q L GL+ ++S  IIHRDLKP N+    +++D  LKI DFGL+       +A+ ++ 
Sbjct: 122 LVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLA------RHADAEMT 172

Query: 128 G---SPLYMAPEV-LQFQRYDEKVNFF 150
           G   +  Y APEV L +  Y++ V+ +
Sbjct: 173 GYVVTRWYRAPEVILNWMHYNQTVDIW 199

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 49.4 bits (118), Expect = 9e-08
 Identities = 41/142 (28%), Positives = 65/142 (45%), Gaps = 24/142 (16%)

Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTAR 69
           +   +HPN++ L      +E    +V+ +   G+L ++IR     P          Q A+
Sbjct: 50  MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAK 109

Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVC 127
                 G+E L S   +HRDL   N +   LD+   +K+ADFGL+  +Y   Y       
Sbjct: 110 ------GMEYLASKKFVHRDLAARNCM---LDESFTVKVADFGLARDIYDKEYYSVHNHT 160

Query: 128 GSPL---YMAPEVLQFQRYDEK 146
           G+ L   +MA E LQ Q++  K
Sbjct: 161 GAKLPVKWMALESLQTQKFTTK 182

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 49.3 bits (118), Expect = 1e-07
 Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 14/96 (14%)

Query: 56  YIRLHGRVPEQTARKFLQQLGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKI 108
           Y  L   +PE+     L ++ +  + +         IIHRD+KP NIL   LD +  +K+
Sbjct: 97  YEVLKSVIPEE----ILGKIAVATVKALNYLKEELKIIHRDVKPSNIL---LDRNGNIKL 149

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD 144
            DFG+S  L       +  G   YMAPE +     D
Sbjct: 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARD 185

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 1e-07
 Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 17/137 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFL--VVEFCAGGNLSSYIRLHGR----V 63
           EL  + ++NH NII L D +      + E  IFL  V+EF     +  Y++ + R    +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           P    + +  QL   L  ++S  I HRDLKP+N+L+    +   LK+ DFG +  L  G 
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQ 225

Query: 122 YAEKVCGSPLYMAPEVL 138
            +     S  Y APE++
Sbjct: 226 RSVSYICSRFYRAPELM 242

Length = 440

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 48.9 bits (116), Expect = 1e-07
 Identities = 35/139 (25%), Positives = 72/139 (51%), Gaps = 14/139 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 51  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 107

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
             Q+  G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +   
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 164

Query: 129 SPL-YMAPEVLQFQRYDEK 146
            P+ + APE   + R+  K
Sbjct: 165 FPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.7 bits (113), Expect = 3e-07
 Identities = 35/140 (25%), Positives = 65/140 (46%), Gaps = 20/140 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------T 67
           E + +   N  +++RL           +++E    G+L SY+R   R   +        +
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPS 117

Query: 68  ARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
            +K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY 174

Query: 123 AEKVCGSPL---YMAPEVLQ 139
             K     L   +M+PE L+
Sbjct: 175 YRKGGKGLLPVRWMSPESLK 194

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 47.7 bits (113), Expect = 3e-07
 Identities = 38/137 (27%), Positives = 67/137 (48%), Gaps = 14/137 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +H NIIRL           ++ E+   G L  Y+R H    E ++ + +  L
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGML 113

Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YP-GNYAEKVC 127
                G++ L+  + +HRDL   NIL   ++ ++  K++DFGLS  L   P G Y     
Sbjct: 114 RGIAAGMKYLSDMNYVHRDLAARNIL---VNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170

Query: 128 GSPL-YMAPEVLQFQRY 143
             P+ + APE + ++++
Sbjct: 171 KIPIRWTAPEAIAYRKF 187

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.6 bits (113), Expect = 4e-07
 Identities = 38/128 (29%), Positives = 62/128 (48%), Gaps = 15/128 (11%)

Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQQLGLEI 79
           S+ H N+++            LV+EFC  G+L  Y+R   R  E        LQ++  EI
Sbjct: 51  SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC-RKAELMTPDPTTLQRMACEI 109

Query: 80  ------LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 130
                 L+ ++ IH DL   N LL+    D+ +KI D+GLS   Y  +Y    +++    
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 131 LYMAPEVL 138
            ++APE++
Sbjct: 167 RWIAPELV 174

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.5 bits (113), Expect = 4e-07
 Identities = 33/76 (43%), Positives = 42/76 (55%), Gaps = 16/76 (21%)

Query: 66  QTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAE 124
           Q AR      G+E L S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  
Sbjct: 181 QVAR------GMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVR 231

Query: 125 KVCGS---PL-YMAPE 136
           K  G    PL +MAPE
Sbjct: 232 K--GDARLPLKWMAPE 245

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 47.3 bits (112), Expect = 5e-07
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR---VPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++   GR   +P       
Sbjct: 51  EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + IHRDL+  NIL+    D ++ KIADFGL+  +    Y A +    P
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAKFP 166

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE   + R+  K
Sbjct: 167 IKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 46.5 bits (110), Expect = 9e-07
 Identities = 31/108 (28%), Positives = 52/108 (48%), Gaps = 8/108 (7%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
           K  LD E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q  
Sbjct: 54  KEILD-EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 111

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
             +  Q+  G+  L    ++HRDL   N+L+        +KI DFGL+
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.5 bits (110), Expect = 1e-06
 Identities = 35/76 (46%), Positives = 44/76 (57%), Gaps = 16/76 (21%)

Query: 66  QTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAE 124
           Q AR      G+E L S   IHRDL   NILLS  +++V +KI DFGL+  +Y   +Y  
Sbjct: 182 QVAR------GMEFLASRKCIHRDLAARNILLS--ENNV-VKICDFGLARDIYKDPDYVR 232

Query: 125 KVCGS---PL-YMAPE 136
           K  GS   PL +MAPE
Sbjct: 233 K--GSARLPLKWMAPE 246

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.3 bits (110), Expect = 1e-06
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 11/106 (10%)

Query: 16  ELNFLSSVNHPNI-----IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L  + HP+I     I L  + +    I++V E     +L   I+ +  +  +  + 
Sbjct: 49  EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQF 107

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           FL QL   L+ +++ ++ HRDLKP+NIL +    D  LKI DFGL+
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLA 150

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.1 bits (109), Expect = 1e-06
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 8/104 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
           E+  L ++ H NI++       +  N I L++EF   G+L  Y+ R   ++  +   K+ 
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
            Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLT 156

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 45.1 bits (107), Expect = 3e-06
 Identities = 33/152 (21%), Positives = 64/152 (42%), Gaps = 23/152 (15%)

Query: 11  SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           + L  E   L  ++H NI+ +     +     F++  +   GNL  +++          +
Sbjct: 53  TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112

Query: 70  KFLQQ----LGLEI------LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
               Q    + ++I      L+   +IH+D+   N ++   D+++ +KI D  LS  L+P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFP 169

Query: 120 GNYAEKVC-----GSPL-YMAPEVLQFQRYDE 145
            +Y    C       P+ +MA E L  + Y  
Sbjct: 170 MDYH---CLGDNENRPVKWMALESLVNKEYSS 198

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.0 bits (106), Expect = 3e-06
 Identities = 29/66 (43%), Positives = 39/66 (59%), Gaps = 6/66 (9%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-Y 132
           G+E L S   IHRDL   NILLS   ++ ++KI DFGL+  +Y   +Y  K     PL +
Sbjct: 191 GMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247

Query: 133 MAPEVL 138
           MAPE +
Sbjct: 248 MAPETI 253

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 44.8 bits (106), Expect = 4e-06
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 12/106 (11%)

Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
           E+  L S+ H NI++     + A      + LV+E+   G+L  Y++ H  R+  +    
Sbjct: 55  EIEILKSLQHDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           +  Q+  G+E L S   +HRDL   NIL   ++ +  +KI DFGL+
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNIL---VESENRVKIGDFGLT 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.9 bits (106), Expect = 4e-06
 Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 30/149 (20%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTA-- 68
           E   L  ++HP ++ L D        C+ L        +L +Y+    R   + + TA  
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS---DLYTYLGARLRPLGLAQVTAVA 266

Query: 69  RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 128
           R+ L    ++ ++   IIHRD+K EN+L++G +D   + + DFG +C      +A     
Sbjct: 267 RQLLS--AIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAAC------FARGSWS 315

Query: 129 SPLYM---------APEVLQFQRYDEKVN 148
           +P +          APEVL    Y   V+
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVD 344

Length = 461

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 44.3 bits (105), Expect = 5e-06
 Identities = 24/62 (38%), Positives = 34/62 (54%), Gaps = 4/62 (6%)

Query: 76  GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
            LE L+S   +IHRD+KP N+L   ++ +  +K+ DFG+S  L          G   YMA
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMA 171

Query: 135 PE 136
           PE
Sbjct: 172 PE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 44.2 bits (104), Expect = 5e-06
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 23/155 (14%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70
           L  EL+     NHPNI+     F A+N +++V  F A G+    I  H    + E     
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105

Query: 71  FLQQLGLEILNS-HHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-- 125
            LQ + L+ L+  HH+  +HR +K  +IL+S +D  V L     GL   L   N+ ++  
Sbjct: 106 ILQGV-LKALDYIHHMGYVHRSVKASHILIS-VDGKVYLS----GLRSNLSMINHGQRLR 159

Query: 126 -VCGSPLY-------MAPEVLQ--FQRYDEKVNFF 150
            V   P Y       ++PEVLQ   Q YD K + +
Sbjct: 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.8 bits (103), Expect = 8e-06
 Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 8/137 (5%)

Query: 12  CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
               E   L   +H NI+RL       N + +V E+ + G L S++R H G++       
Sbjct: 52  GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG 111

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-LSCTLYPGNYAEKVC 127
            L  L  G++ L+    +H+ L    +L++    D++ KI+ F  L        Y     
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKSEAIYTTMSG 168

Query: 128 GSP-LYMAPEVLQFQRY 143
            SP L+ APE +Q+  +
Sbjct: 169 KSPVLWAAPEAIQYHHF 185

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 43.6 bits (103), Expect = 8e-06
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 31/144 (21%)

Query: 16  ELNFLSSVNHPNIIRL----------FDAFQAENCIFLVVEFCAG---GNLSSYIRLHGR 62
           E+  L  +NH NI+ L           D  + +   +LV E+      G L S     G 
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----GL 110

Query: 63  V--PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           V   E   + F++QL  GL   +  + +HRD+K  NIL   L++   +K+ADFGL+  LY
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL---LNNKGQIKLADFGLA-RLY 166

Query: 119 PGN----YAEKVCGSPLYMAPEVL 138
                  Y  KV  +  Y  PE+L
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELL 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 9e-06
 Identities = 27/73 (36%), Positives = 38/73 (52%), Gaps = 8/73 (10%)

Query: 69  RKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAE 124
           +  ++Q+ L  L+  H   I+HRD+KP+NI+ S  +     KI D G +  L  G NY  
Sbjct: 258 QTIMRQI-LFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIP 314

Query: 125 K-VCGSPLYMAPE 136
           K     P Y APE
Sbjct: 315 KEFLLDPRYAAPE 327

Length = 566

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 42.4 bits (100), Expect = 3e-05
 Identities = 28/84 (33%), Positives = 40/84 (47%), Gaps = 26/84 (30%)

Query: 76  GLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFGLSCTLY- 118
            +E ++S  ++HRDLKP+NILL                  L+++ +L I D       Y 
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI-DVDERNICYS 183

Query: 119 ----PGNYAEKVCGSPLYMAPEVL 138
               PG    K+ G+P YMAPE L
Sbjct: 184 SMTIPG----KIVGTPDYMAPERL 203

Length = 932

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 4e-05
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 16/143 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
           E + L ++NHP+II+L   F       L++      +L  Y+     +         R  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAEKVC 127
           L+   ++ L+ + IIHRD+K ENI ++   D   + + DFG +C  +P     N      
Sbjct: 192 LR--AIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAAC--FPVDINANKYYGWA 244

Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
           G+    APE+L    Y   V+ +
Sbjct: 245 GTIATNAPELLARDPYGPAVDIW 267

Length = 391

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 33/133 (24%), Positives = 62/133 (46%), Gaps = 10/133 (7%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           ++S++HP+++RL     +   I LV +    G L  Y+  H   +  Q    +  Q+  G
Sbjct: 63  MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YM 133
           +  L    ++HRDL   N+L+   +    +KI DFGL+  L          G  +   +M
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178

Query: 134 APEVLQFQRYDEK 146
           A E + ++++  +
Sbjct: 179 ALECIHYRKFTHQ 191

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 7e-05
 Identities = 25/65 (38%), Positives = 35/65 (53%), Gaps = 5/65 (7%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG--SPLYM 133
           GL  L+   I+HRD+KPEN+L++    D  +KI DFG +  +  G     + G   P Y 
Sbjct: 321 GLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377

Query: 134 APEVL 138
            PE L
Sbjct: 378 PPEEL 382

Length = 507

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 1e-04
 Identities = 26/66 (39%), Positives = 37/66 (56%), Gaps = 10/66 (15%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL--- 131
           G+E L S + +HRDL   N+LL+      ++KI DFGL+   ++  NY  K  GS     
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSK--GSTFLPV 303

Query: 132 -YMAPE 136
            +MAPE
Sbjct: 304 KWMAPE 309

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.2 bits (94), Expect = 2e-04
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 10/152 (6%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-L 59
           ++K++N  + S    E+  +  + HPNI++L    ++E   +L+ E+  G NLS  +R L
Sbjct: 719 VVKEIND-VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL 777

Query: 60  HGRVPEQTARKFLQQLG-LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
                 + A    + L  L    S  ++  +L PE I++ G  D+  L+++  GL CT  
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLRLSLPGLLCT-- 834

Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                 K   S  Y+APE  + +   EK + +
Sbjct: 835 ----DTKCFISSAYVAPETRETKDITEKSDIY 862

Length = 968

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.5 bits (93), Expect = 2e-04
 Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 11/92 (11%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNS 82
           VN P  +   D         +V+E+  G  L   I  +G    + +R+  + +G   L+S
Sbjct: 61  VNVP-AVYFVD----PENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGK--LHS 113

Query: 83  HHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
             IIH DL   N++LSG    + L I DFGL+
Sbjct: 114 AGIIHGDLTTSNMILSG--GKIYL-I-DFGLA 141

Length = 211

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 39.6 bits (92), Expect = 2e-04
 Identities = 27/66 (40%), Positives = 38/66 (57%), Gaps = 10/66 (15%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGS---PL 131
           G+E L S + +HRDL   N+L+    +  ++KI DFGL+   +   NY  K  GS   PL
Sbjct: 251 GMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK--GSTFLPL 305

Query: 132 -YMAPE 136
            +MAPE
Sbjct: 306 KWMAPE 311

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 38.8 bits (90), Expect = 4e-04
 Identities = 26/104 (25%), Positives = 51/104 (49%), Gaps = 15/104 (14%)

Query: 9   LKSCLDCELNFLSS-------VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L++C +  L  L +         HPNI+  +  F   + ++++  F A G+ +S ++ + 
Sbjct: 35  LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY- 93

Query: 62  RVPEQTARKFLQQL------GLEILNSHHIIHRDLKPENILLSG 99
             PE  +   +  +      GL  L+ +  IHR++K  +IL+SG
Sbjct: 94  -FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG 136

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 37.3 bits (86), Expect = 0.001
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 8/108 (7%)

Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
           K  LD E   ++ V  P + RL       + + LV +    G L  Y+R +  R+  Q  
Sbjct: 54  KEILD-EAYVMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
             +  Q+  G+  L    ++HRDL   N+L+   +    +KI DFGL+
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 36.7 bits (85), Expect = 0.003
 Identities = 26/66 (39%), Positives = 38/66 (57%), Gaps = 10/66 (15%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGS---PL 131
           G++ L S + IHRD+   N+LL+   D  + KI DFGL+  +    NY  K  G+   P+
Sbjct: 224 GMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVK--GNARLPV 278

Query: 132 -YMAPE 136
            +MAPE
Sbjct: 279 KWMAPE 284

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 36.2 bits (83), Expect = 0.004
 Identities = 29/119 (24%), Positives = 57/119 (47%), Gaps = 17/119 (14%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVV---EFCAGGNLSSYI-----RLH 60
               L+ E+  L  +NH NI+++ +  ++E   +++    +F    +L S++        
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWK 261

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
            R   +  R  ++QL   +E ++   +IHRD+K ENI L+    D  + + DFG +   
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPF 317

Length = 501

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 36.0 bits (83), Expect = 0.004
 Identities = 18/39 (46%), Positives = 23/39 (58%), Gaps = 3/39 (7%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           G+  L S + IHRDL   NILL+      + KI DFGL+
Sbjct: 226 GMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLA 261

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	152
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.98
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.98
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.98
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.98
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.98
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.98
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.98
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.98
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.98
KOG0584	632	consensus Serine/threonine protein kinase [General	99.98
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.96
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.96
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.96
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.96
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.96
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.96
PTZ00036	440	glycogen synthase kinase; Provisional	99.96
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.96
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.96
PTZ00283	496	serine/threonine protein kinase; Provisional	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.96
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.96
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.96
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.96
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.96
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.96
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.96
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.96
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.96
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.95
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.95
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.95
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.95
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.95
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.95
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.95
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.95
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.95
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
PTZ00284	467	protein kinase; Provisional	99.95
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.95
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.95
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.95
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.95
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.95
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.95
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.95
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.95
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.95
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.95
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.95
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.95
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.94
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.94
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.94
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.94
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.94
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.94
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.94
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.94
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.94
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.94
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.94
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.94
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.94
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.94
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.94
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.93
KOG3653	534	consensus Transforming growth factor beta/activin	99.93
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.93
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.93
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.93
PHA02882	294	putative serine/threonine kinase; Provisional	99.93
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.93
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.93
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.93
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.93
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.92
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.92
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.92
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.92
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.91
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.91
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.91
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.9
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.9
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.87
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.86
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.84
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.84
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.81
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.76
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.74
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.74
PRK12274	218	serine/threonine protein kinase; Provisional	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.65
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
smart00090	237	RIO RIO-like kinase.	99.58
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.56
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.54
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.53
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.52
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.47
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.45
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.41
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.4
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.39
KOG3087	229	consensus Serine/threonine protein kinase [General	99.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.31
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.29
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.22
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.2
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.08
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.04
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.04
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.0
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.74
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.68
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.66
PRK09902	216	hypothetical protein; Provisional	98.55
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.54
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.48
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.36
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.34
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.28
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.09
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.08
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.08
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.94
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.86
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.65
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.31
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.29
PF01636	239	APH: Phosphotransferase enzyme family This family	97.25
PLN02876	822	acyl-CoA dehydrogenase	97.17
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.11
COG4248	637	Uncharacterized protein with protein kinase and he	97.01
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.58
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.9
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.61
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.55
KOG2270	520	consensus Serine/threonine protein kinase involved	95.4
PHA03111	444	Ser/Thr kinase; Provisional	95.09
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	95.05
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	95.04
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.96
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.93
PRK05231	319	homoserine kinase; Provisional	94.67
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.38
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	93.76
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	93.59
PRK10271	188	thiK thiamine kinase; Provisional	92.94
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	92.65
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.36
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.31
PLN02236	344	choline kinase	92.04
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.94
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	91.88
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.51
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	91.38
COG2334	331	Putative homoserine kinase type II (protein kinase	91.21
PRK09550	401	mtnK methylthioribose kinase; Reviewed	90.92
PRK10593	297	hypothetical protein; Provisional	90.86
PRK06148	1013	hypothetical protein; Provisional	89.59
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	88.94
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	88.66
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	87.96
PRK11768	325	serine/threonine protein kinase; Provisional	87.72
PRK12396	409	5-methylribose kinase; Reviewed	87.46

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-46  Score=261.42  Aligned_cols=149  Identities=54%  Similarity=0.937  Sum_probs=139.2

Q ss_pred             hhhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         4 ~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      +++.+.++.+..|+.+|+.++|||||.++++.++++.+|+|||||.||||.+++.+.+.+++..++.++.|+  |+++||
T Consensus        47 ~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~  126 (429)
T KOG0595|consen   47 KLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH  126 (429)
T ss_pred             ccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345668899999999999999999999999999999999999999999999999999999999999999999  799999


Q ss_pred             hCCCeecCCCCCceEeecCCCC---ceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDD---VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||||+|||++.....   ..+|++|||+||.+.+.....+.||+|.|||||++..++|+.|+|+||+
T Consensus       127 ~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSi  200 (429)
T KOG0595|consen  127 ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSI  200 (429)
T ss_pred             HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHH
Confidence            9999999999999999754222   6899999999999998888999999999999999999999999999984

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-42  Score=240.67  Aligned_cols=141  Identities=37%  Similarity=0.665  Sum_probs=131.0

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecC
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (152)
                      .+++|++||++++|||||+++++|+.++..||||||+.||+|.+++-.++.+.+.....++.|+  |+.|||++||+|||
T Consensus       222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRD  301 (475)
T KOG0615|consen  222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRD  301 (475)
T ss_pred             hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCccccc
Confidence            3679999999999999999999999999999999999999999999999999999999999998  99999999999999


Q ss_pred             CCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC---CcccceeeC
Q 031828           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY---DEKVNFFVS  152 (152)
Q Consensus        90 l~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~---~~~~Dvws~  152 (152)
                      |||+|||+........+|+.|||+|+.........+.||||.|.|||++.++++   ..++|+||+
T Consensus       302 iKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl  367 (475)
T KOG0615|consen  302 IKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL  367 (475)
T ss_pred             CCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeec
Confidence            999999998766778999999999998887778899999999999999998763   347899996

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=234.65  Aligned_cols=144  Identities=40%  Similarity=0.665  Sum_probs=134.0

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+....|..||.+++||+||++...|++.+.+|+|+||+.||.|...+.+++.+++..+..|+++|  |+.|||+.
T Consensus        65 ~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~  144 (357)
T KOG0598|consen   65 EKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK  144 (357)
T ss_pred             hhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC
Confidence            3456778899999999999999999999999999999999999999999999999999999999999998  99999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcccc-CCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+|||+||+|||+   +..+.++|+|||+|+.. ..+....++|||+.|||||++.+.+|+.++|||||
T Consensus       145 gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsL  211 (357)
T KOG0598|consen  145 GIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSL  211 (357)
T ss_pred             CeeeccCCHHHeee---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhH
Confidence            99999999999999   78889999999999854 44456778999999999999999999999999996

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=233.81  Aligned_cols=143  Identities=32%  Similarity=0.572  Sum_probs=134.1

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC-eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ++..+.++.+|+++++.++||+||++|+.|..++ .+.++||||++|+|.+++++.+.+++..+..++.++  ||.|||+
T Consensus       117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~  196 (364)
T KOG0581|consen  117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE  196 (364)
T ss_pred             CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            6777899999999999999999999999999999 599999999999999999998999999999999998  9999996


Q ss_pred             -CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 -~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                       ++|+||||||+|+|+   +..+.+||+|||.++.+..+ ...++.||..|||||-+.+..|+.++|||||
T Consensus       197 ~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSL  263 (364)
T KOG0581|consen  197 ERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSL  263 (364)
T ss_pred             ccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecc
Confidence             899999999999999   67889999999999876555 6678999999999999999999999999997

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-39  Score=235.35  Aligned_cols=144  Identities=34%  Similarity=0.623  Sum_probs=136.3

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      +..+++.+.+|++|.+.++|||||+++++|++.+.+|+|+|+|..++|..++++++.++|..++.++.||  |+.|||++
T Consensus        58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~  137 (592)
T KOG0575|consen   58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL  137 (592)
T ss_pred             CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence            4577899999999999999999999999999999999999999999999999999999999999999998  99999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|||||..|+++   +.+.++|++|||+|..+... .+..+.||||.|.|||++...+.+..+||||+
T Consensus       138 ~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSl  204 (592)
T KOG0575|consen  138 GIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSL  204 (592)
T ss_pred             Cceecccchhheee---cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhh
Confidence            99999999999999   67779999999999987654 67789999999999999999999999999995

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-39  Score=217.49  Aligned_cols=143  Identities=36%  Similarity=0.677  Sum_probs=133.8

Q ss_pred             hhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         5 ~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ++-++.+...+|..+|+.+.||+++++.+.+.+.+.+|+||||.+||.|..++++.+.+++..++.++.++  |++|||+
T Consensus        83 VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~  162 (355)
T KOG0616|consen   83 VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS  162 (355)
T ss_pred             HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh
Confidence            34466788889999999999999999999999999999999999999999999999999999999999998  9999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++++||+||+||++   +..+.+|+.|||+|+.+...  ..+.||||.|+|||++..++|+.++|+|||
T Consensus       163 ~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWal  227 (355)
T KOG0616|consen  163 LDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWAL  227 (355)
T ss_pred             cCeeeccCChHHeee---ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHH
Confidence            999999999999999   78889999999999876544  678999999999999999999999999996

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-38  Score=225.02  Aligned_cols=140  Identities=36%  Similarity=0.577  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCC-eEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ++.|.+|+.+|++++|||||.++|++..+. ..++||||+++|+|.+++..  +..++...+..++.++  |+.|||+++
T Consensus        83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~  162 (362)
T KOG0192|consen   83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG  162 (362)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            679999999999999999999999999887 79999999999999999977  5779999999999999  899999999


Q ss_pred             -CeecCCCCCceEeecCCCCc-eEEEeeccCccccCCC-CccccCCCCCCcccccccc--cCCCCcccceeeC
Q 031828           85 -IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ--FQRYDEKVNFFVS  152 (152)
Q Consensus        85 -~~h~dl~~~nil~~~~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~~Dvws~  152 (152)
                       ++|+||||+|+|+   +... .+||+|||+++..... .......||+.|||||++.  ...|+.++|||||
T Consensus       163 ~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySF  232 (362)
T KOG0192|consen  163 PIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSF  232 (362)
T ss_pred             CeeecccChhhEEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhH
Confidence             9999999999999   5664 9999999999876554 2334478999999999999  5589999999997

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=223.63  Aligned_cols=141  Identities=42%  Similarity=0.746  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+.+++.++ ||||+++++++.....+++||||+.||+|.+++.+.+.+.+..+..++.|+  |+.|||++|+
T Consensus        62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi  141 (370)
T KOG0583|consen   62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGI  141 (370)
T ss_pred             cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCE
Confidence            3567779999999999 999999999999999999999999999999999998899999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCC-ceEEEeeccCcccc-CCCCccccCCCCCCcccccccccCC-CC-cccceeeC
Q 031828           86 IHRDLKPENILLSGLDDD-VMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YD-EKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~-~~~kl~dfg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~-~~~Dvws~  152 (152)
                      +||||||+|+++.   .. .++|++|||++... .......+.|||+.|+|||++.+.. |+ .++||||+
T Consensus       142 ~HRDLK~ENilld---~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~  209 (370)
T KOG0583|consen  142 VHRDLKPENILLD---GNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSL  209 (370)
T ss_pred             eeCCCCHHHEEec---CCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhh
Confidence            9999999999994   55 89999999999877 4666788999999999999999988 86 78999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-39  Score=216.97  Aligned_cols=145  Identities=32%  Similarity=0.617  Sum_probs=128.4

Q ss_pred             hhHhHHHHHHHHHHHHHcCCCcCccceee-eeeeCCe-EEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHH--H
Q 031828            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFD-AFQAENC-IFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL--G   76 (152)
Q Consensus         5 ~~~~~~~~~~~E~~~l~~l~h~ni~~l~~-~~~~~~~-~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i--~   76 (152)
                      ++...+++...|+.+|++++|||||++++ .|..+.. ++++||+|++|||.+.++    +...+++..++.++.|+  |
T Consensus        57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A  136 (375)
T KOG0591|consen   57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA  136 (375)
T ss_pred             ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence            45677899999999999999999999998 6666655 899999999999999986    33459999999999998  8


Q ss_pred             HHHHHh--CC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceee
Q 031828           77 LEILNS--HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        77 l~~lh~--~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                      |..+|.  .+  +.||||||.||++   +..+.+||+|||+++.+.+.. ...+.+|||.||+||.+.+.+|+.+|||||
T Consensus       137 L~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWs  213 (375)
T KOG0591|consen  137 LYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWS  213 (375)
T ss_pred             HHHHhccccccceeeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHH
Confidence            999998  44  8999999999999   577899999999999876654 457889999999999999999999999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      +
T Consensus       214 l  214 (375)
T KOG0591|consen  214 L  214 (375)
T ss_pred             H
Confidence            6

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=224.70  Aligned_cols=139  Identities=31%  Similarity=0.600  Sum_probs=127.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ++-+..|+.+|+..+|+|||++++.|...+.+|+||||++||+|.+.+... .+++.++..++.++  ||.|||.++|+|
T Consensus       314 keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiH  392 (550)
T KOG0578|consen  314 KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIH  392 (550)
T ss_pred             hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceee
Confidence            577889999999999999999999999999999999999999999988654 38999999999987  999999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||.+||++   ..++.+|+.|||+|.++.... ...+.+|||+|||||+.....|++++|||||
T Consensus       393 rDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSL  455 (550)
T KOG0578|consen  393 RDIKSDNILL---TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSL  455 (550)
T ss_pred             eccccceeEe---ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhh
Confidence            9999999999   567789999999999876654 5678899999999999999999999999997

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=218.27  Aligned_cols=140  Identities=27%  Similarity=0.506  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .++|.+|+++|++++|+|||++++++..++.+||||||++.|+|.++++.  ...+...+.+.++.||  |++||.++++
T Consensus       245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~  324 (468)
T KOG0197|consen  245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY  324 (468)
T ss_pred             hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc
Confidence            37788999999999999999999999998899999999999999999986  3458889999999999  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccc--cCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||||..+|||+   +.+..+|++|||+|+.+.......  ...-...|.|||+++.+.++.+||||||
T Consensus       325 IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSF  390 (468)
T KOG0197|consen  325 IHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSF  390 (468)
T ss_pred             cchhhhhhheee---ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeeh
Confidence            999999999999   577799999999999544443321  2222456999999999999999999998

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-36  Score=223.02  Aligned_cols=143  Identities=36%  Similarity=0.731  Sum_probs=133.6

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ......+.+|+.||+-++|||+++++++++.+.++|++.||+++|.|++++...+.+++.....+++||  |+.|+|..+
T Consensus        53 ~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~  132 (786)
T KOG0588|consen   53 SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN  132 (786)
T ss_pred             cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc
Confidence            345678899999999999999999999999999999999999999999999999999999999999998  999999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCC-cccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dvws~  152 (152)
                      |+|||+||+|+|+   +..+++|++|||+|....++....+-||+|.|+|||++.+.+|+ .++||||.
T Consensus       133 icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSC  198 (786)
T KOG0588|consen  133 ICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSC  198 (786)
T ss_pred             ceeccCCchhhhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchh
Confidence            9999999999999   56677999999999887778888999999999999999999986 68999983

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-36  Score=217.71  Aligned_cols=148  Identities=35%  Similarity=0.595  Sum_probs=132.5

Q ss_pred             cchhhHhH------HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHH
Q 031828            2 LKKLNKHL------KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (152)
Q Consensus         2 ~k~~~~~~------~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~   74 (152)
                      +|+++.+.      .+.+..|-.+|.+| .||.|++|+..|+++..+|+|+||+++|+|.+++.+.+.+.+...+.++.+
T Consensus       103 iKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAe  182 (604)
T KOG0592|consen  103 IKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAE  182 (604)
T ss_pred             HhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHH
Confidence            45555433      36677899999999 899999999999999999999999999999999999999999999999999


Q ss_pred             H--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--------------ccccCCCCCCccccccc
Q 031828           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------------YAEKVCGSPLYMAPEVL  138 (152)
Q Consensus        75 i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------------~~~~~~~t~~y~aPE~~  138 (152)
                      |  |++|||++|||||||||+|||+   +.+.+++|.|||.|+.+.+..              ...+++||..|.+||++
T Consensus       183 IldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL  259 (604)
T KOG0592|consen  183 ILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL  259 (604)
T ss_pred             HHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHh
Confidence            8  9999999999999999999999   788999999999998765421              11458899999999999


Q ss_pred             ccCCCCcccceeeC
Q 031828          139 QFQRYDEKVNFFVS  152 (152)
Q Consensus       139 ~~~~~~~~~Dvws~  152 (152)
                      .++..++.+|+|||
T Consensus       260 ~~~~~~~~sDiWAl  273 (604)
T KOG0592|consen  260 NDSPAGPSSDLWAL  273 (604)
T ss_pred             cCCCCCcccchHHH
Confidence            99999999999996

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=201.37  Aligned_cols=149  Identities=36%  Similarity=0.563  Sum_probs=136.4

Q ss_pred             chhhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         3 k~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      |+++.+..+.+.+|+.|.+.++||||+++.+.....+..|+|+|++.|++|..-+-++.-+++..+..++.||  ++.|+
T Consensus        47 ~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yC  126 (355)
T KOG0033|consen   47 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYC  126 (355)
T ss_pred             hhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            4556667889999999999999999999999999999999999999999998776666668888899999998  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceee
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                      |.++|+|||+||.|++++..+...-+|++|||++..+..+.......|||.|||||++...+|+.++||||
T Consensus       127 H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~  197 (355)
T KOG0033|consen  127 HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA  197 (355)
T ss_pred             HhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhh
Confidence            99999999999999999987888899999999999888666678899999999999999999999999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-36  Score=207.15  Aligned_cols=142  Identities=31%  Similarity=0.567  Sum_probs=125.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.-..+|+++|++++|+|+|.+.++|...+.+++|+|||+..-|.++-+....++...+..++.|+  |+.|+|++++
T Consensus        43 ~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~  122 (396)
T KOG0593|consen   43 VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNC  122 (396)
T ss_pred             HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCe
Confidence            33566789999999999999999999999999999999999655555554555669999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccC-CCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +||||||+|||+   ...+.+|+||||+||.+. ++..++..+.|.||.|||.+.+ -+|++++||||+
T Consensus       123 IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAi  188 (396)
T KOG0593|consen  123 IHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAI  188 (396)
T ss_pred             ecccCChhheEE---ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhh
Confidence            999999999999   477899999999999887 5567788899999999999998 569999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=216.70  Aligned_cols=135  Identities=34%  Similarity=0.549  Sum_probs=123.8

Q ss_pred             HHHHHHHHcCC-CcCccceeeeeeeCC-eEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           14 DCELNFLSSVN-HPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        14 ~~E~~~l~~l~-h~ni~~l~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      .+|++-|++++ ||||+++.+++.+.+ .+++||||| ..+|+++++.+ ..|++..++.|+.||  ||.++|.+|+.||
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHR  134 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHR  134 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            47999999998 999999999998887 999999999 68999999754 459999999999999  9999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      |+||+|||+.   ....+||+|||+||.+.+...++..+.|.||.|||++...+ |+.+.||||+
T Consensus       135 DlKPENiLi~---~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~  196 (538)
T KOG0661|consen  135 DLKPENILIS---GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAV  196 (538)
T ss_pred             cCChhheEec---ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHH
Confidence            9999999994   46789999999999999888888999999999999997654 8999999985

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-36  Score=215.91  Aligned_cols=144  Identities=34%  Similarity=0.641  Sum_probs=133.4

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCe-EEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~-~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~l   80 (152)
                      +.++++...+|+.++++++|||||.+++.|+.++. .+++|+||+||++.+.++..+  .+++..+..|+.|+  |+.||
T Consensus        43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl  122 (426)
T KOG0589|consen   43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL  122 (426)
T ss_pred             CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            45677889999999999999999999999999988 999999999999999997554  59999999999998  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+++++|||+|+.||++   .+...+++.|||+|+.+.+.. ...+..|||.||+||++.+.+|+.|+|||||
T Consensus       123 H~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsL  192 (426)
T KOG0589|consen  123 HENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSL  192 (426)
T ss_pred             Hhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhh
Confidence            99999999999999999   567788999999999988776 7788999999999999999999999999997

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=206.48  Aligned_cols=140  Identities=35%  Similarity=0.616  Sum_probs=120.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCC--eEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      .+.+.+|+++|++++|||||+++|......  .+++.|||+++|+|.+++++.+ .+++..+..+..++  |+.|||++|
T Consensus        58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g  137 (313)
T KOG0198|consen   58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG  137 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            567899999999999999999999754444  6899999999999999999887 69999999999998  999999999


Q ss_pred             CeecCCCCCceEeecCCC-CceEEEeeccCccccCC----CCccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYP----GNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~-~~~~kl~dfg~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      ++||||||+|||+.   . ++.+||+|||++.....    ........||+.|||||++..+. ...++|||||
T Consensus       138 ~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSl  208 (313)
T KOG0198|consen  138 IVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSL  208 (313)
T ss_pred             EeccCcccceEEEe---CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhc
Confidence            99999999999994   5 57999999999987653    12234578999999999999632 3359999997

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.5e-36  Score=219.50  Aligned_cols=141  Identities=34%  Similarity=0.655  Sum_probs=130.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ++...+++|++|++.++||||+.++++|++..++|+|.||+.| +|..++...+.++++.+..+..++  |+.|||+++|
T Consensus        43 k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~ri  121 (808)
T KOG0597|consen   43 KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRI  121 (808)
T ss_pred             HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCc
Confidence            4456699999999999999999999999999999999999965 999999999999999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|||+||+|||+   ++.+.+|++|||+|+.+..+.. .+...|||.|||||+..++.|+..+|+||+
T Consensus       122 lhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWsl  186 (808)
T KOG0597|consen  122 LHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSL  186 (808)
T ss_pred             ccccCCcceeee---cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHH
Confidence            999999999999   6788999999999998766543 466789999999999999999999999996

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-35  Score=209.45  Aligned_cols=140  Identities=37%  Similarity=0.712  Sum_probs=132.4

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .-.+++|++||+.++||||+.++++|+..+.+.+||||..+|.|++++...+.+++.....++.||  |+.|+|.++++|
T Consensus        97 lvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvH  176 (668)
T KOG0611|consen   97 LVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVH  176 (668)
T ss_pred             HHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcccee
Confidence            456789999999999999999999999999999999999999999999999999999999999999  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCC-cccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dvws~  152 (152)
                      ||+|.+|||+   +.++++|++|||++-.+......+++||+|-|.+||+.++.+|. +.+|-|||
T Consensus       177 RDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsL  239 (668)
T KOG0611|consen  177 RDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSL  239 (668)
T ss_pred             cccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhH
Confidence            9999999999   68889999999999888777888999999999999999999875 68999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=208.39  Aligned_cols=140  Identities=34%  Similarity=0.586  Sum_probs=125.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+++|++.|+.++||||++++.+|..+..+|+||.||.+|++.++++..  ..+++..+..++.++  ||.|||.+|-
T Consensus        68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~  147 (516)
T KOG0582|consen   68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH  147 (516)
T ss_pred             HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence            688999999999999999999999999999999999999999999999854  348999999999997  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-c---c-ccCCCCCCccccccccc--CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y---A-EKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~---~-~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~  152 (152)
                      ||||+|+.|||+   +.++.+||+|||.+..+..++ +   . .++.||++|||||++..  .+|+.|+|||||
T Consensus       148 IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSf  218 (516)
T KOG0582|consen  148 IHRDVKAGNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSF  218 (516)
T ss_pred             eecccccccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhh
Confidence            999999999999   688899999999987654443 1   1 56689999999999653  569999999997

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=220.01  Aligned_cols=145  Identities=36%  Similarity=0.618  Sum_probs=130.4

Q ss_pred             hhhHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            4 KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         4 ~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ++.+++.++...|.+|+... +||+++.++++|++++++|+||||+.||++.+. .+.+.+++..+..|+..+  ||+||
T Consensus       406 Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fL  484 (694)
T KOG0694|consen  406 ILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFL  484 (694)
T ss_pred             eeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHH
Confidence            34567788899999999888 599999999999999999999999999995443 345679999999999997  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccC-CCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |++||++||||.+|||+   +..+.+||+|||+++.-. .+....|+||||.|||||++.+..|+.++|||||
T Consensus       485 H~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~l  554 (694)
T KOG0694|consen  485 HENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGL  554 (694)
T ss_pred             HhcCceeeecchhheEE---cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHH
Confidence            99999999999999999   788999999999998744 5567889999999999999999999999999996

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-35  Score=209.66  Aligned_cols=138  Identities=33%  Similarity=0.535  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ....+||.||++++||||++|.+.....  +.+|+|+||| ..||.-++...+ .|++.++..++.|+  ||.|||.+|+
T Consensus       161 ~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gv  239 (560)
T KOG0600|consen  161 ITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGV  239 (560)
T ss_pred             HHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCe
Confidence            4456899999999999999999988766  7899999999 589998887654 59999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +|||||..|||+   +..+.+||+|||+|+.+.+..  ..+..+-|.||.|||++.+.. |+.++|+||.
T Consensus       240 lHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~  306 (560)
T KOG0600|consen  240 LHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSV  306 (560)
T ss_pred             eeccccccceEE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhh
Confidence            999999999999   788899999999999876654  456777899999999999864 9999999984

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.7e-35  Score=219.18  Aligned_cols=143  Identities=27%  Similarity=0.548  Sum_probs=128.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--------------CCCHHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFL   72 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~~   72 (152)
                      ...+++|++|+++|..++|||||+|+|+|..++..|+|+|||..|||.+||+...              +++..+.+.++
T Consensus       530 ~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA  609 (774)
T KOG1026|consen  530 NQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIA  609 (774)
T ss_pred             HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHH
Confidence            3478999999999999999999999999999999999999999999999997432              27788999999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccC---CCCCCcccccccccCCCCccc
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---CGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      .||  |+.||-++.++||||.++|+|+   +....|||+|||++|.+++.+++...   .-..+|||||.+..+.+|++|
T Consensus       610 ~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteS  686 (774)
T KOG1026|consen  610 TQIAAGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTES  686 (774)
T ss_pred             HHHHHHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchh
Confidence            999  8999999999999999999999   57779999999999998887655432   224679999999999999999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |||||
T Consensus       687 DVWs~  691 (774)
T KOG1026|consen  687 DVWSF  691 (774)
T ss_pred             hhhhh
Confidence            99996

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=205.36  Aligned_cols=140  Identities=29%  Similarity=0.405  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCC-eEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+|..|+.++.+++|||+++|+|+|.+.+ +.++|+||+++|+|.+.+....  .+++.....++..+  |+.|||...
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~  194 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC  194 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence            345999999999999999999999999888 5999999999999999986544  78999999999888  899999854


Q ss_pred             ---CeecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccC-CCCCCcccccccccCCCCcccceeeC
Q 031828           85 ---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKV-CGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ---~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                         ++|||||+.|||+   +.+.+.|++|||+|+.... .....+. .||.+|+|||+...+..+.++|||||
T Consensus       195 ~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySF  264 (361)
T KOG1187|consen  195 PPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSF  264 (361)
T ss_pred             CCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccc
Confidence               9999999999999   7889999999999965543 3322233 89999999999999889999999997

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-33  Score=200.34  Aligned_cols=141  Identities=31%  Similarity=0.477  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ....+.+|+.+++.++||||+++++++..++..|++|||+++++|.+.+...+.+++..+..++.++  |+.|||+++++
T Consensus        38 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv  117 (323)
T cd05571          38 EVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV  117 (323)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            3456788999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+|++|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus       118 HrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  181 (323)
T cd05571         118 YRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (323)
T ss_pred             eCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCccc
Confidence            99999999999   56778999999998754322 23445679999999999998889999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-34  Score=195.52  Aligned_cols=142  Identities=38%  Similarity=0.774  Sum_probs=132.2

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      +.++.-.+|+.||+++ .||+|+.+.++|+++..+++|+|.|+.|.|.+++...-.+++.....++.++  |+.|+|.++
T Consensus        64 ~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~  143 (411)
T KOG0599|consen   64 EMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN  143 (411)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh
Confidence            4577888999999998 7999999999999999999999999999999999998899999999999998  999999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc------CCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Dvws~  152 (152)
                      |+|||+||+|||+   +.+-++++.|||++.++.++......||||+|+|||.+.-      .+|+..+|+||.
T Consensus       144 IVHRDLKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~  214 (411)
T KOG0599|consen  144 IVHRDLKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC  214 (411)
T ss_pred             hhhcccChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence            9999999999999   6777999999999999999999999999999999999853      358899999984

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.8e-33  Score=203.72  Aligned_cols=141  Identities=26%  Similarity=0.530  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+..|+.++..++|+||+++++.+.+....|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||+.+++
T Consensus        44 ~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~giv  123 (363)
T cd05628          44 QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI  123 (363)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            3567889999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC------------------------------------ccccCCCCC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGSP  130 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~------------------------------------~~~~~~~t~  130 (152)
                      ||||||+||++   +..+.+||+|||+++.+....                                    .....+||+
T Consensus       124 HrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~  200 (363)
T cd05628         124 HRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP  200 (363)
T ss_pred             ecCCCHHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence            99999999999   566789999999987543210                                    012457999


Q ss_pred             CcccccccccCCCCcccceeeC
Q 031828          131 LYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       131 ~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .|+|||++.+..++.++|||||
T Consensus       201 ~Y~aPE~~~~~~~~~~~DvwSl  222 (363)
T cd05628         201 DYIAPEVFMQTGYNKLCDWWSL  222 (363)
T ss_pred             cccCHHHHcCCCCCCchhhhhh
Confidence            9999999999899999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=203.39  Aligned_cols=143  Identities=36%  Similarity=0.653  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .++.+.+|+++|+.+. ||||+.++++|++...+++|||++.||.|.+.+... .+++..+..++.++  ++.|||..|+
T Consensus        78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gv  156 (382)
T KOG0032|consen   78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGV  156 (382)
T ss_pred             cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3578999999999998 999999999999999999999999999999999876 49999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCC-CceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|+||+|+|+..... ...++++|||++.....+......+||+.|+|||++...+|+..+||||+
T Consensus       157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~  224 (382)
T KOG0032|consen  157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSI  224 (382)
T ss_pred             eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHH
Confidence            99999999999975443 35899999999998877667788999999999999999999999999984

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-33  Score=202.98  Aligned_cols=142  Identities=28%  Similarity=0.556  Sum_probs=123.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+++++.++||||+++++++.+++.+|+||||+++++|.+++...+.+++..+..++.++  |+.|||++++
T Consensus        43 ~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~gi  122 (377)
T cd05629          43 DQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGF  122 (377)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC--------------------------------------------
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------------------------------------------  121 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------------------------------------------  121 (152)
                      +|+||||+||++   +..+.++++|||+++.+....                                            
T Consensus       123 vHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (377)
T cd05629         123 IHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK  199 (377)
T ss_pred             eccCCCHHHEEE---CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence            999999999999   567789999999986321100                                            


Q ss_pred             ----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          122 ----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       122 ----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                          .....+||+.|+|||++.+..++.++|||||
T Consensus       200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence                0012468999999999998889999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-33  Score=201.02  Aligned_cols=140  Identities=32%  Similarity=0.607  Sum_probs=126.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+.+++.++||||+++++++..++..|++|||+.+++|.+++..+..+++..+..++.++  |+.|||+.++
T Consensus        73 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  152 (340)
T PTZ00426         73 KQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI  152 (340)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999999999999988889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++.....  ..+.+||+.|+|||++.+..++.++|||||
T Consensus       153 vHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  214 (340)
T PTZ00426        153 VYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTL  214 (340)
T ss_pred             EccCCCHHHEEE---CCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccch
Confidence            999999999999   56778999999999765332  345678999999999998889999999996

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-33  Score=204.17  Aligned_cols=142  Identities=29%  Similarity=0.570  Sum_probs=126.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+-++.|-.+|...++|.||+|+.+|++...+|+||||++|||+..++.+.+.+++..+..|+.++  |+..+|+.|+
T Consensus       183 ~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gy  262 (550)
T KOG0605|consen  183 NQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGY  262 (550)
T ss_pred             hhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCc
Confidence            45677889999999999999999999999999999999999999999999999999999999999997  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC----------------------CC-c--------------------
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------------GN-Y--------------------  122 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~----------------------~~-~--------------------  122 (152)
                      +||||||+|+|+   +..+.+||.|||+|..+..                      .. .                    
T Consensus       263 IHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~  339 (550)
T KOG0605|consen  263 IHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKR  339 (550)
T ss_pred             ccccCChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHh
Confidence            999999999999   7888999999999953211                      00 0                    


Q ss_pred             -----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828          123 -----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       123 -----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                           .-..+|||-|+|||++.+.+|+..+|+|||
T Consensus       340 nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  340 NRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                 012469999999999999999999999996

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-33  Score=197.20  Aligned_cols=142  Identities=35%  Similarity=0.534  Sum_probs=126.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .....+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++...+.+++..+..++.++  |+.|||++++
T Consensus        35 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  114 (312)
T cd05585          35 SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNV  114 (312)
T ss_pred             hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567788999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus       115 ~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  179 (312)
T cd05585         115 IYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL  179 (312)
T ss_pred             EeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceech
Confidence            999999999999   56778999999998754322 23445679999999999999889999999996

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-33  Score=199.57  Aligned_cols=139  Identities=35%  Similarity=0.639  Sum_probs=125.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|++++++++||||+++++++..++..|++|||+.+++|.+.+.+.+.+++..+..++.++  |+.|||+++++
T Consensus        61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  140 (329)
T PTZ00263         61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDII  140 (329)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3567889999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++.....  ....+||+.|+|||++.+..++.++|||||
T Consensus       141 H~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  201 (329)
T PTZ00263        141 YRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTM  201 (329)
T ss_pred             ecCCCHHHEEE---CCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCCCCCcceeech
Confidence            99999999999   56778999999999765432  234678999999999999889999999996

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-33  Score=200.96  Aligned_cols=141  Identities=28%  Similarity=0.588  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ....+.+|+++++.++||||+++++++..++..|+||||+++++|.+++...+.+++..+..++.|+  |+.|||+++++
T Consensus        44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iv  123 (364)
T cd05599          44 QVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYI  123 (364)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            4566889999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC---------------------------------------ccccCC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------------------------------YAEKVC  127 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---------------------------------------~~~~~~  127 (152)
                      |+||||+||++   +..+.++++|||++..+....                                       ...+.+
T Consensus       124 H~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (364)
T cd05599         124 HRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV  200 (364)
T ss_pred             eccCCHHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence            99999999999   567789999999986543211                                       011346


Q ss_pred             CCCCcccccccccCCCCcccceeeC
Q 031828          128 GSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       128 ~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+.|+|||++....++.++|||||
T Consensus       201 gt~~y~aPE~~~~~~~~~~~DiwSl  225 (364)
T cd05599         201 GTPDYIAPEVFLQTGYNKECDWWSL  225 (364)
T ss_pred             cCccccCHHHHcCCCCCCeeeeecc
Confidence            8999999999998899999999997

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.4e-33  Score=198.37  Aligned_cols=141  Identities=32%  Similarity=0.495  Sum_probs=125.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ....+.+|+++++.++||||+++++++..++..|+||||+++++|...+...+.+++..+..++.++  |+.|||+++++
T Consensus        38 ~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  117 (323)
T cd05595          38 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  117 (323)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            4456778999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+|++|||+++..... .......||+.|+|||++.+..++.++|||||
T Consensus       118 H~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  181 (323)
T cd05595         118 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (323)
T ss_pred             ecCCCHHHEEE---cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhh
Confidence            99999999999   56778999999998753322 23345678999999999998889999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-33  Score=198.16  Aligned_cols=139  Identities=35%  Similarity=0.616  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ....+..|+++++.++||||+++++++..++..|++|||+++++|.+++...+.+++..+..++.++  |+.+||+++++
T Consensus        44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv  123 (333)
T cd05600          44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI  123 (333)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3466788999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++....  ......||+.|+|||++.+..++.++|||||
T Consensus       124 H~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  184 (333)
T cd05600         124 HRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSL  184 (333)
T ss_pred             ccCCCHHHEEE---CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecc
Confidence            99999999999   5677899999999975433  3345678999999999998899999999996

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.6e-33  Score=201.27  Aligned_cols=142  Identities=29%  Similarity=0.557  Sum_probs=124.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+++++.++|+||+++++++.+++.+|++|||+++++|.+++.+.+.+++..+..++.++  |+.|||..++
T Consensus        43 ~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~gi  122 (381)
T cd05626          43 NQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF  122 (381)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC---------------------------------------------
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------------------------------------  120 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---------------------------------------------  120 (152)
                      +|+||||+||++   +..+.++++|||+++.....                                             
T Consensus       123 vHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (381)
T cd05626         123 IHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ  199 (381)
T ss_pred             eecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence            999999999999   56678999999997532100                                             


Q ss_pred             ---CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          121 ---NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       121 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                         ....+.+||+.|+|||++.+..++.++|||||
T Consensus       200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             ccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence               00124578999999999998889999999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-32  Score=200.84  Aligned_cols=142  Identities=30%  Similarity=0.587  Sum_probs=123.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+.+++.++|+||+++++.+.+++.+|+||||+++++|.+++.+.+.+++..+..++.|+  |+.|||+.++
T Consensus        43 ~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~i  122 (382)
T cd05625          43 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF  122 (382)
T ss_pred             HHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC---------------------------------------------
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------------------------------------  120 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---------------------------------------------  120 (152)
                      +|+||||+||++   +..+.+||+|||+++.....                                             
T Consensus       123 vHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (382)
T cd05625         123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ  199 (382)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence            999999999999   56778999999997532100                                             


Q ss_pred             ---CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          121 ---NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       121 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                         ....+.+||+.|+|||++.+..++.++|||||
T Consensus       200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             cccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence               00123468999999999998899999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-32  Score=197.35  Aligned_cols=142  Identities=31%  Similarity=0.482  Sum_probs=126.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .....+.+|+++++.++||||+++++++..++..|+||||+++++|...+...+.+++..+..++.++  |+.|||++++
T Consensus        37 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i  116 (328)
T cd05593          37 DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI  116 (328)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34567788999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||
T Consensus       117 vHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  181 (328)
T cd05593         117 VYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  181 (328)
T ss_pred             EecccCHHHeEE---CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCcccc
Confidence            999999999999   5677899999999875332 223345679999999999998889999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-32  Score=200.05  Aligned_cols=141  Identities=29%  Similarity=0.568  Sum_probs=123.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++|+||+++++.+..++.+|+||||+++++|.+++.+.+.+++..+..++.|+  |+.|||+.+++
T Consensus        44 ~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  123 (376)
T cd05598          44 QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI  123 (376)
T ss_pred             hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3567889999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC--------------------------------------------Cc
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------------------NY  122 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~--------------------------------------------~~  122 (152)
                      |+||||+||++   +..+.++|+|||++..+...                                            ..
T Consensus       124 HrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (376)
T cd05598         124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL  200 (376)
T ss_pred             eCCCCHHHEEE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence            99999999999   56778999999997532100                                            00


Q ss_pred             cccCCCCCCcccccccccCCCCcccceeeC
Q 031828          123 AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       123 ~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ....+||+.|+|||++.+..++.++|||||
T Consensus       201 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            123578999999999998899999999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=206.52  Aligned_cols=139  Identities=32%  Similarity=0.540  Sum_probs=126.5

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      +.-.-+|.=|++|+||||+.+.|+|.....+|||||||+.|.|...++....+.......|..+|  |+.|||.+.||||
T Consensus       157 elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHR  236 (904)
T KOG4721|consen  157 ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHR  236 (904)
T ss_pred             hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhh
Confidence            33345778899999999999999999999999999999999999999999999999999999999  8999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||.-|||++   ....+||+|||.++.+......-.++||..|||||++.+++.+.|+|||||
T Consensus       237 DLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSf  297 (904)
T KOG4721|consen  237 DLKSPNILIS---YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSF  297 (904)
T ss_pred             ccCCCceEee---ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehh
Confidence            9999999994   666899999999987655555567899999999999999999999999997

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.2e-32  Score=199.05  Aligned_cols=142  Identities=25%  Similarity=0.546  Sum_probs=125.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+..|+.++..++|+||+++++.+..++.+|+||||+++++|.+++.+.+.+++..+..++.++  |+.+||+.++
T Consensus        43 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~gi  122 (360)
T cd05627          43 EQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF  122 (360)
T ss_pred             hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567888999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC------------------------------------ccccCCCC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGS  129 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~------------------------------------~~~~~~~t  129 (152)
                      +|+||||+||++   +..+.++++|||+++......                                    .....+||
T Consensus       123 vHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  199 (360)
T cd05627         123 IHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGT  199 (360)
T ss_pred             EccCCCHHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCC
Confidence            999999999999   567789999999986542210                                    01235789


Q ss_pred             CCcccccccccCCCCcccceeeC
Q 031828          130 PLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       130 ~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.|+|||++.+..++.++|||||
T Consensus       200 ~~Y~APE~~~~~~~~~~~DiwSl  222 (360)
T cd05627         200 PDYIAPEVFMQTGYNKLCDWWSL  222 (360)
T ss_pred             ccccCHHHHcCCCCCCcceeccc
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-32  Score=195.80  Aligned_cols=140  Identities=36%  Similarity=0.566  Sum_probs=124.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ...+..|+.+++.++||||+++++++..++..|++|||+.+++|.+++.+.+.+++..+..++.++  |+.|||+.+++|
T Consensus        44 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  123 (323)
T cd05584          44 TAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIY  123 (323)
T ss_pred             HHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            456788999999999999999999999999999999999999999999888888999988888888  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++   +..+.+||+|||+++..... .......||+.|+|||++.+..++.++|||||
T Consensus       124 ~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  186 (323)
T cd05584         124 RDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSL  186 (323)
T ss_pred             CCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceeccc
Confidence            9999999999   56778999999998754332 23345678999999999998889999999996

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-32  Score=194.88  Aligned_cols=141  Identities=32%  Similarity=0.500  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh-CCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~-~~~   85 (152)
                      ....+..|+++++.++||||+++++++..++..|+||||+++++|..++.....+++..+..++.++  |+.|||+ .++
T Consensus        38 ~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~i  117 (325)
T cd05594          38 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV  117 (325)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence            3466778999999999999999999999999999999999999999999888889999999999998  8999997 799


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||+++.... ........||+.|+|||++.+..++.++|||||
T Consensus       118 vHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (325)
T cd05594         118 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  182 (325)
T ss_pred             EecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccc
Confidence            999999999999   5677899999999875432 223345679999999999998889999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-32  Score=195.38  Aligned_cols=141  Identities=36%  Similarity=0.569  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ....+..|++++++++||||+++++++..++..|+||||+++++|.+++.+...+++..+..++.++  |+.|||+++++
T Consensus        41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  120 (318)
T cd05582          41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII  120 (318)
T ss_pred             hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            3456778999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +.++.++|+|||+++..... .......|++.|+|||++.+..++.++|||||
T Consensus       121 H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  184 (318)
T cd05582         121 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF  184 (318)
T ss_pred             cCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceecc
Confidence            99999999999   56678999999998765443 23345678999999999998889999999997

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=202.56  Aligned_cols=146  Identities=31%  Similarity=0.563  Sum_probs=132.1

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHH-H-hcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-R-LHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~-~-~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ..++.++++.|+.||+.++||.||.+..-|++++.+++|||-+ +|+..+.+ . +.+.+++..-..++.||  ||.|||
T Consensus       603 p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH  681 (888)
T KOG4236|consen  603 PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH  681 (888)
T ss_pred             CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh
Confidence            3466799999999999999999999999999999999999998 55655554 3 45669999999999998  999999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ..+|+|+|+||+|+|++..++...+|++|||+||.+.......+++|||.|+|||++++++|+.+-|+||.
T Consensus       682 ~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSV  752 (888)
T KOG4236|consen  682 FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSV  752 (888)
T ss_pred             hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceee
Confidence            99999999999999998777778999999999999888888889999999999999999999999999994

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-33  Score=195.89  Aligned_cols=139  Identities=37%  Similarity=0.648  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.+.+.+++..+..++.++  |+.|||+++++
T Consensus        44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  123 (291)
T cd05612          44 QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV  123 (291)
T ss_pred             HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4567889999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+|++|||+++.....  ....+|++.|+|||++.+..++.++|||||
T Consensus       124 H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  184 (291)
T cd05612         124 YRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWAL  184 (291)
T ss_pred             ecCCCHHHeEE---CCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHH
Confidence            99999999999   46678999999998765332  234578999999999998889999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-33  Score=203.74  Aligned_cols=140  Identities=41%  Similarity=0.765  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ++.+.+|+++|+.++|||||+++.+.+.+..+|+||||+.+|.+.+++.+++...+..+..++.|+  |++|||+.+++|
T Consensus        99 ~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivH  178 (596)
T KOG0586|consen   99 RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVH  178 (596)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceec
Confidence            455889999999999999999999999999999999999999999999999998889999999998  999999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCC-cccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dvws~  152 (152)
                      +|||++|+++   +.+.++||+|||++..+.......+.||++.|+|||++.+..|+ +.+|+||+
T Consensus       179 rdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wsl  241 (596)
T KOG0586|consen  179 RDLKAENILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSL  241 (596)
T ss_pred             cccchhhccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhh
Confidence            9999999999   67778999999999999888888999999999999999998875 78999996

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-32  Score=194.78  Aligned_cols=140  Identities=33%  Similarity=0.644  Sum_probs=124.9

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|..+++.+ +||||+++++++..++.+|++|||+++++|..++.+.+.+++..+..++.++  |+.|||+++++
T Consensus        39 ~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv  118 (329)
T cd05588          39 IDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII  118 (329)
T ss_pred             HHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45678899999998 7999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCcccc-CCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++.. .........+||+.|+|||++.+..++.++|+|||
T Consensus       119 H~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (329)
T cd05588         119 YRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL  182 (329)
T ss_pred             ecCCCHHHeEE---CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceech
Confidence            99999999999   56678999999998753 22333456789999999999999889999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-33  Score=193.16  Aligned_cols=135  Identities=30%  Similarity=0.464  Sum_probs=120.1

Q ss_pred             HHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           14 DCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        14 ~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      .+||.+|.+++|||||.+.++....  +.+|+||||| ..||...+..-+ .+...++..++.|+  |+.|||++.|+||
T Consensus       123 LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHR  201 (419)
T KOG0663|consen  123 LREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHR  201 (419)
T ss_pred             HHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEec
Confidence            5899999999999999999988655  5799999999 589999987655 79999999999998  9999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      |+||+|+|+   ...+.+|++|||+||.+.++. ..+..+-|.||.|||++.+.. |+++.|+||+
T Consensus       202 DLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSv  264 (419)
T KOG0663|consen  202 DLKTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSV  264 (419)
T ss_pred             ccchhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhH
Confidence            999999999   577899999999999987764 355667799999999999855 9999999995

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-32  Score=191.11  Aligned_cols=138  Identities=36%  Similarity=0.574  Sum_probs=121.7

Q ss_pred             HHHHHHHHHHHcCCCcC-ccceeeeeeeCC------eEEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHHH--HH
Q 031828           11 SCLDCELNFLSSVNHPN-IIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GL   77 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i--~l   77 (152)
                      ....+|+.+++.++|+| |+.+++++.+.+      .+++|+||+ ..+|..+++...    .++...++.++.|+  |+
T Consensus        55 ~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl  133 (323)
T KOG0594|consen   55 STAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGL  133 (323)
T ss_pred             chhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHH
Confidence            44578999999999999 999999998877      789999998 689999998655    47778999999998  99


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      .|||+++|+||||||+|+++   ++.+.+|++|||+|+...-+ ...+...+|.+|.|||++.+. .|++..||||+
T Consensus       134 ~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~  207 (323)
T KOG0594|consen  134 AFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSL  207 (323)
T ss_pred             HHHHhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhH
Confidence            99999999999999999999   56889999999999976533 346667789999999999986 59999999995

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-33  Score=200.56  Aligned_cols=144  Identities=33%  Similarity=0.611  Sum_probs=132.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .-....+.+|+++|+-++|||||+||++..++..+|+|+|+-.+|+|++++-+ ...+.+.....|+.||  |+.|+|+.
T Consensus        58 ~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL  137 (864)
T KOG4717|consen   58 TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL  137 (864)
T ss_pred             hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh
Confidence            34467788999999999999999999999999999999999999999999854 4569999999999998  99999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCC-cccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dvws~  152 (152)
                      .++|||+||+|+++.  .+-+-+||.|||++-.+.++.+..+.||+..|.|||++.+..|+ +++|||||
T Consensus       138 HVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSL  205 (864)
T KOG4717|consen  138 HVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSL  205 (864)
T ss_pred             hhhcccCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHH
Confidence            999999999999885  56789999999999999999999999999999999999999998 67999996

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-32  Score=203.41  Aligned_cols=142  Identities=30%  Similarity=0.585  Sum_probs=124.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ...+.+++|+++++.++||||+++++++..++..|+||||+++++|.+.+.+    ...+++..+..++.++  |+.++|
T Consensus       107 ~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH  186 (478)
T PTZ00267        107 RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH  186 (478)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4456788899999999999999999999999999999999999999987753    3458889999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++   +..+.+||+|||+++.+....   .....+||+.|+|||++.+..++.++|||||
T Consensus       187 ~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  257 (478)
T PTZ00267        187 SRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL  257 (478)
T ss_pred             hCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHH
Confidence            9999999999999999   567789999999998764432   2345679999999999998889999999996

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=200.56  Aligned_cols=145  Identities=29%  Similarity=0.456  Sum_probs=124.4

Q ss_pred             hhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHH--HHHHHH
Q 031828            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         5 ~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i--~l~~lh   81 (152)
                      +...++..+.+|+++|+.++|||||+++|+...+..++++||+|.||+|.+++++++. ++..+...++.+.  |++|||
T Consensus       200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh  279 (474)
T KOG0194|consen  200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH  279 (474)
T ss_pred             ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence            4467789999999999999999999999999999999999999999999999998875 8888888888887  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccc-cCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++||||..+|+|+   .....+|++|||+++.-..-.... ...-...|+|||.+....|+.++|||||
T Consensus       280 ~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sf  348 (474)
T KOG0194|consen  280 SKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSF  348 (474)
T ss_pred             HCCCcchhHhHHHhee---cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhhe
Confidence            9999999999999999   455568999999987532111111 1123567999999999999999999997

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.1e-32  Score=196.54  Aligned_cols=140  Identities=31%  Similarity=0.586  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++.+|+||||+++++|.+++... .+++..+..++.++  |+.|||+.+++
T Consensus        86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~Iv  164 (370)
T cd05621          86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLI  164 (370)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3456889999999999999999999999999999999999999999998654 57888899999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCC----CCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR----YDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~----~~~~~Dvws~  152 (152)
                      ||||||+||++   +..+.+||+|||+++......  ...+.+||+.|+|||++....    ++.++|||||
T Consensus       165 HrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSl  233 (370)
T cd05621         165 HRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV  233 (370)
T ss_pred             ecCCCHHHEEE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEee
Confidence            99999999999   567789999999998764332  234677999999999997643    7889999996

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.5e-32  Score=192.95  Aligned_cols=141  Identities=31%  Similarity=0.601  Sum_probs=124.6

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|+.++..+ +||||+++++++..++..++||||+++++|...+...+.+++..+..++.++  |+.|||++++
T Consensus        38 ~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i  117 (329)
T cd05618          38 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI  117 (329)
T ss_pred             HHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345678899988876 8999999999999999999999999999999998888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||
T Consensus       118 vH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (329)
T cd05618         118 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL  182 (329)
T ss_pred             eeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecc
Confidence            999999999999   5677899999999875322 233445678999999999999889999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=195.90  Aligned_cols=142  Identities=34%  Similarity=0.624  Sum_probs=126.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .....+..|++++..++|+||+++++++..++..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||+.++
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  122 (350)
T cd05573          43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF  122 (350)
T ss_pred             cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567889999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC------------------------------ccccCCCCCCcccc
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------YAEKVCGSPLYMAP  135 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~------------------------------~~~~~~~t~~y~aP  135 (152)
                      +|+||||+||++   +..+.++|+|||+++......                              ......||+.|+||
T Consensus       123 iH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  199 (350)
T cd05573         123 IHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP  199 (350)
T ss_pred             eccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence            999999999999   567789999999997654432                              22345689999999


Q ss_pred             cccccCCCCcccceeeC
Q 031828          136 EVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       136 E~~~~~~~~~~~Dvws~  152 (152)
                      |++.+..++.++|||||
T Consensus       200 E~~~~~~~~~~~DiwSl  216 (350)
T cd05573         200 EVLRGTPYGLECDWWSL  216 (350)
T ss_pred             HHHcCCCCCCceeeEec
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-32  Score=187.44  Aligned_cols=149  Identities=32%  Similarity=0.551  Sum_probs=129.1

Q ss_pred             cchhhHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeC----CeEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQ   74 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~   74 (152)
                      +|++.+.  ...++|+++.-.. .|||||.++++|+..    ..+.+|||.++||.|++.+..++.  +++..+..++.+
T Consensus        92 LKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~q  169 (400)
T KOG0604|consen   92 LKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQ  169 (400)
T ss_pred             HHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHH
Confidence            3444444  3446777755444 799999999988643    578899999999999999988776  999999999999


Q ss_pred             H--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        75 i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |  |+.|||+.+|.|||+||+|+|.+....+..+||+|||+|+.-..+....+.|.||+|.|||++..+.|+.++|+||+
T Consensus       170 I~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSl  249 (400)
T KOG0604|consen  170 IGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL  249 (400)
T ss_pred             HHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccch
Confidence            9  79999999999999999999998878888999999999987666677789999999999999999999999999996

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.98  E-value=9.9e-32  Score=188.77  Aligned_cols=140  Identities=33%  Similarity=0.471  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+|+++++.++|+||+++.+++..++..++++||+++++|.+.+...  ..+++..+..++.++  |+.|||+.++
T Consensus        44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05631          44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI  123 (285)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            346778999999999999999999999999999999999999998877543  358888999999898  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++............||+.|+|||++.+..++.++|||||
T Consensus       124 iH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl  187 (285)
T cd05631         124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGL  187 (285)
T ss_pred             EeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhH
Confidence            999999999999   5667899999999987654444455678999999999998899999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.98  E-value=9.1e-32  Score=192.36  Aligned_cols=141  Identities=31%  Similarity=0.609  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|+.++.++ +||||+.+++++...+.+|+||||+++++|...+...+.+++..+..++.++  |+.|||++++
T Consensus        38 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~i  117 (327)
T cd05617          38 DIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI  117 (327)
T ss_pred             HHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456688999999888 6999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccC-CCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||+++... ........+||+.|+|||++.+..++.++|||||
T Consensus       118 vHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (327)
T cd05617         118 IYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL  182 (327)
T ss_pred             eccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehh
Confidence            999999999999   466789999999987532 2333456779999999999998899999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=1.3e-31  Score=191.34  Aligned_cols=138  Identities=34%  Similarity=0.576  Sum_probs=119.8

Q ss_pred             HHHHHH-HHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           12 CLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        12 ~~~~E~-~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      .+..|. .+++.++||||+++++++..++..|++|||+++++|.+++...+.+++..+..++.++  |+.|||+.|++|+
T Consensus        41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHr  120 (325)
T cd05602          41 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR  120 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            334444 4578899999999999999999999999999999999999888888999999899998  8999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||+||++   +..+.++|+|||+++.... .......+||+.|+|||++.+..++.++|||||
T Consensus       121 Dlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (325)
T cd05602         121 DLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL  182 (325)
T ss_pred             CCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccc
Confidence            999999999   5667899999999875432 233455679999999999998889999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.98  E-value=1.4e-31  Score=190.91  Aligned_cols=140  Identities=33%  Similarity=0.579  Sum_probs=121.0

Q ss_pred             HHHHHHHH-HHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~-~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+..|. .+++.++||||+++++++...+..|++|||+++++|...+.+...+++..+..++.++  |+.|||+.+++
T Consensus        39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv  118 (321)
T cd05603          39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII  118 (321)
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34455555 4678899999999999999999999999999999999998887889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccC-CCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++... ........+||+.|+|||++.+..++.++|||||
T Consensus       119 H~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (321)
T cd05603         119 YRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL  182 (321)
T ss_pred             eccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCccccc
Confidence            99999999999   567789999999987532 2233445678999999999998889999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-32  Score=196.95  Aligned_cols=139  Identities=32%  Similarity=0.627  Sum_probs=116.1

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      +..++||.||++++|||||+|+++..++  +.+|||+|||..|.+...-.....+.+.+++.++.++  ||+|||.+|++
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgii  232 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGII  232 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCee
Confidence            6889999999999999999999999766  5799999999888876543333338899999999997  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC------CccccCCCCCCcccccccccCC---C-CcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQFQR---Y-DEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~---~-~~~~Dvws~  152 (152)
                      ||||||.|+|+   +..+.+|++|||.+.....+      .......|||.|+|||...++.   + +.+.||||+
T Consensus       233 HRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal  305 (576)
T KOG0585|consen  233 HRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL  305 (576)
T ss_pred             ccccchhheEE---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence            99999999999   56789999999999754222      2334478999999999998732   3 468999996

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.98  E-value=1.8e-31  Score=193.76  Aligned_cols=140  Identities=32%  Similarity=0.591  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++..|++|||+++++|.+++... .+++..+..++.++  |+.|||+++++
T Consensus        86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iv  164 (371)
T cd05622          86 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFI  164 (371)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            3456788999999999999999999999999999999999999999998654 57888888888888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCC----CCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR----YDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~----~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++......  ...+.+||+.|+|||++....    ++.++|||||
T Consensus       165 HrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSl  233 (371)
T cd05622         165 HRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV  233 (371)
T ss_pred             eCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeeh
Confidence            99999999999   567789999999998764432  234567999999999997543    7889999996

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.98  E-value=1.9e-31  Score=190.37  Aligned_cols=139  Identities=36%  Similarity=0.615  Sum_probs=120.4

Q ss_pred             HHHHHHHH-HHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ..+..|.. +++.++||||+++++++..++..|++|||+++++|..++.+.+.+++..+..++.++  |+.|||+++++|
T Consensus        40 ~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH  119 (323)
T cd05575          40 KHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY  119 (323)
T ss_pred             HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            34444544 568899999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++   +.++.+|++|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus       120 ~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (323)
T cd05575         120 RDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL  182 (323)
T ss_pred             CCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCcccccccc
Confidence            9999999999   56778999999998753322 23445678999999999998889999999997

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.98  E-value=2.9e-32  Score=183.17  Aligned_cols=139  Identities=32%  Similarity=0.492  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .-...+|+.+|+.++|+||+.+.++|...+.+-+|+||+ ..+|...++... .++...+..|+.++  |+.|||.+.|+
T Consensus        45 ~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~Il  123 (318)
T KOG0659|consen   45 NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWIL  123 (318)
T ss_pred             cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhh
Confidence            456779999999999999999999999999999999999 589999887554 48899999998887  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc-ccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |||+||.|+|+   +.++.+|++|||+++.+.+.... ...+-|.||.|||.+-+. .|+..+||||.
T Consensus       124 HRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWav  188 (318)
T KOG0659|consen  124 HRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAV  188 (318)
T ss_pred             cccCCccceEE---cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhH
Confidence            99999999999   57889999999999988776543 223679999999999875 49999999983

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7e-34  Score=201.63  Aligned_cols=142  Identities=30%  Similarity=0.560  Sum_probs=128.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+++++|+.++.+++++||.++|+++..+..+|++||||.||++.+.++..+.+.+..+..++.++  |+.|+|.++.
T Consensus        53 deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~k  132 (467)
T KOG0201|consen   53 DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKK  132 (467)
T ss_pred             hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcce
Confidence            44678999999999999999999999999999999999999999999999877777888887788876  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|||+.||++.   ..+.+|++|||.+.++.... ...+++|||+|||||++...+|+.++|||||
T Consensus       133 iHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSL  197 (467)
T KOG0201|consen  133 IHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSL  197 (467)
T ss_pred             ecccccccceeEe---ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhh
Confidence            9999999999994   45899999999998765543 4478999999999999998899999999997

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.98  E-value=1.8e-31  Score=190.34  Aligned_cols=141  Identities=33%  Similarity=0.537  Sum_probs=124.0

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|.++++.+ +||||+++++++..++..|+||||+++++|...+.+.+.+++..+..++.++  |+.|||++++
T Consensus        38 ~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  117 (321)
T cd05591          38 DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV  117 (321)
T ss_pred             HHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345677899988876 8999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++|+|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus       118 vHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (321)
T cd05591         118 IYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWAL  182 (321)
T ss_pred             eccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceech
Confidence            999999999999   56778999999998764332 23445678999999999998889999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.98  E-value=2.3e-31  Score=190.09  Aligned_cols=140  Identities=35%  Similarity=0.619  Sum_probs=121.6

Q ss_pred             HHHHHHHHH-HHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+..|.. +++.++||||+++++++..++..|++|||+++++|...+...+.+++..+..++.++  |+.|||+.|++
T Consensus        39 ~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~giv  118 (325)
T cd05604          39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV  118 (325)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            344555554 577899999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.++|+|||+++.... .......+||+.|+|||++.+..++.++|||||
T Consensus       119 H~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (325)
T cd05604         119 YRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCL  182 (325)
T ss_pred             ecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccc
Confidence            99999999999   5677899999999875332 223445678999999999999889999999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=3.7e-32  Score=199.77  Aligned_cols=142  Identities=35%  Similarity=0.607  Sum_probs=127.9

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC--eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ++..++|..|+.+|+.|+||||++++.++.+..  .+-+|.|++..|+|.++.++.+..+...+..|+.||  ||.|||+
T Consensus        82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs  161 (632)
T KOG0584|consen   82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS  161 (632)
T ss_pred             hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc
Confidence            455699999999999999999999999997664  478999999999999999999999999999999998  9999999


Q ss_pred             CC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.  |+|||||..||++.  +..+.|||+|+|+|.....+. .....|||.|||||+.. ..|+..+|||||
T Consensus       162 ~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaF  229 (632)
T KOG0584|consen  162 QDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAF  229 (632)
T ss_pred             CCCCccccccccceEEEc--CCcCceeecchhHHHHhhccc-cceeccCccccChHHHh-hhcchhhhhhhh
Confidence            97  99999999999995  677899999999998654443 34488999999999998 789999999998

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=2.1e-31  Score=190.02  Aligned_cols=141  Identities=35%  Similarity=0.565  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|..++..+ +||||+++++++...+.+|+||||+++++|.+.+.....+++..+..++.++  |+.|||+.++
T Consensus        38 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~i  117 (320)
T cd05590          38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI  117 (320)
T ss_pred             HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345667888888876 6999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++..... .......||+.|+|||++.+..++.++|||||
T Consensus       118 vH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (320)
T cd05590         118 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAM  182 (320)
T ss_pred             EeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhh
Confidence            999999999999   56678999999998754322 23345678999999999998889999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=7e-32  Score=199.05  Aligned_cols=142  Identities=34%  Similarity=0.467  Sum_probs=123.3

Q ss_pred             HhHHHHHHHHHHHHHcCC-C-----cCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--H
Q 031828            7 KHLKSCLDCELNFLSSVN-H-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--G   76 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~-h-----~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~   76 (152)
                      .+...+...|+.+|+.++ |     -|+|+++++|...+|.|+|+|.+ ..+|.++++++.  .++...++.++.|+  |
T Consensus       223 k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~  301 (586)
T KOG0667|consen  223 KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTA  301 (586)
T ss_pred             hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            344566778999999997 3     39999999999999999999988 799999998765  48899999999998  9


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |.+||+.+||||||||+|||+.... ...+|++|||.|......-  .+.+.+..|.|||++.+.+|+.+.|||||
T Consensus       302 L~~L~~l~IIHcDLKPENILL~~~~-r~~vKVIDFGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSL  374 (586)
T KOG0667|consen  302 LLFLHELGIIHCDLKPENILLKDPK-RSRIKVIDFGSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSL  374 (586)
T ss_pred             HHHHHhCCeeeccCChhheeeccCC-cCceeEEecccccccCCcc--eeeeeccccccchhhccCCCCCccceeeh
Confidence            9999999999999999999997533 3489999999997643332  37778999999999999999999999997

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.7e-31  Score=188.56  Aligned_cols=140  Identities=31%  Similarity=0.524  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+++-|.+||+.++||++++||..|+.+...|++||||+||+|...++++.  .+++..+..|+.++  ||+|||..||
T Consensus       121 l~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGi  200 (459)
T KOG0610|consen  121 LKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGI  200 (459)
T ss_pred             HHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhce
Confidence            3567789999999999999999999999999999999999999999887654  49999999999997  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccC-------C--------------------------C-C----------
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-------P--------------------------G-N----------  121 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-------~--------------------------~-~----------  121 (152)
                      ++|||||+|||+   ..++.+.|.||.++....       +                          . .          
T Consensus       201 vYRDLKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~  277 (459)
T KOG0610|consen  201 VYRDLKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESAS  277 (459)
T ss_pred             eeccCCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccc
Confidence            999999999999   678889999998874321       0                          0 0          


Q ss_pred             -------------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          122 -------------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       122 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                                   +...++||-+|+|||++.+.+.+.++|||+|
T Consensus       278 ~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtf  321 (459)
T KOG0610|consen  278 RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTF  321 (459)
T ss_pred             ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHH
Confidence                         0113468889999999999999999999986

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=3.7e-31  Score=189.45  Aligned_cols=140  Identities=29%  Similarity=0.485  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|+++++.+ +|+||+++++++..++.++++|||+++++|.+++.+...+++..+..++.++  |+.|||+++++
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  127 (332)
T cd05614          48 VEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIV  127 (332)
T ss_pred             HHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            45678899999999 5899999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.++|+|||+++......  .....+||+.|+|||++.+.. ++.++|||||
T Consensus       128 HrDlkp~Nili---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  193 (332)
T cd05614         128 YRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSL  193 (332)
T ss_pred             ecCCCHHHeEE---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccc
Confidence            99999999999   566789999999997654332  233467899999999998654 7889999997

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=3.8e-31  Score=192.00  Aligned_cols=140  Identities=31%  Similarity=0.563  Sum_probs=121.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+..|+.+++.++||||+++++++..++..|+||||+++++|.+++.+. .+++..+..++.++  |+.|||+.+++
T Consensus        86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~iv  164 (370)
T cd05596          86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFI  164 (370)
T ss_pred             hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3456788999999999999999999999999999999999999999988654 57888888888888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccC----CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ----RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~----~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++......  .....+||+.|+|||++.+.    .++.++|||||
T Consensus       165 HrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSl  233 (370)
T cd05596         165 HRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV  233 (370)
T ss_pred             ccCCCHHHEEE---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeeh
Confidence            99999999999   567789999999997654432  23456799999999998753    37889999996

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=4.5e-31  Score=188.86  Aligned_cols=141  Identities=33%  Similarity=0.535  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|+.+++.++|+||+++++++...+..++||||+++++|.+++.+. ..+++..+..++.++  |+.+||+.++
T Consensus        44 ~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i  123 (330)
T cd05601          44 TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY  123 (330)
T ss_pred             HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4567889999999999999999999999999999999999999999999876 678999999999988  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccc------cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ------FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~------~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||++..+.....  .....||+.|+|||++.      ...++.++|||||
T Consensus       124 ~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl  195 (330)
T cd05601         124 VHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL  195 (330)
T ss_pred             EcccCchHheEE---CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecc
Confidence            999999999999   5677899999999987654332  23457899999999987      4557899999996

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=3.4e-31  Score=188.61  Aligned_cols=140  Identities=39%  Similarity=0.670  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHc-CCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|..++.. .+||||+++++++..++..|+||||+++++|..++...+.+++..+..++.++  |+.|||+.+++
T Consensus        39 ~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv  118 (316)
T cd05592          39 VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII  118 (316)
T ss_pred             HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            4455667777765 48999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus       119 H~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (316)
T cd05592         119 YRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSF  182 (316)
T ss_pred             eCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhH
Confidence            99999999999   56778999999999764332 23445678999999999998889999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.2e-33  Score=183.33  Aligned_cols=139  Identities=35%  Similarity=0.605  Sum_probs=127.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH--hcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..++++|++|-+.++||||+++|++|.+...+|+++||...|++...+.  ....+++.....+..|+  |+.|+|..++
T Consensus        66 ~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~V  145 (281)
T KOG0580|consen   66 EHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRV  145 (281)
T ss_pred             hhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCc
Confidence            5788999999999999999999999999999999999999999999998  45569999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+|+|+   +..+..|++|||-+..- +.+...+.|||.-|.+||...+..++..+|+|++
T Consensus       146 IhRdiKpenlLl---g~~~~lkiAdfGwsV~~-p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~l  208 (281)
T KOG0580|consen  146 IHRDIKPENLLL---GSAGELKIADFGWSVHA-PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSL  208 (281)
T ss_pred             ccCCCCHHHhcc---CCCCCeeccCCCceeec-CCCCceeeecccccCCHhhcCCCCccchhhHHHH
Confidence            999999999999   57778999999998644 3667789999999999999999999999999985

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-33  Score=201.72  Aligned_cols=146  Identities=31%  Similarity=0.575  Sum_probs=137.9

Q ss_pred             hhhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         4 ~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      +++.++.+-+..|-.||..++.|+||++|..|.++..+|+.||-|-||.++..++.++.+.+.....++.-+  |++|||
T Consensus       458 IVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH  537 (732)
T KOG0614|consen  458 IVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLH  537 (732)
T ss_pred             ccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHH
Confidence            345677888999999999999999999999999999999999999999999999999999999998888776  999999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ..+|++|||||+|+++   +..+-+||.|||+|+.+.++....++||||.|.|||++.+++.+.++|.|||
T Consensus       538 ~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaL  605 (732)
T KOG0614|consen  538 RKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWAL  605 (732)
T ss_pred             hcCceeccCChhheee---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHH
Confidence            9999999999999999   6788899999999999999999999999999999999999999999999996

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.9e-31  Score=188.45  Aligned_cols=142  Identities=31%  Similarity=0.603  Sum_probs=122.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+..|+.+++.++|+||+.+++++..++.+|+||||+++++|.+++.+ ...+++..+..++.|+  |+.|||+++
T Consensus        43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  122 (331)
T cd05597          43 AETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG  122 (331)
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456688999999999999999999999999999999999999999999976 4568999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCccccccccc-----CCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.++|+|||++..+.....  .....||+.|+|||++..     ..++.++|||||
T Consensus       123 ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  194 (331)
T cd05597         123 YVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL  194 (331)
T ss_pred             eEECCCCHHHEEE---CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehh
Confidence            9999999999999   5677899999999876544332  223568999999999973     347889999996

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=7.4e-31  Score=187.94  Aligned_cols=141  Identities=30%  Similarity=0.603  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|+.++..++|+||+.+++++..++..|+||||+++++|.+++.+ ...+++..+..++.++  |+.++|++++
T Consensus        44 ~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~i  123 (331)
T cd05624          44 ETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY  123 (331)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456688899999999999999999999999999999999999999999976 4568999999999888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCccccccccc-----CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+|++|||+++.+.....  ....+||+.|+|||++..     +.++.++|||||
T Consensus       124 iHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSl  194 (331)
T cd05624         124 VHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL  194 (331)
T ss_pred             eeccCchHHEEE---cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEee
Confidence            999999999999   5667899999999976544332  234578999999999875     457889999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.6e-32  Score=191.09  Aligned_cols=136  Identities=35%  Similarity=0.561  Sum_probs=117.7

Q ss_pred             HHHHHHHHcCCCcCccceeeeeeeCC-----eEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           14 DCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        14 ~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      .+|.++|+.++|||||++.-+|....     ...+||||++ .+|.+.++.    +..++...+.-+..|+  |+.|||.
T Consensus        65 nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~  143 (364)
T KOG0658|consen   65 NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS  143 (364)
T ss_pred             cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence            47999999999999999988775432     3468999994 788888874    5668888999999999  9999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      .||+||||||+|+|+.  ...+.+|++|||.|+.+..+....+...|..|.|||.+.+.. |+.+.||||.
T Consensus       144 ~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSa  212 (364)
T KOG0658|consen  144 HGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSA  212 (364)
T ss_pred             cCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhh
Confidence            9999999999999994  345799999999999988877777778899999999998754 9999999994

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.7e-31  Score=193.93  Aligned_cols=139  Identities=24%  Similarity=0.382  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ++.+.+|+++++.++||||+++++++..+...++++|++ .++|..++.....++...+..++.++  |+.|+|+++++|
T Consensus       127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvH  205 (391)
T PHA03212        127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIH  205 (391)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            456789999999999999999999999999999999998 57899988887789999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCC--CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++   +..+.++|+|||+++.....  .......||+.|+|||++.+..++.++|||||
T Consensus       206 rDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  269 (391)
T PHA03212        206 RDIKAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSA  269 (391)
T ss_pred             CCCChHhEEE---cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHH
Confidence            9999999999   46678999999998653222  22345679999999999998889999999996

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=201.64  Aligned_cols=145  Identities=32%  Similarity=0.532  Sum_probs=126.9

Q ss_pred             hhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHH
Q 031828            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         5 ~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      -+..+.+++.-||.||..++||+|++|++.|..++.+|+..|||+||.+...+-. ...+.+.++..++.++  ||.|||
T Consensus        68 kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH  147 (1187)
T KOG0579|consen   68 KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH  147 (1187)
T ss_pred             cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh
Confidence            3456678888999999999999999999999999999999999999998877754 4469999999999998  999999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      +++|||||||.-|||++   .++.++|+|||.+...... ...+++.|||+|||||+..     ..+|+.++|||||
T Consensus       148 s~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSl  221 (1187)
T KOG0579|consen  148 SQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSL  221 (1187)
T ss_pred             hcchhhhhccccceEEE---ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhh
Confidence            99999999999999994   6778999999998654332 3567899999999999985     3579999999997

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=5e-31  Score=188.80  Aligned_cols=142  Identities=31%  Similarity=0.535  Sum_probs=125.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC-
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH-   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~-   83 (152)
                      ....+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++.....+++..+..++.++  |+.|||+. 
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  123 (331)
T cd06649          44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH  123 (331)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            345678999999999999999999999999999999999999999999999888889999999999998  89999986 


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   ...+.++++|||+++..... ......|++.|+|||++.+..++.++|||||
T Consensus       124 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  188 (331)
T cd06649         124 QIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM  188 (331)
T ss_pred             CEEcCCCChhhEEE---cCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHH
Confidence            59999999999999   46678999999998765332 2345578999999999998889999999996

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-33  Score=189.32  Aligned_cols=143  Identities=28%  Similarity=0.526  Sum_probs=128.1

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      +...+.+..|+.||++++.+++|++||+|-....+|+|||||.-|++.+.++. +..+++..+..++...  ||+|||..
T Consensus        69 ~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~  148 (502)
T KOG0574|consen   69 DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL  148 (502)
T ss_pred             cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH
Confidence            34567888999999999999999999999989999999999999999999974 5569999998888775  99999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +-+|||||.-|||+   +..+..||+|||.+.++... ....++.|||.|||||++..-+|+.++|||||
T Consensus       149 ~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSL  215 (502)
T KOG0574|consen  149 KKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSL  215 (502)
T ss_pred             HHHHhhcccccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhh
Confidence            99999999999999   67889999999999876544 24567889999999999999999999999997

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=5.2e-31  Score=186.52  Aligned_cols=143  Identities=27%  Similarity=0.510  Sum_probs=121.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-------------------CCCHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------RVPEQT   67 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------------------~~~~~~   67 (152)
                      ...+.++.+|++++++++||||+++++++...+..+++|||+++++|.+++....                   .++...
T Consensus        60 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  139 (304)
T cd05096          60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS  139 (304)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHH
Confidence            3446789999999999999999999999999999999999999999999986432                   245667


Q ss_pred             HHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCC
Q 031828           68 ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR  142 (152)
Q Consensus        68 ~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~  142 (152)
                      +..++.++  |+.|||+.+++|+||||+||++   +..+.+|++|||+++.+.....   .....++..|+|||++..+.
T Consensus       140 ~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  216 (304)
T cd05096         140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK  216 (304)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence            78888888  8999999999999999999999   4667899999999976544321   22334577899999999888


Q ss_pred             CCcccceeeC
Q 031828          143 YDEKVNFFVS  152 (152)
Q Consensus       143 ~~~~~Dvws~  152 (152)
                      ++.++|||||
T Consensus       217 ~~~~~Dv~sl  226 (304)
T cd05096         217 FTTASDVWAF  226 (304)
T ss_pred             CCchhhhHHH
Confidence            9999999996

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=9.1e-31  Score=187.53  Aligned_cols=141  Identities=31%  Similarity=0.609  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|+.++..++|+||+.+++++..++..|+||||+++++|.+++.+ ...+++..+..++.++  |+.+||+.++
T Consensus        44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~i  123 (332)
T cd05623          44 ETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY  123 (332)
T ss_pred             HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345688899999999999999999999999999999999999999999976 4568999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++|+|||++........  ....+||+.|+|||++.     ...++.++|||||
T Consensus       124 iHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSl  194 (332)
T cd05623         124 VHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL  194 (332)
T ss_pred             EecCCCHHHEEE---CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEee
Confidence            999999999999   5677899999999876543322  23457899999999986     3458899999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-32  Score=187.54  Aligned_cols=139  Identities=35%  Similarity=0.567  Sum_probs=123.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeee-----CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      -.+..+|+.+++.++|+||+.+++++..     -+.+|+|+|+| +.+|.+.++.+..+++..++.++.|+  |+.|+|+
T Consensus        65 akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS  143 (359)
T KOG0660|consen   65 AKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS  143 (359)
T ss_pred             HHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc
Confidence            4667799999999999999999999865     24689999999 78999999998889999999999998  9999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCC---CCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      .+++|||+||.|+++   +.+...|++|||+||...+   ....+..+.|.||.|||++.. ..||++.||||.
T Consensus       144 AnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSv  214 (359)
T KOG0660|consen  144 ANVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSV  214 (359)
T ss_pred             ccccccccchhheee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhh
Confidence            999999999999999   6777889999999998754   334466788999999999875 569999999994

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=6.3e-31  Score=187.25  Aligned_cols=141  Identities=36%  Similarity=0.572  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|..++... +||||+++++++..++..|+||||+.+++|..++...+.+++..+..++.++  |+.|||++++
T Consensus        38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  117 (316)
T cd05620          38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI  117 (316)
T ss_pred             hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345667788888764 8999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++.... .......+||+.|+|||++.+..++.++|||||
T Consensus       118 vHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  182 (316)
T cd05620         118 IYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF  182 (316)
T ss_pred             EecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhh
Confidence            999999999999   5667899999999875322 223455678999999999998899999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=198.48  Aligned_cols=145  Identities=30%  Similarity=0.531  Sum_probs=128.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhc---CCCCHHHHHHHHHHH--H
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--G   76 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i--~   76 (152)
                      +.+++.-+|+++|++++|+|||+++++=++..      ...++||||+||+|...+++.   ..+++..++.++.++  |
T Consensus        53 r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~a  132 (732)
T KOG4250|consen   53 RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSA  132 (732)
T ss_pred             chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHH
Confidence            55788889999999999999999999876554      457999999999999999754   359999999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCC-CCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +.+||++||+||||||.||++-... .....||+|||.|+.+..+....+..||+.|.+||+... +.|+..+|.|||
T Consensus       133 l~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~  210 (732)
T KOG4250|consen  133 LRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSF  210 (732)
T ss_pred             HHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhh
Confidence            9999999999999999999975433 445789999999999988888889999999999999995 778899999997

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=5.7e-31  Score=187.58  Aligned_cols=141  Identities=36%  Similarity=0.638  Sum_probs=124.2

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|..+++.+ +||||+++++++...+.+|++|||+++++|...+.+.+.+++..+..++.++  |+.|||+.++
T Consensus        38 ~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i  117 (318)
T cd05570          38 DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI  117 (318)
T ss_pred             HHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            456677899999888 7999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++.... .......+|++.|+|||++.+..++.++|+|||
T Consensus       118 vH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  182 (318)
T cd05570         118 IYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWAL  182 (318)
T ss_pred             EccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhH
Confidence            999999999999   5677899999999875322 223345678999999999999899999999996

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-32  Score=199.13  Aligned_cols=144  Identities=26%  Similarity=0.506  Sum_probs=127.1

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~~lh   81 (152)
                      +.+.+.+|.+|+++|.+++||||+.++++|..++.+++++||+++|+|.+|+.++..  ........++.||  |+.||.
T Consensus       575 ~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe  654 (807)
T KOG1094|consen  575 TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE  654 (807)
T ss_pred             chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH
Confidence            356689999999999999999999999999999999999999999999999987643  3455667789999  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccc---cCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++|||+.++|+|+   +..+++|++|||.+|-+.++....   ..+-...|||||.+..+.++++||+|+|
T Consensus       655 s~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWaf  725 (807)
T KOG1094|consen  655 SLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAF  725 (807)
T ss_pred             hhchhhccccccceee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhh
Confidence            9999999999999999   788999999999999877765432   2344678999999999999999999997

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=191.17  Aligned_cols=140  Identities=39%  Similarity=0.567  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..-...|.+|++++..++||.+--.|++++.+|+|+..|+||||.-.+.+.+  .+++..+..|+.+|  ||++||..+|
T Consensus       229 e~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~i  308 (591)
T KOG0986|consen  229 ETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRI  308 (591)
T ss_pred             hHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcce
Confidence            4455689999999999999999999999999999999999999998888766  69999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.||+||+|||+   +..+.++|+|+|+|..+..+......+||.+|||||++.++.|+.+.|+|||
T Consensus       309 VYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~l  372 (591)
T KOG0986|consen  309 VYRDLKPENILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSL  372 (591)
T ss_pred             eeccCChhheee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHH
Confidence            999999999999   7889999999999998888777777899999999999999999999999996

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=7.1e-31  Score=188.34  Aligned_cols=142  Identities=31%  Similarity=0.494  Sum_probs=117.1

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeC-CeEEEEEeecCCCChHHHHHhcC------------------------
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHG------------------------   61 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~------------------------   61 (152)
                      ...+.+.+|+.+++.+ +||||+++++++..+ +.++++|||+++|+|.+++....                        
T Consensus        52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (338)
T cd05102          52 SEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS  131 (338)
T ss_pred             HHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhh
Confidence            3456788999999999 899999999988765 46899999999999999986431                        


Q ss_pred             --------------------------------------CCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCC
Q 031828           62 --------------------------------------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD  101 (152)
Q Consensus        62 --------------------------------------~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~  101 (152)
                                                            .++...+..++.++  |+.|||+++++|+||||+||++   +
T Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~  208 (338)
T cd05102         132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---S  208 (338)
T ss_pred             ccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---c
Confidence                                                  25566777888888  8999999999999999999999   4


Q ss_pred             CCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828          102 DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       102 ~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ....++++|||+++.+.....   .....+++.|+|||++.+..++.++|||||
T Consensus       209 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl  262 (338)
T cd05102         209 ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSF  262 (338)
T ss_pred             CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHH
Confidence            567899999999986533221   123345678999999998889999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=1.1e-30  Score=186.47  Aligned_cols=140  Identities=33%  Similarity=0.579  Sum_probs=122.6

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|..++..+ +|++|+.+++++...+..|+||||+++++|.+.+...+.+++..+..++.++  |+.|||+++++
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  123 (323)
T cd05616          44 VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII  123 (323)
T ss_pred             HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            34567788888877 5889999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+|++|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus       124 HrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  187 (323)
T cd05616         124 YRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF  187 (323)
T ss_pred             ecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhch
Confidence            99999999999   56778999999998754322 23445678999999999999999999999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=8.2e-31  Score=187.88  Aligned_cols=142  Identities=32%  Similarity=0.555  Sum_probs=124.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC-
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH-   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~-   83 (152)
                      ....+.+.+|+++++.++|+||+++++++..++..+++|||+++++|.+++.+.+.+++..+..++.++  |+.|||+. 
T Consensus        44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  123 (333)
T cd06650          44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH  123 (333)
T ss_pred             HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            345677899999999999999999999999999999999999999999999888888999999999888  89999975 


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+|++|||++...... ......+++.|+|||++.+..++.++|+|||
T Consensus       124 ~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  188 (333)
T cd06650         124 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM  188 (333)
T ss_pred             CEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHH
Confidence            79999999999999   45668999999998755332 2334578999999999998889999999996

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=9.6e-31  Score=183.34  Aligned_cols=139  Identities=38%  Similarity=0.556  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      +.+..|+++++.++|+||+++.+++..++..+++|||+++++|.+.+.    .+..+++..+..++.++  |+.|||+.+
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  117 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR  117 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            566789999999999999999999999999999999999999988774    23458899999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.++++|||+++.+.... ......||+.|+|||++.+..++.++|+|||
T Consensus       118 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl  183 (280)
T cd05608         118 IIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFAL  183 (280)
T ss_pred             cccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHH
Confidence            9999999999999   456789999999997654433 2334578999999999999899999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-32  Score=198.81  Aligned_cols=138  Identities=34%  Similarity=0.563  Sum_probs=120.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH-hcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      +-.+++..|+..|.+++|||++.+.|+|..+...|+||||| -|+..+++. ...++.+..+..++...  ||.|||+.+
T Consensus        68 EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~  146 (948)
T KOG0577|consen   68 EKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN  146 (948)
T ss_pred             HHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh
Confidence            33678899999999999999999999999999999999999 577788775 34568888888888875  999999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      .||||||.-|||+   ...+.|||+|||.+....+   ..+++|||+|||||++.   .+.|+.++|||||
T Consensus       147 ~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSL  211 (948)
T KOG0577|consen  147 RIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  211 (948)
T ss_pred             HHhhhccccceEe---cCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeec
Confidence            9999999999999   5778999999999876544   34789999999999986   3569999999997

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=1.1e-30  Score=186.00  Aligned_cols=140  Identities=36%  Similarity=0.584  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHc-CCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|..+++. ++||||+++++++.+++..+++|||+++++|..++.....+++..+..++.++  |+.|||+++++
T Consensus        39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~iv  118 (316)
T cd05619          39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV  118 (316)
T ss_pred             HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            4556678888876 49999999999999999999999999999999999887788999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.++++|||+++..... .......||+.|+|||++.+..++.++|||||
T Consensus       119 Hrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  182 (316)
T cd05619         119 YRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSF  182 (316)
T ss_pred             eCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhH
Confidence            99999999999   56678999999998753222 23345678999999999998889999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=1.4e-30  Score=185.93  Aligned_cols=142  Identities=32%  Similarity=0.578  Sum_probs=123.2

Q ss_pred             hHHHHHHHHHHHHHcCCCc-CccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~-ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+..|.+++..++|+ +|+.+++++...+..|+||||+++++|.+++...+.+++..+..++.++  |+.|||+.+
T Consensus        42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05587          42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG  121 (324)
T ss_pred             hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456778899999999765 6888999999999999999999999999999888889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.++++|||+++.... .......+||+.|+|||++.+..++.++|||||
T Consensus       122 ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  187 (324)
T cd05587         122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAF  187 (324)
T ss_pred             eEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhh
Confidence            9999999999999   5667899999999875322 223345678999999999999889999999996

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=206.57  Aligned_cols=144  Identities=29%  Similarity=0.480  Sum_probs=125.1

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-------CCCCHHHHHHHHHHH--H
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQL--G   76 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i--~   76 (152)
                      +..+..+|.+|..+|+.++||||+++.|++.+.+..++++|||++|||..|+++.       ..+.......++.++  |
T Consensus       735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G  814 (1025)
T KOG1095|consen  735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG  814 (1025)
T ss_pred             CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence            3456789999999999999999999999999999999999999999999999876       237788888999999  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcccc--C-CCCCCcccccccccCCCCcccceeeC
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--V-CGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~--~-~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.||++..+|||||..+|+|+   +.+..+|++|||+|+.+....++..  . .-...|||||.+..+.+++|+|||||
T Consensus       815 ~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsF  890 (1025)
T KOG1095|consen  815 MNYLESKHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSF  890 (1025)
T ss_pred             hHHHHhCCCcCcchhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhh
Confidence            999999999999999999999   4668999999999996554433221  1 22457999999999999999999997

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-30  Score=185.06  Aligned_cols=138  Identities=36%  Similarity=0.571  Sum_probs=118.8

Q ss_pred             HHHHHHHHHHcC---CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           12 CLDCELNFLSSV---NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        12 ~~~~E~~~l~~l---~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+..|..++...   +||||+++++++..++..|++|||+.+++|...+.+.+.+++..+..++.|+  |+.|||+++++
T Consensus        39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~iv  118 (330)
T cd05586          39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV  118 (330)
T ss_pred             HHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            344566666665   6999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.++|+|||+++..... ......+||+.|+|||++.+. .++.++|||||
T Consensus       119 HrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl  183 (330)
T cd05586         119 YRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSL  183 (330)
T ss_pred             eccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceecc
Confidence            99999999999   56678999999998754332 234456799999999999764 48899999996

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.3e-30  Score=181.86  Aligned_cols=140  Identities=32%  Similarity=0.467  Sum_probs=122.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+|+++++.++||||+.+++.+..++..+++|||+++++|.+.+...  ..+++..+..++.++  |+.|||+.++
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05605          44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI  123 (285)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345678999999999999999999999999999999999999999887643  358899999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +..+.++++|||+++............|++.|+|||++.+..++.++|||||
T Consensus       124 vH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~  187 (285)
T cd05605         124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGL  187 (285)
T ss_pred             EecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhH
Confidence            999999999999   5667899999999977644444445678999999999998889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=1.7e-30  Score=185.57  Aligned_cols=140  Identities=35%  Similarity=0.582  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHH---HcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            9 LKSCLDCELNFL---SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         9 ~~~~~~~E~~~l---~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ..+.+.+|+.++   +.++||||+++++++..++..|+||||+++++|...+.. +.+++..+..++.++  |+.|||+.
T Consensus        42 ~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~  120 (324)
T cd05589          42 EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN  120 (324)
T ss_pred             HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345677777665   466899999999999999999999999999999887754 468999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+||+|||+++..... ......+|++.|+|||.+.+..++.++|||||
T Consensus       121 ~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  187 (324)
T cd05589         121 KIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGL  187 (324)
T ss_pred             CeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhH
Confidence            99999999999999   56778999999998754322 23445679999999999998889999999996

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=2.2e-30  Score=181.27  Aligned_cols=139  Identities=33%  Similarity=0.513  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+..|++++++++||||+++.+++..+.+.+++|||+++++|.+.+....  .++...+..++.++  |+.+||+.+++
T Consensus        38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  117 (277)
T cd05607          38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV  117 (277)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            455679999999999999999999999999999999999999988875433  47888888888888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +....++++|||++.............+++.|+|||++.+..++.++|+|||
T Consensus       118 H~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  180 (277)
T cd05607         118 YRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM  180 (277)
T ss_pred             EccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHH
Confidence            99999999999   5667899999999977655444445678999999999998889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=182.88  Aligned_cols=147  Identities=31%  Similarity=0.460  Sum_probs=128.2

Q ss_pred             hHhHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ..+.+.++.+|++++.+++ |+||+.|+++|+++..+|+|||-+.||+|...+.++..+++..+..+..++  ||.|||+
T Consensus       115 ~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~  194 (463)
T KOG0607|consen  115 PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHT  194 (463)
T ss_pred             CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh
Confidence            4577999999999999995 999999999999999999999999999999999999999999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC--------CccccCCCCCCcccccccc---c--CCCCcccce
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEKVCGSPLYMAPEVLQ---F--QRYDEKVNF  149 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~---~--~~~~~~~Dv  149 (152)
                      .||.|||+||+|||....+.-.-+|++||.+...+...        ....+++|+..|||||+..   +  ..|+..+|.
T Consensus       195 kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDl  274 (463)
T KOG0607|consen  195 KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDL  274 (463)
T ss_pred             cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccH
Confidence            99999999999999976566667999999887543221        1235688999999999974   2  248999999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      |||
T Consensus       275 wSL  277 (463)
T KOG0607|consen  275 WSL  277 (463)
T ss_pred             HHH
Confidence            996

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=7.6e-31  Score=184.14  Aligned_cols=141  Identities=28%  Similarity=0.519  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++++..++..|+||||++++.+..+......+++..+..++.++  |+.|||+.+++
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~  122 (287)
T cd07848          43 VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV  122 (287)
T ss_pred             chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3567889999999999999999999999999999999999887776665555678999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+|++|||+++......  ......+++.|+|||++.+..++.++|||||
T Consensus       123 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  187 (287)
T cd07848         123 HRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSV  187 (287)
T ss_pred             cCCCCHHHEEE---cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhH
Confidence            99999999999   566789999999998754332  2234568999999999998889999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=3e-30  Score=184.27  Aligned_cols=140  Identities=31%  Similarity=0.587  Sum_probs=122.2

Q ss_pred             HHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|..+++.+. |++|+++++++..++.+|+||||+++++|.+++...+.+++..+..++.++  |+.|||+++++
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv  123 (323)
T cd05615          44 VECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII  123 (323)
T ss_pred             HHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            456778999998885 577888999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +.++.++|+|||+++...... ......||+.|+|||++.+..++.++|||||
T Consensus       124 HrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  187 (323)
T cd05615         124 YRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY  187 (323)
T ss_pred             ccCCCHHHeEE---CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhh
Confidence            99999999999   566789999999987543322 3345678999999999998889999999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1e-30  Score=187.25  Aligned_cols=139  Identities=27%  Similarity=0.499  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+|+.+++.++||||+++++++...     ...|++|||+ +++|.+++.....+++..+..++.++  |+.|||+
T Consensus        43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  121 (338)
T cd07859          43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT  121 (338)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999987543     3589999999 57999999888889999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCccccccccc--CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~  152 (152)
                      ++++|+||||+||++   +..+.+||+|||+++......    ......+|+.|+|||++.+  ..++.++|||||
T Consensus       122 ~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSl  194 (338)
T cd07859         122 ANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI  194 (338)
T ss_pred             CCeecCCCCHHHeEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHH
Confidence            999999999999999   567789999999997543221    1234578999999999875  568999999996

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=2.4e-30  Score=181.77  Aligned_cols=138  Identities=19%  Similarity=0.253  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .+.+.+|+.+|++++||||+++++++.+    ....+++|||+++|+|.+++.+...++......++.++  |+.++|+.
T Consensus        62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~  141 (283)
T PHA02988         62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY  141 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence            4678899999999999999999999876    35789999999999999999888888888888899888  89999984


Q ss_pred             -CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc--CCCCcccceeeC
Q 031828           84 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus        84 -~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~  152 (152)
                       +++|+||||+||++   +.++.+|++|||+++.....  .....+++.|+|||++.+  ..++.++|||||
T Consensus       142 ~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~Sl  208 (283)
T PHA02988        142 TNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL  208 (283)
T ss_pred             CCCCCCcCChhhEEE---CCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHH
Confidence             89999999999999   56778999999998765332  224567889999999976  679999999996

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=1.3e-30  Score=183.38  Aligned_cols=139  Identities=29%  Similarity=0.508  Sum_probs=118.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+.+|+++++.++||||+++++++..++..+++|||+. ++|.+++...+ .++...+..++.++  |+.|||+++++
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  125 (288)
T cd07871          47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL  125 (288)
T ss_pred             chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            4567799999999999999999999999999999999996 58988887554 47888889999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+|++|||+++...... ......+++.|+|||++.+ ..++.++|||||
T Consensus       126 H~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  190 (288)
T cd07871         126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV  190 (288)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHH
Confidence            99999999999   566789999999987643322 2334567899999999875 458999999995

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.2e-30  Score=189.31  Aligned_cols=138  Identities=28%  Similarity=0.454  Sum_probs=121.4

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      ....+|+++++.++||||+++++++...+..|++||++ +++|.+++.....+++..+..++.++  |+.|||+.+++|+
T Consensus       131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHr  209 (392)
T PHA03207        131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR  209 (392)
T ss_pred             ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            34568999999999999999999999999999999998 57898988777789999999999998  8999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||+||++   +..+.++++|||+++.......   .....||+.|+|||++....++.++|||||
T Consensus       210 Dlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  273 (392)
T PHA03207        210 DVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSA  273 (392)
T ss_pred             CCCHHHEEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHH
Confidence            999999999   5677899999999976544321   234568999999999998899999999996

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.97  E-value=8.5e-30  Score=179.10  Aligned_cols=143  Identities=24%  Similarity=0.555  Sum_probs=122.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-------------CCCHHHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------RVPEQTARKFLQ   73 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~   73 (152)
                      ....+.+.+|++++++++||||+++++++...+..++++||+++++|.+++...+             .+++..+..++.
T Consensus        48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  127 (288)
T cd05093          48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ  127 (288)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHH
Confidence            3456779999999999999999999999999999999999999999999987543             388899999999


Q ss_pred             HH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccc
Q 031828           74 QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVN  148 (152)
Q Consensus        74 ~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~D  148 (152)
                      ++  |+.+||+++++|+||||+||++   +..+.++++|||+++.......   .....+++.|+|||++.+..++.++|
T Consensus       128 ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sD  204 (288)
T cd05093         128 QIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD  204 (288)
T ss_pred             HHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhh
Confidence            98  8999999999999999999999   4667899999999976543321   12334567899999999888999999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      +|||
T Consensus       205 iwsl  208 (288)
T cd05093         205 VWSL  208 (288)
T ss_pred             HHHH
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=4.1e-30  Score=186.87  Aligned_cols=142  Identities=27%  Similarity=0.465  Sum_probs=119.0

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-------------------------
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------------   61 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------------------------   61 (152)
                      ...+.+.+|+++++.+ +|+||+++++++...+..+++|||+++++|.+++....                         
T Consensus        83 ~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (374)
T cd05106          83 DEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITL  162 (374)
T ss_pred             HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccch
Confidence            3456788999999999 89999999999999999999999999999999885421                         


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCc
Q 031828           62 ---------------------------------------------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPEN   94 (152)
Q Consensus        62 ---------------------------------------------~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~n   94 (152)
                                                                   .++...+..++.++  |+.|||+++++|+||||+|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~N  242 (374)
T cd05106         163 EKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARN  242 (374)
T ss_pred             hcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchhe
Confidence                                                         25667788888888  8999999999999999999


Q ss_pred             eEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           95 ILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        95 il~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |++   +....++++|||+++.+.....   .....+++.|+|||++....++.++|||||
T Consensus       243 il~---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl  300 (374)
T cd05106         243 VLL---TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSY  300 (374)
T ss_pred             EEE---eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHH
Confidence            999   4567899999999976543321   112234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=3.9e-30  Score=182.05  Aligned_cols=138  Identities=30%  Similarity=0.482  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ..+.+|+++++.++||||+++++++..+...++||||+. +++.+++... +.+++..+..++.++  |+.|||+++++|
T Consensus        48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH  126 (303)
T cd07869          48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH  126 (303)
T ss_pred             hhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            457789999999999999999999999999999999994 6777777543 568888999999998  999999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +||||+||++   +..+.+|++|||+++..... .......+++.|+|||++.+. .++.++|||||
T Consensus       127 ~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  190 (303)
T cd07869         127 RDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGV  190 (303)
T ss_pred             CCCCHHHEEE---CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHH
Confidence            9999999999   56678999999998754322 223445678999999998754 58889999996

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.97  E-value=8.5e-30  Score=178.42  Aligned_cols=142  Identities=26%  Similarity=0.496  Sum_probs=121.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~   71 (152)
                      ...+.+.+|++++++++||||+++++++...+..++++||+++++|.+++...                ..++...+..+
T Consensus        50 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  129 (283)
T cd05048          50 KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI  129 (283)
T ss_pred             HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHH
Confidence            44677899999999999999999999999888999999999999999999754                34677888888


Q ss_pred             HHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcc
Q 031828           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEK  146 (152)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~  146 (152)
                      +.++  |+.+||+++++|+||||+||++   +....++++|||+++......   ......+++.|+|||.+.+..++.+
T Consensus       130 ~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05048         130 AIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE  206 (283)
T ss_pred             HHHHHHHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh
Confidence            9988  8999999999999999999999   456789999999997654332   1233456788999999988889999


Q ss_pred             cceeeC
Q 031828          147 VNFFVS  152 (152)
Q Consensus       147 ~Dvws~  152 (152)
                      +|||||
T Consensus       207 sDv~sl  212 (283)
T cd05048         207 SDIWSF  212 (283)
T ss_pred             hhHHHH
Confidence            999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=1.4e-29  Score=178.09  Aligned_cols=140  Identities=38%  Similarity=0.683  Sum_probs=125.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++...+.+++..+..++.++  |+.+||+.++
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i  122 (290)
T cd05580          43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI  122 (290)
T ss_pred             hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            34677889999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||+++.....  .....+++.|+|||.+.+..++.++|+|||
T Consensus       123 ~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  184 (290)
T cd05580         123 VYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWAL  184 (290)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHH
Confidence            999999999999   46678999999998765443  345578899999999988888999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=7.6e-30  Score=177.52  Aligned_cols=143  Identities=22%  Similarity=0.384  Sum_probs=121.6

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|++++++++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.++  |+.|||++
T Consensus        47 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~  126 (266)
T cd05064          47 DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM  126 (266)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            344567889999999999999999999999999999999999999999998764 468899999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +.+..++++|||.+.........  ....++..|+|||++.+..++.++|||||
T Consensus       127 ~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  194 (266)
T cd05064         127 GYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSF  194 (266)
T ss_pred             CEeeccccHhhEEE---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHH
Confidence            99999999999999   46678999999987653222211  12334578999999998899999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=1.4e-29  Score=177.94  Aligned_cols=140  Identities=34%  Similarity=0.501  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+..|+.+++.++|+|++.+.+.+..++..+++|||+++++|.+++...+  .+++..+..++.++  |+.|+|+.++
T Consensus        44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i  123 (285)
T cd05630          44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI  123 (285)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            3456789999999999999999999999999999999999999999885433  48888999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||++.............|++.|+|||++.+..++.++|+|||
T Consensus       124 iH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl  187 (285)
T cd05630         124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL  187 (285)
T ss_pred             EeCCCCHHHEEE---CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHH
Confidence            999999999999   5667899999999876544433345578999999999998889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-29  Score=175.10  Aligned_cols=141  Identities=30%  Similarity=0.593  Sum_probs=124.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|++++++++||||+++++++..++..++++|++++++|.+.+.....+++.....++.++  |+.+||+.+++
T Consensus        47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~  126 (263)
T cd06625          47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV  126 (263)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3467889999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc----ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.++++|||+++........    ....+++.|+|||.+.+..++.++|||||
T Consensus       127 H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (263)
T cd06625         127 HRDIKGANILR---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSV  193 (263)
T ss_pred             cCCCCHHHEEE---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHH
Confidence            99999999999   45678999999998765432211    23567889999999998889999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=1.6e-29  Score=178.01  Aligned_cols=142  Identities=25%  Similarity=0.439  Sum_probs=124.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-----------CCCHHHHHHHHHHH-
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL-   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~i-   75 (152)
                      ...+.+.+|++++++++||||+++++++..++..++++|++++++|.+++.+..           .+++..+..++.++ 
T Consensus        61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  140 (296)
T cd05051          61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA  140 (296)
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence            457789999999999999999999999999899999999999999999997665           58889999999998 


Q ss_pred             -HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceee
Q 031828           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        76 -~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                       |+.+||+++++|+||||+||++   +..+.++++|||+++......   ......+++.|+|||.+.+..++.++||||
T Consensus       141 ~al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  217 (296)
T cd05051         141 SGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA  217 (296)
T ss_pred             HHHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence             8999999999999999999999   456789999999997654332   123445677899999999888999999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       218 l  218 (296)
T cd05051         218 F  218 (296)
T ss_pred             h
Confidence            6

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-31  Score=181.26  Aligned_cols=142  Identities=32%  Similarity=0.515  Sum_probs=129.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.-.-|-++|+..+||++..+.-+|+.++.+|+||||..||.|.-.+.+.+.+++.....+-.+|  ||.|||+++|
T Consensus       210 dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~i  289 (516)
T KOG0690|consen  210 DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNI  289 (516)
T ss_pred             HHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCe
Confidence            34455567889999999999999999999999999999999999999999998899999999999887  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccc-cCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.||+|.+|+++   ++++.+|+.|||+++. +..+....++||||.|+|||++...-|+.++|||.+
T Consensus       290 vYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~  354 (516)
T KOG0690|consen  290 VYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGV  354 (516)
T ss_pred             eeeechhhhhee---ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhh
Confidence            999999999999   7899999999999986 445556789999999999999999999999999974

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=8.3e-30  Score=185.31  Aligned_cols=142  Identities=29%  Similarity=0.435  Sum_probs=118.8

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-------------------------
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------------   61 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------------------------   61 (152)
                      ...+.+.+|+++++.+ +||||+++++++...+..+++|||+++|+|.+++....                         
T Consensus        80 ~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (375)
T cd05104          80 TEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQRE  159 (375)
T ss_pred             HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhc
Confidence            3456788999999999 89999999999999999999999999999999986432                         


Q ss_pred             --------------------------------------------------CCCHHHHHHHHHHH--HHHHHHhCCCeecC
Q 031828           62 --------------------------------------------------RVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (152)
Q Consensus        62 --------------------------------------------------~~~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (152)
                                                                        .+++..+..++.++  |+.|||+++++|+|
T Consensus       160 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~D  239 (375)
T cd05104         160 MSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD  239 (375)
T ss_pred             ccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence                                                              25666777888888  89999999999999


Q ss_pred             CCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        90 l~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+||++.   ....+|++|||+++........   ....++..|+|||++.+..++.++|||||
T Consensus       240 lkp~Nill~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~sl  302 (375)
T cd05104         240 LAARNILLT---HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY  302 (375)
T ss_pred             CchhhEEEE---CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHH
Confidence            999999994   5668999999999765443211   12334567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=1.5e-29  Score=179.12  Aligned_cols=142  Identities=29%  Similarity=0.448  Sum_probs=119.1

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~   70 (152)
                      .....+.+|+.++.++ +|+||+++++++..++..|+++||+++++|.+++.+.+                .++...+..
T Consensus        49 ~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  128 (303)
T cd05088          49 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH  128 (303)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHH
Confidence            3456788999999999 89999999999999999999999999999999997543                367888889


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVN  148 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  148 (152)
                      ++.++  |+.+||+++++|+||||+||++   +..+.++++|||+++.............+..|+|||.+.+..++.++|
T Consensus       129 ~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  205 (303)
T cd05088         129 FAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSD  205 (303)
T ss_pred             HHHHHHHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccccc
Confidence            99998  8999999999999999999999   566789999999986432211112223356799999998888999999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      ||||
T Consensus       206 i~sl  209 (303)
T cd05088         206 VWSY  209 (303)
T ss_pred             chhh
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=2.3e-29  Score=178.54  Aligned_cols=142  Identities=32%  Similarity=0.562  Sum_probs=124.9

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh-C
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-H   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~-~   83 (152)
                      ....+++.+|++++++++||||+++++++..++..++++||+++++|.+++.+.+.+++..+..++.++  |+.|||+ .
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  119 (308)
T cd06615          40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH  119 (308)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            344567889999999999999999999999999999999999999999999888889999999999998  8999997 5


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+|++|.||++   +.++.++++|||++...... ......+++.|+|||++.+..++.++|+|||
T Consensus       120 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  184 (308)
T cd06615         120 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSL  184 (308)
T ss_pred             CEEECCCChHHEEE---ecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHH
Confidence            89999999999999   45667999999998765332 2345678899999999988889999999996

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=3e-29  Score=176.22  Aligned_cols=140  Identities=34%  Similarity=0.473  Sum_probs=122.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+|+++++.++|+|++.+.+.+..++..++++||+++++|...+...  ..+++..+..++.++  |+.|||+.++
T Consensus        44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  123 (285)
T cd05632          44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT  123 (285)
T ss_pred             HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            345778999999999999999999999999999999999999998887643  358999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +....++++|||++.............|++.|+|||++.+..++.++|+|||
T Consensus       124 iH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~sl  187 (285)
T cd05632         124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGL  187 (285)
T ss_pred             eecCCCHHHEEE---CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHH
Confidence            999999999999   4566899999999876544433445678999999999998889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-30  Score=193.06  Aligned_cols=144  Identities=31%  Similarity=0.489  Sum_probs=127.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCC--CHHHHHHHHHHH--HHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRV--PEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~--~~~~~~~~~~~i--~l~~lh   81 (152)
                      ++..+-+-.|+.+.++++|.|||+++|++..++++-+.||-.+||+|..+++. .+++  ++.++..+..||  ||.|||
T Consensus       613 sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH  692 (1226)
T KOG4279|consen  613 SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH  692 (1226)
T ss_pred             chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh
Confidence            34456677899999999999999999999999999999999999999999974 5666  788999999998  999999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccC--CCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dvws~  152 (152)
                      ++.|+|||||-.|+|+.  ..++.+|++|||.++++..- ....++.||..|||||++..+  +|+.++|||||
T Consensus       693 en~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~  764 (1226)
T KOG4279|consen  693 ENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSF  764 (1226)
T ss_pred             hcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhc
Confidence            99999999999999994  67889999999999876433 356788999999999999865  49999999997

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.96  E-value=2.6e-29  Score=176.86  Aligned_cols=141  Identities=23%  Similarity=0.531  Sum_probs=121.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKFL   72 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~   72 (152)
                      ..+.+.+|++++++++|+||+++++++..++..+++|||+++++|.+++...+                .+++..+..++
T Consensus        50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  129 (291)
T cd05094          50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA  129 (291)
T ss_pred             HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence            35678999999999999999999999999999999999999999999997543                37788889999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCccc
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      .++  |+.+||+++++|+||||.||++   +.+..++++|||++........   .....++..|+|||.+.+..++.++
T Consensus       130 ~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  206 (291)
T cd05094         130 SQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  206 (291)
T ss_pred             HHHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchh
Confidence            998  8999999999999999999999   5667899999999976544321   2234457789999999988899999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |||||
T Consensus       207 Di~sl  211 (291)
T cd05094         207 DVWSF  211 (291)
T ss_pred             hHHHH
Confidence            99996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.96  E-value=2.2e-29  Score=174.97  Aligned_cols=141  Identities=28%  Similarity=0.526  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ....+.+|+.+++.++||||+++++++..++..|+++||+++++|.+++...+.+++..+..++.++  |+.|+|+.+++
T Consensus        49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  128 (267)
T cd06645          49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM  128 (267)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3456788999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   ...+.++++|||++....... ......|++.|+|||++.   ...++.++|+|||
T Consensus       129 H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSl  195 (267)
T cd06645         129 HRDIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAV  195 (267)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHH
Confidence            99999999999   466789999999987654322 223456889999999984   4458899999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-29  Score=175.32  Aligned_cols=143  Identities=29%  Similarity=0.453  Sum_probs=119.1

Q ss_pred             HhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHH
Q 031828            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~   69 (152)
                      ....+.+.+|+++++++ +||||+++++++...+..+++|||+++++|.+++.++.                .++...+.
T Consensus        36 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~  115 (270)
T cd05047          36 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  115 (270)
T ss_pred             HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHH
Confidence            34456788999999999 89999999999999999999999999999999987543                36778888


Q ss_pred             HHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCccc
Q 031828           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      .++.++  |+.|||+++++|+||||+||++   +.+..++++|||+++.............++.|+|||++....++.++
T Consensus       116 ~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~  192 (270)
T cd05047         116 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  192 (270)
T ss_pred             HHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchh
Confidence            888888  8999999999999999999999   56778999999998532211111122335679999999888899999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |+|||
T Consensus       193 Di~sl  197 (270)
T cd05047         193 DVWSY  197 (270)
T ss_pred             hHHHH
Confidence            99996

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=3.5e-29  Score=172.81  Aligned_cols=143  Identities=28%  Similarity=0.554  Sum_probs=125.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+.+|+++++.++|||++++++++..++..++++||+++++|.+++...  ..+++..+..++.++  |+.+||+
T Consensus        40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~  119 (256)
T cd08529          40 RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS  119 (256)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456788999999999999999999999999999999999999999999998764  458888888898888  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+++|+|++|+||++   +....++++|||+++.+.... ......+++.|+|||+..+..++.++|+|||
T Consensus       120 ~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  187 (256)
T cd08529         120 KKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWAL  187 (256)
T ss_pred             CCcccCCCCcceEEE---eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHH
Confidence            999999999999999   456789999999988665443 2344568889999999998889999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.96  E-value=1.6e-29  Score=182.75  Aligned_cols=139  Identities=35%  Similarity=0.506  Sum_probs=116.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      .....+.+|+.+++.++||||+++++++...+      ..|++|||++ +++.+.+.  ..+++..+..++.++  |+.|
T Consensus        62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~  138 (359)
T cd07876          62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKH  138 (359)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHH
Confidence            34567789999999999999999999986543      4799999995 56666553  347888888888888  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+++++|+||||+||++   +.++.++|+|||+++............+|+.|+|||++.+..++.++|||||
T Consensus       139 LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  208 (359)
T cd07876         139 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  208 (359)
T ss_pred             HHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHH
Confidence            999999999999999999   5677899999999976544444455678999999999999899999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-30  Score=199.86  Aligned_cols=143  Identities=31%  Similarity=0.577  Sum_probs=130.5

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.|+.|-.+|..-+.+=|+.++-.|+++.++|+||||++||||..++.+...+++..+.+|+..+  |+.-+|+-|
T Consensus       116 r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg  195 (1317)
T KOG0612|consen  116 RAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG  195 (1317)
T ss_pred             chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc
Confidence            345789999999999999999999999999999999999999999999999998899999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCccccccccc-----CCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-----QRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~  152 (152)
                      +|||||||+|||+   +..+.+||+|||.|-.+...+  .....+|||-|.|||++..     +.|+..+||||+
T Consensus       196 yVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSl  267 (1317)
T KOG0612|consen  196 YVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSL  267 (1317)
T ss_pred             ceeccCCcceeEe---cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhh
Confidence            9999999999999   788999999999998887655  3567889999999999963     348899999996

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=2.8e-29  Score=183.70  Aligned_cols=142  Identities=27%  Similarity=0.464  Sum_probs=118.9

Q ss_pred             hHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-------------------------
Q 031828            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------------   61 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------------------------   61 (152)
                      ...+.+.+|+++++.+. ||||+++++++...+..|+||||+++|+|.+++.++.                         
T Consensus        82 ~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (400)
T cd05105          82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE  161 (400)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence            44678899999999996 9999999999999999999999999999998875421                         


Q ss_pred             -----------------------------------------------------------------------CCCHHHHHH
Q 031828           62 -----------------------------------------------------------------------RVPEQTARK   70 (152)
Q Consensus        62 -----------------------------------------------------------------------~~~~~~~~~   70 (152)
                                                                                             .++...+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~  241 (400)
T cd05105         162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLS  241 (400)
T ss_pred             cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHH
Confidence                                                                                   255666777


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.++  |+.|||+.+++|+||||+||++   +....+|++|||+++.......   .....+++.|+|||.+.+..++.
T Consensus       242 ~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  318 (400)
T cd05105         242 FTYQVARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT  318 (400)
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc
Confidence            88888  8999999999999999999999   4566899999999976543221   22344677899999999888999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       319 ~~DiwSl  325 (400)
T cd05105         319 LSDVWSY  325 (400)
T ss_pred             hhhHHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=3.8e-29  Score=173.40  Aligned_cols=142  Identities=35%  Similarity=0.663  Sum_probs=126.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+++++.++||||+++++.+..++..++++||+++++|.+++.+...+++..+..++.++  |+.++|++++
T Consensus        35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~  114 (262)
T cd05572          35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI  114 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            34577999999999999999999999999999999999999999999999887788999999999888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|++|+||++   +..+.++++|||+++............+++.|+|||.+.+..++.++|+|||
T Consensus       115 ~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~sl  178 (262)
T cd05572         115 IYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSL  178 (262)
T ss_pred             ccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhh
Confidence            999999999999   4567899999999987655433344567889999999988889999999996

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.2e-29  Score=183.34  Aligned_cols=137  Identities=28%  Similarity=0.419  Sum_probs=118.6

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      ....|+.++++++|+||+++++++...+..++++|++ .++|.+++.+ ...+++..+..++.++  |+.|||+++++|+
T Consensus       103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  181 (357)
T PHA03209        103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR  181 (357)
T ss_pred             ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            3457999999999999999999999999999999999 5688888764 4568999999999998  8999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||+||++   .....++++|||+++............||+.|+|||++.+..++.++|||||
T Consensus       182 Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  242 (357)
T PHA03209        182 DVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSA  242 (357)
T ss_pred             CCCHHHEEE---CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHH
Confidence            999999999   5667899999999875433333445678999999999998899999999996

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=4.6e-29  Score=172.38  Aligned_cols=144  Identities=31%  Similarity=0.504  Sum_probs=125.2

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      +.....++.+|++++++++|+||+++++++...+..++++||+++++|.+++...  ..+++..+..++.++  |+.++|
T Consensus        39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  118 (256)
T cd08221          39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH  118 (256)
T ss_pred             chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3455677899999999999999999999999999999999999999999999765  458889999999988  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++|+|++|+||++   +....+|++|||.+....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       119 ~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~sl  187 (256)
T cd08221         119 KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWAL  187 (256)
T ss_pred             hCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHH
Confidence            9999999999999999   456689999999987654433 2345568899999999988888999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=2.6e-29  Score=173.72  Aligned_cols=139  Identities=17%  Similarity=0.276  Sum_probs=118.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+.+|+++++.++||||+++++++.. +..++++||+++++|.+++.... .++...+..++.++  |+.|||+++++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  123 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV  123 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            5788899999999999999999999887 77899999999999999998766 68888899999898  89999999999


Q ss_pred             ecCCCCCceEeecCC----CCceEEEeeccCccccCCCCccccCCCCCCcccccccccC--CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~----~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dvws~  152 (152)
                      |+||||+||++....    ....++++|||+++....   .....++..|+|||++...  .++.++|||||
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  192 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSF  192 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHH
Confidence            999999999995322    112799999999876543   2234466789999999876  68999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.96  E-value=1.6e-29  Score=179.79  Aligned_cols=142  Identities=27%  Similarity=0.495  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeee--CCeEEEEEeecCCCChHHHHHhc---------CCCCHHHHHHHHHHH--H
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQL--G   76 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i--~   76 (152)
                      ...+.+|++++++++||||+++++++..  +...|+++||+ +++|.+++...         ..+++..+..++.|+  |
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07868          42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence            3457889999999999999999998854  45789999998 56888877532         247888999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecC-CCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccC-CCCccccee
Q 031828           77 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFF  150 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~-~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvw  150 (152)
                      +.|||+++++|+||||+||++... ...+.+|++|||+++......    ......+|+.|+|||++.+. .++.++|||
T Consensus       121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07868         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence            999999999999999999999532 245689999999998654332    22356789999999999864 588999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       201 sl  202 (317)
T cd07868         201 AI  202 (317)
T ss_pred             HH
Confidence            95

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.96  E-value=3.8e-29  Score=175.16  Aligned_cols=144  Identities=24%  Similarity=0.521  Sum_probs=122.3

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC---------------CCCHHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------RVPEQTARK   70 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------------~~~~~~~~~   70 (152)
                      +....+.+.+|+++++.++|+||+++++++...+..++++||+++++|.+++...+               .++...+..
T Consensus        47 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~  126 (280)
T cd05092          47 SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA  126 (280)
T ss_pred             CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHH
Confidence            34556789999999999999999999999999999999999999999999987543               367888888


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.++  |+.|||+.+++|+||||+||++   .....++++|||+++.......   .....+++.|+|||.+.+..++.
T Consensus       127 ~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  203 (280)
T cd05092         127 IASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT  203 (280)
T ss_pred             HHHHHHHHHHHHHHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCc
Confidence            99998  8999999999999999999999   4567899999999876543321   12233467899999999888999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       204 ~~Di~sl  210 (280)
T cd05092         204 ESDIWSF  210 (280)
T ss_pred             hhhHHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.96  E-value=4.4e-29  Score=172.21  Aligned_cols=143  Identities=32%  Similarity=0.548  Sum_probs=120.6

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ......+.+|+++++.++||||+++++++...+..++++||+++++|.+++...+ .+++..+..++.++  |+.|||++
T Consensus        34 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  113 (252)
T cd05084          34 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK  113 (252)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4456789999999999999999999999999999999999999999999987644 47888899999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||+|.||++   +..+.++++|||+++........   .....+..|+|||.+.++.++.++|||||
T Consensus       114 ~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  182 (252)
T cd05084         114 HCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSF  182 (252)
T ss_pred             CccccccchheEEE---cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHH
Confidence            99999999999999   45668999999998754332111   11122456999999998889999999996

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2e-29  Score=186.99  Aligned_cols=138  Identities=24%  Similarity=0.366  Sum_probs=119.5

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ..+.+|++++++++|+||+++++++..++..+++++++ .++|..++... ..++...+..++.++  ||.|||+.+++|
T Consensus       205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH  283 (461)
T PHA03211        205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIH  283 (461)
T ss_pred             cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence            45678999999999999999999999999999999999 57888887654 458999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++   +....++|+|||+++.......   .....||+.|+|||++.+..++.++|||||
T Consensus       284 rDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSl  348 (461)
T PHA03211        284 RDIKTENVLV---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSA  348 (461)
T ss_pred             CcCCHHHEEE---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHH
Confidence            9999999999   4667899999999976533221   234568999999999999889999999996

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.9e-29  Score=175.76  Aligned_cols=143  Identities=26%  Similarity=0.479  Sum_probs=120.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC------------CCCHHHHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------RVPEQTARKFLQQ   74 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------~~~~~~~~~~~~~   74 (152)
                      ...++.+.+|++++++++|+|++++++++..++..+++|||+++++|.+++....            .++...+..++.+
T Consensus        58 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  137 (295)
T cd05097          58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ  137 (295)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence            3456789999999999999999999999999999999999999999999986432            2567778888888


Q ss_pred             H--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccce
Q 031828           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNF  149 (152)
Q Consensus        75 i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv  149 (152)
                      +  |+.|||+++++|+|+||.||++   +.+..+|++|||++........   .....+++.|+|||++.++.++.++|+
T Consensus       138 i~~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  214 (295)
T cd05097         138 IASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV  214 (295)
T ss_pred             HHHHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhH
Confidence            8  8999999999999999999999   4566899999999976543321   122344678999999998889999999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      |||
T Consensus       215 wSl  217 (295)
T cd05097         215 WAF  217 (295)
T ss_pred             HHH
Confidence            996

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.96  E-value=6.3e-29  Score=172.18  Aligned_cols=141  Identities=23%  Similarity=0.482  Sum_probs=118.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+.++++++||||+++++++.. +..+++|||+++++|.+++.. ...+++..+..++.++  |+.++|+++
T Consensus        37 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  115 (257)
T cd05115          37 SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN  115 (257)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence            345678999999999999999999998864 568999999999999999875 4468999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||.||++   +....++++|||+++.......    .....+++.|+|||.+....++.++|||||
T Consensus       116 i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  184 (257)
T cd05115         116 FVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSY  184 (257)
T ss_pred             eeecccchheEEE---cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHH
Confidence            9999999999999   4667899999999976543321    111223567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.96  E-value=5.1e-29  Score=174.18  Aligned_cols=141  Identities=25%  Similarity=0.524  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--------------CCCHHHHHHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFLQQ   74 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~   74 (152)
                      ..+.+.+|+++++.++|+||+++++++..++..+++|||+++++|.+++...+              .+++..+..++.+
T Consensus        51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  130 (280)
T cd05049          51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ  130 (280)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence            46789999999999999999999999999999999999999999999997543              2677788888888


Q ss_pred             H--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccce
Q 031828           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNF  149 (152)
Q Consensus        75 i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv  149 (152)
                      +  |+.++|+++++|+||+|.||++   +....++++|||.++.+.....   .....+++.|+|||++.+..++.++||
T Consensus       131 i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  207 (280)
T cd05049         131 IASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV  207 (280)
T ss_pred             HHHHHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence            8  8999999999999999999999   5668999999999876533321   123345678999999999899999999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      |||
T Consensus       208 ~sl  210 (280)
T cd05049         208 WSF  210 (280)
T ss_pred             HHH
Confidence            996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=4.2e-29  Score=173.53  Aligned_cols=140  Identities=19%  Similarity=0.275  Sum_probs=116.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+..|+.+++.++||||+++++++..+...+++|||+++++|..++... ..+++.....++.|+  |+.|||+.+++
T Consensus        48 ~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  127 (262)
T cd05077          48 SLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLV  127 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeE
Confidence            457788999999999999999999999888999999999999999888753 458999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCC----CCceEEEeeccCccccCCCCccccCCCCCCcccccccc-cCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~----~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~  152 (152)
                      |+||||+||++....    ....++++|||++......   ....++..|+|||.+. +..++.++|||||
T Consensus       128 H~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  195 (262)
T cd05077         128 HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSF  195 (262)
T ss_pred             CCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHH
Confidence            999999999995322    1124899999998654332   2345678899999987 4568999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.96  E-value=3.3e-29  Score=176.05  Aligned_cols=138  Identities=36%  Similarity=0.554  Sum_probs=115.7

Q ss_pred             HHHHHHHHHHHcC---CCcCccceeeeee-----eCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHH
Q 031828           11 SCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus        11 ~~~~~E~~~l~~l---~h~ni~~l~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~   78 (152)
                      ..+.+|+.+++.+   +||||+++++++.     .....++++|++. ++|.+++...  ..+++..+..++.++  |+.
T Consensus        46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~  124 (290)
T cd07862          46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD  124 (290)
T ss_pred             HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence            4566788777765   6999999999885     2356899999995 6898888653  347889999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+.+++|+||||+||++   +..+.++++|||+++............+++.|+|||++.+..++.++|||||
T Consensus       125 ~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  195 (290)
T cd07862         125 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSV  195 (290)
T ss_pred             HHHHCCeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHH
Confidence            9999999999999999999   5667899999999987654444456678999999999998889999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=8.6e-29  Score=173.64  Aligned_cols=142  Identities=25%  Similarity=0.446  Sum_probs=120.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHh
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      .....+.+|+++++.++|||++++.+++...  ...+++|||+++++|.+++.+.. .++...+..++.++  |+.++|+
T Consensus        48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~  127 (284)
T cd05079          48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS  127 (284)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4456789999999999999999999998765  56899999999999999986543 57888999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++|+||||+||++   ..++.++++|||+++.+.....    .....++..|+|||++.+..++.++|||||
T Consensus       128 ~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  198 (284)
T cd05079         128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF  198 (284)
T ss_pred             CCeeecccchheEEE---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhh
Confidence            999999999999999   4566899999999986644321    123445677999999988889999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.96  E-value=1.7e-29  Score=186.98  Aligned_cols=138  Identities=30%  Similarity=0.472  Sum_probs=113.0

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeC--------CeEEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHH--HH
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL--GL   77 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~--------~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i--~l   77 (152)
                      ...+|+.+++.++||||+++++++...        ..++++|||++ +++.+++.    ....++...+..++.++  |+
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL  183 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL  183 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence            345799999999999999998877432        24679999996 56766654    34568899999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      .|||+.+++||||||+||++.  .....+||+|||+++.+..........+|+.|+|||++.+. .++.++|||||
T Consensus       184 ~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  257 (440)
T PTZ00036        184 AYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSL  257 (440)
T ss_pred             HHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence            999999999999999999994  23346999999999877655555566789999999998764 58999999996

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=5.2e-30  Score=177.87  Aligned_cols=142  Identities=32%  Similarity=0.549  Sum_probs=119.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|++.+++++||||+++++++...+..++|+||+++++|.+++...  ..++......++.++  |+.|||++
T Consensus        43 ~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~  122 (259)
T PF07714_consen   43 EEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN  122 (259)
T ss_dssp             HHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            45789999999999999999999999999888899999999999999999876  668999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|++|+++||++   +....+|++|||+++.......   .........|+|||.+....++.++|||||
T Consensus       123 ~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysf  191 (259)
T PF07714_consen  123 NIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSF  191 (259)
T ss_dssp             TEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHH
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999   4567999999999987632221   223345677999999998889999999996

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8e-29  Score=171.52  Aligned_cols=141  Identities=32%  Similarity=0.580  Sum_probs=124.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|++++++++||||+++++++...+.+|++|||+++++|.+++... ..+++..+..++.++  |+.+||++++
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i  122 (262)
T cd06613          43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK  122 (262)
T ss_pred             hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4678899999999999999999999999999999999999999999998766 679999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC---CCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ---RYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~---~~~~~~Dvws~  152 (152)
                      +|+|++|+||++   +..+.++++|||.+....... ......++..|+|||.+...   .++.++|+|||
T Consensus       123 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~sl  190 (262)
T cd06613         123 IHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWAL  190 (262)
T ss_pred             eecCCChhhEEE---CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHH
Confidence            999999999999   566789999999987654432 23445678889999999876   78999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=1.3e-28  Score=173.33  Aligned_cols=142  Identities=32%  Similarity=0.505  Sum_probs=120.3

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~~~~~~~~~   70 (152)
                      .....+.+|+++++++ +|+||+++++++..++.++++|||+++++|..++...                ..+++..+..
T Consensus        57 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  136 (293)
T cd05053          57 KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS  136 (293)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence            4456788999999999 8999999999999999999999999999999998643                3477888888


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.++  |+.|||+.+++|+||||.||++   +..+.++++|||+++.+.....   .....++..|+|||++.+..++.
T Consensus       137 i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  213 (293)
T cd05053         137 FAYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH  213 (293)
T ss_pred             HHHHHHHHHHHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence            99998  8999999999999999999999   4667899999999986544321   12223456799999998888999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       214 ~~Di~sl  220 (293)
T cd05053         214 QSDVWSF  220 (293)
T ss_pred             ccceeeh
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.96  E-value=7.2e-29  Score=175.12  Aligned_cols=142  Identities=28%  Similarity=0.440  Sum_probs=117.8

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~   70 (152)
                      ...+.+.+|+++++++ +||||+++++++...+..++++||+++++|.+++.+..                .++...+..
T Consensus        44 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  123 (297)
T cd05089          44 NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ  123 (297)
T ss_pred             HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHH
Confidence            3456788999999999 79999999999999999999999999999999986542                367788888


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVN  148 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D  148 (152)
                      ++.++  |+.+||+++++|+||||+||++   +.+..+|++|||++..............+..|+|||+.....++.++|
T Consensus       124 i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  200 (297)
T cd05089         124 FASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSD  200 (297)
T ss_pred             HHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhh
Confidence            99998  8999999999999999999999   456789999999986432211111222345699999999888999999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      ||||
T Consensus       201 vwSl  204 (297)
T cd05089         201 VWSF  204 (297)
T ss_pred             HHHH
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=7.9e-29  Score=172.15  Aligned_cols=140  Identities=31%  Similarity=0.549  Sum_probs=123.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|++++++++||||+++++++...+..++++||+++++|.+++...+.+++..+..++.++  |+.++|+.+++|
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH  129 (267)
T cd06628          50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIH  129 (267)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCccc
Confidence            467889999999999999999999999999999999999999999999888888999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||+|+||++   +....++++|||.++......       ......+++.|+|||.+.+..++.++|+|||
T Consensus       130 ~di~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  198 (267)
T cd06628         130 RDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSL  198 (267)
T ss_pred             ccCCHHHEEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHH
Confidence            9999999999   567789999999997664321       1123457888999999998889999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=7e-29  Score=193.37  Aligned_cols=142  Identities=24%  Similarity=0.369  Sum_probs=118.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-----------CCCCHHHHHHHHHHH-
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTARKFLQQL-   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i-   75 (152)
                      ..++++.+|++++++++||||+++++++..++..+++|||++|++|.+++...           ...+...+..++.++ 
T Consensus        44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa  123 (932)
T PRK13184         44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC  123 (932)
T ss_pred             HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence            34677899999999999999999999999999999999999999999988642           123445667788887 


Q ss_pred             -HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-------------------ccccCCCCCCcccc
Q 031828           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------------------YAEKVCGSPLYMAP  135 (152)
Q Consensus        76 -~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-------------------~~~~~~~t~~y~aP  135 (152)
                       |+.|+|+.+++||||||+||++   +..+.++++|||+++......                   .....+||+.|+||
T Consensus       124 ~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP  200 (932)
T PRK13184        124 ATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP  200 (932)
T ss_pred             HHHHHHHHCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence             8999999999999999999999   566789999999997652110                   01234689999999


Q ss_pred             cccccCCCCcccceeeC
Q 031828          136 EVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       136 E~~~~~~~~~~~Dvws~  152 (152)
                      |++.+..++.++|||||
T Consensus       201 E~l~g~~~S~kSDIWSL  217 (932)
T PRK13184        201 ERLLGVPASESTDIYAL  217 (932)
T ss_pred             HHhcCCCCCcHhHHHHH
Confidence            99998899999999996

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=6.6e-29  Score=173.60  Aligned_cols=142  Identities=22%  Similarity=0.399  Sum_probs=118.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------CCCHHHHHHHHHHH--
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQL--   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i--   75 (152)
                      .....+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.+..          .++...+..++.++  
T Consensus        51 ~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  130 (277)
T cd05062          51 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD  130 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHH
Confidence            345678899999999999999999999998899999999999999999986532          24566777788887  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|||+.+++|+||||+||++   +....++++|||+++.......   .....+++.|+|||++.+..++.++|||||
T Consensus       131 ~l~~lH~~~~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  207 (277)
T cd05062         131 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  207 (277)
T ss_pred             HHHHHHHCCcccCCcchheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHH
Confidence            8999999999999999999999   4667899999999876543321   122345678999999998889999999996

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=5.8e-29  Score=194.77  Aligned_cols=147  Identities=34%  Similarity=0.609  Sum_probs=121.7

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee--CCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l   77 (152)
                      .......+..|+.+++.++||||++++++|..  ...+|+||||+++++|.+++..    .+.+++..++.++.|+  ||
T Consensus        52 ~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~AL  131 (1021)
T PTZ00266         52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL  131 (1021)
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence            34556788999999999999999999998854  3578999999999999998865    2568999999999998  89


Q ss_pred             HHHHhC-------CCeecCCCCCceEeecC--------------CCCceEEEeeccCccccCCCCccccCCCCCCccccc
Q 031828           78 EILNSH-------HIIHRDLKPENILLSGL--------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE  136 (152)
Q Consensus        78 ~~lh~~-------~~~h~dl~~~nil~~~~--------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE  136 (152)
                      .|||..       +|+|+||||+|||+...              +....+||+|||++..+..........||+.|+|||
T Consensus       132 aYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPE  211 (1021)
T PTZ00266        132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPE  211 (1021)
T ss_pred             HHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHH
Confidence            999984       49999999999999531              123358999999998765444445667899999999


Q ss_pred             cccc--CCCCcccceeeC
Q 031828          137 VLQF--QRYDEKVNFFVS  152 (152)
Q Consensus       137 ~~~~--~~~~~~~Dvws~  152 (152)
                      ++..  ..++.++|||||
T Consensus       212 vL~ge~~~~s~KSDVWSL  229 (1021)
T PTZ00266        212 LLLHETKSYDDKSDMWAL  229 (1021)
T ss_pred             HHhccCCCCCchhHHHHH
Confidence            9864  348899999996

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=9.1e-29  Score=173.36  Aligned_cols=141  Identities=24%  Similarity=0.503  Sum_probs=119.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-----------------CCCCHHHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------------GRVPEQTARKF   71 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----------------~~~~~~~~~~~   71 (152)
                      ....+.+|+.++++++||||+++++++..++..|++|||+++++|.+++...                 ..+++..+..+
T Consensus        50 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  129 (283)
T cd05090          50 QWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI  129 (283)
T ss_pred             HHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHH
Confidence            3467889999999999999999999999999999999999999999998532                 13677778888


Q ss_pred             HHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcc
Q 031828           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK  146 (152)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~  146 (152)
                      +.++  |+.|||+++++|+|+||+||++   +....++++|||+++.......   .....++..|+|||++.+..++.+
T Consensus       130 ~~~i~~al~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  206 (283)
T cd05090         130 AIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD  206 (283)
T ss_pred             HHHHHHHHHHHHhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCch
Confidence            8888  8999999999999999999999   4567899999999976544321   223345667999999988889999


Q ss_pred             cceeeC
Q 031828          147 VNFFVS  152 (152)
Q Consensus       147 ~Dvws~  152 (152)
                      +|||||
T Consensus       207 ~Dv~sl  212 (283)
T cd05090         207 SDIWSF  212 (283)
T ss_pred             hhhHHH
Confidence            999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.96  E-value=3.6e-29  Score=180.58  Aligned_cols=138  Identities=30%  Similarity=0.501  Sum_probs=114.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .....+.+|+++++.++|+||+++++++...+.+++++||+.+++|...    ....+..+..++.++  |+.|||++++
T Consensus       114 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~i  189 (353)
T PLN00034        114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHI  189 (353)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            4467789999999999999999999999999999999999999998643    235677778888888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-----CCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-----RYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-----~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||+++.+.... ......||..|+|||++...     ..+.++|||||
T Consensus       190 vHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl  259 (353)
T PLN00034        190 VHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL  259 (353)
T ss_pred             eecCCCHHHEEE---cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHH
Confidence            999999999999   566789999999997654332 23456789999999998532     23568999996

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=6.1e-29  Score=186.56  Aligned_cols=140  Identities=24%  Similarity=0.389  Sum_probs=116.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-----CCCHHHHHHHHHHH--HHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+|+++++.++||||+++++++..++..|++++++ ++++..++....     ......+..++.|+  ||.|||
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH  284 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH  284 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            3567889999999999999999999999999999999998 567777764321     12345666788887  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++   +..+.+||+|||+++.+....  ......||+.|+|||++.+..++.++|||||
T Consensus       285 ~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  354 (501)
T PHA03210        285 DKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC  354 (501)
T ss_pred             hCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence            9999999999999999   567789999999998764432  2234678999999999999899999999996

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=2e-28  Score=169.22  Aligned_cols=143  Identities=29%  Similarity=0.601  Sum_probs=123.9

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+..|+.+++.++|+|++++.+.+.+++.+++++||+++++|.+++...  ..+++..+..++.++  |+.+||+
T Consensus        39 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~  118 (255)
T cd08219          39 SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE  118 (255)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            345677889999999999999999999999999999999999999999988653  347888999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++|+||+|.||++   +..+.++++|||.++...... ......+++.|+|||++.+..++.++|+|||
T Consensus       119 ~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl  186 (255)
T cd08219         119 KRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL  186 (255)
T ss_pred             CCcccCCCCcceEEE---CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhh
Confidence            999999999999999   567789999999987654332 2334568889999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=3.9e-29  Score=180.47  Aligned_cols=138  Identities=35%  Similarity=0.516  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....+.+|+.+++.++||||+++++++...      ...|++|||++ +++.+.+..  .++...+..++.++  |+.||
T Consensus        59 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~L  135 (355)
T cd07874          59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHL  135 (355)
T ss_pred             HHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHH
Confidence            356778899999999999999999988644      35799999995 567666643  47888888888888  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+++++|+||||+||++   +.++.+|++|||+++............+|+.|+|||++.+..++.++|||||
T Consensus       136 H~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl  204 (355)
T cd07874         136 HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  204 (355)
T ss_pred             HhCCcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHH
Confidence            99999999999999999   5667899999999987655444455678999999999998889999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=1.2e-28  Score=170.10  Aligned_cols=144  Identities=33%  Similarity=0.604  Sum_probs=125.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ..+...+.+|+++++.++|||++++++.+..++..++++||+++++|.+++....  .+++..+..++.++  |+.++|+
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~  119 (256)
T cd08220          40 KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT  119 (256)
T ss_pred             cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3456789999999999999999999999998999999999999999999997643  47888889999888  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++|+|++|.||++.  .....++++|||.+.............+++.|+|||.+.+..++.++|||||
T Consensus       120 ~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  187 (256)
T cd08220         120 KLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL  187 (256)
T ss_pred             CCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHH
Confidence            9999999999999994  2345689999999987655444445678889999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=9.3e-30  Score=191.29  Aligned_cols=144  Identities=24%  Similarity=0.490  Sum_probs=126.3

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ..+++.+|..|+.||.++.||||++|.|+......+++|.|||++|+|..|++++ +.+...++..++..|  |+.||-+
T Consensus       670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd  749 (996)
T KOG0196|consen  670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD  749 (996)
T ss_pred             cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence            3678999999999999999999999999999999999999999999999999865 458888888888888  7999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCC--CCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCG--SPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~--t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+++||||..+|||+   +.+-.+|++|||++|.+....  .+++.-|  ..+|.|||.+...++|.+||||||
T Consensus       750 m~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSy  820 (996)
T KOG0196|consen  750 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSY  820 (996)
T ss_pred             cCchhhhhhhhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhcccc
Confidence            999999999999999   677899999999999764332  2222222  467999999999999999999996

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.96  E-value=8.3e-29  Score=176.24  Aligned_cols=142  Identities=24%  Similarity=0.360  Sum_probs=119.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+++.+|+.+++.++||||+++++++..+ ..+++++++++|+|.+++.+.. .++...+..++.++  |+.|||++
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~  128 (316)
T cd05108          50 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER  128 (316)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc
Confidence            34467788999999999999999999999765 5779999999999999997643 57888888999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +....+|++|||+++.+......   ....++..|+|||.+.+..++.++|||||
T Consensus       129 ~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  197 (316)
T cd05108         129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY  197 (316)
T ss_pred             CeeccccchhheEe---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHH
Confidence            99999999999999   46678999999999876543321   22334567999999998899999999996

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=6.4e-29  Score=171.91  Aligned_cols=142  Identities=34%  Similarity=0.581  Sum_probs=127.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|++++++++||||+++++.+..+...++++||+.+++|..++.....+++..+..++.++  |+.+||++++
T Consensus        42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (258)
T cd05578          42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI  121 (258)
T ss_pred             hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34678899999999999999999999999999999999999999999999887789999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +..+.++++|||.+.............++..|+|||.+....++.++|+|||
T Consensus       122 ~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  185 (258)
T cd05578         122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSL  185 (258)
T ss_pred             eccCCCHHHeEE---cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhh
Confidence            999999999999   5667899999999977655544455678889999999998889999999996

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=1e-28  Score=171.51  Aligned_cols=142  Identities=30%  Similarity=0.539  Sum_probs=124.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      +..+.+.+|+++++.++|+||+++.+++...+..++++||+++++|.+++.+...+++..+..++.++  |+.++|+.++
T Consensus        44 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  123 (265)
T cd06631          44 KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV  123 (265)
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567899999999999999999999999999999999999999999999887888999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-------CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||.++.....       .......++..|+|||++.+..++.++|+|||
T Consensus       124 ~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  194 (265)
T cd06631         124 VHRDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSI  194 (265)
T ss_pred             ccCCcCHHhEEE---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHH
Confidence            999999999999   56778999999998754321       11223457889999999998889999999995

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=8.4e-29  Score=172.34  Aligned_cols=141  Identities=26%  Similarity=0.457  Sum_probs=115.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC-----CCHHHHHHHHHHH--HHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+|+++++.++|+||+++++.+...+..+++|||+++++|.+++.....     .++.....++.++  |+.|||
T Consensus        38 ~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH  117 (269)
T cd05042          38 EQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH  117 (269)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            356788999999999999999999999999999999999999999999976432     3566777888888  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCccccccccc-------CCCCcccceee
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-------QRYDEKVNFFV  151 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-------~~~~~~~Dvws  151 (152)
                      +++++|+||||.||++   +.+..+|++|||+++.......   .....+++.|+|||++..       ..++.++||||
T Consensus       118 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  194 (269)
T cd05042         118 QADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS  194 (269)
T ss_pred             hcCEecccccHhheEe---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHH
Confidence            9999999999999999   5677899999999875433221   123345677999999753       34678999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       195 l  195 (269)
T cd05042         195 L  195 (269)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.96  E-value=1.3e-28  Score=170.37  Aligned_cols=141  Identities=26%  Similarity=0.452  Sum_probs=120.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+..|+.+++.++||||+++++++. .+..+++|||+++++|.+++.....+++..+..++.++  |+.++|++++
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  116 (257)
T cd05116          38 ALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF  116 (257)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            34678899999999999999999999886 45678999999999999999887789999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||.||++   ..+..++++|||+++.+.....    .....++..|+|||.+....++.++|+|||
T Consensus       117 ~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  184 (257)
T cd05116         117 VHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSF  184 (257)
T ss_pred             eecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHH
Confidence            999999999999   4567899999999976544321    122233578999999988889999999996

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=188.20  Aligned_cols=140  Identities=27%  Similarity=0.462  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .++|..|+.+|+.++|||+|+|+|+|..+..+|||.|||.+|+|.+++++..  .++....+.++.||  |+.||...++
T Consensus       307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknF  386 (1157)
T KOG4278|consen  307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNF  386 (1157)
T ss_pred             HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhh
Confidence            5889999999999999999999999999999999999999999999998643  47777888899999  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||||..+|+|+   ..+..+|++|||++|.+....+.  ....-...|.|||.+..+.++.++|||||
T Consensus       387 IHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAF  452 (1157)
T KOG4278|consen  387 IHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAF  452 (1157)
T ss_pred             hhhhhhhhhccc---cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHH
Confidence            999999999999   57789999999999987655432  12223567999999999999999999997

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.96  E-value=1.3e-28  Score=170.02  Aligned_cols=141  Identities=30%  Similarity=0.506  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc---------CCCCHHHHHHHHHHH--HH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQL--GL   77 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i--~l   77 (152)
                      ..+.+.+|+++++.++|+|++++++++..++..++++||+++++|.+++...         ..+++..+..++.++  |+
T Consensus        39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al  118 (262)
T cd00192          39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM  118 (262)
T ss_pred             HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence            3678899999999999999999999999999999999999999999999875         678999999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+||+++++|+||+|+||++   +..+.++++|||.++......   ......+++.|+|||.+....++.++|||||
T Consensus       119 ~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (262)
T cd00192         119 EYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF  193 (262)
T ss_pred             HHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHH
Confidence            99999999999999999999   566889999999998765432   2334456788999999998889999999995

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=1.4e-28  Score=170.04  Aligned_cols=140  Identities=24%  Similarity=0.503  Sum_probs=119.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|++++++++||||+++++++..++..+++|||+++++|.+++... +.+++..+..++.++  |+.|+|+++++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05114          43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI  122 (256)
T ss_pred             HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            467889999999999999999999999999999999999999999998653 457888889999888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|++|.||++   +....++++|||.++........  ....++..|+|||.+.+..++.++|+|||
T Consensus       123 H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~  187 (256)
T cd05114         123 HRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSF  187 (256)
T ss_pred             ccccCcceEEE---cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHH
Confidence            99999999999   46678999999998765433221  12234567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.96  E-value=7.1e-29  Score=179.69  Aligned_cols=138  Identities=34%  Similarity=0.511  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....+.+|+.+++.++||||+++++++...      ...|+||||++ +++.+.+..  .++...+..++.|+  |+.||
T Consensus        66 ~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~L  142 (364)
T cd07875          66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHL  142 (364)
T ss_pred             hHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHH
Confidence            356778899999999999999999987543      35799999995 577776643  47788888889998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+++++|+||||+||++   +..+.+||+|||+++............+|+.|+|||++.+..++.++|||||
T Consensus       143 H~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  211 (364)
T cd07875         143 HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  211 (364)
T ss_pred             hhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhH
Confidence            99999999999999999   5677899999999986655444455678999999999999899999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=6.1e-29  Score=186.24  Aligned_cols=144  Identities=28%  Similarity=0.512  Sum_probs=121.4

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC--------eEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQ   73 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--------~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~   73 (152)
                      +......+.+|+.++..++|+|++++++.+...+        .++++|||+++++|.+++...    ..+++..+..++.
T Consensus        71 ~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~  150 (496)
T PTZ00283         71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI  150 (496)
T ss_pred             CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHH
Confidence            3455677889999999999999999988775332        368999999999999988642    4588999999999


Q ss_pred             HH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC---CccccCCCCCCcccccccccCCCCcccc
Q 031828           74 QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVN  148 (152)
Q Consensus        74 ~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~D  148 (152)
                      ++  |+.|+|+.+++|+||||+||++   +..+.+||+|||+++.+...   ......+||+.|+|||++.+..++.++|
T Consensus       151 qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D  227 (496)
T PTZ00283        151 QVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD  227 (496)
T ss_pred             HHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHH
Confidence            98  8999999999999999999999   46678999999999765432   2234567999999999999988999999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      ||||
T Consensus       228 VwSl  231 (496)
T PTZ00283        228 MFSL  231 (496)
T ss_pred             HHHH
Confidence            9996

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=1.2e-28  Score=174.41  Aligned_cols=142  Identities=30%  Similarity=0.473  Sum_probs=119.6

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~   70 (152)
                      ...+.+.+|+.+++.+ +||||+++++++..++..+++|||+++++|.+++.+..                .++...+..
T Consensus        62 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (304)
T cd05101          62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS  141 (304)
T ss_pred             HHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHH
Confidence            4456788999999999 89999999999999999999999999999999997542                256667788


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.++  |+.|||+++++|+||||+||++   ...+.++++|||+++.+.....   .....+++.|+|||++.+..++.
T Consensus       142 ~~~qi~~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  218 (304)
T cd05101         142 CTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  218 (304)
T ss_pred             HHHHHHHHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence            88888  8999999999999999999999   4567899999999986643321   22234567899999999888999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       219 ~~Di~sl  225 (304)
T cd05101         219 QSDVWSF  225 (304)
T ss_pred             hhhHHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=1.7e-28  Score=174.44  Aligned_cols=142  Identities=30%  Similarity=0.467  Sum_probs=118.8

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~   70 (152)
                      ...+.+..|+++++.+ +||||+++++++..++..++++||+++++|.+++....                .++...+..
T Consensus        59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  138 (314)
T cd05099          59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS  138 (314)
T ss_pred             HHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHH
Confidence            4456788999999999 69999999999998899999999999999999996532                367778888


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.++  |+.|+|+++++|+||||+||++   ..++.++++|||.++.......   .....++..|+|||.+.+..++.
T Consensus       139 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (314)
T cd05099         139 CAYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH  215 (314)
T ss_pred             HHHHHHHHHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc
Confidence            88888  8999999999999999999999   4567899999999976543221   11222345799999999888999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       216 ~~Diwsl  222 (314)
T cd05099         216 QSDVWSF  222 (314)
T ss_pred             cchhhHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=1.8e-28  Score=171.36  Aligned_cols=140  Identities=24%  Similarity=0.313  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+.+|+.+++.++||||+++++++..++..++||||+++++|..++.+ .+.+++.....++.++  |+.|||+.+++
T Consensus        60 ~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ii  139 (274)
T cd05076          60 ALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLV  139 (274)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCcc
Confidence            45678899999999999999999999999999999999999999999865 4568888888999998  89999999999


Q ss_pred             ecCCCCCceEeecCC----CCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~----~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+||||+||++....    ....++++|||.+......   ....++..|+|||.+.+ ..++.++|||||
T Consensus       140 H~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl  207 (274)
T cd05076         140 HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSF  207 (274)
T ss_pred             CCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence            999999999995321    2235899999988654322   22346778999999875 458999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=3.3e-28  Score=170.46  Aligned_cols=142  Identities=36%  Similarity=0.574  Sum_probs=120.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+++++.++|||++++++.+..++..++++||+++++|..++.+ ...+++..+..++.++  |+.+||+.+
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  123 (282)
T cd06643          44 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK  123 (282)
T ss_pred             HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4456788999999999999999999999999999999999999999887754 4568999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      ++|+||+|+||++   +..+.++++|||+++...... ......+++.|+|||++.     +..++.++|+|||
T Consensus       124 i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  194 (282)
T cd06643         124 IIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL  194 (282)
T ss_pred             eeecCCCcccEEE---ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence            9999999999999   466789999999987643322 233456888999999984     3457889999996

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=1.3e-28  Score=174.26  Aligned_cols=142  Identities=28%  Similarity=0.460  Sum_probs=121.3

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHh
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+.+|+++++++ +|+||+++++++...+..++++||+++++|.+++.....  +++.++..++.++  |+.|+|+
T Consensus        80 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~  159 (302)
T cd05055          80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS  159 (302)
T ss_pred             HHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4456789999999999 799999999999999999999999999999999875433  7899999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++|+||||+||++   +....++++|||+++.......   .....+++.|+|||.+.+..++.++|||||
T Consensus       160 ~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  229 (302)
T cd05055         160 KNCIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY  229 (302)
T ss_pred             CCeehhhhccceEEE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHH
Confidence            999999999999999   4667899999999976543321   122345678999999998889999999995

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=1.3e-28  Score=171.16  Aligned_cols=141  Identities=28%  Similarity=0.509  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.++++++||||+++++++..++..++++||+++++|.+++.+.+.+++..+..++.++  |+.|+|+.+++
T Consensus        49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (267)
T cd06646          49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM  128 (267)
T ss_pred             hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3456788999999999999999999999999999999999999999999877889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      |+|++|.||++   +..+.++++|||+++...... ......+++.|+|||.+.   ...++.++|+|||
T Consensus       129 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~  195 (267)
T cd06646         129 HRDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAV  195 (267)
T ss_pred             ccCCCHHHEEE---CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHH
Confidence            99999999999   566789999999998664332 234456888999999985   3447889999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.96  E-value=1.3e-28  Score=172.14  Aligned_cols=144  Identities=27%  Similarity=0.410  Sum_probs=120.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-------CCCHHHHHHHHHHH--HHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i--~l~~   79 (152)
                      ....+..|+.+++.++|+||+++++++...+..++++||+++++|.+++...+       .+++..+..++.++  |+.|
T Consensus        52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  131 (277)
T cd05036          52 DESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY  131 (277)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            35678899999999999999999999988888999999999999999987653       37888888899998  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+.+++|+||+|+||++........++++|||+++.+.....   ......++.|+|||++.+..++.++|||||
T Consensus       132 LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  207 (277)
T cd05036         132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF  207 (277)
T ss_pred             HHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHH
Confidence            9999999999999999996444445799999999986533221   112233467999999998889999999996

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=1.5e-28  Score=171.86  Aligned_cols=140  Identities=39%  Similarity=0.553  Sum_probs=122.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+..|+++++.++||||+++++++...+..|+++||+++++|.+++.+..  .+++..+..++.++  |+.+||+.++
T Consensus        37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  116 (277)
T cd05577          37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI  116 (277)
T ss_pred             hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4556789999999999999999999999999999999999999999987665  68999999999888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||.+.............++..|+|||++.+..++.++|+|||
T Consensus       117 ~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  180 (277)
T cd05577         117 VYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL  180 (277)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHH
Confidence            999999999999   5667899999999876543333344567788999999988889999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.96  E-value=8.6e-29  Score=179.75  Aligned_cols=140  Identities=30%  Similarity=0.479  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCC-----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+|+.+++.++|+||+++++++..++     ..|+++||+. ++|...+.....+++..+..++.++  |+.|||
T Consensus        42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH  120 (372)
T cd07853          42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH  120 (372)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3457889999999999999999999998776     7899999995 6888888777789999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +.+++|+||||+||++   +..+.+||+|||+++......  ......+++.|+|||++.+. .++.++|||||
T Consensus       121 ~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  191 (372)
T cd07853         121 SAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSV  191 (372)
T ss_pred             hCCeeCCCCChHHEEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhH
Confidence            9999999999999999   567789999999997643322  22344678899999999874 47899999996

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=2.6e-28  Score=171.06  Aligned_cols=140  Identities=29%  Similarity=0.473  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ....+.+|+++++.++||||+++++++...  ...+++|||+++++|.+++... .+++..+..++.++  |+.+||+++
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~  127 (283)
T cd05080          49 NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH  127 (283)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            467788999999999999999999987653  4689999999999999998654 58999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +....++++|||+++.......    .....++..|+|||.+.+..++.++|||||
T Consensus       128 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~sl  196 (283)
T cd05080         128 YIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSF  196 (283)
T ss_pred             eeccccChheEEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHH
Confidence            9999999999999   4567899999999976543321    122334567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=1.5e-28  Score=170.77  Aligned_cols=143  Identities=30%  Similarity=0.584  Sum_probs=122.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ......+.+|+++++.++||||+++++++...+..++++||+++++|.+++..    ...+++..+..++.++  |+.||
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L  122 (267)
T cd08228          43 AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM  122 (267)
T ss_pred             HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            34456788999999999999999999999999999999999999999988753    3347888899999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+++++|+||+|+||++   +..+.++++|||++....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       123 H~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl  192 (267)
T cd08228         123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             hhCCeeCCCCCHHHEEE---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHH
Confidence            99999999999999999   456789999999987654432 2234568889999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.96  E-value=2.8e-28  Score=169.73  Aligned_cols=143  Identities=24%  Similarity=0.453  Sum_probs=120.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ......+..|+.+++.++||||+++.+++..++..++++||+++++|.+++... +.++...+..++.++  |+.+||++
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~  125 (269)
T cd05065          46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM  125 (269)
T ss_pred             HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            445678999999999999999999999999999999999999999999998754 457888889999888  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcccc---CC---CCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VC---GSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~---~~---~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||+|+||++   +....++++|||+++..........   ..   .+..|+|||.+.+..++.++|||||
T Consensus       126 g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl  197 (269)
T cd05065         126 NYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSY  197 (269)
T ss_pred             CEeecccChheEEE---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhh
Confidence            99999999999999   5667899999999875533221111   11   1346999999998889999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=2.3e-28  Score=170.05  Aligned_cols=142  Identities=25%  Similarity=0.453  Sum_probs=121.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++... ..++...+..++.++  |+.+||+.+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  126 (267)
T cd05066          47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG  126 (267)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678899999999999999999999999999999999999999999999765 357888889998888  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc----ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+|+||+||++   +.+..++++|||+++.+......    ....++..|+|||.+.+..++.++|+|||
T Consensus       127 i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  195 (267)
T cd05066         127 YVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSY  195 (267)
T ss_pred             EeehhhchhcEEE---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHH
Confidence            9999999999999   46678999999999865443211    11223467999999998889999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=2e-28  Score=171.49  Aligned_cols=138  Identities=33%  Similarity=0.563  Sum_probs=119.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ......+.+|++++++++||||+++++.+..++..++++||+++++|..+    ..+++..+..++.++  |+.|||+.+
T Consensus        40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~  115 (279)
T cd06619          40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK  115 (279)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34456788999999999999999999999999999999999999998654    346788888888888  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.++++|||++...... ......+++.|+|||++.+..++.++|+|||
T Consensus       116 i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  179 (279)
T cd06619         116 ILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSL  179 (279)
T ss_pred             EeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHH
Confidence            9999999999999   56778999999999765433 2345678999999999998889999999996

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.96  E-value=2.2e-28  Score=169.93  Aligned_cols=141  Identities=29%  Similarity=0.550  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|++++++++||||+++++++..+  ..+++++||+++++|.+++.+...+++.....++.++  |+.++|+++
T Consensus        47 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (265)
T cd06652          47 EVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM  126 (265)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456788999999999999999999988764  4688999999999999999877778888889999988  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCC----CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||+|+||++   +..+.++++|||.++.....    .......++..|+|||.+.+..++.++|+|||
T Consensus       127 i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  195 (265)
T cd06652         127 IVHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSV  195 (265)
T ss_pred             EecCCCCHHHEEe---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHH
Confidence            9999999999998   46678999999998764321    11233567889999999988889999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-29  Score=184.77  Aligned_cols=144  Identities=26%  Similarity=0.450  Sum_probs=125.3

Q ss_pred             hhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHH--HHHHHH
Q 031828            5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         5 ~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ..++.++.|.+|+.+|+.++||||+++.|++.. ...|+|||.++-|.|..++..+.. ++......++.|+  |+.|||
T Consensus       430 ~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe  508 (974)
T KOG4257|consen  430 CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE  508 (974)
T ss_pred             CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH
Confidence            345668999999999999999999999999975 469999999999999999987654 8888888899999  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCC--CCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC--GSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~--~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++||||..+|||+   .....+|++|||++|-+.....+....  -...|||||.++...++++||||-|
T Consensus       509 SkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMF  578 (974)
T KOG4257|consen  509 SKRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMF  578 (974)
T ss_pred             hhchhhhhhhhhheee---cCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHH
Confidence            9999999999999999   456689999999999876665443333  3567999999999999999999975

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.5e-28  Score=179.12  Aligned_cols=143  Identities=24%  Similarity=0.468  Sum_probs=120.2

Q ss_pred             hhHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCC-CHHHHHHHHHHH--HHHHH
Q 031828            5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         5 ~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~i--~l~~l   80 (152)
                      .+....+-+..|+.+|.++ .|.+|+.|+++=..++.+|||||+ ...||.+++++.... +.-.+..+..|+  ++.++
T Consensus       398 ~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~I  476 (677)
T KOG0596|consen  398 ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTI  476 (677)
T ss_pred             cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHH
Confidence            3445568899999999999 489999999999999999999995 578999999877653 335667777776  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCC-----------CCcc
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR-----------YDEK  146 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-----------~~~~  146 (152)
                      |++||||.||||.|+|+.    .+++||+|||+|..+.+..   ...+.+||+.|||||.+....           .+.+
T Consensus       477 H~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~  552 (677)
T KOG0596|consen  477 HQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRK  552 (677)
T ss_pred             HHhceeecCCCcccEEEE----eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCc
Confidence            999999999999999984    5789999999998876653   346778999999999996543           4578


Q ss_pred             cceeeC
Q 031828          147 VNFFVS  152 (152)
Q Consensus       147 ~Dvws~  152 (152)
                      ||||||
T Consensus       553 SDvWSL  558 (677)
T KOG0596|consen  553 SDVWSL  558 (677)
T ss_pred             cchhhh
Confidence            999996

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.96  E-value=2.2e-28  Score=172.55  Aligned_cols=142  Identities=25%  Similarity=0.484  Sum_probs=119.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-----------CCCHHHHHHHHHHH-
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL-   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~i-   75 (152)
                      ...+.+.+|+++++.++|+||+++++++..++..+++|||+++++|.+++....           .++...+..++.++ 
T Consensus        61 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  140 (296)
T cd05095          61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA  140 (296)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHH
Confidence            345788999999999999999999999999999999999999999999987543           25566788888888 


Q ss_pred             -HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceee
Q 031828           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        76 -~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                       |+.+||+.+++|+||||+||++   +..+.++++|||+++.+.....   .....+++.|+|||....+.++.++|+||
T Consensus       141 ~al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS  217 (296)
T cd05095         141 SGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA  217 (296)
T ss_pred             HHHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence             8999999999999999999999   4567899999999976543321   12233467899999988888999999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       218 l  218 (296)
T cd05095         218 F  218 (296)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=2.9e-28  Score=168.83  Aligned_cols=141  Identities=18%  Similarity=0.294  Sum_probs=118.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|+.+++.++|||++++++++..++..+++|||+++++|.+++..++ .+++.....++.++  |+.|||+.++
T Consensus        42 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  121 (258)
T cd05078          42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGL  121 (258)
T ss_pred             HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34678889999999999999999999999889999999999999999997654 47888888899998  8999999999


Q ss_pred             eecCCCCCceEeecCCC-----CceEEEeeccCccccCCCCccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDD-----DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~-----~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +|+||||+||++.+.+.     ...++++|||++....+.   ....+++.|+|||++.+. .++.++|||||
T Consensus       122 iH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  191 (258)
T cd05078         122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSF  191 (258)
T ss_pred             ecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHH
Confidence            99999999999963221     124799999998654332   345678889999999874 47899999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-28  Score=170.54  Aligned_cols=142  Identities=25%  Similarity=0.420  Sum_probs=120.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------CCCHHHHHHHHHHH--
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQL--   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i--   75 (152)
                      .....+.+|+++++.++|+||+++++++..++..++++||+++++|.+++....          .+++..+..++.++  
T Consensus        51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  130 (277)
T cd05032          51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD  130 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence            445678899999999999999999999999999999999999999999986432          25667888888888  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|+|+.+++|+||+|+||++   +..+.++++|||+++.+.....   .....++..|+|||.+.+..++.++|||||
T Consensus       131 ~l~~lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  207 (277)
T cd05032         131 GMAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF  207 (277)
T ss_pred             HHHHHHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence            8999999999999999999999   5667899999999876544321   223445778999999988889999999996

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.96  E-value=3.4e-28  Score=167.48  Aligned_cols=142  Identities=30%  Similarity=0.511  Sum_probs=119.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      .....+.+|+++++.++||||+++++++...+..+++|||+++++|.+++... ..+.+..+..++.++  |+.++|+++
T Consensus        34 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  113 (250)
T cd05085          34 ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN  113 (250)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34567889999999999999999999999999999999999999999988654 347888888888888  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+|++|+||++   +....++++|||+++........  ....+++.|+|||++....++.++|||||
T Consensus       114 ~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  180 (250)
T cd05085         114 CIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSY  180 (250)
T ss_pred             eeecccChheEEE---cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHH
Confidence            9999999999999   46678999999998754332211  12234567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.96  E-value=1.3e-28  Score=170.16  Aligned_cols=138  Identities=38%  Similarity=0.687  Sum_probs=122.7

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecC
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (152)
                      ...+|+.+++.++||||+++++++..++..+++||++++++|.+++.....++...+..++.++  |+.+||+.+++|+|
T Consensus        44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~d  123 (260)
T PF00069_consen   44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRD  123 (260)
T ss_dssp             HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred             hhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3455999999999999999999999999999999999888999999978889999999999998  89999999999999


Q ss_pred             CCCCceEeecCCCCceEEEeeccCcccc-CCCCccccCCCCCCcccccccc-cCCCCcccceeeC
Q 031828           90 LKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFFVS  152 (152)
Q Consensus        90 l~~~nil~~~~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dvws~  152 (152)
                      |||+||++   +..+.++++|||.+... ..........+++.|+|||++. +..++.++|+|||
T Consensus       124 ikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  185 (260)
T PF00069_consen  124 IKPENILL---DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSL  185 (260)
T ss_dssp             BSGGGEEE---STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHH
T ss_pred             cccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999   57788999999998764 2233445567899999999998 7789999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.96  E-value=2.1e-28  Score=168.87  Aligned_cols=140  Identities=31%  Similarity=0.581  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+++++.++|+||+++++++..++..|+++|++.+++|.+++.. ...+++..+..++.++  |+.+||+.+++
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~  121 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI  121 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            67899999999999999999999999999999999999999999999875 3458899999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|++|.||++   +..+.++++|||++....... ......++..|+|||++.+..++.++|||||
T Consensus       122 H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~  185 (256)
T cd06612         122 HRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSL  185 (256)
T ss_pred             cCCCCcceEEE---CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHH
Confidence            99999999999   456789999999987655443 2334557889999999998889999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.96  E-value=3.1e-28  Score=169.58  Aligned_cols=142  Identities=20%  Similarity=0.381  Sum_probs=116.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ...+.+.+|+.+++.++||||+++++.+......+++|||+++++|.+++.+..    ..+...+..++.++  |+.|||
T Consensus        37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH  116 (268)
T cd05086          37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH  116 (268)
T ss_pred             HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence            446789999999999999999999999999899999999999999999987542    35566777888888  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCccccccccc-------CCCCcccceee
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-------QRYDEKVNFFV  151 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-------~~~~~~~Dvws  151 (152)
                      +.+++|+||||+||++   +.++.++++|||++.......   ......++..|+|||++..       ..++.++||||
T Consensus       117 ~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  193 (268)
T cd05086         117 KHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA  193 (268)
T ss_pred             HCCeeccCCccceEEE---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence            9999999999999999   566789999999986432221   2234567889999999853       23578899999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       194 l  194 (268)
T cd05086         194 L  194 (268)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.96  E-value=2.5e-28  Score=169.56  Aligned_cols=140  Identities=26%  Similarity=0.450  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+++++.++|+||+++++++..++.++++|||+++++|.+++....  .++...+..++.++  |+.+||++++
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i  125 (263)
T cd05052          46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF  125 (263)
T ss_pred             HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4678899999999999999999999999999999999999999999986543  47888888899998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccc--cCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   ...+.++++|||+++.........  ....+..|+|||.+.+..++.++|||||
T Consensus       126 ~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  191 (263)
T cd05052         126 IHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  191 (263)
T ss_pred             eecccCcceEEE---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHH
Confidence            999999999999   567789999999997654432211  2223567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.96  E-value=2.2e-28  Score=171.39  Aligned_cols=141  Identities=24%  Similarity=0.518  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKFL   72 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~   72 (152)
                      ..+.+..|+.+++.++||||+++++++..++..++++||+.+++|.+++...                ..++...+..++
T Consensus        51 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (283)
T cd05091          51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV  130 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence            4577889999999999999999999999999999999999999999998532                236777788888


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCccc
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      .++  |+.|+|+++++|+||||.||++   .....+|++|||+++.......   .....+++.|+|||.+.++.++.++
T Consensus       131 ~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (283)
T cd05091         131 TQIAAGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS  207 (283)
T ss_pred             HHHHHHHHHHHHcCccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch
Confidence            888  8999999999999999999999   4566899999999876543321   1233456789999999888899999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |||||
T Consensus       208 Dv~sl  212 (283)
T cd05091         208 DIWSY  212 (283)
T ss_pred             hHHHH
Confidence            99996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1.4e-29  Score=174.11  Aligned_cols=141  Identities=30%  Similarity=0.521  Sum_probs=120.8

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeee-CCeEEEEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHH--HHHHHHh
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...-+|+.+++.++|||++.+..+|.. +..+|+++||. ..+|.+.++..     ..++...+..+++||  |+.|||+
T Consensus        72 ~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~  150 (438)
T KOG0666|consen   72 MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS  150 (438)
T ss_pred             HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence            456689999999999999999999987 78999999998 68999998643     348899999999998  9999999


Q ss_pred             CCCeecCCCCCceEeecC-CCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~-~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +=++|||+||.||++... .+.+++|++|+|++|.+...-    ..+.++-|.||.|||.+.+.. ||++.||||.
T Consensus       151 NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAi  226 (438)
T KOG0666|consen  151 NWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAI  226 (438)
T ss_pred             hheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHH
Confidence            999999999999999643 345899999999999865542    334566799999999999865 9999999984

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=3e-28  Score=168.20  Aligned_cols=141  Identities=33%  Similarity=0.618  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++|+||+++++++..++..++++||+++++|.+++.+...+++..+..++.++  |+.+||+.+++
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  124 (258)
T cd06632          45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV  124 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567899999999999999999999999999999999999999999999887778999998898888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.+|++|||.+.............+++.|+|||.+.... ++.++|+|||
T Consensus       125 H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~sl  188 (258)
T cd06632         125 HRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSL  188 (258)
T ss_pred             cCCCCHHHEEE---CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHH
Confidence            99999999999   467789999999987654444345567889999999998776 8999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.96  E-value=4e-28  Score=171.90  Aligned_cols=141  Identities=30%  Similarity=0.580  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++.+..++..+++|||+++++|.+++...+.+++..+..++.++  |+.|+|+++++
T Consensus        44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  123 (305)
T cd05609          44 QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIV  123 (305)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567889999999999999999999999999999999999999999999888889999999888887  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC----------------ccccCCCCCCcccccccccCCCCccccee
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAPEVLQFQRYDEKVNFF  150 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw  150 (152)
                      |+|++|.||++   +..+.++++|||+++......                ......++..|+|||.+....++.++|+|
T Consensus       124 H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  200 (305)
T cd05609         124 HRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWW  200 (305)
T ss_pred             ccCCchHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHH
Confidence            99999999999   466789999999886321100                11124567889999999888899999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       201 sl  202 (305)
T cd05609         201 AM  202 (305)
T ss_pred             HH
Confidence            96

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=2.4e-28  Score=169.74  Aligned_cols=142  Identities=32%  Similarity=0.570  Sum_probs=123.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|++++++++|+||+++++++...+..++++||+++++|.+++.+.+.+++..+..++.++  |+.+||+++++
T Consensus        46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~  125 (268)
T cd06630          46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII  125 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4578899999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|.||++.  .....++++|||.+..+....     ......++..|+|||.+.+..++.++|+|||
T Consensus       126 H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl  194 (268)
T cd06630         126 HRDVKGANLLID--STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV  194 (268)
T ss_pred             cCCCCHHHEEEc--CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHH
Confidence            999999999993  233469999999987664432     1123457889999999988889999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=2.6e-28  Score=168.96  Aligned_cols=140  Identities=26%  Similarity=0.474  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|++++++++||||+++++++...+..+++|||+.+++|.+++... ..+++..+..++.++  |+.+||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05113          43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI  122 (256)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            467889999999999999999999999888899999999999999998764 358899999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|.||++   +.+..+|++|||.++........  ....++..|+|||.+.+..++.++|||||
T Consensus       123 H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl  187 (256)
T cd05113         123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF  187 (256)
T ss_pred             ccccCcceEEE---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHH
Confidence            99999999999   45678999999998765443221  12234567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.4e-28  Score=168.64  Aligned_cols=140  Identities=25%  Similarity=0.431  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|++++++++|+||+++++++...+..++++|++++++|.+++....  .++...+..++.++  |+.+||+.++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  124 (261)
T cd05068          45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY  124 (261)
T ss_pred             HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4678899999999999999999999999999999999999999999997654  58888999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +..+.++++|||+++........  .....+..|+|||.+.+..++.++|+|||
T Consensus       125 ~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  190 (261)
T cd05068         125 IHRDLAARNVLV---GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF  190 (261)
T ss_pred             eeccCCcceEEE---cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHH
Confidence            999999999999   46678999999999876533211  11222357999999998889999999996

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.96  E-value=3.2e-28  Score=169.09  Aligned_cols=142  Identities=30%  Similarity=0.584  Sum_probs=122.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ...+++.+|+++++.++|+||+++++++..++..++++|++++++|.+++..    ...+++..+..++.++  |+.+||
T Consensus        44 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH  123 (267)
T cd08229          44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH  123 (267)
T ss_pred             HHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4457888999999999999999999999999999999999999999998863    3457888999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++++|+||+|+||++   +..+.++++|||++....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       124 ~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl  192 (267)
T cd08229         124 SRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             HCCeecCCCCHHHEEE---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHH
Confidence            9999999999999999   456789999999987654332 2234568889999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=4.9e-28  Score=168.25  Aligned_cols=142  Identities=23%  Similarity=0.449  Sum_probs=121.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      .....+.+|+.++++++||||+++++++...+..++++||+++++|.+++... +.++...+..++.++  |+.+||+++
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~  126 (266)
T cd05033          47 KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN  126 (266)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            44677889999999999999999999999999999999999999999998764 458899999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCC-Cc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||+|.||++   +....++++|||+++..... ..  .....+++.|+|||.+.+..++.++|||||
T Consensus       127 i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~sl  194 (266)
T cd05033         127 YVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSF  194 (266)
T ss_pred             cccCCCCcceEEE---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHH
Confidence            9999999999999   46678999999999876422 11  112234567999999998889999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.96  E-value=4.2e-28  Score=167.68  Aligned_cols=141  Identities=28%  Similarity=0.422  Sum_probs=122.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|++++++++||||+++++.+.. ...++++|++++++|.+.+.++.  .+++..+..++.++  |+.++|+.
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  116 (257)
T cd05040          38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK  116 (257)
T ss_pred             HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence            456788999999999999999999999988 88999999999999999997654  57889999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||+|+||++   +..+.+|++|||+++.+....    ......++..|+|||.+.+..++.++|||||
T Consensus       117 ~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~sl  186 (257)
T cd05040         117 RFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMF  186 (257)
T ss_pred             CccccccCcccEEE---ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHH
Confidence            99999999999999   456789999999998764422    1123456778999999998889999999996

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.96  E-value=3.9e-28  Score=173.58  Aligned_cols=141  Identities=26%  Similarity=0.386  Sum_probs=117.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+..|+++++.++||||+++++++..++..++|+||+++++|.+++...  ..+++..+..++.++  |+.|||+++
T Consensus        42 ~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  121 (327)
T cd08227          42 MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG  121 (327)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567888999999999999999999999999999999999999999998653  458899999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--------cccCCCCCCccccccccc--CCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   ...+.+++.||+.+........        .....++..|+|||++.+  ..++.++|||||
T Consensus       122 iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl  196 (327)
T cd08227         122 YVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV  196 (327)
T ss_pred             EecCCCChhhEEE---ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHH
Confidence            9999999999999   4566889999986543322111        122345677999999976  358999999996

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.4e-28  Score=168.83  Aligned_cols=139  Identities=26%  Similarity=0.513  Sum_probs=121.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+++.+|+.+++.++|+||+++++++...+..++++|++++++|.+++....  .+++..+..++.++  |+.++|+++
T Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~  122 (256)
T cd05039          43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN  122 (256)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35678899999999999999999999998889999999999999999997665  68999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||+|.||++   +..+.++++|||.++......  .....+..|+|||.+..+.++.++|+|||
T Consensus       123 i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~sl  185 (256)
T cd05039         123 FVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSF  185 (256)
T ss_pred             ccchhcccceEEE---eCCCCEEEccccccccccccc--ccCCCcccccCchhhcCCcCCcHHHHHHH
Confidence            9999999999999   467789999999997653221  23334567999999988889999999996

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=3.5e-28  Score=168.47  Aligned_cols=141  Identities=27%  Similarity=0.507  Sum_probs=120.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|+.++++++|+||+++++++..++..++++|++++++|.+++...  ..++...+..++.++  |+.|||+.+
T Consensus        44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~  123 (261)
T cd05072          44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN  123 (261)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3568899999999999999999999999899999999999999999998653  347788888888888  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||+|+||++   +..+.++++|||+++.......  .....++..|+|||.+....++.++|||||
T Consensus       124 i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  190 (261)
T cd05072         124 YIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  190 (261)
T ss_pred             eeccccchhhEEe---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhh
Confidence            9999999999999   5667899999999976543321  122334667999999998889999999996

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=3.2e-28  Score=171.21  Aligned_cols=142  Identities=30%  Similarity=0.458  Sum_probs=119.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc------------------------CCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GRV   63 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------------------------~~~   63 (152)
                      ...+++.+|+++++.++||||+++++.+..++..++++||+.+++|.+++...                        ..+
T Consensus        45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  124 (290)
T cd05045          45 SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL  124 (290)
T ss_pred             HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCcccccc
Confidence            34567889999999999999999999999999999999999999999988642                        236


Q ss_pred             CHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCccccccc
Q 031828           64 PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVL  138 (152)
Q Consensus        64 ~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~  138 (152)
                      +...+..++.++  |+.+||+.+++|+||+|+||++   .....++++|||+++.......   .....++..|+|||.+
T Consensus       125 ~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~  201 (290)
T cd05045         125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL  201 (290)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence            777888888888  8999999999999999999999   4567899999999976533221   2233456789999999


Q ss_pred             ccCCCCcccceeeC
Q 031828          139 QFQRYDEKVNFFVS  152 (152)
Q Consensus       139 ~~~~~~~~~Dvws~  152 (152)
                      .+..++.++|||||
T Consensus       202 ~~~~~~~~~Di~sl  215 (290)
T cd05045         202 FDHIYTTQSDVWSF  215 (290)
T ss_pred             ccCCcchHhHHHHH
Confidence            88889999999996

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2e-28  Score=181.43  Aligned_cols=146  Identities=30%  Similarity=0.601  Sum_probs=128.0

Q ss_pred             hhhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         4 ~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ++.+.+..-++.|-.||..-+.+=||+||-+|++++.+|+||||++||++..+|-+.+.|++..+..|+.++  |+++.|
T Consensus       667 Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH  746 (1034)
T KOG0608|consen  667 VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH  746 (1034)
T ss_pred             HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH
Confidence            344556677888999999999999999999999999999999999999999999999999999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccC---------CCC-------------------------------
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---------PGN-------------------------------  121 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~---------~~~-------------------------------  121 (152)
                      .-|+|||||||+|||+   +.++.+||.|||+|.-+.         .++                               
T Consensus       747 kmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h  823 (1034)
T KOG0608|consen  747 KMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQH  823 (1034)
T ss_pred             hccceecccCccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhh
Confidence            9999999999999999   788899999999995221         000                               


Q ss_pred             ---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          122 ---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       122 ---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                         .....+||+.|+|||++...+|+..+||||.
T Consensus       824 ~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~  857 (1034)
T KOG0608|consen  824 QRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV  857 (1034)
T ss_pred             hhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence               0123568999999999999999999999983

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.9e-28  Score=167.97  Aligned_cols=140  Identities=26%  Similarity=0.505  Sum_probs=118.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+.+++.++|+||+++++++...+..++++||+++++|.+++... ..+++..+..++.++  |+.+||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  122 (256)
T cd05059          43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            456888999999999999999999999999999999999999999998753 457888999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|++|+||++   +..+.++++|||+++........  ....++..|+|||.+.+..++.++|+|||
T Consensus       123 H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  187 (256)
T cd05059         123 HRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSF  187 (256)
T ss_pred             cccccHhhEEE---CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHH
Confidence            99999999999   46678999999998765432211  11123457999999998889999999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.6e-28  Score=169.01  Aligned_cols=141  Identities=31%  Similarity=0.588  Sum_probs=124.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+++++.++|+|++++++++..+...|+++|++++++|.+++... .+++..+..++.++  |+.++|+.++
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i  119 (274)
T cd06609          41 DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGK  119 (274)
T ss_pred             hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567889999999999999999999999999999999999999999998765 78899999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|++|+||++   +.++.++++|||+++..... .......+++.|+|||.+.+..++.++|||||
T Consensus       120 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~sl  184 (274)
T cd06609         120 IHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSL  184 (274)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHH
Confidence            999999999999   56778999999999876544 23345567889999999998889999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=5.1e-28  Score=169.58  Aligned_cols=142  Identities=27%  Similarity=0.428  Sum_probs=117.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+.+|++++++++||||+++++++...  ...++++||+++++|.+++.+. ..+++..+..++.++  |+.+||+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~  126 (284)
T cd05081          47 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS  126 (284)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4456789999999999999999999987533  4689999999999999998754 458888989999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc----ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++|+||||+||++   +....++++|||+++........    ....++..|+|||++.+..++.++|+|||
T Consensus       127 ~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  197 (284)
T cd05081         127 KRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF  197 (284)
T ss_pred             CCceeccCCHhhEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHH
Confidence            999999999999999   56678999999999865433211    11223445999999998889999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.5e-28  Score=169.54  Aligned_cols=143  Identities=36%  Similarity=0.586  Sum_probs=121.9

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++++.++|+|++++++.+..++..|++|||+++++|..++.+. ..+++..+..++.++  |+.|||+.
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~  122 (280)
T cd06611          43 EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH  122 (280)
T ss_pred             HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345567889999999999999999999999999999999999999999998764 468999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      +++|+|++|+||++   +..+.++++|||++....... ......+++.|+|||.+.     ...++.++|+|||
T Consensus       123 ~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~sl  194 (280)
T cd06611         123 KVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSL  194 (280)
T ss_pred             CcccCCCChhhEEE---CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHH
Confidence            99999999999999   566789999999886543322 234456888999999985     3347789999996

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.1e-29  Score=173.45  Aligned_cols=142  Identities=32%  Similarity=0.620  Sum_probs=131.5

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      +..+.++-|..++.+- +||++|.++.+|+++..+++|.||.+||+|.-.+.+++.+++..+..+..+|  |+.|||++|
T Consensus       292 edidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg  371 (593)
T KOG0695|consen  292 EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG  371 (593)
T ss_pred             ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC
Confidence            4467888899988887 8999999999999999999999999999999989999999999999999988  999999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccc-cCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.||+|..|+|+   +..+.+|+.|+|.++. +.++....++||||.|.|||++.+..|..++|||||
T Consensus       372 iiyrdlkldnvll---daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwal  437 (593)
T KOG0695|consen  372 IIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL  437 (593)
T ss_pred             eeeeeccccceEE---ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHH
Confidence            9999999999999   6888999999999986 566677889999999999999999999999999985

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=5.8e-28  Score=169.15  Aligned_cols=140  Identities=27%  Similarity=0.448  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ....+..|+.++++++||||+++++++.. ...++++|++++++|.+++... +.+++..+..++.++  |+.|+|+.++
T Consensus        52 ~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  130 (279)
T cd05111          52 TFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM  130 (279)
T ss_pred             HHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            34667788889999999999999998754 4578899999999999999754 468899999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +....+|++|||.++.......   .....++..|+|||.+.++.++.++|||||
T Consensus       131 iH~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  197 (279)
T cd05111         131 VHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSY  197 (279)
T ss_pred             eccccCcceEEE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHH
Confidence            999999999999   4667899999999986544321   223446678999999998889999999996

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=8.2e-28  Score=169.28  Aligned_cols=143  Identities=32%  Similarity=0.546  Sum_probs=120.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++++.++|+|++++++.+..++..+++|||+++++|..++.+ ...+++..+..++.++  |+.+||++
T Consensus        50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~  129 (292)
T cd06644          50 EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM  129 (292)
T ss_pred             HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            34567788999999999999999999999999999999999999999887754 4568999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      +++|+|++|+||++   +..+.++++|||++...... .......+++.|+|||++.     ...++.++|+|||
T Consensus       130 ~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  201 (292)
T cd06644         130 KIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL  201 (292)
T ss_pred             CeeecCCCcceEEE---cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence            99999999999999   45678999999998754332 2234456788999999985     3346889999996

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.96  E-value=5.4e-28  Score=168.33  Aligned_cols=141  Identities=26%  Similarity=0.418  Sum_probs=115.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-----CCCHHHHHHHHHHH--HHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+|+.++++++||||+++++++......+++|||+++++|.+++....     ..+...+..++.++  |+.|+|
T Consensus        38 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  117 (269)
T cd05087          38 EQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH  117 (269)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence            34578889999999999999999999998889999999999999999986432     24556677788887  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccC-------CCCcccceee
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-------RYDEKVNFFV  151 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-------~~~~~~Dvws  151 (152)
                      +.+++|+|+||+||++   +....++++|||+++.......   .....+++.|+|||++...       .++.++|+||
T Consensus       118 ~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws  194 (269)
T cd05087         118 KNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS  194 (269)
T ss_pred             HCCEeccccCcceEEE---cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHH
Confidence            9999999999999999   4567899999999865433221   2234567889999998642       3578999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       195 l  195 (269)
T cd05087         195 L  195 (269)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=7.3e-28  Score=167.45  Aligned_cols=142  Identities=30%  Similarity=0.570  Sum_probs=121.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .....+.+|+++++.++||||+++++++...  +..++++|++++++|.+++.+...+++.....++.++  |+.+||++
T Consensus        46 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~  125 (266)
T cd06651          46 KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN  125 (266)
T ss_pred             HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456788999999999999999999988653  5789999999999999999887788999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+|++|+||++   +....++++|||+++......    ......++..|+|||.+.+..++.++|+|||
T Consensus       126 ~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  195 (266)
T cd06651         126 MIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSL  195 (266)
T ss_pred             CeeeCCCCHHHEEE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHH
Confidence            99999999999998   466789999999987653321    1223457888999999998889999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=6.1e-28  Score=168.01  Aligned_cols=142  Identities=27%  Similarity=0.481  Sum_probs=118.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCe------EEEEEeecCCCChHHHHHhc------CCCCHHHHHHHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~------~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i   75 (152)
                      ...+.+.+|+++++.++||||+++++++...+.      .++++||+++++|..++...      ..+++..+..++.++
T Consensus        43 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i  122 (273)
T cd05035          43 SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI  122 (273)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHH
Confidence            445688999999999999999999998865543      79999999999999888432      247888889899998


Q ss_pred             --HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCccccee
Q 031828           76 --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFF  150 (152)
Q Consensus        76 --~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvw  150 (152)
                        |+.|+|+++++|+||||+||++   +....++++|||+++.+......   ....++..|+|||.+....++.++|||
T Consensus       123 ~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~  199 (273)
T cd05035         123 ALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW  199 (273)
T ss_pred             HHHHHHHHhCCeeccccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchH
Confidence              8999999999999999999999   56678999999999876443321   122345679999999888899999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       200 Sl  201 (273)
T cd05035         200 AF  201 (273)
T ss_pred             HH
Confidence            96

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=4.1e-28  Score=168.06  Aligned_cols=141  Identities=24%  Similarity=0.422  Sum_probs=121.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+..|+++++.++|+||+++++++...+..+++|||+++++|.+++...  ..++...+..++.++  |+.+||+++
T Consensus        45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  124 (261)
T cd05148          45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN  124 (261)
T ss_pred             hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567899999999999999999999999999999999999999999999753  347888899999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||+|+||++   +.+..++++|||.+........ .....++..|+|||......++.++|||||
T Consensus       125 i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Diwsl  190 (261)
T cd05148         125 SIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSF  190 (261)
T ss_pred             eeccccCcceEEE---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHH
Confidence            9999999999999   4667899999999976543322 123334667999999998889999999996

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=3.3e-28  Score=170.61  Aligned_cols=141  Identities=31%  Similarity=0.514  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++|+||+++.+++..++..++++||++++.+..+..+...+++..+..++.++  |+.+||+.+++
T Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  122 (288)
T cd07833          43 VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII  122 (288)
T ss_pred             chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4578899999999999999999999999999999999999887777766666678999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+|++|.||++   +..+.++++|||++.......  ......+++.|+|||++.+. .++.++|+|||
T Consensus       123 H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~sl  188 (288)
T cd07833         123 HRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAI  188 (288)
T ss_pred             cCCCCHHHeEE---CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHH
Confidence            99999999999   567789999999987765443  23345678889999999888 78999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=5.8e-28  Score=167.62  Aligned_cols=142  Identities=30%  Similarity=0.567  Sum_probs=123.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ...+.+.+|++++++++|+|++++++++..++..++++||+++++|..++..    ...+++..+..++.++  |+.+||
T Consensus        44 ~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh  123 (267)
T cd08224          44 KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH  123 (267)
T ss_pred             hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            4477899999999999999999999999999999999999999999998864    2347889999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++|+||+|+||++   +.++.++++|||+++...... ......+++.|+|||.+.+..++.++|+|||
T Consensus       124 ~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  192 (267)
T cd08224         124 SKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  192 (267)
T ss_pred             hCCEecCCcChhhEEE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHH
Confidence            9999999999999999   466789999999987654332 2234567889999999998889999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.96  E-value=4.9e-28  Score=169.60  Aligned_cols=140  Identities=29%  Similarity=0.497  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++|+|++++++++..++..++++||++++.+..+......+++..+..++.++  |+.+||+.+++|
T Consensus        44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H  123 (286)
T cd07847          44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH  123 (286)
T ss_pred             cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            456789999999999999999999999999999999999988888887776779999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +||+|.||++   +..+.++++|||++....... ......++..|+|||.+.+ ..++.++|+|||
T Consensus       124 ~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  187 (286)
T cd07847         124 RDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAI  187 (286)
T ss_pred             cCCChhhEEE---cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHH
Confidence            9999999999   456789999999998664443 2334457788999999876 457889999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=3.2e-28  Score=173.00  Aligned_cols=142  Identities=27%  Similarity=0.498  Sum_probs=114.5

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeee--CCeEEEEEeecCCCChHHHHHhc---------CCCCHHHHHHHHHHH--H
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQL--G   76 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i--~   76 (152)
                      ...+.+|+++++.++||||+++++++..  +...++++||++ ++|.+++...         ..+++..+..++.++  |
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  120 (317)
T cd07867          42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG  120 (317)
T ss_pred             cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence            3467889999999999999999998853  467899999984 6787776421         237888889999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecC-CCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccC-CCCccccee
Q 031828           77 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFF  150 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~-~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvw  150 (152)
                      +.|||+.+++|+||||+||++... ...+.+||+|||+++......    ......+|+.|+|||++.+. .++.++|||
T Consensus       121 L~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  200 (317)
T cd07867         121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  200 (317)
T ss_pred             HHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence            999999999999999999998532 245689999999998654332    12345678999999999764 488999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       201 Sl  202 (317)
T cd07867         201 AI  202 (317)
T ss_pred             hH
Confidence            96

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=3.8e-28  Score=170.45  Aligned_cols=138  Identities=34%  Similarity=0.539  Sum_probs=114.9

Q ss_pred             HHHHHHHHHHHcC---CCcCccceeeeeee-----CCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHH
Q 031828           11 SCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus        11 ~~~~~E~~~l~~l---~h~ni~~l~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~   78 (152)
                      ..+.+|+++++.+   +||||+++++++..     ....++++|++. ++|.+++...  ..+++..+..++.++  |+.
T Consensus        44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~  122 (288)
T cd07863          44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD  122 (288)
T ss_pred             hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence            3456788877766   69999999998864     245899999996 5888888653  348899999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|+.+++|+||||+||++   +..+.++++|||+++............+++.|+|||++.+..++.++|||||
T Consensus       123 ~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  193 (288)
T cd07863         123 FLHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSV  193 (288)
T ss_pred             HHHhCCeecCCCCHHHEEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhH
Confidence            9999999999999999999   5667899999999986654444445678899999999998889999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-28  Score=184.49  Aligned_cols=145  Identities=30%  Similarity=0.625  Sum_probs=122.6

Q ss_pred             hhHhHHHHHHHHHHHHHcC-CCcCccceeeeeee-----CCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH-
Q 031828            5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL-   75 (152)
Q Consensus         5 ~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i-   75 (152)
                      .+.+..++++.|..+++.. .|||++.++++|..     ++.+|+|||||.+|+..+++++-  ..+.+..+..++..+ 
T Consensus        54 ~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~l  133 (953)
T KOG0587|consen   54 PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREIL  133 (953)
T ss_pred             CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHH
Confidence            3455677888899999887 79999999999853     36799999999999999999753  347788888888776 


Q ss_pred             -HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCC-----CCcccc
Q 031828           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-----YDEKVN  148 (152)
Q Consensus        76 -~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-----~~~~~D  148 (152)
                       |+.+||.+.++|||+|-.|||+   ...+.+|++|||.+.++.+. ....+..|||.|||||++....     |+..+|
T Consensus       134 rgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D  210 (953)
T KOG0587|consen  134 RGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSD  210 (953)
T ss_pred             HHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccc
Confidence             8999999999999999999999   57789999999999887654 4566788999999999997543     677899


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      +|||
T Consensus       211 ~WsL  214 (953)
T KOG0587|consen  211 LWSL  214 (953)
T ss_pred             hhhc
Confidence            9997

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=1.7e-28  Score=174.11  Aligned_cols=139  Identities=27%  Similarity=0.472  Sum_probs=116.5

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+.+|++++++++||||+++++++..++..+++|||++ +++.+++...+ .++...+..++.++  |+.|||+++++
T Consensus        48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv  126 (309)
T cd07872          48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL  126 (309)
T ss_pred             chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3457789999999999999999999999999999999996 58888776544 47888888888888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.++++|||+++...... ......+++.|+|||.+.+ ..++.++|||||
T Consensus       127 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  191 (309)
T cd07872         127 HRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGV  191 (309)
T ss_pred             cCCCCHHHEEE---CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHH
Confidence            99999999999   566789999999987543322 2234567889999999875 458899999996

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.96  E-value=4.1e-28  Score=170.43  Aligned_cols=142  Identities=26%  Similarity=0.536  Sum_probs=119.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------------CCCH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------RVPE   65 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------------~~~~   65 (152)
                      .....+.+|++++++++||||+++++++..++..++++||+++++|.+++....                      .+++
T Consensus        50 ~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  129 (288)
T cd05050          50 DMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC  129 (288)
T ss_pred             HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCH
Confidence            445778999999999999999999999999899999999999999999986432                      2567


Q ss_pred             HHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCccccccccc
Q 031828           66 QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        66 ~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~  140 (152)
                      ..++.++.++  |+.++|+++++|+||+|.||++   ...+.++++|||+++.+.....   ......+..|+|||.+.+
T Consensus       130 ~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (288)
T cd05050         130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY  206 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence            7788889888  8999999999999999999999   4677899999999876543321   122334567999999998


Q ss_pred             CCCCcccceeeC
Q 031828          141 QRYDEKVNFFVS  152 (152)
Q Consensus       141 ~~~~~~~Dvws~  152 (152)
                      ..++.++|||||
T Consensus       207 ~~~~~~~Dv~sl  218 (288)
T cd05050         207 NRYTTESDVWAY  218 (288)
T ss_pred             CCCCchhHHHHH
Confidence            889999999996

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=8.3e-28  Score=166.10  Aligned_cols=142  Identities=28%  Similarity=0.611  Sum_probs=120.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeee-CCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+.+|++++++++|+|++++.+.+.. ++..++++|++++++|.+++...  ..+++..+..++.++  |+.++|+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~  120 (257)
T cd08223          41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE  120 (257)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            445678899999999999999999988864 44689999999999999998753  348899999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+++|+||+|+||++   +....++++|||++....... ......+++.|+|||++.+..++.++|+|||
T Consensus       121 ~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  188 (257)
T cd08223         121 KHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWAL  188 (257)
T ss_pred             CCeeccCCCchhEEE---ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHH
Confidence            999999999999999   456789999999987654332 2345567889999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=6.7e-28  Score=172.77  Aligned_cols=142  Identities=30%  Similarity=0.475  Sum_probs=118.7

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~   70 (152)
                      ...+.+.+|+++++++ +||||+++++++..++..++++||+++++|.+++.+..                .++...+..
T Consensus        59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  138 (334)
T cd05100          59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS  138 (334)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence            4457889999999999 89999999999998899999999999999999987532                256677778


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.++  |+.|||+++++|+||||+||++   +....++++|||+++.......   .....++..|+|||++.+..++.
T Consensus       139 ~~~qi~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  215 (334)
T cd05100         139 CAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  215 (334)
T ss_pred             HHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence            88888  8999999999999999999999   4567899999999976543221   12223356799999999888999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       216 ~~Di~sl  222 (334)
T cd05100         216 QSDVWSF  222 (334)
T ss_pred             hhhhHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=4.1e-28  Score=169.27  Aligned_cols=141  Identities=21%  Similarity=0.410  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC---------CCCHHHHHHHHHHH--HH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------RVPEQTARKFLQQL--GL   77 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i--~l   77 (152)
                      ..+.+.+|++++++++|+||+++++++...+..|++|||+++++|.+++....         .++...+..++.++  |+
T Consensus        51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l  130 (275)
T cd05046          51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM  130 (275)
T ss_pred             HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence            45779999999999999999999999998889999999999999999997655         68899999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .|||+++++|+||||+||++   +..+.++++|||++.......  ......+++.|+|||.+.+..++.++|||||
T Consensus       131 ~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  204 (275)
T cd05046         131 DHLSNARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSF  204 (275)
T ss_pred             HHhhhcCcccCcCccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHH
Confidence            99999999999999999999   456789999999986543221  1223345677999999988888999999996

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=8.4e-28  Score=166.31  Aligned_cols=140  Identities=27%  Similarity=0.470  Sum_probs=119.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.+.|+|++++++++.. +..++++||+.+++|.+++.+...+++..+..++.++  |+.+||+++++
T Consensus        39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~  117 (257)
T cd05060          39 GKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV  117 (257)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            45678899999999999999999998764 4689999999999999999888789999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc----ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +.++.++++|||.++........    ....++..|+|||.+.+..++.++|||||
T Consensus       118 H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  184 (257)
T cd05060         118 HRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSY  184 (257)
T ss_pred             ccCcccceEEE---cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHH
Confidence            99999999999   46678999999999866443321    11122457999999998889999999996

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-29  Score=181.98  Aligned_cols=143  Identities=28%  Similarity=0.506  Sum_probs=122.9

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ++.+.+.|+.|+..+++-+|.||+-+.|++..++. .+|..+|+|.+|+.++... ..|.......++.|+  |+.|||.
T Consensus       428 t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA  506 (678)
T KOG0193|consen  428 TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA  506 (678)
T ss_pred             CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh
Confidence            45678999999999999999999999999988876 9999999999999998643 347778888899998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccc---cCCCCccccCCCCCCccccccccc---CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT---LYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~---~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~  152 (152)
                      .+|||+|||..||++   ..+..|||.|||++..   +.-........|+..|||||+++.   .+|+..+|||||
T Consensus       507 K~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaF  579 (678)
T KOG0193|consen  507 KNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAF  579 (678)
T ss_pred             hhhhhhhccccceEE---ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhh
Confidence            999999999999999   4568999999999853   323334566778889999999974   369999999997

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=4.5e-28  Score=169.99  Aligned_cols=141  Identities=31%  Similarity=0.549  Sum_probs=123.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh-CC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~-~~   84 (152)
                      .....+.+|+++++.++||||+++++.+..++..++++||+++++|.+++.+.+.++...+..++.++  |+.|||+ .+
T Consensus        45 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~  124 (284)
T cd06620          45 SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR  124 (284)
T ss_pred             hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            44678899999999999999999999999999999999999999999999887889999999999988  8999997 58


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+|++|+||++   .....++++|||++...... ......++..|+|||++.+..++.++|+|||
T Consensus       125 i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~sl  188 (284)
T cd06620         125 IMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSL  188 (284)
T ss_pred             eeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHH
Confidence            9999999999999   46678999999998654322 2334578899999999988889999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.95  E-value=5.6e-28  Score=171.30  Aligned_cols=142  Identities=30%  Similarity=0.476  Sum_probs=119.0

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~   70 (152)
                      .....+..|+.+++.+ +||||+++++++..++..|+++||+++++|.+++....                .++...+..
T Consensus        65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  144 (307)
T cd05098          65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS  144 (307)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence            3456788899999999 79999999999999999999999999999999997542                367788888


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.++  |+.|||+++++|+||||+||++   +..+.++++|||.++.......   .....+++.|+|||.+.+..++.
T Consensus       145 ~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  221 (307)
T cd05098         145 CAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH  221 (307)
T ss_pred             HHHHHHHHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence            89988  8999999999999999999999   4667899999999876543221   11222346799999999888999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|+|||
T Consensus       222 ~~Dvwsl  228 (307)
T cd05098         222 QSDVWSF  228 (307)
T ss_pred             HHHHHHH
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=2.3e-28  Score=172.34  Aligned_cols=141  Identities=26%  Similarity=0.519  Sum_probs=121.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+.+++.++|+|++++++.+..++..++++||+++++|.+++.. +.+++..+..++.++  |+.+||+.++
T Consensus        61 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i  139 (292)
T cd06658          61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGV  139 (292)
T ss_pred             HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            4456788999999999999999999999999999999999999999988754 458888999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +.++.++++|||++....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       140 vH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  204 (292)
T cd06658         140 IHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSL  204 (292)
T ss_pred             eecCCCHHHEEE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHH
Confidence            999999999999   456789999999987543322 2234567889999999988889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.95  E-value=2.8e-28  Score=170.39  Aligned_cols=141  Identities=28%  Similarity=0.545  Sum_probs=122.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+++++.++||||+++++++..++..++|+||+++++|.+++.. +.+++..+..++.++  |+.|||++++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i  122 (277)
T cd06642          44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK  122 (277)
T ss_pred             HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            4457889999999999999999999999999999999999999999988854 467888889999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   ...+.++++|||++..+.... ......++..|+|||++.+..++.++|+|||
T Consensus       123 vH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  187 (277)
T cd06642         123 IHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL  187 (277)
T ss_pred             eccCCChheEEE---eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHH
Confidence            999999999999   456789999999987654432 2233467888999999998889999999996

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=186.28  Aligned_cols=144  Identities=26%  Similarity=0.458  Sum_probs=117.0

Q ss_pred             hHhHHHHHHHHHHHHHcCC-CcCccceeeee-ee---C---CeEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAF-QA---E---NCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL   75 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~-~~---~---~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i   75 (152)
                      +....+.+.+|+++|+.|. |+|||.+++.. ..   +   -.+++.||||.||.|.+++.+  +..|++.+++.|+.++
T Consensus        74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv  153 (738)
T KOG1989|consen   74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV  153 (738)
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence            4556788999999999996 99999999943 21   1   257899999999999999974  3459999999999999


Q ss_pred             --HHHHHHhCC--CeecCCCCCceEeecCCCCceEEEeeccCccccC-CCCc---------cccCCCCCCcccccccc--
Q 031828           76 --GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNY---------AEKVCGSPLYMAPEVLQ--  139 (152)
Q Consensus        76 --~l~~lh~~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-~~~~---------~~~~~~t~~y~aPE~~~--  139 (152)
                        |+.+||.+.  +||||||.+|+|+   ...+.+||||||.+.... ....         ......|+.|+|||++.  
T Consensus       154 ~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly  230 (738)
T KOG1989|consen  154 CEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY  230 (738)
T ss_pred             HHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh
Confidence              999999998  9999999999999   466789999999986422 1111         11234689999999985  


Q ss_pred             -cCCCCcccceeeC
Q 031828          140 -FQRYDEKVNFFVS  152 (152)
Q Consensus       140 -~~~~~~~~Dvws~  152 (152)
                       +.+.+.|+|||||
T Consensus       231 sg~pI~eKsDIWAL  244 (738)
T KOG1989|consen  231 SGLPIGEKSDIWAL  244 (738)
T ss_pred             cCCCCcchhHHHHH
Confidence             4568999999996

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=7.8e-28  Score=172.78  Aligned_cols=141  Identities=31%  Similarity=0.491  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeC-CeEEEEEeecCCCChHHHHHhc--------------------------
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~--------------------------   60 (152)
                      ..+.+.+|+++++++ +|+||+++++++... ..+++++||+++++|.+++...                          
T Consensus        53 ~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  132 (337)
T cd05054          53 EYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR  132 (337)
T ss_pred             HHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccc
Confidence            345678899999999 899999999988654 5688999999999999988542                          


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCC
Q 031828           61 -----------------------------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDD  103 (152)
Q Consensus        61 -----------------------------------~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~  103 (152)
                                                         ..++...+..++.++  |+.|||+++++|+||||.||++.   ..
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~  209 (337)
T cd05054         133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---EN  209 (337)
T ss_pred             cccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CC
Confidence                                               146777888888888  89999999999999999999994   56


Q ss_pred             ceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828          104 VMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       104 ~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ..++|+|||+++.+.....   .....++..|+|||++.+..++.++|||||
T Consensus       210 ~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~Sl  261 (337)
T cd05054         210 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSF  261 (337)
T ss_pred             CcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHH
Confidence            7899999999987643321   123345678999999999999999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.3e-27  Score=167.14  Aligned_cols=141  Identities=26%  Similarity=0.388  Sum_probs=119.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      .....+.+|++++++++|||++++++++.. +..++++||+++++|.+++.++ ..+++..+..++.++  |+.|||+++
T Consensus        51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  129 (279)
T cd05057          51 KANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR  129 (279)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345778899999999999999999999987 7889999999999999998764 458899999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||+|+||++   .....++++|||.++........   ....++..|+|||.+....++.++|+|||
T Consensus       130 i~H~di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  197 (279)
T cd05057         130 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSY  197 (279)
T ss_pred             EEecccCcceEEE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHH
Confidence            9999999999999   45678999999999876543221   11223567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.95  E-value=6.4e-28  Score=167.98  Aligned_cols=143  Identities=27%  Similarity=0.465  Sum_probs=117.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHh------cCCCCHHHHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRL------HGRVPEQTARKFLQQ   74 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~   74 (152)
                      ....+.+.+|+++++.++|+||+++++.+...      ...++++||+++++|.+++..      ...+++..+..++.+
T Consensus        41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  120 (272)
T cd05075          41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD  120 (272)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence            45567889999999999999999999876432      246899999999999988742      223788888899999


Q ss_pred             H--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccce
Q 031828           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNF  149 (152)
Q Consensus        75 i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv  149 (152)
                      +  |+.|||+++++|+||||+||++   +....++++|||+++.+.....   .....+++.|+|||...+..++.++||
T Consensus       121 i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di  197 (272)
T cd05075         121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV  197 (272)
T ss_pred             HHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHH
Confidence            8  8999999999999999999999   5667899999999987644321   123345678999999998889999999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      |||
T Consensus       198 ~sl  200 (272)
T cd05075         198 WSF  200 (272)
T ss_pred             HHH
Confidence            996

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=5.5e-28  Score=170.64  Aligned_cols=140  Identities=30%  Similarity=0.550  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++|+|++++++.+..+...|+|+||+++++|.+++.+ ..++...+..++.++  |+.+||+.+++
T Consensus        60 ~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~  138 (296)
T cd06654          60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI  138 (296)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            356788999999999999999999999999999999999999999998864 457888888999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +.++.++++|||+++...... ......+++.|+|||.+.+..++.++|+|||
T Consensus       139 H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~  202 (296)
T cd06654         139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (296)
T ss_pred             cCCCCHHHEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHH
Confidence            99999999999   456789999999987654332 2234568889999999998889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.95  E-value=9.5e-28  Score=166.88  Aligned_cols=143  Identities=24%  Similarity=0.411  Sum_probs=120.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+..|++++++++|+|++++.+++...+..+++|||+++++|.+++... +.++......++.++  |+.++|+.
T Consensus        47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~  126 (268)
T cd05063          47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM  126 (268)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            344678899999999999999999999999999999999999999999998754 468888899999988  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--c--cCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--E--KVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~--~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+|+||+||++   +.+..++++|||+++........  .  ....++.|+|||++....++.++|||||
T Consensus       127 ~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  196 (268)
T cd05063         127 NYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSF  196 (268)
T ss_pred             CeeccccchhhEEE---cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHH
Confidence            99999999999999   45678999999998765432211  1  1123456999999998889999999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=1.1e-27  Score=167.68  Aligned_cols=142  Identities=24%  Similarity=0.356  Sum_probs=119.1

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ......+.+|+.+++.++|+||+++++++... ..+++++++++|+|.+++..+ ..+++..+..++.++  |+.|+|++
T Consensus        50 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~  128 (279)
T cd05109          50 PKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV  128 (279)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            44567888999999999999999999998754 578999999999999999764 458999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   .....++|+|||+++.......   .....+++.|+|||...+..++.++|||||
T Consensus       129 ~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  197 (279)
T cd05109         129 RLVHRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSY  197 (279)
T ss_pred             CeeccccccceEEE---cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHH
Confidence            99999999999999   4556799999999986643322   112234567999999998889999999996

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.95  E-value=8.6e-28  Score=166.18  Aligned_cols=139  Identities=24%  Similarity=0.461  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeee-eCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ..+.+.+|+.++++++|+|++++++++. .++..++++||+++++|.+++.+..  .+++..+..++.++  |+.++|++
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  121 (256)
T cd05082          42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN  121 (256)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3567889999999999999999998764 4567899999999999999987644  37888888899888  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||+|+||++   +.++.++++|||+++.....  .....++..|+|||++.+..++.++|||||
T Consensus       122 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  185 (256)
T cd05082         122 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF  185 (256)
T ss_pred             CEeccccchheEEE---cCCCcEEecCCccceecccc--CCCCccceeecCHHHHccCCCCchhhhHHH
Confidence            99999999999999   46678999999998754332  223344667999999998889999999996

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=1.1e-27  Score=168.44  Aligned_cols=142  Identities=24%  Similarity=0.403  Sum_probs=117.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------CCCHHHHHHHHHHH--
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQL--   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i--   75 (152)
                      .....+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++....          ......+..++.++  
T Consensus        51 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  130 (288)
T cd05061          51 RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD  130 (288)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHH
Confidence            344567889999999999999999999998899999999999999999997532          23455677788887  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|||+++++|+||||+||++   +..+.++++|||+++.+.....   .....++..|+|||.+.++.++.++|+|||
T Consensus       131 ~l~~lH~~~i~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dvwsl  207 (288)
T cd05061         131 GMAYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSF  207 (288)
T ss_pred             HHHHHHhCCCcCCCCChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHH
Confidence            8999999999999999999999   4567899999999876543221   122334667999999998889999999996

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=166.11  Aligned_cols=142  Identities=28%  Similarity=0.568  Sum_probs=121.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .....+.+|++++++++|+||+++++.+...  +.+++++|++++++|.+++...+.+++..+..++.++  |+.+||++
T Consensus        46 ~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~  125 (264)
T cd06653          46 KEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN  125 (264)
T ss_pred             HHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456888999999999999999999998654  4688999999999999999877778999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC----CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+|++|+||++   +.++.++++|||+++.....    .......++..|+|||.+.+..++.++|+|||
T Consensus       126 ~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  195 (264)
T cd06653         126 MIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSV  195 (264)
T ss_pred             CEecCCCCHHHEEE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHH
Confidence            99999999999999   45678999999999765321    11234567889999999998889999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-29  Score=196.13  Aligned_cols=140  Identities=31%  Similarity=0.586  Sum_probs=122.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ...+.+|..++..++|||+|+++|+=...+..++.||||.+|+|.+.+...+..++.....+..|+  |+.|||.+||+|
T Consensus      1278 ~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVH 1357 (1509)
T KOG4645|consen 1278 FKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVH 1357 (1509)
T ss_pred             CcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCcee
Confidence            356678999999999999999999998889999999999999999999888778888888888887  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCccccccccc---CCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~  152 (152)
                      ||+||.||++   +.++.+|++|||.|..+..+.     ......||+.|||||++.+   ++...++|||||
T Consensus      1358 RDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWsl 1427 (1509)
T KOG4645|consen 1358 RDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSL 1427 (1509)
T ss_pred             cCCCccceee---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcc
Confidence            9999999999   566799999999998876653     2245679999999999975   346678999996

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.95  E-value=1.8e-27  Score=165.78  Aligned_cols=140  Identities=35%  Similarity=0.553  Sum_probs=121.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++|+|++++++++..++..++++||+++++|.+++.+.+.+++..+..++.++  |+.++|+.+++|
T Consensus        52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  131 (272)
T cd06629          52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILH  131 (272)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence            356888999999999999999999999999999999999999999999888889999999999988  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCC--CCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~  152 (152)
                      +||+|+||++   +..+.++++|||+++......   ......++..|+|||.+....  ++.++|+|||
T Consensus       132 ~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~sl  198 (272)
T cd06629         132 RDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSL  198 (272)
T ss_pred             cCCChhhEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHH
Confidence            9999999999   567789999999987543221   123456788999999988654  8899999995

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.95  E-value=1.2e-27  Score=165.88  Aligned_cols=142  Identities=27%  Similarity=0.404  Sum_probs=116.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeee-eCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|+.+++.++|||++++++++. .++..++++||+.+++|.+++.+.. ..+......++.++  |+.|||+.
T Consensus        38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  117 (262)
T cd05058          38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK  117 (262)
T ss_pred             HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34567889999999999999999999775 4556899999999999999987543 45667777788887  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||+|+||++   +....++++|||+++.+....     ......+++.|+|||.+....++.++|||||
T Consensus       118 ~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  188 (262)
T cd05058         118 KFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSF  188 (262)
T ss_pred             CccccccCcceEEE---cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHH
Confidence            99999999999999   456789999999997653321     1123345678999999988889999999996

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=170.12  Aligned_cols=141  Identities=30%  Similarity=0.494  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+..|+++++.++|+||+++++.+...+..|+++||+.+++|.+++...  ..+++..+..++.++  |+.|||+.+
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  123 (316)
T cd05574          44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG  123 (316)
T ss_pred             HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567889999999999999999999999999999999999999999998754  458889999999898  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc------------------------------cccCCCCCCccc
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------------------------AEKVCGSPLYMA  134 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~------------------------------~~~~~~t~~y~a  134 (152)
                      ++|+||||+||++   +.++.++++|||++........                              .....|+..|+|
T Consensus       124 i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~a  200 (316)
T cd05574         124 IVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIA  200 (316)
T ss_pred             eeccCCChHHeEE---cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcC
Confidence            9999999999999   4567899999999865432210                              112357888999


Q ss_pred             ccccccCCCCcccceeeC
Q 031828          135 PEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       135 PE~~~~~~~~~~~Dvws~  152 (152)
                      ||++.+..++.++|||||
T Consensus       201 PE~~~~~~~~~~~Di~sl  218 (316)
T cd05574         201 PEVISGDGHGSAVDWWTL  218 (316)
T ss_pred             HHHHcCCCCCchHHHHHH
Confidence            999998889999999996

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.95  E-value=1.3e-27  Score=164.86  Aligned_cols=141  Identities=30%  Similarity=0.527  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+..|+++++.++|+||+++++++..++..+++||++++++|.+++.....  +++..+..++.++  |+.+||+.+
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~  123 (258)
T smart00219       44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN  123 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            567899999999999999999999999999999999999999999999976554  8999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccc--cCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+|++|+||++   +..+.++++|||+++.........  ...+++.|+|||.+.+..++.++|+|||
T Consensus       124 ~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  190 (258)
T smart00219      124 FIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSF  190 (258)
T ss_pred             eeecccccceEEE---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHH
Confidence            9999999999999   466689999999997654432211  1235678999999988889999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=3.8e-28  Score=171.59  Aligned_cols=140  Identities=26%  Similarity=0.510  Sum_probs=122.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++|||++++++++..++..++++||+++++|..++.. ..+++..+..++.++  |+.+||+.+++
T Consensus        61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iv  139 (297)
T cd06659          61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVI  139 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            356788999999999999999999999999999999999999999987754 457889999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|.||++   +.++.++++|||++....... ......+++.|+|||++.+..++.++|+|||
T Consensus       140 H~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  203 (297)
T cd06659         140 HRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSL  203 (297)
T ss_pred             cCCCCHHHeEE---ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHH
Confidence            99999999999   567789999999987554332 2334568899999999998889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=6.8e-28  Score=173.26  Aligned_cols=136  Identities=30%  Similarity=0.549  Sum_probs=115.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ...+.+|+++++.++||||+++++++...      ...|++++++ +++|.++++ ...+++..+..++.|+  |+.|||
T Consensus        58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH  135 (343)
T cd07878          58 ARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIH  135 (343)
T ss_pred             HHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45677899999999999999999988543      3578999987 789988775 4568999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++   +.++.+|++|||+++....  ......+|+.|+|||++.+ ..++.++|||||
T Consensus       136 ~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  202 (343)
T cd07878         136 SAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  202 (343)
T ss_pred             HCCeecccCChhhEEE---CCCCCEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhH
Confidence            9999999999999999   5677899999999976533  2345578999999999976 468899999996

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.95  E-value=1.7e-27  Score=164.50  Aligned_cols=143  Identities=28%  Similarity=0.588  Sum_probs=123.1

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ......+.+|++++++++||||+++.+++...+..++++||+.+++|.+.+....  .+++..+..++.++  |+.++|+
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  119 (256)
T cd08218          40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD  119 (256)
T ss_pred             hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3455688999999999999999999999999999999999999999999887543  47888899999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++|+|++|+||++   +.+..++++|||.+........ .....+++.|+|||++.+..++.++|+|||
T Consensus       120 ~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  187 (256)
T cd08218         120 RKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWAL  187 (256)
T ss_pred             CCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHH
Confidence            999999999999999   4567899999999976544322 223457888999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.95  E-value=1.3e-27  Score=166.23  Aligned_cols=145  Identities=28%  Similarity=0.446  Sum_probs=119.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-------CCCCHHHHHHHHHHH--HHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i--~l~   78 (152)
                      .....+.+|+++++.++||||+++++++..++..++++||+++++|.+++...       ..++...+..++.++  |+.
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  120 (269)
T cd05044          41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV  120 (269)
T ss_pred             hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence            34667889999999999999999999999889999999999999999998642       236778888888888  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCC--CCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~--~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|+.+++|+|++|+||++....  ....++++|||+++.......   .....++..|+|||.+.++.++.++|||||
T Consensus       121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  199 (269)
T cd05044         121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF  199 (269)
T ss_pred             HHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHH
Confidence            99999999999999999995322  223799999999876533321   122345678999999998889999999996

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.95  E-value=9.7e-28  Score=166.60  Aligned_cols=139  Identities=22%  Similarity=0.429  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|++++++++|+||+++++.+. .+..+++|||+++++|.+++...  ..++...+..++.++  |+.++|+.++
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i  123 (262)
T cd05071          45 PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY  123 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            467899999999999999999999875 45689999999999999999753  347888888899998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   ...+.++++|||.++.+......  ....++..|+|||...+..++.++|+|||
T Consensus       124 ~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvwsl  189 (262)
T cd05071         124 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (262)
T ss_pred             cccccCcccEEE---cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHH
Confidence            999999999999   45678999999999765433221  22345667999999988889999999996

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.95  E-value=5.1e-28  Score=167.83  Aligned_cols=141  Identities=33%  Similarity=0.571  Sum_probs=123.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh-C
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS-H   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~-~   83 (152)
                      .....+.+|++++++++||||+++++.+..++..++++|++++++|.+++... ..+++..+..++.++  |+.++|+ .
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  120 (265)
T cd06605          41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH  120 (265)
T ss_pred             HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC
Confidence            45677889999999999999999999999999999999999999999999876 678999999999998  8999999 9


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||+|+||++   +..+.++++|||.+........ ....++..|+|||.+.+..++.++|+|||
T Consensus       121 ~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  185 (265)
T cd06605         121 KIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSL  185 (265)
T ss_pred             CeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCchhhHHHH
Confidence            99999999999999   4567899999999876533322 22677889999999998889999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=1.4e-27  Score=168.57  Aligned_cols=140  Identities=30%  Similarity=0.577  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++|||++++++++...+..++++||+++++|..++... .+++..+..++.++  |+.+||+.+++
T Consensus        59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~  137 (296)
T cd06655          59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVI  137 (296)
T ss_pred             hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3567889999999999999999999999999999999999999999988654 57889999999988  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +.++.++++|||++........ .....+++.|+|||.+.+..++.++|+|||
T Consensus       138 H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  201 (296)
T cd06655         138 HRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (296)
T ss_pred             cCCCCHHHEEE---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHH
Confidence            99999999999   4667899999999876544322 233467889999999998889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.95  E-value=2.1e-27  Score=166.12  Aligned_cols=141  Identities=28%  Similarity=0.554  Sum_probs=122.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|++++++++|+||+++++.+..++..++++||+++++|.+++.. +.+++..+..++.++  |+.++|+.++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i  122 (277)
T cd06640          44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKK  122 (277)
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4457788999999999999999999999999999999999999999998864 467888888888887  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||++....... ......++..|+|||++.+..++.++|+|||
T Consensus       123 vH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~sl  187 (277)
T cd06640         123 IHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL  187 (277)
T ss_pred             cCcCCChhhEEE---cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHH
Confidence            999999999999   466789999999997654433 2233457888999999998889999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=1.5e-27  Score=174.60  Aligned_cols=141  Identities=28%  Similarity=0.457  Sum_probs=116.9

Q ss_pred             HHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--------------------------
Q 031828            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------------------   61 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--------------------------   61 (152)
                      ..+.+.+|+.++.++. ||||+++++++..++..++|+||+.+|+|.+++.+++                          
T Consensus        83 ~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (401)
T cd05107          83 EKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLS  162 (401)
T ss_pred             HHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccc
Confidence            3457889999999997 9999999999999999999999999999999986432                          


Q ss_pred             ------------------------------------------------------------------------CCCHHHHH
Q 031828           62 ------------------------------------------------------------------------RVPEQTAR   69 (152)
Q Consensus        62 ------------------------------------------------------------------------~~~~~~~~   69 (152)
                                                                                              .++...+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  242 (401)
T cd05107         163 QRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLV  242 (401)
T ss_pred             ccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHH
Confidence                                                                                    13445566


Q ss_pred             HHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCC
Q 031828           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  144 (152)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  144 (152)
                      .++.++  |+.|||+.+++|+||||+||++   .....++++|||+++......   ......+++.|+|||.+.+..++
T Consensus       243 ~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  319 (401)
T cd05107         243 GFSYQVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT  319 (401)
T ss_pred             HHHHHHHHHHHHHhcCCcCcccCCcceEEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC
Confidence            777787  8999999999999999999999   456789999999997643321   12234567889999999988899


Q ss_pred             cccceeeC
Q 031828          145 EKVNFFVS  152 (152)
Q Consensus       145 ~~~Dvws~  152 (152)
                      .++|||||
T Consensus       320 ~~~Dvwsl  327 (401)
T cd05107         320 TLSDVWSF  327 (401)
T ss_pred             cHhHHHHH
Confidence            99999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.95  E-value=1.9e-27  Score=167.09  Aligned_cols=141  Identities=27%  Similarity=0.539  Sum_probs=122.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+.+++.++|||++++++++...+..++++||+++++|.+++.. ..++...+..++.++  |+.++|++++
T Consensus        58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i  136 (285)
T cd06648          58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGV  136 (285)
T ss_pred             hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3456688999999999999999999999999999999999999999999876 568888999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +.++.++++|||.+....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       137 ~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  201 (285)
T cd06648         137 IHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSL  201 (285)
T ss_pred             ecCCCChhhEEE---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHH
Confidence            999999999999   567789999999886543322 2234568889999999998889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.95  E-value=1.1e-27  Score=166.85  Aligned_cols=123  Identities=26%  Similarity=0.509  Sum_probs=110.1

Q ss_pred             CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCC
Q 031828           24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD  101 (152)
Q Consensus        24 ~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~  101 (152)
                      +|||++++++++..++..|++|||+++++|.+++.....+++..+..++.++  |+.++|+.+++|+||+|+||++.   
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---  143 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---  143 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---
Confidence            7999999999999999999999999999999999888789999999999998  89999999999999999999994   


Q ss_pred             CCc-eEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          102 DDV-MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       102 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ... .++++|||+++.....   ....+++.|+|||++.+..++.++|||||
T Consensus       144 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  192 (267)
T PHA03390        144 RAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAV  192 (267)
T ss_pred             CCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHH
Confidence            444 7999999998765332   23467889999999998889999999995

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-29  Score=177.73  Aligned_cols=139  Identities=33%  Similarity=0.628  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      +.-..|.++|.-- +-|+++.++.+|++-+.+|+||||+.||+|.-.+.+-+.+.+..+..++.+|  ||-+||++||+.
T Consensus       394 ectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiY  473 (683)
T KOG0696|consen  394 ECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIY  473 (683)
T ss_pred             cceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeee
Confidence            4444567777665 5689999999999999999999999999999999999999999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCcccc-CCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||..|+++   +..+.+|++|||+++.- .......++||||-|+|||++..++|+.++|||||
T Consensus       474 RDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~  536 (683)
T KOG0696|consen  474 RDLKLDNVML---DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF  536 (683)
T ss_pred             eeccccceEe---ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHH
Confidence            9999999999   68889999999999863 33445678999999999999999999999999996

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.95  E-value=1.7e-27  Score=165.79  Aligned_cols=142  Identities=27%  Similarity=0.469  Sum_probs=118.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|++++++++||||+++++++.. +..+++|||+++++|.+++.+.. .++...+..++.++  |+.++|++
T Consensus        48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  126 (270)
T cd05056          48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK  126 (270)
T ss_pred             HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456788999999999999999999998875 45789999999999999997644 47889999999888  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||+|+||++   ...+.++++|||+++.......  .....+++.|+|||.+....++.++|||||
T Consensus       127 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  194 (270)
T cd05056         127 RFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMF  194 (270)
T ss_pred             CeeccccChheEEE---ecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHH
Confidence            99999999999999   4566899999999876544321  112233567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=1.6e-27  Score=167.20  Aligned_cols=142  Identities=29%  Similarity=0.526  Sum_probs=120.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+.+|++++++++|+||+++++.+..++..++++||+++++|..++...   ..+++..+..++.++  |+.|||
T Consensus        40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH  119 (286)
T cd06622          40 ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK  119 (286)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            344578889999999999999999999999999999999999999999988763   368999999999998  899999


Q ss_pred             h-CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCC------CCcccceeeC
Q 031828           82 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR------YDEKVNFFVS  152 (152)
Q Consensus        82 ~-~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------~~~~~Dvws~  152 (152)
                      + .+++|+||+|+||++   +..+.++++|||++..+... ......+++.|+|||.+.+..      ++.++|+|||
T Consensus       120 ~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diwsl  193 (286)
T cd06622         120 EEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL  193 (286)
T ss_pred             hcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhH
Confidence            6 599999999999999   45778999999998765332 233456788999999986543      4789999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.95  E-value=1.7e-27  Score=169.10  Aligned_cols=143  Identities=24%  Similarity=0.403  Sum_probs=120.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+.+|+++++.++|+||+++++++..++..+++|||++++++.+++.+.  ..+++..+..++.++  |+.|||+
T Consensus        40 ~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~  119 (314)
T cd08216          40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS  119 (314)
T ss_pred             hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445678999999999999999999999999999999999999999999998754  347888888899988  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--------cccCCCCCCcccccccccC--CCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~--~~~~~~Dvws~  152 (152)
                      ++++|+||+|+||++   +.++.++++|||.+........        .....++..|+|||++...  .++.++|+|||
T Consensus       120 ~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~  196 (314)
T cd08216         120 KGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV  196 (314)
T ss_pred             CCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHH
Confidence            999999999999999   4567899999998875533211        2234467789999999763  58899999996

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=3e-27  Score=164.47  Aligned_cols=143  Identities=31%  Similarity=0.472  Sum_probs=119.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCC--CHHHHHHHHHHH--HHHHHHh
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~--~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+++... ..+  ++..+..++.++  |+.+||+
T Consensus        47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~  126 (268)
T cd06624          47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD  126 (268)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            34567899999999999999999999999999999999999999999998754 345  778888888888  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCC--CCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~  152 (152)
                      .+++|+|++|.||++.  .....++++|||.+........ .....+++.|+|||++....  ++.++|+|||
T Consensus       127 ~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl  197 (268)
T cd06624         127 NQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL  197 (268)
T ss_pred             CCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHH
Confidence            9999999999999994  2356899999999876543222 22345788999999987643  7889999996

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=178.77  Aligned_cols=136  Identities=29%  Similarity=0.563  Sum_probs=122.6

Q ss_pred             HHHHHHHHHcCC---CcCccceeeeeeeCCeEEEEEeec-CCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           13 LDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFC-AGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        13 ~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~-~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      +..|++||.+++   |+||++++++|++++.+|+++|-. ++-+|.+++.....+.+..+..++.|+  |+.+||++||+
T Consensus       613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~iv  692 (772)
T KOG1152|consen  613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIV  692 (772)
T ss_pred             cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCce
Confidence            457999999998   999999999999999999999987 456999999999999999999999998  79999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      |||||-+|+.+   +.++.+|++|||.+. +..++.-+.+.||..|.|||++.+..| +..-||||+
T Consensus       693 hrdikdenviv---d~~g~~klidfgsaa-~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwal  755 (772)
T KOG1152|consen  693 HRDIKDENVIV---DSNGFVKLIDFGSAA-YTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL  755 (772)
T ss_pred             ecccccccEEE---ecCCeEEEeeccchh-hhcCCCcceeeeeccccchhhhCCCccCCCcchhhhh
Confidence            99999999999   688899999999875 444556678899999999999999886 467899986

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.95  E-value=2.6e-27  Score=165.73  Aligned_cols=143  Identities=22%  Similarity=0.366  Sum_probs=120.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeee-CCeEEEEEeecCCCChHHHHHhc--------CCCCHHHHHHHHHHH--
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQL--   75 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~i--   75 (152)
                      ....+.+.+|++++++++|+||+++++++.. +...+++++++++++|.+++...        ..+++..+..++.++  
T Consensus        49 ~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~  128 (280)
T cd05043          49 EIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC  128 (280)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHH
Confidence            4556788999999999999999999998765 46789999999999999998653        347888899999888  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|||+.+++|+||+|+||++   .....+|++|||+++.+.....   .....++..|+|||++.+..++.++|||||
T Consensus       129 ~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl  205 (280)
T cd05043         129 GMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF  205 (280)
T ss_pred             HHHHHHHCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHh
Confidence            8999999999999999999999   4667899999999986544321   122345667999999998889999999996

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=1.4e-27  Score=165.28  Aligned_cols=142  Identities=35%  Similarity=0.612  Sum_probs=124.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|++++++++||||+++++.+..++..|+++|++++++|.+++.+.+.+++..+..++.++  |+.+||++++
T Consensus        35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i  114 (265)
T cd05579          35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI  114 (265)
T ss_pred             hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence            34678889999999999999999999999999999999999999999999887789999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC---------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +.+..++++|||++.......         ......++..|+|||......++.++|+|||
T Consensus       115 ~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl  187 (265)
T cd05579         115 IHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSL  187 (265)
T ss_pred             ecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHH
Confidence            999999999999   567789999999987543321         1233457788999999988889999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=1.9e-27  Score=171.58  Aligned_cols=138  Identities=35%  Similarity=0.509  Sum_probs=117.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....+.+|+.+++.++|+||+++++++..+      ...|+++||+. ++|.+.+...  ++...+..++.++  |+.+|
T Consensus        58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~L  134 (353)
T cd07850          58 HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHL  134 (353)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999988644      35799999994 6888877543  7888888899998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+++++|+||||+||++   +..+.++++|||+++............+++.|+|||.+.+..++.++|||||
T Consensus       135 H~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  203 (353)
T cd07850         135 HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  203 (353)
T ss_pred             HhCCeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhH
Confidence            99999999999999999   5677899999999987655444445567889999999998889999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.95  E-value=2.1e-27  Score=166.70  Aligned_cols=141  Identities=33%  Similarity=0.608  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+++++.++|+|++++++.+..++..|+++||+++++|.+++.... .++...+..++.++  |+.+||+.|+
T Consensus        58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi  137 (286)
T cd06614          58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV  137 (286)
T ss_pred             hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            35678899999999999999999999999999999999999999999998776 78999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|++|+||++   +..+.++++|||++....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       138 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  202 (286)
T cd06614         138 IHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSL  202 (286)
T ss_pred             eeCCCChhhEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHH
Confidence            999999999999   466789999999886544332 2234457889999999988889999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=1.9e-27  Score=167.99  Aligned_cols=140  Identities=29%  Similarity=0.549  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++|+|++++++.+..++..++++||+++++|.+++.+ ..+++..+..++.++  |+.+||+.+++
T Consensus        59 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~  137 (297)
T cd06656          59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVI  137 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            356788999999999999999999999999999999999999999999864 457888888888888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.++++|||++........ .....+++.|+|||.+.+..++.++|+|||
T Consensus       138 H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  201 (297)
T cd06656         138 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (297)
T ss_pred             cCCCCHHHEEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHH
Confidence            99999999999   4667899999999876544332 234567889999999998889999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.95  E-value=3.7e-28  Score=170.22  Aligned_cols=139  Identities=31%  Similarity=0.577  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+.+|+++++.++||||+++++++.+.+..++++||++ ++|.+++.. .+.+++..+..++.++  |+.+||+.+++
T Consensus        43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~  121 (284)
T cd07839          43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL  121 (284)
T ss_pred             ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            3567789999999999999999999999999999999995 578777754 4568999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.++++|||+++...... ......+++.|+|||++.+.. ++.++|||||
T Consensus       122 H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  186 (284)
T cd07839         122 HRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA  186 (284)
T ss_pred             cCCCCHHHEEE---cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHH
Confidence            99999999999   466789999999987654332 223445688999999987654 7899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=2e-27  Score=168.22  Aligned_cols=139  Identities=24%  Similarity=0.411  Sum_probs=117.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+.+|+.+++.++||||+++++++..+ ..+++++++++++|.+++.... .+++..+..++.++  |+.|||+++++
T Consensus        53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iv  131 (303)
T cd05110          53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV  131 (303)
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            44688999999999999999999998754 4678999999999999987644 57888889999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   .....+|++|||+++.......   .....++..|+|||.+.+..++.++|||||
T Consensus       132 H~dikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl  197 (303)
T cd05110         132 HRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSY  197 (303)
T ss_pred             ccccccceeee---cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHH
Confidence            99999999999   4566899999999986543321   223345678999999998889999999996

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.95  E-value=4.2e-27  Score=163.05  Aligned_cols=142  Identities=30%  Similarity=0.583  Sum_probs=123.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+..|+++++.++|+||+++++.+...+..++++||+++++|.+++.+...+++..+..++.++  |+.+||+.++
T Consensus        41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  120 (264)
T cd06626          41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI  120 (264)
T ss_pred             HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence            35678999999999999999999999999999999999999999999999877778888999999888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-----cccCCCCCCcccccccccCC---CCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQR---YDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~---~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||.+........     .....+++.|+|||++....   ++.++|||||
T Consensus       121 ~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~  192 (264)
T cd06626         121 VHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSL  192 (264)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHH
Confidence            999999999999   4577899999999876544322     12346788999999998766   8899999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-28  Score=158.05  Aligned_cols=144  Identities=30%  Similarity=0.490  Sum_probs=119.2

Q ss_pred             hhHhHHHHHHHHHHHHHc-CCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHH--HH
Q 031828            5 LNKHLKSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL--GL   77 (152)
Q Consensus         5 ~~~~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i--~l   77 (152)
                      ++..+..+..+|+.+..+ ..+|++|+++|.+...+.+|+.||.+ ..+|..+-+    +.+..++..+-.++..+  |+
T Consensus        83 vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al  161 (282)
T KOG0984|consen   83 VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHAL  161 (282)
T ss_pred             cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHH
Confidence            345667778888886655 48999999999999999999999999 577766653    45678999998888877  99


Q ss_pred             HHHHhC-CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc----CCCCcccceeeC
Q 031828           78 EILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh~~-~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dvws~  152 (152)
                      .|||++ .++|||+||.|||+   +..+++|+||||++.-+..+...+.-.|...|||||.+..    .+|+.+||||||
T Consensus       162 ~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSL  238 (282)
T KOG0984|consen  162 EFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSL  238 (282)
T ss_pred             HHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhh
Confidence            999987 59999999999999   7899999999999976655544444567788999999864    369999999997

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=1.1e-27  Score=164.14  Aligned_cols=135  Identities=26%  Similarity=0.411  Sum_probs=115.6

Q ss_pred             HHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCC
Q 031828           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (152)
Q Consensus        13 ~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl   90 (152)
                      +..|...+....|||++++++++...+..+++|||+++++|.+++.+...+++..+..++.++  |+.++|+.+++|+||
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl  111 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL  111 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence            445666666678999999999999999999999999999999999877789999999999998  899999999999999


Q ss_pred             CCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           91 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        91 ~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+||++   +..+.++++|||.+......  .....++..|+|||......++.++|+||+
T Consensus       112 kp~Nil~---~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  168 (237)
T cd05576         112 NPNNILL---DDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSL  168 (237)
T ss_pred             CHHHEEE---cCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHH
Confidence            9999999   46678999999987654332  233455778999999988889999999995

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PTZ00284 protein kinase; Provisional

Probab=99.95  E-value=1.1e-27  Score=178.52  Aligned_cols=140  Identities=24%  Similarity=0.412  Sum_probs=114.2

Q ss_pred             HHHHHHHHHHHHcCCCc------CccceeeeeeeC-CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828           10 KSCLDCELNFLSSVNHP------NIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~------ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ...+..|+++++.++|.      +++++++++..+ +++|++|+++ +++|.+++.+.+.+++..+..++.|+  ||.||
T Consensus       169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yL  247 (467)
T PTZ00284        169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYF  247 (467)
T ss_pred             HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Confidence            44567788888887654      478888888765 5789999988 78999988888889999999999998  89999


Q ss_pred             Hh-CCCeecCCCCCceEeecCCC-------------CceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcc
Q 031828           81 NS-HHIIHRDLKPENILLSGLDD-------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK  146 (152)
Q Consensus        81 h~-~~~~h~dl~~~nil~~~~~~-------------~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  146 (152)
                      |+ .+++||||||+||++...+.             ...+||+|||.+...  .......+||+.|+|||++.+..++.+
T Consensus       248 H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~  325 (467)
T PTZ00284        248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS  325 (467)
T ss_pred             HhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH
Confidence            98 59999999999999953221             125999999987542  222345689999999999999899999


Q ss_pred             cceeeC
Q 031828          147 VNFFVS  152 (152)
Q Consensus       147 ~Dvws~  152 (152)
                      +|||||
T Consensus       326 ~DiwSl  331 (467)
T PTZ00284        326 TDMWSM  331 (467)
T ss_pred             HHHHHH
Confidence            999996

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.95  E-value=3.2e-27  Score=165.65  Aligned_cols=140  Identities=30%  Similarity=0.623  Sum_probs=115.4

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeee-----eCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l   77 (152)
                      .+.+.+|+.+++.+ +||||+++++++.     .++.++++|||+++++|.+++..    ...+++..+..++.++  |+
T Consensus        58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l  137 (286)
T cd06638          58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL  137 (286)
T ss_pred             HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence            46688899999999 7999999999873     34578999999999999988753    2457888888899888  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-----CCCCcccceee
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVNFFV  151 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws  151 (152)
                      .+||+.+++|+|++|+||++   ...+.++++|||+++.+.... ......|++.|+|||++..     ..++.++||||
T Consensus       138 ~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  214 (286)
T cd06638         138 QHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS  214 (286)
T ss_pred             HHHHhCCccccCCCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence            99999999999999999999   456679999999987654332 2334568899999999853     34788999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       215 l  215 (286)
T cd06638         215 L  215 (286)
T ss_pred             H
Confidence            6

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.9e-27  Score=164.77  Aligned_cols=140  Identities=25%  Similarity=0.457  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+.++++++|+|++++++++......++++|++++++|.+++....  .++...+..++.++  |+.+||++++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i  124 (261)
T cd05034          45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY  124 (261)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4678999999999999999999999998889999999999999999997643  57888889999988  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +..+.++++|||.++.......  ......+..|+|||.+.+..++.++|+|||
T Consensus       125 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  190 (261)
T cd05034         125 IHRDLAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSF  190 (261)
T ss_pred             ccCCcchheEEE---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHH
Confidence            999999999999   4667899999999876543221  112234567999999998889999999995

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.95  E-value=4.7e-27  Score=161.92  Aligned_cols=141  Identities=30%  Similarity=0.505  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ....+.+|+++++.++|+||+++++++...+..++++|++++++|.+++... ..++...+..++.++  |+.++|++++
T Consensus        35 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i  114 (251)
T cd05041          35 LKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC  114 (251)
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            5678899999999999999999999999999999999999999999998653 457888888888887  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|++|+||++   +....++++|||.++........   .....+..|+|||.+.++.++.++|+|||
T Consensus       115 ~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  181 (251)
T cd05041         115 IHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSY  181 (251)
T ss_pred             ehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHH
Confidence            999999999999   56678999999998765422211   12223556999999988889999999996

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.95  E-value=5e-27  Score=164.54  Aligned_cols=130  Identities=32%  Similarity=0.598  Sum_probs=111.8

Q ss_pred             HHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceE
Q 031828           19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENIL   96 (152)
Q Consensus        19 ~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil   96 (152)
                      ++...+|||++.+++.+..++..+++|||+++++|.+++...+.+++..+..++.++  |+.++|+.+++|+||||+||+
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil  129 (279)
T cd05633          50 LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL  129 (279)
T ss_pred             HHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEE
Confidence            333457999999999999999999999999999999999888889999999999998  899999999999999999999


Q ss_pred             eecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           97 LSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        97 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +   +..+.++++|||++...... ......+++.|+|||.+.. ..++.++|+|||
T Consensus       130 ~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  182 (279)
T cd05633         130 L---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSL  182 (279)
T ss_pred             E---CCCCCEEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCchhhhHHH
Confidence            9   56678999999998754332 2234568999999999874 558999999995

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.95  E-value=4.1e-27  Score=165.49  Aligned_cols=140  Identities=30%  Similarity=0.490  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+++++++ +|+||+.+++++..++..++++||+++++|.+++.....+++..+..++.++  |+.+||+.+++
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~  127 (290)
T cd05613          48 TEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGII  127 (290)
T ss_pred             HHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            46778899999999 5899999999999999999999999999999999888888999999898887  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccC--CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +.++.++++|||+++......  ......++..|+|||.+...  .++.++|||||
T Consensus       128 H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl  194 (290)
T cd05613         128 YRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSM  194 (290)
T ss_pred             ccCCCHHHeEE---CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHH
Confidence            99999999999   466789999999987654332  22345688899999998753  46789999985

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.95  E-value=4e-27  Score=163.07  Aligned_cols=142  Identities=33%  Similarity=0.572  Sum_probs=126.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh-CC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~-~~   84 (152)
                      ...+.+.+|++.+.+++|+|++++++++..++..++++||+++++|.+++.....+++..+..++.++  |+.++|+ .+
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~  120 (264)
T cd06623          41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH  120 (264)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence            34678999999999999999999999999999999999999999999999887889999999999998  8999999 99


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc-ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+|++|+||++   +..+.++++|||.+......... ....++..|+|||.+....++.++|+|||
T Consensus       121 ~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  186 (264)
T cd06623         121 IIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSL  186 (264)
T ss_pred             CccCCCCHHHEEE---CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHH
Confidence            9999999999999   56778999999999866444322 24567888999999998889999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=2.3e-27  Score=166.24  Aligned_cols=139  Identities=31%  Similarity=0.512  Sum_probs=117.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+|+.+++.++|||++++++++..++..|+|+||+. ++|.+++...   ..+++..+..++.++  |+.|||+.+
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~  121 (285)
T cd07861          43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR  121 (285)
T ss_pred             hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4668899999999999999999999999999999999996 6888887542   458899999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      ++|+|++|+||++   +.++.++++|||++....... ......+++.|+|||++.+. .++.++|||||
T Consensus       122 i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  188 (285)
T cd07861         122 VLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSI  188 (285)
T ss_pred             eeecCCCHHHEEE---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHH
Confidence            9999999999999   567789999999987543322 22334568889999998754 47889999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.95  E-value=7.3e-27  Score=163.58  Aligned_cols=131  Identities=32%  Similarity=0.581  Sum_probs=113.4

Q ss_pred             HHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCce
Q 031828           18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENI   95 (152)
Q Consensus        18 ~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~ni   95 (152)
                      ++++...||+|+.+.+.+..++..++++||+.+++|.+++.+.+.+++..+..++.++  |+.|||+.+++|+|++|+||
T Consensus        49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni  128 (278)
T cd05606          49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI  128 (278)
T ss_pred             HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence            4455568999999999999999999999999999999999888889999999999998  89999999999999999999


Q ss_pred             EeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           96 LLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        96 l~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      ++   +.++.++++|||++...... ......|+..|+|||++.++ .++.++|+|||
T Consensus       129 li---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~  182 (278)
T cd05606         129 LL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL  182 (278)
T ss_pred             EE---CCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhH
Confidence            99   46678999999998755332 23345789999999999754 58999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.95  E-value=4.7e-27  Score=162.32  Aligned_cols=138  Identities=27%  Similarity=0.491  Sum_probs=116.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|+.+++.++|||++++++++..+ ..++++||+++++|.+++....  .++...+..++.++  |+.++|+.+
T Consensus        42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  120 (254)
T cd05083          42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK  120 (254)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456788999999999999999999998654 4799999999999999997543  47888888888888  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+|++|.||++   ...+.++++|||+++.....  ......+..|+|||.+.+..++.++|+|||
T Consensus       121 ~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  183 (254)
T cd05083         121 LVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSY  183 (254)
T ss_pred             eeccccCcceEEE---cCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHH
Confidence            9999999999999   45678999999998754322  122234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.95  E-value=4e-27  Score=162.98  Aligned_cols=144  Identities=35%  Similarity=0.642  Sum_probs=122.7

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee--CCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l   77 (152)
                      +....+.+..|++++++++|+|++++++.+..  +...++++||+++++|.+++..    ...+++..++.++.++  |+
T Consensus        39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l  118 (265)
T cd08217          39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL  118 (265)
T ss_pred             CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence            34556788899999999999999999997754  4568999999999999999865    3568889999999998  89


Q ss_pred             HHHH-----hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceee
Q 031828           78 EILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        78 ~~lh-----~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                      .++|     +.+++|+||+|.||++   +..+.++++|||++........ .....+++.|+|||.+....++.++|+||
T Consensus       119 ~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s  195 (265)
T cd08217         119 YECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS  195 (265)
T ss_pred             HHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHH
Confidence            9999     8899999999999999   4567899999999987654432 34456889999999999888999999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       196 l  196 (265)
T cd08217         196 L  196 (265)
T ss_pred             H
Confidence            6

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=5.4e-27  Score=162.02  Aligned_cols=140  Identities=26%  Similarity=0.509  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|++++++++|||++++++++......++++||+++++|.+++... ..+++..+..++.++  |+.+||+++++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~  122 (256)
T cd05112          43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            457889999999999999999999999999999999999999999998754 457888888888887  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|++|.||++   +....++++|||.++.......  .....++..|+|||.+.++.++.++|||||
T Consensus       123 h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~sl  187 (256)
T cd05112         123 HRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF  187 (256)
T ss_pred             ccccccceEEE---cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHH
Confidence            99999999999   4567899999999876543321  122234567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=6.1e-27  Score=162.42  Aligned_cols=141  Identities=35%  Similarity=0.609  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc---CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ..+.+.+|+++++.++|+|++++++.+..++..++++|++++++|.+++...   ..+++..+..++.++  |+.+||++
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~  121 (267)
T cd06610          42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN  121 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            5678899999999999999999999999999999999999999999999764   348889999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc-----ccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +++|+|++|+||++   +.++.++++|||++..+......     ....++..|+|||++... .++.++|+|||
T Consensus       122 ~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~sl  193 (267)
T cd06610         122 GQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSF  193 (267)
T ss_pred             CeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhH
Confidence            99999999999999   45678999999999776544322     344678899999999876 68999999996

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.95  E-value=4.8e-27  Score=163.61  Aligned_cols=141  Identities=31%  Similarity=0.581  Sum_probs=118.0

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HH
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GL   77 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l   77 (152)
                      ....+.+|+.+++++ +|+|++++.+++...      ...|+++||+++++|.+++...  ..+++..+..++.++  |+
T Consensus        45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l  124 (272)
T cd06637          45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL  124 (272)
T ss_pred             cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            356788999999998 799999999998653      4689999999999999998764  358889999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccc-----cCCCCcccceee
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFV  151 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws  151 (152)
                      .|||+++++|+|++|+||++   +.+..++++|||++...... .......|++.|+|||++.     ...++.++||||
T Consensus       125 ~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s  201 (272)
T cd06637         125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS  201 (272)
T ss_pred             HHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence            99999999999999999999   46678999999998765332 2334567889999999986     335888999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       202 l  202 (272)
T cd06637         202 L  202 (272)
T ss_pred             H
Confidence            6

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.95  E-value=6.2e-27  Score=162.22  Aligned_cols=139  Identities=24%  Similarity=0.435  Sum_probs=116.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+.++++++|+|++++++++. .+..+++|||+++++|.+++...  ..++...+..++.++  |+.+||+.++
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05070          45 PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            467899999999999999999999885 45689999999999999998753  347888899999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc--ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++.   ....++++|||.+.........  ....++..|+|||.+.+..++.++|+|||
T Consensus       124 ~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  189 (260)
T cd05070         124 IHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (260)
T ss_pred             ccCCCccceEEEe---CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHH
Confidence            9999999999994   5678999999999765433211  12234567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.95  E-value=1.8e-27  Score=166.76  Aligned_cols=141  Identities=32%  Similarity=0.556  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++++..++..++++||++++++..+......++...+..++.++  |+.|||+.+++
T Consensus        43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  122 (286)
T cd07846          43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII  122 (286)
T ss_pred             hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3567889999999999999999999999999999999999998888877766678999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+|++|+||++   +.++.++++|||++........ .....++..|+|||++.+. .++.++|||||
T Consensus       123 h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  187 (286)
T cd07846         123 HRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAV  187 (286)
T ss_pred             ccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHH
Confidence            99999999999   5677899999999876544332 2345578889999998754 47889999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=1.1e-26  Score=160.96  Aligned_cols=140  Identities=26%  Similarity=0.481  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|++++++++|+||+++++.+.. ...++++||+++++|.+++....  .++...+..++.++  |+.++|+++
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~  122 (260)
T cd05073          44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN  122 (260)
T ss_pred             HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            35678899999999999999999999877 77899999999999999997543  36777888888888  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||+|+||++   .....++++|||.+........  .....++..|+|||++....++.++|+|||
T Consensus       123 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~sl  189 (260)
T cd05073         123 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  189 (260)
T ss_pred             ccccccCcceEEE---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHH
Confidence            9999999999999   5677899999999876543321  112234567999999998889999999996

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=9e-27  Score=161.33  Aligned_cols=135  Identities=33%  Similarity=0.616  Sum_probs=116.0

Q ss_pred             HHHHHHHHH-HcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           12 CLDCELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        12 ~~~~E~~~l-~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      .+..|..++ ...+|+|++++++++..++..|+++||+++++|.+++...+.+++..+..++.++  |+.++|+.+++|+
T Consensus        42 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~  121 (260)
T cd05611          42 NVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR  121 (260)
T ss_pred             HHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            344555444 4558999999999999999999999999999999999888889999999999998  8999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+|.||++   +....++++|||+++....   .....+++.|+|||.+.+..++.++|||||
T Consensus       122 dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  179 (260)
T cd05611         122 DIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSL  179 (260)
T ss_pred             CCCHHHeEE---CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHH
Confidence            999999999   4567899999999875332   234567888999999998888999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.95  E-value=6e-27  Score=164.08  Aligned_cols=140  Identities=31%  Similarity=0.561  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+.++++++|||++++++++..++..++|+||+ +++|.+++.. ...+++..+..++.++  |+.+||+.++
T Consensus        42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  120 (286)
T cd07832          42 IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI  120 (286)
T ss_pred             hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3567889999999999999999999999999999999999 9999998864 3568999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +..+.++++|||.+.......  ......++..|+|||.+.+.. ++.++|||||
T Consensus       121 ~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  187 (286)
T cd07832         121 MHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAV  187 (286)
T ss_pred             ecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHH
Confidence            999999999999   457789999999987654433  133456788999999987544 6899999995

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-27  Score=165.18  Aligned_cols=143  Identities=23%  Similarity=0.384  Sum_probs=119.7

Q ss_pred             HhHHHHHHHHHHHHHcCCC--c----CccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--H
Q 031828            7 KHLKSCLDCELNFLSSVNH--P----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--G   76 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h--~----ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~   76 (152)
                      .+-++...-|++++.++.+  |    -++.+.++|.-.++.|+|+|.+ |.++.+++++++  +++-..++.+..|+  +
T Consensus       126 ~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~s  204 (415)
T KOG0671|consen  126 DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLES  204 (415)
T ss_pred             HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHH
Confidence            3457778889999999942  2    3677788999999999999988 789999998765  48889999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCC-----------------CCceEEEeeccCccccCCCCccccCCCCCCcccccccc
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLD-----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ  139 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~-----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~  139 (152)
                      +.+||+.+++|.||||+||++....                 ++..++++|||.|+.-  .....+.+.|..|.|||++.
T Consensus       205 v~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViL  282 (415)
T KOG0671|consen  205 VAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVIL  282 (415)
T ss_pred             HHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchhee
Confidence            9999999999999999999986421                 2346899999998642  22345678899999999999


Q ss_pred             cCCCCcccceeeC
Q 031828          140 FQRYDEKVNFFVS  152 (152)
Q Consensus       140 ~~~~~~~~Dvws~  152 (152)
                      +-+++.++||||+
T Consensus       283 gLGwS~pCDvWSi  295 (415)
T KOG0671|consen  283 GLGWSQPCDVWSI  295 (415)
T ss_pred             ccCcCCccCceee
Confidence            9999999999996

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.2e-27  Score=160.19  Aligned_cols=141  Identities=43%  Similarity=0.665  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+..|+++++.++|+|++++++.+..++..+++||++++++|.+++.....+++..+..++.++  |+.++|+.+++
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~  115 (250)
T cd05123          36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII  115 (250)
T ss_pred             HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            4567899999999999999999999999999999999999999999999888788999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|++|.||++   +..+.++++|||.+...... .......++..|+|||...+...+.++|+|||
T Consensus       116 H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~sl  179 (250)
T cd05123         116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSL  179 (250)
T ss_pred             ecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHH
Confidence            99999999999   45668999999998765443 23345567889999999988888999999986

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=3.6e-27  Score=166.71  Aligned_cols=139  Identities=27%  Similarity=0.467  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+.+|+++++.++||||+++++++..++..++++||++ ++|.+++... ..+++..+..++.++  |+.+||+++++
T Consensus        48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~  126 (301)
T cd07873          48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL  126 (301)
T ss_pred             hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4467789999999999999999999999999999999996 6888887654 458888999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.++++|||+++...... ......+++.|+|||++.+. .++.++|||||
T Consensus       127 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  191 (301)
T cd07873         127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGV  191 (301)
T ss_pred             CCCCCHHHEEE---CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHH
Confidence            99999999999   566789999999987543322 22334568899999998754 47889999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=4.6e-27  Score=162.29  Aligned_cols=143  Identities=31%  Similarity=0.621  Sum_probs=121.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|+++++.++|+|++++++.+..++..++++||+++++|.+++....  .+++..+..++.++  |+.+||++
T Consensus        41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  120 (257)
T cd08225          41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR  120 (257)
T ss_pred             hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456788899999999999999999999999999999999999999999987543  37888899999988  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+|++|.||++.  .....++++|||.+........ .....+++.|+|||++....++.++|+|||
T Consensus       121 ~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~sl  188 (257)
T cd08225         121 KILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSL  188 (257)
T ss_pred             CcccccCCHHHEEEc--CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHH
Confidence            999999999999994  2334679999999876544322 233457889999999988889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=4.7e-27  Score=165.73  Aligned_cols=139  Identities=34%  Similarity=0.517  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...+..|+++++.++|+||+++++++..++..++|+||+ +++|.+++.... .+++..+..++.++  |+.+||+.+++
T Consensus        46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~  124 (298)
T cd07841          46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL  124 (298)
T ss_pred             hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456778999999999999999999999999999999999 899999998766 78999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +.++.++++|||+++...... ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       125 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  189 (298)
T cd07841         125 HRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSV  189 (298)
T ss_pred             ecCCChhhEEE---cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHH
Confidence            99999999999   466789999999998764432 2233456788999999865 457889999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=7.5e-27  Score=160.85  Aligned_cols=142  Identities=37%  Similarity=0.655  Sum_probs=126.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|++++++++|+||+++++.+...  +..++++|++++++|.+++.+...+++..+..++.++  |+.+||+.
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  120 (260)
T cd06606          41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN  120 (260)
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4478899999999999999999999999888  8899999999999999999887789999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+|++|+||++   ...+.++++|||.+........   .....++..|+|||.+....++.++|+|||
T Consensus       121 ~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  189 (260)
T cd06606         121 GIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSL  189 (260)
T ss_pred             CccccCCCHHHEEE---cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHH
Confidence            99999999999999   4567899999999987655542   445678889999999998889999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.95  E-value=9.8e-27  Score=161.29  Aligned_cols=139  Identities=24%  Similarity=0.439  Sum_probs=116.4

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|++++++++|+|++++++++. .+..+++|||+.+++|.+++....  .++...+..++.++  |+.|||+.++
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05069          45 PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            467889999999999999999998875 456889999999999999997543  37788888888888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||.++.......  .....++..|+|||...+..++.++|+|||
T Consensus       124 ~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl  189 (260)
T cd05069         124 IHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  189 (260)
T ss_pred             eecccCcceEEE---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHH
Confidence            999999999999   5677899999999976543321  122334667999999988889999999996

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.95  E-value=9.4e-27  Score=161.96  Aligned_cols=142  Identities=28%  Similarity=0.550  Sum_probs=120.6

Q ss_pred             hHHHHHHHHHHHHHc-CCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....++.+|++++.+ ++||||+++++++..++..++++||+++++|.+++..    ...+++..++.++.++  |+.+|
T Consensus        50 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  129 (269)
T cd08528          50 KSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL  129 (269)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHh
Confidence            344567789988875 7999999999999999999999999999999888742    3458888999999888  89999


Q ss_pred             Hh-CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~-~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+ .+++|+|++|.||++   ...+.++++|||.+.............++..|+|||.+.+..++.++|+|||
T Consensus       130 h~~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~sl  199 (269)
T cd08528         130 HKEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAF  199 (269)
T ss_pred             ccCCceeecCCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHH
Confidence            96 679999999999999   5667899999999976554444445668889999999998889999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.9e-26  Score=158.83  Aligned_cols=142  Identities=28%  Similarity=0.584  Sum_probs=125.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|++++++++|+|++++.+++..++..++++|++++++|.+++.....+++..+..++.++  |+.++|+.++
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i  120 (254)
T cd06627          41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV  120 (254)
T ss_pred             HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            45678999999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|++|.||++   ...+.++++|||.+........ .....++..|+|||...+..++.++|+|||
T Consensus       121 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~l  185 (254)
T cd06627         121 IHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL  185 (254)
T ss_pred             ccCCCCHHHEEE---CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHH
Confidence            999999999999   4567899999999987654432 234567889999999988888999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=6.8e-27  Score=164.47  Aligned_cols=138  Identities=29%  Similarity=0.447  Sum_probs=114.1

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ..+.+|+++++.++|+||+++++++..++..|+++||+. +++.+++.. ...+++..+..++.++  |+.+||+++++|
T Consensus        48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H  126 (291)
T cd07870          48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH  126 (291)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            467789999999999999999999999999999999995 677666654 3457788888888888  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +||||+||++   +..+.++++|||+++...... ......+++.|+|||.+.+. .++.++|||||
T Consensus       127 ~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  190 (291)
T cd07870         127 RDLKPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA  190 (291)
T ss_pred             CCCChHHEEE---cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHH
Confidence            9999999999   466789999999987543322 22334568899999998764 47889999996

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=9.7e-27  Score=162.51  Aligned_cols=142  Identities=25%  Similarity=0.534  Sum_probs=121.5

Q ss_pred             HhHHHHHHHHHHHHHcCC---CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+.+|+.+++.++   |||++++++++..++..+++|||+++++|.+++.. +.+++..+..++.++  |+.+||
T Consensus        40 ~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh  118 (277)
T cd06917          40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH  118 (277)
T ss_pred             chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence            345677889999999997   99999999999999999999999999999998865 478899999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +.+++|+||+|+||++   +..+.++++|||.+....... ......|+..|+|||.+.++ .++.++|+|||
T Consensus       119 ~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  188 (277)
T cd06917         119 KVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSL  188 (277)
T ss_pred             hCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHH
Confidence            9999999999999999   457789999999997765443 23345688899999998754 47889999996

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.94  E-value=8.1e-27  Score=164.01  Aligned_cols=138  Identities=29%  Similarity=0.460  Sum_probs=115.6

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ..+.+|+++++.++|+||+++++++..++..++|+||++ ++|.+++... ..+++..+..++.++  |+.|||+.+++|
T Consensus        48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H  126 (291)
T cd07844          48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH  126 (291)
T ss_pred             hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            456789999999999999999999999999999999996 5898888654 457889999999898  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +||+|+||++   +..+.++++|||+++...... ......++..|+|||++.+ ..++.++|||||
T Consensus       127 ~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl  190 (291)
T cd07844         127 RDLKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGV  190 (291)
T ss_pred             ccCCHHHEEE---cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHH
Confidence            9999999999   566789999999987543222 1223346788999999875 448899999996

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=8e-27  Score=164.53  Aligned_cols=140  Identities=31%  Similarity=0.564  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++|||++++++++..++..|+|+||+++++|.+++.+. .++...+..++.++  |+.+||+++++
T Consensus        59 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~  137 (293)
T cd06647          59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVI  137 (293)
T ss_pred             HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            4567889999999999999999999999999999999999999999998653 47788888888888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|++|+||++   ..++.++++|||++........ .....+++.|+|||.+....++.++|+|||
T Consensus       138 H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  201 (293)
T cd06647         138 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  201 (293)
T ss_pred             eccCCHHHEEE---cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHH
Confidence            99999999999   4567899999998875544332 233467888999999988889999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.94  E-value=1.7e-26  Score=158.52  Aligned_cols=141  Identities=35%  Similarity=0.633  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+++++.++|+|++.+.+.+..++..++++||+++++|.+++... ..+++..+..++.++  |+.+||+.++
T Consensus        40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  119 (253)
T cd05122          40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI  119 (253)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence            5678999999999999999999999999999999999999999999998765 578999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|++|.||++   +..+.++|+|||.+.............++..|+|||.+....++.++|+|||
T Consensus       120 ~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl  183 (253)
T cd05122         120 IHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSL  183 (253)
T ss_pred             ecCCCCHHHEEE---ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHH
Confidence            999999999999   4567899999999977655433345667889999999998888999999995

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=4.5e-27  Score=166.87  Aligned_cols=142  Identities=27%  Similarity=0.502  Sum_probs=115.5

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHH--HHHHH
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      .+.+.+|+++++.++||||+++++++...  +.+++|+||++ +++.+.+...     ..+++..+..++.++  |+.||
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  124 (316)
T cd07842          46 SQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL  124 (316)
T ss_pred             cHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence            46678899999999999999999999888  78999999995 5676666422     257889999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeec-CCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~-~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+.+++|+||+|+||++.. ....+.+|++|||+++.......    .....+++.|+|||++.+. .++.++|||||
T Consensus       125 H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  202 (316)
T cd07842         125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI  202 (316)
T ss_pred             HhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence            9999999999999999942 11277899999999876543321    2344678899999988764 57899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.94  E-value=9.5e-27  Score=160.54  Aligned_cols=141  Identities=38%  Similarity=0.569  Sum_probs=122.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      .....+..|+++++.++|+||+++.+++..+...++++||+++++|.+++.+    ...+++..+..++.++  |+.+||
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh  120 (256)
T cd08530          41 KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH  120 (256)
T ss_pred             HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence            4466778899999999999999999999999999999999999999998865    3457888889999888  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++|+|++|.||++.   ....++++|||++...... ......+++.|+|||.+.+..++.++|+|||
T Consensus       121 ~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~sl  187 (256)
T cd08530         121 EQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSL  187 (256)
T ss_pred             hCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHH
Confidence            99999999999999994   4678999999999766544 3334567889999999998889999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=2.1e-26  Score=163.27  Aligned_cols=137  Identities=34%  Similarity=0.563  Sum_probs=115.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+.+++.++|||++++.+++..++..++++||+. +++.+++.. ...+++..+..++.++  |+.|||+.++
T Consensus        58 ~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i  136 (307)
T cd06607          58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER  136 (307)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34678899999999999999999999999999999999995 667666653 4568999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      +|+|++|.||++   +.++.++++|||++......   ....+++.|+|||++.   ...++.++|||||
T Consensus       137 ~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~  200 (307)
T cd06607         137 IHRDIKAGNILL---TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  200 (307)
T ss_pred             eecCCCcccEEE---CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHH
Confidence            999999999999   56678999999998654332   3456788899999984   3558899999996

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.94  E-value=9.2e-27  Score=163.94  Aligned_cols=138  Identities=28%  Similarity=0.457  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+|++++++++||||+++++++..+  +..|+++||+. ++|.+++.... .+++..+..++.++  |+.|||+.++
T Consensus        49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  127 (293)
T cd07843          49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI  127 (293)
T ss_pred             hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3567899999999999999999998877  88999999996 58988886543 48999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +..+.++++|||+++..... .......+++.|+|||.+.+.. ++.++|+|||
T Consensus       128 ~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  193 (293)
T cd07843         128 LHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV  193 (293)
T ss_pred             eeccCCHHHEEE---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHH
Confidence            999999999999   56678999999999876544 2233455788899999987644 6889999995

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.94  E-value=1.2e-26  Score=163.56  Aligned_cols=141  Identities=25%  Similarity=0.520  Sum_probs=121.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.+++.. +.+++..+..++.++  |+.+||+.++
T Consensus        59 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~gi  137 (292)
T cd06657          59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGV  137 (292)
T ss_pred             hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3466788999999999999999999999999999999999999999987754 457888888898888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|++|+||++   +..+.++++|||++....... ......+++.|+|||.+.+..++.++|+|||
T Consensus       138 vH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  202 (292)
T cd06657         138 IHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL  202 (292)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHH
Confidence            999999999999   456789999999987654332 2233567889999999988888999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.94  E-value=1.6e-26  Score=159.34  Aligned_cols=142  Identities=34%  Similarity=0.634  Sum_probs=124.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      .....+.+|+++++.++|+|++++.+.+..++..++++|++++++|.+++.+.    ..++...+..++.++  |+.+||
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh  120 (258)
T cd08215          41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH  120 (258)
T ss_pred             HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            45677899999999999999999999999999999999999999999999764    568999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++|+|++|.||++   +....++++|||.+....... ......+++.|+|||......++.++|+|||
T Consensus       121 ~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~sl  189 (258)
T cd08215         121 SRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSL  189 (258)
T ss_pred             hCCEecccCChHHeEE---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHH
Confidence            9999999999999999   456789999999987654433 2334567889999999998889999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=176.66  Aligned_cols=144  Identities=31%  Similarity=0.497  Sum_probs=120.1

Q ss_pred             chhhHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            3 KKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         3 k~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      |++++. ..+..+|+.++... +||||+++.+++.++.+.|+|||.+.++-+.+.+...+.+. ..+..|+.++  |+.+
T Consensus       353 kii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~  430 (612)
T KOG0603|consen  353 KIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDY  430 (612)
T ss_pred             eecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHH
Confidence            444333 34456677666665 79999999999999999999999999988888777666555 6777788888  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||++|++|||+||.|||+.  +..+.++++|||.++.....  ..+.+-|..|.|||++...+||.++|||||
T Consensus       431 LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSL  499 (612)
T KOG0603|consen  431 LHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSL  499 (612)
T ss_pred             HHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHH
Confidence            9999999999999999995  35667999999999876554  557778899999999998899999999996

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.94  E-value=1.8e-26  Score=162.38  Aligned_cols=140  Identities=33%  Similarity=0.641  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l   77 (152)
                      .+.+.+|+.+++++ +|||++++++++...     +..++++||+++++|.+++..    ...+++..++.++.++  |+
T Consensus        62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al  141 (291)
T cd06639          62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL  141 (291)
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence            46678899999999 899999999998653     358999999999999988753    3458888999999888  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC-----CCcccceee
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-----YDEKVNFFV  151 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-----~~~~~Dvws  151 (152)
                      .+||+++++|+||+|+||++   .....++++|||+++...... ......++..|+|||++....     ++.++||||
T Consensus       142 ~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s  218 (291)
T cd06639         142 QHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS  218 (291)
T ss_pred             HHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHH
Confidence            99999999999999999999   456689999999987654432 223456788999999986432     688999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       219 l  219 (291)
T cd06639         219 L  219 (291)
T ss_pred             H
Confidence            6

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.94  E-value=1.5e-26  Score=166.39  Aligned_cols=142  Identities=31%  Similarity=0.481  Sum_probs=114.2

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeC-CeEEEEEeecCCCChHHHHHhcC------------------------
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHG------------------------   61 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~------------------------   61 (152)
                      ...+.+.+|+.++.++ +||||+++++++... +..+++|||+++++|.+++....                        
T Consensus        52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  131 (343)
T cd05103          52 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDIS  131 (343)
T ss_pred             HHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchh
Confidence            3456788999999999 689999999988654 56899999999999999986431                        


Q ss_pred             -------------------------------------------CCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceE
Q 031828           62 -------------------------------------------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENIL   96 (152)
Q Consensus        62 -------------------------------------------~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil   96 (152)
                                                                 .++...+..++.++  |+.|||+++++|+||||+||+
T Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  211 (343)
T cd05103         132 EDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNIL  211 (343)
T ss_pred             hhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEE
Confidence                                                       24556667778887  899999999999999999999


Q ss_pred             eecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           97 LSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        97 ~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +   +....++++|||+++.......   .....+++.|+|||.+.+..++.++|||||
T Consensus       212 ~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  267 (343)
T cd05103         212 L---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF  267 (343)
T ss_pred             E---cCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHH
Confidence            9   4667899999999976533221   122334567999999988889999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=2.4e-26  Score=161.48  Aligned_cols=141  Identities=35%  Similarity=0.584  Sum_probs=118.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      .....+.+|+++++.++||||+++++++...  +.++++|||+++++|.+++..    ...++...+..++.++  |+.|
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~  120 (287)
T cd06621          41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY  120 (287)
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            3457789999999999999999999988643  478999999999999887653    3447888889999998  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+.+++|+|++|.||++   +....++++|||++....... .....++..|+|||.+.+..++.++|||||
T Consensus       121 lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl  189 (287)
T cd06621         121 LHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSL  189 (287)
T ss_pred             HHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCchhhHHHH
Confidence            999999999999999999   456679999999986543322 223456788999999998889999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-27  Score=168.74  Aligned_cols=147  Identities=27%  Similarity=0.400  Sum_probs=119.7

Q ss_pred             cchhhHhHHHHHHHHHHHHHcC--CCcCccceeeeeeeC----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l--~h~ni~~l~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i   75 (152)
                      +|+++.++++.+.+|.+|.+++  +|+||+.+.+.-..+    ..+|+|.+|.+.|+|++++.. ..++......++..+
T Consensus       239 VKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~  317 (513)
T KOG2052|consen  239 VKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSI  317 (513)
T ss_pred             EEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHH
Confidence            7899999999999999999995  999999999887544    358999999999999999987 455655555555554


Q ss_pred             --HHHHHHhC--------CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCccccccccc
Q 031828           76 --GLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        76 --~l~~lh~~--------~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~  140 (152)
                        ||.+||..        .|.|||||++|||+   .+++.+-++|+|+|.+.....     .....+||.+|||||++..
T Consensus       318 AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde  394 (513)
T KOG2052|consen  318 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE  394 (513)
T ss_pred             hhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence              89999964        39999999999999   678899999999997654432     2345689999999999975


Q ss_pred             CC----C--CcccceeeC
Q 031828          141 QR----Y--DEKVNFFVS  152 (152)
Q Consensus       141 ~~----~--~~~~Dvws~  152 (152)
                      ..    +  -..+|||||
T Consensus       395 tin~~~Fesyk~ADIYaf  412 (513)
T KOG2052|consen  395 TINMKHFESYKRADIYAF  412 (513)
T ss_pred             hcChhhhhhhhHHHHHHH
Confidence            32    1  245999997

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=2.7e-26  Score=160.55  Aligned_cols=141  Identities=26%  Similarity=0.480  Sum_probs=119.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeee--CCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ..+.+.+|+++++.++|+||+++++++..  ....++++||+++++|.+++.... .++...+..++.++  |+.+||+.
T Consensus        49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~  128 (284)
T cd05038          49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ  128 (284)
T ss_pred             HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence            46789999999999999999999999877  557899999999999999997654 48888889999988  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc----ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+|++|.||++   +..+.++++|||.+.........    ....++..|+|||.+....++.++|+|||
T Consensus       129 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~sl  198 (284)
T cd05038         129 RYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSF  198 (284)
T ss_pred             CeecCCCCHHhEEE---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHH
Confidence            99999999999999   45678999999999876532211    12234556999999988889999999996

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.94  E-value=1.2e-26  Score=165.87  Aligned_cols=142  Identities=20%  Similarity=0.353  Sum_probs=116.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|+.+++.++||||+++++++..++..++++||+.++++.+++.+..  .+++..+..++.++  |+.|||++
T Consensus        41 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~  120 (328)
T cd08226          41 EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN  120 (328)
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345788999999999999999999999999999999999999999999987643  48888888999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--------cccCCCCCCcccccccccC--CCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~--~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   ...+.+++.||+.+........        .....++..|+|||++.+.  .++.++|||||
T Consensus       121 ~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl  196 (328)
T cd08226         121 GYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV  196 (328)
T ss_pred             CeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHH
Confidence            99999999999999   4566899999976543221110        1112345679999999764  47899999996

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=153.26  Aligned_cols=137  Identities=33%  Similarity=0.577  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ....+|+-+++.++|.|||+++++...+....+|+||| ..+|..+... ++.+....+..++.|+  |+.|+|++++.|
T Consensus        46 ssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlh  124 (292)
T KOG0662|consen   46 SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLH  124 (292)
T ss_pred             HHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            56789999999999999999999999999999999999 6788888864 5668888888888887  999999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC-CCcccceee
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFV  151 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws  151 (152)
                      ||+||+|.++   +.++..|++|||+++.+.-+. .....+-|.+|.+|.++-+.. |+++.|+||
T Consensus       125 rdlkpqnlli---n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmws  187 (292)
T KOG0662|consen  125 RDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS  187 (292)
T ss_pred             ccCCcceEEe---ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhh
Confidence            9999999999   678899999999998765553 344556689999999998765 899999998

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.94  E-value=2.1e-26  Score=161.24  Aligned_cols=142  Identities=30%  Similarity=0.579  Sum_probs=117.0

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeee------CCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--H
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--G   76 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~   76 (152)
                      .....+..|+.+++++ +|+|++++++++..      ....|++|||+++++|.+++...  ..+++..+..++.++  |
T Consensus        54 ~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~a  133 (282)
T cd06636          54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG  133 (282)
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHH
Confidence            3456788999999998 79999999999853      45789999999999999998754  347888888888888  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccc-----cCCCCccccee
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFF  150 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvw  150 (152)
                      +.|||+++++|+|++|+||++   +..+.++++|||++...... .......+++.|+|||.+.     ...++.++|+|
T Consensus       134 l~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw  210 (282)
T cd06636         134 LAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW  210 (282)
T ss_pred             HHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence            999999999999999999999   45667999999998754322 2234456889999999986     34578899999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       211 sl  212 (282)
T cd06636         211 SL  212 (282)
T ss_pred             HH
Confidence            96

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=2.6e-26  Score=160.52  Aligned_cols=141  Identities=27%  Similarity=0.556  Sum_probs=121.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+.++++++||||+++++++..++..++++||+++++|.+++.. ..++...+..++.++  |+.+||+.++
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i  122 (277)
T cd06641          44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK  122 (277)
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCe
Confidence            3456788999999999999999999999999999999999999999988864 457888888888888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|++|.||++   +..+.++++|||++..+.... ......++..|+|||.+.+..++.++|+|||
T Consensus       123 ~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl  187 (277)
T cd06641         123 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL  187 (277)
T ss_pred             ecCCCCHHhEEE---CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHH
Confidence            999999999999   466789999999987654432 2234567888999999988888999999995

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=2.1e-26  Score=159.54  Aligned_cols=139  Identities=24%  Similarity=0.502  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+.++++++|+|++++++++. ++..++++|++.+++|.+++....  .++......++.++  |+.+||+.++
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i  123 (260)
T cd05067          45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            467889999999999999999999874 567899999999999999886533  47888888888888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +....++++|||++........  .....++..|+|||++....++.++|+|||
T Consensus       124 ~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~sl  189 (260)
T cd05067         124 IHRDLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  189 (260)
T ss_pred             ecccccHHhEEE---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHH
Confidence            999999999999   4667899999999976543221  123345678999999998889999999996

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2e-26  Score=160.29  Aligned_cols=141  Identities=33%  Similarity=0.607  Sum_probs=117.6

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--   75 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--   75 (152)
                      ..+.+.+|+.+++++ +|+||+++++++....      ..++++||+++++|.+++..    ...+++..+..++.++  
T Consensus        45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~  124 (275)
T cd06608          45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR  124 (275)
T ss_pred             hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence            457789999999999 7999999999997544      48999999999999998864    3468899999999998  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-----CCCCcccce
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVNF  149 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv  149 (152)
                      |+.+||+.+++|+||+|+||++   +..+.++++|||++....... ......+++.|+|||++..     ..++.++||
T Consensus       125 al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv  201 (275)
T cd06608         125 GLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV  201 (275)
T ss_pred             HHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence            8999999999999999999999   456789999999987654332 2344568889999999854     236788999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      |||
T Consensus       202 ~sl  204 (275)
T cd06608         202 WSL  204 (275)
T ss_pred             HHh
Confidence            996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.94  E-value=2.9e-26  Score=159.71  Aligned_cols=142  Identities=26%  Similarity=0.448  Sum_probs=115.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhc------CCCCHHHHHHHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i   75 (152)
                      ...+++.+|++++++++||||+++++++....      ..+++++|+.+++|.+++...      ..++...+..++.++
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i  122 (273)
T cd05074          43 SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI  122 (273)
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Confidence            44667889999999999999999999886432      247889999999998876422      246788888899998


Q ss_pred             --HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCccccee
Q 031828           76 --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF  150 (152)
Q Consensus        76 --~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvw  150 (152)
                        |+.|+|+.+++|+||||+||++   +....++++|||+++.......   .....+++.|++||.+....++.++|||
T Consensus       123 ~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~  199 (273)
T cd05074         123 ASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVW  199 (273)
T ss_pred             HHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhH
Confidence              8999999999999999999999   4567899999999986543321   1233456789999999988899999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       200 sl  201 (273)
T cd05074         200 AF  201 (273)
T ss_pred             HH
Confidence            96

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.94  E-value=3.8e-26  Score=160.89  Aligned_cols=140  Identities=29%  Similarity=0.454  Sum_probs=114.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+++++.++|+||+++++++..++..++|+||++ +++.+.+.....  +++..+..++.++  |+.+||++++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  123 (294)
T PLN00009         45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV  123 (294)
T ss_pred             hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4568899999999999999999999999999999999995 678777765443  5677888888888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +|+||+|+||++.  .....+|++|||+++...... ......+++.|+|||.+.+. .++.++|||||
T Consensus       124 ~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  190 (294)
T PLN00009        124 LHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSV  190 (294)
T ss_pred             eCCCCCcceEEEE--CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHH
Confidence            9999999999994  234578999999997643322 22334567899999998764 47889999996

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.94  E-value=8e-26  Score=161.01  Aligned_cols=137  Identities=34%  Similarity=0.578  Sum_probs=115.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ....+.+|+++++.++|||++++++++..+...++++||+. +++.+.+.. ...+++..+..++.++  |+.+||++++
T Consensus        68 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i  146 (317)
T cd06635          68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM  146 (317)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34678899999999999999999999999999999999996 577777653 4568889999999988  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||++.....   .....+++.|+|||.+.   .+.++.++|||||
T Consensus       147 ~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~sl  210 (317)
T cd06635         147 IHRDIKAGNILL---TEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  210 (317)
T ss_pred             ccCCCCcccEEE---CCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHH
Confidence            999999999999   4567899999998865332   23456788999999984   3568899999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.94  E-value=3.5e-26  Score=159.92  Aligned_cols=136  Identities=32%  Similarity=0.513  Sum_probs=113.9

Q ss_pred             HHHHHHHHHHcCC-CcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           12 CLDCELNFLSSVN-HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        12 ~~~~E~~~l~~l~-h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+|+.+++++. |+|++++++++.++  +..++++||++ +++.+.+... ..+++..+..++.++  |+.+||+.++
T Consensus        43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i  121 (282)
T cd07831          43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI  121 (282)
T ss_pred             hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            3457899999985 99999999999887  88999999996 5777777653 468999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++.   . +.++++|||+++............+++.|+|||.+.. ..++.++|||||
T Consensus       122 ~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  185 (282)
T cd07831         122 FHRDIKPENILIK---D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAV  185 (282)
T ss_pred             eecccCHHHEEEc---C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHH
Confidence            9999999999994   4 8899999999987654444344567889999998754 457889999995

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.94  E-value=3.7e-26  Score=160.51  Aligned_cols=140  Identities=31%  Similarity=0.503  Sum_probs=120.8

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|+++++++ +||||+++.+.+..++..++|+||+++++|.+++.....+++..+..++.++  |+.+||+.+++
T Consensus        48 ~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~  127 (288)
T cd05583          48 AEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGII  127 (288)
T ss_pred             HHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            46688999999999 5999999999999999999999999999999999877788999999999888  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCC--CCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~  152 (152)
                      |+|++|.||++   +....++++|||+++.......  .....+++.|+|||.+.+..  .+.++|+|||
T Consensus       128 H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~sl  194 (288)
T cd05583         128 YRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL  194 (288)
T ss_pred             ccCCCHHHeEE---CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHH
Confidence            99999999999   4567899999999876544322  22346788999999987654  7889999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-26  Score=175.87  Aligned_cols=144  Identities=31%  Similarity=0.539  Sum_probs=124.6

Q ss_pred             hHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHH
Q 031828            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA   68 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~   68 (152)
                      +..+.+.+..|+++|+.+ +|+||+.+.|++..++..++|.||+..|+|..+++..+                .+.....
T Consensus       341 ~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL  420 (609)
T KOG0200|consen  341 SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL  420 (609)
T ss_pred             CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence            446788999999999999 69999999999999999999999999999999998766                3777888


Q ss_pred             HHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcccc--CCC--CCCcccccccccCC
Q 031828           69 RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCG--SPLYMAPEVLQFQR  142 (152)
Q Consensus        69 ~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~--t~~y~aPE~~~~~~  142 (152)
                      ..+..|+  |++||++...+|||+..+|||+   .....+|++|||+++..........  ..+  ...|||||.+....
T Consensus       421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~  497 (609)
T KOG0200|consen  421 LSFAYQIANGMEYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV  497 (609)
T ss_pred             HHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence            9999999  8999999999999999999999   4667899999999987555443321  111  34599999999989


Q ss_pred             CCcccceeeC
Q 031828          143 YDEKVNFFVS  152 (152)
Q Consensus       143 ~~~~~Dvws~  152 (152)
                      |+.+||||||
T Consensus       498 ft~kSDVWSf  507 (609)
T KOG0200|consen  498 FTSKSDVWSF  507 (609)
T ss_pred             ccccchhhHH
Confidence            9999999996

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.94  E-value=1.3e-26  Score=166.07  Aligned_cols=137  Identities=29%  Similarity=0.440  Sum_probs=117.1

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecC
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (152)
                      .+.+|+++++.++|+||+++++++..++..+++||++. ++|.+++.....+++.....++.++  |+.+||+.+++|+|
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d  144 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD  144 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            47789999999999999999999999999999999995 6999999887789999999999998  89999999999999


Q ss_pred             CCCCceEeecCCCCceEEEeeccCccccCCCC---------------ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        90 l~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+|.||++   +..+.++++|||.++......               ......+++.|+|||.+.+. .++.++|+|||
T Consensus       145 l~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  220 (335)
T PTZ00024        145 LSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV  220 (335)
T ss_pred             ccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence            99999999   466789999999997654111               11223457789999998764 37899999995

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.94  E-value=1.8e-26  Score=161.71  Aligned_cols=139  Identities=33%  Similarity=0.565  Sum_probs=117.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|++++++++||||+++++++..++..+++|||+. ++|..++..  ...+++..+..++.++  |+.|||+.++
T Consensus        43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (284)
T cd07860          43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV  121 (284)
T ss_pred             chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4578899999999999999999999999999999999995 688888764  3458889999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +|+|++|+||++   +.++.++++|||+++...... ......+++.|+|||++.+.. ++.++|||||
T Consensus       122 ~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  187 (284)
T cd07860         122 LHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL  187 (284)
T ss_pred             ecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHH
Confidence            999999999999   566789999999987654332 223345678899999987654 6889999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.94  E-value=2.1e-26  Score=159.52  Aligned_cols=140  Identities=31%  Similarity=0.602  Sum_probs=119.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+..|+.+++.++||||+++++++..++..++++||+++++|.+.+..    ...+++..+..++.++  |+.+||+
T Consensus        45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  124 (260)
T cd08222          45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ  124 (260)
T ss_pred             hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            344677899999999999999999999988999999999999999988753    3458899999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+++|+|++|+||++.    ...++++|||.++...... ......+++.|+|||...+..++.++|+|||
T Consensus       125 ~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~sl  191 (260)
T cd08222         125 RRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSL  191 (260)
T ss_pred             cCccccCCChhheEee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHH
Confidence            9999999999999994    3459999999987654432 2334567889999999988888999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.94  E-value=2.2e-26  Score=160.60  Aligned_cols=142  Identities=37%  Similarity=0.639  Sum_probs=123.8

Q ss_pred             hHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|.+++++++ |+||+++++++..++..+++||++.+++|.+++.+.+.++...+..++.++  |+.+||+.+
T Consensus        43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~  122 (280)
T cd05581          43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG  122 (280)
T ss_pred             HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            33567889999999998 999999999999999999999999999999999988889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---------------------cccCCCCCCcccccccccCCC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------AEKVCGSPLYMAPEVLQFQRY  143 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~  143 (152)
                      ++|+|++|+||++   ...+.++++|||++........                     .....++..|+|||......+
T Consensus       123 ~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~  199 (280)
T cd05581         123 IIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA  199 (280)
T ss_pred             eeecCCCHHHeEE---CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence            9999999999999   4667899999999876533221                     123456788999999988889


Q ss_pred             CcccceeeC
Q 031828          144 DEKVNFFVS  152 (152)
Q Consensus       144 ~~~~Dvws~  152 (152)
                      +.++|+|||
T Consensus       200 ~~~~Di~sl  208 (280)
T cd05581         200 GKSSDLWAL  208 (280)
T ss_pred             ChhhhHHHH
Confidence            999999985

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=6.1e-26  Score=159.37  Aligned_cols=141  Identities=28%  Similarity=0.469  Sum_probs=115.9

Q ss_pred             hHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHH-----hcCCCCHHHHHHHHHHH--HHHH
Q 031828            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      .....+.+|+.++.++. |+||+++++++..++..++++|++. .++.++..     ....+++..+..++.++  |+.|
T Consensus        44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  122 (288)
T cd06616          44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY  122 (288)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            34667889999999996 9999999999998889999999984 55544332     23568999999999998  8999


Q ss_pred             HHhC-CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC---CCCcccceeeC
Q 031828           80 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ---RYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~-~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Dvws~  152 (152)
                      ||+. +++|+||+|+||++   +..+.++++|||+++............+++.|+|||++...   .++.++|||||
T Consensus       123 lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl  196 (288)
T cd06616         123 LKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSL  196 (288)
T ss_pred             HhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHH
Confidence            9974 99999999999999   45678999999999765544433445678899999999876   68999999995

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.94  E-value=1.9e-26  Score=165.32  Aligned_cols=140  Identities=31%  Similarity=0.517  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+|+.+++.++||||+++++++..    ....++++||+ +++|.+++.....+++..+..++.++  |+.+||+
T Consensus        47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  125 (334)
T cd07855          47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS  125 (334)
T ss_pred             chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34667789999999999999999998863    34689999999 46899998877779999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-----cccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      ++++|+||||+||++   +..+.+|++|||+++.......     .....++..|+|||.+.. ..++.++|||||
T Consensus       126 ~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl  198 (334)
T cd07855         126 ANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV  198 (334)
T ss_pred             CCeecCCCCHHHEEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHH
Confidence            999999999999999   5677899999999976543221     134567889999999865 458899999996

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.5e-26  Score=165.33  Aligned_cols=141  Identities=31%  Similarity=0.538  Sum_probs=121.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCC-----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ...+.+.+|+.+++.++|+||+++.+++...+     ..|+++||++ ++|.+.+.+...+++..+..++.++  |+.+|
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~L  119 (330)
T cd07834          41 IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL  119 (330)
T ss_pred             hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            34567889999999999999999999987765     7899999996 6899988877789999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+.|++|+||||.||++   +..+.++++|||++.......    ......+++.|+|||.+.+. .++.++|+|||
T Consensus       120 H~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl  193 (330)
T cd07834         120 HSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSV  193 (330)
T ss_pred             HhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHH
Confidence            99999999999999999   456789999999998765443    23345678899999999887 78999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=3e-26  Score=164.50  Aligned_cols=139  Identities=30%  Similarity=0.519  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+|+.+++.++|+||+++++++...     ...|+++||+ +++|.+++...+.+++..+..++.++  |+.+||+
T Consensus        48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  126 (337)
T cd07858          48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS  126 (337)
T ss_pred             hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45677899999999999999999988644     3589999999 57899998888889999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      .+++|+||+|+||++   +..+.++++|||+++..... .......++..|+|||.+.. ..++.++|+|||
T Consensus       127 ~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  195 (337)
T cd07858         127 ANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSV  195 (337)
T ss_pred             CCEecCCCCHHHEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHH
Confidence            999999999999999   46678999999999765443 22344567889999999875 458899999996

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=6.7e-26  Score=158.65  Aligned_cols=138  Identities=31%  Similarity=0.532  Sum_probs=118.6

Q ss_pred             HHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ....+|+..+++++ |+|++++++++..++..+++|||+ ++++.+.+....  .+++..+..++.++  ++.+||++++
T Consensus        42 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i  120 (283)
T cd07830          42 CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF  120 (283)
T ss_pred             HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34557999999998 999999999999999999999999 789998887654  68899999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||.+.............++..|+|||++.. ..++.++|+|||
T Consensus       121 ~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~  185 (283)
T cd07830         121 FHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWAL  185 (283)
T ss_pred             ccCCCChhhEEE---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhH
Confidence            999999999999   5677899999999987655444444567888999998854 457899999996

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=8.7e-26  Score=158.05  Aligned_cols=139  Identities=28%  Similarity=0.474  Sum_probs=113.2

Q ss_pred             HHHHHHHHHH-HHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           10 KSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~-l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+..|..+ ++..+||||+++++++..++..|+++||++ ++|.+++..    ...+++..+..++.++  |+.|||+
T Consensus        43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  121 (283)
T cd06617          43 QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS  121 (283)
T ss_pred             HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            3445556664 666799999999999999999999999995 788777753    2358899999999998  8999999


Q ss_pred             C-CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc----CCCCcccceeeC
Q 031828           83 H-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~-~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dvws~  152 (152)
                      + +++|+||||+||++   +....+|++|||.++............++..|+|||.+.+    ..++.++|+|||
T Consensus       122 ~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl  193 (283)
T cd06617         122 KLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL  193 (283)
T ss_pred             cCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhh
Confidence            7 99999999999999   5677899999999876544333334567889999999865    446889999996

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.94  E-value=4.9e-26  Score=161.11  Aligned_cols=138  Identities=27%  Similarity=0.497  Sum_probs=112.9

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCC--------eEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHH
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--------~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~   79 (152)
                      ..+.+|++++++++||||+++++++...+        ..++++||+. +++.+.+.+.. .+++..+..++.++  |+.+
T Consensus        56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~  134 (310)
T cd07865          56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY  134 (310)
T ss_pred             hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence            35568999999999999999999886553        4599999995 57877776543 58999999999998  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-----cccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      ||+++++|+||+|+||++   +..+.++++|||++........     .....++..|+|||.+.+.. ++.++|+|||
T Consensus       135 lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  210 (310)
T cd07865         135 IHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA  210 (310)
T ss_pred             HHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence            999999999999999999   5667899999999976543321     12345678899999987654 7889999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=5.9e-26  Score=159.01  Aligned_cols=139  Identities=31%  Similarity=0.530  Sum_probs=116.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      .+.+.+|+++++.++|+||+++++++...+..++++||++ ++|.+++....   .+++..+..++.++  |+.+||+.+
T Consensus        42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (284)
T cd07836          42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR  120 (284)
T ss_pred             hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567789999999999999999999999999999999996 58888876543   58899999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      ++|+|++|+||++   +.++.++++|||.++...... ......+++.|+|||++.+. .++.++|+|||
T Consensus       121 i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  187 (284)
T cd07836         121 VLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSV  187 (284)
T ss_pred             eeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHH
Confidence            9999999999999   566789999999987553322 12334568889999998764 47889999996

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.93  E-value=5.9e-26  Score=158.99  Aligned_cols=139  Identities=35%  Similarity=0.556  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+++++.++|||++++++++..++..++++||+ +++|.+++....  .+++..+..++.++  |+.+||+.++
T Consensus        42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~  120 (283)
T cd07835          42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV  120 (283)
T ss_pred             hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356788999999999999999999999999999999999 578999887665  68899999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +|+|++|.||++   +..+.++++|||+++...... ......+++.|+|||++.+. .++.++|+|||
T Consensus       121 ~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  186 (283)
T cd07835         121 LHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSI  186 (283)
T ss_pred             eCCCCCHHHEEE---cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHH
Confidence            999999999999   457789999999987653322 12233567889999988764 47889999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=165.26  Aligned_cols=147  Identities=31%  Similarity=0.507  Sum_probs=123.7

Q ss_pred             cchhhHhHHHHHHHHHHHHHcC--CCcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l--~h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i   75 (152)
                      +|++...+++.|..|-.|.+..  +|+||+.+++.-+..+    .+|+|++|.+.|+|.++++.+ ..+......++..+
T Consensus       238 VKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~Sm  316 (534)
T KOG3653|consen  238 VKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESM  316 (534)
T ss_pred             EEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHH
Confidence            7899999999999999999874  8999999998876555    799999999999999999865 46888888888877


Q ss_pred             --HHHHHHhC---------CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccC
Q 031828           76 --GLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQ  141 (152)
Q Consensus        76 --~l~~lh~~---------~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~  141 (152)
                        |++|||+.         .|.|||||++|||+   ..+..+.|+|||+|.++.+..   .....+||.+|||||++.+.
T Consensus       317 arGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga  393 (534)
T KOG3653|consen  317 ARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA  393 (534)
T ss_pred             HHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence              89999975         49999999999999   577789999999998876543   23457899999999999864


Q ss_pred             C-CC-----cccceeeC
Q 031828          142 R-YD-----EKVNFFVS  152 (152)
Q Consensus       142 ~-~~-----~~~Dvws~  152 (152)
                      . ..     .+.||||+
T Consensus       394 inl~d~~Afkr~DvYam  410 (534)
T KOG3653|consen  394 INLQDRDAFKRIDVYAM  410 (534)
T ss_pred             cccccHHHHHHHHHHHH
Confidence            3 11     35899884

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.93  E-value=1.9e-25  Score=158.52  Aligned_cols=137  Identities=33%  Similarity=0.583  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...++.+|+++++.++|+|++++.+++..+...++++||+. +++.+.+.. ...+++..+..++.++  |+.++|++++
T Consensus        58 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i  136 (308)
T cd06634          58 KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM  136 (308)
T ss_pred             HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567889999999999999999999999999999999995 677776653 4458888888888887  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      +|+||+|.||++   +..+.++++|||++......   ....+++.|+|||.+.   ...++.++|||||
T Consensus       137 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~sl  200 (308)
T cd06634         137 IHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  200 (308)
T ss_pred             ccCCCCHHhEEE---CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHH
Confidence            999999999999   45678999999998764332   3456788999999985   3457889999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=2.8e-25  Score=157.99  Aligned_cols=137  Identities=34%  Similarity=0.553  Sum_probs=115.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ....+.+|+++++.++|||++++++++..+...|+++||+. +++.+++.. ...+++..+..++.++  |+.|||+.++
T Consensus        64 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi  142 (313)
T cd06633          64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM  142 (313)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34568889999999999999999999999999999999995 677777754 4468888998898888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      +|+|++|+||++   ...+.++++|||++....   ......++..|+|||++.   ...++.++|||||
T Consensus       143 ~H~dl~p~nili---~~~~~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~sl  206 (313)
T cd06633         143 IHRDIKAGNILL---TEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  206 (313)
T ss_pred             ecCCCChhhEEE---CCCCCEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHH
Confidence            999999999999   456789999999886432   223456788999999984   3558889999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=7.7e-26  Score=171.10  Aligned_cols=150  Identities=32%  Similarity=0.490  Sum_probs=121.9

Q ss_pred             cchhhHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CC---CCHHHHHHHHHHH-
Q 031828            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GR---VPEQTARKFLQQL-   75 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~---~~~~~~~~~~~~i-   75 (152)
                      +|.+-....+..++|++.++.- +||||+++++.=.++.+.|+..|.| ..+|.+++... ..   .........+.|+ 
T Consensus       538 VKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~  616 (903)
T KOG1027|consen  538 VKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIA  616 (903)
T ss_pred             HHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHH
Confidence            4555455567789999999987 6999999999999999999999999 68999999763 11   1113345556666 


Q ss_pred             -HHHHHHhCCCeecCCCCCceEeecCC--CCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccc
Q 031828           76 -GLEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVN  148 (152)
Q Consensus        76 -~l~~lh~~~~~h~dl~~~nil~~~~~--~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~D  148 (152)
                       |+++||+.+++|||+||+|||+...+  ...+++|+|||+++++..+.    ...+..||-+|+|||++.....+.++|
T Consensus       617 ~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avD  696 (903)
T KOG1027|consen  617 SGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVD  696 (903)
T ss_pred             HHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccc
Confidence             89999999999999999999997532  34589999999999886653    345667899999999999988899999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      |+||
T Consensus       697 iFsl  700 (903)
T KOG1027|consen  697 IFSL  700 (903)
T ss_pred             hhhc
Confidence            9986

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.93  E-value=2.7e-26  Score=160.43  Aligned_cols=140  Identities=36%  Similarity=0.588  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ....+.+|+++++.++|+||+++++++..++..++++||++ +++.+++.. ...+++..+..++.++  |+.+||+.++
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  119 (283)
T cd05118          41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI  119 (283)
T ss_pred             hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34678889999999999999999999999999999999996 588888765 3578899999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +.+..++++|||.+....... ......++..|+|||.+.+. .++.++|+|||
T Consensus       120 ~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~sl  185 (283)
T cd05118         120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSV  185 (283)
T ss_pred             eecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHH
Confidence            999999999999   466789999999987665443 22234567889999999876 68999999995

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.93  E-value=1.7e-25  Score=156.69  Aligned_cols=139  Identities=35%  Similarity=0.561  Sum_probs=116.6

Q ss_pred             HHHHHHHHHHHHcC---CCcCccceeeeeeeCCe-----EEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HH
Q 031828           10 KSCLDCELNFLSSV---NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GL   77 (152)
Q Consensus        10 ~~~~~~E~~~l~~l---~h~ni~~l~~~~~~~~~-----~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l   77 (152)
                      ...+.+|+.+++++   +|+|++++++++...+.     .++++|++. ++|.+++....  .+++..+..++.++  |+
T Consensus        42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al  120 (287)
T cd07838          42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV  120 (287)
T ss_pred             hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence            34566788877766   59999999999987766     999999995 58888886643  48899999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+||+.+++|+|++|.||++   +....++++|||.+.............+++.|+|||.+.+..++.++|+|||
T Consensus       121 ~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~  192 (287)
T cd07838         121 DFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSV  192 (287)
T ss_pred             HHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhH
Confidence            99999999999999999999   4567899999999977654443344457888999999998889999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.93  E-value=1.1e-25  Score=159.61  Aligned_cols=137  Identities=34%  Similarity=0.517  Sum_probs=113.6

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+|+.++++++|+|++++++++...  +..++++||+. ++|.+++.. ...+++..+..++.++  |+.+||+.+++
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  130 (309)
T cd07845          52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFII  130 (309)
T ss_pred             hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456799999999999999999998755  56899999995 588888765 3568999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.++++|||.+....... ......+++.|+|||.+.+ ..++.++|||||
T Consensus       131 H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  195 (309)
T cd07845         131 HRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAV  195 (309)
T ss_pred             cCCCCHHHEEE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHH
Confidence            99999999999   466789999999998765432 2223345778999999875 457899999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=1e-25  Score=157.69  Aligned_cols=140  Identities=31%  Similarity=0.519  Sum_probs=118.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+|+++++.++|+|++++++++...  +..++++||++ ++|..++... ..+++..+..++.++  |+.+||+.
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~  119 (287)
T cd07840          41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN  119 (287)
T ss_pred             chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            345688899999999999999999999887  88999999996 5888888655 568999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +++|+|++|.||++   +..+.++++|||.+.......  ......++..|+|||.+.+ ..++.++|||||
T Consensus       120 ~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~sl  188 (287)
T cd07840         120 GILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSV  188 (287)
T ss_pred             CceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHH
Confidence            99999999999999   567789999999997664443  1233456788999998765 357899999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-25  Score=161.21  Aligned_cols=141  Identities=32%  Similarity=0.553  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeC-CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC--Ce
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH--II   86 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~--~~   86 (152)
                      -.-+|..|.+.+.||.||++|++|.-+ +.+|-|+|||+|.+|.-+++++...++..+..++.++  ||.||-...  |+
T Consensus       513 HAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPII  592 (775)
T KOG1151|consen  513 HACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPII  592 (775)
T ss_pred             HHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCee
Confidence            345799999999999999999999655 6789999999999999999999999999999999998  899999775  99


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--------ccccCCCCCCcccccccccC----CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQ----RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~Dvws~  152 (152)
                      |-||||.|||+.+....+.+|+.|||+++.+....        ......||.||++||.+--+    ..+.++||||.
T Consensus       593 HYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv  670 (775)
T KOG1151|consen  593 HYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV  670 (775)
T ss_pred             eeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence            99999999999877788899999999998875442        23456789999999998654    36889999994

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.93  E-value=7.4e-26  Score=162.35  Aligned_cols=139  Identities=29%  Similarity=0.535  Sum_probs=113.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+|+++++.++|+||+++++++...     ...++++|++. +++...+. ...+++..+..++.++  |+.+||
T Consensus        46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH  123 (336)
T cd07849          46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIH  123 (336)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999887544     35899999995 68877764 3468999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +.+++|+||||+||++   +..+.++++|||+++......    ......+++.|+|||.+.+ ..++.++|||||
T Consensus       124 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  196 (336)
T cd07849         124 SANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSV  196 (336)
T ss_pred             hCCeeccCCCHHHEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHH
Confidence            9999999999999999   567789999999987654322    1233567889999998764 468899999995

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.93  E-value=2.6e-25  Score=156.93  Aligned_cols=133  Identities=17%  Similarity=0.237  Sum_probs=105.9

Q ss_pred             HHHHHHcCCCcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecC
Q 031828           16 ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (152)
Q Consensus        16 E~~~l~~l~h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (152)
                      +...+..++|+|++++++++....    ..+++++++ ..++.+.+......++..+..++.++  |+.|+|+.+++|||
T Consensus        73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrD  151 (294)
T PHA02882         73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGD  151 (294)
T ss_pred             HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            334556678999999998765543    346788876 45777777665556788888889888  89999999999999


Q ss_pred             CCCCceEeecCCCCceEEEeeccCccccCCCC--------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        90 l~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+||++   +....++++|||+++.+....        ......||+.|+|||+..+..++.++|||||
T Consensus       152 iKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSl  219 (294)
T PHA02882        152 IKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESL  219 (294)
T ss_pred             CCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHH
Confidence            99999999   456789999999998654321        1233568999999999999899999999996

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=156.44  Aligned_cols=143  Identities=29%  Similarity=0.508  Sum_probs=118.9

Q ss_pred             hHhHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      +.++..++.+.+.++...+ +|.||+.+|+|..+..+++.||.| ...+..+++. .+++++..+-.+...+  ||.||-
T Consensus       130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK  208 (391)
T KOG0983|consen  130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK  208 (391)
T ss_pred             CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence            4567788888888877764 999999999999999999999998 5566666543 4568887777666554  899987


Q ss_pred             h-CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc---CCCCcccceeeC
Q 031828           82 S-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  152 (152)
Q Consensus        82 ~-~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~  152 (152)
                      + ++++|||+||+|||+   +..+++|++|||++.++..+...+...|.+.|||||-+.-   ..|+..+|||||
T Consensus       209 eKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSl  280 (391)
T KOG0983|consen  209 EKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSL  280 (391)
T ss_pred             HhcceeecccCccceEE---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhh
Confidence            5 589999999999999   7889999999999988877766667778999999999963   358999999997

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.93  E-value=1.8e-25  Score=160.36  Aligned_cols=140  Identities=35%  Similarity=0.560  Sum_probs=115.4

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      .....+.+|+++++++ +|+||+++++++...  ...|+|+||++ ++|..++... .+++.....++.++  |+.+||+
T Consensus        48 ~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~  125 (337)
T cd07852          48 TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS  125 (337)
T ss_pred             hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            3455677899999999 999999999988644  36899999996 6898888665 67888888888888  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC------ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      .+++|+||+|+||++   +..+.++++|||+++......      ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       126 ~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl  199 (337)
T cd07852         126 GNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV  199 (337)
T ss_pred             CCeecCCCCHHHEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence            999999999999999   567789999999997654432      1223467889999998865 457889999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.93  E-value=2.9e-25  Score=156.34  Aligned_cols=140  Identities=29%  Similarity=0.482  Sum_probs=113.4

Q ss_pred             HHHHHHHHHHHHcCC-CcCccceeeeeeeCCe-----EEEEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHH--H
Q 031828           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQL--G   76 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~-----~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i--~   76 (152)
                      ...+.+|+.+++.+. |+||+++++++...+.     .|+++||+++ ++.+++...     ..+++..+..++.++  |
T Consensus        44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  122 (295)
T cd07837          44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG  122 (295)
T ss_pred             chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence            356788999999995 6999999999877655     8999999964 788887542     347899999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +.|||+.+++|+||+|+||++.  ...+.++++|||+++.+... .......+++.|+|||.+.+ ..++.++|+|||
T Consensus       123 L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl  198 (295)
T cd07837         123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSV  198 (295)
T ss_pred             HHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHH
Confidence            9999999999999999999994  22678999999998765332 22233356788999998865 447899999996

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.93  E-value=1.5e-25  Score=156.64  Aligned_cols=139  Identities=35%  Similarity=0.587  Sum_probs=119.4

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|+.+++.++|+|++++++++...+..++++|+++ ++|.+++.+. ..+++..+..++.++  |+.+||+++++
T Consensus        42 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  120 (282)
T cd07829          42 PSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRIL  120 (282)
T ss_pred             cHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4567889999999999999999999999999999999996 6899999776 578999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+|++|+||++   +..+.++++|||.++...... ......++..|+|||.+... .++.++|+|||
T Consensus       121 H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~sl  185 (282)
T cd07829         121 HRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSV  185 (282)
T ss_pred             cCCCChheEEE---cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHH
Confidence            99999999999   456789999999987654433 22334457789999999776 78999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1.5e-25  Score=152.86  Aligned_cols=140  Identities=45%  Similarity=0.804  Sum_probs=124.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|++.++.++|+|++++.+.+......++++|++++++|..++.....++...+..++.++  ++.++|+.+++|
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  110 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH  110 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence            578999999999999999999999999989999999999888999999876668889999999888  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|++|.||++   ...+.++++|||.+.............++..|+|||.+....++.++|+|||
T Consensus       111 ~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~sl  172 (244)
T smart00220      111 RDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSL  172 (244)
T ss_pred             CCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHH
Confidence            9999999999   4557899999999987655444455667889999999998888999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.93  E-value=2.5e-25  Score=159.37  Aligned_cols=139  Identities=29%  Similarity=0.487  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeC----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      .+.+.+|+.+++++ +||||+++++.+...    ...+++++++ +++|.+.+.....+++..+..++.++  |+.+||+
T Consensus        45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~  123 (332)
T cd07857          45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS  123 (332)
T ss_pred             HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45677899999999 599999999875432    4578899988 57899998887889999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      .+++|+||||+||++   +..+.++++|||.++......     ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       124 ~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~sl  196 (332)
T cd07857         124 ANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSV  196 (332)
T ss_pred             CCcccCCCCHHHeEE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHH
Confidence            999999999999999   466789999999997654322     1233568899999998765 458999999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.93  E-value=1.6e-25  Score=158.09  Aligned_cols=139  Identities=27%  Similarity=0.442  Sum_probs=113.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCC----------eEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--H
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G   76 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~----------~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~   76 (152)
                      ...+.+|++++++++|||++++++++....          .+++++||+++ ++...+... ..+++..+..++.++  |
T Consensus        50 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~a  128 (302)
T cd07864          50 PITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG  128 (302)
T ss_pred             hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            356778999999999999999999887654          78999999965 676666543 458999999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +.|||+.+++|+|++|+||++   +....+|++|||.+........  .....++..|+|||.+.+. .++.++|||||
T Consensus       129 L~~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~sl  204 (302)
T cd07864         129 LNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSC  204 (302)
T ss_pred             HHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHH
Confidence            999999999999999999999   5677899999999976544321  1223457789999988653 47889999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-26  Score=158.37  Aligned_cols=137  Identities=36%  Similarity=0.516  Sum_probs=118.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ..+..+|..++..++|+||++++.+|....      .+|+|||++ ..+|.+...  ..+....+..++.|+  |+.++|
T Consensus        59 akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lh  135 (369)
T KOG0665|consen   59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLH  135 (369)
T ss_pred             chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHH
Confidence            356678999999999999999999996443      579999999 688888775  346677888888887  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.||+||||||+||++   ..+..+|+.|||+++.-...-..+....|..|.|||++.+.+|...+||||+
T Consensus       136 s~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSv  203 (369)
T KOG0665|consen  136 SAGIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  203 (369)
T ss_pred             hcceeecccCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhh
Confidence            9999999999999999   6788999999999987666545566778899999999999999999999995

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-26  Score=169.73  Aligned_cols=140  Identities=23%  Similarity=0.377  Sum_probs=121.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..++|.+|+.+|.+++|+|+++|||+..+ ....||+|+++.|+|.+.+.+  ...|.......|+.||  |+.||..++
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr  232 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR  232 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence            56899999999999999999999999987 668999999999999999986  3458888888999999  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc----ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+..+|++++   ....+|++|||+.|.+..+...    ....-...|.|||.+....++.+||||+|
T Consensus       233 lvHRDLAARNllla---sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmy  301 (1039)
T KOG0199|consen  233 LVHRDLAARNLLLA---SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMY  301 (1039)
T ss_pred             hhhhhhhhhhheec---ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhh
Confidence            99999999999995   5668999999999987655322    12223456999999999999999999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.93  E-value=5.1e-25  Score=158.61  Aligned_cols=136  Identities=30%  Similarity=0.546  Sum_probs=113.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      .+.+.+|+.++++++||||+++++++...      ...+++++++ +++|.+.+.. ..+++..+..++.++  |+.|||
T Consensus        60 ~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH  137 (345)
T cd07877          60 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIH  137 (345)
T ss_pred             HHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            46678899999999999999999988643      3478888887 7899887754 458899999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +.+++|+||+|+||++   +..+.++++|||+++....  ......+++.|+|||.+.+ ..++.++|||||
T Consensus       138 ~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  204 (345)
T cd07877         138 SADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  204 (345)
T ss_pred             HCCeeecCCChHHEEE---cCCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHH
Confidence            9999999999999999   4567899999999875432  2334567889999999876 458889999996

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=4.1e-25  Score=159.01  Aligned_cols=137  Identities=31%  Similarity=0.522  Sum_probs=114.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....+.+|+++++.++||||+++++++..++      .++++++++ +++|..++.. ..+++..+..++.++  |+.+|
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~L  134 (343)
T cd07880          57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            3567889999999999999999999987653      468999998 7788887754 568999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+.+++|+||+|.||++   +..+.++++|||+++.....  .....+++.|+|||.+.+ ..++.++|+|||
T Consensus       135 H~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  202 (343)
T cd07880         135 HAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSV  202 (343)
T ss_pred             HhCCeecCCCCHHHEEE---cCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHH
Confidence            99999999999999999   45678999999998764332  234467889999999876 358889999985

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=7.6e-25  Score=154.53  Aligned_cols=140  Identities=28%  Similarity=0.514  Sum_probs=113.3

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHh-C
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNS-H   83 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~-~   83 (152)
                      ....+..|+.++... .|+||+++++++..+...|+++|++ ++++..+... ...+++..+..++.++  |+.|||+ .
T Consensus        56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~  134 (296)
T cd06618          56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH  134 (296)
T ss_pred             HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            345566677766666 4999999999999999999999998 4577776654 4568888888899998  8999997 5


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCC----CCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR----YDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Dvws~  152 (152)
                      +++|+||+|+||++   +.++.++|+|||++..+..........+++.|+|||.+....    ++.++|+|||
T Consensus       135 ~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl  204 (296)
T cd06618         135 GVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL  204 (296)
T ss_pred             CEecCCCcHHHEEE---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence            99999999999999   566789999999987654433333445778899999997553    7889999996

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.92  E-value=7.8e-25  Score=156.73  Aligned_cols=137  Identities=35%  Similarity=0.561  Sum_probs=114.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeee-CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+++++.++||||+++.+++.. .+..++++|++ +++|..+++. ..+++..+..++.++  |+.+||+.++
T Consensus        52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i  129 (328)
T cd07856          52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGV  129 (328)
T ss_pred             hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45678899999999999999999999865 45789999998 6788887754 457888888888888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +|+|++|.||++   +..+.++++|||.++....  ......+++.|+|||.+.+ ..++.++|+|||
T Consensus       130 iH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  192 (328)
T cd07856         130 VHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSA  192 (328)
T ss_pred             ccCCCCHHHEeE---CCCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHH
Confidence            999999999999   5667899999999875432  2234456888999999866 468999999995

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.92  E-value=3.1e-25  Score=148.27  Aligned_cols=143  Identities=25%  Similarity=0.319  Sum_probs=116.9

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHH--
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--   75 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i--   75 (152)
                      .++.+...+|++..++++|||++++++....+     ...|++++|...|+|.+.+...    ..+++.+++.++..+  
T Consensus        59 ~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~  138 (302)
T KOG2345|consen   59 QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICR  138 (302)
T ss_pred             hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHH
Confidence            36678889999999999999999999876433     3589999999999999988632    358999999999998  


Q ss_pred             HHHHHHhCC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--cc--------ccCCCCCCcccccccccCC-
Q 031828           76 GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YA--------EKVCGSPLYMAPEVLQFQR-  142 (152)
Q Consensus        76 ~l~~lh~~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~--------~~~~~t~~y~aPE~~~~~~-  142 (152)
                      |+.+||+..  +.|+||||.||+++   .++.+.+.|||.+....-..  ..        .....|..|.|||.+.-+. 
T Consensus       139 gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~  215 (302)
T KOG2345|consen  139 GLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSH  215 (302)
T ss_pred             HHHHHhccCCcccccCCCcceeEec---CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccC
Confidence            999999999  99999999999994   46789999999987643221  00        1223578899999997543 


Q ss_pred             --CCcccceeeC
Q 031828          143 --YDEKVNFFVS  152 (152)
Q Consensus       143 --~~~~~Dvws~  152 (152)
                        .+.++|||||
T Consensus       216 ~ti~ertDIWSL  227 (302)
T KOG2345|consen  216 CTITERTDIWSL  227 (302)
T ss_pred             cccccccchhhh
Confidence              6789999997

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.92  E-value=3.8e-25  Score=156.60  Aligned_cols=138  Identities=29%  Similarity=0.498  Sum_probs=111.3

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeC--------CeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHH
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      ..+.+|+++++.++|+||+++++++...        ..++++++|+. +++...+.. ...+++..+..++.++  |+.+
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~  130 (311)
T cd07866          52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINY  130 (311)
T ss_pred             hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999887543        34799999985 567666654 3468999999999998  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc------------cccCCCCCCcccccccccC-CCCcc
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------AEKVCGSPLYMAPEVLQFQ-RYDEK  146 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~t~~y~aPE~~~~~-~~~~~  146 (152)
                      ||+.+++|+|++|+||++   +..+.++++|||+++.......            .....+++.|+|||.+.+. .++.+
T Consensus       131 lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  207 (311)
T cd07866         131 LHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA  207 (311)
T ss_pred             HHhCCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence            999999999999999999   5677899999999976533221            1223467889999988654 47899


Q ss_pred             cceeeC
Q 031828          147 VNFFVS  152 (152)
Q Consensus       147 ~Dvws~  152 (152)
                      +|||||
T Consensus       208 ~Dv~sl  213 (311)
T cd07866         208 VDIWGI  213 (311)
T ss_pred             hHhHHH
Confidence            999996

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=9.1e-26  Score=151.70  Aligned_cols=137  Identities=26%  Similarity=0.488  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeC--------CeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHH
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~   79 (152)
                      ....+|+.++..++|+|++.+.+.|...        ..+|+|+++| ..+|.-++.+. ..++...+..++..+  ||.|
T Consensus        61 italreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~  139 (376)
T KOG0669|consen   61 ITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYY  139 (376)
T ss_pred             HHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHH
Confidence            3456899999999999999999877432        3589999999 57999888765 458999999999887  9999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCcccccccccCC-CCcccceee
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFV  151 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws  151 (152)
                      +|...++|||+|+.|+|+   +.++.+|++|||+++.+..+.     .++..+-|.+|.+||.+.+.. |+++.|||+
T Consensus       140 iHr~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWg  214 (376)
T KOG0669|consen  140 IHRNKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWG  214 (376)
T ss_pred             HHHhhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHh
Confidence            999999999999999999   577899999999997654332     234455689999999999765 999999996

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-26  Score=170.96  Aligned_cols=141  Identities=30%  Similarity=0.559  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ...-+++|+-+++.++||||+.+++.+......|+.||||.+|+|.+.-.--+++++.++...+...  |+.|+|+.+-+
T Consensus        55 d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~  134 (829)
T KOG0576|consen   55 DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKI  134 (829)
T ss_pred             cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcc
Confidence            3456778999999999999999999999999999999999999999987777889999999888886  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      |||||-.||++   ...+.+|++|||.+..+... .+...+.|||+|||||+..   .++|...+|+||+
T Consensus       135 hRdiKGanill---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~  201 (829)
T KOG0576|consen  135 HRDIKGANILL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAL  201 (829)
T ss_pred             cccccccceee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhccccccccccccc
Confidence            99999999999   46778999999999877654 3456788999999999985   4579999999985

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.92  E-value=3.9e-26  Score=154.19  Aligned_cols=142  Identities=28%  Similarity=0.440  Sum_probs=112.9

Q ss_pred             HhHHHHHHHHHHHHHc-CCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH-----hcCCCCHHHHHHHHHHH--HHH
Q 031828            7 KHLKSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ..+..++..|.+...+ -+.||||++||..-.++.-|+.||+| ..++..+-+     ++..+++..+..+....  ||.
T Consensus       103 ~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~  181 (361)
T KOG1006|consen  103 EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALD  181 (361)
T ss_pred             hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHH
Confidence            4667888888875544 58999999999998899999999999 566655543     34457776665554433  899


Q ss_pred             HHHhC-CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc--CCCCcccceeeC
Q 031828           79 ILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~-~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~  152 (152)
                      ||-.. .++|||+||+|||+   +..+.+||+|||++..+..+...+.-.|...|||||-+..  .+|+.+||+|||
T Consensus       182 yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSL  255 (361)
T KOG1006|consen  182 YLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSL  255 (361)
T ss_pred             HHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhh
Confidence            98754 69999999999999   6888999999999987766555556678889999999964  469999999997

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.92  E-value=5.8e-25  Score=175.88  Aligned_cols=129  Identities=26%  Similarity=0.414  Sum_probs=106.3

Q ss_pred             HHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH---hCCCeec
Q 031828           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN---SHHIIHR   88 (152)
Q Consensus        14 ~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh---~~~~~h~   88 (152)
                      ..|++++++++||||+++++++..++..|+||||+++++|.++++.   +++.....++.++  |+.|+|   +.+++|+
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~  807 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVG  807 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence            4578999999999999999999999999999999999999999853   7788888899888  899999   5689999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+||++.   .....++. +|.......   .....+|+.|+|||++.+..++.++|||||
T Consensus       808 dlkp~Nil~~---~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~  864 (968)
T PLN00113        808 NLSPEKIIID---GKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGF  864 (968)
T ss_pred             CCCHHhEEEC---CCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhH
Confidence            9999999994   33444443 554432211   223467899999999998899999999996

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.92  E-value=6.7e-25  Score=157.82  Aligned_cols=141  Identities=27%  Similarity=0.568  Sum_probs=113.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC--------------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ   73 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--------------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~   73 (152)
                      ...+.+.+|+++++.++||||+++++++...              ...|+++||+. ++|.+++.. +.+++..+..++.
T Consensus        44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~  121 (342)
T cd07854          44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMY  121 (342)
T ss_pred             chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHH
Confidence            3456788999999999999999999876544              35799999995 688887754 4688999999999


Q ss_pred             HH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCccccccccc-CCCCcc
Q 031828           74 QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEK  146 (152)
Q Consensus        74 ~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~  146 (152)
                      ++  |+.|||+.+++|+||||+||++.  .....++++|||.++.......    .....++..|+|||.+.. ..++.+
T Consensus       122 qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  199 (342)
T cd07854         122 QLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA  199 (342)
T ss_pred             HHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence            98  89999999999999999999994  2445789999999976533211    123356888999998754 458889


Q ss_pred             cceeeC
Q 031828          147 VNFFVS  152 (152)
Q Consensus       147 ~Dvws~  152 (152)
                      +|||||
T Consensus       200 ~DiwSl  205 (342)
T cd07854         200 IDMWAA  205 (342)
T ss_pred             hhHHHH
Confidence            999996

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=5.7e-24  Score=164.34  Aligned_cols=141  Identities=27%  Similarity=0.452  Sum_probs=118.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ....+..|+.+++.++|+||+++++++...+.+|+||||+.+++|.+++...+.+++..++.++.++  ||.|||.++++
T Consensus        47 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIi  126 (669)
T cd05610          47 MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGII  126 (669)
T ss_pred             HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            3577899999999999999999999999999999999999999999999887788999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      |+||||+||++   ...+.++|+|||+++...... ......+|+.|++||....... ...+++||+
T Consensus       127 HrDLKP~NILl---~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~  191 (669)
T cd05610         127 HRDLKPDNMLI---SNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSL  191 (669)
T ss_pred             eCCccHHHEEE---cCCCCEEEEeCCCCccccCCcccccccccCccccCccccccCCCCceeeeeeec
Confidence            99999999999   456789999999998654332 3345678999999997654332 234555553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.92  E-value=7.1e-25  Score=157.73  Aligned_cols=137  Identities=30%  Similarity=0.541  Sum_probs=115.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCe------EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~------~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ..+.+.+|+.+++.++|+|++++.+++..++.      .++++|++ +++|.+++.. ..+++..+..++.++  |+.++
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~L  134 (343)
T cd07851          57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            34667789999999999999999998866554      89999998 6799988865 468999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+.+++|+||+|.||++   ...+.++++|||++......  .....+++.|+|||.+.+ ..++.++|||||
T Consensus       135 H~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  202 (343)
T cd07851         135 HSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  202 (343)
T ss_pred             HHCCeecCCCCHHHeEE---CCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHH
Confidence            99999999999999999   45678999999999765332  334567888999999865 357899999996

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=1.7e-24  Score=155.78  Aligned_cols=135  Identities=30%  Similarity=0.491  Sum_probs=110.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ...+.+|+++++.++||||+++++++....      .+++++|++. .++....  ...+++..+..++.++  |+.+||
T Consensus        58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH  134 (342)
T cd07879          58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIH  134 (342)
T ss_pred             hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999999986542      4699999984 5676654  2357888888888888  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +.+++|+||+|+||++   +..+.++++|||+++....  ......+++.|+|||.+.+ ..++.++|||||
T Consensus       135 ~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl  201 (342)
T cd07879         135 SAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSV  201 (342)
T ss_pred             HCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHH
Confidence            9999999999999999   5677899999999875422  2234466888999999876 458899999996

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.91  E-value=1.6e-24  Score=169.22  Aligned_cols=109  Identities=33%  Similarity=0.617  Sum_probs=90.2

Q ss_pred             EEEEEeecCCCChHHHHHhcCCC-CHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCcccc
Q 031828           41 IFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (152)
Q Consensus        41 ~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~  117 (152)
                      +||-||||+...+.++++.+... .....+.++.+|  |+.|+|+.|+|||||||.||++   +....|||+|||++...
T Consensus       671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~  747 (1351)
T KOG1035|consen  671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDL  747 (1351)
T ss_pred             EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhh
Confidence            58899999888888888766544 467888899998  9999999999999999999999   57789999999999762


Q ss_pred             C----C--------------C-CccccCCCCCCcccccccccCC---CCcccceeeC
Q 031828          118 Y----P--------------G-NYAEKVCGSPLYMAPEVLQFQR---YDEKVNFFVS  152 (152)
Q Consensus       118 ~----~--------------~-~~~~~~~~t~~y~aPE~~~~~~---~~~~~Dvws~  152 (152)
                      .    .              + ...++..||.-|+|||++.+..   |+.|+|+|||
T Consensus       748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSL  804 (1351)
T KOG1035|consen  748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSL  804 (1351)
T ss_pred             hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHH
Confidence            1    0              0 1235567999999999998754   9999999996

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.91  E-value=7.9e-24  Score=143.14  Aligned_cols=141  Identities=41%  Similarity=0.732  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|++.++.++|+|++++++.+...+..++++|++++++|.+++..... +++..+..++.++  ++.++|++++
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  119 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI  119 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            567899999999999999999999999988999999999998899999987666 7888888888887  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCccccccc-ccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVL-QFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~-~~~~~~~~~Dvws~  152 (152)
                      +|+|++|.|+++   +....++++|||.+.......  ......++..|++||.. ....++.++|+|||
T Consensus       120 ~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~l  186 (225)
T smart00221      120 VHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSL  186 (225)
T ss_pred             ecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHH
Confidence            999999999999   455789999999987764432  33445677889999998 55668889999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.91  E-value=5.3e-25  Score=146.20  Aligned_cols=147  Identities=25%  Similarity=0.442  Sum_probs=126.7

Q ss_pred             CcchhhHhHHHHHHHHHHHHHcCC-CcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--
Q 031828            1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--   75 (152)
Q Consensus         1 ~~k~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--   75 (152)
                      |+|.+.+.-...+.+|+.||..+. ||||++++++..++  ...-+++|+..+.+..++.   ..+....+..++.++  
T Consensus        67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLk  143 (338)
T KOG0668|consen   67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLK  143 (338)
T ss_pred             EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHH
Confidence            577888888899999999999996 99999999998766  4567999999888776653   457888889999887  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      ||.|+|+.||.|||+||.|+++.  ......+++|+|+|-.+-++......+.+..|--||.+-. ..|+.+-|+|||
T Consensus       144 ALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~  219 (338)
T KOG0668|consen  144 ALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  219 (338)
T ss_pred             HHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHH
Confidence            99999999999999999999994  4556899999999998888777777788889999999976 458999999996

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.8e-26  Score=155.27  Aligned_cols=139  Identities=30%  Similarity=0.507  Sum_probs=118.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCC-----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      -.++.+|+.++.-++|.|++..++..+...     .+|++.|.+ -.+|..++-....++.+.+.-++.||  |+.|||+
T Consensus        96 ~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs  174 (449)
T KOG0664|consen   96 CKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT  174 (449)
T ss_pred             HHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhh
Confidence            467889999999999999999998876543     357888888 57888888888889999999999998  9999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      .+|.||||||-|.|+   +.+...|++|||++|......  ..+..+-|.+|.|||++.+.. |+.+.||||.
T Consensus       175 A~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSV  244 (449)
T KOG0664|consen  175 ANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSV  244 (449)
T ss_pred             cchhhccCCCccEEe---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehh
Confidence            999999999999999   677889999999999765543  233445578899999999854 9999999994

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=1.4e-24  Score=170.70  Aligned_cols=132  Identities=15%  Similarity=0.157  Sum_probs=101.4

Q ss_pred             HHcCCC-cCccceeeee-------eeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           20 LSSVNH-PNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        20 l~~l~h-~ni~~l~~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      .+.++| +||.+++++|       ..+..++.++|++ +++|.+++... ..+++..+..++.|+  |+.|||++||+||
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            344567 6888899988       2334577888987 77999999753 458999999999998  8999999999999


Q ss_pred             CCCCCceEeecC----------------CCCceEEEeeccCccccCCC-----------------CccccCCCCCCcccc
Q 031828           89 DLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPG-----------------NYAEKVCGSPLYMAP  135 (152)
Q Consensus        89 dl~~~nil~~~~----------------~~~~~~kl~dfg~~~~~~~~-----------------~~~~~~~~t~~y~aP  135 (152)
                      ||||+|||+...                +....+|++|||+++.....                 ......+||++|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999421                22346778888887643110                 001124678999999


Q ss_pred             cccccCCCCcccceeeC
Q 031828          136 EVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       136 E~~~~~~~~~~~Dvws~  152 (152)
                      |++.+..++.++|||||
T Consensus       185 E~~~~~~~~~~sDVwSl  201 (793)
T PLN00181        185 EEDNGSSSNCASDVYRL  201 (793)
T ss_pred             hhhccCCCCchhhhhhH
Confidence            99999899999999996

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.5e-24  Score=164.54  Aligned_cols=141  Identities=26%  Similarity=0.412  Sum_probs=122.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ....++..|+.+|..++|||+++|++++..+. ..+|.+++++|+|.++++.++ ++.....+.|..||  |+.|||+++
T Consensus       740 ~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr  818 (1177)
T KOG1025|consen  740 KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR  818 (1177)
T ss_pred             hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc
Confidence            34678899999999999999999999998665 889999999999999998654 47788889999999  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++||||-++|+|+   .....+|+.|||+++...+....   ....-.+.|||-|.++...|+.++|||||
T Consensus       819 lVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsf  886 (1177)
T KOG1025|consen  819 LVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSF  886 (1177)
T ss_pred             hhhhhhhhhheee---cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhh
Confidence            9999999999999   56678999999999876655422   23334677999999999999999999997

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.90  E-value=1.1e-22  Score=135.63  Aligned_cols=140  Identities=44%  Similarity=0.758  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+++++.++|++++++++++...+..++++|++++++|.+++... ..++......++.++  ++.++|+.+++
T Consensus        35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~  114 (215)
T cd00180          35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII  114 (215)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            478999999999999999999999999989999999999889999998765 467888888898888  89999999999


Q ss_pred             ecCCCCCceEeecCCC-CceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+|++|.||++.   . ...++++|||.+....... ......+...|++||..... .++.++|+||+
T Consensus       115 H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~l  180 (215)
T cd00180         115 HRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL  180 (215)
T ss_pred             ccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHH
Confidence            999999999994   4 5789999999987654432 12334567789999999877 78899999985

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.89  E-value=2.3e-23  Score=151.70  Aligned_cols=139  Identities=29%  Similarity=0.434  Sum_probs=117.1

Q ss_pred             HHHHHHHHHHHHcCCC------cCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHH--HHH
Q 031828           10 KSCLDCELNFLSSVNH------PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--GLE   78 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h------~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i--~l~   78 (152)
                      ...=..|++||++|+.      -++++++..|...+++|||+|.+ ..+|.+.+++.+   .+....+..|+.|+  ||.
T Consensus       472 ~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALk  550 (752)
T KOG0670|consen  472 HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALK  550 (752)
T ss_pred             hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHH
Confidence            4555689999999963      37899999999999999999987 789999998765   37778888999997  999


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .|-.++++|+||||.|||+.  .....+||||||.|.....+. .+...-+.+|.|||++.+-+|+...|+||.
T Consensus       551 lLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSv  621 (752)
T KOG0670|consen  551 LLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSV  621 (752)
T ss_pred             HHHhcCeeecccCccceEec--cCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceee
Confidence            99999999999999999994  456689999999987654433 233445778999999999999999999994

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.2e-21  Score=140.95  Aligned_cols=119  Identities=22%  Similarity=0.247  Sum_probs=91.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccc-eeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIR-LFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~-l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .++.+.+|+++|+.++|+|++. +++.    +..|++|||++|++|... .   ....   ..++.++  |+.++|+.|+
T Consensus        64 ~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~~-~---~~~~---~~~~~~i~~aL~~lH~~gI  132 (365)
T PRK09188         64 ARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHLA-R---PHGD---PAWFRSAHRALRDLHRAGI  132 (365)
T ss_pred             HHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHHh-C---ccch---HHHHHHHHHHHHHHHHCCC
Confidence            4677999999999999999985 4432    457999999999998632 1   1111   3455665  8999999999


Q ss_pred             eecCC-CCCceEeecCCCCceEEEeeccCccccCCCCc---------cccCCCCCCcccccccccC
Q 031828           86 IHRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------AEKVCGSPLYMAPEVLQFQ  141 (152)
Q Consensus        86 ~h~dl-~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~  141 (152)
                      +|||| ||+||++   +..+.++|+|||+++.+...+.         ....++++.|+|||.+...
T Consensus       133 iHrDL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        133 THNDLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eeCCCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999 9999999   4556899999999987644321         1345678889999999754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.87  E-value=7.2e-22  Score=149.96  Aligned_cols=102  Identities=27%  Similarity=0.439  Sum_probs=78.5

Q ss_pred             eeCCeEEEEEeecCCCChHHHHHhcCC--------------------CCHHHHHHHHHHH--HHHHHHhCCCeecCCCCC
Q 031828           36 QAENCIFLVVEFCAGGNLSSYIRLHGR--------------------VPEQTARKFLQQL--GLEILNSHHIIHRDLKPE   93 (152)
Q Consensus        36 ~~~~~~~lv~e~~~~~~l~~~~~~~~~--------------------~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~   93 (152)
                      ..+...++++||+++++|.+++.....                    .....+..++.|+  ||.|||+++++||||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            345679999999999999998864321                    1123455677787  899999999999999999


Q ss_pred             ceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccc
Q 031828           94 NILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQ  139 (152)
Q Consensus        94 nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~  139 (152)
                      ||++.  .....+|++|||+++.+....  ......+++.|+|||.+.
T Consensus       285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~  330 (566)
T PLN03225        285 NIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI  330 (566)
T ss_pred             HEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence            99994  235689999999997654332  234567899999999764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.86  E-value=4.9e-21  Score=143.05  Aligned_cols=125  Identities=26%  Similarity=0.364  Sum_probs=92.5

Q ss_pred             HHHHHHHHHcCCCcCc-----cceeeeeee--------CCeEEEEEeecCCCChHHHHHhcC------------------
Q 031828           13 LDCELNFLSSVNHPNI-----IRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHG------------------   61 (152)
Q Consensus        13 ~~~E~~~l~~l~h~ni-----~~l~~~~~~--------~~~~~lv~e~~~~~~l~~~~~~~~------------------   61 (152)
                      ...|+.++.+++|.++     +++.++|..        ++..|+|+||+++++|.+++....                  
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            3347777777776654     566666642        356899999999999999886321                  


Q ss_pred             ------CCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcccc--CCCCCC
Q 031828           62 ------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL  131 (152)
Q Consensus        62 ------~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~t~~  131 (152)
                            .++...+..++.++  |+.|+|+.+++|+||||.||++   +....++++|||+++.+........  ..+++.
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~  375 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR  375 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence                  12345667778887  8999999999999999999999   4567899999999976544332222  234789


Q ss_pred             ccccccccc
Q 031828          132 YMAPEVLQF  140 (152)
Q Consensus       132 y~aPE~~~~  140 (152)
                      |+|||.+..
T Consensus       376 Y~aPE~l~~  384 (507)
T PLN03224        376 YSPPEELVM  384 (507)
T ss_pred             eeChhhhcC
Confidence            999999864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.84  E-value=1.3e-20  Score=133.77  Aligned_cols=137  Identities=27%  Similarity=0.435  Sum_probs=111.4

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      -+++..|+++|..+ .+.||+++.+++..++...+|+||+++....++..   .++...+..++..+  |+.++|.+||+
T Consensus        78 p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIv  154 (418)
T KOG1167|consen   78 PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIV  154 (418)
T ss_pred             chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCcc
Confidence            35688999999999 58999999999999999999999999888888765   46677788888876  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccC-----------------C-----------------CCcc---------
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY-----------------P-----------------GNYA---------  123 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-----------------~-----------------~~~~---------  123 (152)
                      |||+||.|++..  ...++-.|+|||++....                 +                 .+..         
T Consensus       155 HRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~  232 (418)
T KOG1167|consen  155 HRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPS  232 (418)
T ss_pred             ccCCCccccccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccc
Confidence            999999999995  345567899999997211                 0                 0000         


Q ss_pred             --ccCCCCCCcccccccccCC-CCcccceee
Q 031828          124 --EKVCGSPLYMAPEVLQFQR-YDEKVNFFV  151 (152)
Q Consensus       124 --~~~~~t~~y~aPE~~~~~~-~~~~~Dvws  151 (152)
                        ....||++|.|||++...+ .++++||||
T Consensus       233 ~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  233 ERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             eecccCCCCCCCchHHHhhccCcCCccceee
Confidence              0134899999999998654 789999998

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.84  E-value=1.7e-20  Score=133.03  Aligned_cols=146  Identities=25%  Similarity=0.406  Sum_probs=121.4

Q ss_pred             hhhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeC-CeEEEEEeecCCCChHHHHHhc--------CCCCHHHHHHHHHH
Q 031828            4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQ   74 (152)
Q Consensus         4 ~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~   74 (152)
                      .+|.-+-..+..|.-.+..+.|||+..+.+++..+ ...+.++.+..-|+|..|+...        ..+...+...++.|
T Consensus       325 ~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQ  404 (563)
T KOG1024|consen  325 HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQ  404 (563)
T ss_pred             cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHH
Confidence            34556677888899999999999999999988665 5678889999889999999722        23666777788888


Q ss_pred             H--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCcccce
Q 031828           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNF  149 (152)
Q Consensus        75 i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dv  149 (152)
                      +  |+.+||.++++|.||..+|+++   +..-++|++|-.++|.+-+.++.   +.......|||||.+.+..|+.++|+
T Consensus       405 la~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDv  481 (563)
T KOG1024|consen  405 LAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDV  481 (563)
T ss_pred             HHHHHHHHHhcCcccchhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhh
Confidence            8  8999999999999999999999   56679999999999987666543   33344667999999999999999999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      |||
T Consensus       482 Wsf  484 (563)
T KOG1024|consen  482 WSF  484 (563)
T ss_pred             HHH
Confidence            997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.6e-20  Score=127.59  Aligned_cols=139  Identities=27%  Similarity=0.440  Sum_probs=106.8

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceee-eeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~-~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+|.+|...=-.+ .|.||+.-|+ .|++.+.+.+++||++.|+|..-+... .+.+.....++.|+  |+.|+|+.++
T Consensus        64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknl  142 (378)
T KOG1345|consen   64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNL  142 (378)
T ss_pred             HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccch
Confidence            56777887754444 5889986654 578888899999999999998776543 46788888899998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC---C--CCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ---R--YDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~--~~~~~Dvws~  152 (152)
                      +|||||.+|||+.+ ....++|++|||..+....-  ......+..|.+||.....   .  ..+.+|+|.|
T Consensus       143 VHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wqf  211 (378)
T KOG1345|consen  143 VHRDLKAENILIFD-ADFYRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQF  211 (378)
T ss_pred             hhcccccceEEEec-CCccEEEeeecccccccCce--ehhhhhhcccCCcHHHhhccccceEecccccchhe
Confidence            99999999999975 34559999999998754322  1122335568899987542   2  4678999986

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=2.7e-19  Score=120.30  Aligned_cols=105  Identities=22%  Similarity=0.336  Sum_probs=81.0

Q ss_pred             HHHHHHHHHHHHHcC-----CCcCccceeeeeeeCC---eE-EEEEee--cCCCChHHHHHhcCCCCHHHHHHHHHH-H-
Q 031828            9 LKSCLDCELNFLSSV-----NHPNIIRLFDAFQAEN---CI-FLVVEF--CAGGNLSSYIRLHGRVPEQTARKFLQQ-L-   75 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-----~h~ni~~l~~~~~~~~---~~-~lv~e~--~~~~~l~~~~~~~~~~~~~~~~~~~~~-i-   75 (152)
                      ..+.+.+|+.+++.+     .||||++++++++++.   .+ .+|+||  +.+++|.+++++. .+++. . .++.+ + 
T Consensus        39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~-~-~~~~~~L~  115 (210)
T PRK10345         39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED-V-AQLRQLLK  115 (210)
T ss_pred             hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh-H-HHHHHHHH
Confidence            457799999999999     5799999999999873   43 478999  4479999999764 45555 2 33444 4 


Q ss_pred             HH-HHHHhCCCeecCCCCCceEeecCC-CCceEEEeeccCccc
Q 031828           76 GL-EILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLSCT  116 (152)
Q Consensus        76 ~l-~~lh~~~~~h~dl~~~nil~~~~~-~~~~~kl~dfg~~~~  116 (152)
                      ++ .|||+++|+|+||||+||++...+ ...+++|+|++.++.
T Consensus       116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~  158 (210)
T PRK10345        116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST  158 (210)
T ss_pred             HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence            66 899999999999999999996433 344899999544443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.81  E-value=5.1e-19  Score=124.63  Aligned_cols=141  Identities=40%  Similarity=0.620  Sum_probs=120.1

Q ss_pred             HHHHHHHHHHHHHcCCCc-CccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHH--HHHHHHh
Q 031828            9 LKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~-ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+|+++++.+.|+ +++++.+.+...+..+++++++.++++.++.....   .+.......+..++  ++.++|.
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~  119 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS  119 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            467789999999999988 79999999987777899999999999998877665   68888999999998  7899999


Q ss_pred             CCCeecCCCCCceEeecCCCCc-eEEEeeccCccccCCCC-------ccccCCCCCCccccccccc---CCCCcccceee
Q 031828           83 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQF---QRYDEKVNFFV  151 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~-~~kl~dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws  151 (152)
                      .+++|+|+||+|+++.   ... .++++|||.++......       ......++..|+|||.+.+   ..++...|+||
T Consensus       120 ~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s  196 (384)
T COG0515         120 KGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS  196 (384)
T ss_pred             CCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence            9999999999999993   444 69999999997554432       2356788999999999987   56888999996


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      +
T Consensus       197 ~  197 (384)
T COG0515         197 L  197 (384)
T ss_pred             H
Confidence            4

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=4e-19  Score=127.05  Aligned_cols=140  Identities=24%  Similarity=0.322  Sum_probs=114.7

Q ss_pred             HHHHHHHHHHcCCC----cCccceeeee-eeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHh
Q 031828           12 CLDCELNFLSSVNH----PNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        12 ~~~~E~~~l~~l~h----~ni~~l~~~~-~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      .+..|..++..+..    +++..+++.+ ..++..|+||+.+ |.+|.++.+..  +.++..++..++.|+  ++.++|+
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~  140 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS  140 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence            68889999999973    5888999888 5777899999987 89999988654  458999999999997  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCC--ceEEEeeccCccccC--C-CC-------c-cccCCCCCCcccccccccCCCCcccce
Q 031828           83 HHIIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLY--P-GN-------Y-AEKVCGSPLYMAPEVLQFQRYDEKVNF  149 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~--~~~kl~dfg~~~~~~--~-~~-------~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv  149 (152)
                      .|++||||||.|+.++.....  ..+.+.|||++++..  . .+       . .....||..|+++.+..+...+.+.|+
T Consensus       141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl  220 (322)
T KOG1164|consen  141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL  220 (322)
T ss_pred             cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence            999999999999999643212  579999999998322  1 11       1 123459999999999999999999999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      ||+
T Consensus       221 es~  223 (322)
T KOG1164|consen  221 ESL  223 (322)
T ss_pred             hhH
Confidence            984

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=3.7e-19  Score=128.82  Aligned_cols=96  Identities=31%  Similarity=0.516  Sum_probs=78.4

Q ss_pred             cchhhHh--HHHHHHHHHHHHHcCC-----C---cCccceeeeeeeC----CeEEEEEeecCCCChHHHHHh--cCCCCH
Q 031828            2 LKKLNKH--LKSCLDCELNFLSSVN-----H---PNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRL--HGRVPE   65 (152)
Q Consensus         2 ~k~~~~~--~~~~~~~E~~~l~~l~-----h---~ni~~l~~~~~~~----~~~~lv~e~~~~~~l~~~~~~--~~~~~~   65 (152)
                      +|+..+.  -.+....||.+|++++     |   ..||+|++.|...    .|+|||+|++ |.+|..++..  .+.++.
T Consensus       108 lKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl  186 (590)
T KOG1290|consen  108 LKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPL  186 (590)
T ss_pred             EEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcH
Confidence            4555443  3677889999999984     2   3689999998644    4899999998 8888888864  456999


Q ss_pred             HHHHHHHHHH--HHHHHHh-CCCeecCCCCCceEee
Q 031828           66 QTARKFLQQL--GLEILNS-HHIIHRDLKPENILLS   98 (152)
Q Consensus        66 ~~~~~~~~~i--~l~~lh~-~~~~h~dl~~~nil~~   98 (152)
                      ..+..++.|+  ||.|||. +||||.||||+|||+.
T Consensus       187 ~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  187 SCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            9999999998  9999996 5899999999999873

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=1.2e-18  Score=117.95  Aligned_cols=117  Identities=15%  Similarity=0.202  Sum_probs=88.0

Q ss_pred             HHHHHHHHHcCCCcCccceeeeeeeC--------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           13 LDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        13 ~~~E~~~l~~l~h~ni~~l~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      +++|++.+.+++|++|..+..++...        +..+++|||++|.+|.+..    .+++..    ..++  ++..+|+
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~~----~~~i~~~l~~lH~  153 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISEDV----KAKIKASIESLHQ  153 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccHHH----HHHHHHHHHHHHH
Confidence            68999999999999999998886533        3578999999999998773    233322    3344  7999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .|++|+|++|.|+++.   +.+ ++++|||...........           ..+.....|+.++|+|||
T Consensus       154 ~gi~H~Dikp~Nili~---~~g-i~liDfg~~~~~~e~~a~-----------d~~vler~y~~~~di~~l  208 (232)
T PRK10359        154 HGMVSGDPHKGNFIVS---KNG-LRIIDLSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDL  208 (232)
T ss_pred             cCCccCCCChHHEEEe---CCC-EEEEECCCcccccchhhH-----------HHHHHHhHhcccccccce
Confidence            9999999999999994   344 999999987654222111           113444567789999996

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.76  E-value=7.7e-18  Score=111.98  Aligned_cols=99  Identities=23%  Similarity=0.245  Sum_probs=78.1

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH-HhCCCeec
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL-NSHHIIHR   88 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l-h~~~~~h~   88 (152)
                      ....|++++..+.++++........ . ..++||||++++++.....+...++...+..++.++  ++.++ |+.|++|+
T Consensus        65 ~~~~E~~~l~~l~~~~v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr  142 (190)
T cd05147          65 WAEKEMRNLKRLVTAGIPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHA  142 (190)
T ss_pred             HHHHHHHHHHHHHHCCCCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            3456999999998887755443322 2 238999999887776554445678888899999887  89998 79999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccc
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      |+||.||++.    .+.++++|||++..
T Consensus       143 DlkP~NIli~----~~~v~LiDFG~a~~  166 (190)
T cd05147         143 DLSEYNLLYH----DGKLYIIDVSQSVE  166 (190)
T ss_pred             CCCHHHEEEE----CCcEEEEEcccccc
Confidence            9999999994    35799999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=6.8e-19  Score=134.07  Aligned_cols=136  Identities=35%  Similarity=0.565  Sum_probs=111.9

Q ss_pred             HHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCC
Q 031828           13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (152)
Q Consensus        13 ~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl   90 (152)
                      +..|..+-..+.|+|++.............-.||||++ +|..++...+.+....+-.++.|+  |+.|+|+.|+.|||+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            55677777788999998776666555444445999998 999999887778888888999998  999999999999999


Q ss_pred             CCCceEeecCCCCceEEEeeccCccccCCC-----CccccCCCCCCcccccccccCCCCc-ccceeeC
Q 031828           91 KPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQRYDE-KVNFFVS  152 (152)
Q Consensus        91 ~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~-~~Dvws~  152 (152)
                      |++|+++   ...+.+|++|||.+......     ......+|+..|+|||++....|++ ..||||.
T Consensus       447 K~enll~---~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~  511 (601)
T KOG0590|consen  447 KLENLLV---TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSC  511 (601)
T ss_pred             ccccEEE---ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhc
Confidence            9999999   46669999999998653322     2346678999999999999999985 6999983

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.74  E-value=3.2e-17  Score=109.10  Aligned_cols=103  Identities=19%  Similarity=0.172  Sum_probs=80.5

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh-CCCee
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~-~~~~h   87 (152)
                      ..+..|.+.+.++.++++.....+....  .++||||++++++.........++......++.++  ++.++|. .|++|
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givH  141 (190)
T cd05145          64 AWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVH  141 (190)
T ss_pred             HHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            4457899999999999886555444332  48999999877554433334567778888888888  8999999 99999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~  119 (152)
                      +|+||.||++.    .+.++++|||+++....
T Consensus       142 rDlkP~NIll~----~~~~~liDFG~a~~~~~  169 (190)
T cd05145         142 GDLSEYNILYH----DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCChhhEEEE----CCCEEEEEcccceecCC
Confidence            99999999994    56799999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.74  E-value=4.9e-18  Score=111.37  Aligned_cols=87  Identities=30%  Similarity=0.366  Sum_probs=73.5

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCC
Q 031828           51 GNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC  127 (152)
Q Consensus        51 ~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~  127 (152)
                      |+|.+++... ..+++..++.++.++  |+.|||+++      ||+||++   +.++.+++  ||.++.....    ...
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~----~~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE----QSR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc----cCC
Confidence            6888998764 459999999999998  899999998      9999998   56667887  9998764332    236


Q ss_pred             CCCCcccccccccCCCCcccceeeC
Q 031828          128 GSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       128 ~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+.|+|||++.+..++.++|||||
T Consensus        66 g~~~y~aPE~~~~~~~~~~~DiwSl   90 (176)
T smart00750       66 VDPYFMAPEVIQGQSYTEKADIYSL   90 (176)
T ss_pred             CcccccChHHhcCCCCcchhhHHHH
Confidence            7899999999999999999999996

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=3.2e-17  Score=109.36  Aligned_cols=95  Identities=22%  Similarity=0.223  Sum_probs=74.4

Q ss_pred             HHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ..+.+|+++|+++. ++++++++++    +..+++|+|+.|.+|.+....    .   ...++.++  ++.++|++|++|
T Consensus        46 ~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----~---~~~~~~qi~~~L~~lH~~GIvH  114 (218)
T PRK12274         46 WLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----G---DLAYFRAARRLLQQLHRCGVAH  114 (218)
T ss_pred             HHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----h---hHHHHHHHHHHHHHHHHCcCcc
Confidence            36889999999995 5789999886    346999999999888754321    1   12344555  899999999999


Q ss_pred             cCC-CCCceEeecCCCCceEEEeeccCccccCC
Q 031828           88 RDL-KPENILLSGLDDDVMLKIADFGLSCTLYP  119 (152)
Q Consensus        88 ~dl-~~~nil~~~~~~~~~~kl~dfg~~~~~~~  119 (152)
                      +|| ||.||++   +..+.++++|||++.....
T Consensus       115 rDL~kp~NILv---~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274        115 NDLAKEANWLV---QEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             CCCCCcceEEE---cCCCCEEEEECCCceecCC
Confidence            999 7999999   4566799999999975443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.1e-18  Score=129.55  Aligned_cols=133  Identities=29%  Similarity=0.434  Sum_probs=116.1

Q ss_pred             HHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        12 ~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      ....|-+++..++ ||.++++...++.++..++++++..++++...+.+...+.+.....+...+  +++++|+.+++++
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyr  121 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYR  121 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence            4456788888887 999999999999999999999999999999999888888887777777765  8999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|++||++   +..+.+++.|||.++........   |||..|||||+.+  +...++|+|||
T Consensus       122 d~k~enill---d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~  177 (612)
T KOG0603|consen  122 DYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSF  177 (612)
T ss_pred             cccccceee---cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhh
Confidence            999999999   67888999999999865443322   9999999999998  67889999996

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.68  E-value=1.8e-16  Score=106.51  Aligned_cols=141  Identities=18%  Similarity=0.205  Sum_probs=112.3

Q ss_pred             HHHHHHHHHHHHcCCC-cCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..++.-|..+.+.+++ ..|..+..++....+-.+|||.. |.+|.+++... +.++..+++-++-|+  -++|+|.+++
T Consensus        54 hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~f  132 (341)
T KOG1163|consen   54 HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNF  132 (341)
T ss_pred             CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcc
Confidence            3567789999999975 78888888888888889999988 88998888643 357888888888887  5999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC--------ccccCCCCCCcccccccccCCCCcccceee
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                      +||||||+|+|.+-......+.++|||+|+.+.+..        ......||..|.+-....+...+...|+=|
T Consensus       133 iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeS  206 (341)
T KOG1163|consen  133 IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMES  206 (341)
T ss_pred             ccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhh
Confidence            999999999998755566789999999998865432        123456888998887777666666666644

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=1.1e-15  Score=103.13  Aligned_cols=99  Identities=23%  Similarity=0.314  Sum_probs=83.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ...+.+|+.++..++|+++.....++...+..+++|||++|++|.+.+.....    ....++.++  ++.++|+.+++|
T Consensus        43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H  118 (211)
T PRK14879         43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIH  118 (211)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCccc
Confidence            45688999999999999998888777777788999999999999998865332    556667777  799999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      +|++|.||++.    ...++++|||.++.
T Consensus       119 ~Dl~p~Nil~~----~~~~~liDf~~a~~  143 (211)
T PRK14879        119 GDLTTSNMILS----GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCCCcccEEEE----CCCEEEEECCcccC
Confidence            99999999994    56789999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=1.3e-15  Score=115.65  Aligned_cols=96  Identities=20%  Similarity=0.262  Sum_probs=81.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+++.+|+++++.++|++++....++..+...+++|||+++++|.+++.        ....++.++  ++.++|+.+++|
T Consensus       380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH  451 (535)
T PRK09605        380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH  451 (535)
T ss_pred             HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence            4678899999999999999988777777777899999999999998875        234566666  799999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCcccc
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~  117 (152)
                      +|+||.||++    ....++++|||+++..
T Consensus       452 rDlkp~NILl----~~~~~~liDFGla~~~  477 (535)
T PRK09605        452 GDLTTSNFIV----RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCChHHEEE----ECCcEEEEeCcccccC
Confidence            9999999999    2457899999999764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.65  E-value=1e-15  Score=106.97  Aligned_cols=142  Identities=20%  Similarity=0.290  Sum_probs=116.0

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      +..+++.|-...+.| ..++|...+-+.....+-.+|+|++ |.+|.+++.-.+ .|+..++..++.|+  -++++|++.
T Consensus        66 ~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~  144 (449)
T KOG1165|consen   66 EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD  144 (449)
T ss_pred             CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc
Confidence            346788899988888 4689999988877777889999988 899999887544 48999998888887  599999999


Q ss_pred             CeecCCCCCceEeecCCC--CceEEEeeccCccccCCCC--------ccccCCCCCCcccccccccCCCCcccceee
Q 031828           85 IIHRDLKPENILLSGLDD--DVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~--~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                      +|.|||||+|+|+++...  ...+.++|||+|+.+....        ......||..||+-....+...+...|+=|
T Consensus       145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEa  221 (449)
T KOG1165|consen  145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEA  221 (449)
T ss_pred             eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHH
Confidence            999999999999975432  3468899999999876553        124567899999999888888888877644

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=2.8e-15  Score=100.27  Aligned_cols=97  Identities=23%  Similarity=0.276  Sum_probs=78.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ..++.+|++++..++|+++.....++..++..+++|||++|++|.+.+.....       .++.++  ++.++|+.+++|
T Consensus        41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H  113 (199)
T TIGR03724        41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVH  113 (199)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeec
Confidence            36678899999999988776666566666678999999999999988754321       455666  799999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCcccc
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~  117 (152)
                      +|++|.||++.    ...++++|||+++..
T Consensus       114 ~Dl~~~Nil~~----~~~~~liDfg~a~~~  139 (199)
T TIGR03724       114 GDLTTSNIIVR----DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCCCcceEEEE----CCcEEEEECCCCcCC
Confidence            99999999994    567999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=1.5e-15  Score=119.39  Aligned_cols=135  Identities=26%  Similarity=0.349  Sum_probs=107.6

Q ss_pred             HHHHcCC---CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCC
Q 031828           18 NFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKP   92 (152)
Q Consensus        18 ~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~   92 (152)
                      +++.+|+   -+.|..+...+...+.-.++++|.+.|+|.+++...+..++..+..+..++  .+..||..+|||+||||
T Consensus       743 q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKP  822 (974)
T KOG1166|consen  743 QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKP  822 (974)
T ss_pred             HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCc
Confidence            4455555   235566666667777788999999999999999877788999999999988  69999999999999999


Q ss_pred             CceEeecC----CCCceEEEeeccCccccC---CCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           93 ENILLSGL----DDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        93 ~nil~~~~----~~~~~~kl~dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+++.+.    .....++|+|||.+-.+.   .+..-...++|-.+-++|+..+..|+.++|.|.|
T Consensus       823 DNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGl  889 (974)
T KOG1166|consen  823 DNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGL  889 (974)
T ss_pred             ceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHH
Confidence            99998642    234579999999985432   2223455677888999999999999999998753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=1.4e-14  Score=99.58  Aligned_cols=102  Identities=19%  Similarity=0.218  Sum_probs=77.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCc--cceeeeeeeC-Ce---EEEEEeecCC-CChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNI--IRLFDAFQAE-NC---IFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni--~~l~~~~~~~-~~---~~lv~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      .+..+.+|++++..++|+++  +..+++...+ +.   .++|+|+++| .+|.+++.. ..+++...    .++  ++.+
T Consensus        83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~~----~~i~~~l~~  157 (239)
T PRK01723         83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQW----QAIGQLIAR  157 (239)
T ss_pred             hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHHH----HHHHHHHHH
Confidence            35678899999999998875  5666664433 22   3599999987 688888754 34555443    344  7999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~  118 (152)
                      +|+.|++|+|+||.||++.   ....++++|||.++...
T Consensus       158 lH~~GI~HrDlkp~NILv~---~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        158 FHDAGVYHADLNAHNILLD---PDGKFWLIDFDRGELRT  193 (239)
T ss_pred             HHHCCCCCCCCCchhEEEc---CCCCEEEEECCCcccCC
Confidence            9999999999999999994   45579999999987643

>smart00090 RIO RIO-like kinase

Probab=99.58  E-value=1.2e-14  Score=99.73  Aligned_cols=100  Identities=21%  Similarity=0.223  Sum_probs=76.0

Q ss_pred             HHHHHHHHHHHcCCCcC--ccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC-C
Q 031828           11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH-I   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~n--i~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~-~   85 (152)
                      ..+..|+++++++.+..  +.++++.   . ..++||||+++.++.................++.++  ++.++|+.+ +
T Consensus        95 ~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~i  170 (237)
T smart00090       95 LWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGEL  170 (237)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence            45678999999997533  3333332   2 358999999888877655444455666667788887  899999999 9


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~  118 (152)
                      +|+|+||.||++.    ...++++|||.+....
T Consensus       171 iH~Dikp~NIli~----~~~i~LiDFg~a~~~~  199 (237)
T smart00090      171 VHGDLSEYNILVH----DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EeCCCChhhEEEE----CCCEEEEEChhhhccC
Confidence            9999999999994    5679999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.56  E-value=5e-16  Score=113.60  Aligned_cols=107  Identities=33%  Similarity=0.586  Sum_probs=88.6

Q ss_pred             eEEEEEeecCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCc
Q 031828           40 CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS  114 (152)
Q Consensus        40 ~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~  114 (152)
                      ++|+.|++|.-.+|.+++..+..   .+....+.++.++  |+.|   ++.+|+|+||.||++.   .+..+|+.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhhe
Confidence            57899999999999999975443   4556677788888  7888   8999999999999984   4447899999998


Q ss_pred             cccCCCC-------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          115 CTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       115 ~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .......       ..+.-.||++||+||.+.+..|+.++|||||
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaL  448 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYAL  448 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhH
Confidence            7654433       3456789999999999999999999999986

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.54  E-value=1.3e-14  Score=107.32  Aligned_cols=130  Identities=25%  Similarity=0.395  Sum_probs=103.3

Q ss_pred             HHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC-eecCCCCCce
Q 031828           20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI-IHRDLKPENI   95 (152)
Q Consensus        20 l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~-~h~dl~~~ni   95 (152)
                      |+.+.|.|+.++.|.+..++..+.|.+||..|+|.+.+.. ...+.......+..++  |+.|+|...+ .|+.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999986 3346666777777787  9999998876 9999999999


Q ss_pred             EeecCCCCceEEEeeccCccccCCC---CccccCCCCCCcccccccccCC-------CCcccceeeC
Q 031828           96 LLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR-------YDEKVNFFVS  152 (152)
Q Consensus        96 l~~~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Dvws~  152 (152)
                      ++   +....+|+.|||+.......   ..........-|.|||.+....       .+.+.|+|||
T Consensus        81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~  144 (484)
T KOG1023|consen   81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF  144 (484)
T ss_pred             ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence            99   67889999999998654321   1111111234599999998641       3677999996

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=4.7e-14  Score=101.04  Aligned_cols=126  Identities=33%  Similarity=0.442  Sum_probs=88.0

Q ss_pred             CCcCccceeeeeee---------------------------CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH-
Q 031828           24 NHPNIIRLFDAFQA---------------------------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-   75 (152)
Q Consensus        24 ~h~ni~~l~~~~~~---------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i-   75 (152)
                      +|||||++.+.|.+                           +...|+||.-+ ..+|.+++..+.. +.....-++.|+ 
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~-s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHR-SYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCC-chHHHHHHHHHHH
Confidence            59999999887722                           23578999877 5789888865543 444444455665 


Q ss_pred             -HHHHHHhCCCeecCCCCCceEeecC-CCCceEEEeeccCccccCCCC-------ccccCCCCCCcccccccccCC----
Q 031828           76 -GLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQFQR----  142 (152)
Q Consensus        76 -~l~~lh~~~~~h~dl~~~nil~~~~-~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~----  142 (152)
                       |+.+||.+|+.|||+|++|||+.-. +.-....++|||++---...+       -....-|.-..||||+....+    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence             9999999999999999999998632 333467889999984322211       111223455689999997543    


Q ss_pred             --CCcccceee
Q 031828          143 --YDEKVNFFV  151 (152)
Q Consensus       143 --~~~~~Dvws  151 (152)
                        -..++|.|+
T Consensus       432 vvny~kAD~WA  442 (598)
T KOG4158|consen  432 VVNYEKADTWA  442 (598)
T ss_pred             eeccchhhhhh
Confidence              135789997

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.52  E-value=5.9e-15  Score=101.08  Aligned_cols=138  Identities=21%  Similarity=0.330  Sum_probs=103.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      +...+|..|.--++-+.||||+.+++.|..+....++..|++.|+|+..+.....  ....++..++.++  |+.|||+.
T Consensus       229 risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl  308 (448)
T KOG0195|consen  229 RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL  308 (448)
T ss_pred             hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc
Confidence            4456788888889999999999999999999999999999999999999876544  5567777888888  89999987


Q ss_pred             C--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCC---cccceeeC
Q 031828           84 H--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD---EKVNFFVS  152 (152)
Q Consensus        84 ~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~---~~~Dvws~  152 (152)
                      .  +.--.+.+..+++.. +-..++..+|--++.      +......+|.||+||.++..+-+   .++|+|||
T Consensus       309 ep~ipr~~lns~hvmide-dltarismad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsf  375 (448)
T KOG0195|consen  309 EPMIPRFYLNSKHVMIDE-DLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSF  375 (448)
T ss_pred             chhhhhhhcccceEEecc-hhhhheecccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHH
Confidence            5  444457788888732 122234444433332      12334567899999999876633   57999997

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.47  E-value=3.4e-13  Score=90.28  Aligned_cols=96  Identities=25%  Similarity=0.284  Sum_probs=71.8

Q ss_pred             HHHHHHHHHHHcCCCcC--ccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~n--i~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .....|..++..+.+++  +...++    ....+++|||+++++|......      .....++.++  ++..+|+.+++
T Consensus        78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~  147 (198)
T cd05144          78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGII  147 (198)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCC
Confidence            45778999999998774  334433    2345899999999888765321      2234455555  78999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~  119 (152)
                      |+|++|.||++   +....++++|||.+.....
T Consensus       148 H~Dl~p~Nill---~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         148 HGDLSEFNILV---DDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cCCCCcccEEE---cCCCcEEEEECCccccCCC
Confidence            99999999999   4567899999999965443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.45  E-value=3.1e-13  Score=85.89  Aligned_cols=97  Identities=23%  Similarity=0.355  Sum_probs=77.9

Q ss_pred             HHHHHHHHHHHHcCCC--cCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC--
Q 031828           10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH--   83 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~--   83 (152)
                      ...+..|+.+++.+++  .++++++.++..++..++++|++++..+..+       +......+..++  ++..+|..  
T Consensus        35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~  107 (155)
T cd05120          35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL  107 (155)
T ss_pred             hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence            4678999999999976  5888999888888889999999988776543       334444455555  68889985  


Q ss_pred             -CCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           84 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        84 -~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                       +++|+|++|.|+++.   +...++++|||.++.
T Consensus       108 ~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~  138 (155)
T cd05120         108 LVLCHGDLHPGNILVD---DGKILGIIDWEYAGY  138 (155)
T ss_pred             eEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence             699999999999994   457899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.5e-12  Score=83.75  Aligned_cols=96  Identities=22%  Similarity=0.282  Sum_probs=77.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHH--HHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~--l~~lh~~~~~h   87 (152)
                      +.+-.+|+.++.+++-..|....-+..+++...++|||.+|..|.+.+...       ...++..+|  +.-||..|++|
T Consensus        43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givH  115 (204)
T COG3642          43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVH  115 (204)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeec
Confidence            567789999999998777777666666777788999999999998888654       134555564  77899999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      +|+.++|++++    ..++.++|||++..
T Consensus       116 GDLTtsNiIl~----~~~i~~IDfGLg~~  140 (204)
T COG3642         116 GDLTTSNIILS----GGRIYFIDFGLGEF  140 (204)
T ss_pred             CCCccceEEEe----CCcEEEEECCcccc
Confidence            99999999984    33489999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.40  E-value=8.4e-14  Score=109.14  Aligned_cols=93  Identities=38%  Similarity=0.665  Sum_probs=71.6

Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC---C------
Q 031828           51 GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---N------  121 (152)
Q Consensus        51 ~~l~~~~~~~~~~~~~~~~~~~~~i~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---~------  121 (152)
                      ||-...++.-+.++...      -++++|+|.-+++|+|+||.|.++   ..-+.+|+.|||+++.....   .      
T Consensus       136 gDc~tllk~~g~lPvdm------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~eg~I  206 (1205)
T KOG0606|consen  136 GDCATLLKNIGPLPVDM------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLKEGHI  206 (1205)
T ss_pred             chhhhhcccCCCCcchh------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhhhcch
Confidence            44444455545555443      137999999999999999999999   46778999999999753211   0      


Q ss_pred             -------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          122 -------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       122 -------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                             ....+||||.|.|||++..++|+..+||||+
T Consensus       207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwam  244 (1205)
T KOG0606|consen  207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAM  244 (1205)
T ss_pred             HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHH
Confidence                   1245799999999999999999999999985

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=6e-14  Score=107.29  Aligned_cols=139  Identities=32%  Similarity=0.530  Sum_probs=113.3

Q ss_pred             HHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHH-HhcC-CCCHHHHHHHHHHH--HHHHHH-hCC
Q 031828           11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHG-RVPEQTARKFLQQL--GLEILN-SHH   84 (152)
Q Consensus        11 ~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~-~~~~~~~~~~~~~i--~l~~lh-~~~   84 (152)
                      .....|..+-+.+. |+|++++++.....+..++..++..++++.... .... ..+......++.++  ++.|+| ..+
T Consensus        65 ~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~  144 (601)
T KOG0590|consen   65 EHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG  144 (601)
T ss_pred             hhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc
Confidence            44455777777776 999999999999999999999999999998887 4443 46667778888888  899999 999


Q ss_pred             CeecCCCCCceEeecCCCCc-eEEEeeccCccccCC-CC---ccccCCC-CCCcccccccccCC-CCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYP-GN---YAEKVCG-SPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~-~~kl~dfg~~~~~~~-~~---~~~~~~~-t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +.|+|++|+|.++   ...+ ..+..|||+|..+.. .+   .....+| ++.|+|||...+.. ..+..|+||.
T Consensus       145 ~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~  216 (601)
T KOG0590|consen  145 VTHRDIKPSNSLL---DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSL  216 (601)
T ss_pred             cccCCCCCccchh---ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccc
Confidence            9999999999998   4455 899999999987655 32   2345678 99999999999854 4578999984

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.33  E-value=1.5e-11  Score=80.10  Aligned_cols=107  Identities=21%  Similarity=0.270  Sum_probs=82.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCC-CChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHhCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      +.+..+|++++.+++--.|....-++.+....+++|||.+| .++.+++.....  ........++..+  .+.-||.++
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd  133 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND  133 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC
Confidence            56778999999999877777777777777778899999965 478888764332  2222224666667  388899999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      ++|+||.++||++.+.+....+.++|||++..
T Consensus       134 iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  134 IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99999999999997655566778999999853

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.31  E-value=2e-11  Score=81.23  Aligned_cols=99  Identities=15%  Similarity=0.218  Sum_probs=69.4

Q ss_pred             HHHHHHHHHHHHcCCC--cCccceeeeeeeCCeEEEEEeecCCCChHH-HHHhcCCCCHHHHHHHHHHH--HHHHH-HhC
Q 031828           10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQL--GLEIL-NSH   83 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~~~~~~~~~~~~~i--~l~~l-h~~   83 (152)
                      +...++|...|+++..  -+++.++.+    ...+++|||+.+..+.. .++ ...++......+..++  ++..+ |..
T Consensus        70 ~~wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~  144 (197)
T cd05146          70 RMWAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKEC  144 (197)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3455589999999964  455566654    45679999996544422 222 2234545555566666  57766 899


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcccc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~  117 (152)
                      |++|+|+++.||++.    .+.+.++|||.+...
T Consensus       145 glVHGDLs~~NIL~~----~~~v~iIDF~qav~~  174 (197)
T cd05146         145 NLVHADLSEYNMLWH----DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CeecCCCCHHHEEEE----CCcEEEEECCCceeC
Confidence            999999999999994    356899999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.29  E-value=4e-13  Score=105.94  Aligned_cols=133  Identities=20%  Similarity=0.263  Sum_probs=99.7

Q ss_pred             HHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCC
Q 031828           15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKP   92 (152)
Q Consensus        15 ~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~   92 (152)
                      .|++ +.-.++||++.+--+-..+...|+|=+|. ..+|.+.+.-+.-+...+.+-++.|+  |+.-+|..|+.|+|||.
T Consensus        71 ~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKs  148 (1431)
T KOG1240|consen   71 EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKS  148 (1431)
T ss_pred             HHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCcccccccc
Confidence            4555 66679999999988888888889999988 68999999876666777777777887  99999999999999999


Q ss_pred             CceEeecCCCCceEEEeeccCcccc-CCCC-c------cccCCCCCCcccccccccCC-----------CCcccceeeC
Q 031828           93 ENILLSGLDDDVMLKIADFGLSCTL-YPGN-Y------AEKVCGSPLYMAPEVLQFQR-----------YDEKVNFFVS  152 (152)
Q Consensus        93 ~nil~~~~~~~~~~kl~dfg~~~~~-~~~~-~------~~~~~~t~~y~aPE~~~~~~-----------~~~~~Dvws~  152 (152)
                      +|||++   .=+.+.|.||.-.+.. .+.+ .      -++-....+|.|||-+-...           .+++.||+|+
T Consensus       149 ENILiT---SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~  224 (1431)
T KOG1240|consen  149 ENILIT---SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSA  224 (1431)
T ss_pred             ceEEEe---eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhh
Confidence            999995   3447889999766542 2211 1      12222345699999986522           4567788774

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.22  E-value=1e-10  Score=86.97  Aligned_cols=105  Identities=22%  Similarity=0.214  Sum_probs=69.0

Q ss_pred             HHHHHHHHHHcCC-----CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHhCCC
Q 031828           12 CLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGLEILNSHHI   85 (152)
Q Consensus        12 ~~~~E~~~l~~l~-----h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~l~~lh~~~~   85 (152)
                      ++.+|++.+.+++     ++++.-..-+....+..+++|||++|.++.+..... .......+........+..+|..|+
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCc
Confidence            4666777666653     343332222222334578999999999998876532 1222222222122224677899999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP  119 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~  119 (152)
                      +|+|++|.||++   ..+++++++|||++..+..
T Consensus       279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence            999999999999   4567899999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.20  E-value=1.3e-10  Score=76.96  Aligned_cols=95  Identities=22%  Similarity=0.318  Sum_probs=63.1

Q ss_pred             HHHHHHHHcCCCcC--ccceeeeeeeCCeEEEEEeecCCCChHH-HHHhcCCCCHHHHHHHHHHH--HHHHHHh-CCCee
Q 031828           14 DCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQL--GLEILNS-HHIIH   87 (152)
Q Consensus        14 ~~E~~~l~~l~h~n--i~~l~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~~~~~~~~~~~~~i--~l~~lh~-~~~~h   87 (152)
                      ..|.+.+..+.+..  +.++++.    ...+++|||++++.+.. .+... ... .....++.++  ++.++|. .+++|
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH  138 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVH  138 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCc
Confidence            35666666664433  3344432    23589999998843321 11111 111 4455666666  7999999 99999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~  118 (152)
                      +|++|.||++.    ...++++|||.+....
T Consensus       139 ~Dl~p~Nili~----~~~~~liDfg~a~~~~  165 (187)
T cd05119         139 GDLSEYNILVD----DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCCChhhEEEE----CCcEEEEECccccccc
Confidence            99999999994    6689999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=2.4e-09  Score=74.78  Aligned_cols=105  Identities=16%  Similarity=0.142  Sum_probs=76.4

Q ss_pred             HHHHHHHHHHcCCCcCccc--eeeeeee-----CCeEEEEEeecCCC-ChHHHHHh--cCCCCHHHHHHHHHHH--HHHH
Q 031828           12 CLDCELNFLSSVNHPNIIR--LFDAFQA-----ENCIFLVVEFCAGG-NLSSYIRL--HGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~--l~~~~~~-----~~~~~lv~e~~~~~-~l~~~~~~--~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      .+.+|...+..+...+|..  +.++.+.     ...-++|+|++++. +|.+++..  ....+......++.++  .+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            4778999888886555543  3445543     23468999999875 78888754  2334555666777777  4888


Q ss_pred             HHhCCCeecCCCCCceEeec----CCCCceEEEeeccCccc
Q 031828           80 LNSHHIIHRDLKPENILLSG----LDDDVMLKIADFGLSCT  116 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~----~~~~~~~kl~dfg~~~~  116 (152)
                      ||+.|++|+|+++.||++..    ......+.++||+.++.
T Consensus       154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99999999999999999963    12356899999998853

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.08  E-value=7.9e-10  Score=83.86  Aligned_cols=100  Identities=20%  Similarity=0.363  Sum_probs=80.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH-hCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN-SHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh-~~~~~   86 (152)
                      .+...+-++-|+.++||||+++++.++.++..|+|.|-+  ..|...+++.+   ...+..-+.||  ||.||| +++++
T Consensus        53 ~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lv  127 (690)
T KOG1243|consen   53 TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLV  127 (690)
T ss_pred             hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCee
Confidence            455677788999999999999999999999999999987  46666666544   33333344555  899997 66799


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCcccc
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~  117 (152)
                      |+++....+++   ...+..||++|.++...
T Consensus       128 HgNv~~~SVfV---n~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  128 HGNVCKDSVFV---NESGEWKLGGLELVSKA  155 (690)
T ss_pred             eccEeeeeEEE---cCCCcEEEeeeEEEecc
Confidence            99999999999   67889999999887543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.08  E-value=2.6e-10  Score=74.26  Aligned_cols=92  Identities=24%  Similarity=0.237  Sum_probs=65.0

Q ss_pred             HHHHHHHHHHHcCCCcCcc-ceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC--
Q 031828           11 SCLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI--   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~-~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~--   85 (152)
                      ..+..|+.+++.+.+.+++ +++....  +..++|||+++|.++...    ....    .....++  ++..||..++  
T Consensus        37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~----~~~~----~~~~~~l~~~l~~LH~~~~~~  106 (170)
T cd05151          37 INRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE----DFSD----PENLEKIAKLLKKLHSSPLPD  106 (170)
T ss_pred             cCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc----cccC----HHHHHHHHHHHHHHhCCCCCC
Confidence            4567899999998655543 5555443  335799999998877543    0111    1233444  6889999875  


Q ss_pred             ---eecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           86 ---IHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        86 ---~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                         +|+|++|.||++.    ...++++||+.+..
T Consensus       107 ~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~  136 (170)
T cd05151         107 LVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM  136 (170)
T ss_pred             ceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence               9999999999994    34689999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=3e-09  Score=71.68  Aligned_cols=108  Identities=20%  Similarity=0.244  Sum_probs=80.8

Q ss_pred             HHHHHHHHHHHHcCCCcCc--cceeeeeeeCC----eEEEEEeecCCC-ChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828           10 KSCLDCELNFLSSVNHPNI--IRLFDAFQAEN----CIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni--~~l~~~~~~~~----~~~lv~e~~~~~-~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      .....+|...+..+....|  +.++++.+...    ..++|+|.+++. +|.+++......+......++.++  .+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            4567788888888754444  45555555432    358999999774 899998764445666667777777  48889


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCcccc
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~  117 (152)
                      |+.|++|+|+++.|||+...+....+.++||+-++..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999965444568999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.04  E-value=1.9e-10  Score=85.74  Aligned_cols=133  Identities=29%  Similarity=0.488  Sum_probs=103.7

Q ss_pred             HHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHH------HHHHHHhCCCe
Q 031828           15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL------GLEILNSHHII   86 (152)
Q Consensus        15 ~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i------~l~~lh~~~~~   86 (152)
                      +|+...+++ .|+|.++.+..++..+..++-.|.+ +.++..+...... ++...++..+.+.      |+.++|.+.++
T Consensus       166 ~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~  244 (524)
T KOG0601|consen  166 REFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIV  244 (524)
T ss_pred             chhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCccc
Confidence            456656666 4899999999999999999999998 5787777765444 6777776665543      79999999999


Q ss_pred             ecCCCCCceEeecCCCC-ceEEEeeccCccccCCCCcc------ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDD-VMLKIADFGLSCTLYPGNYA------EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~-~~~kl~dfg~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |.+++|.|++..   .+ ..+++.|||+...+.++...      ....+...|++||+.+ +.++..+|++|+
T Consensus       245 ~~~~kp~~i~~~---~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl  313 (524)
T KOG0601|consen  245 HDDLKPANIFTT---SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSL  313 (524)
T ss_pred             ccccchhheecc---cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcch
Confidence            999999999984   44 68899999999887665422      1124566799999988 467888899885

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.04  E-value=4.8e-11  Score=83.51  Aligned_cols=105  Identities=21%  Similarity=0.247  Sum_probs=64.0

Q ss_pred             EEEEeecCCCChHHHHHh---cCCC----CHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeecc
Q 031828           42 FLVVEFCAGGNLSSYIRL---HGRV----PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG  112 (152)
Q Consensus        42 ~lv~e~~~~~~l~~~~~~---~~~~----~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg  112 (152)
                      +++|+-+ -+||.+++..   ....    ....-..+..|+  .++++|..|++|+||+|+|+++   +.++.+.|.||+
T Consensus       115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F~  190 (288)
T PF14531_consen  115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--GG
T ss_pred             hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcChH
Confidence            5677766 6788887641   1111    122223344554  6899999999999999999999   678899999998


Q ss_pred             CccccCCCCccccCCCCCCcccccccccC--------CCCcccceeeC
Q 031828          113 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--------RYDEKVNFFVS  152 (152)
Q Consensus       113 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~~~~~Dvws~  152 (152)
                      ..........  ....+..|.+||.....        .++.+.|.|+|
T Consensus       191 ~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~L  236 (288)
T PF14531_consen  191 SLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQL  236 (288)
T ss_dssp             GEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHH
T ss_pred             HHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHH
Confidence            7765433221  12334678999987542        36788898874

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.00  E-value=1.3e-09  Score=82.60  Aligned_cols=79  Identities=20%  Similarity=0.190  Sum_probs=51.1

Q ss_pred             eEEEEEeecCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHhCCCeecCCCCCceEeecCC-CCceEEEeeccCccc
Q 031828           40 CIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLSCT  116 (152)
Q Consensus        40 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~i~l~~lh~~~~~h~dl~~~nil~~~~~-~~~~~kl~dfg~~~~  116 (152)
                      ..++||||+.|+++.+.-  .+.+ .............-+..+...|++|+|++|.||++...+ ..++++++|||++..
T Consensus       235 ~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        235 ETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             CceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence            456999999999998753  2222 222221111111123345678999999999999995321 123899999999987


Q ss_pred             cCC
Q 031828          117 LYP  119 (152)
Q Consensus       117 ~~~  119 (152)
                      +..
T Consensus       314 l~~  316 (537)
T PRK04750        314 LNK  316 (537)
T ss_pred             CCH
Confidence            654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.99  E-value=9e-10  Score=77.70  Aligned_cols=126  Identities=17%  Similarity=0.332  Sum_probs=91.7

Q ss_pred             HcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHhCC--Cee
Q 031828           21 SSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNSHH--IIH   87 (152)
Q Consensus        21 ~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i--~l~~lh~~~--~~h   87 (152)
                      -.+-|.|+++++.++.+.     ....++.||+..|++.+++++-    ..+.......|+.|+  |+.|||++.  ++|
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih  201 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH  201 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence            344689999999888544     3578899999999999999742    347778888999998  999999997  999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccc--cCCC----C--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCT--LYPG----N--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~--~~~~----~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++..+.+++   ..++-+|+.   .+..  .-+.    .  ......+-++|.|||.=..-..+.++|||+|
T Consensus       202 gnlTc~tifi---q~ngLIkig---~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f  268 (458)
T KOG1266|consen  202 GNLTCDTIFI---QHNGLIKIG---SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF  268 (458)
T ss_pred             CCcchhheee---cCCceEEec---ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence            9999999998   455555543   2211  0000    0  1112234577899998766667788999986

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=1.2e-08  Score=67.67  Aligned_cols=98  Identities=21%  Similarity=0.386  Sum_probs=60.4

Q ss_pred             HHHHHHHHHHHHcCCCc--CccceeeeeeeCCeEEEEEeecC--CCChHHHHHhcCCCCHHHHHHHHHHH--H-HHHHHh
Q 031828           10 KSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCA--GGNLSSYIRLHGRVPEQTARKFLQQL--G-LEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~--ni~~l~~~~~~~~~~~lv~e~~~--~~~l~~~~~~~~~~~~~~~~~~~~~i--~-l~~lh~   82 (152)
                      +...++|.+.|.++...  ++++++.+.  .  ..+||||++  |..+..+....  ++......++.++  . ...+|.
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~--~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~  125 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDYN--R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHK  125 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEEE--T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEEe--C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHh
Confidence            57788999999999876  455665443  2  469999997  55555443322  1112223333333  2 334689


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcccc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~  117 (152)
                      .|++|+|+++.||++.   .. .+.++|||.+...
T Consensus       126 ~givHGDLs~~NIlv~---~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  126 AGIVHGDLSEYNILVD---DG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TTEEESS-STTSEEEE---TT-CEEE--GTTEEET
T ss_pred             cCceecCCChhhEEee---cc-eEEEEecCcceec
Confidence            9999999999999994   22 7999999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.74  E-value=7.4e-09  Score=77.47  Aligned_cols=135  Identities=21%  Similarity=0.248  Sum_probs=96.9

Q ss_pred             HHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCC
Q 031828           14 DCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDL   90 (152)
Q Consensus        14 ~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl   90 (152)
                      ..|+.+...+ -|.++++.+..+......|+-.|||+++++.....-...+.+...+....++  ++.++|...++|.|+
T Consensus       313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~  392 (524)
T KOG0601|consen  313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDV  392 (524)
T ss_pred             hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccc
Confidence            3566666666 4888999888887777888999999998887766444446677777777777  799999999999999


Q ss_pred             CCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcc--cccccccCCCCcccceeeC
Q 031828           91 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM--APEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        91 ~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~--aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|.||++.+.  .+..++.|||+...+...  .......-++.  +|.......+..++|++||
T Consensus       393 ~psni~i~~~--~~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl  452 (524)
T KOG0601|consen  393 KPSNILISND--GFFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSL  452 (524)
T ss_pred             cccceeeccc--hhhhhcccccccccccee--cccccccccccccchhhccccccccccccccc
Confidence            9999998532  267888999987642111  11122223333  5555555667788888876

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.68  E-value=9.8e-08  Score=64.51  Aligned_cols=47  Identities=15%  Similarity=0.176  Sum_probs=35.2

Q ss_pred             HHHHHHHHHHHHcCCCc--CccceeeeeeeC---CeEEEEEeecCCCChHHH
Q 031828           10 KSCLDCELNFLSSVNHP--NIIRLFDAFQAE---NCIFLVVEFCAGGNLSSY   56 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~--ni~~l~~~~~~~---~~~~lv~e~~~~~~l~~~   56 (152)
                      ...+..|.++++.+++.  ++.+++.+....   +..+++||+++|.++.+.
T Consensus        39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~   90 (223)
T cd05154          39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDR   90 (223)
T ss_pred             cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCC
Confidence            46788999999999763  456777776654   357899999988776543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.66  E-value=1.9e-08  Score=76.58  Aligned_cols=134  Identities=23%  Similarity=0.323  Sum_probs=94.9

Q ss_pred             HHHHHHHHHHHcCCCcC-ccceeeeeeeCCeEEEEEeecCCC-ChHHHH-HhcCCCCHHHHHHHHHH-H-HHHHHHhCCC
Q 031828           11 SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGG-NLSSYI-RLHGRVPEQTARKFLQQ-L-GLEILNSHHI   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~n-i~~l~~~~~~~~~~~lv~e~~~~~-~l~~~~-~~~~~~~~~~~~~~~~~-i-~l~~lh~~~~   85 (152)
                      ...+.++++|.+++||| .+..++.++.+...++.++++.++ +...-. .....+.+.+....... . ++.++|+.--
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~  357 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK  357 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence            34567899999999999 778888888888999999999766 221111 01111222222222222 1 6888887766


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+|    ||+.    .+...+..+|+....+.......+..+++.|+|||+...+.+....|.||+
T Consensus       358 ~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~  416 (829)
T KOG0576|consen  358 VHRD----NILG----SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSL  416 (829)
T ss_pred             cCcc----cccc----cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCC
Confidence            7777    7775    445678899998877666555667789999999999999999999999984

>PRK09902 hypothetical protein; Provisional

Probab=98.55  E-value=1.4e-06  Score=58.63  Aligned_cols=107  Identities=14%  Similarity=0.156  Sum_probs=75.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCcc--ceeeeee-e--C--CeEEEEEeecCC-CChHHHHHhcC--CCCHHHHHHHHHHH--H
Q 031828            9 LKSCLDCELNFLSSVNHPNII--RLFDAFQ-A--E--NCIFLVVEFCAG-GNLSSYIRLHG--RVPEQTARKFLQQL--G   76 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~--~l~~~~~-~--~--~~~~lv~e~~~~-~~l~~~~~~~~--~~~~~~~~~~~~~i--~   76 (152)
                      -+..|.+|...+..+...++.  .+. ++. .  +  -.-++|+|-+++ .+|.+++.+..  ..+......+..++  .
T Consensus        62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~  140 (216)
T PRK09902         62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA  140 (216)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence            467889999999998654443  433 222 1  1  135789997744 58888875532  34566666677777  5


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCcccc
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL  117 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~  117 (152)
                      +.-||+.|+.|+|+.+.||++... ....++++||.-++..
T Consensus       141 ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        141 FKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRRR  180 (216)
T ss_pred             HHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccchh
Confidence            889999999999999999999432 2346999999988753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.54  E-value=6.3e-07  Score=67.06  Aligned_cols=97  Identities=18%  Similarity=0.313  Sum_probs=76.1

Q ss_pred             HHHHHHcCCCcCccceeeeeeeC----CeEEEEEeecCC-CChHHHHH---------------hcCCCCHHHHHHHHHHH
Q 031828           16 ELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAG-GNLSSYIR---------------LHGRVPEQTARKFLQQL   75 (152)
Q Consensus        16 E~~~l~~l~h~ni~~l~~~~~~~----~~~~lv~e~~~~-~~l~~~~~---------------~~~~~~~~~~~~~~~~i   75 (152)
                      -++.++++.|.|+|.+.++|...    ..+++|++|.++ ++|.++.=               ++...++..+|.++.|+
T Consensus       323 lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QL  402 (655)
T KOG3741|consen  323 LVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQL  402 (655)
T ss_pred             HHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHH
Confidence            37889999999999999999733    468999999875 56766541               22347789999999998


Q ss_pred             --HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           76 --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        76 --~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                        ||.++|+.|+.-+-+.+.+|++.   ...++++..-|+..
T Consensus       403 taaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  403 TAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHHHHhcCceeecccHhHeEee---CcceEEEeccccee
Confidence              89999999998899999999994   33367776555543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.48  E-value=6.3e-08  Score=77.12  Aligned_cols=131  Identities=30%  Similarity=0.469  Sum_probs=95.0

Q ss_pred             HHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceE
Q 031828           19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENIL   96 (152)
Q Consensus        19 ~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil   96 (152)
                      +.-..++|.++.....+......++++++..++++...+.+-+.........+...+  +.++||...+.|+|++|.+.+
T Consensus       857 ~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l  936 (1205)
T KOG0606|consen  857 ILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL  936 (1205)
T ss_pred             ccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchh
Confidence            333344566666555555566789999999999999998877766655555555554  799999998999999999999


Q ss_pred             eecCCCCceEEEeeccCccccC---------------------CC-----------CccccCCCCCCcccccccccCCCC
Q 031828           97 LSGLDDDVMLKIADFGLSCTLY---------------------PG-----------NYAEKVCGSPLYMAPEVLQFQRYD  144 (152)
Q Consensus        97 ~~~~~~~~~~kl~dfg~~~~~~---------------------~~-----------~~~~~~~~t~~y~aPE~~~~~~~~  144 (152)
                      .   ...+..++.+||......                     ..           .......+|+.|.+||.+.+....
T Consensus       937 ~---~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen  937 I---AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred             h---cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence            7   466667778876332110                     00           012235688999999999999999


Q ss_pred             cccceeeC
Q 031828          145 EKVNFFVS  152 (152)
Q Consensus       145 ~~~Dvws~  152 (152)
                      ..+|+|++
T Consensus      1014 s~ad~~~~ 1021 (1205)
T KOG0606|consen 1014 SAADWWSS 1021 (1205)
T ss_pred             Ccchhhhh
Confidence            99999974

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.36  E-value=9.7e-06  Score=54.94  Aligned_cols=68  Identities=25%  Similarity=0.381  Sum_probs=48.6

Q ss_pred             CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           39 NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        39 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      ...+++|||++|..|.+...    +++.....+..  ++.-+|..|+.|+|..|.|++++    ...++++||+..+.
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----i~e~~~~ki~~--~ikqlH~~G~~HGD~hpgNFlv~----~~~i~iID~~~k~~  183 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----IDEDLAEKIVE--AIKQLHKHGFYHGDPHPGNFLVS----NNGIRIIDTQGKRM  183 (229)
T ss_pred             eEEEEEEEEecCeecccchh----cCHHHHHHHHH--HHHHHHHcCCccCCCCcCcEEEE----CCcEEEEECccccc
Confidence            34678999999988876542    23221111111  57889999999999999999984    34589999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.34  E-value=3.5e-06  Score=58.54  Aligned_cols=98  Identities=19%  Similarity=0.246  Sum_probs=67.8

Q ss_pred             HHHHHHHHHHHHHcCCCc--CccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~--ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~l~~lh~~~~~   86 (152)
                      .+...++|.++|.++.-.  .+.+.+++    +...+|||+..|..|...-- ....+......++..+...|  ..|++
T Consensus       152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-~~en~~~il~~il~~~~~~~--~~GiV  224 (304)
T COG0478         152 SRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-DVENPDEILDKILEEVRKAY--RRGIV  224 (304)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-cccCHHHHHHHHHHHHHHHH--HcCcc
Confidence            356778999999999654  66666643    45789999998866654321 11122233333444444444  79999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      |+|+++=||++   +.++.+.++||-.+..
T Consensus       225 HGDlSefNIlV---~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         225 HGDLSEFNILV---TEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ccCCchheEEE---ecCCCEEEEeCccccc
Confidence            99999999999   5677899999987754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.28  E-value=3e-05  Score=51.99  Aligned_cols=103  Identities=27%  Similarity=0.382  Sum_probs=72.5

Q ss_pred             HHHHHHHHHHHHcCC------CcCccceeeeeeeCCeEEEEEeecCC------CChHHHHHhcCCCCHHHHHHHHHHHHH
Q 031828           10 KSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQLGL   77 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~------h~ni~~l~~~~~~~~~~~lv~e~~~~------~~l~~~~~~~~~~~~~~~~~~~~~i~l   77 (152)
                      ..+..+|+.-...+.      +..|.+++|+.+++-..-+|+|.+.+      .+|.+++++ +.++. .....+.+ -.
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~-f~  131 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDE-FK  131 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHH-HH
Confidence            566777777666655      78899999999999877888887632      457777743 33554 33332222 35


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCc-eEEEee-ccCcc
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDV-MLKIAD-FGLSC  115 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~-~~kl~d-fg~~~  115 (152)
                      .+|-+++|+.+|++|.||++...+... .+.++| ||...
T Consensus       132 ~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  132 RYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             HHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence            678889999999999999998655555 677787 66543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.09  E-value=3.1e-05  Score=58.92  Aligned_cols=105  Identities=20%  Similarity=0.238  Sum_probs=71.6

Q ss_pred             HHHHHHHHHHcCC-----CcCccceeeeeeeCCeEEEEEeecCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHhCC
Q 031828           12 CLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGLEILNSHH   84 (152)
Q Consensus        12 ~~~~E~~~l~~l~-----h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~i~l~~lh~~~   84 (152)
                      ++.+|+.-+.+++     .+++.-..-+++-.+.-.++|||+.|..+.+..  +. ...+...+.....+.-+..+-..|
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHHhcC
Confidence            4556666666653     344443333444445567999999998888884  33 334544544444444455556689


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG  120 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~  120 (152)
                      +.|+|..|-||++   ...+++-+.|||+...+.+.
T Consensus       286 ffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 FFHADPHPGNILV---RSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccccCCCccceEE---ecCCcEEEEcCcceecCCHH
Confidence            9999999999999   56678999999999876553

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.08  E-value=1.4e-06  Score=68.51  Aligned_cols=65  Identities=18%  Similarity=0.292  Sum_probs=44.6

Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+++..|.+.+..  .+....++.|||.++....+.   ......||+.|+|||++.+..++.++|||||
T Consensus       499 ~~~~~~p~~~~~~--~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSl  566 (669)
T cd05610         499 PTQKPRPHGNLYQ--TPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWAL  566 (669)
T ss_pred             CCCCCCCCCceeE--CCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHH
Confidence            3445555533332  334456778898876654332   2345678999999999999889999999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.08  E-value=5.2e-06  Score=63.92  Aligned_cols=74  Identities=20%  Similarity=0.315  Sum_probs=56.9

Q ss_pred             HHHHHHhC-CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-----cccC-----CCCCCcccccccccCCCC
Q 031828           76 GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKV-----CGSPLYMAPEVLQFQRYD  144 (152)
Q Consensus        76 ~l~~lh~~-~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~-----~~t~~y~aPE~~~~~~~~  144 (152)
                      |+.|+|.. +++|+++.|++|.+   ...+..|++.|+++.....+..     .+..     .....|.|||++.+...+
T Consensus       111 gl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~  187 (700)
T KOG2137|consen  111 GLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNT  187 (700)
T ss_pred             hhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccc
Confidence            78999976 69999999999998   6777899999988865443211     1111     123459999999988888


Q ss_pred             cccceeeC
Q 031828          145 EKVNFFVS  152 (152)
Q Consensus       145 ~~~Dvws~  152 (152)
                      .++|++||
T Consensus       188 ~~sd~fSl  195 (700)
T KOG2137|consen  188 PASDVFSL  195 (700)
T ss_pred             ccccceee
Confidence            99999986

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.94  E-value=0.0001  Score=56.20  Aligned_cols=89  Identities=19%  Similarity=0.270  Sum_probs=59.1

Q ss_pred             ccceeeeeeeCCeEEEEEeecCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHhCCCeecCCCCCceEeecC-CCCc
Q 031828           28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGL-DDDV  104 (152)
Q Consensus        28 i~~l~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~i~l~~lh~~~~~h~dl~~~nil~~~~-~~~~  104 (152)
                      |.+++..+.  +.-.++|||++|..+.+.-  ++.+ ++...+.....+.-..-+-..|++|+|-.|-||++.+. ....
T Consensus       266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~  342 (538)
T KOG1235|consen  266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDE  342 (538)
T ss_pred             CCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCc
Confidence            445544442  3467999999997665553  3333 45555544444443444556789999999999999632 2466


Q ss_pred             eEEEeeccCccccCC
Q 031828          105 MLKIADFGLSCTLYP  119 (152)
Q Consensus       105 ~~kl~dfg~~~~~~~  119 (152)
                      .+.+.|||+...+..
T Consensus       343 ~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  343 EIVLLDHGLYAVISH  357 (538)
T ss_pred             cEEEEcccccccccH
Confidence            889999999876543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.86  E-value=0.00012  Score=50.43  Aligned_cols=54  Identities=13%  Similarity=0.043  Sum_probs=37.4

Q ss_pred             chhhHhHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHH
Q 031828            3 KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY   56 (152)
Q Consensus         3 k~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~   56 (152)
                      |.........+.+|+++++.+. +--+.+++++...++..+++|++++|.++...
T Consensus        28 k~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          28 KIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             EecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            3333332446778999988884 34456777777766678999999988776543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.65  E-value=0.0012  Score=45.25  Aligned_cols=43  Identities=19%  Similarity=0.188  Sum_probs=33.2

Q ss_pred             HHHHHHHHHHHHcCCCcC--ccceeeeeeeCCeEEEEEeecCCCC
Q 031828           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGN   52 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~n--i~~l~~~~~~~~~~~lv~e~~~~~~   52 (152)
                      .....+|.++++.+..-.  +.+.+.+....+...++||+++|.+
T Consensus        36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172        36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            456789999999986544  4677777777777889999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.44  E-value=0.0011  Score=44.16  Aligned_cols=96  Identities=25%  Similarity=0.298  Sum_probs=67.6

Q ss_pred             HHHHHHHHcCCC-cCccceeeeeeeCCeEEEEEeecCCCChHHH---HHhcCCCCHHHHHHHHHHH--HHHHHHh---CC
Q 031828           14 DCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFLQQL--GLEILNS---HH   84 (152)
Q Consensus        14 ~~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i--~l~~lh~---~~   84 (152)
                      ..|..+|+.+++ +++++++|+|-    .+++.|+.+.+++...   +.+....++.....++.++  .+..++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888999976 68999999993    2568898876654321   1111234666777777776  4666665   34


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      +.-+|++++|+.+   ..++++|++|...+..
T Consensus        83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEE---eCCCcEEEEechhcch
Confidence            7889999999999   4567899999877643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.31  E-value=0.001  Score=54.76  Aligned_cols=145  Identities=23%  Similarity=0.217  Sum_probs=94.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCe----EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      .+.....-|+..+....|+|++.++.+...+..    ..+..+++...++...+..-+..+....+.+..+.  |+.++|
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence            344555667788889999999999988754422    22445778888888888777778888887777776  999999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEe--eccCccccCCCCccccCCCCCCcccccccccCCCCcc--cceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIA--DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK--VNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~--~Dvws~  152 (152)
                      +....|.-+......-......+.+...  ||+.++.............+..|.|||.......+.+  .|+|.+
T Consensus       304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHH
Confidence            9855444333332221111233344444  7777766555544444455666888888876655544  688753

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.29  E-value=0.0024  Score=44.25  Aligned_cols=99  Identities=18%  Similarity=0.146  Sum_probs=58.4

Q ss_pred             HHHHHHHHHHHcCC--CcCccceeeeeeeCCeEEEEEeecCCC-ChHHHHHhcCCCCHHHHHHHHHHH--HHHHH-HhCC
Q 031828           11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQL--GLEIL-NSHH   84 (152)
Q Consensus        11 ~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l-h~~~   84 (152)
                      .....|..-|+++.  +-.+.+.+.+.    ...++|||++.. .-.-.++..+ +.......+..++  .+.-| +..+
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~-~e~~e~~~~~~~~v~~~~~l~~~a~  187 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP-LELEEAEGLYEDVVEYMRRLYKEAG  187 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC-cCchhHHHHHHHHHHHHHHHHHhcC
Confidence            45556777666663  33444444443    246899998432 2222222222 1222333333433  33433 4489


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~  118 (152)
                      ++|+||+.=|||+   . .+.+.++|+|.|....
T Consensus       188 LVHgDLSEyNiL~---~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 LVHGDLSEYNILV---H-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccccchhhheEE---E-CCeEEEEECccccccC
Confidence            9999999999998   3 6688999999986543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.25  E-value=0.0036  Score=42.35  Aligned_cols=54  Identities=19%  Similarity=0.223  Sum_probs=35.2

Q ss_pred             cchhhHh-HHHHHHHHHHHHHcCCCc--Cccceeeee---eeCCeEEEEEeecCCCChHH
Q 031828            2 LKKLNKH-LKSCLDCELNFLSSVNHP--NIIRLFDAF---QAENCIFLVVEFCAGGNLSS   55 (152)
Q Consensus         2 ~k~~~~~-~~~~~~~E~~~l~~l~h~--ni~~l~~~~---~~~~~~~lv~e~~~~~~l~~   55 (152)
                      +|..... ....+..|..+++.+...  .+.+++...   ......+++|++++|..+..
T Consensus        25 lK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   25 LKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             EEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             EEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            3444333 567788999998888533  355666643   23346799999998887777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.17  E-value=0.0063  Score=49.41  Aligned_cols=43  Identities=14%  Similarity=0.369  Sum_probs=32.7

Q ss_pred             HHHHHHHHHHHHcCC-CcCc--cceeeeeeeC---CeEEEEEeecCCCC
Q 031828           10 KSCLDCELNFLSSVN-HPNI--IRLFDAFQAE---NCIFLVVEFCAGGN   52 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~-h~ni--~~l~~~~~~~---~~~~lv~e~~~~~~   52 (152)
                      ...+.+|.++|+.+. |.++  .+++.++.+.   +..|+|||+++|..
T Consensus        82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            356889999999995 6665  6777777654   46789999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.11  E-value=0.0032  Score=43.24  Aligned_cols=29  Identities=34%  Similarity=0.552  Sum_probs=23.3

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      +++|+|+.+.|+++.   ......++||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~---~~~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQ---DGRLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEE---CCCEEEEEeCcccC
Confidence            489999999999994   33445699999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.01  E-value=0.0041  Score=46.49  Aligned_cols=97  Identities=15%  Similarity=0.158  Sum_probs=64.1

Q ss_pred             EEEEEeecCCC-ChHHHHH------hcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeec
Q 031828           41 IFLVVEFCAGG-NLSSYIR------LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF  111 (152)
Q Consensus        41 ~~lv~e~~~~~-~l~~~~~------~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~df  111 (152)
                      .-+.|..+.+- .+..+.+      ......+...++....+  +..-+|..|..-+|++++|++++   ....+.+.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcc
Confidence            45666666443 2233321      12336667777777777  56679999999999999999994   5667888764


Q ss_pred             cCccccCCCCccccCCCCCCccccccccc
Q 031828          112 GLSCTLYPGNYAEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus       112 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~  140 (152)
                      ..-..-..+....-.+|...|.+||...-
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~  190 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQTL  190 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhcc
Confidence            33222223333445678899999998873

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.58  E-value=0.016  Score=41.04  Aligned_cols=30  Identities=33%  Similarity=0.660  Sum_probs=24.1

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .+++|+|+.|.|+++.   ....+.++||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFD---GDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence            3699999999999994   44456899998874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.90  E-value=0.00042  Score=58.81  Aligned_cols=136  Identities=13%  Similarity=0.062  Sum_probs=88.9

Q ss_pred             HHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHH-H-HHHHHHhC-
Q 031828           13 LDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQ-L-GLEILNSH-   83 (152)
Q Consensus        13 ~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~-i-~l~~lh~~-   83 (152)
                      ...|..-.++..|+++.....-....  ..-|..++++.+|++.+.+-+.-    .+.+..+.....+ + +..-+|.. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            33444455566788877665444322  34688899999999999885432    1222222222222 1 33334433 


Q ss_pred             ----CCeecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceee
Q 031828           84 ----HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        84 ----~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                          --+|.++++.|.++   ..+.++++.++|+.+...+ ........+++.|++|++.+...++.++|+|.
T Consensus      1356 nlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred             cCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence                26899999999988   5777899999999872222 22344566788899999999888898899986

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.61  E-value=0.041  Score=40.16  Aligned_cols=93  Identities=23%  Similarity=0.301  Sum_probs=59.4

Q ss_pred             HHHHHHHHHHHcCCCc--CccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHH-HHHHHhCCCee
Q 031828           11 SCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG-LEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~--ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~-l~~lh~~~~~h   87 (152)
                      -...+|...|+.+.-.  -+.+.+    +.+..++|||++.|..|.+.-.-   ....++..-+  ++ +--|-.+|+||
T Consensus       155 laa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d~~~ly~~l--m~~Iv~la~~GlIH  225 (465)
T KOG2268|consen  155 LAATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV---EDPPTLYDDL--MGLIVRLANHGLIH  225 (465)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeec---CChHHHHHHH--HHHHHHHHHcCcee
Confidence            3455788888888532  233333    23467899999988887654211   1112221111  12 33466899999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      +|..-=||++   .....+.++||-...
T Consensus       226 gDFNEFNimv---~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  226 GDFNEFNIMV---KDDDKIVVIDFPQMV  250 (465)
T ss_pred             cccchheeEE---ecCCCEEEeechHhh
Confidence            9999999999   456679999997653

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.55  E-value=0.085  Score=39.09  Aligned_cols=70  Identities=21%  Similarity=0.263  Sum_probs=46.5

Q ss_pred             CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHH-HHHHHHHhC--CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           39 NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-LGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        39 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~-i~l~~lh~~--~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .+.|++|++. |+++.-.-    .-...++..+++. +++.+.-+.  .+-|+++.-.||++   + .+++.++||.++|
T Consensus       299 ~y~yl~~kdh-gt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Cceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeeee
Confidence            4567888876 56654321    1233444444444 355544444  47899999999999   4 7899999999998


Q ss_pred             cc
Q 031828          116 TL  117 (152)
Q Consensus       116 ~~  117 (152)
                      .-
T Consensus       370 l~  371 (488)
T COG5072         370 LS  371 (488)
T ss_pred             cc
Confidence            43

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.40  E-value=0.12  Score=38.42  Aligned_cols=99  Identities=23%  Similarity=0.268  Sum_probs=62.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCCh-HHHHHhcCCCCHHHHHHHHHHH--HHH-HHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL-SSYIRLHGRVPEQTARKFLQQL--GLE-ILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~~i--~l~-~lh~~~~   85 (152)
                      +-....|++-|++++...|.-..-....  ...+||+|+..... ...| +.-.++...+..+..++  -+. ..+.+++
T Consensus       210 k~WAEKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~L  286 (520)
T KOG2270|consen  210 KTWAEKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRL  286 (520)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhce
Confidence            3455677888888776665544433332  25689999943221 1222 22235555555555444  122 3467899


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      +|.||+-=|+|+    ..+.+.++|-+.+.
T Consensus       287 VHADLSEfN~Ly----hdG~lyiIDVSQSV  312 (520)
T KOG2270|consen  287 VHADLSEFNLLY----HDGKLYIIDVSQSV  312 (520)
T ss_pred             eccchhhhhheE----ECCEEEEEEccccc
Confidence            999999999998    56788999988774

>PHA03111 Ser/Thr kinase; Provisional

Probab=95.09  E-value=0.064  Score=39.16  Aligned_cols=51  Identities=27%  Similarity=0.458  Sum_probs=34.0

Q ss_pred             HHHHHHHHHHHHHHHHh------CCCeecCCCCCceEeecCCCC---------------ceEEEeeccCccc
Q 031828           66 QTARKFLQQLGLEILNS------HHIIHRDLKPENILLSGLDDD---------------VMLKIADFGLSCT  116 (152)
Q Consensus        66 ~~~~~~~~~i~l~~lh~------~~~~h~dl~~~nil~~~~~~~---------------~~~kl~dfg~~~~  116 (152)
                      .-+..++.|++|-|+--      ..++|.||||.|||+-+.+..               .+++|-||.+++.
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  350 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV  350 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence            45566777777666332      248999999999999754422               2355667776653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=95.05  E-value=0.3  Score=33.09  Aligned_cols=86  Identities=21%  Similarity=0.334  Sum_probs=56.7

Q ss_pred             HHHHHHHHHHHHcCC---CcCc--cceeeeeeeC------------------CeEEEEEeecCCCChHHHHHhcCCCCHH
Q 031828           10 KSCLDCELNFLSSVN---HPNI--IRLFDAFQAE------------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQ   66 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~---h~ni--~~l~~~~~~~------------------~~~~lv~e~~~~~~l~~~~~~~~~~~~~   66 (152)
                      .+-|.+|-+...+++   +.++  ++.+|+..-.                  ...-||-||.+...         .+...
T Consensus        98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~  168 (207)
T PF13095_consen   98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR  168 (207)
T ss_pred             cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh
Confidence            346778888888774   4455  7888877211                  12346777765433         23444


Q ss_pred             HHHHHHHHHHHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCc
Q 031828           67 TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS  114 (152)
Q Consensus        67 ~~~~~~~~i~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~  114 (152)
                      .+..+..  -+..+|..||+-+|+++.|..-        -+++|||.+
T Consensus       169 ~~~~~~~--dl~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~  206 (207)
T PF13095_consen  169 DIPQMLR--DLKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS  206 (207)
T ss_pred             HHHHHHH--HHHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence            4444444  3578899999999999999972        378999854

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=95.04  E-value=0.083  Score=35.07  Aligned_cols=97  Identities=19%  Similarity=0.231  Sum_probs=61.1

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCcc-ceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHhCCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHHI   85 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~-~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~l~~lh~~~~   85 (152)
                      +.-+..+..|++++..++-.++. .++.+...    ++.|||..|..|.......   ....+...+..  ---|-..||
T Consensus        56 ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~---~rk~l~~vlE~--a~~LD~~GI  126 (201)
T COG2112          56 DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG---DRKHLLRVLEK--AYKLDRLGI  126 (201)
T ss_pred             CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc---cHHHHHHHHHH--HHHHHHhcc
Confidence            44578899999999999876665 44444332    3459999887887665321   23333333322  112334577


Q ss_pred             eecCCCC--CceEeecCCCCceEEEeeccCccc
Q 031828           86 IHRDLKP--ENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        86 ~h~dl~~--~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      -|+.++-  .|+++    ....+.++||.-|+.
T Consensus       127 ~H~El~~~~k~vlv----~~~~~~iIDFd~At~  155 (201)
T COG2112         127 EHGELSRPWKNVLV----NDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence            8887764  45555    334789999998874

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.96  E-value=0.18  Score=34.96  Aligned_cols=85  Identities=20%  Similarity=0.213  Sum_probs=54.9

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH-HHHHHHhC--CCee
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSH--HIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i-~l~~lh~~--~~~h   87 (152)
                      ..+..+.++++++.  .|+++..=  ..-.+-++.|.|....            ....-.+...+ ++.-.|+.  +.+|
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~~N~i~agi~~L~~fH~~~~~~lH  166 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INFSNFITAGIKDLMDFHSENQHCLH  166 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cchhHHHHHhHHHHHHhhccCCCeec
Confidence            44567777888775  36666511  2224568889883211            11222233435 67778843  5899


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCc
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLS  114 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~  114 (152)
                      +|..|+||+.   ++.+.+|+.|-+..
T Consensus       167 GD~np~NiM~---D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  167 GDCNPDNIMC---DKFGYLKLVDPVCL  190 (308)
T ss_pred             CCCChhheee---cCCCCEEecChhhh
Confidence            9999999998   78889999986543

The function of this family is unknown.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.93  E-value=0.054  Score=39.67  Aligned_cols=51  Identities=25%  Similarity=0.442  Sum_probs=34.9

Q ss_pred             HHHHHHHHHHHHHHHH--h----CCCeecCCCCCceEeecCCCC---------------ceEEEeeccCccc
Q 031828           66 QTARKFLQQLGLEILN--S----HHIIHRDLKPENILLSGLDDD---------------VMLKIADFGLSCT  116 (152)
Q Consensus        66 ~~~~~~~~~i~l~~lh--~----~~~~h~dl~~~nil~~~~~~~---------------~~~kl~dfg~~~~  116 (152)
                      .-+..++.|+||-|+-  .    ..++|.||||.|||+-++...               .++++-||.+++.
T Consensus       275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence            4456667778877732  2    248999999999998654322               3466778887764

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK05231 homoserine kinase; Provisional

Probab=94.67  E-value=0.031  Score=40.11  Aligned_cols=30  Identities=33%  Similarity=0.633  Sum_probs=24.1

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .+++|+|+.+.||++.   ......++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFE---GDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEE---CCceEEEEeccccc
Confidence            3799999999999994   33345799999874

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.38  E-value=0.039  Score=39.30  Aligned_cols=33  Identities=30%  Similarity=0.400  Sum_probs=25.0

Q ss_pred             CCeecCCCCCceEeecC-CCCceEEEeeccCccc
Q 031828           84 HIIHRDLKPENILLSGL-DDDVMLKIADFGLSCT  116 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~-~~~~~~kl~dfg~~~~  116 (152)
                      .++|+|+.+.||++... .....+.++||+.|..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            47999999999999421 0025789999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=93.76  E-value=0.061  Score=36.74  Aligned_cols=31  Identities=23%  Similarity=0.347  Sum_probs=24.9

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      .++|+|+.+.||++.+  ....+.++||..|..
T Consensus       171 ~l~H~Dl~~~Nil~~~--~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNE--EKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeC--CCCCEEEEEcccCCc
Confidence            4899999999999952  135689999998753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=93.59  E-value=0.069  Score=38.21  Aligned_cols=30  Identities=37%  Similarity=0.751  Sum_probs=24.5

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .+++|+|+.+.|+++.   .+..+.++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFD---GDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence            4799999999999994   34456899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.94  E-value=0.099  Score=34.87  Aligned_cols=28  Identities=21%  Similarity=0.380  Sum_probs=22.9

Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      .+|+|+.|.|++++   .. .++++|++.+..
T Consensus        79 p~H~D~~~~N~~~~---~~-~~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHS---AS-GLRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEE---CC-CEEEEeCCcccC
Confidence            68999999999984   33 388999998853

>TIGR02721 ycfN_thiK thiamine kinase

Probab=92.65  E-value=0.1  Score=36.25  Aligned_cols=28  Identities=21%  Similarity=0.417  Sum_probs=22.9

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .++|+|+.|.||++.   ..+ +.++||+.+.
T Consensus       147 ~l~H~Dl~~~Nil~~---~~~-~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVT---PQG-LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEe---CCC-CEEEeccccC
Confidence            489999999999995   222 7899999875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.36  E-value=0.079  Score=35.72  Aligned_cols=31  Identities=35%  Similarity=0.573  Sum_probs=19.9

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      .+.|+|+.+.||++.  .....++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEET--SSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEec--cCCCeEEEecHHHHhh
Confidence            379999999999982  3567899999998853

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.31  E-value=0.14  Score=36.13  Aligned_cols=30  Identities=33%  Similarity=0.422  Sum_probs=25.3

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      -++|+|+.|.|++.   .+.+.++|+||..|..
T Consensus       154 v~cH~Dl~~~N~l~---t~~~~l~LIDWEyAg~  183 (269)
T COG0510         154 VPCHNDLNPGNLLL---TDKGGLFLIDWEYAGL  183 (269)
T ss_pred             eeecCCCCccceEE---cCCCcEEEEecccCCC
Confidence            47999999999998   3457899999988753

>PLN02236 choline kinase

Probab=92.04  E-value=0.16  Score=37.09  Aligned_cols=31  Identities=23%  Similarity=0.454  Sum_probs=25.2

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      .++|+|+++.||++.  .....+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMID--EETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence            479999999999985  2235799999998864

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.94  E-value=0.16  Score=33.92  Aligned_cols=34  Identities=29%  Similarity=0.337  Sum_probs=25.0

Q ss_pred             CCCeecCCCCCceEeecCCC--CceEEEeeccCccc
Q 031828           83 HHIIHRDLKPENILLSGLDD--DVMLKIADFGLSCT  116 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~--~~~~kl~dfg~~~~  116 (152)
                      ..++|+|+.+.|+++.....  ...+.++||..++.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            35899999999999852111  12688999998753

subfamily of choline kinases

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=91.88  E-value=0.15  Score=36.42  Aligned_cols=29  Identities=31%  Similarity=0.438  Sum_probs=23.6

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .+++|+|+.+.|+++.   . ..+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence            4689999999999984   2 457899999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.51  E-value=0.18  Score=35.66  Aligned_cols=31  Identities=26%  Similarity=0.463  Sum_probs=23.6

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      .++|+|+.+.|+++.+  ......++||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~--~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDE--DARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeC--CCCEEEEECcHhccc
Confidence            3899999999999952  123456999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=91.38  E-value=0.2  Score=36.43  Aligned_cols=30  Identities=30%  Similarity=0.490  Sum_probs=24.7

Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      +.|+|+.+.||++.  .....++++||+.|..
T Consensus       184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence            69999999999984  2345799999998854

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=91.21  E-value=0.21  Score=36.40  Aligned_cols=28  Identities=43%  Similarity=0.725  Sum_probs=23.2

Q ss_pred             CeecCCCCCceEeecCCCCc-eEEEeeccCcc
Q 031828           85 IIHRDLKPENILLSGLDDDV-MLKIADFGLSC  115 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~-~~kl~dfg~~~  115 (152)
                      ++|+|+.|.|+++.   ... .+.++||+-+.
T Consensus       199 iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFD---DDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEc---CCCCeeeEEEccccc
Confidence            89999999999994   333 47899999875

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=90.92  E-value=0.52  Score=35.32  Aligned_cols=29  Identities=21%  Similarity=0.397  Sum_probs=23.7

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      ..++|+|+.+.||++.    ...++++|+.++.
T Consensus       223 ~~l~HgDl~~gni~~~----~~~~~viD~E~a~  251 (401)
T PRK09550        223 EALLHGDLHTGSIFVT----EEETKVIDPEFAF  251 (401)
T ss_pred             CceeeccCCcccEEee----CCCcEEEeccccc
Confidence            3589999999999994    2358999998774

>PRK10593 hypothetical protein; Provisional

Probab=90.86  E-value=1.1  Score=32.10  Aligned_cols=44  Identities=14%  Similarity=0.083  Sum_probs=34.2

Q ss_pred             HHHHHHHHHHHHcCCC---cCccceeeeeee---CCeEEEEEeecCCCCh
Q 031828           10 KSCLDCELNFLSSVNH---PNIIRLFDAFQA---ENCIFLVVEFCAGGNL   53 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h---~ni~~l~~~~~~---~~~~~lv~e~~~~~~l   53 (152)
                      ...+..|...++.+.-   ..+.++++++..   .+..++|||++++.++
T Consensus        51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            4688999999998853   367788887754   3668999999988765

>PRK06148 hypothetical protein; Provisional

Probab=89.59  E-value=0.4  Score=40.23  Aligned_cols=33  Identities=30%  Similarity=0.481  Sum_probs=24.2

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .+++|+|+.+.||++.........-++|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            369999999999999532222334599999874

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=88.94  E-value=0.25  Score=35.08  Aligned_cols=31  Identities=32%  Similarity=0.445  Sum_probs=24.1

Q ss_pred             CeecCCCCCceEeecCCC--CceEEEeeccCcc
Q 031828           85 IIHRDLKPENILLSGLDD--DVMLKIADFGLSC  115 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~--~~~~kl~dfg~~~  115 (152)
                      ++|+|+++.||++...+.  ...+.++||-.++
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeecccccc
Confidence            899999999999953221  2378999998875

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=88.66  E-value=0.44  Score=34.59  Aligned_cols=29  Identities=21%  Similarity=0.488  Sum_probs=23.9

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .++|+|+.+.|+++.   +...+-++||+.+.
T Consensus       199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~  227 (321)
T COG3173         199 VLVHGDYRPGNLIID---PGRPTGVLDWELAT  227 (321)
T ss_pred             eeeeCCcccCCEEEe---CCCeeEEEeccccc
Confidence            489999999999995   33348899999875

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=87.96  E-value=0.35  Score=34.72  Aligned_cols=29  Identities=17%  Similarity=0.240  Sum_probs=24.3

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      +++|+|+.+.|+++   ++.+.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence            69999999999999   455568889998774

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=87.72  E-value=0.4  Score=34.76  Aligned_cols=27  Identities=30%  Similarity=0.338  Sum_probs=22.4

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      +++|+|+.+.|+++.   .  .+.++||+-+.
T Consensus       197 ~liHgD~h~~NvL~~---d--~~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR---D--GPHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc---C--CcEEEeCCCCC
Confidence            589999999999982   2  46789999875

>PRK12396 5-methylribose kinase; Reviewed

Probab=87.46  E-value=0.52  Score=35.35  Aligned_cols=27  Identities=22%  Similarity=0.406  Sum_probs=22.5

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLS  114 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~  114 (152)
                      .++|+|+.|.||+++    ....|++|..++
T Consensus       228 aLlHGDlHtGSI~v~----~~~~kvIDpEFA  254 (409)
T PRK12396        228 ALIHGDLHTGSVFVK----NDSTKVIDPEFA  254 (409)
T ss_pred             hhccCcCCCCCEEec----CCceEEEccccc
Confidence            489999999999984    335899998776

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	152
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-26
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-26
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-26
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-26
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-26
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-25
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-25
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-25
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-25
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-25
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-25
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-25
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-25
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-24
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-23
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-23
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-23
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-22
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-22
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-22
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-21
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-21
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-21
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-21
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-21
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-21
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-21
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-21
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-21
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-21
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-21
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-21
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-21
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-21
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-21
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-21
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-20
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-20
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-20
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-20
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-20
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-20
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-19
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-19
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-19
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-19
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-18
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-18
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-18
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-18
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-18
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-18
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-18
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-18
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-18
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-18
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-18
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-18
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-18
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-18
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-18
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-18
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-18
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-18
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-18
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		8e-18
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-18
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-18
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-18
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-18
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		9e-18
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-18
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-17
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-17
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-17
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-17
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-17
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-17
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-17
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-17
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-17
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-17
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-17
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-17
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-17
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-17
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-17
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-17
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-17
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-17
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-17
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-17
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-17
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-17
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-17
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-17
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-17
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-17
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-17
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-16
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-16
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-16
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-16
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-16
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-15
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-15
3soa_A	444	Full-Length Human Camkii Length = 444		1e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-15
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-15
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-15
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-15
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-14
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-13
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		8e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-12
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-12
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-09
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-09
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-09
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-09
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-08
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		7e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-07
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		4e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-06
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-06
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-06
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-05
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-05
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-05
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-05
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-05
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-05
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-05
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-05
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-05
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		7e-05
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-05
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-05
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-05
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-05

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  115 bits (288), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 84/131 (64%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++  +  +I+HRDLK EN+LL G   D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 124 VSAVQYCHQKYIVHRDLKAENLLLDG---DMNIKIADFGFSNEFTVGNKLDTFCGSPPYA 180
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 181 APELFQGKKYD 191

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  115 bits (287), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 62/145 (42%), Positives = 93/145 (64%), Gaps = 8/145 (5%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +LKK + H++  ++ E+++L  + HP+II+L+D       I +V+E+ AGG L  YI   
Sbjct: 46  LLKKSDMHMR--VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK 102
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
            R+ E   R+F QQ+   +E  + H I+HRDLKPEN+LL   DD++ +KIADFGLS  + 
Sbjct: 103 KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMT 159
Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRY 143
            GN+ +  CGSP Y APEV+  + Y
Sbjct: 160 DGNFLKTSCGSPNYAAPEVINGKLY 184

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  113 bits (283), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 55/131 (41%), Positives = 83/131 (63%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  ++ CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYA 179
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 55/131 (41%), Positives = 82/131 (62%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 55/131 (41%), Positives = 82/131 (62%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 55/131 (41%), Positives = 82/131 (62%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 179
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 82/131 (62%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  111 bits (278), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 52/131 (39%), Positives = 82/131 (62%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 120
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G   +  CGSP Y 
Sbjct: 121 VSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYA 177
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 178 APELFQGKKYD 188

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 91/137 (66%), Gaps = 6/137 (4%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 57  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 115
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           R+F QQ+   +E  + H I+HRDLKPEN+LL   D+ + +KIADFGLS  +  GN+ +  
Sbjct: 116 RRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTS 172
Query: 127 CGSPLYMAPEVLQFQRY 143
           CGSP Y APEV+  + Y
Sbjct: 173 CGSPNYAAPEVISGKLY 189

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  110 bits (276), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 91/137 (66%), Gaps = 6/137 (4%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 56  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 114
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           R+F QQ+   +E  + H I+HRDLKPEN+LL   D+ + +KIADFGLS  +  GN+ +  
Sbjct: 115 RRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTS 171
Query: 127 CGSPLYMAPEVLQFQRY 143
           CGSP Y APEV+  + Y
Sbjct: 172 CGSPNYAAPEVISGKLY 188

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  110 bits (276), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 91/137 (66%), Gaps = 6/137 (4%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 47  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 105
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           R+F QQ+   +E  + H I+HRDLKPEN+LL   D+ + +KIADFGLS  +  GN+ +  
Sbjct: 106 RRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTS 162
Query: 127 CGSPLYMAPEVLQFQRY 143
           CGSP Y APEV+  + Y
Sbjct: 163 CGSPNYAAPEVISGKLY 179

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  110 bits (275), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 91/137 (66%), Gaps = 6/137 (4%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           ++  ++ E+++L  + HP+II+L+D  ++++ I +V+E+ AG  L  YI    ++ EQ A
Sbjct: 51  MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA 109
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           R+F QQ+   +E  + H I+HRDLKPEN+LL   D+ + +KIADFGLS  +  GN+ +  
Sbjct: 110 RRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTS 166
Query: 127 CGSPLYMAPEVLQFQRY 143
           CGSP Y APEV+  + Y
Sbjct: 167 CGSPNYAAPEVISGKLY 183

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  110 bits (275), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 81/131 (61%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++LV+E+ +GG +  Y+  HG + E+ AR   +Q+
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQI 115
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D+ +KIADFG S     GN  +  CGSP Y 
Sbjct: 116 VSAVQYCHQKFIVHRDLKAENLL---LDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 172
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 173 APELFQGKKYD 183

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  110 bits (274), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 51/131 (38%), Positives = 82/131 (62%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR+ E+ AR   +Q+
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G   +  CG+P Y 
Sbjct: 124 VSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 181 APELFQGKKYD 191

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 54/131 (41%), Positives = 78/131 (59%), Gaps = 5/131 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NHPNI++LF+  + E  ++LV E+ +GG +  Y+  HGR  E+ AR   +Q+
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 76  GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   H   I+HRDLK EN+L   LD D  +KIADFG S     GN  +  CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLL---LDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYA 179
Query: 134 APEVLQFQRYD 144
           APE+ Q ++YD
Sbjct: 180 APELFQGKKYD 190

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  105 bits (261), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 60/150 (40%), Positives = 83/150 (55%), Gaps = 11/150 (7%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+         F+V+E+ +GG L  
Sbjct: 41  VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100
Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YI  HGRV E  AR+  QQ+   ++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 157
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
           S  +  G +    CGSP Y APEV+  + Y
Sbjct: 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  105 bits (261), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 60/150 (40%), Positives = 83/150 (55%), Gaps = 11/150 (7%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+         F+V+E+ +GG L  
Sbjct: 41  VKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100
Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YI  HGRV E  AR+  QQ+   ++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 101 YICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 157
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
           S  +  G +    CGSP Y APEV+  + Y
Sbjct: 158 SNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  104 bits (259), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 87/150 (58%), Gaps = 11/150 (7%)
Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LN+     LD       E+  L    HP+II+L+      + IF+V+E+ +GG L  
Sbjct: 46  VKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFD 105
Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YI  +GR+ E+ +R+  QQ+  G++  + H ++HRDLKPEN+L   LD  +  KIADFGL
Sbjct: 106 YICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGL 162
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
           S  +  G +    CGSP Y APEV+  + Y
Sbjct: 163 SNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 83/137 (60%), Gaps = 8/137 (5%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 51  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 110
Query: 66  QTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           +  RK ++ L LE++ + H   I+HRDLKPENILL   DDD+ +K+ DFG SC L PG  
Sbjct: 111 KETRKIMRAL-LEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK 166
Query: 123 AEKVCGSPLYMAPEVLQ 139
             +VCG+P Y+APE+++
Sbjct: 167 LREVCGTPSYLAPEIIE 183

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 83/137 (60%), Gaps = 8/137 (5%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 66  QTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           +  RK ++ L LE++ + H   I+HRDLKPENILL   DDD+ +K+ DFG SC L PG  
Sbjct: 124 KETRKIMRAL-LEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK 179
Query: 123 AEKVCGSPLYMAPEVLQ 139
             +VCG+P Y+APE+++
Sbjct: 180 LREVCGTPSYLAPEIIE 196

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 8/137 (5%)
Query: 7   KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 66  QTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
           +  RK ++ L LE++ + H   I+HRDLKPENILL   DDD+ +K+ DFG SC L PG  
Sbjct: 124 KETRKIMRAL-LEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEK 179
Query: 123 AEKVCGSPLYMAPEVLQ 139
              VCG+P Y+APE+++
Sbjct: 180 LRSVCGTPSYLAPEIIE 196

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 53/137 (38%), Positives = 83/137 (60%), Gaps = 3/137 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV+E   GG L   I L  +  E  A   ++Q+
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G   L+ H+I+HRDLKPEN+LL     D ++KI DFGLS     G   ++  G+  Y+
Sbjct: 131 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 190
Query: 134 APEVLQFQRYDEKVNFF 150
           APEVL+ ++YDEK + +
Sbjct: 191 APEVLR-KKYDEKCDVW 206

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-22,   Method: Composition-based stats.
 Identities = 53/137 (38%), Positives = 83/137 (60%), Gaps = 3/137 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV+E   GG L   I L  +  E  A   ++Q+
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G   L+ H+I+HRDLKPEN+LL     D ++KI DFGLS     G   ++  G+  Y+
Sbjct: 114 LSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYI 173
Query: 134 APEVLQFQRYDEKVNFF 150
           APEVL+ ++YDEK + +
Sbjct: 174 APEVLR-KKYDEKCDVW 189

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 87/150 (58%), Gaps = 2/150 (1%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + KK  +  +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   
Sbjct: 51  IAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK 110
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           G   E+ A + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    
Sbjct: 111 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 170
Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVN 148
           PG+     CG+P Y+APEVL  + Y + V+
Sbjct: 171 PGSVLSTACGTPGYVAPEVLAQKPYSKAVD 200

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 83/141 (58%), Gaps = 2/141 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 128 GSPLYMAPEVLQFQRYDEKVN 148
           G+P Y+APEVL  + Y + V+
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVD 200

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 83/141 (58%), Gaps = 2/141 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 128 GSPLYMAPEVLQFQRYDEKVN 148
           G+P Y+APEVL  + Y + V+
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVD 200

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 54/137 (39%), Positives = 82/137 (59%), Gaps = 3/137 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S++HPNII+LFD F+ +   +LV EF  GG L   I    +  E  A   ++Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  L+ H+I+HRD+KPENILL   +  + +KI DFGLS             G+  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 134 APEVLQFQRYDEKVNFF 150
           APEVL+ ++Y+EK + +
Sbjct: 216 APEVLK-KKYNEKCDVW 231

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 46/119 (38%), Positives = 77/119 (64%), Gaps = 5/119 (4%)
Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL 80
             HP+II L D++++ + +FLV +    G L  Y+     + E+  R  ++ L   +  L
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFL 216
Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
           ++++I+HRDLKPENILL   DD++ ++++DFG SC L PG    ++CG+P Y+APE+L+
Sbjct: 217 HANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 50/141 (35%), Positives = 83/141 (58%), Gaps = 2/141 (1%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I   G   E+ A 
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS    PG+     C
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 179
Query: 128 GSPLYMAPEVLQFQRYDEKVN 148
           G+P Y+APEVL  + Y + V+
Sbjct: 180 GTPGYVAPEVLAQKPYSKAVD 200

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 51/137 (37%), Positives = 78/137 (56%), Gaps = 3/137 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 134 APEVLQFQRYDEKVNFF 150
           APEVL+   YDEK + +
Sbjct: 191 APEVLR-GTYDEKCDVW 206

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 51/137 (37%), Positives = 78/137 (56%), Gaps = 3/137 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 134 APEVLQFQRYDEKVNFF 150
           APEVL+   YDEK + +
Sbjct: 191 APEVLR-GTYDEKCDVW 206

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 53/133 (39%), Positives = 81/133 (60%), Gaps = 7/133 (5%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGL 77
           LS V HP IIR++  FQ    IF+++++  GG L S +R   R P   A+ +  +  L L
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           E L+S  II+RDLKPENIL   LD +  +KI DFG +   Y  +    +CG+P Y+APEV
Sbjct: 120 EYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAK--YVPDVTYXLCGTPDYIAPEV 174
Query: 138 LQFQRYDEKVNFF 150
           +  + Y++ ++++
Sbjct: 175 VSTKPYNKSIDWW 187

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 80/128 (62%), Gaps = 3/128 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 131 LYMAPEVL 138
            Y+APEVL
Sbjct: 181 TYLAPEVL 188

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 80/128 (62%), Gaps = 3/128 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 131 LYMAPEVL 138
            Y+APEVL
Sbjct: 181 TYLAPEVL 188

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 80/128 (62%), Gaps = 3/128 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 120 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 131 LYMAPEVL 138
            Y+APEVL
Sbjct: 180 TYLAPEVL 187

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 80/128 (62%), Gaps = 3/128 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 131 LYMAPEVL 138
            Y+APEVL
Sbjct: 181 TYLAPEVL 188

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 80/128 (62%), Gaps = 3/128 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 260 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 131 LYMAPEVL 138
            Y+APEVL
Sbjct: 320 TYLAPEVL 327

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 80/128 (62%), Gaps = 3/128 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 131 LYMAPEVL 138
            Y+APEVL
Sbjct: 306 TYLAPEVL 313

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Composition-based stats.
 Identities = 51/137 (37%), Positives = 78/137 (56%), Gaps = 3/137 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R  E  A + ++Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS         +   G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 134 APEVLQFQRYDEKVNFF 150
           APEVL+   YDEK + +
Sbjct: 191 APEVLR-GTYDEKCDVW 206

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 80/128 (62%), Gaps = 3/128 (2%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + + 
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 73  QQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q  L ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P
Sbjct: 127 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 131 LYMAPEVL 138
            Y+APEVL
Sbjct: 187 TYLAPEVL 194

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 52/137 (37%), Positives = 83/137 (60%), Gaps = 3/137 (2%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L+D F+ +   +LV+E   GG L   I    +  E  A   ++Q+
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  L+ H+I+HRDLKPEN+LL   + D ++KI DFGLS         ++  G+  Y+
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 134 APEVLQFQRYDEKVNFF 150
           APEVL+ ++YDEK + +
Sbjct: 206 APEVLR-KKYDEKCDVW 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 84/148 (56%), Gaps = 2/148 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KK  K  +S ++ E+  L  + H NI+ L D +++ N ++LV++  +GG L   I   G 
Sbjct: 57  KKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF 116
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E+ A   ++Q+   +  L+   I+HRDLKPEN+L    D++  + I+DFGLS     G
Sbjct: 117 YTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG 176
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVN 148
           +     CG+P Y+APEVL  + Y + V+
Sbjct: 177 DVMSTACGTPGYVAPEVLAQKPYSKAVD 204

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/152 (38%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 2   LKKLNKHL-KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           LK L K + K  +  E+  L  ++HPNII+L + F+    I LV+E   GG L   I   
Sbjct: 83  LKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK 142
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           G   E+ A   ++Q+   +  L+ + I+HRDLKPEN+L +    D  LKIADFGLS  + 
Sbjct: 143 GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                + VCG+P Y APE+L+   Y  +V+ +
Sbjct: 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMW 234

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 50/140 (35%), Positives = 81/140 (57%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR  EQ +  F+
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 121
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           ++L   L   +   +IHRD+KPEN+L+    +   LKIADFG S    P      +CG+ 
Sbjct: 122 EELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTL 177
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 178 DYLPPEMIEGKTHDEKVDLW 197

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 50/140 (35%), Positives = 81/140 (57%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR  EQ +  F+
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           ++L   L   +   +IHRD+KPEN+L+    +   LKIADFG S    P      +CG+ 
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHA-PSLRRRXMCGTL 176
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 177 DYLPPEMIEGKTHDEKVDLW 196

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 52/143 (36%), Positives = 80/143 (55%), Gaps = 7/143 (4%)
Query: 3   KKLNKHLKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           KK+ K+    +D    E+  + S++HPNIIRL++ F+    I+LV+E C GG L   + +
Sbjct: 57  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-V 115
Query: 60  HGRV-PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           H RV  E  A + ++ +   +   H  ++ HRDLKPEN L      D  LK+ DFGL+  
Sbjct: 116 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 175
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQ 139
             PG       G+P Y++P+VL+
Sbjct: 176 FKPGKMMRTKVGTPYYVSPQVLE 198

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 52/143 (36%), Positives = 80/143 (55%), Gaps = 7/143 (4%)
Query: 3   KKLNKHLKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           KK+ K+    +D    E+  + S++HPNIIRL++ F+    I+LV+E C GG L   + +
Sbjct: 40  KKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-V 98
Query: 60  HGRV-PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
           H RV  E  A + ++ +   +   H  ++ HRDLKPEN L      D  LK+ DFGL+  
Sbjct: 99  HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQ 139
             PG       G+P Y++P+VL+
Sbjct: 159 FKPGKMMRTKVGTPYYVSPQVLE 181

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 79/145 (54%), Gaps = 3/145 (2%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 76  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 135
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + ++Q+  G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 136 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 195
Query: 128 GSPLYMAPEVLQFQRYDEKVNFFVS 152
           G+  Y+APEVL    YDEK + + +
Sbjct: 196 GTAYYIAPEVLH-GTYDEKCDVWST 219

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 83/137 (60%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 119 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 176
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 83/137 (60%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 112 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 169
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 170 NIFGTPEFVAPEIVNYE 186

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 83/137 (60%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A 
Sbjct: 73  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 132
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +K+ DFG++  +  GN  +
Sbjct: 133 QFLKQILDGVHYLHSKRIAHFDLKPENIML--LDKNVPNPRIKLIDFGIAHKIEAGNEFK 190
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 191 NIFGTPEFVAPEIVNYE 207

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 51/143 (35%), Positives = 78/143 (54%), Gaps = 3/143 (2%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 70  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + ++Q+  G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 130 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 189
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
           G+  Y+APEVL    YDEK + +
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVW 211

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 51/143 (35%), Positives = 78/143 (54%), Gaps = 3/143 (2%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 93  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 152
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + ++Q+  G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 153 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 212
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
           G+  Y+APEVL    YDEK + +
Sbjct: 213 GTAYYIAPEVLH-GTYDEKCDVW 234

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 51/143 (35%), Positives = 78/143 (54%), Gaps = 3/143 (2%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 94  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 153
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + ++Q+  G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 154 RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI 213
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
           G+  Y+APEVL    YDEK + +
Sbjct: 214 GTAYYIAPEVLH-GTYDEKCDVW 235

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 83/149 (55%), Gaps = 10/149 (6%)
Query: 1   MLKKLNKHLKSC----LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           ++K +NK         ++ E+  L S++HPNII++F+ F+  + +++V+E C GG L   
Sbjct: 51  VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLER 110
Query: 57  I---RLHGR-VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           I   +  G+ + E    + ++Q+   L   +S H++H+DLKPENIL         +KI D
Sbjct: 111 IVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170
Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
           FGL+       ++    G+ LYMAPEV +
Sbjct: 171 FGLAELFKSDEHSTNAAGTALYMAPEVFK 199

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 51/143 (35%), Positives = 76/143 (53%), Gaps = 3/143 (2%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           K  L  E+  L  ++HPNI +L++ F+ +   +LV E   GG L   I    R  E  A 
Sbjct: 70  KESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           + ++Q+  G+   + + I+HRDLKPEN+LL     D  ++I DFGLS         +   
Sbjct: 130 RIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI 189
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
           G+  Y+APEVL    YDEK + +
Sbjct: 190 GTAYYIAPEVLH-GTYDEKCDVW 211

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 83/134 (61%), Gaps = 7/134 (5%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  + + 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 128 GSPLYMAPEVLQFQ 141
           G+P ++APE++ ++
Sbjct: 179 GTPAFVAPEIVNYE 192

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/139 (37%), Positives = 83/139 (59%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L+ VNHP +++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 79  MERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 138
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
             LGL+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS   +     A   CG+  
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVE 195
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPEV+  Q +    +++
Sbjct: 196 YMAPEVVNRQGHSHSADWW 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 87/157 (55%), Gaps = 12/157 (7%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
           +KL K  +     E   L  + HPNI+R +D++++    + CI LV E    G L +Y++
Sbjct: 62  RKLTKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLK 121
Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                  +  R + +Q+  GL+ L++    IIHRDLK +NI ++G    V  KI D GL+
Sbjct: 122 RFKVXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGLA 179
Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
            TL   ++A+ V G+P + APE  + ++YDE V+ + 
Sbjct: 180 -TLKRASFAKAVIGTPEFXAPEXYE-EKYDESVDVYA 214

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 171
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGATWT--LCGTPEYL 226
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 227 APEIILSKGYNKAVDWWA 244

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 175 NIFGTPEFVAPEIVNYE 191

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 83/134 (61%), Gaps = 7/134 (5%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  + + 
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 128 GSPLYMAPEVLQFQ 141
           G+P ++APE++ ++
Sbjct: 179 GTPEFVAPEIVNYE 192

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 117 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 174
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 175 NIFGTPEFVAPEIVNYE 191

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 84/137 (61%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 85/138 (61%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG++ S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 85/138 (61%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG++ S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 81/136 (59%), Gaps = 6/136 (4%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 136 EVLQFQRYDEKVNFFV 151
           E+L+ + Y   V+++ 
Sbjct: 223 EILRGEDYGFSVDWWA 238

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 17/155 (10%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGLEIL-------NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            E+   + + QL L +          H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 117 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           L +  ++A++  G+P YM+PE +    Y+EK + +
Sbjct: 166 LNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIW 200

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 81/136 (59%), Gaps = 6/136 (4%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 74  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 133
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 134 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 190
Query: 136 EVLQFQRYDEKVNFFV 151
           E+L+ + Y   V+++ 
Sbjct: 191 EILRGEDYGFSVDWWA 206

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 85/138 (61%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 137
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D+   +++ DFG +  +    +   +CG+P Y+
Sbjct: 138 VLTFEYLHSLDLIYRDLKPENLL---IDEQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 192
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 193 APEIILSKGYNKAVDWWA 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 81/136 (59%), Gaps = 6/136 (4%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 59  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 118
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 119 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 175
Query: 136 EVLQFQRYDEKVNFFV 151
           E+L+ + Y   V+++ 
Sbjct: 176 EILRGEDYGFSVDWWA 191

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 17/155 (10%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGLEIL-------NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            E+   + + QL L +          H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 117 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           L +  ++A+   G+P YM+PE +    Y+EK + +
Sbjct: 166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIW 200

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 81/136 (59%), Gaps = 6/136 (4%)
Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 179
Query: 136 EVLQFQRYDEKVNFFV 151
           E+L+ + Y   V+++ 
Sbjct: 180 EILRGEDYGFSVDWWA 195

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 17/155 (10%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I    +    +
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 64  PEQTARKFLQQLGLEIL-------NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
            E+   + + QL L +          H ++HRDLKP N+ L G  +   +K+ DFGL+  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 165
Query: 117 L-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           L +  ++A+   G+P YM+PE +    Y+EK + +
Sbjct: 166 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIW 200

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +K+ DFGL+  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGLAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 47/137 (34%), Positives = 83/137 (60%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  + HPN+I L + ++ +  + L+ E  AGG L  ++     + E+ A 
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT 117
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
           +FL+Q+  G+  L+S  I H DLKPENI+L  LD +V    +KI DFGL+  +  GN  +
Sbjct: 118 EFLKQILNGVYYLHSLQIAHFDLKPENIML--LDRNVPKPRIKIIDFGLAHKIDFGNEFK 175
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 176 NIFGTPEFVAPEIVNYE 192

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 83/139 (59%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 76  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 135
Query: 75  LGLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
           L L +  L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 136 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 192
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPEV+  + + +  +++
Sbjct: 193 YMAPEVVNRRGHTQSADWW 211

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 83/139 (59%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 75  LGLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
           L L +  L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPEV+  + + +  +++
Sbjct: 192 YMAPEVVNRRGHTQSADWW 210

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 81/149 (54%), Gaps = 3/149 (2%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           +KK      S L+ E+  L  + H NI+ L D +++    +LV++  +GG L   I   G
Sbjct: 42  IKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG 101
Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
              E+ A   +QQ+   ++ L+ + I+HRDLKPEN+L    +++  + I DFGLS  +  
Sbjct: 102 VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQ 160
Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVN 148
                  CG+P Y+APEVL  + Y + V+
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVD 189

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 171
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 226
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 227 APEIILSKGYNKAVDWWA 244

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 145
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 146 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 200
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 201 APEIILSKGYNKAVDWWA 218

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 83/139 (59%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L +
Sbjct: 75  MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134
Query: 75  LGLEI--LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 131
           L L +  L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 191
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPEV+  + + +  +++
Sbjct: 192 YMAPEVVNRRGHTQSADWW 210

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLI---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIIISKGYNKAVDWWA 223

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/145 (36%), Positives = 85/145 (58%), Gaps = 12/145 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + +    R   ++  + + +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 75  LGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
             L+ LN  H   IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTP 199
Query: 131 LYMAPEVL-----QFQRYDEKVNFF 150
            +MAPEV+     + + YD K + +
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 79/140 (56%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   R  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHA-PSSRRDTLCGTL 174
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLW 194

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E     +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +K+ADFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIKVADFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 84/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +++ DFGL+  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIQVTDFGLAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/145 (36%), Positives = 85/145 (58%), Gaps = 12/145 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + +    R   ++  + + +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 75  LGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
             L+ LN  H   IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRXIQRRDSFIGTP 199
Query: 131 LYMAPEVL-----QFQRYDEKVNFF 150
            +MAPEV+     + + YD K + +
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/128 (40%), Positives = 69/128 (53%), Gaps = 3/128 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +++E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            +S  I HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 132 CHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 140 FQRYDEKV 147
            Q YD K+
Sbjct: 191 RQEYDGKI 198

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 52/128 (40%), Positives = 69/128 (53%), Gaps = 3/128 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKIADFG S      +  +   G+P Y+APEVL 
Sbjct: 131 AHAMQVAHRDLKLENTLLDG-SPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL 189
Query: 140 FQRYDEKV 147
            + YD KV
Sbjct: 190 KKEYDGKV 197

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 2/151 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
                  G+P Y++PEVL+   Y + V+ + 
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLW 195

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 2/151 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
                  G+P Y++PEVL+   Y + V+ + 
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDTLCGTL 171
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLW 191

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/145 (36%), Positives = 85/145 (58%), Gaps = 12/145 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + +    R   ++  + + +
Sbjct: 83  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 142
Query: 75  LGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
             L+ LN  H   IIHRDLK  NIL + LD D+  K+ADFG+S          +   G+P
Sbjct: 143 QTLDALNYLHDNKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRXIQRRDXFIGTP 199
Query: 131 LYMAPEVL-----QFQRYDEKVNFF 150
            +MAPEV+     + + YD K + +
Sbjct: 200 YWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 2/151 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
                  G+P Y++PEVL+   Y + V+ + 
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWT--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 136
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 137 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWT--LCGTPEYL 191
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 192 APEIILSKGYNKAVDWWA 209

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 2/151 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 41  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 101 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 160
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
                  G+P Y++PEVL+   Y + V+ + 
Sbjct: 161 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 191

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   R  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI 118
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSNGE---LKIADFGWSVHA-PSSRRTTLCGTL 174
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLW 194

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDDLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +   ++CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTELCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 171
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 172 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 226
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 227 APEIILSKGYNKAVDWWA 244

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 82/138 (59%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 82/138 (59%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 88/147 (59%), Gaps = 8/147 (5%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 88/147 (59%), Gaps = 8/147 (5%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 79/140 (56%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +  + +CG+ 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRDDLCGTL 196
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 197 DYLPPEMIEGRMHDEKVDLW 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI 143
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 198
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 199 APEIILSKGYNKAVDWWA 216

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 54  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 113
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 114 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 169
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 170 DYLPPEMIEGRMHDEKVDLW 189

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG SC   P +    + G+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSCHA-PSSRRTTLSGTL 171
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLW 191

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLW 195

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 52  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 112 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 167
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 168 DYLPPEMIEGRMHDEKVDLW 187

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           AP ++  + Y++ V+++ 
Sbjct: 206 APAIILSKGYNKAVDWWA 223

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 59  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 118
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 119 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 174
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLW 194

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 175
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLW 195

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 82/138 (59%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P + +L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQI 151
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +K+ DFG +  +    +   +CG+P Y+
Sbjct: 152 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIKVTDFGFAKRVKGRTWX--LCGTPEYL 206
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 207 APEIILSKGYNKAVDWWA 224

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 88/147 (59%), Gaps = 8/147 (5%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
            +CG+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LCGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN++   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLM---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 72  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 131
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 132 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 187
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 188 DYLPPEMIEGRMHDEKVDLW 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 56  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 115
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 171
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLW 191

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKKVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRAALCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTXLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 143
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 144 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 198
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 199 APEIILSKGYNKAVDWWA 216

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 172
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 173 DYLPPEMIEGRMHDEKVDLW 192

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 55  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 115 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTDLCGTL 170
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLW 190

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+  GG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 81  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 140
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 141 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 196
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 197 DYLPPEMIEGRMHDEKVDLW 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 88/147 (59%), Gaps = 8/147 (5%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ 66
           K ++  L+ E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E 
Sbjct: 83  KQIEHTLN-EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP 141
Query: 67  TARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            AR +  Q  L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +  
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX- 197
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
            + G+P Y+APE++  + Y++ V+++ 
Sbjct: 198 -LAGTPEYLAPEIILSKGYNKAVDWWA 223

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 77/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 119
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    +CG+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTL 175
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE ++ + +DEKV+ +
Sbjct: 176 DYLPPEXIEGRXHDEKVDLW 195

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 40  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 99
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 156
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 157 NRERLLNKMCGTLPYVAPELLKRREF 182

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMCGTLPYVAPELLKRREF 184

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 79/146 (54%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+CG+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMCGTLPYVAPELLKRREF 183

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 5/153 (3%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
             E  A   +QQ+ LE +N  H   I+HRDLKPEN+LL+       +K+ADFGL+  +  
Sbjct: 100 YSEADASHCIQQI-LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG 158
Query: 120 GNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
              A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 159 DQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWA 191

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/153 (35%), Positives = 78/153 (50%), Gaps = 5/153 (3%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
             E  A   +QQ+ LE +N  H   I+HRDLKPEN+LL+       +K+ADFGL+  +  
Sbjct: 100 YSEADASHCIQQI-LESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG 158
Query: 120 GNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
              A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 159 DQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWA 191

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   +CG+P  +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LCGTPEAL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 80/134 (59%), Gaps = 7/134 (5%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           ++ E++ L  V HPNII L D ++    + L++E  +GG L  ++     + E+ A  F+
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAEKVC 127
           +Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   + + 
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 128 GSPLYMAPEVLQFQ 141
           G+P ++APE++ ++
Sbjct: 180 GTPEFVAPEIVNYE 193

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 83/138 (60%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +    +   + G+P Y+
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRVKGRTWX--LXGTPEYL 205
Query: 134 APEVLQFQRYDEKVNFFV 151
           APE++  + Y++ V+++ 
Sbjct: 206 APEIILSKGYNKAVDWWA 223

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 69/128 (53%), Gaps = 3/128 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 130 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 188
Query: 140 FQRYDEKV 147
            + YD KV
Sbjct: 189 KKEYDGKV 196

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 58  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 117
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIA+FG S    P +    +CG+ 
Sbjct: 118 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHA-PSSRRTTLCGTL 173
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLW 193

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 57  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI 116
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIA+FG S    P +    +CG+ 
Sbjct: 117 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIANFGWSVHA-PSSRRTTLCGTL 172
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 173 DYLPPEMIEGRMHDEKVDLW 192

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/128 (39%), Positives = 69/128 (53%), Gaps = 3/128 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 140 FQRYDEKV 147
            + YD KV
Sbjct: 190 KKEYDGKV 197

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 77/128 (60%), Gaps = 11/128 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV---PEQTARKFL 72
           E+     + HP+I+ L++ F+  N ++LV+E C  G ++ Y++   RV    E  AR F+
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFM 118
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            Q+  G+  L+SH I+HRDL   N+LL+    ++ +KIADFGL+  L  P      +CG+
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHYTLCGT 175
Query: 130 PLYMAPEV 137
           P Y++PE+
Sbjct: 176 PNYISPEI 183

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 78/139 (56%), Gaps = 7/139 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++  S ++H NI+ + D  + ++C +LV+E+  G  LS YI  HG +   TA  F  Q+
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI 120
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 131
             G++  +   I+HRD+KP+NIL   +D +  LKI DFG++  L   +  +   V G+  
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y +PE  + +  DE  + +
Sbjct: 178 YFSPEQAKGEATDECTDIY 196

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 88/157 (56%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 46  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N   + C +P Y+APEVL  ++YD+  + +
Sbjct: 165 AKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/139 (34%), Positives = 77/139 (55%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +L +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 75  LGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           + + + + H   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG+  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPE+L    ++  V+++
Sbjct: 187 YMAPEILMRSGHNRAVDWW 205

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/139 (34%), Positives = 77/139 (55%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +L +
Sbjct: 70  AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 75  LGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           + + + + H   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG+  
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           YMAPE+L    ++  V+++
Sbjct: 187 YMAPEILMRSGHNRAVDWW 205

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 62  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 120
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 121 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 180
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 181 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 217

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 92  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 150
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 151 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 247

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 52  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 110
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 111 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 170
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 171 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 207

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 47  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 105
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 106 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 165
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 166 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 202

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 53  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 111
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 112 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 171
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 172 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 208

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 46  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 104
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 105 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 164
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 165 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 201

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 3/152 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 58  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 117
Query: 63  VPEQTARKFLQQLGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +L+ H   ++HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 118 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE 177
Query: 121 NYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
             A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWA 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 77/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   S + HPNI+RL+  F     ++L++E+   G +   ++   +  EQ    ++
Sbjct: 60  LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI 119
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            +L   L   +S  +IHRD+KPEN+LL    +   LKIADFG S    P +    + G+ 
Sbjct: 120 TELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRXXLXGTL 175
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + +DEKV+ +
Sbjct: 176 DYLPPEMIEGRMHDEKVDLW 195

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 54  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 112
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 113 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 172
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 173 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 209

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 98  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 156
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 157 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 216
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 217 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 253

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 167 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 203

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 83/140 (59%), Gaps = 12/140 (8%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-- 62
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C      S + LH R  
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---RRRSLLELHKRRK 137
Query: 63  -VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-Y 118
            V E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + +
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEF 194
Query: 119 PGNYAEKVCGSPLYMAPEVL 138
            G   + +CG+P Y+APEVL
Sbjct: 195 DGERKKTLCGTPNYIAPEVL 214

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 83/140 (59%), Gaps = 12/140 (8%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-- 62
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C      S + LH R  
Sbjct: 65  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---RRRSLLELHKRRK 121
Query: 63  -VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-Y 118
            V E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + +
Sbjct: 122 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEF 178
Query: 119 PGNYAEKVCGSPLYMAPEVL 138
            G   + +CG+P Y+APEVL
Sbjct: 179 DGERKKDLCGTPNYIAPEVL 198

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 83/140 (59%), Gaps = 12/140 (8%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-- 62
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C      S + LH R  
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---RRRSLLELHKRRK 137
Query: 63  -VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-Y 118
            V E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + +
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEF 194
Query: 119 PGNYAEKVCGSPLYMAPEVL 138
            G   + +CG+P Y+APEVL
Sbjct: 195 DGERKKDLCGTPNYIAPEVL 214

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 83/140 (59%), Gaps = 12/140 (8%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-- 62
           L  H K  +  E+    S+++P+++     F+ ++ +++V+E C      S + LH R  
Sbjct: 81  LKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEIC---RRRSLLELHKRRK 137
Query: 63  -VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-Y 118
            V E  AR F++Q   G++ L+++ +IHRDLK  N+    L+DD+ +KI DFGL+  + +
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLF---LNDDMDVKIGDFGLATKIEF 194
Query: 119 PGNYAEKVCGSPLYMAPEVL 138
            G   + +CG+P Y+APEVL
Sbjct: 195 DGERKKXLCGTPNYIAPEVL 214

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 77/153 (50%), Gaps = 5/153 (3%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +LV +   GG L   I     
Sbjct: 67  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 126
Query: 63  VPEQTARKFLQQLGLEILN---SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
             E  A   + Q+ LE +N    H I+HRDLKPEN+LL+       +K+ADFGL+  +  
Sbjct: 127 YSEADASHCIHQI-LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQG 185
Query: 120 GNYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
              A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 186 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWA 218

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 78/133 (58%), Gaps = 9/133 (6%)
Query: 26  PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLG--L 77
           P+I+ + D ++     + C+ +++E   GG L S I+  G     E+ A + ++ +G  +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+APEV
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEV 181
Query: 138 LQFQRYDEKVNFF 150
           L  ++YD+  + +
Sbjct: 182 LGPEKYDKSCDMW 194

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 77/152 (50%), Gaps = 3/152 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + H NI+RL D+   E   +LV +   GG L   I     
Sbjct: 40  KKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 99
Query: 63  VPEQTARKFLQQLGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +L+ H   ++HRDLKPEN+LL+       +K+ADFGL+  +   
Sbjct: 100 YSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD 159
Query: 121 NYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
             A     G+P Y++PEVL+ + Y + V+ + 
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWA 191

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 42  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 101
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+ G+  Y+APE+L+ + +
Sbjct: 159 NRERLLNKMXGTLPYVAPELLKRREF 184

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 78/133 (58%), Gaps = 9/133 (6%)
Query: 26  PNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLG--L 77
           P+I+ + D ++     + C+ +++E   GG L S I+  G     E+ A + ++ +G  +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+APEV
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTPCYTPYYVAPEV 200
Query: 138 LQFQRYDEKVNFF 150
           L  ++YD+  + +
Sbjct: 201 LGPEKYDKSCDMW 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+ G+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREF 183

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+ G+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREF 183

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+ G+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREF 183

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 14/146 (9%)
Query: 9   LKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +K  +DC  N    +      NH N+++ +   +  N  +L +E+C+GG L   I     
Sbjct: 41  MKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG 100
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           +PE  A++F  QL  G+  L+   I HRD+KPEN+LL   D+   LKI+DFGL+      
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 157
Query: 121 NYAE---KVCGSPLYMAPEVLQFQRY 143
           N      K+ G+  Y+APE+L+ + +
Sbjct: 158 NRERLLNKMXGTLPYVAPELLKRREF 183

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 82/150 (54%), Gaps = 12/150 (8%)
Query: 10  KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
           K+  DC  E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +
Sbjct: 74  KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE+T  K+  QL   LE ++S  ++HRD+KP N+ ++      ++K+ D GL        
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 190
Query: 122 Y-AEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             A  + G+P YM+PE +    Y+ K + +
Sbjct: 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIW 220

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 85/157 (54%), Gaps = 9/157 (5%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V E   GG L S I
Sbjct: 92  LKXLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRI 150
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A +  + +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 151 QDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXW 247

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKI  FG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 140 FQRYDEKV 147
            + YD KV
Sbjct: 190 KKEYDGKV 197

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 77/152 (50%), Gaps = 3/152 (1%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
Query: 63  VPEQTARKFLQQLGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +L+ H   ++HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 121 NYAE-KVCGSPLYMAPEVLQFQRYDEKVNFFV 151
             A     G+P Y++PEVL+   Y + V+ + 
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWA 198

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
           S+ HPNI+R  +       + +V+E+ +GG L   I   GR  E  AR F QQL  G+  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            ++  + HRDLK EN LL G      LKI  FG S +    +  +   G+P Y+APEVL 
Sbjct: 131 CHAMQVCHRDLKLENTLLDG-SPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 140 FQRYDEKV 147
            + YD KV
Sbjct: 190 KKEYDGKV 197

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 81/144 (56%), Gaps = 7/144 (4%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS +  HP +  +F  FQ +  +F V+E+  GG+L  +I+   +     A 
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 122
Query: 70  KFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKV 126
            +  +  LGL+ L+S  I++RDLK +NIL   LD D  +KIADFG+      G+    + 
Sbjct: 123 FYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNEF 179
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
           CG+P Y+APE+L  Q+Y+  V+++
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWW 203

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 6/129 (4%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L  +I+  GR  E  A  +  ++  GL  L S 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAPEVLQFQR 142
            II+RDLK +N++L   D +  +KIADFG+    ++ G   +  CG+P Y+APE++ +Q 
Sbjct: 141 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 143 YDEKVNFFV 151
           Y + V+++ 
Sbjct: 198 YGKSVDWWA 206

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 80/137 (58%), Gaps = 7/137 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           +  ++ E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV---MLKIADFGLSCTLYPGNYAE 124
            F++Q+  G+  L++  I H DLKPENI+L  LD ++    +K+ DFGL+  +  G   +
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIML--LDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 125 KVCGSPLYMAPEVLQFQ 141
            + G+P ++APE++ ++
Sbjct: 177 NIFGTPEFVAPEIVNYE 193

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 6/129 (4%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH 83
           P + +L   FQ  + ++ V+E+  GG+L  +I+  GR  E  A  +  ++  GL  L S 
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPLYMAPEVLQFQR 142
            II+RDLK +N++L   D +  +KIADFG+    ++ G   +  CG+P Y+APE++ +Q 
Sbjct: 462 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 143 YDEKVNFFV 151
           Y + V+++ 
Sbjct: 519 YGKSVDWWA 527

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 78/133 (58%), Gaps = 8/133 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  + 
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 177
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 131
            L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 178 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 132 YMAPEVLQFQRYD 144
           Y++PEVL+ Q  D
Sbjct: 235 YISPEVLKSQGGD 247

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 78/133 (58%), Gaps = 8/133 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  + 
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 182
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 131
            L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 132 YMAPEVLQFQRYD 144
           Y++PEVL+ Q  D
Sbjct: 240 YISPEVLKSQGGD 252

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 78/133 (58%), Gaps = 8/133 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ AR +  + 
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 182
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 131
            L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG    +        +   G+P 
Sbjct: 183 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 239
Query: 132 YMAPEVLQFQRYD 144
           Y++PEVL+ Q  D
Sbjct: 240 YISPEVLKSQGGD 252

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 7/144 (4%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS +  HP +  +F  FQ +  +F V+E+  GG+L  +I+   +     A 
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 121
Query: 70  KFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKV 126
            +  +  LGL+ L+S  I++RDLK +NIL   LD D  +KIADFG+      G+      
Sbjct: 122 FYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCKENMLGDAKTNXF 178
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
           CG+P Y+APE+L  Q+Y+  V+++
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWW 202

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 69/129 (53%), Gaps = 3/129 (2%)
Query: 25  HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH 84
           HPNI++L + F  +   FLV+E   GG L   I+      E  A   +++L   + + H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 85  I--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLYMAPEVLQFQ 141
           +  +HRDLKPEN+L +  +D++ +KI DFG +    P N   K  C +  Y APE+L   
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 142 RYDEKVNFF 150
            YDE  + +
Sbjct: 185 GYDESCDLW 193

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/145 (40%), Positives = 78/145 (53%), Gaps = 18/145 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           EL  LS VNHPNI++L+ A    N + LV+E+  GG+L  Y  LHG   +P  TA   + 
Sbjct: 52  ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSL--YNVLHGAEPLPYYTAAHAMS 107
Query: 74  -----QLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
                  G+  L+S     +IHRDLKP N+LL  +    +LKI DFG +C +       K
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK 165
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
             GS  +MAPEV +   Y EK + F
Sbjct: 166 --GSAAWMAPEVFEGSNYSEKCDVF 188

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/145 (40%), Positives = 78/145 (53%), Gaps = 18/145 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           EL  LS VNHPNI++L+ A    N + LV+E+  GG+L  Y  LHG   +P  TA   + 
Sbjct: 51  ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSL--YNVLHGAEPLPYYTAAHAMS 106
Query: 74  QL-----GLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
                  G+  L+S     +IHRDLKP N+LL  +    +LKI DFG +C +       K
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL--VAGGTVLKICDFGTACDIQTHMTNNK 164
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
             GS  +MAPEV +   Y EK + F
Sbjct: 165 --GSAAWMAPEVFEGSNYSEKCDVF 187

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 84/149 (56%), Gaps = 6/149 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 60  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 119
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 120 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 176
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 177 RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 205

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 84/149 (56%), Gaps = 6/149 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 115
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 172
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 201

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 84/149 (56%), Gaps = 6/149 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 56  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 115
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 116 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 172
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 173 RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 201

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 80/139 (57%), Gaps = 9/139 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P  +   ++ G+P 
Sbjct: 127 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSEMVGTPY 181
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MAPEV+  + Y  KV+ +
Sbjct: 182 WMAPEVVTRKAYGPKVDIW 200

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 196 QYVSPELL 203

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 71/125 (56%), Gaps = 5/125 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  +  + HP ++ L+ +FQ E  +F+VV+   GG+L  +++ +    E+T + F+ +L
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              L+ L +  IIHRD+KP+NIL   LD+   + I DF ++  L        + G+  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 134 APEVL 138
           APE+ 
Sbjct: 182 APEMF 186

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 78/145 (53%), Gaps = 7/145 (4%)
Query: 11  SCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   LS + NHP + +LF  FQ  + +F V+EF  GG+L  +I+   R  E  AR
Sbjct: 68  ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR 127
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKV 126
            +  ++   L  L+   II+RDLK +N+L   LD +   K+ADFG+    +  G      
Sbjct: 128 FYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCKEGICNGVTTATF 184
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFFV 151
           CG+P Y+APE+LQ   Y   V+++ 
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWA 209

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 78/139 (56%), Gaps = 9/139 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 127 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MAPEV+  + Y  KV+ +
Sbjct: 182 WMAPEVVTRKAYGPKVDIW 200

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 139 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 196 QYVSPELL 203

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 78/139 (56%), Gaps = 9/139 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 127 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSXMVGTPY 181
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MAPEV+  + Y  KV+ +
Sbjct: 182 WMAPEVVTRKAYGPKVDIW 200

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 78/139 (56%), Gaps = 9/139 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   LE L+S+ +IHRD+K +NILL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 128 Q--ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSXMVGTPY 182
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MAPEV+  + Y  KV+ +
Sbjct: 183 WMAPEVVTRKAYGPKVDIW 201

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 117 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 174 QYVSPELL 181

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 118 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 175 QYVSPELL 182

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 123
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 124 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 181 QYVSPELL 188

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 84/149 (56%), Gaps = 6/149 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 54  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 113
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 114 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 170
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 199

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 197 QYVSPELL 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 119 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 176 QYVSPELL 183

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 197 QYVSPELL 204

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 84/149 (56%), Gaps = 6/149 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 139
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 140 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 196
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 13/141 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H +  ++     +   
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHG 162
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
              GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P +
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPYW 216
Query: 133 MAPEV---LQFQRYDEKVNFF 150
           MAPEV   +   +YD KV+ +
Sbjct: 217 MAPEVILAMDEGQYDGKVDVW 237

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 120 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 177 QYVSPELL 184

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 197 QYVSPELL 204

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 200 QYVSPELL 207

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 197 QYVSPELL 204

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 84/149 (56%), Gaps = 6/149 (4%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
           L  H +  +  E++   S+ H +++     F+  + +F+V+E C   +L    +    + 
Sbjct: 78  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 137
Query: 65  EQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
           E  AR +L+Q  LG + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G 
Sbjct: 138 EPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGE 194
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             + +CG+P Y+APEVL  + +  +V+ +
Sbjct: 195 RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 223

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 13/141 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E+ FL  + HPN I+    +  E+  +LV+E+C G + S  + +H +  ++     +   
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHG 123
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
              GL  L+SH++IHRD+K  NILLS   +  ++K+ DFG +  + P N      G+P +
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPYW 177
Query: 133 MAPEV---LQFQRYDEKVNFF 150
           MAPEV   +   +YD KV+ +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVW 198

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 20/152 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--------LHGRVPEQT 67
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+          G + E T
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----- 120
               L+++  GLE L+ +  IHRD+K  NILL    +D  ++IADFG+S  L  G     
Sbjct: 118 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 174
Query: 121 NYAEKV-CGSPLYMAPEVL-QFQRYDEKVNFF 150
           N   K   G+P +MAPEV+ Q + YD K + +
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 206

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 82/151 (54%), Gaps = 9/151 (5%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KK  KH+ S  +     L +V HP ++ L  +FQ  + ++ V+++  GG L  +++    
Sbjct: 79  KKEEKHIMSERNV---LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC 135
Query: 63  VPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYP 119
             E  AR +  ++   L  L+S +I++RDLKPENILL   D    + + DFGL    +  
Sbjct: 136 FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEH 192
Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            +     CG+P Y+APEVL  Q YD  V+++
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 223

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 20/152 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--------LHGRVPEQT 67
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+          G + E T
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----- 120
               L+++  GLE L+ +  IHRD+K  NILL    +D  ++IADFG+S  L  G     
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITR 179
Query: 121 NYAEKV-CGSPLYMAPEVL-QFQRYDEKVNFF 150
           N   K   G+P +MAPEV+ Q + YD K + +
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 80/133 (60%), Gaps = 8/133 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + ++  N P +++LF AFQ +  +++V+E+  GG+L + +  +  VPE+ A+ +  + 
Sbjct: 125 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 183
Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 131
            L L+ ++S  +IHRD+KP+N+L   LD    LK+ADFG    +      + +   G+P 
Sbjct: 184 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPD 240
Query: 132 YMAPEVLQFQRYD 144
           Y++PEVL+ Q  D
Sbjct: 241 YISPEVLKSQGGD 253

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 143 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 200 QYVSPELL 207

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 144
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 145 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 202 QYVSPELL 209

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 46/134 (34%), Positives = 78/134 (58%), Gaps = 4/134 (2%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL-SSYIRLHGRVPEQTA 68
           K  +  E++ ++ ++H N+I+L+DAF+++N I LV+E+  GG L    I     + E   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             F++Q+  G+  ++  +I+H DLKPENIL    D    +KI DFGL+    P    +  
Sbjct: 190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN 248
Query: 127 CGSPLYMAPEVLQF 140
            G+P ++APEV+ +
Sbjct: 249 FGTPEFLAPEVVNY 262

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 41/127 (32%), Positives = 74/127 (58%), Gaps = 4/127 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 157
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 158 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 216
Query: 133 MAPEVLQ 139
            APEV +
Sbjct: 217 AAPEVAE 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 41/127 (32%), Positives = 74/127 (58%), Gaps = 4/127 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 133 MAPEVLQ 139
            APEV +
Sbjct: 323 AAPEVAE 329

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 146
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 147 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 204 QYVSPELL 211

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 79/145 (54%), Gaps = 7/145 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 125
             +++Q+   L   + ++IIHRD+KPEN+LL+  ++   +K+ DFG++  L   G  A  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
             G+P +MAPEV++ + Y + V+ +
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVW 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/128 (34%), Positives = 71/128 (55%), Gaps = 8/128 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  ++
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +    A    G+ 
Sbjct: 142 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198
Query: 131 LYMAPEVL 138
            Y++PE+L
Sbjct: 199 QYVSPELL 206

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 83/141 (58%), Gaps = 10/141 (7%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ +N ++LV+++  GG+L + + +   R+
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRL 172
Query: 64  PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYP 119
           PE+ AR +L ++ + I + H  H +HRD+KP+NIL   +D +  +++ADFG SC   +  
Sbjct: 173 PEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG-SCLKLMED 228
Query: 120 GNYAEKVC-GSPLYMAPEVLQ 139
           G     V  G+P Y++PE+LQ
Sbjct: 229 GTVQSSVAVGTPDYISPEILQ 249

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 116
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 117 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 173
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 174 YLAPEVLEDNDYGRAVDWW 192

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 78/139 (56%), Gaps = 9/139 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +        Q A   R+ L
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 73  QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPL 131
           Q   LE L+S+ +IHR++K +NILL G+D  V  K+ DFG    + P       + G+P 
Sbjct: 128 Q--ALEFLHSNQVIHRNIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPY 182
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MAPEV+  + Y  KV+ +
Sbjct: 183 WMAPEVVTRKAYGPKVDIW 201

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 118
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 119 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 175
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 176 YLAPEVLEDNDYGRAVDWW 194

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 74/139 (53%), Gaps = 6/139 (4%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++       E+ AR +  +
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSPL 131
           +   LE L+S  +++RD+K EN++   LD D  +KI DFGL    +  G   +  CG+P 
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKEGISDGATMKXFCGTPE 170
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           Y+APEVL+   Y   V+++
Sbjct: 171 YLAPEVLEDNDYGRAVDWW 189

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 79/140 (56%), Gaps = 8/140 (5%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           L +   SC   E + L + +   I +L  AFQ EN ++LV+E+  GG+L + +   G R+
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 64  PEQTARKFLQQLGLEILNSHHI--IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           P + AR +L ++ + I + H +  +HRD+KP+NIL   LD    +++ADFG    L    
Sbjct: 160 PAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFGSCLKLRADG 216
Query: 122 YAEKV--CGSPLYMAPEVLQ 139
               +   G+P Y++PE+LQ
Sbjct: 217 TVRSLVAVGTPDYLSPEILQ 236

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 81/145 (55%), Gaps = 7/145 (4%)
Query: 11  SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
            C   E   L+ ++ P  + +L   FQ  + ++ V+E+  GG+L  +I+  G+  E  A 
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKV 126
            +  ++  GL  L+   II+RDLK +N++L   D +  +KIADFG+    +  G    + 
Sbjct: 124 FYAAEISIGLFFLHKRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMMDGVTTREF 180
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFFV 151
           CG+P Y+APE++ +Q Y + V+++ 
Sbjct: 181 CGTPDYIAPEIIAYQPYGKSVDWWA 205

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 12  CLDCELNFLSSVNHPNII---RLFDAFQ--AENCI-FLVVEFCAGGNLSSYIRLHGR--- 62
           CL  E+  +  +NHPN++    + D  Q  A N +  L +E+C GG+L  Y+        
Sbjct: 61  CL--EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 118
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E   R  L  +   L  L+ + IIHRDLKPENI+L      ++ KI D G +  L  G
Sbjct: 119 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 178
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
               +  G+  Y+APE+L+ ++Y   V+++
Sbjct: 179 ELCTEFVGTLQYLAPELLEQKKYTVTVDYW 208

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 12  CLDCELNFLSSVNHPNII---RLFDAFQ--AENCI-FLVVEFCAGGNLSSYIRLHGR--- 62
           CL  E+  +  +NHPN++    + D  Q  A N +  L +E+C GG+L  Y+        
Sbjct: 60  CL--EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 117
Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E   R  L  +   L  L+ + IIHRDLKPENI+L      ++ KI D G +  L  G
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
               +  G+  Y+APE+L+ ++Y   V+++
Sbjct: 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYW 207

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 51/142 (35%), Positives = 78/142 (54%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+  +II+RDLKPEN+L   LDDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 129 SPLYMAPEVLQFQRYDEKVNFF 150
           +P +MAPE+L  + YD  V++F
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYF 373

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 51/142 (35%), Positives = 78/142 (54%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+  +II+RDLKPEN+L   LDDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 129 SPLYMAPEVLQFQRYDEKVNFF 150
           +P +MAPE+L  + YD  V++F
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYF 373

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 51/142 (35%), Positives = 78/142 (54%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+  +II+RDLKPEN+L   LDDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 129 SPLYMAPEVLQFQRYDEKVNFF 150
           +P +MAPE+L  + YD  V++F
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYF 373

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 51/142 (35%), Positives = 78/142 (54%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----RLHGRVPEQTARKF 71
           E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I      +    E  A  +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCG 128
             Q+  GLE L+  +II+RDLKPEN+L   LDDD  ++I+D GL+  L  G    K   G
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 129 SPLYMAPEVLQFQRYDEKVNFF 150
           +P +MAPE+L  + YD  V++F
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYF 373

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 47/132 (35%), Positives = 74/132 (56%), Gaps = 7/132 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G+   PE  A  +  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++  GLE L+   I++RDLKPENIL   LDD   ++I+D GL+  +  G   +   G+  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENIL---LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 132 YMAPEVLQFQRY 143
           YMAPEV++ +RY
Sbjct: 351 YMAPEVVKNERY 362

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 77/140 (55%), Gaps = 7/140 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E   L  VN   ++ L  A++ ++ + LV+    GG+L  +I   G+   PE  A  +  
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++  GLE L+   I++RDLKPENIL   LDD   ++I+D GL+  +  G   +   G+  
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENIL---LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 132 YMAPEVLQFQRYDEKVNFFV 151
           YMAPEV++ +RY    +++ 
Sbjct: 351 YMAPEVVKNERYTFSPDWWA 370

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 80/141 (56%), Gaps = 8/141 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV---PEQTARKFL 72
           E+  L+++ HPNI++  ++F+    +++V+++C GG+L   I     V    +Q    F+
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 73  QQ-LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 130
           Q  L L+ ++   I+HRD+K +NI L+    D  +++ DFG++  L       + C G+P
Sbjct: 133 QICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 131 LYMAPEVLQFQRYDEKVNFFV 151
            Y++PE+ + + Y+ K + + 
Sbjct: 190 YYLSPEICENKPYNNKSDIWA 210

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID-SMANSFVGTRSY 188
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 189 MSPERLQGTHYSVQSDIW 206

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 74/138 (53%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P I R F ++     +++++E+  GG+    ++  G + E      L+++
Sbjct: 67  EITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 125
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 126 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNXFVGTPFW 182
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV++   YD K + +
Sbjct: 183 MAPEVIKQSAYDFKADIW 200

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 81/145 (55%), Gaps = 12/145 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E+  L++ +HP I++L  A+  +  +++++EFC GG + +  + L   + E   +   +
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 124
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
           Q+   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S   L      +   G+P
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKNLKTLQKRDSFIGTP 181
Query: 131 LYMAPEVLQFQR-----YDEKVNFF 150
            +MAPEV+  +      YD K + +
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIW 206

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 81/145 (55%), Gaps = 12/145 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQ 73
            E+  L++ +HP I++L  A+  +  +++++EFC GG + +  + L   + E   +   +
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 116
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 130
           Q+   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S   L      +   G+P
Sbjct: 117 QMLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKNLKTLQKRDSFIGTP 173
Query: 131 LYMAPEVLQFQR-----YDEKVNFF 150
            +MAPEV+  +      YD K + +
Sbjct: 174 YWMAPEVVMCETMKDTPYDYKADIW 198

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L     A +  G+  Y
Sbjct: 117 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DEMANEFVGTRSY 172
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 173 MSPERLQGTHYSVQSDIW 190

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 197 MSPERLQGTHYSVQSDIW 214

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 114 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 169
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 170 MSPERLQGTHYSVQSDIW 187

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 231
Query: 133 MAPEVLQFQRYDEKVNFF 150
           M+PE LQ   Y  + + +
Sbjct: 232 MSPERLQGTHYSVQSDIW 249

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/131 (36%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQ 74
           E+  LS V H NII++ D F+ +    LV+E    G +L ++I  H R+ E  A    +Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           L   +  L    IIHRD+K ENI+++   +D  +K+ DFG +  L  G      CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 133 MAPEVLQFQRY 143
            APEVL    Y
Sbjct: 196 CAPEVLMGNPY 206

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 79/140 (56%), Gaps = 8/140 (5%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ EN ++LV+++  GG+L + + +   ++
Sbjct: 129 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL 188
Query: 64  PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE  AR ++ ++ L I + H  H +HRD+KP+N+L   LD +  +++ADFG    +    
Sbjct: 189 PEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL---LDVNGHIRLADFGSCLKMNDDG 245
Query: 122 YAEK--VCGSPLYMAPEVLQ 139
             +     G+P Y++PE+LQ
Sbjct: 246 TVQSSVAVGTPDYISPEILQ 265

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 79/140 (56%), Gaps = 8/140 (5%)
Query: 5   LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
           L +   +C   E + L + +   I  L  AFQ EN ++LV+++  GG+L + + +   ++
Sbjct: 113 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKL 172
Query: 64  PEQTARKFLQQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           PE  AR ++ ++ L I + H  H +HRD+KP+N+L   LD +  +++ADFG    +    
Sbjct: 173 PEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL---LDVNGHIRLADFGSCLKMNDDG 229
Query: 122 YAEK--VCGSPLYMAPEVLQ 139
             +     G+P Y++PE+LQ
Sbjct: 230 TVQSSVAVGTPDYISPEILQ 249

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTA 68
           K  +  E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I     ++ E   
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             +++Q   GL+ ++ H I+H D+KPENI+         +KI DFGL+  L P    +  
Sbjct: 152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCE-TKKASSVKIIDFGLATKLNPDEIVKVT 210
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFFV 151
             +  + APE++      E V F+ 
Sbjct: 211 TATAEFAAPEIVD----REPVGFYT 231

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 74/134 (55%), Gaps = 11/134 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEVLQFQRY 143
             Y APE+L   +Y
Sbjct: 167 LWYRAPEILLGXKY 180

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/128 (40%), Positives = 73/128 (57%), Gaps = 10/128 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E+  L  ++HPNII L DAF  ++ I LV +F    +L   I+ +  V  P       L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 74  QL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 130
            L GLE L+ H I+HRDLKP N+L   LD++ +LK+ADFGL+ +    N  Y  +V  + 
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLAKSFGSPNRAYXHQVV-TR 176
Query: 131 LYMAPEVL 138
            Y APE+L
Sbjct: 177 WYRAPELL 184

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/135 (36%), Positives = 77/135 (57%), Gaps = 13/135 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 116
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YP-GNYAEKVCG 128
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P   Y  +V  
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVV- 172
Query: 129 SPLYMAPEVLQFQRY 143
           +  Y APE+L   +Y
Sbjct: 173 TLWYRAPEILLGXKY 187

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKDFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 69/119 (57%), Gaps = 4/119 (3%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL--GLEILN 81
           P +I L + ++  + I L++E+ AGG + S     L   V E    + ++Q+  G+  L+
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 140
            ++I+H DLKP+NILLS +     +KI DFG+S  +       ++ G+P Y+APE+L +
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKPEN+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPENLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 169 LWYRAPEIL 177

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 78/140 (55%), Gaps = 6/140 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           L  E+   + ++HPNI+RL++ F     I+L++E+   G L   ++      EQ     +
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIM 129
Query: 73  QQLGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
           ++L   ++  H   +IHRD+KPEN+LL        LKIADFG S    P    + +CG+ 
Sbjct: 130 EELADALMYCHGKKVIHRDIKPENLLLGLK---GELKIADFGWSVHA-PSLRRKTMCGTL 185
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+ PE+++ + ++EKV+ +
Sbjct: 186 DYLPPEMIEGRMHNEKVDLW 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKDFMDASALTG-IPLPLIKSYL 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 169 LWYRAPEIL 177

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF +  +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLKDFMDASALTG-IPLPLIKSYL 112
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 173
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 174 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 128 GSPLYMAPEVLQFQRYDEKVNFFVS 152
           G+  +MAPEV+  +  D KV+ + S
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSS 256

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 128 GSPLYMAPEVLQFQRYDEKVNFFVS 152
           G+  +MAPEV+  +  D KV+ + S
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSS 242

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L +++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKTFMDASALTG-IPLPLIKSYL 112
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A  +L Q 
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 175
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 176 LEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 128 GSPLYMAPEVLQFQRYDEKVNFFVS 152
           G+  +MAPEV+  +  D KV+ + S
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSS 258

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 64/117 (54%), Gaps = 7/117 (5%)
Query: 39  NCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPEN 94
            C+F+ +EFC  G L  +I  R   ++ +  A +  +Q+  G++ ++S  +IHRDLKP N
Sbjct: 107 KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSN 166
Query: 95  ILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
           I L    D   +KI DFGL  +L       +  G+  YM+PE +  Q Y ++V+ + 
Sbjct: 167 IFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYA 220

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 73/129 (56%), Gaps = 9/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ +   + P++++ + ++     +++V+E+C  G++S  IRL  +   E      LQ 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSP 130
              GLE L+    IHRD+K  NIL   L+ +   K+ADFG++  L     A++  V G+P
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTP 189
Query: 131 LYMAPEVLQ 139
            +MAPEV+Q
Sbjct: 190 FWMAPEVIQ 198

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 10/145 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + +  P I+ L+ A +    + + +E   GG+L   ++  G +PE  A  +L Q 
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 194
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------VC 127
             GLE L+S  I+H D+K +N+LLS   D     + DFG +  L P    +       + 
Sbjct: 195 LEGLEYLHSRRILHGDVKADNVLLS--SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 128 GSPLYMAPEVLQFQRYDEKVNFFVS 152
           G+  +MAPEV+  +  D KV+ + S
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSS 277

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLSFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 133
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 134 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 190
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV++   YD K + +
Sbjct: 191 MAPEVIKQSAYDSKADIW 208

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 16/148 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL   + +  P I+ L+ A +    + + +E   GG+L   ++  G +PE  A  +L Q 
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 175
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---------GNYAE 124
             GLE L+S  I+H D+K +N+LLS   D     + DFG +  L P         G+Y  
Sbjct: 176 LEGLEYLHSRRILHGDVKADNVLLS--SDGSHAALCDFGHAVCLQPDGLGKDLLTGDY-- 231
Query: 125 KVCGSPLYMAPEVLQFQRYDEKVNFFVS 152
            + G+  +MAPEV+  +  D KV+ + S
Sbjct: 232 -IPGTETHMAPEVVLGRSCDAKVDVWSS 258

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 74/140 (52%), Gaps = 26/140 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----------VP 64
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH             + 
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 126
Query: 65  EQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNY 122
            QTAR      G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++
Sbjct: 127 RQTAR------GMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSH 177
Query: 123 A-EKVCGSPLYMAPEVLQFQ 141
             E++ GS L+MAPEV++ Q
Sbjct: 178 QFEQLSGSILWMAPEVIRMQ 197

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 167
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 74/140 (52%), Gaps = 26/140 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----------VP 64
           E+  L    H NI+ LF  +  +  + +V ++C G +L  Y  LH             + 
Sbjct: 58  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 114
Query: 65  EQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNY 122
            QTAR      G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++
Sbjct: 115 RQTAR------GMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATVKSRWSGSH 165
Query: 123 A-EKVCGSPLYMAPEVLQFQ 141
             E++ GS L+MAPEV++ Q
Sbjct: 166 QFEQLSGSILWMAPEVIRMQ 185

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 113
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 170
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV++   YD K + +
Sbjct: 171 MAPEVIKQSAYDSKADIW 188

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 73/138 (52%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  +   + + + ++   + +++++E+  GG+    +R  G   E      L+++
Sbjct: 71  EITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 129
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   D   +K+ADFG++  L           G+P +
Sbjct: 130 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 186
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV+Q   YD K + +
Sbjct: 187 MAPEVIQQSAYDSKADIW 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 76/144 (52%), Gaps = 15/144 (10%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 126
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
             +  Y APEVL    Y   V+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLW 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 23/156 (14%)
Query: 16  ELNFLSSVNHPNIIRL---FDAFQAE-------------NCIFLVVEFCAGGNLSSYI-- 57
           E+  L+ ++H NI+     +D F  +              C+F+ +EFC  G L  +I  
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           R   ++ +  A +  +Q+  G++ ++S  +I+RDLKP NI L    D   +KI DFGL  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVT 170
Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
           +L       +  G+  YM+PE +  Q Y ++V+ + 
Sbjct: 171 SLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYA 206

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 76/144 (52%), Gaps = 15/144 (10%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 126
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
             +  Y APEVL    Y   V+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLW 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/130 (36%), Positives = 75/130 (57%), Gaps = 13/130 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 116
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YP-GNYAEKVCG 128
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P   Y  +V  
Sbjct: 117 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVV- 172
Query: 129 SPLYMAPEVL 138
           +  Y APE+L
Sbjct: 173 TLWYRAPEIL 182

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 109
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 166
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 167 LWYRAPEIL 175

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 110
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 111 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 167
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 168 LWYRAPEIL 176

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 113
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 170
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 171 LWYRAPEIL 179

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 169 LWYRAPEIL 177

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 76/144 (52%), Gaps = 15/144 (10%)
Query: 17  LNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
           L  L +  HPN++RLFD         E  + LV E     +L++Y+       VP +T +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 126
             + QL  GL+ L+SH ++HRDLKP+NIL++       +K+ADFGL+  +Y    A   V
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA-RIYSFQMALTSV 179
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
             +  Y APEVL    Y   V+ +
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLW 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 165
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 113
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 114 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 170
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 171 LWYRAPEIL 179

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++    L G +P    + +L
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTG-IPLPLIKSYL 111
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 112 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 168
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 169 LWYRAPEIL 177

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 185
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV++   YD K + +
Sbjct: 186 MAPEVIKQSAYDSKADIW 203

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/131 (35%), Positives = 66/131 (50%), Gaps = 4/131 (3%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILN 81
            HPNII L D +     ++LV E   GG L   I       E+ A   L  +G  +E L+
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 82  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 139
           S  ++HRDLKP NIL +    +   L+I DFG +  L   N      C +  ++APEVL+
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 140 FQRYDEKVNFF 150
            Q YDE  + +
Sbjct: 199 RQGYDEGCDIW 209

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 74/138 (53%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 113
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 114 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFW 170
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV++   YD K + +
Sbjct: 171 MAPEVIKQSAYDSKADIW 188

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 73/140 (52%), Gaps = 26/140 (18%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----------VP 64
           E+  L    H NI+ LF  +     + +V ++C G +L  Y  LH             + 
Sbjct: 70  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL--YHHLHASETKFEMKKLIDIA 126
Query: 65  EQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNY 122
            QTAR      G++ L++  IIHRDLK  NI L    +D  +KI DFGL+   + + G++
Sbjct: 127 RQTAR------GMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSH 177
Query: 123 A-EKVCGSPLYMAPEVLQFQ 141
             E++ GS L+MAPEV++ Q
Sbjct: 178 QFEQLSGSILWMAPEVIRMQ 197

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 71/138 (51%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++   R+PE+   K    +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 76  --GLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 124 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 179
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE LQ   Y  + + +
Sbjct: 180 MAPERLQGTHYSVQSDIW 197

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/131 (35%), Positives = 66/131 (50%), Gaps = 4/131 (3%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILN 81
            HPNII L D +     ++LV E   GG L   I       E+ A   L  +G  +E L+
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 82  SHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ 139
           S  ++HRDLKP NIL +    +   L+I DFG +  L   N      C +  ++APEVL+
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 140 FQRYDEKVNFF 150
            Q YDE  + +
Sbjct: 199 RQGYDEGCDIW 209

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 72/133 (54%), Gaps = 11/133 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+  L  ++HPN+++L +      E+ +++V E    G +     L   + E  AR + Q
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQ 144
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGS 129
            L  G+E L+   IIHRD+KP N+L+    +D  +KIADFG+S   + G+ A      G+
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNE-FKGSDALLSNTVGT 200
Query: 130 PLYMAPEVLQFQR 142
           P +MAPE L   R
Sbjct: 201 PAFMAPESLSETR 213

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 6/126 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + HPN++ L + F+ +  + LV E+C    L    R    VPE   +    Q 
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLY 132
              +   + H+ IHRD+KPENIL++      ++K+ DFG +  L  P +Y +    +  Y
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 133 MAPEVL 138
            +PE+L
Sbjct: 169 RSPELL 174

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 12/143 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  ++HP +++ +     E  I++V E+ + G L +Y+R HG+  E +  + L+  
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMC 110
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                G+  L SH  IHRDL   N L   +D D+ +K++DFG++  +    Y   V    
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCL---VDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF 167
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APEV  + +Y  K + + 
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWA 190

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV E     +L +++    L G +P    + +L
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVH-QDLKTFMDASALTG-IPLPLIKSYL 108
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYTHEVVT 165
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 166 LWYRAPEIL 174

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 75/137 (54%), Gaps = 7/137 (5%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 135 PEVLQFQ-RYDEKVNFF 150
           PEVLQ    YD   ++F
Sbjct: 359 PEVLQKGVAYDSSADWF 375

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 75/137 (54%), Gaps = 7/137 (5%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 135 PEVLQFQ-RYDEKVNFF 150
           PEVLQ    YD   ++F
Sbjct: 359 PEVLQKGVAYDSSADWF 375

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG- 61
           + L   LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G 
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA 208
Query: 62  RVPEQTARKFL--QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           R+  +T  + +     G+E L S   IHRDL   N L++   +  +LKI+DFG+S     
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD 265
Query: 120 GNYAEK--VCGSPL-YMAPEVLQFQRYDEKVNFF 150
           G YA    +   P+ + APE L + RY  + + +
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 75/137 (54%), Gaps = 7/137 (5%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 358
Query: 135 PEVLQFQ-RYDEKVNFF 150
           PEVLQ    YD   ++F
Sbjct: 359 PEVLQKGVAYDSSADWF 375

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 75/137 (54%), Gaps = 7/137 (5%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-- 74
           L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  +  
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 75  LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 134
           LGLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YMA
Sbjct: 302 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 357
Query: 135 PEVLQFQ-RYDEKVNFF 150
           PEVLQ    YD   ++F
Sbjct: 358 PEVLQKGVAYDSSADWF 374

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 81  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 140 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 194
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 195 GSILWMAPEVIRMQ 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 141 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 195
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 196 GSILWMAPEVIRMQ 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 82  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 141 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 195
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 196 GSILWMAPEVIRMQ 209

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 74  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 133 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 187
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 188 GSILWMAPEVIRMQ 201

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 125
             +++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A  
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
             G+P +MAPEV++ + Y + V+ +
Sbjct: 195 RVGTPHFMAPEVVKREPYGKPVDVW 219

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 56  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 114
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI    L +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 115 TAQ--GMDYLHAKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKSRWSGSHQFEQLS 169
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 170 GSILWMAPEVIRMQ 183

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+APEVL+   Y   V+++
Sbjct: 314 EYLAPEVLEDNDYGRAVDWW 333

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTA 68
           L  E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEK 125
             +++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
             G+P +MAPEV++ + Y + V+ +
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVW 217

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 259
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 260 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTP 316
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+APEVL+   Y   V+++
Sbjct: 317 EYLAPEVLEDNDYGRAVDWW 336

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 113 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATEKSRWSGSHQFEQLS 167
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 168 GSILWMAPEVIRMQ 181

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 117
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 118 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 173 GSILWMAPEVIRMQ 186

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 117 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 173
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+APEVL+   Y   V+++
Sbjct: 174 EYLAPEVLEDNDYGRAVDWW 193

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 59  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 117
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 118 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 172
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 173 GSILWMAPEVIRMQ 186

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +  +  + +V ++C G +L  ++ +     E       AR+
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 113 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 168 GSILWMAPEVIRMQ 181

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 71/129 (55%), Gaps = 11/129 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
           E++ L  +NHPNI++L D    EN ++LV E     +L  ++    L G +P    + +L
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTG-IPLPLIKSYL 112
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 129
            QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+     P         +
Sbjct: 113 FQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFGVPVRTYXHEVVT 169
Query: 130 PLYMAPEVL 138
             Y APE+L
Sbjct: 170 LWYRAPEIL 178

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 117
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 118 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 174
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+APEVL+   Y   V+++
Sbjct: 175 EYLAPEVLEDNDYGRAVDWW 194

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++       E  AR +  +
Sbjct: 59  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 75  L--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGL-SCTLYPGNYAEKVCGSP 130
           +   L+ L+S  ++++RDLK EN++L   D D  +KI DFGL    +  G   +  CG+P
Sbjct: 119 IVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFCGTP 175
Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            Y+APEVL+   Y   V+++
Sbjct: 176 EYLAPEVLEDNDYGRAVDWW 195

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 70/136 (51%), Gaps = 6/136 (4%)
Query: 6   NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +K +K     E+  L  + H N++ L +  + +   +LV EF     L         +  
Sbjct: 64  DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY 123
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNY 122
           Q  +K+L Q+  G+   +SH+IIHRD+KPENIL+S      ++K+ DFG + TL  PG  
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 180
Query: 123 AEKVCGSPLYMAPEVL 138
            +    +  Y APE+L
Sbjct: 181 YDDEVATRWYRAPELL 196

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 69/134 (51%), Gaps = 12/134 (8%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILNSHH 84
           NI+ L + F+ +   +LV E   GG++ ++I+      E+ A + ++ +   L+ L++  
Sbjct: 72  NILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 85  IIHRDLKPENILLSGLDDDVMLKIADFGL--------SCTLYPGNYAEKVCGSPLYMAPE 136
           I HRDLKPENIL    +    +KI DF L        SCT          CGS  YMAPE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 137 VLQFQRYDEKVNFF 150
           V++   + ++  F+
Sbjct: 192 VVEV--FTDQATFY 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 74/134 (55%), Gaps = 14/134 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----QTARK 70
           E+  L    H NI+ LF  +     + +V ++C G +L  ++ +     E       AR+
Sbjct: 54  EVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYA-EKVC 127
             Q  G++ L++  IIHRDLK  NI L    +D+ +KI DFGL+   + + G++  E++ 
Sbjct: 113 TAQ--GMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLS 167
Query: 128 GSPLYMAPEVLQFQ 141
           GS L+MAPEV++ Q
Sbjct: 168 GSILWMAPEVIRMQ 181

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 9/140 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  ++HPNI+ L D   +E C+ LV EF               + +   + +L QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
             G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+    +   +Y  +V  +  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 132 YMAPEVLQ-FQRYDEKVNFF 150
           Y AP+VL   ++Y   V+ +
Sbjct: 185 YRAPDVLMGSKKYSTSVDIW 204

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 74/140 (52%), Gaps = 9/140 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  ++HPNI+ L D   +E C+ LV EF               + +   + +L QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 131
             G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+    +   +Y  +V  +  
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 132 YMAPEVLQ-FQRYDEKVNFF 150
           Y AP+VL   ++Y   V+ +
Sbjct: 185 YRAPDVLMGSKKYSTSVDIW 204

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 74/138 (53%), Gaps = 22/138 (15%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---------VPEQ 66
           E+  L    H NI+ LF  +  ++ + +V ++C G +L  ++ +            +  Q
Sbjct: 82  EVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQ 140
Query: 67  TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGN-YA 123
           TA+      G++ L++ +IIHRD+K  NI    L + + +KI DFGL+   + + G+   
Sbjct: 141 TAQ------GMDYLHAKNIIHRDMKSNNIF---LHEGLTVKIGDFGLATVKSRWSGSQQV 191
Query: 124 EKVCGSPLYMAPEVLQFQ 141
           E+  GS L+MAPEV++ Q
Sbjct: 192 EQPTGSVLWMAPEVIRMQ 209

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 9/154 (5%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG- 61
           + L   LK+    E   L   +HPNI+RL      +  I++V+E   GG+  +++R  G 
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA 208
Query: 62  RVPEQTARKFL--QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
           R+  +T  + +     G+E L S   IHRDL   N L++   +  +LKI+DFG+S     
Sbjct: 209 RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEAD 265
Query: 120 GNYAEK--VCGSPL-YMAPEVLQFQRYDEKVNFF 150
           G  A    +   P+ + APE L + RY  + + +
Sbjct: 266 GVXAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 77/138 (55%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 129
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 130 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 186
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE++    Y  +V+ +
Sbjct: 187 MAPELISRLPYGPEVDIW 204

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 77/138 (55%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 125
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 126 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 182
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE++    Y  +V+ +
Sbjct: 183 MAPELISRLPYGPEVDIW 200

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 25/150 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 72  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 131
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 132 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVT---ENNVMKIADF 188
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVL 138
           GL+  +   +Y +K     L   +MAPE L
Sbjct: 189 GLARDINNIDYYKKTTNGRLPVKWMAPEAL 218

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 77  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 136
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 137 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 193
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 194 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 226

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 76/138 (55%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +   +H N++ ++ ++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSV 150
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L  L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 151 LRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYW 207
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPEV+    Y  +V+ +
Sbjct: 208 MAPEVISRLPYGTEVDIW 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 77/138 (55%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 134
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 135 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 191
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE++    Y  +V+ +
Sbjct: 192 MAPELISRLPYGPEVDIW 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 77/138 (55%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 136
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 137 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 193
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE++    Y  +V+ +
Sbjct: 194 MAPELISRLPYGPEVDIW 211

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 25/150 (16%)
Query: 11  SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 247
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVL 138
           GL+  +   +Y +K     L   +MAPE L
Sbjct: 248 GLARDINNIDYYKKTTNGRLPVKWMAPEAL 277

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 74  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 133
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 134 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 190
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 191 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 223

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 73/141 (51%), Gaps = 9/141 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ EF A G+L  +++    G+V       F  
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA 116
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 117 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE + F  +  K N +
Sbjct: 174 IKWTAPEAINFGCFTIKSNVW 194

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++       +  
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL 131
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +   +G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 130 PLYMAPEVLQFQRYDEKVNFF 150
             Y APEV+    Y E V+ +
Sbjct: 189 RYYRAPEVILGMGYKENVDIW 209

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++       +  
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL 131
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +   +G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 130 PLYMAPEVLQFQRYDEKVNFF 150
             Y APEV+    Y E V+ +
Sbjct: 189 RYYRAPEVILGMGYKENVDIW 209

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 68/141 (48%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++       +  
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL 131
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +   +G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 132 LYQMLVGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYVVT 188
Query: 130 PLYMAPEVLQFQRYDEKVNFF 150
             Y APEV+    Y E V+ +
Sbjct: 189 RYYRAPEVILGMGYKENVDIW 209

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 77/138 (55%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 179
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 180 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 236
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE++    Y  +V+ +
Sbjct: 237 MAPELISRLPYGPEVDIW 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ +++IADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMRIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 14/145 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPE----QTAR 69
           E++ +  + H NI+RL+D    EN + LV EF    +L  Y+  R  G  P        +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKV 126
            F  QL  GL   + + I+HRDLKP+N+L   ++    LK+ DFGL+     P N     
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 127 CGSPLYMAPEVLQFQR-YDEKVNFF 150
             +  Y AP+VL   R Y   ++ +
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIW 193

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 77/138 (55%), Gaps = 7/138 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +    H N++ +++++   + +++V+EF  GG L+  +  H R+  EQ A   L  
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAV 256
Query: 75  L-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
           L  L +L++  +IHRD+K ++ILL+    D  +K++DFG    +       K + G+P +
Sbjct: 257 LQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYW 313
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE++    Y  +V+ +
Sbjct: 314 MAPELISRLPYGPEVDIW 331

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DATLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 37/167 (22%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCAGGNLSSYIRLHGRV 63
           E+  L+ + HP I+R F+A+  +N             +++ ++ C   NL  +  ++GR 
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW--MNGRC 110
Query: 64  P-EQTARK-----FLQ-QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
             E+  R      FLQ    +E L+S  ++HRDLKP NI  + +DD  ++K+ DFGL   
Sbjct: 111 TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDD--VVKVGDFGLVTA 167
Query: 117 LYPGNYAEKV-------------CGSPLYMAPEVLQFQRYDEKVNFF 150
           +      + V              G+ LYM+PE +    Y  KV+ F
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIF 214

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 68/143 (47%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 71  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--HMELDHERMS 127
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 128 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTASTNFMMTPYV 184
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 185 VTRYYRAPEVILGMGYKENVDIW 207

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 73/137 (53%), Gaps = 19/137 (13%)
Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR-LHGRVPEQT 67
           E+N L   +H  NI   + AF  +N       ++LV+EFC  G+++  I+   G   ++ 
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 68  A-----RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGN 121
                 R+ L+  GL  L+ H +IHRD+K +N+LL+   ++  +K+ DFG+S  L     
Sbjct: 130 WIAYICREILR--GLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVG 184
Query: 122 YAEKVCGSPLYMAPEVL 138
                 G+P +MAPEV+
Sbjct: 185 RRNTFIGTPYWMAPEVI 201

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 30/156 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 71  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 128
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 129 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 185
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 186 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 220

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E+  +  + HPN+++       +  +  + E+  GG L   I+ +  + P      F + 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 125
           +  G+  L+S +IIHRDL   N L+    ++  + +ADFGL+  +       +       
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 126 --------VCGSPLYMAPEVLQFQRYDEKVNFF 150
                   V G+P +MAPE++  + YDEKV+ F
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 30/156 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 70  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 127
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 128 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 184
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 185 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 219

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 30/156 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 135
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 30/156 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 67  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 124
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 125 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 181
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 182 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 216

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 30/156 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQAREPPGLEY 135
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 227

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 48/184 (26%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--- 58
           ++++N      +  E+  +  ++HPNI RL++ ++ E  I LV+E C GG+L   +    
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 59  ------------------------------LHG-------RVPEQTARKFLQQL--GLEI 79
                                         +HG          E+     ++Q+   L  
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 134
           L++  I HRD+KPEN L S  +    +K+ DFGLS   Y  N  E        G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 135 PEVL 138
           PEVL
Sbjct: 243 PEVL 246

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILN 81
            HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L+
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 82  SHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEV 137
           +  ++HRDLKP NIL    SG  + +  +I DFG +  L   N      C +  ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESI--RICDFGFAKQLRAENGLLXTPCYTANFVAPEV 191
Query: 138 LQFQRYDEKVNFF 150
           L+ Q YD   + +
Sbjct: 192 LERQGYDAACDIW 204

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +      L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKNTTNGRLPVKWMAPEAL-FDR 234

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 30/156 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 176
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 233
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 234 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 268

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 29/152 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 120
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 121 CYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 177
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVL 138
           DFGL+  ++  +Y +K     L   +MAPE L
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG--LEILN 81
            HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L+
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 82  SHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEV 137
           +  ++HRDLKP NIL    SG  + +  +I DFG +  L   N      C +  ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESI--RICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191
Query: 138 LQFQRYDEKVNFF 150
           L+ Q YD   + +
Sbjct: 192 LERQGYDAACDIW 204

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 69/127 (54%), Gaps = 4/127 (3%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ L+   H NI+ L ++F++   + ++ EF +G ++   I      + E+    ++ Q
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +   L+ L+SH+I H D++PENI+         +KI +FG +  L PG+    +  +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSST-IKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 133 MAPEVLQ 139
            APEV Q
Sbjct: 170 YAPEVHQ 176

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 75/156 (48%), Gaps = 30/156 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEY 135
Query: 65  ---------EQTARK------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K      +    G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 CYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           DFGL+  ++  +Y +K     L   +MAPE L F R
Sbjct: 193 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-FDR 227

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++V + + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 9/131 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           E N + ++ H  ++RL+     E  I+++ E+ A G+L  +++    G+V       F  
Sbjct: 58  EANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
           Q+  G+  +   + IHRDL+  N+L+S   + +M KIADFGL+  +    Y A +    P
Sbjct: 118 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 131 L-YMAPEVLQF 140
           + + APE + F
Sbjct: 175 IKWTAPEAINF 185

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 70/129 (54%), Gaps = 8/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+     + H NI++   +F     I + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 129
           +Q+  GL+ L+ + I+HRD+K +N+L++      +LKI+DFG S  L   N   E   G+
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGT 186
Query: 130 PLYMAPEVL 138
             YMAPE++
Sbjct: 187 LQYMAPEII 195

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++       +  
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL 124
Query: 70  KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
            +    G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T            +
Sbjct: 125 LYQMLXGIKHLHSAGIIHRDLKPSNIVVKS---DXTLKILDFGLARTAGTSFMMTPYVVT 181
Query: 130 PLYMAPEVLQFQRYDEKVNFF 150
             Y APEV+    Y E V+ +
Sbjct: 182 RYYRAPEVILGMGYKENVDIW 202

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NLS  I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 70/129 (54%), Gaps = 8/129 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
           E+     + H NI++   +F     I + +E   GG+LS+ +R      +  EQT   + 
Sbjct: 55  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 114
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 129
           +Q+  GL+ L+ + I+HRD+K +N+L++      +LKI+DFG S  L   N   E   G+
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGT 172
Query: 130 PLYMAPEVL 138
             YMAPE++
Sbjct: 173 LQYMAPEII 181

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +  +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +  +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T       E   
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDLW 209

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------- 60
           S L  E+  +  +  H NII L  A   +  ++++V + + GNL  Y+R           
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSY 144
Query: 61  --GRVPEQTAR-------KFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
              RVPE+           +    G+E L S   IHRDL   N+L++   ++ ++KIADF
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADF 201
Query: 112 GLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           GL+  +   +Y +K     L   +MAPE L F R
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEAL-FDR 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T       E   
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMEPEV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS---SYI 57
           M+    +  +  L  E+  +    H N++ ++ ++     +++++EF  GG L+   S +
Sbjct: 77  MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV 136
Query: 58  RLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           RL+           LQ L    L++  +IHRD+K ++ILL+ LD  V  K++DFG    +
Sbjct: 137 RLNEEQIATVCEAVLQALAY--LHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQI 191
Query: 118 YPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVNFF 150
                  K + G+P +MAPEV+    Y  +V+ +
Sbjct: 192 SKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 69/121 (57%), Gaps = 9/121 (7%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL++ +S   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 48  LKMLQDCPKARREVELHWRAS-QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 106
Query: 58  RLHG--RVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +G  ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
Query: 114 S 114
           +
Sbjct: 167 A 167

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIW 210

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 72  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 128
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 129 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 185
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIW 208

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 67/141 (47%), Gaps = 17/141 (12%)
Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           K+ NK +   LD     L S + P I++ F  F     +F+ +E           R+ G 
Sbjct: 64  KEENKRILMDLDV---VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 63  VPEQTARKFLQQLGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           +PE    + L ++ + I+ +       H +IHRD+KP NILL   D+   +K+ DFG+S 
Sbjct: 121 IPE----RILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISG 173
Query: 116 TLYPGNYAEKVCGSPLYMAPE 136
            L      ++  G   YMAPE
Sbjct: 174 RLVDDKAKDRSAGCAAYMAPE 194

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 38/168 (22%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 481
Query: 58  RLHGRVPEQTARKFLQQLG------------LEILNSHHIIHRDLKPENILLSGLDDDVM 105
           ++         RKF   L             L  L S   +HRD+   N+L+S  D    
Sbjct: 482 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---C 529
Query: 106 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
           +K+ DFGLS  +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 577

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 58/101 (57%), Gaps = 5/101 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+RL D   ++  + LV EFC       +   +G +  +  + FL QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
             GL   +S +++HRDLKP+N+L   ++ +  LK+ADFGL+
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLADFGLA 148

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIW 210

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIW 203

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 122
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 179
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIW 202

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMS 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIW 203

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQME--LDHERMS 167
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 224
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIW 247

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/143 (33%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        ++LV+E     NL   I++   +  +   
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMS 167
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 224
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIW 247

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 38/168 (22%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTARKFLQQLG------------LEILNSHHIIHRDLKPENILLSGLDDDVM 105
           ++         RKF   L             L  L S   +HRD+   N+L+S  D    
Sbjct: 102 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATD---C 149
Query: 106 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
           +K+ DFGLS  +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 150 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 35/172 (20%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+ +E+C  G L   I
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 58  RLHG--RVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                 +  ++  R F Q L  L  ++S  IIHRDLKP NI    +D+   +KI DFGL+
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLA 163
Query: 115 CTLY-------------PGNYA--EKVCGSPLYMAPEVLQFQ-RYDEKVNFF 150
             ++             PG+        G+ +Y+A EVL     Y+EK++ +
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL+K  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 179
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 180 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 25/165 (15%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 174
Query: 110 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+      + A+++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 175 DFGLA-----RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 25/165 (15%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 174
Query: 110 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+      + A+++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 175 DFGLA-----RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 25/165 (15%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 174
Query: 110 DFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+      + A+++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 175 DFGLA-----RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 21/149 (14%)
Query: 20  LSSVNHPNIIRLFD-----AFQAENCIFLVVEFCAGGNLSSYIRLHGR-------VPEQT 67
           +   +HPN+IRL       + Q      +++ F   G+L +Y+ L+ R       +P QT
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQT 148
Query: 68  ARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 124
             KF+    LG+E L++ + +HRDL   N +L    DD+ + +ADFGLS  +Y G+Y   
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 125 -KVCGSPL-YMAPEVLQFQRYDEKVNFFV 151
            ++   P+ ++A E L  + Y  K + + 
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWA 234

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NIL+S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANILISATN---AVKVVDFGIARAIADSGNSVXQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVNFF 150
            V G+  Y++PE  +    D + + +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKIL 172
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 173 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKIL 172
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 173 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 11  SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----- 64
           S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y  L  R P     
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY--LQARRPPGLEF 135
Query: 65  ---------EQTARKFLQQ------LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + K L         G+E L S   IHRDL   N+L++   +D ++KIA
Sbjct: 136 SFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 192
Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQR 142
           DFGL+  ++  +  +K     L   +MAPE L F R
Sbjct: 193 DFGLARDIHHIDXXKKTTNGRLPVKWMAPEAL-FDR 227

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 57/119 (47%), Gaps = 7/119 (5%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ--LGLEIL 80
            HP  +RL  A++    ++L  E C G +L  +    G  +PE     +L+   L L  L
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
           +S  ++H D+KP NI L         K+ DFGL   L      E   G P YMAPE+LQ
Sbjct: 174 HSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ 229

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 124 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 180
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLW 203

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 63  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 121
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 122 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDXELKIL 178
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 179 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 38/168 (22%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 481
Query: 58  RLHGRVPEQTARKFLQQLG------------LEILNSHHIIHRDLKPENILLSGLDDDVM 105
           ++         RKF   L             L  L S   +HRD+   N+L+S  D    
Sbjct: 482 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---C 529
Query: 106 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
           +K+ DFGLS  +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 577

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKIL 173
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 174 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 134
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 135 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 191
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLW 214

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 130
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 187
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIW 210

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 172
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 173 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 74/132 (56%), Gaps = 11/132 (8%)
Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LGLEILNSH 83
           P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +  L LE L+  
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 84  HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---CGSPLYMAPEVLQF 140
            II+RD+K ENIL   LD +  + + DFGLS   +  +  E+    CG+  YMAP++++ 
Sbjct: 179 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIVRG 234
Query: 141 --QRYDEKVNFF 150
               +D+ V+++
Sbjct: 235 GDSGHDKAVDWW 246

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKIL 169
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 170 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +  +++P I+RL    QAE  + LV+E   GG L  + +     +P     + L Q
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS- 129
             +G++ L   + +HRDL   N+LL    +    KI+DFGLS  L   +  Y  +  G  
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 130 PL-YMAPEVLQFQRYDEKVNFF 150
           PL + APE + F+++  + + +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVW 197

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/143 (34%), Positives = 67/143 (46%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L  VNH NII L + F  +        ++LV+E     NL   I  H  +  +   
Sbjct: 73  ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--HMELDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMTPYV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y   V+ +
Sbjct: 187 VTRYYRAPEVILGMGYAANVDIW 209

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 173
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 174 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 49  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 107
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 108 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 164
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 165 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 107 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 163
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 164 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 117
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 118 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 174
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 175 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 71  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 129
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 130 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 186
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 187 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 225

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 102 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 158
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 159 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 197

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 46  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 104
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 105 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 161
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 162 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 200

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 173
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 174 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 126 RSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 184
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 138
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 185 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 224

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 107 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 163
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 164 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 107 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 163
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 164 DFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 48  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 106
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 107 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 163
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 202

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 169
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 170 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 133
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 134 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 190
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 191 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 230

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 169
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 170 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 58  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 116
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 117 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 173
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 174 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 179
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 180 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 54  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 112
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 113 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 169
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 170 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 49  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 107
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 108 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 164
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 165 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 40  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 98
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 99  QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 155
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 194

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 45  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 103
Query: 58  RLHGRVPEQTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           ++     +  +     +     L  L S   +HRD+   N+L+S  D    +K+ DFGLS
Sbjct: 104 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 160
Query: 115 CTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
             +    Y +   G  P+ +MAPE + F+R+    + ++
Sbjct: 161 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWM 199

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 64  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 122
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 123 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 179
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 180 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 63  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 121
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 122 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 178
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 179 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 57  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 115
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 116 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 172
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 173 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 62  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 120
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 121 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 177
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 178 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 51  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 109
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 110 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 166
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 167 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 206

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 23/164 (14%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 58  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 117
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           +L++ ++      E       Q L GL+ ++S  IIHRDLKP N+    +++D  L+I D
Sbjct: 118 DLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDSELRILD 174
Query: 111 FGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
           FGL+         E++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 175 FGLAR-----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 116
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFF 150
           +    Y  +V  +  Y AP+VL   ++Y   ++ +
Sbjct: 152 IPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 116
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFF 150
           +    Y  +V  +  Y AP+VL   ++Y   ++ +
Sbjct: 152 IPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 187
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 188 DFGLA--RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 129
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 130 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 186
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 187 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 75  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 133
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 134 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 190
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 191 DFGLA--RHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIW 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 50  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 108
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 109 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 165
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 166 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 205

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 187
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 188 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 71  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 129
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 130 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 186
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 187 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 5/101 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  + H NI+RL D   ++  + LV EFC       +   +G +  +  + FL QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
             GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA 148

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 72  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 130
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 131 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 187
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 188 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMTPEV 186
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIW 209

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVNFF 150
            V G+  Y++PE  +    D + + +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 21/163 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 106
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 107 ADLNNIVKC-AKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 162
Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
            DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 163 LDFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYI--RLHGRVPEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+         + V 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALDPVV 172
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEVL    Y   V+ +
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMW 195

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVNFF 150
            V G+  Y++PE  +    D + + +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 79  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 138
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 139 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 194
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVNFF 150
            V G+  Y++PE  +    D + + +
Sbjct: 195 AVIGTAQYLSPEQARGDSVDARSDVY 220

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++D  +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVNFF 150
            V G+  Y++PE  +    D + + +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 83/168 (49%), Gaps = 23/168 (13%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK  + + +     E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG
Sbjct: 51  LKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 110
Query: 62  ----------RVPEQTARKFL---QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVML 106
                        E T  + L   QQ+  G+  L S H +HRDL   N L+    +++++
Sbjct: 111 PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLV 167
Query: 107 KIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 150
           KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 168 KIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVW 214

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 23/164 (14%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 58  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 117
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           +L++ ++      E       Q L GL+ ++S  IIHRDLKP N+    +++D  L+I D
Sbjct: 118 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDSELRILD 174
Query: 111 FGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
           FGL+         E++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 175 FGLAR-----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDSELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL C  +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFGL-CR-HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S +NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 23/164 (14%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F     I       +V    G 
Sbjct: 50  VKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA 109
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           +L++ ++      E       Q L GL+ ++S  IIHRDLKP N+    +++D  L+I D
Sbjct: 110 DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILD 166
Query: 111 FGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVNFF 150
           FGL+         E++ G   +  Y APE+ L +  Y++ V+ +
Sbjct: 167 FGLA-----RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 205

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S +NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 76/162 (46%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 138
             +  ++KI DFGL+  +Y  P    +     PL +MAPE +
Sbjct: 183 --EKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETI 222

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGFVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 141
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 142 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVW 222

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E     +L   + +  
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCE 94
Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-- 116
           G +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFG 151
Query: 117 LYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFF 150
           +    Y  ++  +  Y AP+VL   ++Y   ++ +
Sbjct: 152 IPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 124
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 125 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVW 205

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 32/153 (20%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKI 191
Query: 109 ADFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVL 138
           +DFGLS  +Y   +Y ++  G  P+ +MA E L
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL 224

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 23/148 (15%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYI--RLHGRVPEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+       +P +T +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 123
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+       Y+ ++ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI-----YSYQMA 175
Query: 128 GSPL-----YMAPEVLQFQRYDEKVNFF 150
            +P+     Y APEVL    Y   V+ +
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMW 203

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  +  VNH NII L + F  +        +++V+E     NL   I++   +  +   
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMS 131
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             L Q+  G++ L+S  IIHRDLKP NI++     D  LKI DFGL+ T           
Sbjct: 132 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMVPFV 188
Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEV+    Y E V+ +
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIW 211

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 77/162 (47%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 101 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 160
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 161 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 219
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 138
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 220 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 259

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 49  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 108
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
Query: 132 --YMAPEVLQFQRYDEKVNFFV 151
             +  PEVL + ++  K + + 
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWA 186

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 169
Query: 132 --YMAPEVLQFQRYDEKVNFFV 151
             +  PEVL + ++  K + + 
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWA 191

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 23/148 (15%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYI--RLHGRVPEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+       Y+ ++ 
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARI-----YSYQMA 167
Query: 128 GSPL-----YMAPEVLQFQRYDEKVNFF 150
            +P+     Y APEVL    Y   V+ +
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMW 195

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 53  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 112
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 113 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 168
Query: 132 --YMAPEVLQFQRYDEKVNFFV 151
             +  PEVL + ++  K + + 
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWA 190

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 151
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 152 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 208
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVW 232

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 29/130 (22%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKI 191
Query: 109 ADFGLSCTLY 118
           +DFGLS  +Y
Sbjct: 192 SDFGLSRDVY 201

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 129 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 221

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           D+GL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DYGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 153
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 154 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 213
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 214 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 246

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 144 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 203
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 204 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 236

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 13/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 76  -----GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKV 126
                G+  L++ +  I+HRDLK  N+L   +D    +K+ DFGLS  L    +  ++  
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLL---VDKKYTVKVCDFGLS-RLKASXFLXSKXA 199
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
            G+P +MAPEVL+ +  +EK + +
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVY 223

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 76/162 (46%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 138
             +  ++KI DFGL+  +Y  P    +     PL +MAPE +
Sbjct: 183 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 222

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 119
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 120 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 175
Query: 132 --YMAPEVLQFQRYDEKVNFFV 151
             +  PEVL + ++  K + + 
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWA 197

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 29/130 (22%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----------- 63
            E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V           
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 64  -------PEQTAR------KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                  P++ A        F  Q+  G++ L    ++HRDL   NIL++   +   +KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVA---EGRKMKI 191
Query: 109 ADFGLSCTLY 118
           +DFGLS  +Y
Sbjct: 192 SDFGLSRDVY 201

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 68/131 (51%), Gaps = 13/131 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFL 72
           E+  L  + H N+I+L D    + +  +++V+E+C  G       +   R P   A  + 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC--- 127
            QL  GLE L+S  I+H+D+KP N+LL+       LKI+  G++  L+P   A+  C   
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEALHP-FAADDTCRTS 171
Query: 128 -GSPLYMAPEV 137
            GSP +  PE+
Sbjct: 172 QGSPAFQPPEI 182

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 75/152 (49%), Gaps = 30/152 (19%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---------EQ 66
           E    + + HPN++ L      +  + ++  +C+ G+L  ++ +  R P         ++
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM--RSPHSDVGSTDDDR 136
Query: 67  TARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           T +  L+             G+E L+SHH++H+DL   N+L+    D + +KI+D GL  
Sbjct: 137 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFR 193
Query: 116 TLYPGNYAEKVCGSPL----YMAPEVLQFQRY 143
            +Y  +Y  K+ G+ L    +MAPE + + ++
Sbjct: 194 EVYAADYY-KLLGNSLLPIRWMAPEAIMYGKF 224

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 164 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 223
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 224 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 256

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y   V GS   
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 184
Query: 132 --YMAPEVLQFQRYDEKVNFFV 151
             +  PEVL + ++  K + + 
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWA 206

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 75/152 (49%), Gaps = 30/152 (19%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---------EQ 66
           E    + + HPN++ L      +  + ++  +C+ G+L  ++ +  R P         ++
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM--RSPHSDVGSTDDDR 119
Query: 67  TARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           T +  L+             G+E L+SHH++H+DL   N+L+    D + +KI+D GL  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLFR 176
Query: 116 TLYPGNYAEKVCGSPL----YMAPEVLQFQRY 143
            +Y  +Y  K+ G+ L    +MAPE + + ++
Sbjct: 177 EVYAADYY-KLLGNSLLPIRWMAPEAIMYGKF 207

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 154
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 155 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 214
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
            Y  K   + L   +M PE      +  K + +
Sbjct: 215 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 247

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
            Y  K   + L   +M PE      +  K + +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 270

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 16  ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL+FL      S  NH NI+R           F+++E  AGG+L S++R     P Q + 
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             +  L         G + L  +H IHRD+   N LL+      + KI DFG++  +Y  
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEKVNFF 150
           +Y  K   + L   +M PE      +  K + +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 76/158 (48%), Gaps = 23/158 (14%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RLHGR--VPEQTARK------------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDD 103
           R      VP +   K            F    G+E L S   IHRDL   NILLS   + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS---EK 180
Query: 104 VMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 138
            ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 181 NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 21/163 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +  +      +LV+ F  G
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-G 113
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   ++ H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL---AVNEDCELKI 169
Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
            DFGL+           V  +  Y APEV L + RY + V+ +
Sbjct: 170 LDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIW 210

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 139
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 149 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 25/149 (16%)
Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYI--RLHGRVPEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+       +P +T +
Sbjct: 57  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK 115
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------CTLYPGN 121
             ++Q   GL+ L+++ I+HRDLKPENIL++       +K+ADFGL+        L+P  
Sbjct: 116 DLMRQFLRGLDFLHANCIVHRDLKPENILVTS---GGTVKLADFGLARIYSYQMALFP-- 170
Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
               V  +  Y APEVL    Y   V+ +
Sbjct: 171 ----VVVTLWYRAPEVLLQSTYATPVDMW 195

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 139
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSP 130
            +  G+  L+    +HRDL   N+L   +D +++ K++DFGLS  L    + A    G  
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 131 L---YMAPEVLQFQRYDEKVNFF 150
           +   + APE + F+ +    + +
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVW 238

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L    Y++ V+ +
Sbjct: 168 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIW 207

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 71  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 129
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 139
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 130 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 35/172 (20%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+ +E+C    L   I
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI 106
Query: 58  RLHG--RVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                 +  ++  R F Q L  L  ++S  IIHRDLKP NI    +D+   +KI DFGL+
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLA 163
Query: 115 CTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVNFF 150
             ++             PG+        G+ +Y+A EVL     Y+EK++ +
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 139
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 17/146 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQ- 73
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +  P + + K    
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 74  ---QLGLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 126
               LG+E + + +  I+HRDL+  NI L  LD++  V  K+ADFGLS      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGL 186
Query: 127 CGSPLYMAPEVL--QFQRYDEKVNFF 150
            G+  +MAPE +  + + Y EK + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTY 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 76/162 (46%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 138
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 174 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 213

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 76/157 (48%), Gaps = 26/157 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
           E   L+++ H +I++ +      + + +V E+   G+L+ ++R HG          P Q 
Sbjct: 67  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 68  ARKF-LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
             +  L Q+         G+  L S H +HRDL   N L+     ++++KI DFG+S  +
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMSRDV 183
Query: 118 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 150
           Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 184 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVW 219

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 74  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 132
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 139
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 133 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 13/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 171
Query: 131 L---YMAPEVLQFQRYDEKVNFFV 151
               + APE L + ++  K + + 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWA 195

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 139
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 177 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 13/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 76  -----GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKV 126
                G+  L++ +  I+HR+LK  N+L+   D    +K+ DFGLS  L    +  ++  
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS-RLKASTFLSSKSA 199
Query: 127 CGSPLYMAPEVLQFQRYDEKVNFF 150
            G+P +MAPEVL+ +  +EK + +
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVY 223

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 62/117 (52%), Gaps = 10/117 (8%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 70  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 128
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQ 139
           +H DLKP N L+     D MLK+ DFG++  + P   +   +   G+  YM PE ++
Sbjct: 129 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 81  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-G 139
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 140 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 196
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y+  V+ +
Sbjct: 197 DFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIW 236

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 71/144 (49%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGL+  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLARVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 41/138 (29%), Positives = 69/138 (50%), Gaps = 11/138 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +  +++P I+RL    QAE  + LV+E   GG L  + +     +P     + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS- 129
             +G++ L   + +HR+L   N+LL    +    KI+DFGLS  L   +  Y  +  G  
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 130 PL-YMAPEVLQFQRYDEK 146
           PL + APE + F+++  +
Sbjct: 502 PLKWYAPECINFRKFSSR 519

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 119
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 123
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 176
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +     P+ + APE + + ++  K + +
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVW 204

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 65  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
Query: 58  R------LHGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSGL 100
           R      +  + PE   + FL              G+E L S   IHRDL   NILLS  
Sbjct: 125 RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-- 182
Query: 101 DDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 138
            +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 183 -EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 222

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 107
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 123
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 108 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 164
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +     P+ + APE + + ++  K + +
Sbjct: 165 QTHGKWPVKWYAPECINYYKFSSKSDVW 192

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 109
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 123
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 110 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 166
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +     P+ + APE + + ++  K + +
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVW 194

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 123
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 114 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 170
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +     P+ + APE + + ++  K + +
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVW 198

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 127
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 123
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 128 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 184
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +     P+ + APE + + ++  K + +
Sbjct: 185 QTHGKWPVKWYAPECINYYKFSSKSDVW 212

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSP 130
            +  G+  L+    +HRDL   N+L   +D +++ K++DFGLS  L    + A    G  
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVL---VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 131 L---YMAPEVLQFQRYDEKVNFF 150
           +   + APE + F+ +    + +
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVW 238

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 113
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 114 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENXYKA 170
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVNFF 150
           +  G  P+ + APE + + ++  K + +
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVW 198

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 76/162 (46%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 100 LDDDVMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 138
             +  ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 174 --EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 213

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E    G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGAVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/158 (34%), Positives = 76/158 (48%), Gaps = 23/158 (14%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RLHGR--VPEQTARK------------FLQQLGLEILNSHHIIHRDLKPENILLSGLDDD 103
           R      VP +   K            F    G+E L S   IHRDL   NILLS   + 
Sbjct: 124 RSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS---EK 180
Query: 104 VMLKIADFGLSCTLYPG-NYAEKVCGS-PL-YMAPEVL 138
            ++KI DFGL+  +Y   +Y  K     PL +MAPE +
Sbjct: 181 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 218

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 123
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 130 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 186
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +     P+ + APE + + ++  K + +
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVW 214

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 129
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NY--A 123
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY  A
Sbjct: 130 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 186
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +     P+ + APE + + ++  K + +
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVW 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E    G+L S++R H    + T  + +  L
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGML 124
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 125 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVW 205

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 38/168 (22%)
Query: 9   LKSCLDC-----------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K+C +C           E   +   +HP+I++L      EN +++++E C  G L S++
Sbjct: 43  IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 101
Query: 58  RLHGRVPEQTARKFLQQLG------------LEILNSHHIIHRDLKPENILLSGLDDDVM 105
           ++         RKF   L             L  L S   +HRD+   N+L+S  D    
Sbjct: 102 QV---------RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---C 149
Query: 106 LKIADFGLSCTLYPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVNFFV 151
           +K+ DFGLS  +      +   G  P+ +MAPE + F+R+    + ++
Sbjct: 150 VKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWM 197

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 70/144 (48%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E+   G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGL   L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWA 202

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H++S +  E+  L     H N++ L + F+ E+  +LV E   GG++ S+I  
Sbjct: 45  IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 60  HGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
                E  A   +Q +   L+ L++  I HRDLKPENIL    +    +KI DFGL   +
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGI 164
Query: 118 ------YPGNYAE--KVCGSPLYMAPEVLQ 139
                  P +  E    CGS  YMAPEV++
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 14/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E + +   +HPNIIRL         + +V E    G+L S++R H    + T  + +  L
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--AQFTVIQLVGML 153
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVC 127
                G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 128 GSPL-YMAPEVLQFQRYDEKVNFF 150
             P+ + +PE + ++++    + +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVW 234

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWA 202

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 13/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 171
Query: 131 L---YMAPEVLQFQRYDEKVNFFV 151
               + APE L + ++  K + + 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWA 195

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/142 (35%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 11  SCLDCELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVP 64
           S  D E+  L  S  HPN+IR F   +     ++ +E CA   L  Y+        G  P
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEP 120
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLK--IADFGLSCTLYPG 120
                  LQQ   GL  L+S +I+HRDLKP NIL+S  +    +K  I+DFGL   L  G
Sbjct: 121 ----ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176
Query: 121 NYA----EKVCGSPLYMAPEVL 138
            ++      V G+  ++APE+L
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEML 198

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 61/117 (52%), Gaps = 10/117 (8%)
Query: 28  IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI 85
           IIRL+D    +  I++V+E C   +L+S+++    +     + + + +   +  ++ H I
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148
Query: 86  IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQ 139
           +H DLKP N L+     D MLK+ DFG++  + P       +   G+  YM PE ++
Sbjct: 149 VHSDLKPANFLIV----DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 13/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++++EF   GNL  Y+R   R  E  A   L   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 118
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 174
Query: 131 L---YMAPEVLQFQRYDEKVNFFV 151
               + APE L + ++  K + + 
Sbjct: 175 FPIKWTAPESLAYNKFSIKSDVWA 198

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
            FGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 GFGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 73/138 (52%), Gaps = 12/138 (8%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           +S    E++ L ++ H +II+       Q E  + LV+E+   G+L  Y+  H     Q 
Sbjct: 60  RSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL 119
Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
              F QQ+  G+  L+S H IHR+L   N+L   LD+D ++KI DFGL+  +  G+   +
Sbjct: 120 LL-FAQQICEGMAYLHSQHYIHRNLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 126 V---CGSPL-YMAPEVLQ 139
           V     SP+ + APE L+
Sbjct: 176 VREDGDSPVFWYAPECLK 193

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 10/143 (6%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
           CE + +   +HPN++ L         + +V+EF   G L +++R H G+         L+
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR 152
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--PGNYAEKVCGS 129
            +  G+  L     +HRDL   NIL   ++ +++ K++DFGLS  +   P        G 
Sbjct: 153 GIAAGMRYLADMGYVHRDLAARNIL---VNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 130 -PL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE +Q++++    + +
Sbjct: 210 IPVRWTAPEAIQYRKFTSASDVW 232

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           D GL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DAGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 42/144 (29%), Positives = 74/144 (51%), Gaps = 10/144 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 413 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 471
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 472 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 528
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEK 146
           +  G  P+ + APE + + ++  K
Sbjct: 529 QTHGKWPVKWYAPECINYYKFSSK 552

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 42/144 (29%), Positives = 74/144 (51%), Gaps = 10/144 (6%)
Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           LK  L  E N +  +++P I+R+    +AE+ + LV+E    G L+ Y++ +  V ++  
Sbjct: 414 LKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNI 472
Query: 69  RKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAE 124
            + + Q  +G++ L   + +HRDL   N+LL         KI+DFGLS  L      Y  
Sbjct: 473 IELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKA 529
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEK 146
           +  G  P+ + APE + + ++  K
Sbjct: 530 QTHGKWPVKWYAPECINYYKFSSK 553

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 73/145 (50%), Gaps = 18/145 (12%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 125
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
                 + APE L+ +++  K + +
Sbjct: 180 ------WTAPEALREKKFSTKSDVW 198

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 73/145 (50%), Gaps = 18/145 (12%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 125
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 108 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 164
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
                 + APE L+ +++  K + +
Sbjct: 165 ------WTAPEALREKKFSTKSDVW 183

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           D GL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DRGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 80/144 (55%), Gaps = 26/144 (18%)
Query: 16  ELNFLSSVNHPNIIRLFD--------------AFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++F+              +    N +++V E+    +L++ +   G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-QG 115
Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDP 173
Query: 120 -----GNYAEKVCGSPLYMAPEVL 138
                G+ +E +  +  Y +P +L
Sbjct: 174 HYSHKGHLSEGLV-TKWYRSPRLL 196

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 118
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 119 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAPAGAKF 175
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWA 198

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 74/160 (46%), Gaps = 25/160 (15%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 58  RLHGR-----VPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSGLD 101
           R          PE   + FL              G+E L S   IHRDL   NILLS   
Sbjct: 126 RSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS--- 182
Query: 102 DDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 138
           +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 183 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 222

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAPAGAKF 176
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWA 199

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 54  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 113
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +    Y     GS   
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEYTSSR-GSKFP 169
Query: 132 --YMAPEVLQFQRYDEKVNFFV 151
             +  PEVL + ++  K + + 
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWA 191

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWA 199

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 15/146 (10%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E    +++NHP I+ ++   +AE       ++V+E+  G  L   +   G +  + A + 
Sbjct: 62  EAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 72  LQQLGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEK-- 125
           +     + LN  H   IIHRD+KP NI++S  +    +K+ DFG++  +   GN   +  
Sbjct: 122 IAD-ACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIARAIADSGNSVTQTA 177
Query: 126 -VCGSPLYMAPEVLQFQRYDEKVNFF 150
            V G+  Y++PE  +    D + + +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVY 203

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           D GL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DGGLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 117
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWA 197

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 119
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWA 199

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 121
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWA 201

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 138
             +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 174 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 213

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWA 202

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 78/146 (53%), Gaps = 17/146 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +  P + + K    
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 75  L----GLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 126
           L    G+E + + +  I+HRDL+  NI L  LD++  V  K+ADFG S      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV--HSVSGL 186
Query: 127 CGSPLYMAPEVL--QFQRYDEKVNFF 150
            G+  +MAPE +  + + Y EK + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTY 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWA 202

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 13/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 122
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 123 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTXTAHAGAK 178
Query: 131 L---YMAPEVLQFQRYDEKVNFFV 151
               + APE L + ++  K + + 
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWA 202

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 73/145 (50%), Gaps = 18/145 (12%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 125
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
                 + APE L+ +++  K + +
Sbjct: 352 ------WTAPEALREKKFSTKSDVW 370

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F         N ++LV     G
Sbjct: 52  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-G 110
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
            +L++ ++      +       Q L GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 111 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKIL 167
Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DF L+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 168 DFYLA--RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 75/162 (46%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++VEFC  GNLS+Y+
Sbjct: 64  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 182
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 138
             +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 183 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 222

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 130
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 131 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L + ++  K + + 
Sbjct: 188 PIKWTAPESLAYNKFSIKSDVWA 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 13/144 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+ 
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTFTAHAGAK 171
Query: 131 L---YMAPEVLQFQRYDEKVNFFV 151
               + APE L + ++  K + + 
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWA 195

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   ++V E+   GNL  Y+R   R  E TA   L   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR-EEVTAVVLLYMA 136
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHRDL   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 137 TQISSAMEYLEKKNFIHRDLAARNCLVG---ENHVVKVADFGLSRLMTGDTYTAHAGAKF 193
Query: 130 PL-YMAPEVLQFQRYDEKVNFFV 151
           P+ + APE L +  +  K + + 
Sbjct: 194 PIKWTAPESLAYNTFSIKSDVWA 216

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 12/145 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E    + + HPNII L      E  + LV+EF  GG L+  +    R+P      +  Q+
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQI 114
Query: 76  --GLEILNSHH---IIHRDLKPENILL-----SGLDDDVMLKIADFGLSCTLYPGNYAEK 125
             G+  L+      IIHRDLK  NIL+     +G   + +LKI DFGL+   +       
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKMS 173
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
             G+  +MAPEV++   + +  + +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVW 198

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 73/138 (52%), Gaps = 12/138 (8%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
           +S    E++ L ++ H +II+       Q E  + LV+E+   G+L  Y+  H     Q 
Sbjct: 60  RSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL 119
Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
              F QQ+  G+  L++ H IHR+L   N+L   LD+D ++KI DFGL+  +  G+   +
Sbjct: 120 LL-FAQQICEGMAYLHAQHYIHRNLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 126 V---CGSPL-YMAPEVLQ 139
           V     SP+ + APE L+
Sbjct: 176 VREDGDSPVFWYAPECLK 193

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 33/167 (19%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 39  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 97
Query: 55  SYIRLHGRV----PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS---------- 98
             I  + R+     E   +  L Q+  GL  ++S  ++H D+KP NI +S          
Sbjct: 98  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 157
Query: 99  -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 158 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 201

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 33/167 (19%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 37  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 95
Query: 55  SYIRLHGRV----PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS---------- 98
             I  + R+     E   +  L Q+  GL  ++S  ++H D+KP NI +S          
Sbjct: 96  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 155
Query: 99  -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 156 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 199

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 33/167 (19%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 41  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 99
Query: 55  SYIRLHGRV----PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS---------- 98
             I  + R+     E   +  L Q+  GL  ++S  ++H D+KP NI +S          
Sbjct: 100 DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159
Query: 99  -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 160 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 203

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 33/167 (19%)
Query: 2   LKKLNKHLKSCLDCELNFLSSV-------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K+  K L   +D E N L  V        H +++R F A+  ++ + +  E+C GG+L+
Sbjct: 39  IKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLA 97
Query: 55  SYIRLHGRV----PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS---------- 98
             I  + R+     E   +  L Q+  GL  ++S  ++H D+KP NI +S          
Sbjct: 98  DAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 157
Query: 99  -GLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            G +DD     VM KI D G    +      E   G   ++A EVLQ
Sbjct: 158 EGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---GDSRFLANEVLQ 201

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 52  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 109
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 110 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVW 189

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 69/141 (48%), Gaps = 7/141 (4%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + H NII L       + + L+ E+ A  +L  Y+  +  V  +  + FL QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTL-YPGNYAEKVCGSP 130
             G+   +S   +HRDLKP+N+LLS  D  +  +LKI DFGL+     P         + 
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 131 LYMAPEVLQFQR-YDEKVNFF 150
            Y  PE+L   R Y   V+ +
Sbjct: 202 WYRPPEILLGSRHYSTSVDIW 222

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 62  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 119
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 120 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVW 199

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 78/146 (53%), Gaps = 17/146 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  +S++NHPNI++L+      N   +V+EF   G+L  Y RL  +  P + + K    
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDL--YHRLLDKAHPIKWSVKLRLM 128
Query: 75  L----GLEILNSHH--IIHRDLKPENILLSGLDDD--VMLKIADFGLSCTLYPGNYAEKV 126
           L    G+E + + +  I+HRDL+  NI L  LD++  V  K+ADF LS      +    +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV--HSVSGL 186
Query: 127 CGSPLYMAPEVL--QFQRYDEKVNFF 150
            G+  +MAPE +  + + Y EK + +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTY 212

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 63  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 120
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVW 200

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVW 194

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 11/138 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E +A   L   
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 324
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHR+L   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 381
Query: 130 PL-YMAPEVLQFQRYDEK 146
           P+ + APE L + ++  K
Sbjct: 382 PIKWTAPESLAYNKFSIK 399

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 8/140 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y        P+
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 168
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            + +PEV  F RY  K + +
Sbjct: 169 KWASPEVFSFSRYSSKSDVW 188

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 232 AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y  +     
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKF 347
Query: 130 PL-YMAPEVLQFQRYDEKVNFF 150
           P+ + APE + F  +  K + +
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVW 369

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQ 74
           E   + +++H  +++L+     +  IF++ E+ A G L +Y+R +  R   Q   +  + 
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  +        V GS   
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFP 184
Query: 132 --YMAPEVLQFQRYDEKVNFFV 151
             +  PEVL + ++  K + + 
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWA 206

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 67  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 124
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y  +    
Sbjct: 125 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 130 -PL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVW 204

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 10/142 (7%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 59  AEANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 117
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGS 129
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y A +    
Sbjct: 118 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIEDNEYTAREGAKF 174
Query: 130 PL-YMAPEVLQFQRYDEKVNFF 150
           P+ + APE + F  +  K + +
Sbjct: 175 PIKWTAPEAINFGSFTIKSDVW 196

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 74/162 (45%), Gaps = 27/162 (16%)
Query: 1   MLKKLNKHLK-SCLDCELNFLSSVNHP-NIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+   H +   L  EL  L  + H  N++ L  A  +    + ++ EFC  GNLS+Y+
Sbjct: 55  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
Query: 58  RL-------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPENILLSG 99
           R        +   PE   + FL              G+E L S   IHRDL   NILLS 
Sbjct: 115 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS- 173
Query: 100 LDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-YMAPEVL 138
             +  ++KI DFGL+  +   P    +     PL +MAPE +
Sbjct: 174 --EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 213

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 72/140 (51%), Gaps = 12/140 (8%)
Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            L+S    E+  L ++ H +I++       Q E  + LV+E+   G+L  Y+  H  V  
Sbjct: 53  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGL 111
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
                F QQ+  G+  L++ H IHR L   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 112 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVL---LDNDRLVKIGDFGLAKAVPEGHEY 168
Query: 124 EKV---CGSPL-YMAPEVLQ 139
            +V     SP+ + APE L+
Sbjct: 169 YRVREDGDSPVFWYAPECLK 188

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 72/140 (51%), Gaps = 12/140 (8%)
Query: 8   HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
            L+S    E+  L ++ H +I++       Q E  + LV+E+   G+L  Y+  H  V  
Sbjct: 52  QLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGL 110
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
                F QQ+  G+  L++ H IHR L   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 111 AQLLLFAQQICEGMAYLHAQHYIHRALAARNVL---LDNDRLVKIGDFGLAKAVPEGHEY 167
Query: 124 EKV---CGSPL-YMAPEVLQ 139
            +V     SP+ + APE L+
Sbjct: 168 YRVREDGDSPVFWYAPECLK 187

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 168
Query: 132 --YMAPEVLQFQRYDEKVNFF 150
             + +PEV  F RY  K + +
Sbjct: 169 VKWASPEVFSFSRYSSKSDVW 189

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 11/138 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  E  A   L   
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMA 363
Query: 76  -----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS- 129
                 +E L   + IHR+L   N L+    ++ ++K+ADFGLS  +    Y        
Sbjct: 364 TQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKF 420
Query: 130 PL-YMAPEVLQFQRYDEK 146
           P+ + APE L + ++  K
Sbjct: 421 PIKWTAPESLAYNKFSIK 438

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 72/145 (49%), Gaps = 12/145 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPN+I L         + ++ EF   G+L S++R + G+         L+
Sbjct: 83  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 142
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVC 127
            +  G++ L   + +HRDL   NIL   ++ +++ K++DFGLS  L        Y   + 
Sbjct: 143 GIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 199
Query: 128 GS-PL-YMAPEVLQFQRYDEKVNFF 150
           G  P+ + APE +Q++++    + +
Sbjct: 200 GKIPIRWTAPEAIQYRKFTSASDVW 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 74/140 (52%), Gaps = 16/140 (11%)
Query: 10  KSCLDCELNFLSSVNHPNIIRLF----DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
           +S    E++ L ++ H +II+      DA  A   + LV+E+   G+L  Y+  H     
Sbjct: 77  RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPRHSIGLA 134
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
           Q    F QQ+  G+  L++ H IHRDL   N+L   LD+D ++KI DFGL+  +  G+  
Sbjct: 135 QLLL-FAQQICEGMAYLHAQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEX 190
Query: 124 EKV---CGSPL-YMAPEVLQ 139
            +V     SP+ + APE L+
Sbjct: 191 YRVREDGDSPVFWYAPECLK 210

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 12/138 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +    HPNIIRL         + ++ EF   G L S++RL+ G+         L+
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 123
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVC 127
            +  G+  L     +HRDL   NIL   ++ +++ K++DFGLS  L   +    Y   + 
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 128 GS-PL-YMAPEVLQFQRY 143
           G  P+ + APE + F+++
Sbjct: 181 GKIPIRWTAPEAIAFRKF 198

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 35/172 (20%)
Query: 11  SCLDCELNFLSSVNHPNIIRLFDAF-------------QAENCIFLVVEFCAGGNLSSYI 57
           S +  E+  L+S+NH  ++R + A+             + ++ +F+  E+C    L   I
Sbjct: 47  STILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI 106
Query: 58  RLHG--RVPEQTARKFLQQL-GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                 +  ++  R F Q L  L  ++S  IIHR+LKP NI    +D+   +KI DFGL+
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIF---IDESRNVKIGDFGLA 163
Query: 115 CTLY-------------PGNYAE--KVCGSPLYMAPEVLQFQ-RYDEKVNFF 150
             ++             PG+        G+  Y+A EVL     Y+EK++ +
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXY 215

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 19/150 (12%)
Query: 16  ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTA 68
           E+  L  + HPN+I L   F   A+  ++L+ ++ A  +L   I+ H      + P Q  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 126
Query: 69  RKFLQQL------GLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 117
           R  ++ L      G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      L
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
            P    + V  +  Y APE+L   R+  K 
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKA 216

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 18/145 (12%)
Query: 15  CELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
            E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEK 125
              +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL    S T   G    K
Sbjct: 114 SLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 170
Query: 126 VCGSPLYMAPEVLQFQRYDEKVNFF 150
                 + APE L+   +  K + +
Sbjct: 171 ------WTAPEALREAAFSTKSDVW 189

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 66/140 (47%), Gaps = 8/140 (5%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 72  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y        P+
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 188
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            + +PEV  F RY  K + +
Sbjct: 189 KWASPEVFSFSRYSSKSDVW 208

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 55  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 114
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 170
Query: 132 --YMAPEVLQFQRYDEKVNFF 150
             + +PEV  F RY  K + +
Sbjct: 171 VKWASPEVFSFSRYSSKSDVW 191

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 50  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 165
Query: 132 --YMAPEVLQFQRYDEKVNFF 150
             + +PEV  F RY  K + +
Sbjct: 166 VKWASPEVFSFSRYSSKSDVW 186

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 34/168 (20%)
Query: 14  DCELNFLSSVNHPNI-IRLFDAFQAENCI------------FLVVEFCAGGNLSSYIR-- 58
           D  L+  S ++ P++ IR  D F  +N +            ++ ++ C   NL  ++   
Sbjct: 96  DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 59  --LHGRVPEQTARKFLQ-QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
             L  R        F+Q    +E L+S  ++HRDLKP NI  + +DD  ++K+ DFGL  
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT-MDD--VVKVGDFGLVT 212
Query: 116 TLYPGNYAEKV-------------CGSPLYMAPEVLQFQRYDEKVNFF 150
            +      + V              G+ LYM+PE +    Y  KV+ F
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIF 260

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 52  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 111
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y     G+   
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSST-GTKFP 167
Query: 132 --YMAPEVLQFQRYDEKVNFF 150
             + +PEV  F RY  K + +
Sbjct: 168 VKWASPEVFSFSRYSSKSDVW 188

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +++K   H++S +  E+  L     H N++ L + F+ E+  +LV E   GG++ S+I  
Sbjct: 45  IIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104
Query: 60  HGRVPEQTARKFLQQLG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
                E  A   +Q +   L+ L++  I HRDLKPENIL    +    +KI DF L   +
Sbjct: 105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
Query: 118 ------YPGNYAE--KVCGSPLYMAPEVLQ 139
                  P +  E    CGS  YMAPEV++
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 138
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 139 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 195
Query: 132 -YMAPEVLQ 139
            +MAPE L+
Sbjct: 196 RWMAPESLK 204

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 79  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 138
Query: 62  RVPEQTARK--------FLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
              +  A           L QL         G+  L   H +HRDL   N L+      +
Sbjct: 139 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 195
Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 150
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 196 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVW 244

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 132 -YMAPEVLQ 139
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 56  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 115
Query: 62  RVPEQTARK--------FLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
              +  A           L QL         G+  L   H +HRDL   N L+      +
Sbjct: 116 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 172
Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 150
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 173 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVW 221

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 134 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 190

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R HG
Sbjct: 50  LKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 109
Query: 62  RVPEQTARK--------FLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
              +  A           L QL         G+  L   H +HRDL   N L+      +
Sbjct: 110 PDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGL 166
Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVNFF 150
           ++KI DFG+S  +Y  +Y  +V G  +    +M PE + ++++  + + +
Sbjct: 167 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVW 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 27/148 (18%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTARKF-LQ 73
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E          TA     Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 142
Query: 74  QL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
           QL         G++ L+    IHRDL   NIL+    ++ + KIADFGLS       Y +
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 197
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVNFF 150
           K  G  P+ +MA E L +  Y    + +
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVW 225

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 145 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 202 KWMALESLQTQKFTTKSDVW 221

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 145 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 202 KWMALESLQTQKFTTKSDVW 221

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 27/148 (18%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTARKF-LQ 73
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E          TA     Q
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 132
Query: 74  QL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
           QL         G++ L+    IHRDL   NIL+    ++ + KIADFGLS       Y +
Sbjct: 133 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 187
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVNFF 150
           K  G  P+ +MA E L +  Y    + +
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVW 215

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 103 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 162
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 163 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 220 KWMALESLQTQKFTTKSDVW 239

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 104 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 163
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 164 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 221 KWMALESLQTQKFTTKSDVW 240

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 143 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 200 KWMALESLQTQKFTTKSDVW 219

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 140 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 197 KWMALESLQTQKFTTKSDVW 216

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 144 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 201 KWMALESLQTQKFTTKSDVW 220

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 77  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 136
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 137 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 194 KWMALESLQTQKFTTKSDVW 213

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 61/126 (48%), Gaps = 12/126 (9%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGLEILNS 82
            HP +IRL D F+ +    LV+E      +L  YI   G + E  +R F  Q+   I + 
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 83  HH--IIHRDLKPENILLSGLDDDVM---LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           H   ++HRD+K ENIL+     D+     K+ DFG    L+   Y +   G+ +Y  PE 
Sbjct: 156 HSRGVVHRDIKDENILI-----DLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEW 209
Query: 138 LQFQRY 143
           +   +Y
Sbjct: 210 ISRHQY 215

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 141
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   Y       G+ L  
Sbjct: 142 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 199 KWMALESLQTQKFTTKSDVW 218

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 13/99 (13%)
Query: 42  FLVVEFCAGGNLSSYIRLHGRV-------PEQTARKFLQQL--GLEILNSHHIIHRDLKP 92
            +++ F   G+L +++ L  R+       P QT  +F+  +  G+E L+S + IHRDL  
Sbjct: 107 MVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAA 165
Query: 93  ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
            N +L+   +D+ + +ADFGLS  +Y G+Y  + C S L
Sbjct: 166 RNCMLA---EDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 53  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 110
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHR+L+  NIL+S   D +  KIADFGL+  +    Y A +   
Sbjct: 111 AAQIAEGMAFIEERNYIHRNLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVW 190

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 132
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 133 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 189

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 134 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 190

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 14/139 (10%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +    HPNIIRL         + ++ EF   G L S++RL+ G+         L+
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR 125
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
            +  G+  L     +HRDL   NIL   ++ +++ K++DFGLS  L   N ++    S L
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEE-NSSDPTETSSL 181
Query: 132 -------YMAPEVLQFQRY 143
                  + APE + F+++
Sbjct: 182 GGKIPIRWTAPEAIAFRKF 200

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 135 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 191

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+    +   LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 149 GVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 205

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 162 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 218

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 163 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 219

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 156
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 157 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 213

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+    +   LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 149 GVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 205

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 130 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 186

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+    +   LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDL--NRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 177 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 233

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 150 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 206

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + +V E+   G+L ++++ + G+         L+ 
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRG 132
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 129
           +  G++ L+    +HRDL   NIL   ++ +++ K++DFGLS  L       Y  +    
Sbjct: 133 ISAGMKYLSDMGYVHRDLAARNIL---INSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 130 PL-YMAPEVLQFQRYDEKVNFF 150
           P+ + APE + F+++    + +
Sbjct: 190 PIRWTAPEAIAFRKFTSASDVW 211

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 122 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 181
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 182 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGLEILNSHH- 84
            +IRL D F+  +   L++E      +L  +I   G + E+ AR F  Q+   + + H+ 
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 85  -IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 143
            ++HRD+K ENIL+     +  LK+ DFG    L    Y +   G+ +Y  PE +++ RY
Sbjct: 169 GVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRYHRY 225

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVW 194

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/142 (23%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 80  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 139
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 129
           +  G++ L+    +HRDL   NIL   ++ +++ K++DFG+S  L       Y  +    
Sbjct: 140 IGSGMKYLSDMSAVHRDLAARNIL---VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 196
Query: 130 PL-YMAPEVLQFQRYDEKVNFF 150
           P+ + APE + ++++    + +
Sbjct: 197 PIRWTAPEAIAYRKFTSASDVW 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 60/129 (46%), Gaps = 20/129 (15%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +Y   Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV 196
Query: 132 -YMAPEVLQ 139
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/142 (23%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 59  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 118
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 129
           +  G++ L+    +HRDL   NIL   ++ +++ K++DFG+S  L       Y  +    
Sbjct: 119 IGSGMKYLSDMSYVHRDLAARNIL---VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 175
Query: 130 PL-YMAPEVLQFQRYDEKVNFF 150
           P+ + APE + ++++    + +
Sbjct: 176 PIRWTAPEAIAYRKFTSASDVW 197

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/142 (23%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNII L         + ++ E+   G+L +++R + GR         L+ 
Sbjct: 65  EASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRG 124
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCGS 129
           +  G++ L+    +HRDL   NIL   ++ +++ K++DFG+S  L       Y  +    
Sbjct: 125 IGSGMKYLSDMSYVHRDLAARNIL---VNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI 181
Query: 130 PL-YMAPEVLQFQRYDEKVNFF 150
           P+ + APE + ++++    + +
Sbjct: 182 PIRWTAPEAIAYRKFTSASDVW 203

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 11/147 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 61  GRVPEQTAR---KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 113
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 181
Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            S          ++ G+  YMAPE L+
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEALR 208

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 63/127 (49%), Gaps = 8/127 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 131
           L  GL   +   ++HRDLKP+N+L++   +   LK+ADFGL+     P    +    +  
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 132 YMAPEVL 138
           Y  P++L
Sbjct: 166 YRPPDIL 172

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 145 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 202 KWMALESLQTQKFTTKSDVW 221

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 68/143 (47%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 129
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +       +    
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 130 -PL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVW 194

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 146 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 203 KWMALESLQTQKFTTKSDVW 222

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++EF   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI 114
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKF 197

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 58  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 115
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 116 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 172
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVW 195

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 59  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 116
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 117 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 173
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVW 196

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 85  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 144
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 145 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 202 KWMALESLQTQKFTTKSDVW 221

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI 114
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKF 197

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 90  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 149
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 150 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 207 KWMALESLQTQKFTTKSDVW 226

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 83  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 142
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L  
Sbjct: 143 GMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 200 KWMALESLQTQKFTTKSDVW 219

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 12/136 (8%)
Query: 24  NHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL--GLEI 79
           +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  G++ 
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 207
Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL---YMA 134
           L S   +HRDL   N +L   D+   +K+ADFGL+  +Y   +       G+ L   +MA
Sbjct: 208 LASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 135 PEVLQFQRYDEKVNFF 150
            E LQ Q++  K + +
Sbjct: 265 LESLQTQKFTTKSDVW 280

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 11/147 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 61  GRVPEQTAR---KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 113
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 181
Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            S          ++ G+  YMAPE L+
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEALR 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 66  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 123
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 124 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVW 203

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 65  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 122
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 123 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVW 202

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 57  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 114
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVW 194

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 11/147 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+  ++   H N++ L       + + LV  +   G+L   +   
Sbjct: 59  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 118
Query: 61  GRVPEQTAR---KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 113
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 175
Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            S          ++ G+  YMAPE L+
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPEALR 202

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
            E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    + + T  K L  
Sbjct: 63  AEANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDM 120
Query: 75  L-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 128
                 G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +      A +   
Sbjct: 121 AAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 129 SPL-YMAPEVLQFQRYDEKVNFF 150
            P+ + APE + +  +  K + +
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVW 200

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPN+I L         + ++ EF   G+L S++R + G+         L+
Sbjct: 57  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 116
Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVC 127
            +  G++ L   + +HR L   NIL   ++ +++ K++DFGLS  L        Y   + 
Sbjct: 117 GIAAGMKYLADMNYVHRALAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 173
Query: 128 GS-PL-YMAPEVLQFQRYDEKVNFF 150
           G  P+ + APE +Q++++    + +
Sbjct: 174 GKIPIRWTAPEAIQYRKFTSASDVW 198

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HR+L   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 140 ADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 196
Query: 132 -YMAPEVLQ 139
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 27/148 (18%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTARKF-LQ 73
           +HPNII L  A +    ++L +E+   GNL  ++R   RV E          TA     Q
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQ 139
Query: 74  QL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
           QL         G++ L+    IHR+L   NIL+    ++ + KIADFGLS       Y +
Sbjct: 140 QLLHFAADVARGMDYLSQKQFIHRNLAARNILVG---ENYVAKIADFGLSRG--QEVYVK 194
Query: 125 KVCGS-PL-YMAPEVLQFQRYDEKVNFF 150
           K  G  P+ +MA E L +  Y    + +
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVW 222

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 20/129 (15%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 140
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HR+L   N +++    D  +KI DFG++  +Y  +Y  K     L  
Sbjct: 141 ADGMAYLNAKKFVHRNLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 197
Query: 132 -YMAPEVLQ 139
            +MAPE L+
Sbjct: 198 RWMAPESLK 206

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 37/129 (28%), Positives = 70/129 (54%), Gaps = 18/129 (13%)
Query: 19  FLSSVNHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
           FL+ V HP+I+++F+  +      +   ++V+E+  G +L    R  G ++P   A  +L
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIAYL 188
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            ++   L  L+S  +++ DLKPENI+L+    +  LK+ D G    +    Y   + G+P
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGY---LYGTP 241
Query: 131 LYMAPEVLQ 139
            + APE+++
Sbjct: 242 GFQAPEIVR 250

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 16/142 (11%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---- 75
           LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRLEICI 146
Query: 76  ----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGNYAEKVCG 128
               GL  L++  IIHRD+K  NIL   LD++ + KI DFG+S     L   +    V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 129 SPLYMAPEVLQFQRYDEKVNFF 150
           +  Y+ PE     R  EK + +
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVY 225

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKF 194

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 58  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 173
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 174 EXXKVKEPGESPIFWYAPESLTESKF 199

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 10/133 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI---FLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E   L  +NH NI++LF A + E       L++EFC  G+L + +            +FL
Sbjct: 57  EFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 73  QQL-----GLEILNSHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             L     G+  L  + I+HR++KP NI+ + G D   + K+ DFG +  L        +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 127 CGSPLYMAPEVLQ 139
            G+  Y+ P++ +
Sbjct: 176 YGTEEYLHPDMYE 188

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 71  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 186
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKF 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 59  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 117
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 118 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 174
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 175 EXXKVKEPGESPIFWYAPESLTESKF 200

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 56  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 114
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 171
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKF 197

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 65/128 (50%), Gaps = 16/128 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL D    E+ +     ++V+E  A  
Sbjct: 58  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEI-ADS 116
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L    +    + EQ  +  L  L  G + ++   IIHRDLKP N L   L+ D  +KI 
Sbjct: 117 DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCL---LNQDCSVKIC 173
Query: 110 DFGLSCTL 117
           DFGL+ T+
Sbjct: 174 DFGLARTI 181

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 71  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 129
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 186
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 187 EXXKVKEPGESPIFWYAPESLTESKF 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 84  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 142
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 199
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 200 EXXKVKEPGESPIFWYAPESLTESKF 225

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 67/142 (47%), Gaps = 16/142 (11%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL---- 75
           LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRLEICI 146
Query: 76  ----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGNYAEKVCG 128
               GL  L++  IIHRD+K  NIL   LD++ + KI DFG+S     L   +    V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 129 SPLYMAPEVLQFQRYDEKVNFF 150
           +  Y+ PE     R  EK + +
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVY 225

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 51  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 109
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 110 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 166
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 167 EXXKVKEPGESPIFWYAPESLTESKF 192

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 57  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 115
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 116 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 172
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 173 EXXKVKEPGESPIFWYAPESLTESKF 198

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 52  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 110
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 111 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 167
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 168 EXXKVKEPGESPIFWYAPESLTESKF 193

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 60  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 175
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 176 EXXKVKEPGESPIFWYAPESLTESKF 201

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKF 194

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 74/165 (44%), Gaps = 32/165 (19%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----------------L 59
           E   ++  ++PNI++L         + L+ E+ A G+L+ ++R                 
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 60  HGRV--PEQTARKFLQQL--------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
             RV  P        +QL        G+  L+    +HRDL   N L+    +++++KIA
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIA 216
Query: 110 DFGLSCTLYPGNY--AEKVCGSPL-YMAPEVLQFQRYDEKVNFFV 151
           DFGLS  +Y  +Y  A+     P+ +M PE + + RY  + + + 
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 10/133 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI---FLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
           E   L  +NH NI++LF A + E       L++EFC  G+L + +            +FL
Sbjct: 57  EFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 73  QQL-----GLEILNSHHIIHRDLKPENIL-LSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
             L     G+  L  + I+HR++KP NI+ + G D   + K+ DFG +  L        +
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXL 175
Query: 127 CGSPLYMAPEVLQ 139
            G+  Y+ P++ +
Sbjct: 176 YGTEEYLHPDMYE 188

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 20/150 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L    H NII + D  +          +++V++     +L   I     +  +  R
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 161
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGN--- 121
            FL QL  GL+ ++S  +IHRDLKP N+L   ++++  LKI DFG++   CT  P     
Sbjct: 162 YFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT-SPAEHQY 217
Query: 122 YAEKVCGSPLYMAPE-VLQFQRYDEKVNFF 150
           +  +   +  Y APE +L    Y + ++ +
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLW 247

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKIRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 179 IKWTAPEAALYGRFTIKSDVW 199

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 84  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 143
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +L   D+   +K+ADFGL+  +Y           G+ L  
Sbjct: 144 GMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 201 KWMALESLQTQKFTTKSDVW 220

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 73/141 (51%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 179 IKWTAPEAALYGRFTIKSDVW 199

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 22/163 (13%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   + +      +LV+ F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 113
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   + L  +  E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 114 -DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKI 167
Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
            DFGL+   +          +  Y APEV L +  Y++ V+ +
Sbjct: 168 LDFGLA--RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 208

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 20/150 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           EL  L    H NII + D  +          +++V++     +L   I     +  +  R
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVR 162
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLYPGN--- 121
            FL QL  GL+ ++S  +IHRDLKP N+L   ++++  LKI DFG++   CT  P     
Sbjct: 163 YFLYQLLRGLKYMHSAQVIHRDLKPSNLL---VNENCELKIGDFGMARGLCT-SPAEHQY 218
Query: 122 YAEKVCGSPLYMAPE-VLQFQRYDEKVNFF 150
           +  +   +  Y APE +L    Y + ++ +
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLW 248

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 157
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 214
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 250

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 128
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 185
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 221

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 122
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 179
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 215

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 126
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 183
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 219

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 129
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 186
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 128
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 185
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 221

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 345 IKWTAPEAALYGRFTIKSDVW 365

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 18/141 (12%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72
            E N + ++ H  +++L  A   +  I+++ EF A G+L  +++     + P      F 
Sbjct: 226 AEANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 284
Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL         A      P
Sbjct: 285 AQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGL---------ARVGAKFP 332
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE + F  +  K + +
Sbjct: 333 IKWTAPEAINFGSFTIKSDVW 353

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 21/154 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------HGRVPEQTA 68
           E + +   N  +++RL           +++E    G+L SY+R        +  +   + 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 69  RKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
            K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 128 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 184
Query: 124 EKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
            K     L   +M+PE L+   F  Y +  +F V
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 218

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 345 IKWTAPEAALYGRFTIKSDVW 365

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 135
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETD 192
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 56  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 171
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 172 IKWTAPEAALYGRFTIKSDVW 192

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 179 IKWTAPEAALYGRFTIKSDVW 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 54  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 169
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 170 IKWTAPEAALYGRFTIKSDVW 190

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 52  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 167
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 168 IKWTAPEAALYGRFTIKSDVW 188

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 21/154 (13%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------HGRVPEQTA 68
           E + +   N  +++RL           +++E    G+L SY+R        +  +   + 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 69  RKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
            K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194
Query: 124 EKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
            K     L   +M+PE L+   F  Y +  +F V
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 68/140 (48%), Gaps = 12/140 (8%)
Query: 20  LSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQL-- 75
           +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  Q+  
Sbjct: 86  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 145
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL-- 131
           G++ L S   +HRDL   N +   LD+   +K+ADFGL+  +    +       G+ L  
Sbjct: 146 GMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 132 -YMAPEVLQFQRYDEKVNFF 150
            +MA E LQ Q++  K + +
Sbjct: 203 KWMALESLQTQKFTTKSDVW 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 23/149 (15%)
Query: 10  KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE--- 65
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 66  ------QTARK-----FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
                  TA       F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFG 209
Query: 113 LSCTLY-PGNYAEKVCGS-PL-YMAPEVL 138
           L+  +    NY  K     P+ +MAPE +
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESI 238

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 23/149 (15%)
Query: 10  KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-- 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 67  ---------TARKFLQ-----QLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
                    + R  L        G+  L S + IHRD+   N+LL+   +  + KI DFG
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFG 209
Query: 113 LSCTLY-PGNYAEKVCGS-PL-YMAPEVL 138
           L+  +    NY  K     P+ +MAPE +
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESI 238

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 53  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 111
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHRDL   NIL   ++++  +KI DFGL+  L    
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL---VENENRVKIGDFGLTKVLPQDK 168
Query: 122 YAEKV---CGSPL-YMAPEVLQFQRY 143
              KV     SP+ + APE L   ++
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKF 194

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 16/134 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
           E+  L    H NII + D  +A        ++LV     G +L   ++      +     
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICY- 148
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 205
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 206 EYVATRWYRAPEIM 219

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 122
Query: 67  TARKFLQQL-----GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q       G+  LN++  +HRDL   N  ++   +D  +KI DFG++  +Y  +
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVA---EDFTVKIGDFGMTRDIYETD 179
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
           Y  K     L   +M+PE L+   F  Y +  +F V
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 157

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 230 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 288
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL   +    Y A +    P
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLGRLIEDNEYTARQGAKFP 345
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 346 IKWTAPEAALYGRFTIKSDVW 366

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 161

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 25/149 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHG-------RVP 64
           E+  L  + H NI++   A +    +    +L+  F   G+LS +++ +         + 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 65  EQTAR--KFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           E  AR   +L +   GL+  +   I HRD+K +N+LL    +++   IADFGL+     G
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAG 184
Query: 121 NYAEKV---CGSPLYMAPEVLQ----FQR 142
             A       G+  YMAPEVL+    FQR
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQR 213

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 22/163 (13%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   + +      +LV+ F   
Sbjct: 72  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 131
Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   + +     E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 132 -DLQKIMGME--FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL---AVNEDCELKI 185
Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
            DFGL+   +          +  Y APEV L +  Y++ V+ +
Sbjct: 186 LDFGLA--RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 226

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 157

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 167

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 157

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 124 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 161

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G+  L S   IHRDL   N+LL+  D   ++KI DFGL
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGL 167

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 179 IKWTAPEAALYGRFTIKSDVW 199

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++       R+P+      
Sbjct: 229 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 345 IKWTAPEAALYGRFTIKSDVW 365

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 34/137 (24%), Positives = 70/137 (51%), Gaps = 10/137 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 312 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE   + R+  K
Sbjct: 428 IKWTAPEAALYGRFTIK 444

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 63/147 (42%), Gaps = 11/147 (7%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           M+    + LK   D E+   +   H N++ L       + + LV  +   G+L   +   
Sbjct: 56  MVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL 115
Query: 61  GRVPEQTAR---KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-- 113
              P  +     K  Q    G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL  
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLAR 172
Query: 114 -SCTLYPGNYAEKVCGSPLYMAPEVLQ 139
            S          ++ G+  Y APE L+
Sbjct: 173 ASEKFAQXVXXSRIVGTTAYXAPEALR 199

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 70/141 (49%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++       R+P+      
Sbjct: 60  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 176 IKWTAPEAALYGRFTIKSDVW 196

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 70/157 (44%), Gaps = 24/157 (15%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 103 LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 149
Query: 59  -LHGRVPEQTARKFLQQLGLEIL----NSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
              G V     RKF QQ+   +L        IIH DLKPENILL        +KI DFG 
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGS 207
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           SC L  G    +   S  Y +PEVL    YD  ++ +
Sbjct: 208 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMW 242

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 16/128 (12%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCI-----FLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL+D    ++ +     ++V+E  A  
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L    +    + E+  +  L  L  G   ++   IIHRDLKP N L   L+ D  +K+ 
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171
Query: 110 DFGLSCTL 117
           DFGL+ T+
Sbjct: 172 DFGLARTI 179

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 15/142 (10%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHG-RV 63
           +HL+   + E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+
Sbjct: 54  EHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 112
Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 ++  Q+  G+E L +   IHR+L   NIL   ++++  +KI DFGL+  L P +
Sbjct: 113 DHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNIL---VENENRVKIGDFGLTKVL-PQD 168
Query: 122 ---YAEKVCG-SPL-YMAPEVL 138
              Y  K  G SP+ + APE L
Sbjct: 169 KEYYKVKEPGESPIFWYAPESL 190

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL   NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 179 IKWTAPEAALYGRFTIKSDVW 199

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 74/142 (52%), Gaps = 17/142 (11%)
Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+ +  +  +DC     E+  L+ +NH +++++ D    ++      +++V+E  A  
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141
Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +     R    + E   +  L  L  G++ ++S  I+HRDLKP N L   ++ D  +K+ 
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198
Query: 110 DFGLSCTL-YPGNYAEKVCGSP 130
           DFGL+ T+ YP N   ++  SP
Sbjct: 199 DFGLARTVDYPENGNSQLPISP 220

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 70/157 (44%), Gaps = 24/157 (15%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 84  LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 130
Query: 59  -LHGRVPEQTARKFLQQLGLEIL----NSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
              G V     RKF QQ+   +L        IIH DLKPENILL        +KI DFG 
Sbjct: 131 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGS 188
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           SC L  G    +   S  Y +PEVL    YD  ++ +
Sbjct: 189 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMW 223

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 70/157 (44%), Gaps = 24/157 (15%)
Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-- 58
           +L+ +NKH     D E+ +        I+ L   F   N + LV E  +  NL   +R  
Sbjct: 103 LLELMNKH-----DTEMKYY-------IVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNT 149
Query: 59  -LHGRVPEQTARKFLQQLGLEIL----NSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
              G V     RKF QQ+   +L        IIH DLKPENILL        +KI DFG 
Sbjct: 150 NFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRXAIKIVDFGS 207
Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           SC L  G    +   S  Y +PEVL    YD  ++ +
Sbjct: 208 SCQL--GQRIYQXIQSRFYRSPEVLLGMPYDLAIDMW 242

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 25/142 (17%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK-------FLQQ 74
           S +HPN+IR + +   +  +++ +E C   NL   +       E    +        L+Q
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGLSCTLYPGNY 122
           +  G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL   L  G  
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 123 AEKV-----CGSPLYMAPEVLQ 139
           + +       G+  + APE+L+
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLE 205

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 17/146 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQT 67
           E+  L+  +HPNI+ L D F      A + ++LV E     +L+  I  H +   +  Q 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135
Query: 68  ARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
            + F+    LGL +L+   ++HRDL P NILL+  +D   + I DF L+           
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTH 192
Query: 126 VCGSPLYMAPE-VLQFQRYDEKVNFF 150
                 Y APE V+QF+ + + V+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMW 218

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL   F +      E  + LV+++           Y R    +P  
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 201
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 202 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 259
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 260 SYICSRYYRAPELI 273

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 71/146 (48%), Gaps = 17/146 (11%)
Query: 16  ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQT 67
           E+  L+  +HPNI+ L D F      A + ++LV E     +L+  I  H +   +  Q 
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQH 135
Query: 68  ARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
            + F+    LGL +L+   ++HRDL P NILL+  +D   + I DF L+           
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND---ITICDFNLAREDTADANKTH 192
Query: 126 VCGSPLYMAPE-VLQFQRYDEKVNFF 150
                 Y APE V+QF+ + + V+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMW 218

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 83/165 (50%), Gaps = 20/165 (12%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 39  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 97
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 98  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 154
Query: 109 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVNFFV 151
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    + ++
Sbjct: 155 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 199

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 22/148 (14%)
Query: 24  NHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQL--- 75
           NHPNI+RL         A++  +L++ F   G L + I RL  +    T  + L  L   
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEK 125
             GLE +++    HRDLKP NILL      V++ +     +C    G        ++A +
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 126 VCGSPLYMAPEVLQFQRY---DEKVNFF 150
            C +  Y APE+   Q +   DE+ + +
Sbjct: 204 RC-TISYRAPELFSVQSHCVIDERTDVW 230

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 83/165 (50%), Gaps = 20/165 (12%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 35  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 93
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 94  ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 150
Query: 109 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVNFFV 151
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    + ++
Sbjct: 151 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 195

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 83/165 (50%), Gaps = 20/165 (12%)
Query: 3   KKLNKHLKSCL-DCELN----------FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
           +K+N  +K+C  DC L+           + +++HP+I++L    + E   ++++E    G
Sbjct: 51  EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYG 109
Query: 52  NLSSYI-RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            L  Y+ R    +   T   +  Q+   +  L S + +HRD+   NIL++  +    +K+
Sbjct: 110 ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKL 166
Query: 109 ADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVNFFV 151
            DFGLS  +   +Y +  V   P+ +M+PE + F+R+    + ++
Sbjct: 167 GDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWM 211

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 59/129 (45%), Gaps = 20/129 (15%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 132 -YMAPEVLQ 139
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 59/129 (45%), Gaps = 20/129 (15%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 136
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 137 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 193
Query: 132 -YMAPEVLQ 139
            +MAPE L+
Sbjct: 194 RWMAPESLK 202

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 59/129 (45%), Gaps = 20/129 (15%)
Query: 27  NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--- 75
           +++RL           +V+E  A G+L SY+R          GR P  T ++ +Q     
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPTLQEMIQMAAEI 139
Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-- 131
             G+  LN+   +HRDL   N +++    D  +KI DFG++  +   +   K     L  
Sbjct: 140 ADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV 196
Query: 132 -YMAPEVLQ 139
            +MAPE L+
Sbjct: 197 RWMAPESLK 205

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 72/141 (51%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 179 IKWTAPEAALYGRFTIKSDVW 199

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/148 (23%), Positives = 66/148 (44%), Gaps = 22/148 (14%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +   +H NIIRL         + ++ E+   G L  ++R      E+     + QL
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR------EKDGEFSVLQL 149
Query: 76  ---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYA 123
                    G++ L + + +HRDL   NIL   ++ +++ K++DFGLS  L       Y 
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 124 EKVCGSPL-YMAPEVLQFQRYDEKVNFF 150
                 P+ + APE + ++++    + +
Sbjct: 207 TSGGKIPIRWTAPEAISYRKFTSASDVW 234

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+ + G L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y A +    P
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 179 IKWTAPEAALYGRFTIKSDVW 199

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 72/139 (51%), Gaps = 14/139 (10%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q+  G
Sbjct: 69  IGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPL- 131
           +  L  H ++HR+L   N+LL        +++ADFG++  L P +    Y+E    +P+ 
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIK 182
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MA E + F +Y  + + +
Sbjct: 183 WMALESIHFGKYTHQSDVW 201

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKIXDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/142 (23%), Positives = 71/142 (50%), Gaps = 12/142 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V+E+ + G+L  +++     + R+P+      
Sbjct: 63  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  L   N      G+  
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA-RLIEDNEXTARQGAKF 177
Query: 132 ---YMAPEVLQFQRYDEKVNFF 150
              + APE   + R+  K + +
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVW 199

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 72/139 (51%), Gaps = 14/139 (10%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--G 76
           + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q+  G
Sbjct: 87  IGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 145
Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPL- 131
           +  L  H ++HR+L   N+LL        +++ADFG++  L P +    Y+E    +P+ 
Sbjct: 146 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSE--AKTPIK 200
Query: 132 YMAPEVLQFQRYDEKVNFF 150
           +MA E + F +Y  + + +
Sbjct: 201 WMALESIHFGKYTHQSDVW 219

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 13/143 (9%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEF-CAGGNLSSYIRL--HG 61
           K L+   D +     S+   +I++L D F  +  N + +V+ F   G NL + I+   H 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 62  RVPEQTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLDDD---VMLKIADFGLSC 115
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KIAD G +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 116 TLYPGNYAEKVCGSPLYMAPEVL 138
             Y  +Y   +  +  Y +PEVL
Sbjct: 187 -WYDEHYTNSIQ-TREYRSPEVL 207

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 74/143 (51%), Gaps = 13/143 (9%)
Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEF-CAGGNLSSYIRL--HG 61
           K L+   D +     S+   +I++L D F  +  N + +V+ F   G NL + I+   H 
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 62  RVPEQTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLDDD---VMLKIADFGLSC 115
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KIAD G +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 116 TLYPGNYAEKVCGSPLYMAPEVL 138
             Y  +Y   +  +  Y +PEVL
Sbjct: 187 -WYDEHYTNSIQ-TREYRSPEVL 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/141 (23%), Positives = 70/141 (49%), Gaps = 10/141 (7%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++       R+P+      
Sbjct: 60  EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 130
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    + A +    P
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 131 L-YMAPEVLQFQRYDEKVNFF 150
           + + APE   + R+  K + +
Sbjct: 176 IKWTAPEAALYGRFTIKSDVW 196

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSD---LKICDFGLARVADPDHDHTGFLT 187
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 188 EYVATRWYRAPEIM 201

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 30/151 (19%)
Query: 16  ELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFC--------AGGNLSSY-IRLHGRVPE 65
           E+  L+ S +HPN+IR + +   +  +++ +E C           N+S   ++L     E
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK---E 132
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGL 113
                 L+Q+  G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 114 SCTLYPGNYAEKV-----CGSPLYMAPEVLQ 139
              L  G    +       G+  + APE+L+
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLE 223

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 25/142 (17%)
Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK-------FLQQ 74
           S +HPN+IR + +   +  +++ +E C   NL   +       E    +        L+Q
Sbjct: 65  SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGLSCTLYPGNY 122
           +  G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL   L  G  
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 183
Query: 123 AEKV-----CGSPLYMAPEVLQ 139
             +       G+  + APE+L+
Sbjct: 184 XFRXNLNNPSGTSGWRAPELLE 205

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 30/151 (19%)
Query: 16  ELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFC--------AGGNLSSY-IRLHGRVPE 65
           E+  L+ S +HPN+IR + +   +  +++ +E C           N+S   ++L     E
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK---E 132
Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD----------DDVMLKIADFGL 113
                 L+Q+  G+  L+S  IIHRDLKP+NIL+S             +++ + I+DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 114 SCTLYPGNYAEKV-----CGSPLYMAPEVLQ 139
              L  G    +       G+  + APE+L+
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLE 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 14/147 (9%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR------VPEQTA 68
            E+  +S   H N++RL           LV  + A G+++S +R           P++  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 69  RKFLQQLGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA- 123
                  GL  L+ H    IIHRD+K  NIL   LD++    + DFGL+  + Y   +  
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDXHVX 200
Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             V G+  ++APE L   +  EK + F
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVF 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 181 SXICSRYYRAPELI 194

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 181 SXICSRYYRAPELI 194

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 12/140 (8%)
Query: 13  LDCELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTAR 69
           L  E+  L ++ H NI++          N I L++EF   G+L  Y+ +   ++  +   
Sbjct: 70  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129
Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
           K+  Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+  +        V 
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEXXTVK 186
Query: 128 ---GSPL-YMAPEVLQFQRY 143
               SP+ + APE L   ++
Sbjct: 187 DDRDSPVFWYAPECLMQSKF 206

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTA 68
           L  E+  L ++ H NI++ +     E   N I L++EF   G+L  Y+ +   ++  +  
Sbjct: 58  LKKEIEILRNLYHENIVK-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 116
Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
            K+  Q+  G++ L S   +HRDL   N+L   ++ +  +KI DFGL+  +        V
Sbjct: 117 LKYAVQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 127 C---GSPL-YMAPEVLQFQRY 143
                SP+ + APE L   ++
Sbjct: 174 KDDRDSPVFWYAPECLMQSKF 194

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 163
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 164 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 220
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 221 LQDYDYSLDMW 231

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 144 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 200
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 201 LQDYDYSLDMW 211

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 26/146 (17%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 122
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 117
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 179
Query: 118 -YPGNYAEKVCGSPLYMAPEVLQFQR 142
             P  Y  +V  +  Y  PE+L  +R
Sbjct: 180 SQPNRYXNRVV-TLWYRPPELLLGER 204

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 143
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 144 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 200
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 201 LQDYDYSLDMW 211

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GL 77
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYTXIQSRFYRAPEV 270
Query: 138 LQFQRYDEKVNFF 150
           +   RY   ++ +
Sbjct: 271 ILGARYGMPIDMW 283

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 144
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 145 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 201
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 202 LQDYDYSLDMW 212

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 66/131 (50%), Gaps = 12/131 (9%)
Query: 26  PNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNI++L D    Q      L+ E+    N + +  L+  + +   R ++ +L   L+  +
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCH 142
Query: 82  SHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-Q 139
           S  I+HRD+KP N++   +D ++  L++ D+GL+   +PG        S  +  PE+L  
Sbjct: 143 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 140 FQRYDEKVNFF 150
            Q YD  ++ +
Sbjct: 200 LQDYDYSLDMW 210

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 26/146 (17%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFT 123
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 117
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 118 -YPGNYAEKVCGSPLYMAPEVLQFQR 142
             P  Y  +V  +  Y  PE+L  +R
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGER 205

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GL 77
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYTXIQSRFYRAPEV 270
Query: 138 LQFQRYDEKVNFF 150
           +   RY   ++ +
Sbjct: 271 ILGARYGMPIDMW 283

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 14/147 (9%)
Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR------VPEQTA 68
            E+  +S   H N++RL           LV  + A G+++S +R           P++  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 69  RKFLQQLGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA- 123
                  GL  L+ H    IIHRD+K  NIL   LD++    + DFGL+  + Y   +  
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLAKLMDYKDXHVX 192
Query: 124 EKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             V G   ++APE L   +  EK + F
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVF 219

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 12/133 (9%)
Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GL 77
           N  N+I + + F   N I +  E  +  NL   I+ +      +P    RKF   +   L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCL 213
Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           + L+ + IIH DLKPENILL        +K+ DFG SC  Y          S  Y APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLK-QQGRSGIKVIDFGSSC--YEHQRVYXXIQSRFYRAPEV 270
Query: 138 LQFQRYDEKVNFF 150
           +   RY   ++ +
Sbjct: 271 ILGARYGMPIDMW 283

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 26/146 (17%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFT 123
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 117
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 118 -YPGNYAEKVCGSPLYMAPEVLQFQR 142
             P  Y  +V  +  Y  PE+L  +R
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGER 205

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 187
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 188 EYVATRWYRAPEIM 201

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 53  LSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           L S+IR    +P      ++ QL   +  ++S  I HRD+KP+N+L++  D+   LK+ D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN--TLKLCD 185
Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAPEVL 138
           FG +  L P   +     S  Y APE++
Sbjct: 186 FGSAKKLIPSEPSVAXICSRFYRAPELM 213

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 131 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 187
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 188 EYVATRWYRAPEIM 201

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 19/145 (13%)
Query: 10  KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQ 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R      + ++
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 67  TARK--------FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
             R         F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARD 209
Query: 117 LY-PGNYAEKVCGS-PL-YMAPEVL 138
           +    NY  K     P+ +MAPE +
Sbjct: 210 IMNDSNYIVKGNARLPVKWMAPESI 234

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 124 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 181
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 182 SXICSRYYRAPELI 195

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 181 SXICSRYYRAPELI 194

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 26/146 (17%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--------IFLVVEFCA---GGNLSSYIRLHGRVP 64
           E+  L  + H N++ L +  + +          I+LV +FC     G LS+ +    +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFT 123
Query: 65  EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----- 117
               ++ +Q L  GL  ++ + I+HRD+K  N+L++    D +LK+ADFGL+        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKN 180
Query: 118 -YPGNYAEKVCGSPLYMAPEVLQFQR 142
             P  Y  +V  +  Y  PE+L  +R
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGER 205

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 183
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 184 EYVATRWYRAPEIM 197

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 127 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 183
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 184 EYVATRWYRAPEIM 197

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 205
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 206 EYVATRWYRAPEIM 219

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 137 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 193
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 194 EYVATRWYRAPEIM 207

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 129 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 185
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 186 EYVATRWYRAPEIM 199

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 190
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 191 EYVATRWYRAPEIM 204

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 135 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 191
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 192 EYVATRWYRAPEIM 205

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 126 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 182
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 183 EYVATRWYRAPEIM 196

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLT 189
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 190 EYVATRWYRAPEIM 203

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLX 189
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 190 EXVATRWYRAPEIM 203

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 181 SXICSRYYRAPELI 194

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 44/74 (59%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAE 124
           FL Q+  GL+ ++S +++HRDLKP N+LL+   D   LKI DFGL+    P +    +  
Sbjct: 134 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLX 190
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 191 EXVATRWYRAPEIM 204

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS---YIRLHGRVPEQ 66
           EL  +  V HPN++ L   F      + E  + LV+E+       +   Y +L   +P  
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML 141
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL       +LK+ DFG +  L  G    
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPNV 199
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 200 SXICSRYYRAPELI 213

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 127 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 184
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 185 SXICSRYYRAPELI 198

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 19/145 (13%)
Query: 10  KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQ 66
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R      + ++
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 67  TARK--------FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
             R         F  Q+  G+  L S + IHRD+   N+LL+   +  + KI DFGL+  
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARD 201
Query: 117 LY-PGNYAEKVCGS-PL-YMAPEVL 138
           +    NY  K     P+ +MAPE +
Sbjct: 202 IMNDSNYIVKGNARLPVKWMAPESI 226

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 181 SYICSRYYRAPELI 194

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 142 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 199
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 200 SXICSRYYRAPELI 213

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 181 SYICSRYYRAPELI 194

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 131 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 188
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 189 SXICSRYYRAPELI 202

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 193 SXICSRYYRAPELI 206

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 135 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 192
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 193 SXICSRYYRAPELI 206

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/118 (34%), Positives = 53/118 (44%), Gaps = 24/118 (20%)
Query: 42  FLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGLEILNSHH----IIHRDL 90
            LV+E+   G+L  Y+ LH        R+     R  L  L  E+    H    I HRDL
Sbjct: 88  LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRG-LAYLHTELPRGDHYKPAISHRDL 146
Query: 91  KPENILLSGLDDDVMLKIADFGLSCTLY------PG---NYAEKVCGSPLYMAPEVLQ 139
              N+L+    +D    I+DFGLS  L       PG   N A    G+  YMAPEVL+
Sbjct: 147 NSRNVLVK---NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 181 SYICSRYYRAPELI 194

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 63/147 (42%), Gaps = 24/147 (16%)
Query: 19  FLSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE---------QTA 68
            +  +NHPN++ L       E    +++ +   G+L  +IR   R P          Q A
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134
Query: 69  RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AE 124
           R      G+E L     +HRDL   N +   LD+   +K+ADFGL+  +    Y      
Sbjct: 135 R------GMEYLAEQKFVHRDLAARNCM---LDESFTVKVADFGLARDILDREYYSVQQH 185
Query: 125 KVCGSPL-YMAPEVLQFQRYDEKVNFF 150
           +    P+ + A E LQ  R+  K + +
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVW 212

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGNLS---SYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 136 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 193
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 194 SYICSRYYRAPELI 207

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 128 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 185
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 186 SYICSRYYRAPELI 199

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 215 SXICSRYYRAPELI 228

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 70/142 (49%), Gaps = 12/142 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
           E   +  + H  +++L+ A  +E  I +V E+ + G+L  +++       R+P+      
Sbjct: 53  EAQVMKKLRHEKLVQLY-AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 111
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-- 129
               G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  L   N      G+  
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLA-RLIEDNEXTARQGAKF 167
Query: 130 PL-YMAPEVLQFQRYDEKVNFF 150
           P+ + APE   + R+  K + +
Sbjct: 168 PIKWTAPEAALYGRFTIKSDVW 189

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 150
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 151 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 208
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 209 SYICSRYYRAPELI 222

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+L+    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVLIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 27/152 (17%)
Query: 10  KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP---- 64
           K  L  EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   R P    
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKRPPGLEY 151
Query: 65  ---------EQTARK----FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                    EQ + +    F  Q+  G+  L S + IHRD+   N+LL+   +  + KI 
Sbjct: 152 SYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIG 208
Query: 110 DFGLSCTLY-PGNYAEKVCGS-PL-YMAPEVL 138
           DFGL+  +    NY  K     P+ +MAPE +
Sbjct: 209 DFGLARDIMNDSNYIVKGNARLPVKWMAPESI 240

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 33/168 (19%)
Query: 1   MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           MLK K +   +  L  EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R
Sbjct: 82  MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 141
Query: 59  L--------------HGRVPEQTARKFLQ-----------QLGLEILNSHHIIHRDLKPE 93
                            R+ E+     L              G+E L     +HRDL   
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201
Query: 94  NILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS-PL-YMAPEVL 138
           N+L++      ++KI DFGL+  +    NY  +     P+ +MAPE L
Sbjct: 202 NVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 214
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 215 SYICSRYYRAPELI 228

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 67/142 (47%), Gaps = 12/142 (8%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGR---VPEQTARKF 71
           E   +  + H  +++L+ A  +E  I++V E+   G+L  +++   GR   +P       
Sbjct: 54  EAQIMKKLKHDKLVQLY-AVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAA 112
Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
               G+  +   + IHRDL+  NIL+    + ++ KIADFGL+  L   N      G+  
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVG---NGLICKIADFGLA-RLIEDNEXTARQGAKF 168
Query: 132 ---YMAPEVLQFQRYDEKVNFF 150
              + APE   + R+  K + +
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVW 190

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 158
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 159 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 216
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 217 SYICSRYYRAPELI 230

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 16  ELNFLSSVNHPNIIRL----FDAFQAENCIFL--VVEFCAGGN---LSSYIRLHGRVPEQ 66
           EL  +  ++H NI+RL    + + + ++ ++L  V+++           Y R    +P  
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 160
Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ DFG +  L  G    
Sbjct: 161 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNV 218
Query: 125 KVCGSPLYMAPEVL 138
               S  Y APE++
Sbjct: 219 SYICSRYYRAPELI 232

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/78 (38%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--PGNYAEKVCGSPL-Y 132
           G+E L+S   IHRDL   NILLS   ++ ++KI DFGL+  +Y  P    +     PL +
Sbjct: 211 GMEFLSSRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKW 267
Query: 133 MAPEVLQFQRYDEKVNFF 150
           MAPE +  + Y  K + +
Sbjct: 268 MAPESIFDKIYSTKSDVW 285

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 129
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +   +
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETD 186
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
              K     L   +M+PE L+   F  Y +  +F V
Sbjct: 187 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 222

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 25/156 (16%)
Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E + +   N  +++RL           +++E    G+L SY+R     PE          
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVLAPP 120
Query: 67  TARKFLQQLG-----LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  K +Q  G     +  LN++  +HRDL   N +++   +D  +KI DFG++  +   +
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIXETD 177
Query: 122 YAEKVCGSPL---YMAPEVLQ---FQRYDEKVNFFV 151
              K     L   +M+PE L+   F  Y +  +F V
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 27/74 (36%), Positives = 43/74 (58%), Gaps = 9/74 (12%)
Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAE 124
           FL Q+  GL+ ++S +++HRDLKP N+L++   D   LKI DFGL+    P      +  
Sbjct: 149 FLYQILRGLKYIHSANVLHRDLKPSNLLINTTCD---LKICDFGLARIADPEHDHTGFLT 205
Query: 125 KVCGSPLYMAPEVL 138
           +   +  Y APE++
Sbjct: 206 EXVATRWYRAPEIM 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 7/93 (7%)
Query: 25  HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG-LEILN 81
           H NI+ L +  +A+N   ++LV ++    +L + IR +   P        Q +  ++ L+
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           S  ++HRD+KP NILL+    +  +K+ADFGLS
Sbjct: 127 SGGLLHRDMKPSNILLNA---ECHVKVADFGLS 156

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 27/65 (41%), Positives = 34/65 (52%), Gaps = 10/65 (15%)
Query: 85  IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV---CGSPLYMAPEVLQ-- 139
           I HRD K +N+LL     D+   +ADFGL+    PG          G+  YMAPEVL+  
Sbjct: 144 IAHRDFKSKNVLLK---SDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGA 200
Query: 140 --FQR 142
             FQR
Sbjct: 201 INFQR 205

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L+  +  + + L  EL+     NHPNI+     F A+N +++V  F A G+    I  H 
Sbjct: 62  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121
Query: 61  --GRVPEQTARKFLQQLGLEILNS-HHI--IHRDLKPENILLSGLDDDVMLKIADFGLSC 115
             G    + A  ++ Q  L+ L+  HH+  +HR +K  +IL+S +D  V L      LS 
Sbjct: 122 MDGM--NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSM 178
Query: 116 TLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVNFF 150
             + G     V   P Y       ++PEVLQ   Q YD K + +
Sbjct: 179 ISH-GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 64/142 (45%), Gaps = 14/142 (9%)
Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGLEI 79
           + S + P I++ + A   E   ++ +E  +      Y  ++  + +    + L ++ L  
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLAT 134
Query: 80  LNSHH-------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           + + +       IIHRD+KP NIL   LD    +K+ DFG+S  L       +  G   Y
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNIL---LDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPY 191
Query: 133 MAPEVL----QFQRYDEKVNFF 150
           MAPE +      Q YD + + +
Sbjct: 192 MAPERIDPSASRQGYDVRSDVW 213

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           L+  +  + + L  EL+     NHPNI+     F A+N +++V  F A G+    I  H 
Sbjct: 46  LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 105
Query: 61  --GRVPEQTARKFLQQLGLEILNS-HHI--IHRDLKPENILLSGLDDDVMLKIADFGLSC 115
             G    + A  ++ Q  L+ L+  HH+  +HR +K  +IL+S +D  V L      LS 
Sbjct: 106 MDGM--NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSM 162
Query: 116 TLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVNFF 150
             + G     V   P Y       ++PEVLQ   Q YD K + +
Sbjct: 163 ISH-GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 205

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 153
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 154 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 212 QMYDYSLDMW 221

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 146
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 147 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 205 QMYDYSLDMW 214

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 149 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 207 QMYDYSLDMW 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 15/120 (12%)
Query: 43  LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSG 99
           LV+E+   G L  +++ H  R+       +  Q+  G+E L S   +HRDL   NIL   
Sbjct: 87  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL--- 143
Query: 100 LDDDVMLKIADFGLSCTLYPGNYAEKVCGSP-----LYMAPEVLQ---FQRYDEKVNFFV 151
           ++ +  +KIADFGL+  L P +    V   P      + APE L    F R  +  +F V
Sbjct: 144 VESEAHVKIADFGLA-KLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 202

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 206 QMYDYSLDMW 215

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 64/130 (49%), Gaps = 10/130 (7%)
Query: 26  PNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
           PNII L D  +        LV E     N + + +L+  + +   R ++ ++   L+  +
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHV---NNTDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL-QF 140
           S  I+HRD+KP N+++    +   L++ D+GL+   +PG        S  +  PE+L  +
Sbjct: 148 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 141 QRYDEKVNFF 150
           Q YD  ++ +
Sbjct: 206 QMYDYSLDMW 215
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	152
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-53
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-50
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-50
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-50
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-50
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-50
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-49
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-49
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-49
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-49
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-49
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-49
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-48
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-48
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-47
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-47
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-47
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-46
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-46
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-46
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-46
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-46
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-46
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-46
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-46
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-46
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-45
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-45
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-45
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-45
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-45
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-45
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-45
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-45
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-45
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-45
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-45
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-45
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-44
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-44
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-44
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-44
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-44
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-43
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-43
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-42
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-42
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-42
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-42
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-42
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-42
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-42
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-42
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-41
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-40
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-40
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-38
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-38
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-38
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-38
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-36
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-36
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-36
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-36
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-35
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-35
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-35
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-34
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-34
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-34
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-33
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-33
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-33
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-33
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-32
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-32
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-32
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-32
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-31
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-31
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-31
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-31
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-31
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-30
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-30
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-28
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-28
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-28
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-27
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-26
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-25
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-24
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-23
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-23
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-22
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-20
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-20
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-17
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-17
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-15
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-14
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-05

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  176 bits (447), Expect = 6e-53
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 11/156 (7%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSY 56
           ++L+   +     E+  +  +NHPN++   +       +       L +E+C GG+L  Y
Sbjct: 49  QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY 108

Query: 57  IRLHGR---VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
           +        + E   R  L  +   L  L+ + IIHRDLKPENI+L      ++ KI D 
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168

Query: 112 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
           G +  L  G    +  G+  Y+APE+L+ ++Y   V
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTV 204

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  163 bits (414), Expect = 1e-50
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 17/161 (10%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLH 60
               + +      E   L  +NH NI++LF   +        L++EFC  G+L + +   
Sbjct: 45  ISFLRPVDV-QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103

Query: 61  GR---VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLS 114
                +PE      L+ +  G+  L  + I+HR++KP NI+   G D   + K+ DFG +
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKV 147
             L        + G+  Y+ P++ +         ++Y   V
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  161 bits (409), Expect = 2e-50
 Identities = 46/146 (31%), Positives = 77/146 (52%), Gaps = 10/146 (6%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
            +   L+     E+   S + HPNI+RL+  F     ++L++E+   G +   ++   + 
Sbjct: 51  GVEHQLRR----EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF 106

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
            EQ    ++ +L   L   +S  +IHRD+KPEN+L   L     LKIADFG S    P +
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWS-VHAPSS 162

Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKV 147
               +CG+  Y+ PE+++ + +DEKV
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKV 188

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  162 bits (411), Expect = 4e-50
 Identities = 52/137 (37%), Positives = 81/137 (59%), Gaps = 6/137 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + +  Q+
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183

Query: 134 APEVLQ---FQRYDEKV 147
           APEVL       Y+  V
Sbjct: 184 APEVLVSVGTAGYNRAV 200

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  160 bits (407), Expect = 6e-50
 Identities = 50/146 (34%), Positives = 80/146 (54%), Gaps = 10/146 (6%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
            +   L+     E+   S + HPNI+R+++ F     I+L++EF   G L   ++ HGR 
Sbjct: 56  GVEHQLRR----EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
            EQ +  F+++L   L   +   +IHRD+KPEN+L   +     LKIADFG S    P  
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLL---MGYKGELKIADFGWS-VHAPSL 167

Query: 122 YAEKVCGSPLYMAPEVLQFQRYDEKV 147
               +CG+  Y+ PE+++ + +DEKV
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKV 193

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  161 bits (410), Expect = 7e-50
 Identities = 43/135 (31%), Positives = 78/135 (57%), Gaps = 6/135 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++   S+ H +++     F+  + +F+V+E C   +L    +    + E  AR +L+Q+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 132
             G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G   + +CG+P Y
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207

Query: 133 MAPEVLQFQRYDEKV 147
           +APEVL  + +  +V
Sbjct: 208 IAPEVLSKKGHSFEV 222

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  159 bits (405), Expect = 1e-49
 Identities = 45/134 (33%), Positives = 71/134 (52%), Gaps = 3/134 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  + S++HPNIIRL++ F+    I+LV+E C GG L   +       E  A + ++ +
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +   +  ++ HRDLKPEN L      D  LK+ DFGL+    PG       G+P Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175

Query: 134 APEVLQFQRYDEKV 147
           +P+VL+   Y  + 
Sbjct: 176 SPQVLE-GLYGPEC 188

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  160 bits (406), Expect = 1e-49
 Identities = 43/135 (31%), Positives = 78/135 (57%), Gaps = 6/135 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++   S+ H +++     F+  + +F+V+E C   +L    +    + E  AR +L+Q+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 132
             G + L+ + +IHRDLK  N+    L++D+ +KI DFGL+  + Y G   + +CG+P Y
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181

Query: 133 MAPEVLQFQRYDEKV 147
           +APEVL  + +  +V
Sbjct: 182 IAPEVLSKKGHSFEV 196

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  159 bits (405), Expect = 1e-49
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 2/147 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 42  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKV 147
                  G+P Y++PEVL+   Y + V
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPV 188

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  162 bits (413), Expect = 2e-49
 Identities = 52/137 (37%), Positives = 81/137 (59%), Gaps = 6/137 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  +NHP II++ + F AE+  ++V+E   GG L   +  + R+ E T + +  Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++ L+ + IIHRDLKPEN+LLS  ++D ++KI DFG S  L   +    +CG+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308

Query: 134 APEVLQ---FQRYDEKV 147
           APEVL       Y+  V
Sbjct: 309 APEVLVSVGTAGYNRAV 325

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  160 bits (407), Expect = 3e-49
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 2/147 (1%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+ Q E+  +LV +   GG L   I     
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +S+ I+HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKV 147
                  G+P Y++PEVL+   Y + V
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPV 211

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  160 bits (406), Expect = 9e-49
 Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 16/148 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
           E   L  +NH NI++LF   +        L++EFC  G+L + +        +PE     
Sbjct: 57  EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
            L+ +  G+  L  + I+HR++KP NI+   G D   + K+ DFG +  L        + 
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176

Query: 128 GSPLYMAPEVLQF--------QRYDEKV 147
           G+  Y+ P++ +         ++Y   V
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATV 204

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  157 bits (399), Expect = 1e-48
 Identities = 52/147 (35%), Positives = 78/147 (53%), Gaps = 3/147 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
                   S +  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A + ++Q+  G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS      
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKV 147
              +   G+  Y+APEVL+   YDEK 
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKC 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  155 bits (393), Expect = 7e-48
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 7/151 (4%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----R 58
           K  ++     ++ E+  L S++HPNII++F+ F+  + +++V+E C GG L   I     
Sbjct: 57  KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116

Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
               + E    + ++Q+   L   +S H++H+DLKPENIL         +KI DFGL+  
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176

Query: 117 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
                ++    G+ LYMAPEV + +    K 
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKC 206

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  155 bits (395), Expect = 1e-47
 Identities = 54/144 (37%), Positives = 86/144 (59%), Gaps = 5/144 (3%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
            +LN      L  E+  +  +NHPNI++LF+  + E  ++L++E+ +GG +  Y+  HGR
Sbjct: 51  TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           + E+ AR   +Q+   ++  +   I+HRDLK EN+L   LD D+ +KIADFG S     G
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVG 167

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYD 144
              +  CG+P Y APE+ Q ++YD
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYD 191

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  152 bits (387), Expect = 5e-47
 Identities = 55/131 (41%), Positives = 76/131 (58%), Gaps = 5/131 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L    HP+II+L+         F+V+E+ +GG L  YI  HGRV E  AR+  QQ+
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              ++  + H ++HRDLKPEN+L   LD  +  KIADFGLS  +  G +    CGSP Y 
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177

Query: 134 APEVLQFQRYD 144
           APEV+  + Y 
Sbjct: 178 APEVISGRLYA 188

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  153 bits (388), Expect = 6e-47
 Identities = 51/149 (34%), Positives = 81/149 (54%), Gaps = 3/149 (2%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            +KK      S L+ E+  L  + H NI+ L D +++    +LV++  +GG L   I   
Sbjct: 41  CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           G   E+ A   +QQ+   ++ L+ + I+HRDLKPEN+L    +++  + I DFGLS    
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160

Query: 119 PGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
            G  +   CG+P Y+APEVL  + Y + V
Sbjct: 161 NGIMST-ACGTPGYVAPEVLAQKPYSKAV 188

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  153 bits (389), Expect = 1e-46
 Identities = 53/134 (39%), Positives = 76/134 (56%), Gaps = 2/134 (1%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNII+L + F+    I LV+E   GG L   I   G   E+ A   ++Q+
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +  L+ + I+HRDLKPEN+L +    D  LKIADFGLS  +      + VCG+P Y 
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217

Query: 134 APEVLQFQRYDEKV 147
           APE+L+   Y  +V
Sbjct: 218 APEILRGCAYGPEV 231

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  156 bits (396), Expect = 2e-46
 Identities = 52/147 (35%), Positives = 78/147 (53%), Gaps = 3/147 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
                   S +  E+  L  ++HPNI++LF+  +  +  ++V E   GG L   I    R
Sbjct: 58  ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A + ++Q+  G+  ++ H+I+HRDLKPENILL   + D  +KI DFGLS      
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKV 147
              +   G+  Y+APEVL+   YDEK 
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKC 203

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  156 bits (395), Expect = 2e-46
 Identities = 54/147 (36%), Positives = 85/147 (57%), Gaps = 3/147 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
             ++    S L  E+  L  ++HPNI++L+D F+ +   +LV+E   GG L   I    +
Sbjct: 73  TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK 132

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   ++Q+  G+  L+ H+I+HRDLKPEN+LL   + D ++KI DFGLS      
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192

Query: 121 NYAEKVCGSPLYMAPEVLQFQRYDEKV 147
              ++  G+  Y+APEVL+ ++YDEK 
Sbjct: 193 KKMKERLGTAYYIAPEVLR-KKYDEKC 218

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  152 bits (385), Expect = 2e-46
 Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 12/151 (7%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 176

Query: 118 YPG---NYAEKVCGSPLYMAPEVLQFQRYDE 145
            P       +   G+  YM PE ++      
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  156 bits (395), Expect = 3e-46
 Identities = 49/134 (36%), Positives = 74/134 (55%), Gaps = 3/134 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L  ++HPNI++L++ F+ +   +LV E   GG L   I    R  E  A + ++Q+
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  ++ + I+HRDLKPEN+LL     D  ++I DFGLS         +   G+  Y+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 134 APEVLQFQRYDEKV 147
           APEVL    YDEK 
Sbjct: 196 APEVLH-GTYDEKC 208

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  150 bits (382), Expect = 3e-46
 Identities = 45/136 (33%), Positives = 76/136 (55%), Gaps = 7/136 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+     + HP+I+ L++ F+  N ++LV+E C  G ++ Y++       E  AR F+ Q
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 131
           +  G+  L+SH I+HRDL   N+L   L  ++ +KIADFGL+  L  P      +CG+P 
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLL---LTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177

Query: 132 YMAPEVLQFQRYDEKV 147
           Y++PE+     +  + 
Sbjct: 178 YISPEIATRSAHGLES 193

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  152 bits (386), Expect = 3e-46
 Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 12/151 (7%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 43  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 101

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 102 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 157

Query: 118 YPG---NYAEKVCGSPLYMAPEVLQFQRYDE 145
            P       +   G+  YM PE ++      
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  150 bits (381), Expect = 4e-46
 Identities = 47/134 (35%), Positives = 75/134 (55%), Gaps = 8/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NH N+++ +   +  N  +L +E+C+GG L   I     +PE  A++F  QL
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 130
             G+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+      N      K+CG+ 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 131 LYMAPEVLQFQRYD 144
            Y+APE+L+ + + 
Sbjct: 172 PYVAPELLKRREFH 185

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  155 bits (394), Expect = 4e-46
 Identities = 54/134 (40%), Positives = 80/134 (59%), Gaps = 3/134 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L S++HPNII+LFD F+ +   +LV EF  GG L   I    +  E  A   ++Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+  L+ H+I+HRD+KPENILL   +  + +KI DFGLS             G+  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 134 APEVLQFQRYDEKV 147
           APEVL+ ++Y+EK 
Sbjct: 216 APEVLK-KKYNEKC 228

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  152 bits (385), Expect = 7e-46
 Identities = 52/131 (39%), Positives = 69/131 (52%), Gaps = 3/131 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+    S+ HPNI+R  +       + +++E+ +GG L   I   GR  E  AR F QQL
Sbjct: 66  EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G+   +S  I HRDLK EN LL G      LKI DFG S +    +  +   G+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184

Query: 134 APEVLQFQRYD 144
           APEVL  Q YD
Sbjct: 185 APEVLLRQEYD 195

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  150 bits (380), Expect = 1e-45
 Identities = 55/141 (39%), Positives = 82/141 (58%), Gaps = 12/141 (8%)

Query: 16  ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E++ L  V+ HPNII+L D ++     FLV +    G L  Y+     + E+  RK ++ 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           L   +  L+  +I+HRDLKPENILL   DDD+ +K+ DFG SC L PG    +VCG+P Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189

Query: 133 MAPEVLQ------FQRYDEKV 147
           +APE+++         Y ++V
Sbjct: 190 LAPEIIECSMNDNHPGYGKEV 210

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  152 bits (385), Expect = 1e-45
 Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 12/151 (7%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           L++ +         E+ +L+ +   +  IIRL+D    +  I++V+E C   +L+S+++ 
Sbjct: 90  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              +     + + + +   +  ++ H I+H DLKP N L+     D MLK+ DFG++  +
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 204

Query: 118 YPG---NYAEKVCGSPLYMAPEVLQFQRYDE 145
            P       +   G+  YM PE ++      
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  150 bits (381), Expect = 1e-45
 Identities = 47/134 (35%), Positives = 75/134 (55%), Gaps = 8/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+     +NH N+++ +   +  N  +L +E+C+GG L   I     +PE  A++F  QL
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 130
             G+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+      N      K+CG+ 
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 131 LYMAPEVLQFQRYD 144
            Y+APE+L+ + + 
Sbjct: 172 PYVAPELLKRREFH 185

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  153 bits (388), Expect = 1e-45
 Identities = 47/148 (31%), Positives = 73/148 (49%), Gaps = 3/148 (2%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           KKL+      L+ E      + HPNI+RL D+   E   +L+ +   GG L   I     
Sbjct: 47  KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             E  A   +QQ+   +   +   ++HR+LKPEN+LL+       +K+ADFGL+  +   
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166

Query: 121 NYA-EKVCGSPLYMAPEVLQFQRYDEKV 147
             A     G+P Y++PEVL+   Y + V
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPV 194

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  151 bits (383), Expect = 1e-45
 Identities = 48/132 (36%), Positives = 81/132 (61%), Gaps = 11/132 (8%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
            HP+II L D++++ + +FLV +    G L  Y+     + E+  R  ++ L   +  L+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-- 139
           +++I+HRDLKPENILL   DD++ ++++DFG SC L PG    ++CG+P Y+APE+L+  
Sbjct: 218 ANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274

Query: 140 ----FQRYDEKV 147
                  Y ++V
Sbjct: 275 MDETHPGYGKEV 286

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  148 bits (376), Expect = 2e-45
 Identities = 45/135 (33%), Positives = 78/135 (57%), Gaps = 3/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+N L  + HPNII L D F+ +  + L++E  +GG L  ++     + E  A +FL+Q+
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117

Query: 76  --GLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L+S  I H DLKPENI+L      +  +K+ DFG++  +  GN  + + G+P +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177

Query: 133 MAPEVLQFQRYDEKV 147
           +APE++ ++    + 
Sbjct: 178 VAPEIVNYEPLGLEA 192

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  149 bits (379), Expect = 3e-45
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 4/150 (2%)

Query: 2   LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +K ++K +++    E+  L     HPNI++L + F  +   FLV+E   GG L   I+  
Sbjct: 41  VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
               E  A   +++L   +  ++   ++HRDLKPEN+L +  +D++ +KI DFG +    
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160

Query: 119 PGNYA-EKVCGSPLYMAPEVLQFQRYDEKV 147
           P N   +  C +  Y APE+L    YDE  
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESC 190

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  149 bits (379), Expect = 3e-45
 Identities = 42/150 (28%), Positives = 78/150 (52%), Gaps = 5/150 (3%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RL 59
           ++  +  ++ +  E+  L      P +I L + ++  + I L++E+ AGG + S     L
Sbjct: 65  RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              V E    + ++Q+  G+  L+ ++I+H DLKP+NILLS +     +KI DFG+S  +
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
                  ++ G+P Y+APE+L +       
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTAT 214

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  149 bits (378), Expect = 4e-45
 Identities = 48/132 (36%), Positives = 69/132 (52%), Gaps = 6/132 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E+  LS V H NII++ D F+ +    LV+E   +G +L ++I  H R+ E  A    +Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           L   +  L    IIHRD+K ENI++    +D  +K+ DFG +  L  G      CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195

Query: 133 MAPEVLQFQRYD 144
            APEVL    Y 
Sbjct: 196 CAPEVLMGNPYR 207

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  152 bits (386), Expect = 4e-45
 Identities = 54/131 (41%), Positives = 80/131 (61%), Gaps = 5/131 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  L    HP+II+L+      + IF+V+E+ +GG L  YI  +GR+ E+ +R+  QQ+
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             G++  + H ++HRDLKPEN+L   LD  +  KIADFGLS  +  G +    CGSP Y 
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182

Query: 134 APEVLQFQRYD 144
           APEV+  + Y 
Sbjct: 183 APEVISGRLYA 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  149 bits (378), Expect = 4e-45
 Identities = 44/135 (32%), Positives = 78/135 (57%), Gaps = 3/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL+Q+
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 76  --GLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L+S  I H DLKPENI+L         +KI DFGL+  +  GN  + + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 133 MAPEVLQFQRYDEKV 147
           +APE++ ++    + 
Sbjct: 184 VAPEIVNYEPLGLEA 198

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  149 bits (379), Expect = 4e-45
 Identities = 39/139 (28%), Positives = 73/139 (52%), Gaps = 7/139 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
           E +    + HP+I+ L + + ++  +++V EF  G +L   I           E  A  +
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCG 128
           ++Q+   L   + ++IIHRD+KP  +LL+  ++   +K+  FG++  L   G  A    G
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195

Query: 129 SPLYMAPEVLQFQRYDEKV 147
           +P +MAPEV++ + Y + V
Sbjct: 196 TPHFMAPEVVKREPYGKPV 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  148 bits (376), Expect = 6e-45
 Identities = 40/135 (29%), Positives = 74/135 (54%), Gaps = 3/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  V H N+I L D ++    + L++E  +GG L  ++     + E+ A  F++Q+
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 76  --GLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L++  I H DLKPENI+L         +K+ DFGL+  +  G   + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 133 MAPEVLQFQRYDEKV 147
           +APE++ ++    + 
Sbjct: 185 VAPEIVNYEPLGLEA 199

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  149 bits (377), Expect = 1e-44
 Identities = 42/135 (31%), Positives = 75/135 (55%), Gaps = 3/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  V HPNII L D ++    + L++E  +GG L  ++     + E+ A  F++Q+
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 76  --GLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L++  I H DLKPENI+L         +K+ DFGL+  +  G   + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 133 MAPEVLQFQRYDEKV 147
           +APE++ ++    + 
Sbjct: 185 VAPEIVNYEPLGLEA 199

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  146 bits (370), Expect = 2e-44
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 24/166 (14%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE----------------NCIFLVV 45
           +K++  + +     E+  L+ ++H NI+     +                    C+F+ +
Sbjct: 41  IKRVKYNNEKAER-EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99

Query: 46  EFCAGGNLSSYI--RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD 101
           EFC  G L  +I  R   ++ +  A +  +Q+  G++ ++S  +I+RDLKP NI L    
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---V 156

Query: 102 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
           D   +KI DFGL  +L       +  G+  YM+PE +  Q Y ++V
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEV 202

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (374), Expect = 2e-44
 Identities = 37/150 (24%), Positives = 78/150 (52%), Gaps = 8/150 (5%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
           + +++   +     E+  L+++ HPNI++  ++F+    +++V+++C GG+L   I    
Sbjct: 59  ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
                E     +  Q+   L+ ++   I+HRD+K +NI    L  D  +++ DFG++  L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF---LTKDGTVQLGDFGIARVL 175

Query: 118 YPG-NYAEKVCGSPLYMAPEVLQFQRYDEK 146
                 A    G+P Y++PE+ + + Y+ K
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNK 205

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  147 bits (373), Expect = 2e-44
 Identities = 58/131 (44%), Positives = 83/131 (63%), Gaps = 6/131 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+++L  + HP+II+L+D       I +V+E+ AGG L  YI    R+ E   R+F QQ+
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
              +E  + H I+HRDLKPEN+LL   DD++ +KIADFGLS  +  GN+ +  CGSP Y 
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174

Query: 134 APEVLQFQRYD 144
           APEV+  + Y 
Sbjct: 175 APEVINGKLYA 185

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  146 bits (370), Expect = 7e-44
 Identities = 42/129 (32%), Positives = 61/129 (47%), Gaps = 4/129 (3%)

Query: 23  VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL 80
             HPNII L D +     +++V E   GG L   I       E+ A   L  +   +E L
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 81  NSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVL 138
           ++  ++HRDLKP NIL      +   ++I DFG +  L   N      C +  ++APEVL
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192

Query: 139 QFQRYDEKV 147
           + Q YD   
Sbjct: 193 ERQGYDAAC 201

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  144 bits (366), Expect = 3e-43
 Identities = 26/145 (17%), Positives = 59/145 (40%), Gaps = 17/145 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
           EL  ++ + +   +         + ++++ E+    ++  +              +P Q 
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152

Query: 68  ARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
            +  ++ +      +++  +I HRD+KP NIL   +D +  +K++DFG S         +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGES-EYMVDKKIK 208

Query: 125 KVCGSPLYMAPEVLQFQR--YDEKV 147
              G+  +M PE    +      KV
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKV 233

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  143 bits (363), Expect = 5e-43
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 10/135 (7%)

Query: 16  ELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFL 72
           E+  L  V+     +IRL D F+  +   L++E      +L  +I   G + E+ AR F 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGS 129
            Q+   +   ++  ++HRD+K ENIL   +D +   LK+ DFG    L          G+
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211

Query: 130 PLYMAPEVLQFQRYD 144
            +Y  PE +++ RY 
Sbjct: 212 RVYSPPEWIRYHRYH 226

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  146 bits (371), Expect = 2e-42
 Identities = 41/135 (30%), Positives = 75/135 (55%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
           E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   H ++ E  A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  GL  ++ ++ +H DLKPENI+ +    +  LK+ DFGL+  L P    +   G+  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322

Query: 133 MAPEVLQFQRYDEKV 147
            APEV + +      
Sbjct: 323 AAPEVAEGKPVGYYT 337

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  142 bits (361), Expect = 3e-42
 Identities = 45/135 (33%), Positives = 76/135 (56%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ ++ ++H N+I+L+DAF+++N I LV+E+  GG L   I      + E     F++Q
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +  G+  ++  +I+H DLKPENIL    D    +KI DFGL+    P    +   G+P +
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEF 254

Query: 133 MAPEVLQFQRYDEKV 147
           +APEV+ +       
Sbjct: 255 LAPEVVNYDFVSFPT 269

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  140 bits (356), Expect = 3e-42
 Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 11/136 (8%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           E+  L  ++HPN+++L +      E+ +++V E    G +         + E  AR + Q
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQ 144

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSP 130
            L  G+E L+   IIHRD+KP N+L   + +D  +KIADFG+S      +       G+P
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201

Query: 131 LYMAPEVLQFQR--YD 144
            +MAPE L   R  + 
Sbjct: 202 AFMAPESLSETRKIFS 217

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  142 bits (361), Expect = 3e-42
 Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I        E     +++Q
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
              GL+ ++ H I+H D+KPENI+         +KI DFGL+  L P    +    +  +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEF 216

Query: 133 MAPEVLQFQRYDEKV 147
            APE++  +      
Sbjct: 217 AAPEIVDREPVGFYT 231

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  143 bits (362), Expect = 4e-42
 Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 8/132 (6%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL-- 75
             P+I+R+ D ++       C+ +V+E   GG L S I  R      E+ A + ++ +  
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 135
            ++ L+S +I HRD+KPEN+L +    + +LK+ DFG +      N     C +P Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 136 EVLQFQRYDEKV 147
           EVL  ++YD+  
Sbjct: 233 EVLGPEKYDKSC 244

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  141 bits (357), Expect = 4e-42
 Identities = 37/127 (29%), Positives = 58/127 (45%), Gaps = 6/127 (4%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQL--GL 77
           +   HP +IRL D F+ +    LV+E      +L  YI   G + E  +R F  Q+   +
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152

Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 137
           +  +S  ++HRD+K ENIL+         K+ DFG    L          G+ +Y  PE 
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSG-ALLHDEPYTDFDGTRVYSPPEW 209

Query: 138 LQFQRYD 144
           +   +Y 
Sbjct: 210 ISRHQYH 216

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (356), Expect = 4e-42
 Identities = 46/158 (29%), Positives = 67/158 (42%), Gaps = 14/158 (8%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K+     +   D      E+     V  HP  +RL  A++    ++L  E C G +L  
Sbjct: 87  VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ 145

Query: 56  YIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
           +    G  +PE     +L+     L  L+S  ++H D+KP NI L         K+ DFG
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFG 202

Query: 113 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           L   L      E   G P YMAPE+LQ   Y    + F
Sbjct: 203 LLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVF 239

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  140 bits (355), Expect = 6e-42
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 15/139 (10%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN 81
            H N++ L + F+ E+  +LV E   GG++ S+I       E  A   +Q +   L+ L+
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 82  SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--------CGSPLYM 133
           +  I HRDLKPENIL    +    +KI DF L   +        +        CGS  YM
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 134 APEVL-----QFQRYDEKV 147
           APEV+     +   YD++ 
Sbjct: 189 APEVVEAFSEEASIYDKRC 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  140 bits (355), Expect = 9e-42
 Identities = 38/135 (28%), Positives = 69/135 (51%), Gaps = 4/135 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
           E++ L+   H NI+ L ++F++   + ++ EF +G ++   I      + E+    ++ Q
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
           +   L+ L+SH+I H D++PENI+         +KI +FG +  L PG+    +  +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEY 169

Query: 133 MAPEVLQFQRYDEKV 147
            APEV Q        
Sbjct: 170 YAPEVHQHDVVSTAT 184

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  138 bits (350), Expect = 3e-41
 Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 35/164 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-------------CIFLVVEFCAGGNLSSYIRLHGR 62
           E+  L+S+NH  ++R + A+                  +F+ +E+C  G L   I     
Sbjct: 52  EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111

Query: 63  -VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-- 117
                   +  +Q+   L  ++S  IIHRDLKP NI    +D+   +KI DFGL+  +  
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLAKNVHR 168

Query: 118 -------------YPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKV 147
                           +      G+ +Y+A EVL     Y+EK+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (347), Expect = 5e-41
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 17/160 (10%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL 59
              + +  K  L  E+N L  + HPNI+R +D         +++V+E+C GG+L+S I  
Sbjct: 41  YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100

Query: 60  HGR----VPEQTARKFLQQL--GLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 108
             +    + E+   + + QL   L+         H ++HRDLKP N+ L   D    +K+
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 157

Query: 109 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKV 147
            DFGL+  L     +A+   G+P YM+PE +    Y+EK 
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKS 197

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  138 bits (349), Expect = 5e-41
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 14/139 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGN--LSSYIRLHGRVPEQTARKF 71
           E+  L  + H N+I+L D    E    +++V+E+C  G   +   +    R P   A  +
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGY 114

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKV 126
             QL  GLE L+S  I+H+D+KP N+L   L     LKI+  G++  L+P    +     
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLL---LTTGGTLKISALGVAEALHPFAADDTCRTS 171

Query: 127 CGSPLYMAPEVLQFQR-YD 144
            GSP +  PE+      + 
Sbjct: 172 QGSPAFQPPEIANGLDTFS 190

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  136 bits (345), Expect = 2e-40
 Identities = 43/139 (30%), Positives = 75/139 (53%), Gaps = 10/139 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
           E++ L  +NHPN+I+ + +F  +N + +V+E    G+LS  I+   +    +PE+T  K+
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCG 128
             QL   LE ++S  ++HRD+KP N+    +    ++K+ D GL          A  + G
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVF---ITATGVVKLGDLGLGRFFSSKTTAAHSLVG 198

Query: 129 SPLYMAPEVLQFQRYDEKV 147
           +P YM+PE +    Y+ K 
Sbjct: 199 TPYYMSPERIHENGYNFKS 217

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  136 bits (345), Expect = 3e-40
 Identities = 42/132 (31%), Positives = 74/132 (56%), Gaps = 9/132 (6%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL-- 75
             P+I+ + D ++     + C+ +++E   GG L S I  R      E+ A + ++ +  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 135
            ++ L+SH+I HRD+KPEN+L +  + D +LK+ DFG +      N  +  C +P Y+AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAP 198

Query: 136 EVLQFQRYDEKV 147
           EVL  ++YD+  
Sbjct: 199 EVLGPEKYDKSC 210

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  136 bits (343), Expect = 8e-40
 Identities = 49/195 (25%), Positives = 80/195 (41%), Gaps = 50/195 (25%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           ++++N      +  E+  +  ++HPNI RL++ ++ E  I LV+E C GG+L   + +  
Sbjct: 64  IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123

Query: 62  RVP----------------------------------------EQTARKFLQQL--GLEI 79
                                                      E+     ++Q+   L  
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183

Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 134
           L++  I HRD+KPEN L S  +    +K+ DFGLS   Y  N  E        G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242

Query: 135 PEVLQF--QRYDEKV 147
           PEVL    + Y  K 
Sbjct: 243 PEVLNTTNESYGPKC 257

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  131 bits (332), Expect = 2e-38
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 10/147 (6%)

Query: 9   LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
           L+     EL   + ++ P I+ L+ A +    + + +E   GG+L   I+  G +PE  A
Sbjct: 93  LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 125
             +L Q   GLE L++  I+H D+K +N+LLS   D     + DFG +  L P    +  
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSL 210

Query: 126 -----VCGSPLYMAPEVLQFQRYDEKV 147
                + G+  +MAPEV+  +  D KV
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKV 237

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  132 bits (335), Expect = 3e-38
 Identities = 41/129 (31%), Positives = 73/129 (56%), Gaps = 5/129 (3%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           EL  +  + HP ++ L+ +FQ E  +F+VV+   GG+L  +++ +    E+T + F+ + 
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            + L+ L +  IIHRD+KP+NIL   LD+   + I DF ++  L        + G+  YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181

Query: 134 APEVLQFQR 142
           APE+   ++
Sbjct: 182 APEMFSSRK 190

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (329), Expect = 3e-38
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 34/176 (19%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCA 49
           L       +  +  E+  L+ + HP I+R F+A+  +N             +++ ++ C 
Sbjct: 40  LPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98

Query: 50  GGNLSSYIRLHGRV---PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV 104
             NL  ++     +             Q+   +E L+S  ++HRDLKP NI       D 
Sbjct: 99  KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIF---FTMDD 155

Query: 105 MLKIADFGLSCTL-------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
           ++K+ DFGL   +                       G+ LYM+PE +    Y  KV
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  130 bits (330), Expect = 4e-38
 Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 8/137 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + +S ++HP  ++L+  FQ +  ++  + +   G L  YIR  G   E   R +  + 
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 130
              LE L+   IIHRDLKPENIL   L++D+ ++I DFG +  L P +   +     G+ 
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 131 LYMAPEVLQFQRYDEKV 147
            Y++PE+L  +   +  
Sbjct: 197 QYVSPELLTEKSACKSS 213

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  132 bits (334), Expect = 6e-38
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 14/158 (8%)

Query: 3   KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           K++     S  D E+  L  S  HPN+IR F   +     ++ +E C    L  Y+    
Sbjct: 54  KRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112

Query: 62  RV-PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCT 116
                      LQQ   GL  L+S +I+HRDLKP NIL+S       +   I+DFGL   
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172

Query: 117 LYPGNYAEK----VCGSPLYMAPEVLQ---FQRYDEKV 147
           L  G ++      V G+  ++APE+L     +     V
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV 210

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  131 bits (331), Expect = 2e-37
 Identities = 44/177 (24%), Positives = 77/177 (43%), Gaps = 33/177 (18%)

Query: 3   KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           K++          E+  L+ S +HPN+IR + +   +  +++ +E C   NL   +    
Sbjct: 45  KRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN 103

Query: 62  -------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS----------GLDD 102
                     E      L+Q+  G+  L+S  IIHRDLKP+NIL+S             +
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163

Query: 103 DVMLKIADFGLSCTLYPGNYAEK-----VCGSPLYMAPEVLQ-------FQRYDEKV 147
           ++ + I+DFGL   L  G  + +       G+  + APE+L+        +R    +
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  127 bits (320), Expect = 5e-37
 Identities = 54/154 (35%), Positives = 86/154 (55%), Gaps = 12/154 (7%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF----QAENCIFLVVEFCAGGNLSSYI 57
            +KL K  +     E   L  + HPNI+R +D++    + + CI LV E    G L +Y+
Sbjct: 61  DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120

Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +    +  +  R + +Q+  GL+ L++    IIHRDLK +NI ++G    V  KI D GL
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGL 178

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
             TL   ++A+ V G+P +MAPE+ + ++YDE V
Sbjct: 179 -ATLKRASFAKAVIGTPEFMAPEMYE-EKYDESV 210

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (322), Expect = 6e-37
 Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 29/172 (16%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLS 54
           LK++  H +   +    E +     NHPNI+RL      E    +  +L++ F   G L 
Sbjct: 59  LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 55  SYI----RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
           + I         + E      L  +  GLE +++    HRDLKP NIL   L D+    +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL---LGDEGQPVL 175

Query: 109 ADFGLSCTL--YPGNYAE--------KVCGSPLYMAPEVLQFQRY---DEKV 147
            D G       +     +            +  Y APE+   Q +   DE+ 
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  126 bits (318), Expect = 2e-36
 Identities = 39/140 (27%), Positives = 68/140 (48%), Gaps = 11/140 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E+  +  + HPNI+    A      + +V E+ + G+L   +   G   +   R+ L   
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143

Query: 75  ----LGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVC 127
                G+  L++ +  I+HR+LK  N+L   +D    +K+ DFGLS         ++   
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLL---VDKKYTVKVCDFGLSRLKASTFLSSKSAA 200

Query: 128 GSPLYMAPEVLQFQRYDEKV 147
           G+P +MAPEVL+ +  +EK 
Sbjct: 201 GTPEWMAPEVLRDEPSNEKS 220

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (320), Expect = 2e-36
 Identities = 32/165 (19%), Positives = 61/165 (36%), Gaps = 18/165 (10%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + K  N          +  L        ++ + A   +N   LV E  + G L + I L+
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161

Query: 61  GR-----VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL--------SGLDDDVM 105
                  +P+     F  ++   +E ++   IIH D+KP+N +L           D    
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 106 LKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
           L + D G S  +     G      C +  +   E+L  + ++ ++
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  125 bits (317), Expect = 2e-36
 Identities = 51/140 (36%), Positives = 72/140 (51%), Gaps = 14/140 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  LS VNHPNI++L+ A     C+  V+E+  GG+L + +     +P  TA   +   
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108

Query: 76  -----GLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
                G+  L+S     +IHRDLKP N+LL       +LKI DFG +C +    +     
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNK 164

Query: 128 GSPLYMAPEVLQFQRYDEKV 147
           GS  +MAPEV +   Y EK 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKC 184

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  125 bits (316), Expect = 5e-36
 Identities = 54/134 (40%), Positives = 79/134 (58%), Gaps = 7/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   LS V HP IIR++  FQ    IF+++++  GG L S +R   R P   A+ +  + 
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L LE L+S  II+RDLKPENIL   LD +  +KI DFG +   Y  +    +CG+P Y+
Sbjct: 116 CLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFA--KYVPDVTYTLCGTPDYI 170

Query: 134 APEVLQFQRYDEKV 147
           APEV+  + Y++ +
Sbjct: 171 APEVVSTKPYNKSI 184

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  125 bits (316), Expect = 1e-35
 Identities = 45/134 (33%), Positives = 79/134 (58%), Gaps = 7/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E   L +VN P +++L  +F+  + +++V+E+ AGG + S++R  GR  E  AR +  Q 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI 150

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
            L  E L+S  +I+RDLKPEN+L   +D    +++ DFG +  +        +CG+P  +
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEAL 205

Query: 134 APEVLQFQRYDEKV 147
           APE++  + Y++ V
Sbjct: 206 APEIILSKGYNKAV 219

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  123 bits (310), Expect = 1e-35
 Identities = 44/143 (30%), Positives = 64/143 (44%), Gaps = 14/143 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E    + + HPNII L      E  + LV+EF  GG L+    L G+ +P      +  Q
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQ 113

Query: 75  LG-----LEILNSHHIIHRDLKPENILLS-----GLDDDVMLKIADFGLSCTLYPGNYAE 124
           +      L       IIHRDLK  NIL+      G   + +LKI DFGL+   +      
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKM 172

Query: 125 KVCGSPLYMAPEVLQFQRYDEKV 147
              G+  +MAPEV++   + +  
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGS 195

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  123 bits (310), Expect = 5e-35
 Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 9/152 (5%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
           L+K   + K   +    E   L +  HP +  L  AFQ  + +  V+E+  GG L  ++ 
Sbjct: 38  LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97

Query: 59  LHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-C 115
                 E+ AR +  +    LE L+S  +++RD+K EN++   LD D  +KI DFGL   
Sbjct: 98  RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKE 154

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
            +  G   +  CG+P Y+APEVL+   Y   V
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  126 bits (317), Expect = 7e-35
 Identities = 52/159 (32%), Positives = 82/159 (51%), Gaps = 13/159 (8%)

Query: 2   LKKLNK-HLKS-----CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
            KKL K  +K          E   L  VN   ++ L  A++ ++ + LV+    GG+L  
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273

Query: 56  YIRLHGRV--PEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
           +I   G+   PE  A  +  +   GLE L+   I++RDLKPENILL   DD   ++I+D 
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDL 330

Query: 112 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           GL+  +  G   +   G+  YMAPEV++ +RY    +++
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  122 bits (308), Expect = 1e-34
 Identities = 49/139 (35%), Positives = 73/139 (52%), Gaps = 6/139 (4%)

Query: 12  CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
               E N L  V HP I+ L  AFQ    ++L++E+ +GG L   +   G   E TA  +
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 72  LQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCG 128
           L +  + L  L+   II+RDLKPENI+   L+    +K+ DFGL   +++ G      CG
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183

Query: 129 SPLYMAPEVLQFQRYDEKV 147
           +  YMAPE+L    ++  V
Sbjct: 184 TIEYMAPEILMRSGHNRAV 202

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  120 bits (303), Expect = 2e-34
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 13/141 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  +S++NHPNI++L+        +  V+EF   G+L   +      +      + +  
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130

Query: 75  --LGLEILNSHH--IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCG 128
             LG+E + + +  I+HRDL+  NI L  LD    V  K+ADFGLS      +    + G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLG 188

Query: 129 SPLYMAPEVLQFQ--RYDEKV 147
           +  +MAPE +  +   Y EK 
Sbjct: 189 NFQWMAPETIGAEEESYTEKA 209

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  120 bits (303), Expect = 4e-34
 Identities = 51/135 (37%), Positives = 80/135 (59%), Gaps = 6/135 (4%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ- 74
           E + L  VNHP I++L  AFQ E  ++L+++F  GG+L + +       E+  + +L + 
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135

Query: 75  -LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLY 132
            L L+ L+S  II+RDLKPENIL   LD++  +K+ DFGLS  ++     A   CG+  Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192

Query: 133 MAPEVLQFQRYDEKV 147
           MAPEV+  + + +  
Sbjct: 193 MAPEVVNRRGHTQSA 207

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  120 bits (302), Expect = 5e-34
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 21/150 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  +  + HPN+++       +  +  + E+  GG L   I+      P      F + 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 125
              G+  L+S +IIHRDL   N L   + ++  + +ADFGL+  +       +       
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCL---VRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 126 --------VCGSPLYMAPEVLQFQRYDEKV 147
                   V G+P +MAPE++  + YDEKV
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  121 bits (306), Expect = 8e-34
 Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 1   MLKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +LKK   + K   +    E   L +  HP +  L  +FQ  + +  V+E+  GG L  ++
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                  E  AR +  +    L+ L+S   +++RDLK EN++   LD D  +KI DFGL 
Sbjct: 240 SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM---LDKDGHIKITDFGLC 296

Query: 115 -CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
              +  G   +  CG+P Y+APEVL+   Y   V
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 330

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (296), Expect = 2e-33
 Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 27/156 (17%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARK 70
           E+   + +  H +++R F A+  ++ + +  E+C GG+L+  I  + R+     E   + 
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 71  FLQQL--GLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFG 112
            L Q+  GL  ++S  ++H D+KP NI +S                   + VM KI D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 113 LSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKV 147
               +   +  +   G   ++A EVLQ    +  K 
Sbjct: 180 HVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKA 212

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  117 bits (296), Expect = 2e-33
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 15/142 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQ 73
           E+  L    H NI+       A    I  V ++C G +L  ++     +   +      +
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC---TLYPGNYAEKVCG 128
           Q   G++ L++  IIHRDLK  NI    L +D  +KI DFGL+         +  E++ G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIF---LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 129 SPLYMAPEVLQFQ---RYDEKV 147
           S L+MAPEV++ Q    Y  + 
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQS 206

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  118 bits (299), Expect = 3e-33
 Identities = 52/153 (33%), Positives = 78/153 (50%), Gaps = 10/153 (6%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   L      C   E      +  HP +  +F  FQ +  +F V+E+  GG+L  +I
Sbjct: 50  LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 114
           +   +     A  +  +  LGL+ L+S  I++RDLK +NIL   LD D  +KIADFG+  
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCK 166

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
             +         CG+P Y+APE+L  Q+Y+  V
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV 199

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (297), Expect = 6e-33
 Identities = 47/134 (35%), Positives = 70/134 (52%), Gaps = 7/134 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           EL  L   N P I+  + AF ++  I + +E   GG+L   ++  GR+PEQ   K    +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140

Query: 76  --GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             GL  L   H I+HRD+KP NIL++   +   +K+ DFG+S  L   + A    G+  Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196

Query: 133 MAPEVLQFQRYDEK 146
           M+PE LQ   Y  +
Sbjct: 197 MSPERLQGTHYSVQ 210

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  120 bits (302), Expect = 8e-33
 Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 13/159 (8%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
           L K     +        E   L+ V+   I+ L  AF+ +  + LV+    GG++  +I 
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277

Query: 58  ---RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
                +    E  A  +  Q   GLE L+  +II+RDLKPEN+L   LDDD  ++I+D G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRISDLG 334

Query: 113 LSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           L+          +   G+P +MAPE+L  + YD  V++F
Sbjct: 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYF 373

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  117 bits (296), Expect = 1e-32
 Identities = 52/153 (33%), Positives = 80/153 (52%), Gaps = 10/153 (6%)

Query: 2   LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           L+K   L K  +  +  E N  L +V HP ++ L  +FQ  + ++ V+++  GG L  ++
Sbjct: 71  LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 130

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 114
           +      E  AR +  +    L  L+S +I++RDLKPENIL   LD    + + DFGL  
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---LDSQGHIVLTDFGLCK 187

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
             +   +     CG+P Y+APEVL  Q YD  V
Sbjct: 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTV 220

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (291), Expect = 2e-32
 Identities = 30/150 (20%), Positives = 58/150 (38%), Gaps = 22/150 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+       H N++    A  +   + ++   C G  L S +R    V      R+  Q+
Sbjct: 79  EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------V 126
           +  G+  L++  I+H+DLK +N+      D+  + I DFGL           +       
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 127 CGSPLYMAPEVLQFQR---------YDEKV 147
            G   ++APE+++            + +  
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  116 bits (292), Expect = 4e-32
 Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 12/154 (7%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   +      C   E   L+     P + +L   FQ  + ++ V+E+  GG+L  +I
Sbjct: 53  LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
           +  GR  E  A  +  +  +GL  L S  II+RDLK +N++   LD +  +KIADFG+ C
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 168

Query: 116 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
              ++ G   +  CG+P Y+APE++ +Q Y + V
Sbjct: 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 202

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  118 bits (298), Expect = 4e-32
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 16/161 (9%)

Query: 2   LKKLNK-HLKS-----CLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN 52
           +K L+K  +K          E   LS V+    P I+ +  AF   + +  +++   GG+
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278

Query: 53  LSSYIRLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
           L  ++  HG   E   R +  +  LGLE +++  +++RDLKP NIL   LD+   ++I+D
Sbjct: 279 LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISD 335

Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFF 150
            GL+C            G+  YMAPEVLQ    YD   ++F
Sbjct: 336 LGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 375

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  115 bits (290), Expect = 5e-32
 Identities = 47/132 (35%), Positives = 78/132 (59%), Gaps = 6/132 (4%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 123 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179

Query: 136 EVLQFQRYDEKV 147
           E+L+ + Y   V
Sbjct: 180 EILRGEDYGFSV 191

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  115 bits (290), Expect = 7e-32
 Identities = 56/153 (36%), Positives = 77/153 (50%), Gaps = 10/153 (6%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   L      C   E   LS   NHP + +LF  FQ  + +F V+EF  GG+L  +I
Sbjct: 56  LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 114
           +   R  E  AR +  +    L  L+   II+RDLK +N+L   LD +   K+ADFG+  
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCK 172

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
             +  G      CG+P Y+APE+LQ   Y   V
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAV 205

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (285), Expect = 1e-31
 Identities = 42/133 (31%), Positives = 71/133 (53%), Gaps = 8/133 (6%)

Query: 13  LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVP--EQTAR 69
           L  E+     + H NI++   +F     I + +E   GG+LS+ +R   G +   EQT  
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-V 126
            + +Q+  GL+ L+ + I+HRD+K +N+L++     +  KI+DFG S  L   N   +  
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL--KISDFGTSKRLAGINPCTETF 183

Query: 127 CGSPLYMAPEVLQ 139
            G+  YMAPE++ 
Sbjct: 184 TGTLQYMAPEIID 196

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  115 bits (289), Expect = 1e-31
 Identities = 47/132 (35%), Positives = 78/132 (59%), Gaps = 6/132 (4%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ--LG 76
           F  + NHP ++ L   FQ E+ +F V+E+  GG+L  +++   ++PE+ AR +  +  L 
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 135
           L  L+   II+RDLK +N+L   LD +  +K+ D+G+    L PG+     CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222

Query: 136 EVLQFQRYDEKV 147
           E+L+ + Y   V
Sbjct: 223 EILRGEDYGFSV 234

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  115 bits (290), Expect = 1e-31
 Identities = 49/150 (32%), Positives = 84/150 (56%), Gaps = 14/150 (9%)

Query: 2   LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L+K   +K    +    E + ++  N P +++LF AFQ +  +++V+E+  GG+L +
Sbjct: 99  MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158

Query: 56  YIRLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            +  +  VPE+ AR +  +  L L+ ++S   IHRD+KP+N+L   LD    LK+ADFG 
Sbjct: 159 LMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGT 214

Query: 114 S--CTLYPGNYAEKVCGSPLYMAPEVLQFQ 141
                       +   G+P Y++PEVL+ Q
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (284), Expect = 2e-31
 Identities = 31/162 (19%), Positives = 57/162 (35%), Gaps = 21/162 (12%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLH 60
             +         ++  +   +  N +        +  +++ ++ C   NL  ++      
Sbjct: 99  LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 117
                        Q+   +E L+S  ++HRDLKP NI       D ++K+ DFGL   + 
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIF---FTMDDVVKVGDFGLVTAMD 215

Query: 118 ------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
                                 G+ LYM+PE +    Y  KV
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  114 bits (288), Expect = 3e-31
 Identities = 48/157 (30%), Positives = 87/157 (55%), Gaps = 16/157 (10%)

Query: 2   LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K LNK   LK    +C   E + L + +   I  L  AFQ +N ++LV+++  GG+L +
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163

Query: 56  YI-RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
            + +   R+PE+ AR +L +  + ++ ++  H +HRD+KP+NIL   +D +  +++ADFG
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG 220

Query: 113 LSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEK 146
             C     +   +     G+P Y++PE+LQ     + 
Sbjct: 221 S-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  112 bits (283), Expect = 6e-31
 Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 8/133 (6%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E   L  +   P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167

Query: 75  --LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 130
             L LE L+   II+RD+K ENIL   LD +  + + DFGLS          A   CG+ 
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 131 LYMAPEVLQFQRY 143
            YMAP++++    
Sbjct: 225 EYMAPDIVRGGDS 237

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  115 bits (288), Expect = 1e-30
 Identities = 50/153 (32%), Positives = 81/153 (52%), Gaps = 10/153 (6%)

Query: 2   LKK---LNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           LKK   +      C   E   L+     P + +L   FQ  + ++ V+E+  GG+L  +I
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433

Query: 58  RLHGRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 114
           +  GR  E  A  +  +  +GL  L S  II+RDLK +N++   LD +  +KIADFG+  
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGMCK 490

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
             ++ G   +  CG+P Y+APE++ +Q Y + V
Sbjct: 491 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 523

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  111 bits (280), Expect = 1e-30
 Identities = 40/180 (22%), Positives = 67/180 (37%), Gaps = 37/180 (20%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSV-NHPNIIRLFDAF-------QAENCIFLVVEFCAG 50
           LK+L  + +        E+ F+  +  HPNI++   A              FL++     
Sbjct: 58  LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117

Query: 51  GNLSSYI---RLHGRVPEQTARKFLQQL--GLEILNSHH--IIHRDLKPENILLSGLDDD 103
           G L  ++      G +   T  K   Q    ++ ++     IIHRDLK EN+L   L + 
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL---LSNQ 174

Query: 104 VMLKIADFGLSCTLYPGNYAEK-------------VCGSPLYMAPEVLQFQR---YDEKV 147
             +K+ DFG + T+                        +P+Y  PE++         EK 
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  112 bits (282), Expect = 2e-30
 Identities = 47/151 (31%), Positives = 82/151 (54%), Gaps = 14/151 (9%)

Query: 2   LKKLNKHL---KSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K +NK     +  + C   E + L + +   I +L  AFQ EN ++LV+E+  GG+L +
Sbjct: 91  MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150

Query: 56  YIRLHG-RVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
            +   G R+P + AR +L +  + ++ ++    +HRD+KP+NIL   LD    +++ADFG
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFG 207

Query: 113 LSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ 141
               L       +    G+P Y++PE+LQ  
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  108 bits (273), Expect = 6e-30
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 29/132 (21%)

Query: 24  NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQL-- 75
             P+I+R+ D ++       C+ +V+E   GG L S I  R      E+ A + ++ +  
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 135
            ++ L+S +I HRD+KPEN+L +    + +LK+ DFG                     A 
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AK 168

Query: 136 EVLQFQRYDEKV 147
           E    ++YD+  
Sbjct: 169 ETTG-EKYDKSC 179

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (271), Expect = 2e-29
 Identities = 42/138 (30%), Positives = 75/138 (54%), Gaps = 11/138 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPE-QTA---RK 70
           E++ +   + P++++ + ++     +++V+E+C  G++S  IRL    + E + A   + 
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133

Query: 71  FLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS 129
            L+  GLE L+    IHRD+K  NILL+  +     K+ADFG++  L         V G+
Sbjct: 134 TLK--GLEYLHFMRKIHRDIKAGNILLN-TEGHA--KLADFGVAGQLTDTMAKRNTVIGT 188

Query: 130 PLYMAPEVLQFQRYDEKV 147
           P +MAPEV+Q   Y+   
Sbjct: 189 PFWMAPEVIQEIGYNCVA 206

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (270), Expect = 3e-29
 Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 12/140 (8%)

Query: 16  ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           +L+ +  S + P I++ F  F     +F+ +E           R+ G +PE+   K    
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA 132

Query: 75  L--GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           +   L  L   H +IHRD+KP NILL        +K+ DFG+S  L      ++  G   
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAA 189

Query: 132 YMAPEVLQFQR-----YDEK 146
           YMAPE +         YD +
Sbjct: 190 YMAPERIDPPDPTKPDYDIR 209

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  106 bits (267), Expect = 3e-29
 Identities = 28/143 (19%), Positives = 57/143 (39%), Gaps = 18/143 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
           E   L   +HPN++ +  A Q+       L+  +   G+L + +       V +  A KF
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116

Query: 72  LQQL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
              +  G+  L++    I    L   +++   +D+D+  +I+   +  +           
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVM---IDEDMTARISMADVKFSFQSPG----RM 169

Query: 128 GSPLYMAPEVLQFQRYD---EKV 147
            +P ++APE LQ +  D      
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSA 192

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  107 bits (268), Expect = 4e-29
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 7/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +     + E       ++ 
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCREC 125

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
              LE L+S+ +IHRD+K +NILL  +D  V  K+ DFG    + P       + G+P +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLG-MDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 133 MAPEVLQFQRYDEKV 147
           MAPEV+  + Y  KV
Sbjct: 183 MAPEVVTRKAYGPKV 197

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (269), Expect = 4e-29
 Identities = 37/135 (27%), Positives = 71/135 (52%), Gaps = 7/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  +    H N++ ++ ++     +++++EF  GG L+  +    R+ E+      + +
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAV 150

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 132
              L  L++  +IHRD+K ++ILL+ LD  V  K++DFG    +       K + G+P +
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 133 MAPEVLQFQRYDEKV 147
           MAPEV+    Y  +V
Sbjct: 208 MAPEVISRSLYATEV 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  106 bits (267), Expect = 5e-29
 Identities = 43/123 (34%), Positives = 67/123 (54%), Gaps = 13/123 (10%)

Query: 21  SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE 78
           S ++H NI+ + D  + ++C +LV+E+  G  LS YI  HG +   TA  F  Q+  G++
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125

Query: 79  ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYM 133
             +   I+HRD+KP+NIL   +D +  LKI DFG+       +L        V G+  Y 
Sbjct: 126 HAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSL---TQTNHVLGTVQYF 179

Query: 134 APE 136
           +PE
Sbjct: 180 SPE 182

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  105 bits (264), Expect = 2e-28
 Identities = 39/135 (28%), Positives = 72/135 (53%), Gaps = 7/135 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS  + P + + + ++  +  +++++E+  GG+    +   G + E      L+++
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLY 132
             GL+ L+S   IHRD+K  N+LLS   +   +K+ADFG++  L           G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185

Query: 133 MAPEVLQFQRYDEKV 147
           MAPEV++   YD K 
Sbjct: 186 MAPEVIKQSAYDSKA 200

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  106 bits (266), Expect = 2e-28
 Identities = 50/139 (35%), Positives = 70/139 (50%), Gaps = 15/139 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTA---RKF 71
           E+ FL  + HPN I+    +  E+  +LV+E+C G            + E + A      
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 163

Query: 72  LQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           LQ  GL  L+SH++IHRD+K  NILLS     V  K+ DFG +  + P N      G+P 
Sbjct: 164 LQ--GLAYLHSHNMIHRDVKAGNILLS-EPGLV--KLGDFGSASIMAPAN---SFVGTPY 215

Query: 132 YMAPEVLQFQR---YDEKV 147
           +MAPEV+       YD KV
Sbjct: 216 WMAPEVILAMDEGQYDGKV 234

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  104 bits (262), Expect = 4e-28
 Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 29/138 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
           E++ L  +NHPNI++L D    EN ++LV EF    +L  ++        P    + +L 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLF 110

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           QL  GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+          +  G P+
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 157

Query: 132 -----------YMAPEVL 138
                      Y APE+L
Sbjct: 158 RTYTHEVVTLWYRAPEIL 175

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (262), Expect = 4e-28
 Identities = 36/137 (26%), Positives = 62/137 (45%), Gaps = 28/137 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  + HPN++ L + F+ +  + LV E+C    +   +  + R VPE   +    Q
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
               +   + H+ IHRD+KPENIL   +    ++K+ DFG +          ++   P  
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENIL---ITKHSVIKLCDFGFA----------RLLTGPSD 157

Query: 132 ----------YMAPEVL 138
                     Y +PE+L
Sbjct: 158 YYDDEVATRWYRSPELL 174

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  104 bits (262), Expect = 5e-28
 Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 26/138 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + H NII L       + + L+ E+    +L  Y+  +  V  +  + FL QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 76  --GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
             G+   +S   +HRDLKP+N+LLS     +  +LKI DFGL+          +  G P+
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAFGIPI 191

Query: 132 -----------YMAPEVL 138
                      Y  PE+L
Sbjct: 192 RQFTHEIITLWYRPPEIL 209

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  103 bits (260), Expect = 6e-28
 Identities = 45/143 (31%), Positives = 78/143 (54%), Gaps = 16/143 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L++ +HP I++L  A+  +  +++++EFC GG + + +    R   E   +   +Q
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGS 129
           +   L  L+S  IIHRDLK  N+L++ L+ D+  ++ADFG+S         +K     G+
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKN--LKTLQKRDSFIGT 180

Query: 130 PLYMAPEV-----LQFQRYDEKV 147
           P +MAPEV     ++   YD K 
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKA 203

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  104 bits (261), Expect = 9e-28
 Identities = 20/139 (14%), Positives = 42/139 (30%), Gaps = 16/139 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCA------GGNLSSYIRLHGRVPEQT 67
             + +       +IR+    +       F +           G  L S+   H  +    
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
             +   Q+   L  L+ + ++H  L+P +I+   LD    + +  F              
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLV---RDGARVV 261

Query: 126 VCGSPLYMAPEVLQFQRYD 144
              S  +  PE+   +   
Sbjct: 262 SSVSRGFEPPELEARRATI 280

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  102 bits (256), Expect = 3e-27
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 28/137 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  ++HPNI+ L D   +E C+ LV EF    +L   +  +     +   + +L Q
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  G+   + H I+HRDLKP+N+L   ++ D  LK+ADFGL+          +  G P+ 
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLA----------RAFGIPVR 174

Query: 132 ----------YMAPEVL 138
                     Y AP+VL
Sbjct: 175 SYTHEVVTLWYRAPDVL 191

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  102 bits (256), Expect = 3e-27
 Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 28/137 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E+  L  + H N++ L +  + +   +LV EF     +   + L    +  Q  +K+L Q
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQ 132

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+   +SH+IIHRD+KPENIL   +    ++K+ DFG +          +   +P  
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENIL---VSQSGVVKLCDFGFA----------RTLAAPGE 179

Query: 132 ----------YMAPEVL 138
                     Y APE+L
Sbjct: 180 VYDDEVATRWYRAPELL 196

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (254), Expect = 5e-27
 Identities = 47/149 (31%), Positives = 79/149 (53%), Gaps = 20/149 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
           E+  +S  +HPNI+  + +F  ++ ++LV++  +GG++   I+      E  +       
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122

Query: 72  ----LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 125
               L+++  GLE L+ +  IHRD+K  NIL   L +D  ++IADFG+S  L  G    +
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNIL---LGEDGSVQIADFGVSAFLATGGDITR 179

Query: 126 ------VCGSPLYMAPEVL-QFQRYDEKV 147
                   G+P +MAPEV+ Q + YD K 
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKA 208

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (253), Expect = 5e-27
 Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 28/137 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L  + H NI+RL D   ++  + LV EFC   +L  Y          +  + FL Q
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+          +  G P+ 
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA----------RAFGIPVR 156

Query: 132 ----------YMAPEVL 138
                     Y  P+VL
Sbjct: 157 CYSAEVVTLWYRPPDVL 173

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  102 bits (256), Expect = 5e-27
 Identities = 50/137 (36%), Positives = 71/137 (51%), Gaps = 28/137 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E+  L  ++HPNII L DAF  ++ I LV +F    +L   I+ +  V      + ++  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
              GLE L+ H I+HRDLKP N+L   LD++ +LK+ADFGL+          K  GSP  
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLA----------KSFGSPNR 167

Query: 132 ----------YMAPEVL 138
                     Y APE+L
Sbjct: 168 AYTHQVVTRWYRAPELL 184

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  100 bits (252), Expect = 8e-27
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 28/137 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  + H NI++L+D    +  + LV E     +L   + +        TA+ FL Q
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+          +  G P+ 
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLA----------RAFGIPVR 155

Query: 132 ----------YMAPEVL 138
                     Y AP+VL
Sbjct: 156 KYTHEIVTLWYRAPDVL 172

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  101 bits (254), Expect = 1e-26
 Identities = 38/146 (26%), Positives = 64/146 (43%), Gaps = 17/146 (11%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
           EL+     NHPNI+     F A+N +++V  F A G+    I  H    + E      LQ
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---- 127
            +   L+ ++    +HR +K  +IL+S  D  V   ++    + ++      ++V     
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISV-DGKV--YLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 128 ----GSPLYMAPEVLQ--FQRYDEKV 147
                   +++PEVLQ   Q YD K 
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKS 218

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  100 bits (250), Expect = 2e-26
 Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 14/142 (9%)

Query: 16  ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKF 71
           +L+  + +V+ P  +  + A   E  +++ +E         Y   I     +PE    K 
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 72  LQQL--GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 128
              +   LE L+S   +IHRD+KP N+L++     V  K+ DFG+S  L      +   G
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQV--KMCDFGISGYLVDDVAKDIDAG 171

Query: 129 SPLYMAPEV----LQFQRYDEK 146
              YMAPE     L  + Y  K
Sbjct: 172 CKPYMAPERINPELNQKGYSVK 193

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  102 bits (255), Expect = 3e-26
 Identities = 34/128 (26%), Positives = 69/128 (53%), Gaps = 16/128 (12%)

Query: 19  FLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
           FL+ V HP+I+++F+  +  +       ++V+E+  G +L        ++P   A  +L 
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLL 189

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           ++   L  L+S  +++ DLKPENI+L+  ++ +  K+ D G    +   N    + G+P 
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT--EEQL--KLIDLGAVSRI---NSFGYLYGTPG 242

Query: 132 YMAPEVLQ 139
           + APE+++
Sbjct: 243 FQAPEIVR 250

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 99.3 bits (248), Expect = 3e-26
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 23/165 (13%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNL 53
            +K  N   +   +   E   +   +HPN+IRL       + Q      +++ F   G+L
Sbjct: 69  TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128

Query: 54  SSYIRLHGRVPEQTARKFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDV 104
            +Y+    R+        LQ L         G+E L++ + +HRDL   N +L   DD  
Sbjct: 129 HTYLLYS-RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--DDMT 185

Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           +  +ADFGLS  +Y G+Y  +   + +   ++A E L  + Y  K
Sbjct: 186 V-CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK 229

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 99.2 bits (248), Expect = 4e-26
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 13/126 (10%)

Query: 21  SSVNHPNIIRLFD----AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL- 75
           +++NHP I+ ++D       A    ++V+E+  G  L   +   G +  + A + +    
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126

Query: 76  -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEKVCGSP 130
             L   + + IIHRD+KP NI++S       +K+ DFG+    + +         V G+ 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 131 LYMAPE 136
            Y++PE
Sbjct: 184 QYLSPE 189

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 99.3 bits (248), Expect = 4e-26
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 22/149 (14%)

Query: 16  ELNFLSSVNHPNIIRLF------DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
           E   +   +HP++ +L        A        +++ F   G+L +++    R+ E    
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFN 133

Query: 70  KFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
             LQ L         G+E L+S + IHRDL   N +L+  +D  +  +ADFGLS  +Y G
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA--EDMTV-CVADFGLSRKIYSG 190

Query: 121 NYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           +Y  + C S L   ++A E L    Y   
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVH 219

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 99.7 bits (248), Expect = 6e-26
 Identities = 20/137 (14%), Positives = 33/137 (24%), Gaps = 17/137 (12%)

Query: 24  NHPNIIRLFDAFQAENC--IFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQL 75
           + P   +L             L++   +         L       G            QL
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
                 L S  ++H    P+N+    +  D  L + D         G           Y 
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLF---IMPDGRLMLGDVSAL--WKVGTRGPASSVPVTYA 258

Query: 134 APEVLQFQR--YDEKVN 148
             E L      +   +N
Sbjct: 259 PREFLNASTATFTHALN 275

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.4 bits (246), Expect = 1e-25
 Identities = 39/137 (28%), Positives = 62/137 (45%), Gaps = 28/137 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
           E++ L  + H NI+ L D    E  + LV E+    +L  Y+   G +      + FL Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           L  GL   +   ++HRDLKP+N+L   +++   LK+ADFGL+          +    P  
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLL---INERGELKLADFGLA----------RAKSIPTK 155

Query: 132 ----------YMAPEVL 138
                     Y  P++L
Sbjct: 156 TYDNEVVTLWYRPPDIL 172

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 98.1 bits (245), Expect = 1e-25
 Identities = 41/143 (28%), Positives = 63/143 (44%), Gaps = 12/143 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +S  NH NI+R           F+++E  AGG+L S++R     P Q +   +  L
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 76  ---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
                    G + L  +H IHRD+   N LL+      + KI DFG++  +Y  +Y  K 
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202

Query: 127 CGSPL---YMAPEVLQFQRYDEK 146
             + L   +M PE      +  K
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSK 225

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 97.4 bits (243), Expect = 2e-25
 Identities = 37/157 (23%), Positives = 61/157 (38%), Gaps = 29/157 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           EL     + H NI+    +      +   ++L+  +   G+L  Y++L   +   +  + 
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRI 110

Query: 72  LQQL--GLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
           +  +  GL  L+           I HRDLK +NIL   +  +    IAD GL+       
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQST 167

Query: 122 YAEKV-----CGSPLYMAPEVL------QFQRYDEKV 147
               V      G+  YMAPEVL            ++V
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV 204

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 97.9 bits (244), Expect = 2e-25
 Identities = 37/157 (23%), Positives = 58/157 (36%), Gaps = 29/157 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+     + H NI+    A          ++LV ++   G+L  Y+  +  V  +   K 
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKL 144

Query: 72  LQQL--GLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 GL  L+           I HRDLK +NIL   +  +    IAD GL+       
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVRHDSAT 201

Query: 122 YAEKV-----CGSPLYMAPEVL------QFQRYDEKV 147
               +      G+  YMAPEVL      +     ++ 
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 97.3 bits (243), Expect = 2e-25
 Identities = 32/127 (25%), Positives = 60/127 (47%), Gaps = 15/127 (11%)

Query: 22  SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
            +  P+++ + D  + +  +++ +    G +L++ +R  G +    A   ++Q+   L+ 
Sbjct: 90  RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYMA 134
            ++    HRD+KPENIL+S  DD     + DFG+        L          G+  YMA
Sbjct: 150 AHAAGATHRDVKPENILVSA-DDFA--YLVDFGIASATTDEKL---TQLGNTVGTLYYMA 203

Query: 135 PEVLQFQ 141
           PE  +F 
Sbjct: 204 PE--RFS 208

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 97.4 bits (243), Expect = 2e-25
 Identities = 39/143 (27%), Positives = 60/143 (41%), Gaps = 15/143 (10%)

Query: 16  ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARK 70
           +L+  + S + P I++ + A   E   ++ +E  +      Y      L   +PE+   K
Sbjct: 70  DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129

Query: 71  FLQQL--GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
                   L  L     IIHRD+KP NILL     ++  K+ DFG+S  L       +  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNI--KLCDFGISGQLVDSIAKTRDA 186

Query: 128 GSPLYMAPEVLQFQR----YDEK 146
           G   YMAPE +        YD +
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVR 209

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 97.3 bits (243), Expect = 2e-25
 Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 33/142 (23%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------PEQTAR 69
           E++ +  + H NI+RL+D    EN + LV EF    +L  Y+                 +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
            F  QL  GL   + + I+HRDLKP+N+L   ++    LK+ DFGL+          +  
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLA----------RAF 158

Query: 128 GSPL-----------YMAPEVL 138
           G P+           Y AP+VL
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVL 180

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 97.7 bits (244), Expect = 2e-25
 Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 33/147 (22%)

Query: 20  LSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFL 72
           L +  HPN++RLFD         E  + LV E     +L++Y+        P +T +  +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            QL  GL+ L+SH ++HRDLKP+NIL   +     +K+ADFGL+          ++    
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNIL---VTSSGQIKLADFGLA----------RIYSFQ 173

Query: 131 L----------YMAPEVLQFQRYDEKV 147
           +          Y APEVL    Y   V
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPV 200

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 98.2 bits (245), Expect = 2e-25
 Identities = 40/140 (28%), Positives = 61/140 (43%), Gaps = 12/140 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   +S  NH NI+R           F+++E  AGG+L S++R     P Q +   +  L
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 76  ---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
                    G + L  +H IHRD+   N LL+      + KI DFG++  +Y   Y  K 
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243

Query: 127 CGSPL---YMAPEVLQFQRY 143
             + L   +M PE      +
Sbjct: 244 GCAMLPVKWMPPEAFMEGIF 263

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 97.3 bits (243), Expect = 3e-25
 Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 10/134 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q    +  Q
Sbjct: 67  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 130
           +  G+  L    ++HRDL   N+L+        +KI DFGL+  L          G   P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 131 L-YMAPEVLQFQRY 143
           + +MA E +  + Y
Sbjct: 183 IKWMALESILHRIY 196

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 96.6 bits (241), Expect = 3e-25
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 12/141 (8%)

Query: 15  CELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFL 72
            E   +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F 
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCG 128
            Q+  G++ L S   +HRDL   N +L   +   + K+ADFGL+  +Y   Y       G
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEYYSVHNKTG 191

Query: 129 SPL---YMAPEVLQFQRYDEK 146
           + L   +MA E LQ Q++  K
Sbjct: 192 AKLPVKWMALESLQTQKFTTK 212

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 97.6 bits (243), Expect = 5e-25
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 39/152 (25%)

Query: 15  CELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR---------V 63
            E+  L  + HPN+I L   F   A+  ++L+ ++    +L   I+ H           +
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125

Query: 64  PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG 120
           P    +  L Q+  G+  L+++ ++HRDLKP NIL+ G   +   +KIAD G +      
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179

Query: 121 NYAEKVCGSPL--------------YMAPEVL 138
               ++  SPL              Y APE+L
Sbjct: 180 ----RLFNSPLKPLADLDPVVVTFWYRAPELL 207

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.1 bits (242), Expect = 5e-25
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 12/140 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
           E   +   +HPN++ L     ++E    +V+ +   G+L ++IR     P  +    F  
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 129
           Q+  G++ L S   +HRDL   N +L   +   + K+ADFGL+  +Y   +       G+
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEFDSVHNKTGA 256

Query: 130 PL---YMAPEVLQFQRYDEK 146
            L   +MA E LQ Q++  K
Sbjct: 257 KLPVKWMALESLQTQKFTTK 276

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 96.1 bits (240), Expect = 6e-25
 Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 33/150 (22%)

Query: 17  LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRV--PEQTAR 69
           L  L +  HPN++RL D            + LV E     +L +Y+        P +T +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 70  KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             ++Q   GL+ L+++ I+HRDLKPENIL   +     +K+ADFGL+          ++ 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENIL---VTSGGTVKLADFGLA----------RIY 170

Query: 128 GSPL----------YMAPEVLQFQRYDEKV 147
              +          Y APEVL    Y   V
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPV 200

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 96.7 bits (241), Expect = 6e-25
 Identities = 35/157 (22%), Positives = 59/157 (37%), Gaps = 29/157 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+     + H NI+    A      +   ++L+ ++   G+L  Y++    +  ++  K 
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKL 139

Query: 72  LQQL--GL-----EILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 121
                 GL     EI ++     I HRDLK +NIL   +  +    IAD GL+       
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVKFISDT 196

Query: 122 YAEKV-----CGSPLYMAPEVL------QFQRYDEKV 147
               +      G+  YM PEVL         +     
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA 233

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 95.8 bits (239), Expect = 7e-25
 Identities = 38/140 (27%), Positives = 63/140 (45%), Gaps = 12/140 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
           E   +  +NHPN++ L       E    +++ +   G+L  +IR   R P  +    F  
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 129
           Q+  G+E L     +HRDL   N +L    +   +K+ADFGL+  +    Y   ++   +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 130 PL---YMAPEVLQFQRYDEK 146
            L   + A E LQ  R+  K
Sbjct: 189 RLPVKWTALESLQTYRFTTK 208

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.5 bits (238), Expect = 1e-24
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 24/151 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGRVP---E 65
           E+N L    +H NI   + AF        ++ ++LV+EFC  G+++  I+         E
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 66  QTA---RKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 122
             A   R+ L+  GL  L+ H +IHRD+K +N+LL+  + +V  K+ DFG+S  L     
Sbjct: 130 WIAYICREILR--GLSHLHQHKVIHRDIKGQNVLLT-ENAEV--KLVDFGVSAQLDRTVG 184

Query: 123 AEK-VCGSPLYMAPEVLQFQR-----YDEKV 147
                 G+P +MAPEV+         YD K 
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKS 215

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 95.5 bits (238), Expect = 1e-24
 Identities = 34/137 (24%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
            +  + S++H +I+RL       + + LV ++   G+L  ++R H G +  Q    +  Q
Sbjct: 65  HMLAIGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L  H ++HR+L   N+LL        +++ADFG++  L P +       +   
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 132 --YMAPEVLQFQRYDEK 146
             +MA E + F +Y  +
Sbjct: 181 IKWMALESIHFGKYTHQ 197

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 95.4 bits (238), Expect = 1e-24
 Identities = 33/146 (22%), Positives = 62/146 (42%), Gaps = 18/146 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---L 72
           E + +   N  +++RL           +++E    G+L SY+R                L
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 73  QQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 123
            ++         G+  LN++  +HRDL   N +++   +D  +KI DFG++  +Y  +Y 
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194

Query: 124 EKVCGSPL---YMAPEVLQFQRYDEK 146
            K     L   +M+PE L+   +   
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTY 220

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.5 bits (238), Expect = 3e-24
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 19/160 (11%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
           +KK+ +  +     EL  +  ++H NI+RL   F      + E  + LV+++     +  
Sbjct: 84  IKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYR 141

Query: 56  YIRLHGR----VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
             R + R    +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ 
Sbjct: 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199

Query: 110 DFGLSCTLYPGN-YAEKVCGSPLYMAPEV-LQFQRYDEKV 147
           DFG +  L  G      +C S  Y APE+      Y   +
Sbjct: 200 DFGSAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSI 238

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 94.3 bits (235), Expect = 4e-24
 Identities = 34/134 (25%), Positives = 59/134 (44%), Gaps = 10/134 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   ++SV++P++ RL       + + L+ +    G L  Y+R H   +  Q    +  Q
Sbjct: 67  EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +  G+  L    ++HRDL   N+L+        +KI DFGL+  L          G  + 
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 132 --YMAPEVLQFQRY 143
             +MA E +  + Y
Sbjct: 183 IKWMALESILHRIY 196

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 93.4 bits (233), Expect = 4e-24
 Identities = 37/137 (27%), Positives = 71/137 (51%), Gaps = 12/137 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFL 72
           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR         KF 
Sbjct: 64  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
             +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 177

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE L+ +++  K
Sbjct: 178 VKWTAPEALREKKFSTK 194

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 95.5 bits (238), Expect = 5e-24
 Identities = 37/137 (27%), Positives = 72/137 (52%), Gaps = 12/137 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R  GR  +      KF 
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
             +   +E L  ++ +HRDL   N+L+S   +D + K++DFGL+          K+   P
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 349

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE L+ +++  K
Sbjct: 350 VKWTAPEALREKKFSTK 366

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 93.1 bits (232), Expect = 1e-23
 Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 23/151 (15%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--- 71
           EL  +S +  H NI+ L  A      + ++ E+C  G+L +++R   RV E         
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 72  ----LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
                + L         G+  L S + IHRD+   N+LL+   +  + KI DFGL+  + 
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIM 215

Query: 119 PGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
             +       + L   +MAPE +    Y  +
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 246

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 92.7 bits (231), Expect = 1e-23
 Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 23/166 (13%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK+ ++  +     E   L+ + H +I+R F        + +V E+   G+L+ ++R H
Sbjct: 78  ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137

Query: 61  GRVPEQTARKF--------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDD 103
           G   +  A           L QL         G+  L   H +HRDL   N L+      
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QG 194

Query: 104 VMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           +++KI DFG+S  +Y  +Y      + L   +M PE + ++++  +
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 240

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 93.2 bits (232), Expect = 2e-23
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 17/136 (12%)

Query: 16  ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGR----VPE 65
           EL  +  V HPN++ L   F      + E  + LV+E+     +    R + +    +P 
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140

Query: 66  QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y 122
              + ++ QL   L  ++S  I HRD+KP+N+LL       +LK+ DFG +  L  G   
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPN 198

Query: 123 AEKVCGSPLYMAPEVL 138
              +C S  Y APE++
Sbjct: 199 VSYIC-SRYYRAPELI 213

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 91.5 bits (228), Expect = 3e-23
 Identities = 37/167 (22%), Positives = 72/167 (43%), Gaps = 24/167 (14%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            LK      +     E   L+++ H +I++ +      + + +V E+   G+L+ ++R H
Sbjct: 52  ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111

Query: 61  GRVPEQTARKF---------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDD 102
           G                   L Q+         G+  L S H +HRDL   N L+     
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---A 168

Query: 103 DVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           ++++KI DFG+S  +Y  +Y      + L   +M PE + ++++  +
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 215

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 91.1 bits (227), Expect = 3e-23
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 11/135 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R             
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q+   +E L   + IHRDL   N L+    ++ ++K+ADFGLS  L  G+      G+  
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174

Query: 132 ---YMAPEVLQFQRY 143
              + APE L + ++
Sbjct: 175 PIKWTAPESLAYNKF 189

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 92.4 bits (229), Expect = 5e-23
 Identities = 20/143 (13%), Positives = 45/143 (31%), Gaps = 15/143 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI--FLVVEFCAG------GNLSSYIRLHGRVPEQT 67
             + +       +IR+    +    +  F +              L S+   H  +    
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212

Query: 68  ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 124
             +   Q+   L  L+ + ++H  L+P +I+   LD    + +  F           +  
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLVRDGASAVSPI 269

Query: 125 -KVCGSPLYMAPEVLQFQRYDEK 146
            +    P   A  +L F ++   
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPT 292

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 91.4 bits (227), Expect = 6e-23
 Identities = 39/150 (26%), Positives = 57/150 (38%), Gaps = 29/150 (19%)

Query: 15  CELNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
             +  +  + H NI R                 LV+E+   G+L  Y+ LH      ++ 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 70  KFLQQL--GL-----EILNSHH----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
           +    +  GL     E+    H    I HRDL   N+L   + +D    I+DFGLS  L 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL---VKNDGTCVISDFGLSMRLT 171

Query: 119 PGNYAEK---------VCGSPLYMAPEVLQ 139
                             G+  YMAPEVL+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 90.9 bits (226), Expect = 7e-23
 Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 23/143 (16%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+  L  + H NI++   A +    +    +L+  F   G+LS +++ +  V        
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126

Query: 72  LQQL--GLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + +  GL  L+             I HRD+K +N+L   L +++   IADFGL+     
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEA 183

Query: 120 GNYAEK---VCGSPLYMAPEVLQ 139
           G  A       G+  YMAPEVL+
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLE 206

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 90.3 bits (225), Expect = 7e-23
 Identities = 36/168 (21%), Positives = 72/168 (42%), Gaps = 25/168 (14%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
            LK      L+     E    + + HPN++ L      +  + ++  +C+ G+L  ++ +
Sbjct: 46  TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105

Query: 60  HGRVPEQTARKF---------LQQL---------GLEILNSHHIIHRDLKPENILLSGLD 101
                +  +                         G+E L+SHH++H+DL   N+L+    
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 162

Query: 102 DDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           D + +KI+D GL   +Y  +Y + +  S L   +MAPE + + ++   
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID 210

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 91.5 bits (228), Expect = 8e-23
 Identities = 41/129 (31%), Positives = 66/129 (51%), Gaps = 9/129 (6%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEIL 80
           +HPNI+RL      +  I++V+E   GG+  +++R  G  +  +T  + +     G+E L
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEV 137
            S   IHRDL   N L++   +  +LKI+DFG+S     G YA       +   + APE 
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286

Query: 138 LQFQRYDEK 146
           L + RY  +
Sbjct: 287 LNYGRYSSE 295

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 90.4 bits (225), Expect = 1e-22
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 32/160 (20%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
           E N L  VNHP++I+L+ A   +  + L+VE+   G+L  ++R   +V            
Sbjct: 76  EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135

Query: 72  -------------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
                        +  L         G++ L    ++HRDL   NIL++  +   M KI+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKM-KIS 192

Query: 110 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           DFGLS  +Y  +   K     +   +MA E L    Y  +
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 89.6 bits (223), Expect = 2e-22
 Identities = 46/154 (29%), Positives = 69/154 (44%), Gaps = 26/154 (16%)

Query: 16  ELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF-- 71
           EL  L  + +H N++ L  A  +    + ++VEFC  GNLS+Y+R               
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 72  -------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
                  L+ L         G+E L S   IHRDL   NILLS   +  ++KI DFGL+ 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLAR 196

Query: 116 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
            +Y      +   + L   +MAPE +  + Y  +
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 230

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 91.0 bits (226), Expect = 2e-22
 Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 11/138 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
           E   +  + HPN+++L      E   +++ EF   GNL  Y+R   R  V          
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q+   +E L   + IHR+L   N L+    ++ ++K+ADFGLS  L  G+      G+  
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 381

Query: 132 ---YMAPEVLQFQRYDEK 146
              + APE L + ++  K
Sbjct: 382 PIKWTAPESLAYNKFSIK 399

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 91.1 bits (226), Expect = 2e-22
 Identities = 31/137 (22%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++       +  +      
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 130
           Q+  G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y  +     P
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 427

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE   + R+  K
Sbjct: 428 IKWTAPEAALYGRFTIK 444

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 88.4 bits (220), Expect = 3e-22
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 8/133 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
           E   +  ++HP +++ +     E  I++V E+ + G L +Y+R HG+ +      +    
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 131
           +  G+  L SH  IHRDL   N L+     D+ +K++DFG++  +    Y   V    P+
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169

Query: 132 -YMAPEVLQFQRY 143
            + APEV  + +Y
Sbjct: 170 KWSAPEVFHYFKY 182

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 88.0 bits (219), Expect = 3e-22
 Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 8/133 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  ++HP +++L+     +  I LV EF   G LS Y+R   G    +T       
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 131
           +  G+  L    +IHRDL   N L+    ++ ++K++DFG++  +    Y        P+
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169

Query: 132 -YMAPEVLQFQRY 143
            + +PEV  F RY
Sbjct: 170 KWASPEVFSFSRY 182

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 88.5 bits (220), Expect = 3e-22
 Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 12/141 (8%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L ++ H NI++          N I L++EF   G+L  Y+  +  ++  +   K+
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 127
             Q+  G++ L S   +HRDL   N+L+     +  +KI DFGL+  +      Y  K  
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDD 188

Query: 128 G-SPL-YMAPEVLQFQRYDEK 146
             SP+ + APE L   ++   
Sbjct: 189 RDSPVFWYAPECLMQSKFYIA 209

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.5 bits (220), Expect = 5e-22
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 12/140 (8%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
            E++ L ++ H +II+            + LV+E+   G+L  Y+  H  +       F 
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-- 128
           QQ+  G+  L++ H IHRDL   N+LL    +D ++KI DFGL+  +  G+   +V    
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG 197

Query: 129 -SPL-YMAPEVLQFQRYDEK 146
            SP+ + APE L+  ++   
Sbjct: 198 DSPVFWYAPECLKEYKFYYA 217

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 87.7 bits (218), Expect = 7e-22
 Identities = 39/135 (28%), Positives = 64/135 (47%), Gaps = 11/135 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E+N + S++H N+IRL+        + +V E    G+L   +R H G     T  ++  Q
Sbjct: 71  EVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 131
           +  G+  L S   IHRDL   N+LL+      ++KI DFGL   L    ++        +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 132 ---YMAPEVLQFQRY 143
              + APE L+ + +
Sbjct: 187 PFAWCAPESLKTRTF 201

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 89.4 bits (222), Expect = 7e-22
 Identities = 31/137 (22%), Positives = 66/137 (48%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E   +  + H  +++L+     E  I++V E+ + G+L  +++       +  +      
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 130
           Q+  G+  +   + +HRDL+  NIL+    ++++ K+ADFGL+  +    Y  +     P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE   + R+  K
Sbjct: 345 IKWTAPEAALYGRFTIK 361

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 87.7 bits (218), Expect = 8e-22
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 30/172 (17%)

Query: 1   MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           MLK  + HL        EL  LS + NH NI+ L  A        ++ E+C  G+L +++
Sbjct: 60  MLKP-SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118

Query: 58  RLH-----------GRVPEQTARKFLQQL---------GLEILNSHHIIHRDLKPENILL 97
           R               + +      L+ L         G+  L S + IHRDL   NILL
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178

Query: 98  SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           +     +  KI DFGL+  +   +       + L   +MAPE +    Y  +
Sbjct: 179 T--HGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 88.6 bits (220), Expect = 9e-22
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 19/159 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        +++V+E    
Sbjct: 55  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MD 113

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            NL   I++   +  +     L Q+  G++ L+S  IIHRDLKP NI+   +  D  LKI
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV---VKSDCTLKI 168

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
            DFGL+ T            +  Y APEV+    Y E V
Sbjct: 169 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 207

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 87.3 bits (217), Expect = 9e-22
 Identities = 38/134 (28%), Positives = 69/134 (51%), Gaps = 10/134 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E N +  +++P I+R+    +AE+   LV+E    G L+ Y++ +  V ++   + + Q+
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS--P 130
             G++ L   + +HRDL   N+LL         KI+DFGLS  L    NY +       P
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 131 L-YMAPEVLQFQRY 143
           + + APE + + ++
Sbjct: 184 VKWYAPECINYYKF 197

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 87.8 bits (218), Expect = 1e-21
 Identities = 38/176 (21%), Positives = 73/176 (41%), Gaps = 33/176 (18%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           MLK+  +  +++    E   ++  ++PNI++L         + L+ E+ A G+L+ ++R 
Sbjct: 84  MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143

Query: 60  HGRVPEQTARKF-----------------LQQL---------GLEILNSHHIIHRDLKPE 93
                  +                       +          G+  L+    +HRDL   
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203

Query: 94  NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           N L+   ++ V+ KIADFGLS  +Y  +Y +      +   +M PE + + RY  +
Sbjct: 204 NCLVG--ENMVV-KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE 256

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 86.9 bits (216), Expect = 1e-21
 Identities = 34/135 (25%), Positives = 65/135 (48%), Gaps = 12/135 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E N +  + H  ++RL+ A   +  I+++ E+   G+L  +++    +     +      
Sbjct: 58  EANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 131
           Q+  G+  +   + IHRDL+  NIL+S   D +  KIADFGL+  +    Y  +  G+  
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTARE-GAKF 172

Query: 132 ---YMAPEVLQFQRY 143
              + APE + +  +
Sbjct: 173 PIKWTAPEAINYGTF 187

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.7 bits (220), Expect = 1e-21
 Identities = 51/159 (32%), Positives = 74/159 (46%), Gaps = 19/159 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        ++LV+E    
Sbjct: 92  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MD 150

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            NL   I+    +  +     L Q+  G++ L+S  IIHRDLKP NI+   +  D  LKI
Sbjct: 151 ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV---VKSDCTLKI 205

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
            DFGL+ T            +  Y APEV+    Y E V
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 244

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 87.4 bits (217), Expect = 2e-21
 Identities = 40/161 (24%), Positives = 66/161 (40%), Gaps = 32/161 (19%)

Query: 15  CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF-- 71
            EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R       +   ++  
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 72  --------------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                          + L         G+E L     +HRDL   N+L++     V+ KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVV-KI 213

Query: 109 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
            DFGL+  +   +       + L   +MAPE L    Y  K
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 88.4 bits (219), Expect = 2e-21
 Identities = 36/133 (27%), Positives = 67/133 (50%), Gaps = 9/133 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +HP+I++L         +++++E C  G L S++++    +   +   +  Q
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 131
           L   L  L S   +HRD+   N+L+S    +  +K+ DFGLS  +    Y +   G  P+
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556

Query: 132 -YMAPEVLQFQRY 143
            +MAPE + F+R+
Sbjct: 557 KWMAPESINFRRF 569

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 86.5 bits (215), Expect = 2e-21
 Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 14/148 (9%)

Query: 7   KHLKSCLDCELNFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           K +K     E  F+       +++H  +++L+     +  IF++ E+ A G L +Y+R  
Sbjct: 54  KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
             R   Q   +  + +   +E L S   +HRDL   N L++   D  ++K++DFGLS  +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV 170

Query: 118 YPGNYAEKVCGS-PL-YMAPEVLQFQRY 143
               Y   V    P+ +  PEVL + ++
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKF 198

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 86.6 bits (215), Expect = 2e-21
 Identities = 37/140 (26%), Positives = 63/140 (45%), Gaps = 12/140 (8%)

Query: 16  ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
           E+  L +++   I++            + LV+E+   G L  +++ H  R+       + 
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG- 128
            Q+  G+E L S   +HRDL   NIL+     +  +KIADFGL+  L    +Y       
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPG 190

Query: 129 -SPL-YMAPEVLQFQRYDEK 146
            SP+ + APE L    +  +
Sbjct: 191 QSPIFWYAPESLSDNIFSRQ 210

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 86.6 bits (215), Expect = 2e-21
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 10/135 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E + +   +HPNIIRL           +V E+   G+L +++R H G+         L+ 
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 129
           +  G+  L+    +HRDL   N+L+     +++ K++DFGLS  L     A         
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216

Query: 130 PL-YMAPEVLQFQRY 143
           P+ + APE + F+ +
Sbjct: 217 PIRWTAPEAIAFRTF 231

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 87.8 bits (218), Expect = 3e-21
 Identities = 37/137 (27%), Positives = 68/137 (49%), Gaps = 10/137 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
           E N + ++ H  +++L  A   +  I+++ EF A G+L  +++      +   +   F  
Sbjct: 233 EANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 130
           Q+  G+  +   + IHRDL+  NIL+S     ++ KIADFGL+  +    Y  +     P
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFP 348

Query: 131 L-YMAPEVLQFQRYDEK 146
           + + APE + F  +  K
Sbjct: 349 IKWTAPEAINFGSFTIK 365

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 85.7 bits (213), Expect = 3e-21
 Identities = 36/133 (27%), Positives = 67/133 (50%), Gaps = 9/133 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +HP+I++L         +++++E C  G L S++++    +   +   +  Q
Sbjct: 66  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 131
           L   L  L S   +HRD+   N+L+S    +  +K+ DFGLS  +    Y +   G  P+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181

Query: 132 -YMAPEVLQFQRY 143
            +MAPE + F+R+
Sbjct: 182 KWMAPESINFRRF 194

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 86.7 bits (215), Expect = 3e-21
 Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 12/141 (8%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+      ++
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 127
             Q+  G+E L +   IHRDL   NIL+    ++  +KI DFGL+  L      Y  K  
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEP 207

Query: 128 G-SPL-YMAPEVLQFQRYDEK 146
           G SP+ + APE L   ++   
Sbjct: 208 GESPIFWYAPESLTESKFSVA 228

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 85.8 bits (213), Expect = 4e-21
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 12/141 (8%)

Query: 15  CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
            E+  L S+ H NI++            + L++E+   G+L  Y++ H  R+      ++
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 127
             Q+  G+E L +   IHRDL   NIL+    ++  +KI DFGL+  L      +  K  
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEP 176

Query: 128 G-SPL-YMAPEVLQFQRYDEK 146
           G SP+ + APE L   ++   
Sbjct: 177 GESPIFWYAPESLTESKFSVA 197

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 86.2 bits (214), Expect = 6e-21
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 37/168 (22%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +         +LV+ F  G
Sbjct: 55  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MG 113

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   ++ H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKI 169

Query: 109 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 147
            DFGL+          +   S +        Y APEV L + RY + V
Sbjct: 170 LDFGLA----------RQADSEMTGYVVTRWYRAPEVILNWMRYTQTV 207

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 85.8 bits (213), Expect = 6e-21
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 25/153 (16%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--- 71
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R       + +      
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 72  ------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                  + L         G+E L S   IHRDL   N+L++   ++ ++KIADFGL+  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARD 206

Query: 117 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           +   +Y +K     L   +MAPE L  + Y  +
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 86.4 bits (214), Expect = 7e-21
 Identities = 33/125 (26%), Positives = 65/125 (52%), Gaps = 16/125 (12%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+ +  +  +DC     E+  L+ +NH +++++ D    ++      +++V+E  A  
Sbjct: 83  IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +     R    + E   +  L  L  G++ ++S  I+HRDLKP N L   ++ D  +K+ 
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198

Query: 110 DFGLS 114
           DFGL+
Sbjct: 199 DFGLA 203

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 85.9 bits (213), Expect = 8e-21
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 25/153 (16%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--- 71
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y+R       + +      
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 72  ------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                  + L         G+E L S   IHRDL   N+L++  +++VM KIADFGL+  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARD 252

Query: 117 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           +   +Y +K     L   +MAPE L  + Y  +
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 285

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 85.1 bits (211), Expect = 1e-20
 Identities = 35/136 (25%), Positives = 66/136 (48%), Gaps = 10/136 (7%)

Query: 15  CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
            E + +   +HPNIIRL         + +V E+   G+L S++R H  +         L+
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154

Query: 74  QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP 130
            +  G++ L+    +HRDL   NIL++    +++ K++DFGL   L     A     G  
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211

Query: 131 L---YMAPEVLQFQRY 143
           +   + +PE + ++++
Sbjct: 212 IPIRWTSPEAIAYRKF 227

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 84.2 bits (209), Expect = 1e-20
 Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 11/135 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  +++P I+RL         + LV+E   GG L  ++      +P     + L Q
Sbjct: 60  EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 131
           +  G++ L   + +HRDL   N+LL    +    KI+DFGLS  L    +Y         
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175

Query: 132 ---YMAPEVLQFQRY 143
              + APE + F+++
Sbjct: 176 PLKWYAPECINFRKF 190

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 84.7 bits (210), Expect = 2e-20
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 22/160 (13%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F   +        +LV+ F   
Sbjct: 54  IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQ 112

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L   +    +  E+  +  + Q+  GL+ ++S  ++HRDLKP N+    +++D  LKI
Sbjct: 113 TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA---VNEDCELKI 167

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKV 147
            DFGL+           V  +  Y APEV L +  Y++ V
Sbjct: 168 LDFGLARHADA-EMTGYV-VTRWYRAPEVILSWMHYNQTV 205

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 85.2 bits (211), Expect = 2e-20
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 40/182 (21%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+N+  +  +DC     E+  L+ +    IIRL+D    ++      +++V+E  A  
Sbjct: 56  IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L    +    + E+  +  L  L  G   ++   IIHRDLKP N L   L+ D  +K+ 
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171

Query: 110 DFGLSCTLYPGNYAEKVCGSPL-----------------------YMAPEV-LQFQRYDE 145
           DFGL+ T+        V                            Y APE+ L  + Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231

Query: 146 KV 147
            +
Sbjct: 232 SI 233

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 83.8 bits (208), Expect = 2e-20
 Identities = 34/134 (25%), Positives = 67/134 (50%), Gaps = 11/134 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   + +++HP+I++L    + E   ++++E    G L  Y+  +   +   T   +  Q
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 131
           +   +  L S + +HRD+   NIL++       +K+ DFGLS  +   +Y  K   + L 
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177

Query: 132 --YMAPEVLQFQRY 143
             +M+PE + F+R+
Sbjct: 178 IKWMSPESINFRRF 191

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 84.3 bits (209), Expect = 2e-20
 Identities = 45/154 (29%), Positives = 64/154 (41%), Gaps = 28/154 (18%)

Query: 15  CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF-- 71
            EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R    +    A     
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 72  -------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
                   QQL         G++ L+    IHRDL   NIL+    ++ + KIADFGLS 
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSR 190

Query: 116 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
                    K     L   +MA E L +  Y   
Sbjct: 191 G---QEVYVKKTMGRLPVRWMAIESLNYSVYTTN 221

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 84.3 bits (209), Expect = 2e-20
 Identities = 34/135 (25%), Positives = 63/135 (46%), Gaps = 10/135 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +   +H NIIRL         + ++ E+   G L  ++R   G          L+ 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSPL 131
           +  G++ L + + +HRDL   NIL++    +++ K++DFGLS  L     A     G  +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212

Query: 132 ---YMAPEVLQFQRY 143
              + APE + ++++
Sbjct: 213 PIRWTAPEAISYRKF 227

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 84.0 bits (208), Expect = 4e-20
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 25/153 (16%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--- 71
           E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y++       + +      
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 72  ------LQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                  + L         G+E L S   IHRDL   N+L++   +D ++KIADFGL+  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARD 240

Query: 117 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEK 146
           ++  +Y +K     L   +MAPE L  + Y  +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 273

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 82.7 bits (205), Expect = 5e-20
 Identities = 28/151 (18%), Positives = 71/151 (47%), Gaps = 13/151 (8%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L K +++         + +S ++H +++  +      +   LV EF   G+L +Y++ +
Sbjct: 47  VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD-----DDVMLKIADFG 112
              +      +  +QL   +  L  + +IH ++  +NILL   +     +   +K++D G
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166

Query: 113 LSCTLYPGNYAEKVCGSPL-YMAPEVLQFQR 142
           +S T+ P +  ++     + ++ PE ++  +
Sbjct: 167 ISITVLPKDILQE----RIPWVPPECIENPK 193

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.1 bits (206), Expect = 5e-20
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 12/127 (9%)

Query: 24  NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI 79
             PNII L D  +        LV E     +     +    + +   R ++ ++   L+ 
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 145

Query: 80  LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVL 138
            +S  I+HRD+KP N+++        L++ D+GL+   +PG  Y  +V  S  +  PE+L
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELL 202

Query: 139 -QFQRYD 144
             +Q YD
Sbjct: 203 VDYQMYD 209

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.4 bits (207), Expect = 5e-20
 Identities = 35/142 (24%), Positives = 67/142 (47%), Gaps = 26/142 (18%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYI-RLHGRVPEQ 66
           E+  L  + H N++ L +  + +          I+LV +FC   +L+  +  +  +    
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124

Query: 67  TARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 124
             ++ +Q L  GL  ++ + I+HRD+K  N+L   +  D +LK+ADFGL+   +  + A+
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADFGLA-RAF--SLAK 178

Query: 125 KVCGSPL--------YMAPEVL 138
               +          Y  PE+L
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELL 200

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.4 bits (207), Expect = 6e-20
 Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 30/170 (17%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK+       L       E+  L    H NII +F+  + ++      ++++ E     
Sbjct: 41  IKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-MQT 98

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L   I     + +   + F+ Q    +++L+  ++IHRDLKP N+L   ++ +  LK+ 
Sbjct: 99  DLHRVIS-TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL---INSNCDLKVC 154

Query: 110 DFGLSCTLYPGNYAEKVCGSPL-----------YMAPEV-LQFQRYDEKV 147
           DFGL+  +                         Y APEV L   +Y   +
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 83.8 bits (207), Expect = 8e-20
 Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 11/135 (8%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
           E   +  +++P I+RL         + LV+E   GG L  ++      +P     + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 131
           +  G++ L   + +HR+L   N+LL    +    KI+DFGLS  L    +Y         
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501

Query: 132 ---YMAPEVLQFQRY 143
              + APE + F+++
Sbjct: 502 PLKWYAPECINFRKF 516

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.3 bits (204), Expect = 1e-19
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 21/149 (14%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA-------ENCIFLVVEFCAGGNLSSYIRLHGR----VP 64
            +  L+ ++HPNI++L   F         +  + +V+E+     L    R + R     P
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127

Query: 65  EQTARKFLQQL--GLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
               + FL QL   +  L   S ++ HRD+KP N+L++  D    LK+ DFG +  L P 
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPS 185

Query: 121 N-YAEKVCGSPLYMAPEV-LQFQRYDEKV 147
                 +C S  Y APE+    Q Y   V
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHYTTAV 213

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 82.4 bits (204), Expect = 1e-19
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 37/168 (22%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  +S +       EL  L  + H N+I L D F           ++LV     G
Sbjct: 59  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 117

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
            +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI
Sbjct: 118 ADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKI 173

Query: 109 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 147
            DFGL+          +     +        Y APE+ L +  Y++ V
Sbjct: 174 LDFGLA----------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTV 211

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 81.3 bits (201), Expect = 4e-19
 Identities = 42/179 (23%), Positives = 79/179 (44%), Gaps = 38/179 (21%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNL 53
           +KK+    ++  D      E+  L+ ++ H NI+ L +  +A+N   ++LV ++    +L
Sbjct: 39  VKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL 97

Query: 54  SSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
            + IR    +     +  + QL   ++ L+S  ++HRD+KP NIL   L+ +  +K+ADF
Sbjct: 98  HAVIR-ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNIL---LNAECHVKVADF 153

Query: 112 GLSCTLYPGNYAEKVCGSPL----------------------YMAPEV-LQFQRYDEKV 147
           GLS +              +                      Y APE+ L   +Y + +
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.2 bits (201), Expect = 4e-19
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 31/167 (18%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
           +KK++   +    C     E+  L    H NII + D  +A        +++V +     
Sbjct: 57  IKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-MET 114

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L   ++    +       FL Q+  GL+ ++S +++HRDLKP N+L   L+    LKI 
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKIC 170

Query: 110 DFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 147
           DFGL+    P    +      L        Y APE+ L  + Y + +
Sbjct: 171 DFGLARVADP----DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.8 bits (200), Expect = 5e-19
 Identities = 41/142 (28%), Positives = 65/142 (45%), Gaps = 15/142 (10%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVP--EQTA 68
           E+  L+  +HPNI+ L D F          ++LV E     +L+  I    R+    Q  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIH-DQRIVISPQHI 136

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 126
           + F+  +  GL +L+   ++HRDL P NIL   L D+  + I DF L+            
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNIL---LADNNDITICDFNLAREDTADANKTHY 193

Query: 127 CGSPLYMAPEV-LQFQRYDEKV 147
                Y APE+ +QF+ + + V
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLV 215

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.4 bits (199), Expect = 5e-19
 Identities = 39/157 (24%), Positives = 76/157 (48%), Gaps = 33/157 (21%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENC--------------IFLVVEFCAGGNLSSYIRLHG 61
           E+  +  ++H NI+++F+                     +++V E+    +L++ +   G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLE-QG 115

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + E+ AR F+ QL  GL+ ++S +++HRDLKP N+ ++   +D++LKI DFGL+  + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173

Query: 120 GNYAEKVCGSPL--------YMAPEV-LQFQRYDEKV 147
                      L        Y +P + L    Y + +
Sbjct: 174 ----HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI 206

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 2e-18
 Identities = 43/192 (22%), Positives = 75/192 (39%), Gaps = 51/192 (26%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------------------------ 37
           LKK+ +  +     EL+ +  ++H NII+L D F                          
Sbjct: 37  LKKVLQDPRYKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95

Query: 38  --------------ENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQL--GL 77
                            + +++E+     L   ++   R    +P      ++ QL   +
Sbjct: 96  VNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154

Query: 78  EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPE 136
             ++S  I HRD+KP+N+L++  D+   LK+ DFG +  L P       +C S  Y APE
Sbjct: 155 GFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPE 211

Query: 137 V-LQFQRYDEKV 147
           + L    Y   +
Sbjct: 212 LMLGATEYTPSI 223

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.1 bits (190), Expect = 5e-18
 Identities = 20/113 (17%), Positives = 35/113 (30%), Gaps = 18/113 (15%)

Query: 20  LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLE 78
           LS ++ P + R+ D         +V E+  GG+L          P    R         +
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIRAMQSLAAAAD 143

Query: 79  ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------------LSCTLY 118
             +   +      P  + +S  D DV   +A                +  +LY
Sbjct: 144 AAHRAGVALSIDHPSRVRVSI-DGDV--VLAYPATMPDANPQDDIRGIGASLY 193

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 76.5 bits (189), Expect = 1e-17
 Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 18/133 (13%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E+  LS   HP+++ L       N + L+ ++   GNL  +  L+G      +  + Q+L
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRL 142

Query: 76  --------GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--- 124
                   GL  L++  IIHRD+K  NIL   LD++ + KI DFG+S             
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGIS-KKGTELDQTHLS 198

Query: 125 -KVCGSPLYMAPE 136
             V G+  Y+ PE
Sbjct: 199 TVVKGTLGYIDPE 211

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 77.1 bits (190), Expect = 1e-17
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 22/159 (13%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSY 56
           +L+++N    +  D            +I++L D F  +      + +V E   G NL + 
Sbjct: 68  LLQRVNDADNTKEDSM-------GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119

Query: 57  IRL--HGRVPEQTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLDD---DVMLKI 108
           I+   H  +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D     + +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
           AD G +C  +   +      +  Y +PEVL    +    
Sbjct: 180 ADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGA 216

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 74.8 bits (184), Expect = 9e-17
 Identities = 46/151 (30%), Positives = 62/151 (41%), Gaps = 20/151 (13%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ L K  K             N  N+I + + F   N I +  E     NL   I+ +
Sbjct: 146 ILEHLRKQDKD------------NTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKN 192

Query: 61  G--RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                     RKF   +   L+ L+ + IIH DLKPENILL        +K+ DFG SC 
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSC- 250

Query: 117 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
            Y          S  Y APEV+   RY   +
Sbjct: 251 -YEHQRVYTYIQSRFYRAPEVILGARYGMPI 280

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 71.5 bits (176), Expect = 1e-15
 Identities = 41/143 (28%), Positives = 58/143 (40%), Gaps = 36/143 (25%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
           E+  +S   H N++RL           LV  + A G+++S   L  R   Q         
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQ 134

Query: 67  -----TARKFLQQLGLEILNSH-----HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
                +AR      GL  L  H      IIHRD+K  NIL   LD++    + DFGL+  
Sbjct: 135 RIALGSAR------GLAYL--HDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLA-K 182

Query: 117 LYPGNYAE---KVCGSPLYMAPE 136
           L           V G+  ++APE
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPE 205

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 71.7 bits (176), Expect = 1e-15
 Identities = 49/153 (32%), Positives = 61/153 (39%), Gaps = 22/153 (14%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ +NKH                   I+ L   F   N + LV E     NL   +R  
Sbjct: 103 LLELMNKHDTE------------MKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT 149

Query: 61  GRVP--EQTARKFLQQL--GLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                     RKF QQ+   L  L +    IIH DLKPENILL        +KI DFG S
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
           C    G    +   S  Y +PEVL    YD  +
Sbjct: 209 C--QLGQRIYQYIQSRFYRSPEVLLGMPYDLAI 239

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.0 bits (175), Expect = 1e-15
 Identities = 37/145 (25%), Positives = 54/145 (37%), Gaps = 43/145 (29%)

Query: 16  ELNFLSSVNHPNIIRL--FDAFQAENCI-----FLVVEFCAGGNLSSYIRLHGRVPEQ-- 66
           E+  ++   H N++ L  F               LV  +   G+L    RL         
Sbjct: 80  EIKVMAKCQHENLVELLGF-------SSDGDDLCLVYVYMPNGSLLD--RLSCLDGTPPL 130

Query: 67  -----------TARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
                       A       G+  L+ +H IHRD+K  NIL   LD+    KI+DFGL+ 
Sbjct: 131 SWHMRCKIAQGAAN------GINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLA- 180

Query: 116 TLYPGNYAE----KVCGSPLYMAPE 136
                        ++ G+  YMAPE
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPE 205

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 66.6 bits (163), Expect = 6e-14
 Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 35/158 (22%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +LKK+ +  K             N    + + D F     + +  E   G N   +++ +
Sbjct: 69  VLKKIKEKDKE------------NKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKEN 115

Query: 61  GRV--PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVM----------- 105
                P    R    QL   L  L+ + + H DLKPENIL    + + +           
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175

Query: 106 -----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 138
                +++ADFG +   +   +   +  +  Y  PEV+
Sbjct: 176 VKNTSIRVADFGSAT--FDHEHHTTIVATRHYRPPEVI 211

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 65.8 bits (161), Expect = 1e-13
 Identities = 34/158 (21%), Positives = 62/158 (39%), Gaps = 35/158 (22%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +L+ LN    +            +    +++ + F+    I +V E   G +   +I+ +
Sbjct: 64  VLEHLNTTDPN------------STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110

Query: 61  GRV--PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL----------------SGL 100
           G +       RK   Q+   +  L+S+ + H DLKPENIL                    
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170

Query: 101 DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 138
             +  +K+ DFG +   Y   +   +  +  Y APEV+
Sbjct: 171 LINPDIKVVDFGSAT--YDDEHHSTLVSTRHYRAPEVI 206

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 63.9 bits (156), Expect = 6e-13
 Identities = 32/154 (20%), Positives = 56/154 (36%), Gaps = 34/154 (22%)

Query: 16  ELNFLSSVNH-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTA 68
           E + L  + +      NI++    F   + + L+ E   G +L   I  +       +  
Sbjct: 81  EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139

Query: 69  RKFLQQL--GLEILNSHHIIHRDLKPENILL----------------------SGLDDDV 104
           + +  ++   L  L    + H DLKPENILL                             
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 105 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 138
            +K+ DFG +   +  +Y   +  +  Y APEV+
Sbjct: 200 GIKLIDFGCAT--FKSDYHGSIINTRQYRAPEVI 231

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.1 bits (148), Expect = 6e-12
 Identities = 27/74 (36%), Positives = 39/74 (52%), Gaps = 6/74 (8%)

Query: 76  GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---Y 132
           G+E L S   IHRDL   NILLS   +  ++KI DFGL+  +Y      +   + L   +
Sbjct: 205 GMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261

Query: 133 MAPEVLQFQRYDEK 146
           MAPE +  + Y  +
Sbjct: 262 MAPETIFDRVYTIQ 275

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 43.0 bits (101), Expect = 1e-05
 Identities = 29/134 (21%), Positives = 47/134 (35%), Gaps = 5/134 (3%)

Query: 1   MLKK-LNKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
           MLK+         L  EL  L  + +H N++ L  A  +    + ++VEFC  GNLS+Y 
Sbjct: 59  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY- 117

Query: 58  RLHGRVPEQTARKFLQQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
            L  +  E    K       +  +    I  DLK     ++           +      +
Sbjct: 118 -LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176

Query: 118 YPGNYAEKVCGSPL 131
                 E +    L
Sbjct: 177 EEEEAPEDLYKDFL 190

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.9 bits (135), Expect = 3e-10
 Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 5/117 (4%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRL-FDAFQAENCIFLVVEFCAGGNLSSYIRL 59
             +++ K        E   L  +  P         F+  +  F+V+E   G +L      
Sbjct: 86  FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           +G   + T  +   ++   LE ++ +  +H D+K  N+LL G  +   + +AD+GLS
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLS 200

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.4 bits (128), Expect = 3e-09
 Identities = 38/125 (30%), Positives = 59/125 (47%), Gaps = 24/125 (19%)

Query: 2   LK--KLNKHLKSCLDCELNFLSSV-----NHPN---IIRLFDAFQAEN------CIFLVV 45
           +K  K  +H       E+  L SV     N PN   +++L D F+         C  +V 
Sbjct: 67  MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVF 124

Query: 46  EFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGL 100
           E   G +L  +I    +  +P    +K +QQ+  GL+ L++   IIH D+KPENILLS  
Sbjct: 125 EV-LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183

Query: 101 DDDVM 105
           +  + 
Sbjct: 184 EQYIR 188

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.1 bits (125), Expect = 9e-09
 Identities = 23/133 (17%), Positives = 49/133 (36%), Gaps = 24/133 (18%)

Query: 4   KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-------------------FLV 44
           K+       L  EL F      P  I+ +   +    +                   F++
Sbjct: 71  KVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130

Query: 45  VEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD 101
           ++   G +L      + +    +T  +   ++   LE ++ H  +H D+K  N+LL    
Sbjct: 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYK 188

Query: 102 DDVMLKIADFGLS 114
           +   + + D+GL+
Sbjct: 189 NPDQVYLVDYGLA 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.6 bits (116), Expect = 1e-07
 Identities = 18/77 (23%), Positives = 39/77 (50%), Gaps = 6/77 (7%)

Query: 42  FLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL 97
           FLV+    G +L S + +  +  + E++  +   +L   LE L+ +  +H ++  ENI +
Sbjct: 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192

Query: 98  SGLDDDVMLKIADFGLS 114
              +D   + +A +G +
Sbjct: 193 -DPEDQSQVTLAGYGFA 208

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.4 bits (113), Expect = 3e-07
 Identities = 23/92 (25%), Positives = 40/92 (43%), Gaps = 4/92 (4%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEILNS 82
             I  +       +   +V+E   G +L        R    +T      Q+   +E ++S
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 83  HHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
            + IHRD+KP+N L+       ++ I DFGL+
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.8 bits (108), Expect = 1e-06
 Identities = 22/94 (23%), Positives = 38/94 (40%), Gaps = 4/94 (4%)

Query: 24  NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEIL 80
               I  +       +   LV++   G +L        R    +T      Q+   +E +
Sbjct: 61  GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 81  NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
           +S   +HRD+KP+N L+        + I DFGL+
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.3 bits (105), Expect = 3e-06
 Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 6/94 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEILNS 82
             I +++          +V+E   G +L     L  R    +T      QL   +E ++S
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 83  HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS 114
            ++I+RD+KPEN L+   G     ++ I DF L+
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.9 bits (104), Expect = 4e-06
 Identities = 21/94 (22%), Positives = 44/94 (46%), Gaps = 6/94 (6%)

Query: 26  PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQL--GLEILNS 82
             I  ++   Q      LV++   G +L   + L GR    +T     +Q+   ++ ++ 
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 83  HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS 114
             +++RD+KP+N L+      +  M+ + DFG+ 
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 41.4 bits (96), Expect = 3e-05
 Identities = 18/87 (20%), Positives = 30/87 (34%), Gaps = 5/87 (5%)

Query: 38  ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL-GLEIL-NSHHIIHRDLKPENI 95
           ++ +F+V+EF  GG     +R              Q    L +   S    HRDL   N+
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193

Query: 96  LLSGLDDDVMLKIADFGLSCTLYPGNY 122
           L   L    + K+       +    + 
Sbjct: 194 L---LKKTSLKKLHYTLNGKSSTIPSC 217

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	152
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.98
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.98
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.98
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.98
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.98
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.98
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.98
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.98
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.98
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.98
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.98
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.98
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.98
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.98
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.98
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.98
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.98
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.98
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.98
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.98
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.98
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.98
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.97
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.96
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
3uqc_A	286	Probable conserved transmembrane protein; structur	99.92
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.62
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.26
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.95
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.87
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.35
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.21
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.05
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.58
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.3
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.24
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.36
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	93.7
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	93.35
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.9
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	92.19
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	90.63
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	90.1
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	89.98
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.99
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	88.61
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	88.31
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.89
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	87.05
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	86.4
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.26
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	81.39

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.3e-45  Score=258.45  Aligned_cols=141  Identities=31%  Similarity=0.574  Sum_probs=130.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++|+.++||||++++++|++++.+|+|||||+||+|.+++.+.+.+++..+..++.|+  |+.|||+++|+
T Consensus        75 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~Ii  154 (311)
T 4aw0_A           75 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII  154 (311)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            3578999999999999999999999999999999999999999999999999999999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC---CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||||+|||+   +.++.+||+|||+|+.+...   ....+.+||+.|||||++.+..|+.++|||||
T Consensus       155 HRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl  220 (311)
T 4aw0_A          155 HRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL  220 (311)
T ss_dssp             CSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHH
T ss_pred             cCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHH
Confidence            99999999999   56778999999999876543   24567899999999999999999999999995

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-44  Score=258.57  Aligned_cols=144  Identities=26%  Similarity=0.568  Sum_probs=129.4

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      +...++.+.+|+++|++++|||||++++++++++.+|+|||||+||+|.+++..++  .+++..+..++.|+  ||.|||
T Consensus        63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH  142 (350)
T 4b9d_A           63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH  142 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45567889999999999999999999999999999999999999999999997543  47899999999998  999999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||||+|||+   +.++.+||+|||+|+.+.... ...+.+||+.|||||++.+..|+.++|||||
T Consensus       143 ~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSl  211 (350)
T 4b9d_A          143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWAL  211 (350)
T ss_dssp             HTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             HCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHH
Confidence            9999999999999999   567789999999998765432 3456789999999999999999999999996

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-44  Score=257.54  Aligned_cols=141  Identities=25%  Similarity=0.523  Sum_probs=128.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..++.+.+|+++|+.++|||||+++++|.+++.+|+|||||+||+|.+++.+ +.+++..+..++.|+  ||.|||+++|
T Consensus       113 ~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~I  191 (346)
T 4fih_A          113 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGV  191 (346)
T ss_dssp             SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            3456788999999999999999999999999999999999999999999875 569999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+|||+   +.++.+||+|||+|+.+... ....+.+||+.|||||++.+..|+.++|||||
T Consensus       192 iHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl  256 (346)
T 4fih_A          192 IHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL  256 (346)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             ccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence            999999999999   56778999999999877544 34567899999999999999999999999996

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-43  Score=248.27  Aligned_cols=143  Identities=34%  Similarity=0.657  Sum_probs=126.3

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      +...++.|.+|+++|++++|||||+++++|++    ++.+|+|||||++|+|.+++.+.+.+++..+..++.|+  |+.|
T Consensus        65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~y  144 (290)
T 3fpq_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            44567889999999999999999999999865    35689999999999999999998899999999999998  9999


Q ss_pred             HHhCC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           80 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+++  |+||||||+|||+.  +..+.+||+|||+|+.. ......+.+||+.|||||++.+ .|+.++|||||
T Consensus       145 lH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~-~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSl  215 (290)
T 3fpq_A          145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAF  215 (290)
T ss_dssp             HHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGC-CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred             HHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeC-CCCccCCcccCccccCHHHcCC-CCCcHHHHHHH
Confidence            99998  99999999999994  24578999999999753 3344567899999999999874 69999999996

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.8e-44  Score=246.87  Aligned_cols=140  Identities=41%  Similarity=0.788  Sum_probs=117.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++|+.++||||+++++++++++.+|+||||+ +|+|.+++.+++.+++..+..++.|+  |+.|||+++++
T Consensus        56 ~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~Ii  134 (275)
T 3hyh_A           56 MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIV  134 (275)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3577999999999999999999999999999999999999 78999999999999999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      ||||||+||++   +.++.+||+|||+|+.........+.+||+.|||||++.+..| +.++|||||
T Consensus       135 HRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSl  198 (275)
T 3hyh_A          135 HRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC  198 (275)
T ss_dssp             CCCCCTTTEEE---CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHH
T ss_pred             cccCChHHeEE---CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHH
Confidence            99999999999   5677899999999987766666677899999999999998886 579999996

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=258.64  Aligned_cols=141  Identities=25%  Similarity=0.523  Sum_probs=128.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..++.+.+|+.+|+.++|||||+++++|.+++.+|+|||||+||+|.++++. +.+++..+..++.|+  ||.|||+++|
T Consensus       190 ~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~I  268 (423)
T 4fie_A          190 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGV  268 (423)
T ss_dssp             SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3457789999999999999999999999999999999999999999999865 469999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+|||+   +.++.+||+|||+|+.+... ....+.+||+.|||||++.+..|+.++|||||
T Consensus       269 iHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSl  333 (423)
T 4fie_A          269 IHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL  333 (423)
T ss_dssp             ECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHH
T ss_pred             ecccCCHHHEEE---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHH
Confidence            999999999999   56778999999999876544 34567899999999999999999999999996

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-44  Score=252.03  Aligned_cols=141  Identities=36%  Similarity=0.564  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ....+.+|+++|++++||||+++++++++++.+|+|||||+||+|.+++.+.+.+++..+..++.|+  |+.|||+++++
T Consensus        69 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~Ii  148 (304)
T 3ubd_A           69 DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII  148 (304)
T ss_dssp             ECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            3457889999999999999999999999999999999999999999999999999999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||||+|||+   +..+.+||+|||+|+..... ....+.+||+.|||||++.+..|+.++|||||
T Consensus       149 HRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl  212 (304)
T 3ubd_A          149 YRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF  212 (304)
T ss_dssp             CSSCCGGGEEE---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             CCCCCHHHeEE---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccch
Confidence            99999999999   56778999999999865443 34567899999999999999999999999996

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.6e-44  Score=250.13  Aligned_cols=144  Identities=23%  Similarity=0.535  Sum_probs=128.5

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-------------CCCCHHHHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------------GRVPEQTARKFL   72 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~   72 (152)
                      +...+++|.+|+++|++++|||||++++++.+++..|+|||||++|+|.+++.+.             ..+++..+..++
T Consensus        55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~  134 (299)
T 4asz_A           55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA  134 (299)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence            4556788999999999999999999999999999999999999999999999754             358999999999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCccc
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      .|+  |+.|||+++++||||||+|||+   +.+..+||+|||+|+.......   .....||+.|||||++.++.|+.++
T Consensus       135 ~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~  211 (299)
T 4asz_A          135 QQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES  211 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh
Confidence            999  8999999999999999999999   5678999999999987654432   2335689999999999999999999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |||||
T Consensus       212 DVwS~  216 (299)
T 4asz_A          212 DVWSL  216 (299)
T ss_dssp             HHHHH
T ss_pred             hHHHH
Confidence            99996

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.2e-43  Score=250.04  Aligned_cols=136  Identities=33%  Similarity=0.519  Sum_probs=121.7

Q ss_pred             HHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCC
Q 031828           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLK   91 (152)
Q Consensus        14 ~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~   91 (152)
                      .+|+.+|+.++|||||++++++.+++.+|+|||||+||+|.+++++.+.+++..+..++.|+  ||.|||+++|+|||||
T Consensus        98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK  177 (336)
T 4g3f_A           98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK  177 (336)
T ss_dssp             THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred             HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence            47999999999999999999999999999999999999999999998999999999999998  9999999999999999


Q ss_pred             CCceEeecCCCCc-eEEEeeccCccccCCCC------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           92 PENILLSGLDDDV-MLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        92 ~~nil~~~~~~~~-~~kl~dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+|||+.   .++ .+||+|||+|+.+....      ...+.+||+.|||||++.+..|+.++|||||
T Consensus       178 p~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSl  242 (336)
T 4g3f_A          178 ADNVLLS---SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS  242 (336)
T ss_dssp             GGGEEEC---TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHHEEEe---CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHH
Confidence            9999994   444 69999999998765432      1234689999999999999999999999996

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=248.78  Aligned_cols=144  Identities=23%  Similarity=0.482  Sum_probs=121.2

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc---------------CCCCHHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------GRVPEQTARK   70 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~   70 (152)
                      +...+++|.+|+++|++++|||||++++++.+++..|+|||||++|+|.+++.+.               +.+++..+..
T Consensus        83 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~  162 (329)
T 4aoj_A           83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA  162 (329)
T ss_dssp             SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHH
Confidence            4556788999999999999999999999999999999999999999999999753               3488999999


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.|+  |+.|||+++++||||||+|||+   +....+||+|||+++......   .....+||+.|||||++.+..|+.
T Consensus       163 i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~  239 (329)
T 4aoj_A          163 VASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT  239 (329)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHhcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCc
Confidence            99998  8999999999999999999999   467899999999998764433   224567999999999999999999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       240 ~sDvwS~  246 (329)
T 4aoj_A          240 ESDVWSF  246 (329)
T ss_dssp             HHHHHHH
T ss_pred             cccccch
Confidence            9999996

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=241.40  Aligned_cols=142  Identities=25%  Similarity=0.465  Sum_probs=120.3

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.|.+|+++|++++|||||++++++.. +.+|+|||||++|+|.+++... ..+++..+..++.|+  |+.|||++
T Consensus        73 ~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~  151 (307)
T 3omv_A           73 PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK  151 (307)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4567889999999999999999999998864 5689999999999999999754 569999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC---CccccCCCCCCccccccccc---CCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~  152 (152)
                      +++||||||+|||+   +.++.+||+|||+|+.....   ....+.+||+.|||||++.+   +.|+.++|||||
T Consensus       152 ~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~  223 (307)
T 3omv_A          152 NIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSY  223 (307)
T ss_dssp             TCBCSCCCSSSEEE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHH
T ss_pred             CccCCccCHHHEEE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhH
Confidence            99999999999999   46789999999999865432   23456789999999999964   358999999996

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-42  Score=244.60  Aligned_cols=142  Identities=23%  Similarity=0.503  Sum_probs=126.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF   71 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~   71 (152)
                      ..+++|.+|+.+|++++|||||++++++..++..++|||||++|+|.+++...                ..+++.....+
T Consensus        71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i  150 (308)
T 4gt4_A           71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL  150 (308)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence            34678999999999999999999999999999999999999999999999643                34888999999


Q ss_pred             HHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcc
Q 031828           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEK  146 (152)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~  146 (152)
                      +.|+  |+.|||+++++||||||+|||+   +....+||+|||+++.+....   .....+||+.|||||++.++.|+.+
T Consensus       151 ~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k  227 (308)
T 4gt4_A          151 VAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID  227 (308)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence            9998  8999999999999999999999   567899999999998764432   2345678999999999999999999


Q ss_pred             cceeeC
Q 031828          147 VNFFVS  152 (152)
Q Consensus       147 ~Dvws~  152 (152)
                      +|||||
T Consensus       228 sDVwSf  233 (308)
T 4gt4_A          228 SDIWSY  233 (308)
T ss_dssp             HHHHHH
T ss_pred             chhhhH
Confidence            999996

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=9e-42  Score=240.02  Aligned_cols=143  Identities=28%  Similarity=0.537  Sum_probs=116.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC------------eEEEEEeecCCCChHHHHHhcCC---CCHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF   71 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------------~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~   71 (152)
                      ...++.+.+|+++|++++|||||++++++...+            .+|++||||++|+|.+++.....   .+...+..+
T Consensus        44 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i  123 (299)
T 4g31_A           44 ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI  123 (299)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHH
Confidence            345678999999999999999999999986543            47999999999999999987655   345667888


Q ss_pred             HHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-------------ccccCCCCCCccccc
Q 031828           72 LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------------YAEKVCGSPLYMAPE  136 (152)
Q Consensus        72 ~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~t~~y~aPE  136 (152)
                      +.|+  |+.|||+++++||||||+|||+   +.++.+||+|||+|+.+....             ...+.+||+.|||||
T Consensus       124 ~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE  200 (299)
T 4g31_A          124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE  200 (299)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred             HHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence            8998  9999999999999999999999   567789999999998764332             123468999999999


Q ss_pred             ccccCCCCcccceeeC
Q 031828          137 VLQFQRYDEKVNFFVS  152 (152)
Q Consensus       137 ~~~~~~~~~~~Dvws~  152 (152)
                      ++.+..|+.++|||||
T Consensus       201 ~~~~~~y~~~~DiwSl  216 (299)
T 4g31_A          201 QIHGNSYSHKVDIFSL  216 (299)
T ss_dssp             HHTTCCCCTHHHHHHH
T ss_pred             HHcCCCCCCHHHHHHH
Confidence            9999999999999996

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.2e-40  Score=237.41  Aligned_cols=143  Identities=31%  Similarity=0.476  Sum_probs=124.1

Q ss_pred             HhHHHHHHHHHHHHHcCCC-cCccceeeeeeeC-CeEEEEEeecCCCChHHHHHhc----------------CCCCHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA   68 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~----------------~~~~~~~~   68 (152)
                      ..+.+.|.+|+++|++++| ||||+++++|..+ +.+|+|||||++|+|.+++++.                ..+++..+
T Consensus       108 ~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~  187 (353)
T 4ase_A          108 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL  187 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHH
T ss_pred             hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHH
Confidence            3456789999999999965 8999999998664 5789999999999999999753                23788999


Q ss_pred             HHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCC
Q 031828           69 RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY  143 (152)
Q Consensus        69 ~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~  143 (152)
                      ..++.|+  |+.|||+++++||||||+|||+   +.++.+||+|||+|+.+....   ...+.+||+.|||||++.++.|
T Consensus       188 ~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y  264 (353)
T 4ase_A          188 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY  264 (353)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence            9999998  8999999999999999999999   567799999999998765433   2345678999999999999999


Q ss_pred             CcccceeeC
Q 031828          144 DEKVNFFVS  152 (152)
Q Consensus       144 ~~~~Dvws~  152 (152)
                      +.++|||||
T Consensus       265 ~~ksDVwS~  273 (353)
T 4ase_A          265 TIQSDVWSF  273 (353)
T ss_dssp             CHHHHHHHH
T ss_pred             CCcccEeeh
Confidence            999999996

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-39  Score=245.58  Aligned_cols=145  Identities=29%  Similarity=0.520  Sum_probs=131.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++|+.++||||++++++|++++.+|++||||+||+|.+++.. .+.+++..+..++.|+  ||.|||++
T Consensus       195 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~  274 (573)
T 3uto_A          195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN  274 (573)
T ss_dssp             HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34567899999999999999999999999999999999999999999999864 4579999999999998  99999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++||||||+||++.. ...+.+||+|||+|+.+.......+.+||+.|||||++.+..|+.++|||||
T Consensus       275 ~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSl  342 (573)
T 3uto_A          275 NYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV  342 (573)
T ss_dssp             TEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             CeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHH
Confidence            9999999999999952 2346899999999998877766778899999999999999999999999995

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.5e-39  Score=243.61  Aligned_cols=134  Identities=32%  Similarity=0.570  Sum_probs=121.9

Q ss_pred             HHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCC
Q 031828           15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKP   92 (152)
Q Consensus        15 ~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~   92 (152)
                      .++.+++.++||||++++++|++++.+|+||||++||+|.+++.+.+.+++..+..++.|+  ||.|||++||+||||||
T Consensus       241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKP  320 (689)
T 3v5w_A          241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP  320 (689)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred             HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence            3467778889999999999999999999999999999999999999999999999999998  99999999999999999


Q ss_pred             CceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           93 ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        93 ~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +|||+   +..+.+||+|||+|+.+... ...+.+||+.|||||++.. ..|+.++|||||
T Consensus       321 eNILl---d~~G~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSL  377 (689)
T 3v5w_A          321 ANILL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL  377 (689)
T ss_dssp             GGEEE---CTTSCEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred             HHeEE---eCCCCEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHH
Confidence            99999   57789999999999876443 4567899999999999975 579999999996

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.1e-39  Score=227.68  Aligned_cols=147  Identities=27%  Similarity=0.360  Sum_probs=117.6

Q ss_pred             cchhhHhHHHHHHH--HHHHHHcCCCcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (152)
Q Consensus         2 ~k~~~~~~~~~~~~--E~~~l~~l~h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i   75 (152)
                      +|+++....+.+..  |+..+..++||||+++++++..++    .+|+||||+++|+|.+++.+. .+++.....++.++
T Consensus        31 vK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~i  109 (303)
T 3hmm_A           31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST  109 (303)
T ss_dssp             EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHH
T ss_pred             EEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHH
Confidence            56666555555544  455556789999999999997653    589999999999999999754 57888888899998


Q ss_pred             --HHHHHHhC--------CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-----cccCCCCCCccccccccc
Q 031828           76 --GLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        76 --~l~~lh~~--------~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~  140 (152)
                        |+.|||++        +++||||||+|||+   +.++.+||+|||+++.......     ....+||+.|||||++.+
T Consensus       110 a~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~  186 (303)
T 3hmm_A          110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  186 (303)
T ss_dssp             HHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcc
Confidence              89999987        89999999999999   5778999999999987644321     234679999999999976


Q ss_pred             C------CCCcccceeeC
Q 031828          141 Q------RYDEKVNFFVS  152 (152)
Q Consensus       141 ~------~~~~~~Dvws~  152 (152)
                      .      .++.++|||||
T Consensus       187 ~~~~~~~~~~~k~DVwS~  204 (303)
T 3hmm_A          187 SINMKHFESFKRADIYAM  204 (303)
T ss_dssp             CSCTTCHHHHHHHHHHHH
T ss_pred             cccccCCccChhHhhhhH
Confidence            4      36789999996

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=231.00  Aligned_cols=141  Identities=28%  Similarity=0.504  Sum_probs=122.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeee------CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      ...+.+.+|+++|+.++||||+++++++..      .+.+|+||||| +|+|.+++.+.+.+++..+..++.|+  ||.|
T Consensus        95 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~y  173 (398)
T 4b99_A           95 TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY  173 (398)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999998754      36789999999 47899999988899999999999998  9999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-----CccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      ||+++++||||||+|||+   +..+.+|++|||+|+.+...     ....+.+||+.|+|||++.+.. |+.++||||+
T Consensus       174 lH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl  249 (398)
T 4b99_A          174 MHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV  249 (398)
T ss_dssp             HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred             HHHCcCcCCCcCcccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence            999999999999999999   56778999999999876432     2345789999999999988754 6899999995

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-38  Score=228.22  Aligned_cols=139  Identities=20%  Similarity=0.359  Sum_probs=119.1

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...++.+|+++|+.+ +||||++++++|.+++++|+||||+++++|.++++   .+++..+..++.|+  |+.|||++||
T Consensus        62 ~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gI  138 (361)
T 4f9c_A           62 HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGI  138 (361)
T ss_dssp             CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356688999999998 69999999999999999999999999999999884   58999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----------------------------ccccCCCCCCccccc
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------------YAEKVCGSPLYMAPE  136 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~t~~y~aPE  136 (152)
                      +||||||+|||+.  ...+.+||+|||+|+......                             ...+.+||++|+|||
T Consensus       139 iHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE  216 (361)
T 4f9c_A          139 VHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE  216 (361)
T ss_dssp             ECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred             EeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            9999999999995  234689999999997543221                             123468999999999


Q ss_pred             ccccCC-CCcccceeeC
Q 031828          137 VLQFQR-YDEKVNFFVS  152 (152)
Q Consensus       137 ~~~~~~-~~~~~Dvws~  152 (152)
                      ++.+.. |+.++||||+
T Consensus       217 ~l~~~~~y~~~~DiWSl  233 (361)
T 4f9c_A          217 VLTKCPNQTTAIDMWSA  233 (361)
T ss_dssp             HHTTCSCCCTHHHHHHH
T ss_pred             HHcCCCCCCCccchhhh
Confidence            998754 8999999995

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.9e-36  Score=214.35  Aligned_cols=146  Identities=32%  Similarity=0.526  Sum_probs=131.9

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ....+.+.+|+++++.++||||+++++++..++..|+||||+.+++|.+.+.....+++..+..++.++  |+.|||+++
T Consensus        69 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~  148 (362)
T 2bdw_A           69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  148 (362)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            455678999999999999999999999999999999999999999999999888889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++........+||+|||+++...........+||+.|+|||++.+..++.++|||||
T Consensus       149 ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  216 (362)
T 2bdw_A          149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC  216 (362)
T ss_dssp             CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred             eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHH
Confidence            99999999999996444456799999999987765555566789999999999998899999999996

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.7e-36  Score=212.42  Aligned_cols=143  Identities=37%  Similarity=0.708  Sum_probs=131.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ....+.+.+|+++++.++||||+++++++..++..|+||||+++++|.+++...+.+++..+..++.++  |+.|||+++
T Consensus        55 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~  134 (328)
T 3fe3_A           55 PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR  134 (328)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345677889999999999999999999999999999999999999999999888889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCC-cccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.+|++|||+++...........+||+.|+|||++.+..++ .++|||||
T Consensus       135 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  200 (328)
T 3fe3_A          135 IVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSL  200 (328)
T ss_dssp             CCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHH
T ss_pred             EeccCCCHHHEEE---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhh
Confidence            9999999999999   56778999999999887766667778999999999999988865 78999995

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1e-35  Score=212.44  Aligned_cols=141  Identities=33%  Similarity=0.511  Sum_probs=128.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||+++++
T Consensus        48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  127 (337)
T 1o6l_A           48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  127 (337)
T ss_dssp             CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4567889999999999999999999999999999999999999999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||||+||++   +..+.+||+|||+++.... .....+.+||+.|+|||++.+..++.++|||||
T Consensus       128 HrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  191 (337)
T 1o6l_A          128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  191 (337)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred             cCcCCHHHEEE---CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccc
Confidence            99999999999   5677899999999986433 334567789999999999999999999999996

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=217.73  Aligned_cols=147  Identities=29%  Similarity=0.474  Sum_probs=132.2

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      +....+.+.+|+++++.++||||+++++++..++..|+||||+.+++|.+.+...+.+++..+..++.++  |+.|||++
T Consensus        50 ~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~  129 (444)
T 3soa_A           50 SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM  129 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4456778999999999999999999999999999999999999999999999988899999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++......+.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||
T Consensus       130 givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl  199 (444)
T 3soa_A          130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC  199 (444)
T ss_dssp             TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHH
Confidence            99999999999999654456789999999998765443 2356789999999999998899999999995

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.8e-35  Score=211.97  Aligned_cols=143  Identities=29%  Similarity=0.579  Sum_probs=129.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.++  |+.|||+++++|
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  138 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            577899999999999999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCC-CceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++...+. ...+|++|||+++...........+||+.|+|||++.+..++.++|||||
T Consensus       139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  204 (361)
T 2yab_A          139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  204 (361)
T ss_dssp             CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHH
Confidence            999999999952211 22799999999988766655667789999999999998899999999995

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-35  Score=212.37  Aligned_cols=140  Identities=31%  Similarity=0.565  Sum_probs=128.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++||||+++++++.+.+..|+||||+.+++|.+++...+.+++..+..++.++  |+.|||++|++|
T Consensus        59 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH  138 (384)
T 4fr4_A           59 VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIH  138 (384)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            567889999999999999999999999999999999999999999999988889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc---CCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~  152 (152)
                      +||||+||++   +..+.+||+|||+++.+.......+.+||+.|+|||++..   ..++.++|||||
T Consensus       139 rDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSl  203 (384)
T 4fr4_A          139 RDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSL  203 (384)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHH
T ss_pred             ccCcHHHeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeech
Confidence            9999999999   5677899999999987766666678899999999999974   458999999996

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.6e-35  Score=214.24  Aligned_cols=141  Identities=32%  Similarity=0.617  Sum_probs=127.7

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|..+++++ +||||+++++++.+++..|+||||+++++|..++.+.+.+++..+..++.++  |+.|||++++
T Consensus        95 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi  174 (396)
T 4dc2_A           95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI  174 (396)
T ss_dssp             -CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            346688999999887 8999999999999999999999999999999999988899999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCcccc-CCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+++.. .......+.+||+.|+|||++.+..++.++|||||
T Consensus       175 vHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diwsl  239 (396)
T 4dc2_A          175 IYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL  239 (396)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             EeccCCHHHEEE---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHH
Confidence            999999999999   57788999999999863 33445667899999999999999999999999996

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.4e-35  Score=209.56  Aligned_cols=151  Identities=31%  Similarity=0.550  Sum_probs=116.2

Q ss_pred             cchhhHhHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      +|.++......+.+|+.+++.+. ||||+++++++.+++..|+||||+++++|.+++...+.+++..+..++.++  |+.
T Consensus        41 vK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~  120 (325)
T 3kn6_A           41 VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS  120 (325)
T ss_dssp             EEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHH
T ss_pred             EEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence            57777777788999999999997 999999999999999999999999999999999998889999999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+++++|+||||+||++...+....+||+|||+++...... .....++|+.|+|||++.+..++.++|||||
T Consensus       121 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl  195 (325)
T 3kn6_A          121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSL  195 (325)
T ss_dssp             HHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHH
T ss_pred             HHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHH
Confidence            9999999999999999999654444589999999998654433 3456678999999999999899999999995

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.8e-35  Score=207.99  Aligned_cols=142  Identities=32%  Similarity=0.618  Sum_probs=128.5

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|..+++.+ +||||+++++++.+++..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||+++
T Consensus        51 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  130 (345)
T 3a8x_A           51 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG  130 (345)
T ss_dssp             HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4467788999999988 8999999999999999999999999999999999988889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccC-CCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++||||||+||++   +..+.+||+|||+++... ......+.+||+.|+|||++.+..++.++|||||
T Consensus       131 ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  196 (345)
T 3a8x_A          131 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL  196 (345)
T ss_dssp             CBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             ceecCCCHHHEEE---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHH
Confidence            9999999999999   567789999999998643 3334567789999999999999899999999996

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=204.58  Aligned_cols=144  Identities=28%  Similarity=0.541  Sum_probs=126.8

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      +....+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.++  |+.|||+
T Consensus        47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (310)
T 3s95_A           47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS  126 (310)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            456678899999999999999999999999999999999999999999999987 4568999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---------------ccCCCCCCcccccccccCCCCccc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------------EKVCGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      ++++|+||||+||++   +..+.+||+|||+++........               ....||+.|+|||++.+..++.++
T Consensus       127 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  203 (310)
T 3s95_A          127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV  203 (310)
T ss_dssp             TTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred             CCccCCCCCcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH
Confidence            999999999999999   56778999999999865433211               156789999999999999999999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |||||
T Consensus       204 Di~sl  208 (310)
T 3s95_A          204 DVFSF  208 (310)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99996

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.1e-35  Score=210.55  Aligned_cols=141  Identities=36%  Similarity=0.562  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|..+++.+ +||||+++++++.+++..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||++++
T Consensus        66 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi  145 (353)
T 3txo_A           66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGI  145 (353)
T ss_dssp             THHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            456788999999998 7999999999999999999999999999999999988899999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+++..... ....+.+||+.|+|||++.+..++.++|||||
T Consensus       146 vHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  210 (353)
T 3txo_A          146 IYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAM  210 (353)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHH
T ss_pred             cccCCCHHHEEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcc
Confidence            999999999999   56778999999999764333 34556789999999999998889999999995

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=205.82  Aligned_cols=143  Identities=31%  Similarity=0.603  Sum_probs=128.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ++.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...+.+++..+..++.++  |+.|||+.+++|
T Consensus        58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH  137 (326)
T 2y0a_A           58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH  137 (326)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence            577999999999999999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCC-CCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++.... ....+||+|||+++............||+.|+|||++.+..++.++|||||
T Consensus       138 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  203 (326)
T 2y0a_A          138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  203 (326)
T ss_dssp             CCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHH
T ss_pred             CCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHH
Confidence            99999999995322 223799999999987765555566789999999999998899999999996

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.9e-35  Score=223.35  Aligned_cols=139  Identities=19%  Similarity=0.224  Sum_probs=110.9

Q ss_pred             HhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.+.+++.+.+++..   ++.|+  ||.|+|++
T Consensus       282 ~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~  358 (569)
T 4azs_A          282 QRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQ  358 (569)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHC
Confidence            34467899999999999 79999999999999999999999999999999999888888754   56787  99999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+||||||+|||+   +.++.+||+|||+|+..... ....+.+||+.|+|||++.+ .+..++|+||+
T Consensus       359 GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~  424 (569)
T 4azs_A          359 GFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSA  424 (569)
T ss_dssp             TCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------------
T ss_pred             CceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCccccccc
Confidence            99999999999999   56778999999999876543 33456789999999999985 46678899984

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.6e-35  Score=208.89  Aligned_cols=143  Identities=27%  Similarity=0.518  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .+.+.+|+++++.++||||+++++++..++..|+||||+++++|.+.+.+.    ..+++..+..++.++  |+.|||++
T Consensus        70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~  149 (351)
T 3c0i_A           70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN  149 (351)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            577999999999999999999999999999999999999999998877543    248999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++...+....+|++|||+++....... ....+||+.|+|||++.+..++.++|||||
T Consensus       150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  219 (351)
T 3c0i_A          150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGC  219 (351)
T ss_dssp             TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHH
Confidence            999999999999996444455699999999987655432 456689999999999999899999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-34  Score=204.76  Aligned_cols=139  Identities=37%  Similarity=0.651  Sum_probs=127.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|..+++.++||||+++++++.+.+..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||+++++
T Consensus        49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  128 (318)
T 1fot_A           49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII  128 (318)
T ss_dssp             CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3567889999999999999999999999999999999999999999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++....  ...+.+||+.|+|||++.+..++.++|||||
T Consensus       129 HrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  189 (318)
T 1fot_A          129 YRDLKPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSF  189 (318)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred             ccCCChheEEE---cCCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCCCCCcccchhhh
Confidence            99999999999   5677899999999976533  3446789999999999999999999999996

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-34  Score=206.93  Aligned_cols=139  Identities=42%  Similarity=0.780  Sum_probs=127.4

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ...+.+|+.+++.++||||+++++++..++..++||||+ +++|.+++...+.+++..+..++.++  |+.|||+++++|
T Consensus        53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  131 (336)
T 3h4j_B           53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH  131 (336)
T ss_dssp             SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            457899999999999999999999999999999999999 78999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      +||||+||++   +..+.+|++|||+++.........+.+||+.|+|||++.+..+ +.++|||||
T Consensus       132 ~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  194 (336)
T 3h4j_B          132 RDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC  194 (336)
T ss_dssp             CCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHH
T ss_pred             cCCchhhEEE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHH
Confidence            9999999999   5677899999999987766666677889999999999998776 689999995

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8e-35  Score=214.01  Aligned_cols=140  Identities=31%  Similarity=0.621  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|..+++.++||||+++++++.+++..|+||||+++|+|.+++.+ .+.+++..+..++.++  |+.|||+.+++
T Consensus       118 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gii  197 (437)
T 4aw2_A          118 TACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYV  197 (437)
T ss_dssp             TCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            34488999999999999999999999999999999999999999999987 4679999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      ||||||+||++   +..+.+||+|||+++.......  ....+||+.|+|||++.     ...++.++|||||
T Consensus       198 HrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl  267 (437)
T 4aw2_A          198 HRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL  267 (437)
T ss_dssp             CCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred             ecccCHHHeeE---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence            99999999999   5677999999999987654432  34578999999999997     4568999999996

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-34  Score=203.15  Aligned_cols=143  Identities=32%  Similarity=0.568  Sum_probs=123.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ....+.+.+|+.+++.++||||+++++++..++..|++|||+++++|.+++...+.+++..+..++.++  |+.+||+++
T Consensus        52 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  131 (294)
T 4eqm_A           52 EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR  131 (294)
T ss_dssp             HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            344678999999999999999999999999999999999999999999999988889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.+|++|||+++......  ......||+.|+|||++.+..++.++|||||
T Consensus       132 i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  198 (294)
T 4eqm_A          132 IVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI  198 (294)
T ss_dssp             CCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHH
T ss_pred             cccCCCCHHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHH
Confidence            9999999999999   566789999999997654432  2344678999999999999889999999995

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6e-35  Score=210.20  Aligned_cols=151  Identities=21%  Similarity=0.321  Sum_probs=129.9

Q ss_pred             cchhhHhHHHHHHHHHHHHHcCC---CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-----cCCCCHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQ   73 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~   73 (152)
                      +|+++......+..|+++++.++   |+||+.+++++..++..++||||+++++|.+++..     ...+++..+..++.
T Consensus       100 vK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~  179 (365)
T 3e7e_A          100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM  179 (365)
T ss_dssp             EEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHH
T ss_pred             EEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHH
Confidence            56666666778899999999997   89999999999999999999999999999999974     45699999999999


Q ss_pred             HH--HHHHHHhCCCeecCCCCCceEeec--------CCCCceEEEeeccCccccC---CCCccccCCCCCCccccccccc
Q 031828           74 QL--GLEILNSHHIIHRDLKPENILLSG--------LDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        74 ~i--~l~~lh~~~~~h~dl~~~nil~~~--------~~~~~~~kl~dfg~~~~~~---~~~~~~~~~~t~~y~aPE~~~~  140 (152)
                      ++  |+.|||+++++||||||+||++..        ....+.+||+|||+++.+.   ........+||+.|+|||++.+
T Consensus       180 qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  259 (365)
T 3e7e_A          180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN  259 (365)
T ss_dssp             HHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred             HHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence            98  899999999999999999999943        1126789999999997543   2234456789999999999999


Q ss_pred             CCCCcccceeeC
Q 031828          141 QRYDEKVNFFVS  152 (152)
Q Consensus       141 ~~~~~~~Dvws~  152 (152)
                      ..++.++|||||
T Consensus       260 ~~~~~~~Diwsl  271 (365)
T 3e7e_A          260 KPWNYQIDYFGV  271 (365)
T ss_dssp             CCBSTHHHHHHH
T ss_pred             CCCCccccHHHH
Confidence            999999999996

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-34  Score=206.05  Aligned_cols=145  Identities=26%  Similarity=0.458  Sum_probs=129.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++++.++||||+++++++...+..+++|||+++++|.+++.... .+++..+..++.++  |+.|||++
T Consensus        42 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~  121 (321)
T 1tki_A           42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH  121 (321)
T ss_dssp             THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3456778999999999999999999999999999999999999999999997654 69999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++.. ...+.+|++|||+++............||+.|+|||++.+..++.++|||||
T Consensus       122 givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  189 (321)
T 1tki_A          122 NIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL  189 (321)
T ss_dssp             TEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred             CCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHH
Confidence            9999999999999952 1267899999999988766655566789999999999998889999999995

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-34  Score=206.12  Aligned_cols=141  Identities=35%  Similarity=0.578  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|..+++.+ +||||+++++++.+++..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||++++
T Consensus        60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i  139 (345)
T 1xjd_A           60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI  139 (345)
T ss_dssp             CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356778899999876 9999999999999999999999999999999999988889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+++.... .....+.+||+.|+|||++.+..++.++|||||
T Consensus       140 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  204 (345)
T 1xjd_A          140 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF  204 (345)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             EeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHH
Confidence            999999999999   5677899999999986433 234567789999999999999999999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.9e-34  Score=206.10  Aligned_cols=141  Identities=33%  Similarity=0.576  Sum_probs=127.6

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+..|..+++.+ +||||+++++++...+..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||++++
T Consensus        63 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi  142 (353)
T 2i0e_A           63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI  142 (353)
T ss_dssp             CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            356788999999988 8999999999999999999999999999999999988889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+++.... .....+.+||+.|+|||++.+..++.++|||||
T Consensus       143 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  207 (353)
T 2i0e_A          143 IYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF  207 (353)
T ss_dssp             BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHH
T ss_pred             EeccCCHHHEEE---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccch
Confidence            999999999999   5677899999999986433 334567789999999999999999999999996

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-34  Score=206.74  Aligned_cols=139  Identities=32%  Similarity=0.566  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++++.+++..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||+++++
T Consensus        84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  163 (350)
T 1rdq_E           84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI  163 (350)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3567889999999999999999999999999999999999999999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++.....  ..+.+||+.|+|||++.+..++.++|||||
T Consensus       164 HrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  224 (350)
T 1rdq_E          164 YRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWAL  224 (350)
T ss_dssp             CCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             cccCccceEEE---CCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecc
Confidence            99999999999   56778999999999875433  346689999999999999999999999996

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.2e-34  Score=201.44  Aligned_cols=140  Identities=30%  Similarity=0.552  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.+. .+++..+..++.++  |+.|||+++++
T Consensus        60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~  138 (297)
T 3fxz_A           60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVI  138 (297)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence            3577889999999999999999999999999999999999999999998764 58999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||++....... ......||+.|+|||++.+..++.++|||||
T Consensus       139 H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  202 (297)
T 3fxz_A          139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (297)
T ss_dssp             CCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHH
T ss_pred             eCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHH
Confidence            99999999999   567789999999998765443 3455689999999999999999999999995

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.8e-35  Score=208.73  Aligned_cols=144  Identities=38%  Similarity=0.574  Sum_probs=113.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++...+.+++..+..++.++  |+.|||+.+++
T Consensus        91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  170 (349)
T 2w4o_A           91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV  170 (349)
T ss_dssp             --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            4567889999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++...+..+.+||+|||+++............||+.|+|||++.+..++.++|||||
T Consensus       171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  236 (349)
T 2w4o_A          171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSV  236 (349)
T ss_dssp             CCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHH
T ss_pred             ecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHH
Confidence            999999999996434577899999999987655444556789999999999998889999999996

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.6e-34  Score=206.39  Aligned_cols=144  Identities=32%  Similarity=0.535  Sum_probs=128.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.++  |+.|||+.+
T Consensus       128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  207 (373)
T 2x4f_A          128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY  207 (373)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678999999999999999999999999999999999999999999888654 458999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.. +....+||+|||+++.+.........+||+.|+|||++.+..++.++|||||
T Consensus       208 ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  274 (373)
T 2x4f_A          208 ILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSV  274 (373)
T ss_dssp             EECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHH
T ss_pred             cccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHH
Confidence            999999999999853 3456899999999988766666666789999999999998889999999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-34  Score=213.81  Aligned_cols=140  Identities=40%  Similarity=0.738  Sum_probs=128.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++||||+++++++..++..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||+++++|
T Consensus        60 ~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  139 (476)
T 2y94_A           60 VGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH  139 (476)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCc
Confidence            467899999999999999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      +||||+||++   +..+.+||+|||+++.........+.+||+.|+|||++.+..+ +.++|||||
T Consensus       140 rDLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  202 (476)
T 2y94_A          140 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSS  202 (476)
T ss_dssp             SCCSGGGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHH
T ss_pred             ccccHHHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhh
Confidence            9999999999   5677899999999987766656667889999999999998775 689999995

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.8e-34  Score=203.48  Aligned_cols=141  Identities=34%  Similarity=0.537  Sum_probs=118.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++...+.+++..+..++.++  |+.|||+++++
T Consensus        64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  143 (327)
T 3a62_A           64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII  143 (327)
T ss_dssp             -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            4566789999999999999999999999999999999999999999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus       144 H~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  207 (327)
T 3a62_A          144 YRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSL  207 (327)
T ss_dssp             CCCCCTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHH
T ss_pred             cccCCHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhH
Confidence            99999999999   56778999999999764332 23456789999999999998889999999996

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.5e-34  Score=197.02  Aligned_cols=144  Identities=31%  Similarity=0.594  Sum_probs=130.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++...+.+++..+..++.++  |+.+||++++
T Consensus        48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  127 (277)
T 3f3z_A           48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV  127 (277)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34678899999999999999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++...+....++++|||++.............+|+.|+|||++.+ .++.++|||||
T Consensus       128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~sl  193 (277)
T 3f3z_A          128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSA  193 (277)
T ss_dssp             ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHH
T ss_pred             cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-cCCchhhehhH
Confidence            9999999999995545667899999999988766666667789999999999875 48999999995

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-33  Score=196.75  Aligned_cols=146  Identities=32%  Similarity=0.526  Sum_probs=131.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ....+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+.+.....+++..+..++.++  |+.+||+++
T Consensus        46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  125 (284)
T 3kk8_A           46 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG  125 (284)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            445678899999999999999999999999999999999999999999999888889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++........++++|||.+.............||+.|+|||++.+..++.++|||||
T Consensus       126 i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (284)
T 3kk8_A          126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC  193 (284)
T ss_dssp             EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHH
Confidence            99999999999996544455699999999987766555566789999999999999899999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-34  Score=211.42  Aligned_cols=139  Identities=32%  Similarity=0.600  Sum_probs=124.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++.+ ..+++..+..++.++  |+.|||+++++|
T Consensus       113 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givH  191 (410)
T 3v8s_A          113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIH  191 (410)
T ss_dssp             CSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            34588999999999999999999999999999999999999999999875 468999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCC----CCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR----YDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~----~~~~~Dvws~  152 (152)
                      |||||+||++   +..+.+||+|||+++......  ...+.+||+.|+|||++.+..    ++.++|||||
T Consensus       192 rDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSl  259 (410)
T 3v8s_A          192 RDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV  259 (410)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHH
T ss_pred             ccCCHHHeeE---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecc
Confidence            9999999999   577789999999998765543  245778999999999998765    7899999996

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-34  Score=215.43  Aligned_cols=140  Identities=34%  Similarity=0.525  Sum_probs=127.7

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+++++.++||||+++++++.+++..|+||||++|++|.+++...+.  +++..+..++.++  |+.|||++++
T Consensus       228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI  307 (576)
T 2acx_A          228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI  307 (576)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            46688999999999999999999999999999999999999999999976544  8999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||+++.+.........+||+.|+|||++.+..++.++|||||
T Consensus       308 vHrDLKPeNILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSL  371 (576)
T 2acx_A          308 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWAL  371 (576)
T ss_dssp             ECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHH
T ss_pred             eccCCchheEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHH
Confidence            999999999999   5677899999999987766555566789999999999999899999999996

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-34  Score=207.83  Aligned_cols=144  Identities=28%  Similarity=0.518  Sum_probs=128.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      .....+.+|+++++.++||||+++++++..++..++||||+.+++|.+++.... .+++..+..++.++  |+.|||+++
T Consensus        90 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  169 (387)
T 1kob_A           90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS  169 (387)
T ss_dssp             HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            346678999999999999999999999999999999999999999999987554 68999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.. .....+||+|||+++...........+||+.|+|||++.+..++.++|||||
T Consensus       170 ivHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  236 (387)
T 1kob_A          170 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI  236 (387)
T ss_dssp             EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             eeecccchHHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeH
Confidence            999999999999942 2346799999999988766555556689999999999999889999999996

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.4e-34  Score=207.09  Aligned_cols=141  Identities=34%  Similarity=0.571  Sum_probs=119.1

Q ss_pred             HHHHHHHHHHH-HHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~-l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ....+..|..+ ++.++||||+++++++.+.+..|+||||+++++|.+++.+.+.+++..+..++.++  |+.|||++++
T Consensus        81 ~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gi  160 (373)
T 2r5t_A           81 EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI  160 (373)
T ss_dssp             ----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34556677776 57789999999999999999999999999999999999988889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCC-CCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+++.... .....+.+||+.|+|||++.+..++.++|||||
T Consensus       161 vHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  225 (373)
T 2r5t_A          161 VYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL  225 (373)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHH
T ss_pred             eecCCCHHHEEE---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHH
Confidence            999999999999   5677899999999986433 334567789999999999999999999999996

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-34  Score=209.03  Aligned_cols=141  Identities=33%  Similarity=0.589  Sum_probs=125.3

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|..++..++||||+++++++.+++..|+||||+++++|.+++.+.+ .+++..+..++.++  |+.|||++++
T Consensus       104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi  183 (412)
T 2vd5_A          104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY  183 (412)
T ss_dssp             GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34568899999999999999999999999999999999999999999998754 69999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccc-------cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-------FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~-------~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+++.......  ....+||+.|+|||++.       ...++.++|||||
T Consensus       184 iHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSl  256 (412)
T 2vd5_A          184 VHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWAL  256 (412)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHH
T ss_pred             eecccCHHHeee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHH
Confidence            999999999999   5677899999999987655432  34568999999999997       3568999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.7e-34  Score=211.66  Aligned_cols=143  Identities=38%  Similarity=0.638  Sum_probs=129.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++..|+||||+.+++|.+.+.....+++..+..++.++  |+.|||+++++
T Consensus        79 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  158 (494)
T 3lij_A           79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV  158 (494)
T ss_dssp             TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            3577899999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++........+||+|||+++...........+||+.|+|||++. ..++.++|||||
T Consensus       159 H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~Diwsl  223 (494)
T 3lij_A          159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSI  223 (494)
T ss_dssp             CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHH
T ss_pred             eccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHH
Confidence            99999999999654455679999999998776666666778999999999987 569999999995

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-33  Score=200.29  Aligned_cols=143  Identities=27%  Similarity=0.526  Sum_probs=120.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC-----------------------------------------------
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----------------------------------------------   39 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----------------------------------------------   39 (152)
                      ....+.+.+|+++++.++||||+++++++...+                                               
T Consensus        45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  124 (332)
T 3qd2_B           45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV  124 (332)
T ss_dssp             TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence            345688999999999999999999999985543                                               


Q ss_pred             ----------eEEEEEeecCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCc
Q 031828           40 ----------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDV  104 (152)
Q Consensus        40 ----------~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~  104 (152)
                                ..+++|||+++++|.+++.....   .+...+..++.++  |+.|||+++++|+||||+||++   +..+
T Consensus       125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~  201 (332)
T 3qd2_B          125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD  201 (332)
T ss_dssp             -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred             ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCC
Confidence                      38999999999999999987554   4555678888888  8999999999999999999999   5667


Q ss_pred             eEEEeeccCccccCCCC-------------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          105 MLKIADFGLSCTLYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       105 ~~kl~dfg~~~~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+||+|||+++......             ......||+.|+|||++.+..++.++|||||
T Consensus       202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  262 (332)
T 3qd2_B          202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL  262 (332)
T ss_dssp             CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHH
T ss_pred             CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHH
Confidence            89999999998765432             2234578999999999999899999999995

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-33  Score=209.89  Aligned_cols=143  Identities=36%  Similarity=0.645  Sum_probs=127.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++++..++.+|+||||+.+++|.+.+...+.+++..+..++.++  |+.|||+++++
T Consensus        64 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv  143 (486)
T 3mwu_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV  143 (486)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            4577899999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++...+....+||+|||+++...........+||+.|+|||++.+ .++.++|||||
T Consensus       144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  208 (486)
T 3mwu_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSA  208 (486)
T ss_dssp             CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHH
T ss_pred             eccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHH
Confidence            999999999996545566899999999987766655667789999999999975 59999999995

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-33  Score=209.59  Aligned_cols=143  Identities=38%  Similarity=0.666  Sum_probs=129.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+.+...+.+++..+..++.++  |+.|||+++++
T Consensus        89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  168 (504)
T 3q5i_A           89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIV  168 (504)
T ss_dssp             THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3577899999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++...+....+||+|||+++...........+||+.|+|||++. +.++.++|||||
T Consensus       169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Diwsl  233 (504)
T 3q5i_A          169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSC  233 (504)
T ss_dssp             CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHH
T ss_pred             eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHH
Confidence            99999999999644444579999999998776665666778999999999987 469999999995

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-33  Score=203.35  Aligned_cols=143  Identities=29%  Similarity=0.457  Sum_probs=124.7

Q ss_pred             HhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHH
Q 031828            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~   69 (152)
                      ....+.+.+|+++++.+ +||||+++++++..++..|+||||+++++|.+++....                .++...+.
T Consensus       127 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (370)
T 2psq_A          127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV  206 (370)
T ss_dssp             HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHH
Confidence            34567899999999999 89999999999999999999999999999999998653                37888899


Q ss_pred             HHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCC
Q 031828           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  144 (152)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  144 (152)
                      .++.++  |+.|||+++++|+||||+||++   +..+.+||+|||+++......   ......+|+.|+|||++.+..++
T Consensus       207 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  283 (370)
T 2psq_A          207 SCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT  283 (370)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC
Confidence            999998  8999999999999999999999   567789999999998654432   22334567889999999988999


Q ss_pred             cccceeeC
Q 031828          145 EKVNFFVS  152 (152)
Q Consensus       145 ~~~Dvws~  152 (152)
                      .++|||||
T Consensus       284 ~~~Dvwsl  291 (370)
T 2psq_A          284 HQSDVWSF  291 (370)
T ss_dssp             HHHHHHHH
T ss_pred             cHHHHHHH
Confidence            99999996

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.7e-34  Score=210.43  Aligned_cols=141  Identities=31%  Similarity=0.484  Sum_probs=118.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh-CCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-HHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~-~~~   85 (152)
                      ....+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++...+.+++..+..++.++  ||.|||+ .++
T Consensus       191 ~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~gi  270 (446)
T 4ejn_A          191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV  270 (446)
T ss_dssp             ----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence            3466788999999999999999999999999999999999999999999988889999999999998  8999998 999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus       271 iHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  335 (446)
T 4ejn_A          271 VYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  335 (446)
T ss_dssp             CCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             EECCCCHHHEEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhh
Confidence            999999999999   56678999999999764333 34456789999999999999999999999996

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=204.56  Aligned_cols=140  Identities=34%  Similarity=0.551  Sum_probs=126.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCC-ChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+.+++.++||||+++++++..++..+++||++.++ +|.+++.....+++..+..++.++  |+.|||+++++
T Consensus        73 ~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv  152 (335)
T 3dls_A           73 LGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDII  152 (335)
T ss_dssp             TEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            446778999999999999999999999999999999998666 999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++...........+||+.|+|||++.+..+ +.++|||||
T Consensus       153 H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  216 (335)
T 3dls_A          153 HRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSL  216 (335)
T ss_dssp             CSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHH
T ss_pred             EeccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhH
Confidence            99999999999   5677899999999987766655666789999999999998776 789999996

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.9e-34  Score=207.14  Aligned_cols=142  Identities=30%  Similarity=0.579  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHH-cCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHH
Q 031828           11 SCLDCELNFLS-SVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus        11 ~~~~~E~~~l~-~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ..+.+|++++. ..+||||+++++++..    .+.+|+||||+.+++|.+++...+  .+++..+..++.++  |+.|||
T Consensus        99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH  178 (400)
T 1nxk_A           99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  178 (400)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45678888874 4589999999999875    567899999999999999998654  48999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++......+.+||+|||+++.........+.+||+.|+|||++.+..++.++|||||
T Consensus       179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  249 (400)
T 1nxk_A          179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL  249 (400)
T ss_dssp             HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred             HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence            99999999999999996433367899999999987665555667889999999999998899999999996

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-33  Score=198.94  Aligned_cols=143  Identities=27%  Similarity=0.453  Sum_probs=117.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+.+|++++++++||||+++++++..++..++||||+++++|.+++...+.   +++..+..++.++  |+.|||
T Consensus        75 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  154 (309)
T 3p86_A           75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH  154 (309)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            44567889999999999999999999999999999999999999999999986554   8999999999998  899999


Q ss_pred             hCC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++  ++|+||||+||++   +..+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  225 (309)
T 3p86_A          155 NRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF  225 (309)
T ss_dssp             TSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHH
T ss_pred             cCCCCEECCCCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHH
Confidence            999  9999999999999   567789999999997544332 2345678999999999999899999999996

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-33  Score=198.51  Aligned_cols=143  Identities=28%  Similarity=0.556  Sum_probs=127.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++...+.+++..+..++.++  |+.+||+.+++|
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH  138 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            577999999999999999999999999999999999999999999999988889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCC-CceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++..... ...++++|||+++............||+.|+|||++.+..++.++|||||
T Consensus       139 ~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  204 (321)
T 2a2a_A          139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  204 (321)
T ss_dssp             CCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHH
Confidence            999999999942211 12799999999987766555566779999999999998899999999996

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-33  Score=210.02  Aligned_cols=140  Identities=36%  Similarity=0.516  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .+.+.+|+++++.++||||+++++++..++..|+||||++|++|.+++...    ..+++..+..++.++  |+.|||++
T Consensus       229 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~  308 (543)
T 3c4z_A          229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR  308 (543)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc
Confidence            467889999999999999999999999999999999999999999998754    358999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+||+|||+++.+..... ....+||+.|+|||++.+..++.++|||||
T Consensus       309 gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSl  375 (543)
T 3c4z_A          309 NIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFAL  375 (543)
T ss_dssp             TEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHH
T ss_pred             CCcccCCChHHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcc
Confidence            99999999999999   5677899999999987655433 345689999999999999999999999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.8e-33  Score=202.48  Aligned_cols=142  Identities=37%  Similarity=0.565  Sum_probs=115.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++...+.+++..+..++.++  |+.|||+++++|
T Consensus        60 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH  139 (361)
T 3uc3_A           60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH  139 (361)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCS
T ss_pred             cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            467889999999999999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcc-cceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK-VNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Dvws~  152 (152)
                      +||||+||++.. .....+||+|||+++............||+.|+|||++.+..++.+ +|||||
T Consensus       140 ~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  204 (361)
T 3uc3_A          140 RDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC  204 (361)
T ss_dssp             CCCCGGGEEECS-SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHH
T ss_pred             CCCCHHHEEEcC-CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehh
Confidence            999999999942 2233599999999976544444556779999999999988887655 899995

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4e-33  Score=202.16  Aligned_cols=143  Identities=25%  Similarity=0.400  Sum_probs=125.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++...  ..+++..+..++.++  |+.|||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  146 (389)
T 3gni_B           67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH  146 (389)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            445678889999999999999999999999999999999999999999999865  669999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--------ccccCCCCCCccccccccc--CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~  152 (152)
                      ++++|+||||+||++   +..+.+|++|||.+.......        ......||+.|+|||++.+  ..++.++|||||
T Consensus       147 ~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  223 (389)
T 3gni_B          147 MGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV  223 (389)
T ss_dssp             TTEECCCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred             CCeecCCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence            999999999999999   567799999999886543221        1233478899999999987  579999999996

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-33  Score=198.49  Aligned_cols=144  Identities=26%  Similarity=0.467  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCC--eEEEEEeecCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ..+.+.+|+++++.++||||+++++++...+  ..++||||+++++|.+++.....   +++..+..++.++  |+.|||
T Consensus        50 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH  129 (319)
T 4euu_A           50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR  129 (319)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577889999999999999999999997665  78999999999999999976443   8999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeec-CCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc--------cCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--------FQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~-~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++.. .+....+||+|||+++............||+.|+|||++.        +..++.++|||||
T Consensus       130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl  209 (319)
T 4euu_A          130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI  209 (319)
T ss_dssp             HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred             HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence            999999999999999732 2355679999999998876666666778999999999986        4678999999996

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-33  Score=210.41  Aligned_cols=143  Identities=36%  Similarity=0.629  Sum_probs=130.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++++..++..++|+|++.+++|.+.+...+.+++..+..++.++  |+.|||+++++
T Consensus        69 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv  148 (484)
T 3nyv_A           69 DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV  148 (484)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4678999999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++......+.+||+|||+++.+.........+||+.|+|||++.+ .++.++|||||
T Consensus       149 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  213 (484)
T 3nyv_A          149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWST  213 (484)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHH
T ss_pred             eCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHH
Confidence            999999999996545667899999999987766655566789999999999975 69999999995

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.7e-33  Score=206.95  Aligned_cols=141  Identities=25%  Similarity=0.435  Sum_probs=118.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ...+++.+|+.+++.++||||+++++++...     +.+|+|||++ +++|.+++.....+++..++.++.++  ||.||
T Consensus        94 ~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~L  172 (458)
T 3rp9_A           94 IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV  172 (458)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            4467889999999999999999999998433     5799999998 68999999888889999999999998  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----------------------------ccccCCCCCCc
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------------------YAEKVCGSPLY  132 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----------------------------~~~~~~~t~~y  132 (152)
                      |+.+++||||||+|||+   +..+.+||+|||+++......                            .....+||++|
T Consensus       173 H~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  249 (458)
T 3rp9_A          173 HSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY  249 (458)
T ss_dssp             HHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTT
T ss_pred             HhCCcCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccc
Confidence            99999999999999999   567789999999998754221                            22445789999


Q ss_pred             cccccc-ccCCCCcccceeeC
Q 031828          133 MAPEVL-QFQRYDEKVNFFVS  152 (152)
Q Consensus       133 ~aPE~~-~~~~~~~~~Dvws~  152 (152)
                      +|||++ ....++.++|||||
T Consensus       250 ~aPE~~~~~~~~~~~~DiwSl  270 (458)
T 3rp9_A          250 RAPELILLQENYTEAIDVWSI  270 (458)
T ss_dssp             CCHHHHTTCCCCCTHHHHHHH
T ss_pred             cChHHhhCCCCCCcHhHHHHH
Confidence            999986 45669999999996

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-34  Score=204.47  Aligned_cols=147  Identities=24%  Similarity=0.351  Sum_probs=125.8

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-------CCCHHHHHHHHHHH--H
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQL--G   76 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i--~   76 (152)
                      +......+.+|+.+++.++||||+++++++..++..++||||+++++|.+++....       .++...+..++.++  |
T Consensus       114 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a  193 (367)
T 3l9p_A          114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG  193 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHH
T ss_pred             ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHH
Confidence            34556678899999999999999999999999999999999999999999997653       48889999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC---CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.|||+++++|+||||+||++...+....+||+|||+++.+...   .......+|+.|+|||++.+..++.++|||||
T Consensus       194 L~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl  272 (367)
T 3l9p_A          194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF  272 (367)
T ss_dssp             HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHH
Confidence            99999999999999999999954344557999999999754222   22334567899999999998899999999996

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.1e-33  Score=194.57  Aligned_cols=141  Identities=30%  Similarity=0.541  Sum_probs=121.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHH-HhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+.+++.++||||+++++++..++..++||||+++ ++.+.+ ...+.+++..+..++.++  |+.|||+++
T Consensus        43 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~  121 (292)
T 3o0g_A           43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN  121 (292)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3457788999999999999999999999999999999999965 555555 446779999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||
T Consensus       122 ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  188 (292)
T 3o0g_A          122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA  188 (292)
T ss_dssp             EECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred             eecCCCCHHHEEE---cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHH
Confidence            9999999999999   567789999999998765432 345567899999999998766 8999999995

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.7e-33  Score=213.86  Aligned_cols=142  Identities=33%  Similarity=0.583  Sum_probs=128.3

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+..|..++..+ +||||+.+++++.+.+.+|+||||+++++|.+++.+.+.+++..+..++.++  ||.|||+.+
T Consensus       383 ~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g  462 (674)
T 3pfq_A          383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG  462 (674)
T ss_dssp             TTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456788899999988 7999999999999999999999999999999999988899999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccC-CCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++||||||+|||+   +..+.+||+|||+++... ......+.+||+.|+|||++.+..|+.++|||||
T Consensus       463 IiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSl  528 (674)
T 3pfq_A          463 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF  528 (674)
T ss_dssp             EECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHH
T ss_pred             eEeccCChhhEEE---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEech
Confidence            9999999999999   567789999999998643 3334567889999999999999999999999996

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3e-33  Score=207.15  Aligned_cols=140  Identities=34%  Similarity=0.512  Sum_probs=115.3

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ....+++.+|+.+++.++||||+++++++...      +.+|+||||++ +++.+.+..  .+++..+..++.|+  |+.
T Consensus       102 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~-~~l~~~~~~--~l~~~~~~~~~~qil~aL~  178 (464)
T 3ttj_A          102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIK  178 (464)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHTS--CCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCC-CCHHHHHhh--cCCHHHHHHHHHHHHHHHH
Confidence            44567888999999999999999999999654      46799999995 556666643  48999999999998  999


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+.+++||||||+||++   +..+.+||+|||+++...........+||++|+|||++.+..|+.++|||||
T Consensus       179 ~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  249 (464)
T 3ttj_A          179 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  249 (464)
T ss_dssp             HHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence            9999999999999999999   5677899999999987766555667889999999999999999999999995

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=199.48  Aligned_cols=144  Identities=25%  Similarity=0.446  Sum_probs=123.5

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      +...++.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... +.+++..+..++.++  |+.|||+
T Consensus        90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~  169 (325)
T 3kul_A           90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD  169 (325)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3455778999999999999999999999999999999999999999999999754 569999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+++|+||||+||++   +..+.++|+|||+++......    ......+|+.|+|||++.+..++.++|||||
T Consensus       170 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  240 (325)
T 3kul_A          170 LGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSF  240 (325)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHH
T ss_pred             CCeeCCCCCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHH
Confidence            999999999999999   567789999999998764432    1223345778999999998899999999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.9e-34  Score=204.14  Aligned_cols=141  Identities=30%  Similarity=0.483  Sum_probs=123.7

Q ss_pred             HHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        12 ~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      ...+|++++.++ +||||+++++++.+++..|+||||+++++|.+.+.+.+.+++..+..++.++  |+.|||+++++|+
T Consensus        61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHr  140 (342)
T 2qr7_A           61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHR  140 (342)
T ss_dssp             CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence            356788888887 7999999999999999999999999999999999988889999999999998  8999999999999


Q ss_pred             CCCCCceEeecCCC-CceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           89 DLKPENILLSGLDD-DVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||+||++...+. ...+|++|||+++..... ....+.+||+.|+|||++.+..++.++|||||
T Consensus       141 Dlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  206 (342)
T 2qr7_A          141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSL  206 (342)
T ss_dssp             CCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeH
Confidence            99999999853222 246999999999876543 34456789999999999998889999999996

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-33  Score=193.97  Aligned_cols=142  Identities=32%  Similarity=0.625  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .+.+.+|+++++.++||||+++++++...+..++||||+++++|.+.+..    ...+++..+..++.++  |+.+||+.
T Consensus        64 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  143 (285)
T 3is5_A           64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ  143 (285)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            57889999999999999999999999999999999999999999998853    3669999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++...+....+||+|||+++............+|+.|+|||++. +.++.++|||||
T Consensus       144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~sl  211 (285)
T 3is5_A          144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSA  211 (285)
T ss_dssp             TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHH
T ss_pred             CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehH
Confidence            99999999999999654556789999999998766555556678899999999986 568999999995

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-32  Score=195.33  Aligned_cols=143  Identities=29%  Similarity=0.565  Sum_probs=128.9

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...++.+.+|+.+++.++||||+++++++..++..+++|||+.+++|.+++.....+++..+..++.++  |+.|||+++
T Consensus        82 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  161 (335)
T 2owb_A           82 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR  161 (335)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345788999999999999999999999999999999999999999999999888889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.++|+|||+++..... .......||+.|+|||++.+..++.++|||||
T Consensus       162 ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  227 (335)
T 2owb_A          162 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI  227 (335)
T ss_dssp             EECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHH
T ss_pred             CEecCCCchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHH
Confidence            9999999999999   56678999999999876533 23445678999999999998889999999996

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-32  Score=191.59  Aligned_cols=143  Identities=31%  Similarity=0.632  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++||||+++++++..++..+++||++++++|.+++.....+++..+..++.++  |+.+||+.+++|
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  131 (283)
T 3bhy_A           52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH  131 (283)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            678999999999999999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCC-CCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||+|+||++.... ....++++|||+++............+++.|+|||++.+..++.++|||||
T Consensus       132 ~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  197 (283)
T 3bhy_A          132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  197 (283)
T ss_dssp             SCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhH
Confidence            99999999995322 123799999999987665554556678999999999998889999999996

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.7e-33  Score=196.04  Aligned_cols=140  Identities=25%  Similarity=0.496  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.+ ..+++..+..++.++  |+.|||+.+++
T Consensus        85 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iv  163 (321)
T 2c30_A           85 RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVI  163 (321)
T ss_dssp             SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            357788999999999999999999999999999999999999999998864 468999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+|++|||+++...... ......||+.|+|||++.+..++.++|||||
T Consensus       164 H~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  227 (321)
T 2c30_A          164 HRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSL  227 (321)
T ss_dssp             CCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             cCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHH
Confidence            99999999999   566789999999998765432 3355679999999999998889999999996

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.7e-33  Score=203.34  Aligned_cols=141  Identities=26%  Similarity=0.461  Sum_probs=120.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ...+++.+|+.+++.++||||+++++++...     +..|+|||++ +++|.++++....+++..++.++.++  |+.||
T Consensus        67 ~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~L  145 (432)
T 3n9x_A           67 IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI  145 (432)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            4457889999999999999999999999766     5799999998 47999999988889999999999998  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----------------------ccccCCCCCCcccccc
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------YAEKVCGSPLYMAPEV  137 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----------------------~~~~~~~t~~y~aPE~  137 (152)
                      |+.+++||||||+||++   +..+.+||+|||+++......                       .....+||++|+|||+
T Consensus       146 H~~givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  222 (432)
T 3n9x_A          146 HESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL  222 (432)
T ss_dssp             HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHH
T ss_pred             HHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence            99999999999999999   567789999999998764332                       1356789999999998


Q ss_pred             c-ccCCCCcccceeeC
Q 031828          138 L-QFQRYDEKVNFFVS  152 (152)
Q Consensus       138 ~-~~~~~~~~~Dvws~  152 (152)
                      + ....++.++|||||
T Consensus       223 ~~~~~~~~~~~DiwSl  238 (432)
T 3n9x_A          223 ILLQENYTKSIDIWST  238 (432)
T ss_dssp             HTTCSCCCTHHHHHHH
T ss_pred             HhcCCCCCcccccchH
Confidence            6 45569999999996

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-33  Score=198.66  Aligned_cols=143  Identities=24%  Similarity=0.474  Sum_probs=124.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc------------------------CC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GR   62 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------------------------~~   62 (152)
                      ....+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++...                        ..
T Consensus        91 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (343)
T 1luf_A           91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP  170 (343)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCC
Confidence            345678999999999999999999999999999999999999999999999764                        46


Q ss_pred             CCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccc
Q 031828           63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEV  137 (152)
Q Consensus        63 ~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~  137 (152)
                      +++..++.++.++  |+.|||+++++|+||||+||++   +..+.+||+|||+++......   ......+|+.|+|||+
T Consensus       171 l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            8889999999998  8999999999999999999999   566789999999997654332   2234567889999999


Q ss_pred             cccCCCCcccceeeC
Q 031828          138 LQFQRYDEKVNFFVS  152 (152)
Q Consensus       138 ~~~~~~~~~~Dvws~  152 (152)
                      +.+..++.++|||||
T Consensus       248 ~~~~~~~~~~Di~sl  262 (343)
T 1luf_A          248 IFYNRYTTESDVWAY  262 (343)
T ss_dssp             HHHCCCCHHHHHHHH
T ss_pred             hccCCcCcccccHHH
Confidence            998899999999996

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.3e-32  Score=190.54  Aligned_cols=143  Identities=29%  Similarity=0.563  Sum_probs=128.6

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...++.+.+|+.+++.++||||+++++++..++..+++||++++++|.+++.....+++..+..++.++  |+.+||+++
T Consensus        56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  135 (294)
T 2rku_A           56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR  135 (294)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345788999999999999999999999999999999999999999999999888889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||+|+||++   +..+.++++|||+++...... ......||+.|+|||++.+..++.++|||||
T Consensus       136 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  201 (294)
T 2rku_A          136 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI  201 (294)
T ss_dssp             EECCCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHH
T ss_pred             ccccCCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHH
Confidence            9999999999999   567789999999998764332 3445678999999999998889999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.2e-33  Score=205.57  Aligned_cols=141  Identities=35%  Similarity=0.639  Sum_probs=115.8

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      ..+.+|++++++++||||+++++++. .+..++||||+++++|.+++...+.+++..+..++.++  |+.|||+++++|+
T Consensus       185 ~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr  263 (419)
T 3i6u_A          185 LNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHR  263 (419)
T ss_dssp             CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35789999999999999999999985 45689999999999999999888889999999999998  8999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc---CCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~  152 (152)
                      ||||+||++...+....+||+|||+++.........+.+||+.|+|||++..   ..++.++|||||
T Consensus       264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl  330 (419)
T 3i6u_A          264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL  330 (419)
T ss_dssp             CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred             CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence            9999999996544456799999999987765555567789999999999863   567889999996

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.5e-33  Score=199.49  Aligned_cols=140  Identities=36%  Similarity=0.772  Sum_probs=127.4

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ++.+.+|+.+++.+ +||||+++++++...+..++||||+++++|.+++.....+++..+..++.++  |+.|||+.|++
T Consensus       143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~  222 (365)
T 2y7j_A          143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIV  222 (365)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            67788999999999 8999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc------CCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Dvws~  152 (152)
                      |+||||.||++   +..+.++++|||++..+.........+||+.|+|||++.+      ..++.++|||||
T Consensus       223 H~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl  291 (365)
T 2y7j_A          223 HRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC  291 (365)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHH
T ss_pred             cCCCCHHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhH
Confidence            99999999999   5677899999999988776666667889999999999863      358899999996

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-33  Score=200.17  Aligned_cols=140  Identities=35%  Similarity=0.641  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++.....+++..+..++.++  |+.|||+++++|
T Consensus        49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH  128 (323)
T 3tki_A           49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH  128 (323)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            467889999999999999999999999999999999999999999999887789999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      +||||+||++   +..+.+||+|||+++.+....   .....+||+.|+|||++.+..+ +.++|||||
T Consensus       129 ~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  194 (323)
T 3tki_A          129 RDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC  194 (323)
T ss_dssp             SCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHH
T ss_pred             cccchHHEEE---eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHH
Confidence            9999999999   566789999999997654332   2345689999999999988775 678999995

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.1e-33  Score=198.18  Aligned_cols=139  Identities=21%  Similarity=0.267  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+++++.+ +||||+++++++..++..++|||++ +++|.+++.. .+.+++..+..++.++  |+.|||+.++
T Consensus        48 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  126 (330)
T 2izr_A           48 APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL  126 (330)
T ss_dssp             SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            45688999999999 9999999999999999999999999 9999999986 3679999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCce-----EEEeeccCccccCCCCc--------cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~-----~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++.   ..+.     +||+|||+++.+.....        .....||+.|+|||++.+..++.++|||||
T Consensus       127 iHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  203 (330)
T 2izr_A          127 IYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEAL  203 (330)
T ss_dssp             ECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             eccCCCHHHeeec---cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHH
Confidence            9999999999994   3444     99999999987544321        246679999999999999999999999996

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.6e-33  Score=200.01  Aligned_cols=143  Identities=23%  Similarity=0.436  Sum_probs=115.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...++.+.+|++++++++||||+++++++..++..++||||+++++|.+++.+.+ .+++..+..++.++  |+.|||+.
T Consensus        87 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (373)
T 2qol_A           87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM  166 (373)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4557789999999999999999999999999999999999999999999998654 58999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+||+|||+++.......    .....+++.|+|||++.+..++.++|||||
T Consensus       167 ~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~Sl  236 (373)
T 2qol_A          167 GYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY  236 (373)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             CeeCCCCCcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHH
Confidence            99999999999999   5677899999999986543321    122234678999999999899999999996

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-32  Score=199.70  Aligned_cols=143  Identities=29%  Similarity=0.455  Sum_probs=125.4

Q ss_pred             HhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHH
Q 031828            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~   69 (152)
                      ....+.+.+|+++++.+ +||||+++++++..++..++||||+++++|.+++....                .+++..+.
T Consensus       115 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  194 (382)
T 3tt0_A          115 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV  194 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHH
Confidence            34567889999999999 99999999999999999999999999999999998654                48999999


Q ss_pred             HHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCC
Q 031828           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  144 (152)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  144 (152)
                      .++.++  |+.|||+.+++|+||||+||++   +..+.+||+|||+++......   ......+|+.|+|||++.+..++
T Consensus       195 ~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  271 (382)
T 3tt0_A          195 SCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT  271 (382)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC
T ss_pred             HHHHHHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC
Confidence            999998  8999999999999999999999   566789999999998664432   22344567889999999998999


Q ss_pred             cccceeeC
Q 031828          145 EKVNFFVS  152 (152)
Q Consensus       145 ~~~Dvws~  152 (152)
                      .++|||||
T Consensus       272 ~~~Diwsl  279 (382)
T 3tt0_A          272 HQSDVWSF  279 (382)
T ss_dssp             HHHHHHHH
T ss_pred             chhHHHHH
Confidence            99999996

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.9e-33  Score=195.01  Aligned_cols=143  Identities=29%  Similarity=0.454  Sum_probs=124.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC------------------------
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR------------------------   62 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~------------------------   62 (152)
                      ....+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++.....                        
T Consensus        67 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (314)
T 2ivs_A           67 PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA  146 (314)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CE
T ss_pred             HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccC
Confidence            44567889999999999999999999999999999999999999999999986543                        


Q ss_pred             CCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccc
Q 031828           63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEV  137 (152)
Q Consensus        63 ~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~  137 (152)
                      +++..+..++.++  |+.|||+++++|+||||+||++.   ..+.++|+|||+++.......   .....+++.|+|||+
T Consensus       147 ~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             ECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            7888999999998  89999999999999999999994   567899999999987644322   233456788999999


Q ss_pred             cccCCCCcccceeeC
Q 031828          138 LQFQRYDEKVNFFVS  152 (152)
Q Consensus       138 ~~~~~~~~~~Dvws~  152 (152)
                      +.+..++.++|||||
T Consensus       224 ~~~~~~~~~~Di~sl  238 (314)
T 2ivs_A          224 LFDHIYTTQSDVWSF  238 (314)
T ss_dssp             HHHCEECHHHHHHHH
T ss_pred             hcCCCcCchhhHHHH
Confidence            998889999999996

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-33  Score=192.21  Aligned_cols=140  Identities=26%  Similarity=0.464  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++... ..+++..+..++.++  |+.+||+.+++
T Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~  128 (269)
T 4hcu_A           49 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI  128 (269)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            567899999999999999999999999999999999999999999999654 458999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.++++|||+++......  ......+|+.|+|||++.+..++.++|||||
T Consensus       129 H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (269)
T 4hcu_A          129 HRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  193 (269)
T ss_dssp             CSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             cCCcchheEEE---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHH
Confidence            99999999999   466789999999997654432  2234456778999999998899999999995

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-32  Score=194.14  Aligned_cols=139  Identities=32%  Similarity=0.543  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+++++.++||||+++++++..++..++||||++ +++.+.+.... .+++..+..++.++  |+.|||+++++
T Consensus        63 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv  141 (311)
T 3niz_A           63 PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL  141 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            5678899999999999999999999999999999999996 58888776543 48999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||
T Consensus       142 H~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  206 (311)
T 3niz_A          142 HRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSI  206 (311)
T ss_dssp             CCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred             cCCCchHhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHH
Confidence            99999999999   566789999999998765432 3445678999999999976 458999999995

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.2e-33  Score=204.12  Aligned_cols=139  Identities=25%  Similarity=0.482  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCC-eEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHHHHHhC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ..+.+.+|+++|++++||||+++++++...+ ..++||||+++++|.+++...+.  +++..+..++.++  |+.|||++
T Consensus       229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~  308 (450)
T 1k9a_A          229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN  308 (450)
T ss_dssp             TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999999999999987664 79999999999999999987654  7889999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+||+|||+++.....  .....+++.|+|||++.+..++.++|||||
T Consensus       309 ~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl  372 (450)
T 1k9a_A          309 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF  372 (450)
T ss_dssp             TEECSCCCGGGEEE---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHH
T ss_pred             CeeCCCCCHhhEEE---CCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHH
Confidence            99999999999999   56778999999999754332  223456889999999999999999999996

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.98  E-value=1.5e-33  Score=198.95  Aligned_cols=142  Identities=25%  Similarity=0.453  Sum_probs=117.2

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      .....+.+|+++++.++||||+++++++...+    ..|+||||+++++|.+++...+.+++..+..++.++  |+.|||
T Consensus        54 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH  133 (311)
T 3ork_A           54 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH  133 (311)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34567899999999999999999999987653    359999999999999999988889999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++.   ..+.+||+|||+++.+....    ......||+.|+|||++.+..++.++|||||
T Consensus       134 ~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  205 (311)
T 3ork_A          134 QNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL  205 (311)
T ss_dssp             HTTCCCCCCCGGGEEEE---TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHH
T ss_pred             HCCCCcCCCCHHHEEEc---CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHH
Confidence            99999999999999994   56789999999997654432    2234568999999999999899999999996

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.98  E-value=7.2e-33  Score=191.53  Aligned_cols=141  Identities=26%  Similarity=0.511  Sum_probs=124.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++...+ .+++..+..++.++  |+.+||+.++
T Consensus        46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  125 (268)
T 3sxs_A           46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF  125 (268)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            35678999999999999999999999999999999999999999999997654 48999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++.......  .....+|+.|+|||++.+..++.++|||||
T Consensus       126 ~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  191 (268)
T 3sxs_A          126 IHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAF  191 (268)
T ss_dssp             EESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHH
T ss_pred             ecCCcCcceEEE---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHH
Confidence            999999999999   5677899999999986654432  233445678999999998889999999995

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.98  E-value=3.4e-33  Score=194.94  Aligned_cols=143  Identities=19%  Similarity=0.323  Sum_probs=122.1

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.++  |+.|||++
T Consensus        53 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~  132 (289)
T 4fvq_A           53 RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN  132 (289)
T ss_dssp             GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            34567899999999999999999999999999999999999999999999987654 8999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCC-----ceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDD-----VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~-----~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++......     ..++++|||++......   ....+|+.|+|||++.+ ..++.++|||||
T Consensus       133 ~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  204 (289)
T 4fvq_A          133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSF  204 (289)
T ss_dssp             TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred             CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence            99999999999999632211     12999999998654332   23456888999999987 668999999996

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.98  E-value=2.7e-32  Score=190.14  Aligned_cols=139  Identities=35%  Similarity=0.638  Sum_probs=125.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++||||+++++++..++..+++||++++++|.+++...+.+++..+..++.++  |+.+||+++++|
T Consensus        58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  137 (284)
T 2vgo_A           58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH  137 (284)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            467899999999999999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||+|+||++   +..+.++++|||++...... ......|++.|+|||++.+..++.++|||||
T Consensus       138 ~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  198 (284)
T 2vgo_A          138 RDIKPENLLM---GYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCA  198 (284)
T ss_dssp             CCCSGGGEEE---CTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHH
T ss_pred             cCCCHHHEEE---cCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhhH
Confidence            9999999999   56678999999998654432 3345678999999999999889999999995

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.98  E-value=7.1e-33  Score=195.59  Aligned_cols=144  Identities=33%  Similarity=0.509  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+++++++ +||||+++++++..++..++||||+++++|.+++.....+++..+..++.++  |+.|||++++
T Consensus        53 ~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  132 (316)
T 2ac3_A           53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI  132 (316)
T ss_dssp             CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            467889999999985 7999999999999999999999999999999999888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC--------ccccCCCCCCccccccccc-----CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF-----QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dvws~  152 (152)
                      +|+||||+||++...+....+|++|||+++......        .....+||+.|+|||++..     ..++.++|||||
T Consensus       133 vH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  212 (316)
T 2ac3_A          133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL  212 (316)
T ss_dssp             CCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHH
T ss_pred             eeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhH
Confidence            999999999999543333459999999987653221        1234568999999999975     458899999996

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.98  E-value=2.3e-32  Score=190.07  Aligned_cols=139  Identities=32%  Similarity=0.577  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.....+++..+..++.++  |+.+||+.+++|
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H  132 (279)
T 3fdn_A           53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH  132 (279)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEE
T ss_pred             HHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            567889999999999999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++   +..+.++++|||++...... ......+++.|+|||++.+..++.++|||||
T Consensus       133 ~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (279)
T 3fdn_A          133 RDIKPENLLL---GSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL  193 (279)
T ss_dssp             CCCCGGGEEE---CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             ccCChHhEEE---cCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCCCCccchhHhH
Confidence            9999999999   56778999999988654332 3345678999999999998889999999995

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.98  E-value=2.2e-33  Score=202.98  Aligned_cols=143  Identities=32%  Similarity=0.533  Sum_probs=123.1

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++|+.++||||+++++++..++..++||||+++++|.+++...+ .++...+..++.++  |+.|||+.
T Consensus       153 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~  232 (377)
T 3cbl_A          153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK  232 (377)
T ss_dssp             HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3456778899999999999999999999999899999999999999999997654 58999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc---ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+||+|||+++........   ....+++.|+|||++.++.++.++|||||
T Consensus       233 ~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  301 (377)
T 3cbl_A          233 CCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF  301 (377)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred             CcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHH
Confidence            99999999999999   56678999999999865433211   11224667999999998889999999996

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.98  E-value=8.3e-33  Score=192.57  Aligned_cols=141  Identities=24%  Similarity=0.441  Sum_probs=123.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++.. ...+++..+..++.++  |+.+||++++
T Consensus        62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  141 (283)
T 3gen_A           62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF  141 (283)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            356789999999999999999999999999999999999999999999976 4569999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++......  ......+|+.|+|||++.+..++.++|||||
T Consensus       142 ~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  207 (283)
T 3gen_A          142 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF  207 (283)
T ss_dssp             CCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             cCCCCccceEEE---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHH
Confidence            999999999999   567789999999997654432  1233446778999999998899999999995

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.98  E-value=1.6e-32  Score=192.97  Aligned_cols=143  Identities=34%  Similarity=0.569  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++++...+..+++||++++++|.+++...+.+++..+..++.++  |+.+||+.+++
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (304)
T 2jam_A           49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV  128 (304)
T ss_dssp             ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3567889999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++...+....++++|||+++.... .......||+.|+|||++.+..++.++|||||
T Consensus       129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  193 (304)
T 2jam_A          129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI  193 (304)
T ss_dssp             CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHH
T ss_pred             ccCCCHHHEEEecCCCCCCEEEccCCcceecCC-CccccccCCCCccChHHhccCCCCchhhHHHH
Confidence            999999999985445667899999999865432 23344568999999999998889999999995

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.98  E-value=1.9e-32  Score=190.25  Aligned_cols=140  Identities=31%  Similarity=0.625  Sum_probs=104.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+.+++.++||||+++++++...+..++++||+++++|.+++... ..+++..+..++.++  |+.+||+++++
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  134 (278)
T 3cok_A           55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL  134 (278)
T ss_dssp             HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            467899999999999999999999999999999999999999999999865 568999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.++++|||++....... ......+|+.|+|||++.+..++.++|||||
T Consensus       135 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  198 (278)
T 3cok_A          135 HRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSL  198 (278)
T ss_dssp             CSSCCGGGEEE---CTTCCEEECCCTTCEECC----------------------------CTHHHHH
T ss_pred             cCCCCHHHEEE---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHH
Confidence            99999999999   566789999999998764332 2345678999999999998889999999995

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.98  E-value=2.2e-32  Score=192.74  Aligned_cols=142  Identities=29%  Similarity=0.532  Sum_probs=120.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|++++++++||||+++++++..++..++||||+++++|.+++...+.+++..+..++.++  |+.+||++++
T Consensus        44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~i  123 (311)
T 4agu_A           44 VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC  123 (311)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            44677889999999999999999999999999999999999999999998888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++++|||+++..... .......+|+.|+|||++.+ ..++.++|||||
T Consensus       124 vH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  189 (311)
T 4agu_A          124 IHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAI  189 (311)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHH
T ss_pred             cCCCCChhhEEE---cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHH
Confidence            999999999999   56778999999999876533 23455678999999999976 568999999995

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.98  E-value=7e-33  Score=206.60  Aligned_cols=141  Identities=26%  Similarity=0.431  Sum_probs=123.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|+++|++++||||+++++++..++..++||||+++++|.+++...  ..+++..+..++.++  |+.|||+++
T Consensus       259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~  338 (495)
T 1opk_A          259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  338 (495)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4678999999999999999999999999999999999999999999999864  348899999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.+||+|||+++.......  .....+++.|+|||++.+..++.++|||||
T Consensus       339 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl  405 (495)
T 1opk_A          339 FIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  405 (495)
T ss_dssp             EECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred             cccCCCChhhEEE---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhH
Confidence            9999999999999   5677899999999987644322  223445678999999998899999999996

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.98  E-value=5.4e-33  Score=194.60  Aligned_cols=143  Identities=26%  Similarity=0.436  Sum_probs=118.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+.+|+++++.++||||+++++++...  ...++||||+++++|.+++.... .+++..+..++.++  |+.|||
T Consensus        52 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH  131 (295)
T 3ugc_A           52 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG  131 (295)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh
Confidence            44567899999999999999999999998543  56899999999999999997654 48999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++|+||||+||++.   ..+.+||+|||+++......    ......+++.|+|||++.+..++.++|||||
T Consensus       132 ~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  203 (295)
T 3ugc_A          132 TKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSF  203 (295)
T ss_dssp             HTTCCCSCCSGGGEEEE---ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             cCCcccCCCCHhhEEEc---CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHH
Confidence            99999999999999994   56789999999998654432    1223446777999999999999999999996

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.98  E-value=2.3e-32  Score=198.21  Aligned_cols=141  Identities=28%  Similarity=0.460  Sum_probs=118.4

Q ss_pred             HhHHHHHHHHHHHHHcCC-CcCccceeeeeeeCC--eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ......+.+|+.+++.+. ||||+++++++..++  .+|+||||++ ++|.+++.. +.+++..+..++.++  |+.|||
T Consensus        49 ~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH  126 (388)
T 3oz6_A           49 STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLH  126 (388)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            445677889999999997 999999999997554  7999999995 689988875 468999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC----------------------CccccCCCCCCcccccccc
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----------------------NYAEKVCGSPLYMAPEVLQ  139 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~----------------------~~~~~~~~t~~y~aPE~~~  139 (152)
                      +.+++||||||+||++   +..+.+||+|||+++.+...                      ......+||++|+|||++.
T Consensus       127 ~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (388)
T 3oz6_A          127 SGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL  203 (388)
T ss_dssp             HTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred             hCCEEeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence            9999999999999999   56778999999999865321                      1224467999999999998


Q ss_pred             c-CCCCcccceeeC
Q 031828          140 F-QRYDEKVNFFVS  152 (152)
Q Consensus       140 ~-~~~~~~~Dvws~  152 (152)
                      + ..++.++|||||
T Consensus       204 ~~~~~~~~~DiwSl  217 (388)
T 3oz6_A          204 GSTKYTKGIDMWSL  217 (388)
T ss_dssp             TCCCCCTHHHHHHH
T ss_pred             CCCCCCChhhHHHH
Confidence            6 568999999995

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.98  E-value=6.4e-32  Score=191.20  Aligned_cols=139  Identities=31%  Similarity=0.505  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc------CCCCHHHHHHHHHHH--HHHHHH
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      .+.+.+|+++++.++||||+++++++..++..++||||++ ++|.+++...      ..+++..+..++.++  |+.|||
T Consensus        47 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH  125 (317)
T 2pmi_A           47 PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH  125 (317)
T ss_dssp             CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999999999999999999996 6999988653      358899999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++   +..+.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||
T Consensus       126 ~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  195 (317)
T 2pmi_A          126 ENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSC  195 (317)
T ss_dssp             HTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HCCeeeCCCChHHeEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHH
Confidence            9999999999999999   56778999999999876433 233456789999999999864 58999999996

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.98  E-value=1.4e-32  Score=195.13  Aligned_cols=143  Identities=29%  Similarity=0.453  Sum_probs=121.2

Q ss_pred             HhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHH
Q 031828            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~   69 (152)
                      ....+.+.+|+++++++ +||||+++++++..++..+++|||+++++|.+++....                .+++..++
T Consensus        66 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (327)
T 1fvr_A           66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  145 (327)
T ss_dssp             ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHH
Confidence            34567789999999999 99999999999999999999999999999999997654                68999999


Q ss_pred             HHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCccc
Q 031828           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      .++.++  |+.+||+++++|+||||+||++   +..+.+||+|||+++............+++.|+|||++.+..++.++
T Consensus       146 ~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  222 (327)
T 1fvr_A          146 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  222 (327)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchh
Confidence            999998  8999999999999999999999   56678999999999754333333445568899999999988899999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |||||
T Consensus       223 Di~sl  227 (327)
T 1fvr_A          223 DVWSY  227 (327)
T ss_dssp             HHHHH
T ss_pred             cchHH
Confidence            99996

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.98  E-value=7.2e-32  Score=190.00  Aligned_cols=138  Identities=33%  Similarity=0.529  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHcCC---CcCccceeeeeeeCC-----eEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--HHH
Q 031828           11 SCLDCELNFLSSVN---HPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--GLE   78 (152)
Q Consensus        11 ~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--~l~   78 (152)
                      ..+.+|+.+++.++   ||||+++++++....     ..+++||++. ++|.+++.....  +++..+..++.++  |+.
T Consensus        56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~  134 (308)
T 3g33_A           56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD  134 (308)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            46678888877764   999999999997764     5899999995 699999987654  8999999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+++++|+||||+||++   +..+.+||+|||+++............||+.|+|||++.+..++.++|||||
T Consensus       135 ~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  205 (308)
T 3g33_A          135 FLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSV  205 (308)
T ss_dssp             HHHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHH
T ss_pred             HHHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHH
Confidence            9999999999999999999   5677899999999987665555667789999999999998899999999996

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.98  E-value=6.7e-32  Score=190.45  Aligned_cols=141  Identities=21%  Similarity=0.400  Sum_probs=116.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++..++++|++++++|.+++...+.+++..+..++.++  |+.+||+.+++
T Consensus        77 ~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  156 (309)
T 2h34_A           77 FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT  156 (309)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCC
Confidence            3578999999999999999999999999999999999999999999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.++++|||++.......  ......+++.|+|||++.+..++.++|||||
T Consensus       157 H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  221 (309)
T 2h34_A          157 HRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYAL  221 (309)
T ss_dssp             CSCCCGGGEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHH
T ss_pred             cCCCChHHEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHH
Confidence            99999999999   566789999999987654432  2235578999999999998889999999996

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.98  E-value=6e-32  Score=194.03  Aligned_cols=148  Identities=24%  Similarity=0.366  Sum_probs=125.9

Q ss_pred             cchhh--HhHHHHHHHHHHHHHcCC-----CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHH
Q 031828            2 LKKLN--KHLKSCLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFL   72 (152)
Q Consensus         2 ~k~~~--~~~~~~~~~E~~~l~~l~-----h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~   72 (152)
                      +|++.  ....+.+..|+.+++.++     ||||+++++++...+..++|||++ +++|.+++....  .+++..+..++
T Consensus        65 vK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~  143 (360)
T 3llt_A           65 VKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYC  143 (360)
T ss_dssp             EEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHH
T ss_pred             EEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHH
Confidence            45443  344667888999999997     999999999999999999999999 999999998654  48999999999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecC----------------------CCCceEEEeeccCccccCCCCccccCCC
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGL----------------------DDDVMLKIADFGLSCTLYPGNYAEKVCG  128 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~----------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~  128 (152)
                      .++  |+.|||+++++|+||||+||++...                      .....+||+|||+++....  ......|
T Consensus       144 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~g  221 (360)
T 3llt_A          144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIIN  221 (360)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCS
T ss_pred             HHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccC
Confidence            998  8999999999999999999999421                      1256899999999975433  2345678


Q ss_pred             CCCcccccccccCCCCcccceeeC
Q 031828          129 SPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       129 t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|+|||++.+..++.++|||||
T Consensus       222 t~~y~aPE~~~~~~~~~~~Diwsl  245 (360)
T 3llt_A          222 TRQYRAPEVILNLGWDVSSDMWSF  245 (360)
T ss_dssp             CGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             cccccCcHHHcCCCCCCccchHHH
Confidence            999999999999999999999996

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.98  E-value=1.1e-32  Score=197.67  Aligned_cols=142  Identities=31%  Similarity=0.486  Sum_probs=121.6

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCC-eEEEEEeecCCCChHHHHHhcCC-----------------------
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR-----------------------   62 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~-----------------------   62 (152)
                      ...+.+.+|+++++.+ +||||+++++++..++ ..+++|||+++++|.+++.....                       
T Consensus        67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (359)
T 3vhe_A           67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP  146 (359)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred             HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence            4457799999999999 7899999999998764 48999999999999999976533                       


Q ss_pred             -------------------------------------------CCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEe
Q 031828           63 -------------------------------------------VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL   97 (152)
Q Consensus        63 -------------------------------------------~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~   97 (152)
                                                                 +++..+..++.++  |+.|||+++++|+||||+||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll  226 (359)
T 3vhe_A          147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  226 (359)
T ss_dssp             -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence                                                       7888899999998  8999999999999999999999


Q ss_pred             ecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           98 SGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        98 ~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                         +..+.+||+|||+++......   ......+|+.|+|||++.+..++.++|||||
T Consensus       227 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  281 (359)
T 3vhe_A          227 ---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF  281 (359)
T ss_dssp             ---CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             ---cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhH
Confidence               566789999999998654332   2334567889999999998899999999996

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.98  E-value=4e-32  Score=188.38  Aligned_cols=140  Identities=40%  Similarity=0.725  Sum_probs=117.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++||||+++++++..++..+++||++++++|.+++...+.+++..+..++.++  |+.+||+.+++|
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  134 (276)
T 2h6d_A           55 VGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH  134 (276)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            467889999999999999999999999999999999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      +||+|+||++   +..+.++++|||++.............+++.|+|||++.+..+ +.++|||||
T Consensus       135 ~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  197 (276)
T 2h6d_A          135 RDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC  197 (276)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHH
T ss_pred             CCCChhhEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHH
Confidence            9999999999   5667899999999987655544456678999999999987765 589999995

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=9.8e-33  Score=195.49  Aligned_cols=142  Identities=27%  Similarity=0.388  Sum_probs=124.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHHH--HHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ...+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++....    .+++..+..++.++  |+.|||
T Consensus        77 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  156 (321)
T 2qkw_B           77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH  156 (321)
T ss_dssp             SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence            446789999999999999999999999999999999999999999999986543    48889999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++   +..+.+|++|||+++......   ......||+.|+|||++.+..++.++|||||
T Consensus       157 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  227 (321)
T 2qkw_B          157 TRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF  227 (321)
T ss_dssp             HTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHH
T ss_pred             CCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhH
Confidence            9999999999999999   567789999999997643322   2234568999999999998899999999996

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=4.4e-32  Score=188.76  Aligned_cols=142  Identities=27%  Similarity=0.446  Sum_probs=121.3

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      .....+.+|+..+..+ +||||+++++++..++..+++|||+++++|.+++...    ..+++..+..++.++  |+.||
T Consensus        52 ~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l  131 (289)
T 1x8b_A           52 VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI  131 (289)
T ss_dssp             HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence            4567788999999999 9999999999999999999999999999999999764    668999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCC----------------CCceEEEeeccCccccCCCCccccCCCCCCcccccccccC-CC
Q 031828           81 NSHHIIHRDLKPENILLSGLD----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RY  143 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~----------------~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~  143 (152)
                      |+++++|+||||+||++...+                ....++++|||.+.......   ...||+.|+|||++.+. .+
T Consensus       132 H~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~  208 (289)
T 1x8b_A          132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTH  208 (289)
T ss_dssp             HHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTT
T ss_pred             HhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCC
Confidence            999999999999999995322                44579999999998754432   34589999999999876 46


Q ss_pred             CcccceeeC
Q 031828          144 DEKVNFFVS  152 (152)
Q Consensus       144 ~~~~Dvws~  152 (152)
                      +.++|||||
T Consensus       209 ~~~~Di~sl  217 (289)
T 1x8b_A          209 LPKADIFAL  217 (289)
T ss_dssp             HHHHHHHHH
T ss_pred             CchhhHHHH
Confidence            689999996

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=2.1e-32  Score=191.15  Aligned_cols=139  Identities=30%  Similarity=0.512  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+++++.++||||+++++++..++..+++||+++ ++|.+++... +.+++..+..++.++  |+.|||+++++
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  122 (288)
T 1ob3_A           44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL  122 (288)
T ss_dssp             CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4678899999999999999999999999999999999996 5998888754 568999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||
T Consensus       123 H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  187 (288)
T 1ob3_A          123 HRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV  187 (288)
T ss_dssp             CSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred             cCCCCHHHEEE---cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHH
Confidence            99999999999   56778999999999765433 233456789999999999764 58999999995

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.97  E-value=4.2e-32  Score=188.80  Aligned_cols=139  Identities=30%  Similarity=0.601  Sum_probs=122.7

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeee----------------CCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHH
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQA----------------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL   72 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~----------------~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~   72 (152)
                      +.+.+|+++++.++||||+++++++..                .+..+++|||+++++|.+++...  ..+++..+..++
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~  128 (284)
T 2a19_B           49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF  128 (284)
T ss_dssp             GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence            467889999999999999999998854                34589999999999999999754  568999999999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCccccee
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF  150 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw  150 (152)
                      .++  |+.+||+++++|+||||+||++.   ..+.++|+|||+++............+|+.|+|||++.+..++.++|||
T Consensus       129 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  205 (284)
T 2a19_B          129 EQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY  205 (284)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHH
T ss_pred             HHHHHHHHHHHhCCeeeccCCHHHEEEc---CCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhH
Confidence            998  89999999999999999999994   5668999999999877665555567789999999999988899999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       206 sl  207 (284)
T 2a19_B          206 AL  207 (284)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=2e-32  Score=193.92  Aligned_cols=143  Identities=25%  Similarity=0.429  Sum_probs=114.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeE------EEEEeecCCCChHHHHHhcC------CCCHHHHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHG------RVPEQTARKFLQQ   74 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~------~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~   74 (152)
                      ....+.+.+|+++++.++||||+++++++...+..      ++++||+.+++|.+++....      .+++..+..++.+
T Consensus        66 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~q  145 (323)
T 3qup_A           66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD  145 (323)
T ss_dssp             CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHH
Confidence            34567899999999999999999999999877654      99999999999999986433      5899999999999


Q ss_pred             H--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccce
Q 031828           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNF  149 (152)
Q Consensus        75 i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv  149 (152)
                      +  |+.|||+++++|+||||+||++   +..+.+||+|||+++.......   .....+++.|+|||++.+..++.++||
T Consensus       146 i~~al~~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  222 (323)
T 3qup_A          146 IACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV  222 (323)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccch
Confidence            8  8999999999999999999999   5667899999999987644432   223446778999999999899999999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      |||
T Consensus       223 ~sl  225 (323)
T 3qup_A          223 WAF  225 (323)
T ss_dssp             HHH
T ss_pred             hhH
Confidence            996

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=1.3e-32  Score=195.03  Aligned_cols=139  Identities=29%  Similarity=0.394  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHHH--HHHHHHhC-
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQL--GLEILNSH-   83 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i--~l~~lh~~-   83 (152)
                      ..+.+|+++++.++||||+++++++..++..+++|||+.+++|.+++....    .+++..+..++.++  |+.|||++ 
T Consensus        72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  151 (326)
T 3uim_A           72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC  151 (326)
T ss_dssp             CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999999999999999999999999999999999997543    38899999999998  89999999 


Q ss_pred             --CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 --HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 --~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                        +++|+||||+||++   +..+.++|+|||+++......  ......||+.|+|||++.+..++.++|||||
T Consensus       152 ~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  221 (326)
T 3uim_A          152 DPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY  221 (326)
T ss_dssp             SSCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHH
T ss_pred             CCCeEeCCCchhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhH
Confidence              99999999999999   566789999999998764332  2344568999999999998889999999996

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.97  E-value=2e-32  Score=190.59  Aligned_cols=142  Identities=27%  Similarity=0.499  Sum_probs=112.5

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+.+++.++||||+++++++. ++..++||||+++++|.+++.... .+++..+..++.++  |+.+||++
T Consensus        57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  135 (281)
T 1mp8_A           57 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK  135 (281)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345678999999999999999999999985 567899999999999999997654 58999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++.   ..+.+|++|||+++.......  .....+++.|+|||++.+..++.++|||||
T Consensus       136 ~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  203 (281)
T 1mp8_A          136 RFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF  203 (281)
T ss_dssp             TCCCSCCSGGGEEEE---ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             CeecccccHHHEEEC---CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHH
Confidence            999999999999994   566899999999987644332  233456788999999998899999999996

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=2.4e-32  Score=191.73  Aligned_cols=141  Identities=25%  Similarity=0.440  Sum_probs=122.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ..+.+.+|+++++.++||||+++++++..+  +..+++|||+++++|.+++.. ...+++..+..++.++  |+.+||++
T Consensus        66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  145 (302)
T 4e5w_A           66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR  145 (302)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence            357889999999999999999999999876  668999999999999999954 4569999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++.   ..+.++++|||+++......    ......+|+.|+|||++.+..++.++|||||
T Consensus       146 ~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  215 (302)
T 4e5w_A          146 QYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF  215 (302)
T ss_dssp             TEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             CcccCCCchheEEEc---CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHH
Confidence            999999999999994   56689999999998765443    2234567888999999998889999999996

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=1.1e-32  Score=193.18  Aligned_cols=147  Identities=24%  Similarity=0.388  Sum_probs=122.2

Q ss_pred             cchhhHhHHHHHHHHHHHHHc--CCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~--l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i   75 (152)
                      +|+++....+.+..|.+++..  ++||||+++++++..    .+..+++|||+++++|.++++. ..+++..+..++.++
T Consensus        36 vK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i  114 (301)
T 3q4u_A           36 VKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSI  114 (301)
T ss_dssp             EEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHH
T ss_pred             EEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHH
Confidence            577766667777788888877  799999999998654    2468999999999999999954 568999999999998


Q ss_pred             --HHHHHH--------hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-----cccCCCCCCccccccccc
Q 031828           76 --GLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        76 --~l~~lh--------~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~  140 (152)
                        |+.|||        +.+++|+||||+||++   +..+.+||+|||+++.......     .....||+.|+|||++.+
T Consensus       115 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  191 (301)
T 3q4u_A          115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE  191 (301)
T ss_dssp             HHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence              899999        9999999999999999   5677899999999976543321     234578999999999987


Q ss_pred             C------CCCcccceeeC
Q 031828          141 Q------RYDEKVNFFVS  152 (152)
Q Consensus       141 ~------~~~~~~Dvws~  152 (152)
                      .      .++.++|||||
T Consensus       192 ~~~~~~~~~~~~~Dvwsl  209 (301)
T 3q4u_A          192 TIQVDCFDSYKRVDIWAF  209 (301)
T ss_dssp             CCCTTCHHHHHHHHHHHH
T ss_pred             cCCCCcccCCchhhHHHH
Confidence            6      45578999996

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=5e-34  Score=203.34  Aligned_cols=137  Identities=23%  Similarity=0.308  Sum_probs=110.4

Q ss_pred             HHHHHHHHHHHHcCC---------C-----------------cCccceeeeeee-------------CCeEEEEEeecCC
Q 031828           10 KSCLDCELNFLSSVN---------H-----------------PNIIRLFDAFQA-------------ENCIFLVVEFCAG   50 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~---------h-----------------~ni~~l~~~~~~-------------~~~~~lv~e~~~~   50 (152)
                      .+.+.+|+.+++.++         |                 |||+++++++..             ++..|+||||+++
T Consensus        67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~  146 (336)
T 2vuw_A           67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG  146 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred             HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence            377889999999886         5                 445555555443             6789999999988


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH-hCCCeecCCCCCceEeecCC-----------------CCceEEEee
Q 031828           51 GNLSSYIRLHGRVPEQTARKFLQQL--GLEILN-SHHIIHRDLKPENILLSGLD-----------------DDVMLKIAD  110 (152)
Q Consensus        51 ~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh-~~~~~h~dl~~~nil~~~~~-----------------~~~~~kl~d  110 (152)
                      |++.+.+.+ +.+++..+..++.|+  |+.||| +++++||||||+||++...+                 ....+||+|
T Consensus       147 g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D  225 (336)
T 2vuw_A          147 GIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID  225 (336)
T ss_dssp             CEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred             CccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence            876665543 568999999999998  899999 99999999999999996432                 123899999


Q ss_pred             ccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          111 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       111 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+++.....    ..+||+.|+|||++.+.. +.++|||||
T Consensus       226 FG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl  262 (336)
T 2vuw_A          226 YTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRL  262 (336)
T ss_dssp             CTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHH
T ss_pred             ccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhh
Confidence            9999865432    457899999999999766 889999995

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.97  E-value=4.3e-32  Score=192.60  Aligned_cols=146  Identities=25%  Similarity=0.424  Sum_probs=127.0

Q ss_pred             cchhhHhHHHHHHHHHHHHHcCC-CcCccceeeeeee--CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--H
Q 031828            2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--G   76 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~   76 (152)
                      +|.++....+.+.+|+.+++.++ ||||+++++++..  ....+++||++.+++|.+++.   .+++..+..++.++  |
T Consensus        66 vK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~  142 (330)
T 3nsz_A           66 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKA  142 (330)
T ss_dssp             EEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHH
T ss_pred             EEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHH
Confidence            56666666788999999999997 9999999999987  567899999999999998874   37889999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +.|||+++++|+||||+||++.  .....+||+|||+++............+++.|+|||++.+ ..++.++|||||
T Consensus       143 l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  217 (330)
T 3nsz_A          143 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  217 (330)
T ss_dssp             HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHH
Confidence            9999999999999999999994  2334899999999987766655666788999999999987 568999999996

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=2e-32  Score=196.60  Aligned_cols=142  Identities=32%  Similarity=0.555  Sum_probs=125.1

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC-
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH-   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~-   83 (152)
                      ....+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...+.+++..+..++.++  |+.|||+. 
T Consensus        72 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~  151 (360)
T 3eqc_A           72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH  151 (360)
T ss_dssp             HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            455788999999999999999999999999999999999999999999999988889999999999998  89999985 


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.++|+|||+++..... ......||+.|+|||++.+..++.++|||||
T Consensus       152 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  216 (360)
T 3eqc_A          152 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM  216 (360)
T ss_dssp             CCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHH
T ss_pred             CEEcCCccHHHEEE---CCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHH
Confidence            99999999999999   56678999999998754322 2345678999999999999899999999995

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=2.5e-32  Score=196.55  Aligned_cols=139  Identities=14%  Similarity=0.191  Sum_probs=117.3

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeC----CeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      .+..|+..++.++||||+++++++...    ...++||||+ +++|.+++... +.+++..+..++.++  |+.|||+.+
T Consensus        94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~  172 (364)
T 3op5_A           94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE  172 (364)
T ss_dssp             HHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            344566677788899999999998764    4589999999 99999999875 569999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--------cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.. ...+.+||+|||+++.+.....        .....||+.|+|||++.+..++.++|||||
T Consensus       173 iiHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  247 (364)
T 3op5_A          173 YVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEIL  247 (364)
T ss_dssp             EECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             eEEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHH
Confidence            999999999999952 2567899999999976543321        134559999999999999889999999996

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=1.2e-32  Score=195.29  Aligned_cols=147  Identities=27%  Similarity=0.433  Sum_probs=121.8

Q ss_pred             cchhh--HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 031828            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (152)
Q Consensus         2 ~k~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i   75 (152)
                      +|++.  .........|+.++++++||||+++++++...+    .+++||||+++++|.++++.. .+++..+..++.++
T Consensus        52 vK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi  130 (322)
T 3soc_A           52 VKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETM  130 (322)
T ss_dssp             EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHH
T ss_pred             EEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHH
Confidence            45443  334455667899999999999999999998743    479999999999999999764 58999999999998


Q ss_pred             --HHHHHHhC----------CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCccccccccc
Q 031828           76 --GLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        76 --~l~~lh~~----------~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~  140 (152)
                        |+.|||+.          +++|+||||+||++   +..+.+||+|||+++......   ......||+.|+|||++.+
T Consensus       131 ~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (322)
T 3soc_A          131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG  207 (322)
T ss_dssp             HHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhccc
Confidence              89999999          99999999999999   567789999999998765433   2334678999999999986


Q ss_pred             C-----CCCcccceeeC
Q 031828          141 Q-----RYDEKVNFFVS  152 (152)
Q Consensus       141 ~-----~~~~~~Dvws~  152 (152)
                      .     .++.++|||||
T Consensus       208 ~~~~~~~~~~~~Diwsl  224 (322)
T 3soc_A          208 AINFQRDAFLRIDMYAM  224 (322)
T ss_dssp             CCCCCHHHHHHHHHHHH
T ss_pred             ccccCcCCCccchhHHH
Confidence            3     46678999996

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=7e-33  Score=201.52  Aligned_cols=144  Identities=26%  Similarity=0.465  Sum_probs=123.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCC--eEEEEEeecCCCChHHHHHhcCC---CCHHHHHHHHHHH--HHHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ..+.+.+|+++++.++||||+++++++...+  ..++||||+++++|.+++.....   +++..+..++.++  |+.|||
T Consensus        50 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  129 (396)
T 4eut_A           50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR  129 (396)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            3577889999999999999999999998664  78999999999999999975433   8999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeec-CCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc--------CCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~-~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++.. .+....+||+|||+++............||+.|+|||++.+        ..++.++|||||
T Consensus       130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl  209 (396)
T 4eut_A          130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI  209 (396)
T ss_dssp             HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred             HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence            999999999999999732 23556799999999987766555566789999999999875        467889999996

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.6e-32  Score=195.89  Aligned_cols=142  Identities=28%  Similarity=0.462  Sum_probs=122.4

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-----------------------CC
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------RV   63 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------------------~~   63 (152)
                      ...+.+.+|+.+++++ +||||+++++++..++..+++|||+++++|.+++....                       .+
T Consensus        90 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  169 (344)
T 1rjb_A           90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL  169 (344)
T ss_dssp             --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccC
Confidence            4567899999999999 89999999999999999999999999999999997643                       26


Q ss_pred             CHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCccccccc
Q 031828           64 PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVL  138 (152)
Q Consensus        64 ~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~  138 (152)
                      ++..+..++.++  |+.|||+++++|+||||+||++   +..+.++|+|||+++.......   .....+|+.|+|||++
T Consensus       170 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  246 (344)
T 1rjb_A          170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  246 (344)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence            888899999998  8999999999999999999999   4667899999999976544322   2334567889999999


Q ss_pred             ccCCCCcccceeeC
Q 031828          139 QFQRYDEKVNFFVS  152 (152)
Q Consensus       139 ~~~~~~~~~Dvws~  152 (152)
                      .+..++.++|||||
T Consensus       247 ~~~~~~~~~Di~sl  260 (344)
T 1rjb_A          247 FEGIYTIKSDVWSY  260 (344)
T ss_dssp             HHCCCCHHHHHHHH
T ss_pred             ccCCCChhHhHHHH
Confidence            98899999999996

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.97  E-value=1.3e-31  Score=187.68  Aligned_cols=142  Identities=39%  Similarity=0.758  Sum_probs=127.4

Q ss_pred             hHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..++.+.+|+++++++. ||||+++++++..++..+++||++++++|.+++.....+++..+..++.++  |+.+||+.+
T Consensus        65 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  144 (298)
T 1phk_A           65 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN  144 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34677889999999995 999999999999999999999999999999999988889999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc------cCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dvws~  152 (152)
                      ++|+||+|+||++   +..+.++++|||++.............+++.|+|||++.      ...++.++|||||
T Consensus       145 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~sl  215 (298)
T 1phk_A          145 IVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST  215 (298)
T ss_dssp             EECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred             cccCCCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhH
Confidence            9999999999999   566789999999998776655556678899999999985      4468899999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=4e-32  Score=190.49  Aligned_cols=139  Identities=31%  Similarity=0.577  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeee--CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+++++.++||||+++++++..  .+..++||||+++++|.++.. ...+++..+..++.++  |+.|||++++
T Consensus        80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i  158 (298)
T 2zv2_A           80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKI  158 (298)
T ss_dssp             -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4678999999999999999999999986  568999999999999987653 4568999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC---CCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR---YDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||+++...... ......||+.|+|||++.+..   ++.++|||||
T Consensus       159 vH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl  226 (298)
T 2zv2_A          159 IHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAM  226 (298)
T ss_dssp             ECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHH
T ss_pred             eccCCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhH
Confidence            999999999999   566789999999998765443 334567899999999998765   3778999996

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=189.37  Aligned_cols=140  Identities=31%  Similarity=0.488  Sum_probs=115.8

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ........|+..+..+ +||||+++++++..++..++|||++ +++|.+++...+ .+++..+..++.++  |+.|||+.
T Consensus        98 ~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  176 (311)
T 3p1a_A           98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ  176 (311)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3344555566555554 9999999999999999999999999 778888886544 59999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+||+|||+++............||+.|+|||++.+ .++.++|||||
T Consensus       177 ~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diwsl  241 (311)
T 3p1a_A          177 GLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSL  241 (311)
T ss_dssp             TEECCCCSGGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHH
T ss_pred             CEecCCCCHHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHH
Confidence            99999999999999   5677899999999987665555566779999999999885 78999999996

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=3.3e-32  Score=193.54  Aligned_cols=142  Identities=30%  Similarity=0.462  Sum_probs=116.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++||||+++++++..++..++||||++ ++|.+++.....+++..+..++.++  |+.|||+++++|
T Consensus        77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH  155 (329)
T 3gbz_A           77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLH  155 (329)
T ss_dssp             ---CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             chhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEC
Confidence            5667899999999999999999999999999999999996 6999999988889999999999998  899999999999


Q ss_pred             cCCCCCceEeecC--CCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           88 RDLKPENILLSGL--DDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~--~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +||||+||++...  .....+||+|||+++..... .......+|+.|+|||++.+.. ++.++|||||
T Consensus       156 ~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  224 (329)
T 3gbz_A          156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSI  224 (329)
T ss_dssp             SCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHH
Confidence            9999999999532  23446999999999876433 2334567899999999998754 8999999996

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.97  E-value=1.9e-32  Score=194.03  Aligned_cols=142  Identities=37%  Similarity=0.660  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ...+.+|+++++.++||||+++++++..++ .++||||+++++|.+++.....+++..+..++.++  |+.|||+++++|
T Consensus        59 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  137 (322)
T 2ycf_A           59 ALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH  137 (322)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            346889999999999999999999997655 89999999999999999888889999999999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      +||||+||++...+....+||+|||+++............||+.|+|||++.   ...++.++|||||
T Consensus       138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl  205 (322)
T 2ycf_A          138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL  205 (322)
T ss_dssp             CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHH
T ss_pred             cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHH
Confidence            9999999999643444569999999998765544445567899999999974   4568899999996

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=3.1e-32  Score=193.56  Aligned_cols=141  Identities=24%  Similarity=0.360  Sum_probs=120.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+.+++.++||||+++++++..++ .+++++++.+++|.+++.. ...+++..+..++.++  |+.|||+++
T Consensus        59 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  137 (327)
T 3poz_A           59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  137 (327)
T ss_dssp             -CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            44678999999999999999999999998755 7889999999999999976 4568999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.   ..+.+||+|||+++.......   .....+|+.|+|||++.+..++.++|||||
T Consensus       138 ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  205 (327)
T 3poz_A          138 LVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY  205 (327)
T ss_dssp             CCCSCCCGGGEEEE---ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             eeCCCCChheEEEC---CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhh
Confidence            99999999999994   566899999999987654432   233456788999999999999999999996

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=2.9e-31  Score=185.40  Aligned_cols=143  Identities=34%  Similarity=0.666  Sum_probs=123.9

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      +....+.+.+|+.+++.++||||+++++++..    .+..++||||+++++|.+++.....+++..+..++.++  |+.|
T Consensus        65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~  144 (290)
T 1t4h_A           65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence            45567889999999999999999999998865    45689999999999999999988889999999999998  8999


Q ss_pred             HHhCC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           80 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+.+  ++|+||||+||++.  ...+.++|+|||++...... ......||+.|+|||++. +.++.++|||||
T Consensus       145 lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~sl  215 (290)
T 1t4h_A          145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAF  215 (290)
T ss_dssp             HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHH
T ss_pred             HHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHH
Confidence            99999  99999999999993  25668999999999654332 344567899999999887 458999999995

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=3.5e-32  Score=191.60  Aligned_cols=142  Identities=29%  Similarity=0.427  Sum_probs=124.5

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC------------------CCCHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQTA   68 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------------~~~~~~~   68 (152)
                      ...+.+.+|+.+++++ +||||+++++++..++..+++|||+++++|.+++....                  .+++..+
T Consensus        68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (313)
T 1t46_A           68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL  147 (313)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred             HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence            4568899999999999 99999999999999999999999999999999997654                  3889999


Q ss_pred             HHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCC
Q 031828           69 RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY  143 (152)
Q Consensus        69 ~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~  143 (152)
                      ..++.++  |+.+||+++++|+||||+||++   +..+.+|++|||+++.......   .....+|+.|+|||++.+..+
T Consensus       148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  224 (313)
T 1t46_A          148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY  224 (313)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCccceEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence            9999998  8999999999999999999999   4667899999999987654432   233456788999999998899


Q ss_pred             CcccceeeC
Q 031828          144 DEKVNFFVS  152 (152)
Q Consensus       144 ~~~~Dvws~  152 (152)
                      +.++|||||
T Consensus       225 ~~~~Di~sl  233 (313)
T 1t46_A          225 TFESDVWSY  233 (313)
T ss_dssp             CHHHHHHHH
T ss_pred             ChHHHHHHH
Confidence            999999996

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=1.2e-31  Score=192.13  Aligned_cols=138  Identities=34%  Similarity=0.581  Sum_probs=120.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH-hcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+++++.++||||+++++++..++..++||||+. |++.+++. ....+++..+..++.++  |+.|||+++
T Consensus        96 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  174 (348)
T 1u5q_A           96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN  174 (348)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            445778999999999999999999999999999999999996 67877775 45679999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.   ..+.+||+|||+++....   .....||+.|+|||++.   .+.++.++|||||
T Consensus       175 ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl  239 (348)
T 1u5q_A          175 MIHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  239 (348)
T ss_dssp             CBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHH
T ss_pred             eeeCCCCHHHEEEC---CCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHH
Confidence            99999999999994   667899999999976543   23567899999999985   4668999999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=6.7e-32  Score=196.09  Aligned_cols=141  Identities=26%  Similarity=0.532  Sum_probs=119.7

Q ss_pred             HhHHHHHHHHHHHHHcCC--CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+.+|+++++.++  ||||+++++++..++.+|+||| +.+++|.+++.....+++..+..++.++  |+.|||+
T Consensus        95 ~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~  173 (390)
T 2zmd_A           95 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  173 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445688999999999996  5999999999999999999999 5689999999988889999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCccccccccc-----------CCCCcccc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKVN  148 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-----------~~~~~~~D  148 (152)
                      ++++|+||||+||++.    .+.+||+|||+++.+....   .....+||+.|+|||++.+           ..++.++|
T Consensus       174 ~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  249 (390)
T 2zmd_A          174 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD  249 (390)
T ss_dssp             TTCCCCCCCGGGEEES----SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHH
T ss_pred             CCeeecCCCHHHEEEE----CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhh
Confidence            9999999999999993    3679999999998764432   2345679999999999975           35889999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      ||||
T Consensus       250 iwSl  253 (390)
T 2zmd_A          250 VWSL  253 (390)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=1.2e-31  Score=190.62  Aligned_cols=142  Identities=30%  Similarity=0.497  Sum_probs=120.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+.+++.++||||+++++++...+..++||||+++++|.++......+++..+..++.++  |+.+||+.++
T Consensus        66 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  145 (331)
T 4aaa_A           66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI  145 (331)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            44667889999999999999999999999999999999999999999888777889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.++|+|||+++...... ......+|+.|+|||++.+. .++.++|||||
T Consensus       146 vH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl  211 (331)
T 4aaa_A          146 IHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAI  211 (331)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHH
T ss_pred             EccCcChheEEE---cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHH
Confidence            999999999999   566789999999997654432 33456789999999999875 68999999995

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=5.7e-32  Score=193.30  Aligned_cols=141  Identities=25%  Similarity=0.507  Sum_probs=118.3

Q ss_pred             HhHHHHHHHHHHHHHcCCC--cCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+.+|+.+++.++|  |||+++++++..++..++|||+ .+++|.+++...+.+++..+..++.++  |+.|||+
T Consensus        48 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~  126 (343)
T 3dbq_A           48 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  126 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3446788999999999976  9999999999999999999994 588999999998889999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCccccccccc-----------CCCCcccc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKVN  148 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-----------~~~~~~~D  148 (152)
                      ++++|+||||+||++.    .+.+||+|||+++......   .....+||+.|+|||++.+           ..++.++|
T Consensus       127 ~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  202 (343)
T 3dbq_A          127 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  202 (343)
T ss_dssp             TTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHH
T ss_pred             CCeecCCCCcceEEEE----CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhh
Confidence            9999999999999994    4579999999998764432   2345679999999999965           56889999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      ||||
T Consensus       203 iwsl  206 (343)
T 3dbq_A          203 VWSL  206 (343)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=2.1e-32  Score=195.26  Aligned_cols=145  Identities=32%  Similarity=0.595  Sum_probs=117.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--------------------------
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------------------   60 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------------------------   60 (152)
                      ....+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++...                          
T Consensus        69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (345)
T 3hko_A           69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE  148 (345)
T ss_dssp             -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence            345678999999999999999999999999999999999999999999988420                          


Q ss_pred             --------------CCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---
Q 031828           61 --------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---  121 (152)
Q Consensus        61 --------------~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---  121 (152)
                                    ..+++..+..++.++  |+.|||+.+++|+||||+||++.. +....+||+|||+++.+....   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~  227 (345)
T 3hko_A          149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE  227 (345)
T ss_dssp             HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-
T ss_pred             ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc
Confidence                          113566777888888  899999999999999999999942 223379999999998653321   


Q ss_pred             --ccccCCCCCCccccccccc--CCCCcccceeeC
Q 031828          122 --YAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus       122 --~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~  152 (152)
                        ......||+.|+|||++.+  ..++.++|||||
T Consensus       228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             -------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             cccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence              2345678999999999975  568999999996

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=3.4e-32  Score=207.98  Aligned_cols=140  Identities=27%  Similarity=0.476  Sum_probs=120.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++|+.++||||+++++++.. +..++||||+++++|.+++.....+++..+..++.++  |+.|||+++++
T Consensus       413 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ii  491 (635)
T 4fl3_A          413 LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV  491 (635)
T ss_dssp             GHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            46789999999999999999999999964 5588999999999999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++.   ..+.+||+|||+++.+....    ......+|+.|+|||++.+..++.++|||||
T Consensus       492 HrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSl  558 (635)
T 4fl3_A          492 HRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF  558 (635)
T ss_dssp             CSCCSGGGEEEE---ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             CCCCChHhEEEe---CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHH
Confidence            999999999994   56689999999998764432    1223446788999999999899999999996

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7.4e-32  Score=194.45  Aligned_cols=139  Identities=31%  Similarity=0.520  Sum_probs=121.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ....+++.+|+++++.++||||+++++++..++      .+|+|||++ +++|.++++. ..+++..+..++.++  |+.
T Consensus        65 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~  142 (367)
T 1cm8_A           65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLR  142 (367)
T ss_dssp             HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            344677899999999999999999999997653      469999999 8899999876 568999999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |||+++++|+||||+||++   +..+.+||+|||+++....  ......+|++|+|||++.+ ..++.++|||||
T Consensus       143 ~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  212 (367)
T 1cm8_A          143 YIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSV  212 (367)
T ss_dssp             HHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred             HHHHCCccccCcCHHHEEE---cCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHH
Confidence            9999999999999999999   5677899999999986543  2445678999999999987 679999999995

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=195.56  Aligned_cols=140  Identities=16%  Similarity=0.181  Sum_probs=121.6

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+|+.+++.++||||+++++++..    ++..|++||++ +++|.+++...+.+++..+..++.++  |+.|||+++
T Consensus        93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  171 (345)
T 2v62_A           93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE  171 (345)
T ss_dssp             HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            456788999999999999999999987    67899999999 99999999877789999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.. +....+||+|||+++.+....        ......||+.|+|||++.+..++.++|||||
T Consensus       172 ivH~Dlkp~NIll~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  246 (345)
T 2v62_A          172 YVHGDIKAANLLLGY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL  246 (345)
T ss_dssp             EECSCCSGGGEEEES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred             eeCCCcCHHHEEEcc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence            999999999999953 222389999999998764322        1245678999999999998889999999996

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.1e-31  Score=191.27  Aligned_cols=143  Identities=22%  Similarity=0.403  Sum_probs=119.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+..+.+|+++++.++||||+++++++...+..++|||++++++|.+++... ..+++..+..++.++  |+.+||+.
T Consensus        87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  166 (333)
T 1mqb_A           87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM  166 (333)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345678999999999999999999999999999999999999999999999765 568999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+||+|||+++.......    .....+|+.|+|||++.+..++.++|||||
T Consensus       167 ~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  236 (333)
T 1mqb_A          167 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF  236 (333)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred             CeeCCCCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHH
Confidence            99999999999999   5677899999999986543321    122345778999999998889999999996

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=4.1e-32  Score=187.46  Aligned_cols=140  Identities=26%  Similarity=0.463  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+++++.++||||+++++++..++..+++||++++++|.+++... ..+++..+..++.++  |+.+||+.+++
T Consensus        47 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  126 (267)
T 3t9t_A           47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI  126 (267)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            567899999999999999999999999999999999999999999999765 458999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.++++|||+++......  ......+++.|+|||++.+..++.++|||||
T Consensus       127 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  191 (267)
T 3t9t_A          127 HRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  191 (267)
T ss_dssp             CSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             cCCCchheEEE---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhh
Confidence            99999999999   566789999999997654322  1233456788999999998889999999995

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=1.5e-31  Score=192.94  Aligned_cols=140  Identities=34%  Similarity=0.492  Sum_probs=111.3

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ....+.+.+|+.+++.++||||+++++++...+      ..|+||||++ ++|.+.+.  ..+++..+..++.++  |+.
T Consensus        65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~  141 (371)
T 2xrw_A           65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIK  141 (371)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHH
Confidence            345677889999999999999999999997664      7899999995 67888875  358899999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+++++|+||||+||++   +..+.+||+|||+++............||+.|+|||++.+..++.++|||||
T Consensus       142 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  212 (371)
T 2xrw_A          142 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  212 (371)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence            9999999999999999999   5677899999999987655444556788999999999999899999999995

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=3.3e-32  Score=193.23  Aligned_cols=146  Identities=24%  Similarity=0.352  Sum_probs=124.6

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-------CCCHHHHHHHHHHH--HH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQL--GL   77 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i--~l   77 (152)
                      ......+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++....       .++...+..++.++  |+
T Consensus        74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al  153 (327)
T 2yfx_A           74 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC  153 (327)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHH
Confidence            4456788999999999999999999999999999999999999999999998653       38888999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+||+++++|+||||+||++...+....++|+|||+++......   ......+++.|+|||++.+..++.++|||||
T Consensus       154 ~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  231 (327)
T 2yfx_A          154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF  231 (327)
T ss_dssp             HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHH
Confidence            99999999999999999999643455679999999997543322   2234567889999999998889999999996

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=1.2e-31  Score=190.90  Aligned_cols=142  Identities=30%  Similarity=0.481  Sum_probs=124.1

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~   70 (152)
                      ...+.+.+|+++++.+ +||||+++++++..++..++||||+++++|.+++....                .+++..+..
T Consensus        82 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (334)
T 2pvf_A           82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS  161 (334)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHH
Confidence            4567889999999999 89999999999999999999999999999999998654                378889999


Q ss_pred             HHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCc
Q 031828           71 FLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE  145 (152)
Q Consensus        71 ~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~  145 (152)
                      ++.++  |+.|||+++++|+||||+||++   +..+.+||+|||+++.......   .....+++.|+|||++.+..++.
T Consensus       162 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  238 (334)
T 2pvf_A          162 CTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH  238 (334)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh
Confidence            99998  8999999999999999999999   5677899999999987654332   23345678899999999888999


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       239 ~~Di~sl  245 (334)
T 2pvf_A          239 QSDVWSF  245 (334)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=8.4e-32  Score=191.33  Aligned_cols=144  Identities=28%  Similarity=0.504  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .+..+.+|+.+++.++ ||||+++++++..++..++||||+.+++|.+++...  ..+++..+..++.++  |+.+||++
T Consensus        71 ~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~  150 (327)
T 3lm5_A           71 CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN  150 (327)
T ss_dssp             CHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3578899999999994 699999999999999999999999999999988543  568999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++......+.+||+|||+++............||+.|+|||++.+..++.++|||||
T Consensus       151 givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  219 (327)
T 3lm5_A          151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNI  219 (327)
T ss_dssp             TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHH
Confidence            999999999999995433367899999999987765555556789999999999999999999999995

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=4.8e-32  Score=200.19  Aligned_cols=140  Identities=26%  Similarity=0.488  Sum_probs=120.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|+++|+.++||||+++++++. .+..++||||+++++|.+++...  ..++...+..++.++  |+.|||+++
T Consensus       226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  304 (454)
T 1qcf_A          226 SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN  304 (454)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4678999999999999999999999986 56789999999999999999754  258888899999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.+||+|||+++.......  .....+++.|+|||++....++.++|||||
T Consensus       305 ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  371 (454)
T 1qcf_A          305 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSF  371 (454)
T ss_dssp             CCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             ccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhH
Confidence            9999999999999   5677899999999987543321  223445778999999998899999999996

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=8.7e-32  Score=191.07  Aligned_cols=143  Identities=24%  Similarity=0.381  Sum_probs=123.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeee--eCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~--~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+.+|++++++++||||+++++++.  ..+..++||||+++++|.+++.. ...+++..+..++.++  |+.+||
T Consensus        65 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH  144 (327)
T 3lxl_A           65 PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG  144 (327)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            455677999999999999999999999886  44679999999999999999976 3458999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++|+||||+||++.   ..+.++|+|||+++......    ......+|+.|+|||++.+..++.++|||||
T Consensus       145 ~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  216 (327)
T 3lxl_A          145 SRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF  216 (327)
T ss_dssp             HTTEECSCCSGGGEEEE---ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHH
T ss_pred             hCCccCCCCChhhEEEC---CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHH
Confidence            99999999999999994   56789999999998764433    2234457888999999998889999999996

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4e-32  Score=195.04  Aligned_cols=140  Identities=30%  Similarity=0.506  Sum_probs=122.3

Q ss_pred             HHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+++++.+ +||||+++++++..++..++||||+++++|.+++.....+++..+..++.++  |+.|||+.+++
T Consensus       102 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  181 (355)
T 1vzo_A          102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII  181 (355)
T ss_dssp             GGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45677899999999 6999999999999999999999999999999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCccccccccc--CCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++.+....  .....+||+.|+|||++.+  ..++.++|||||
T Consensus       182 H~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl  248 (355)
T 1vzo_A          182 YRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL  248 (355)
T ss_dssp             CCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred             cCCCCHHHEEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHH
Confidence            99999999999   567789999999998654332  2345679999999999985  347899999996

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=2.8e-31  Score=187.09  Aligned_cols=143  Identities=30%  Similarity=0.579  Sum_probs=116.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....+.+.+|+.+++.++||||+++++++..++..+++||++.+++|.+++..    ...+++..+..++.++  |+.+|
T Consensus        73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  152 (310)
T 2wqm_A           73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM  152 (310)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence            45578899999999999999999999999999999999999999999999864    4568999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.+++|+||+|+||++   +..+.++++|||+++...... ......+++.|+|||++.+..++.++|||||
T Consensus       153 H~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  222 (310)
T 2wqm_A          153 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSL  222 (310)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHH
T ss_pred             hhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHH
Confidence            99999999999999999   567789999999987654432 2344578999999999998889999999996

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=1.1e-31  Score=187.34  Aligned_cols=143  Identities=36%  Similarity=0.645  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|++++++++||||+++++++...+..++++|++++++|.+.+.....+++..+..++.++  |+.+||+++++
T Consensus        64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  143 (287)
T 2wei_A           64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIV  143 (287)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4678899999999999999999999999999999999999999999999888889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++...+....+|++|||+++............+++.|+|||++.+ .++.++|||||
T Consensus       144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~sl  208 (287)
T 2wei_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSA  208 (287)
T ss_dssp             CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHH
T ss_pred             ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhH
Confidence            999999999996444456799999999987655444445567889999999875 48999999996

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.97  E-value=1.2e-31  Score=189.73  Aligned_cols=142  Identities=21%  Similarity=0.376  Sum_probs=123.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----------CCCCHHHHHHHHHHH--
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQL--   75 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i--   75 (152)
                      .....+.+|+.+++.++||||+++++++..++..+++||++++++|.+++...          ..++...+..++.++  
T Consensus        70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  149 (322)
T 1p4o_A           70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD  149 (322)
T ss_dssp             HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence            45667899999999999999999999999999999999999999999998653          346888999999998  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.+||+++++|+||||+||++   +..+.+||+|||+++......   ......+|+.|+|||++.+..++.++|||||
T Consensus       150 ~l~~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  226 (322)
T 1p4o_A          150 GMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF  226 (322)
T ss_dssp             HHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH
Confidence            8999999999999999999999   566789999999997654332   1233456888999999998889999999995

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=1.2e-31  Score=187.66  Aligned_cols=143  Identities=17%  Similarity=0.241  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|+.+++.+ +|+|++++++++..+...+++||++ +++|.+++...+ .+++..+..++.++  |+.|||+++
T Consensus        48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  126 (298)
T 1csn_A           48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS  126 (298)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            356688999999999 7999999999999999999999999 999999998654 59999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCC--CCceEEEeeccCccccCCCC--------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~--~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++....  ....++|+|||+++......        ......||+.|+|||++.+..++.++|||||
T Consensus       127 ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  204 (298)
T 1csn_A          127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL  204 (298)
T ss_dssp             EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHH
Confidence            99999999999995321  22349999999998764432        1345678999999999999889999999996

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=4.3e-32  Score=197.77  Aligned_cols=142  Identities=27%  Similarity=0.503  Sum_probs=112.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeee--CCeEEEEEeecCCCChHHHHHhc---------CCCCHHHHHHHHHHH--H
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQL--G   76 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i--~   76 (152)
                      ...+.+|+.+++.++||||+++++++..  +...++||||+. ++|.+++...         ..+++..+..++.++  |
T Consensus        62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  140 (405)
T 3rgf_A           62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG  140 (405)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence            4568899999999999999999999954  678999999995 6888877532         248999999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecC-CCCceEEEeeccCccccCCC----CccccCCCCCCcccccccccC-CCCccccee
Q 031828           77 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFF  150 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~-~~~~~~kl~dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvw  150 (152)
                      +.|||+++++|+||||+||++... ...+.+||+|||+++.....    ......+||+.|+|||++.+. .++.++|||
T Consensus       141 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  220 (405)
T 3rgf_A          141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW  220 (405)
T ss_dssp             HHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred             HHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhH
Confidence            999999999999999999999533 34568999999999876433    223456789999999999874 489999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       221 Sl  222 (405)
T 3rgf_A          221 AI  222 (405)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=1.4e-31  Score=187.65  Aligned_cols=143  Identities=27%  Similarity=0.402  Sum_probs=121.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeee-eeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~-~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+.+|+.++++++||||+++++++ ..++..+++|||+++++|.+++... ..++...+..++.++  |+.+||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~  146 (298)
T 3f66_A           67 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS  146 (298)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34567889999999999999999999985 4556789999999999999999754 458889999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++|+||||+||++   +..+.+|++|||+++......     ......+|+.|+|||.+.+..++.++|||||
T Consensus       147 ~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  218 (298)
T 3f66_A          147 KKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF  218 (298)
T ss_dssp             TTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             CCccCCCCchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHH
Confidence            999999999999999   567789999999997654432     1233456788999999998899999999995

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=2.1e-31  Score=187.18  Aligned_cols=141  Identities=27%  Similarity=0.556  Sum_probs=125.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++.. +.+++..+..++.++  |+.+||+.++
T Consensus        62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  140 (303)
T 3a7i_A           62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK  140 (303)
T ss_dssp             TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3467899999999999999999999999999999999999999999999864 568999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||+|+||++   +..+.++++|||++....... ......||+.|+|||++.+..++.++|||||
T Consensus       141 ~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  205 (303)
T 3a7i_A          141 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL  205 (303)
T ss_dssp             ECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             ccCCCChheEEE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHH
Confidence            999999999999   566789999999997765443 2345678999999999999889999999996

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=4.2e-32  Score=200.45  Aligned_cols=139  Identities=21%  Similarity=0.417  Sum_probs=116.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+.+|+++|++++||||+++++++.. +..++||||+++++|.+++...  ..++...+..++.++  |+.|||++++
T Consensus       223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  301 (452)
T 1fmk_A          223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  301 (452)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            5679999999999999999999999876 6789999999999999999643  458999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||+++.......  .....+++.|+|||++.+..++.++|||||
T Consensus       302 vHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl  367 (452)
T 1fmk_A          302 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  367 (452)
T ss_dssp             CCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             eCCCCChhhEEE---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhH
Confidence            999999999999   4667899999999986543321  223446778999999998899999999996

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=7.2e-32  Score=188.14  Aligned_cols=142  Identities=26%  Similarity=0.434  Sum_probs=124.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|+++++.++||||+++++++..++..++|||++++++|.+++....  .+++..+..++.++  |+.+||++
T Consensus        51 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  130 (288)
T 3kfa_A           51 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK  130 (288)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence            346788999999999999999999999999999999999999999999998643  48999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.++++|||+++.......  .....+|+.|+|||++.+..++.++|||||
T Consensus       131 ~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  198 (288)
T 3kfa_A          131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  198 (288)
T ss_dssp             TCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             CccCCCCCcceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHH
Confidence            99999999999999   5667899999999986654332  233446788999999998899999999995

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.97  E-value=1.7e-31  Score=189.07  Aligned_cols=141  Identities=29%  Similarity=0.476  Sum_probs=122.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|+++++.++||||+++++++...  ..++++|||+++++|.+++... .+++..+..++.++  |+.+||+.
T Consensus        75 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~  153 (318)
T 3lxp_A           75 QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ  153 (318)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567899999999999999999999999874  6789999999999999998764 48999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.++|+|||+++.......    .....+|+.|+|||++.+..++.++|||||
T Consensus       154 ~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  223 (318)
T 3lxp_A          154 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF  223 (318)
T ss_dssp             TEECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             CccCCCCchheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHH
Confidence            99999999999999   5667899999999987655431    234557888999999998889999999995

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=9.9e-32  Score=204.75  Aligned_cols=141  Identities=26%  Similarity=0.474  Sum_probs=118.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+++|+.++||||+++++++.. +..++||||+++++|.+++... ..+++..+..++.++  |+.|||+++
T Consensus       378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  456 (613)
T 2ozo_A          378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN  456 (613)
T ss_dssp             TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            356789999999999999999999999976 5699999999999999999654 458999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.   ..+.+||+|||+++.+.....    .....+++.|+|||++.+..++.++|||||
T Consensus       457 iiHrDlkp~NILl~---~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSl  525 (613)
T 2ozo_A          457 FVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY  525 (613)
T ss_dssp             CCCSCCSGGGEEEE---ETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             EEcCcCCHHHEEEc---CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHH
Confidence            99999999999994   566899999999987643321    122345688999999998999999999996

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.4e-31  Score=186.23  Aligned_cols=142  Identities=24%  Similarity=0.388  Sum_probs=122.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeE-EEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-FLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~-~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|+++++.++||||+++++++..++.. ++++|++.+++|.+++.. ...+++..+..++.++  |+.+||++
T Consensus        64 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  143 (298)
T 3pls_A           64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ  143 (298)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4567889999999999999999999999876554 999999999999999976 4558889999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+|++|||+++......     ......+++.|+|||.+.+..++.++|||||
T Consensus       144 ~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  214 (298)
T 3pls_A          144 KFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSF  214 (298)
T ss_dssp             TCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH
T ss_pred             CcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhH
Confidence            99999999999999   566789999999997654322     2234557888999999999899999999996

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.7e-32  Score=195.88  Aligned_cols=142  Identities=27%  Similarity=0.407  Sum_probs=113.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeee-eCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~-~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|+.++++++||||+++++++. .++..++||||+++++|.+++.+.. .++...+..++.++  |+.|||++
T Consensus       132 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  211 (373)
T 3c1x_A          132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK  211 (373)
T ss_dssp             HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45678999999999999999999999865 4567899999999999999997654 47888889999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++   +..+.+||+|||+++.+....     ......+|+.|+|||++.+..++.++|||||
T Consensus       212 ~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl  282 (373)
T 3c1x_A          212 KFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF  282 (373)
T ss_dssp             TCCCSCCCGGGEEE---CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             CEecCccchheEEE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHH
Confidence            99999999999999   567789999999998654332     1233456788999999999899999999996

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=1.2e-31  Score=187.55  Aligned_cols=140  Identities=26%  Similarity=0.468  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++++.++||||+++++++ ..+..+++||++++++|.+++...+.+++..+..++.++  |+.+||+++++
T Consensus        61 ~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  139 (291)
T 1xbb_A           61 LKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV  139 (291)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            367899999999999999999999999 566789999999999999999988889999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++.   ..+.++++|||+++.......    .....+++.|+|||++.+..++.++|||||
T Consensus       140 H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  206 (291)
T 1xbb_A          140 HRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF  206 (291)
T ss_dssp             CSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             cCCCCcceEEEe---CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHH
Confidence            999999999994   566899999999987644322    122345788999999998889999999996

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=3.8e-32  Score=199.68  Aligned_cols=150  Identities=33%  Similarity=0.498  Sum_probs=117.1

Q ss_pred             cchhhHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GL   77 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l   77 (152)
                      +|++.....+.+.+|+++++.+ +||||+++++++..++..|++||++. ++|.+++.... ...+..+..++.++  |+
T Consensus        53 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL  131 (432)
T 3p23_A           53 VKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGL  131 (432)
T ss_dssp             EEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHH
T ss_pred             EEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHH
Confidence            4555555555677899999999 89999999999999999999999995 69999997654 34555566788887  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCC--CCceEEEeeccCccccCCC----CccccCCCCCCccccccccc---CCCCcccc
Q 031828           78 EILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQF---QRYDEKVN  148 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~--~~~~~kl~dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~---~~~~~~~D  148 (152)
                      .|||+++++|+||||+||++...+  ....++|+|||+++.....    ......+||+.|+|||++.+   ..++.++|
T Consensus       132 ~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~D  211 (432)
T 3p23_A          132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD  211 (432)
T ss_dssp             HHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHH
T ss_pred             HHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHH
Confidence            999999999999999999995322  2346889999999876543    23345679999999999983   55788999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      ||||
T Consensus       212 iwSl  215 (432)
T 3p23_A          212 IFSA  215 (432)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=1.7e-31  Score=185.16  Aligned_cols=141  Identities=35%  Similarity=0.633  Sum_probs=124.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++..++..++++|++++++|.+++.....+++..+..++.++  |+.+||+++++
T Consensus        48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  127 (276)
T 2yex_A           48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  127 (276)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4578899999999999999999999999999999999999999999999877789999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.++++|||.+.......   ......|++.|+|||++.+..+ +.++|||||
T Consensus       128 H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  194 (276)
T 2yex_A          128 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC  194 (276)
T ss_dssp             CSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHH
T ss_pred             ccCCChHHEEE---ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHH
Confidence            99999999999   566789999999997654332   2345678999999999987775 678999995

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=7.5e-31  Score=185.07  Aligned_cols=140  Identities=29%  Similarity=0.534  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH-hcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++. ....+++..+..++.++  |+.+||+.+++
T Consensus        68 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~  147 (314)
T 3com_A           68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI  147 (314)
T ss_dssp             CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Confidence            5678999999999999999999999999999999999999999999987 45679999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||+|+||++   +..+.++|+|||++....... ......+++.|+|||++.+..++.++|||||
T Consensus       148 H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  211 (314)
T 3com_A          148 HRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSL  211 (314)
T ss_dssp             CCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHH
T ss_pred             CCCcCHHHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHH
Confidence            99999999999   566789999999997664432 2345678999999999999889999999996

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=6.1e-32  Score=192.13  Aligned_cols=142  Identities=27%  Similarity=0.458  Sum_probs=123.1

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--------------CCCCHHHHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------GRVPEQTARKFL   72 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--------------~~~~~~~~~~~~   72 (152)
                      ...+.+.+|+.+++.+ +||||+++++++..++..++||||+++++|.+++...              ..+++..+..++
T Consensus        91 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (333)
T 2i1m_A           91 DEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS  170 (333)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHH
Confidence            4567899999999999 8999999999999999999999999999999998743              347889999999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCccc
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      .++  |+.|||+++++|+||||+||++.   ..+.++|+|||+++.......   .....+|+.|+|||++.+..++.++
T Consensus       171 ~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  247 (333)
T 2i1m_A          171 SQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS  247 (333)
T ss_dssp             HHHHHHHHHHHHTTEECSCCSGGGCEEE---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHhcCCcccCCcccceEEEC---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHH
Confidence            998  89999999999999999999994   567899999999976543321   2334567889999999988899999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |||||
T Consensus       248 Di~sl  252 (333)
T 2i1m_A          248 DVWSY  252 (333)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99996

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=1.9e-31  Score=189.34  Aligned_cols=139  Identities=24%  Similarity=0.427  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+.+++.++||||+++++++. ++..++|+||+.+++|.+++... +.+++..+..++.++  |+.|||+++++
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  137 (325)
T 3kex_A           59 FQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV  137 (325)
T ss_dssp             BCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            356778999999999999999999986 45689999999999999999764 468888999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+||||+||++   +..+.+||+|||+++.+....   ......+++.|+|||++.+..++.++|||||
T Consensus       138 H~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  203 (325)
T 3kex_A          138 HRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSY  203 (325)
T ss_dssp             CSCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             CCccchheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHh
Confidence            99999999999   566789999999998765443   2234567789999999998899999999996

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.4e-31  Score=187.23  Aligned_cols=147  Identities=24%  Similarity=0.382  Sum_probs=121.4

Q ss_pred             cchhhHhHHHHHHHHHHHHHcC--CCcCccceeeeeeeC----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l--~h~ni~~l~~~~~~~----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i   75 (152)
                      +|.+.......+..|.+++...  +||||+++++++...    +..+++|||+++++|.++++.. .+++..+..++.++
T Consensus        65 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i  143 (337)
T 3mdy_A           65 VKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS  143 (337)
T ss_dssp             EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHH
T ss_pred             EEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHH
Confidence            5666555666667777777765  899999999999877    7899999999999999999654 68999999999998


Q ss_pred             --HHHHHHhC--------CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-----cccCCCCCCccccccccc
Q 031828           76 --GLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        76 --~l~~lh~~--------~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~  140 (152)
                        |+.|||+.        +++|+||||+||++   +..+.+||+|||+++.+.....     .....||+.|+|||++.+
T Consensus       144 ~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  220 (337)
T 3mdy_A          144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE  220 (337)
T ss_dssp             HHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence              89999998        99999999999999   5677899999999976544322     235678999999999987


Q ss_pred             CCCCcc------cceeeC
Q 031828          141 QRYDEK------VNFFVS  152 (152)
Q Consensus       141 ~~~~~~------~Dvws~  152 (152)
                      ..++..      +|||||
T Consensus       221 ~~~~~~~~~~~~~Diwsl  238 (337)
T 3mdy_A          221 SLNRNHFQSYIMADMYSF  238 (337)
T ss_dssp             CCCTTCTHHHHHHHHHHH
T ss_pred             ccCCccccCccccchHHH
Confidence            766655      999996

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=6.6e-31  Score=184.84  Aligned_cols=141  Identities=28%  Similarity=0.442  Sum_probs=122.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh---cCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+.+|+++++.++||||+++++++..++..+++||++++++|.+++..   ...+++..+..++.++  |+.+||+
T Consensus        72 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  151 (307)
T 2nru_A           72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE  151 (307)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            4567899999999999999999999999999999999999999999999873   3458999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .+++|+||||+||++   +..+.++++|||+++......   ......||+.|+|||++.+ .++.++|||||
T Consensus       152 ~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~sl  220 (307)
T 2nru_A          152 NHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSF  220 (307)
T ss_dssp             TTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHH
T ss_pred             CCeecCCCCHHHEEE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHH
Confidence            999999999999999   567789999999997654432   2234578999999999874 58899999996

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=1.9e-31  Score=184.60  Aligned_cols=141  Identities=30%  Similarity=0.486  Sum_probs=114.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCC---
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHH---   84 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~---   84 (152)
                      .+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++. .+.+++..+..++.++  |+.+||+++   
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~  128 (271)
T 3dtc_A           50 IENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVP  128 (271)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Confidence            4678899999999999999999999999999999999999999999885 4578999999999998  899999999   


Q ss_pred             CeecCCCCCceEeecCC-----CCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~-----~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++....     ....++++|||+++...... .....||+.|+|||++.+..++.++|||||
T Consensus       129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  200 (271)
T 3dtc_A          129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSY  200 (271)
T ss_dssp             CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHH
T ss_pred             eeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHH
Confidence            88999999999995321     25679999999997654432 234578999999999998889999999995

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.97  E-value=4.3e-31  Score=186.32  Aligned_cols=143  Identities=28%  Similarity=0.451  Sum_probs=115.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC-----eEEEEEeecCCCChHHHHH------hcCCCCHHHHHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIR------LHGRVPEQTARKFLQQL   75 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~~~i   75 (152)
                      ....+.+.+|+.+++.++||||+++++++...+     ..++++||+++++|.+++.      ....+++..++.++.++
T Consensus        77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi  156 (313)
T 3brb_A           77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI  156 (313)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence            344677899999999999999999999997654     3599999999999999984      23458999999999998


Q ss_pred             --HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCccccee
Q 031828           76 --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFF  150 (152)
Q Consensus        76 --~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw  150 (152)
                        |+.|||+++++|+||||+||++   +..+.+|++|||+++......   ......+++.|+|||.+.+..++.++|||
T Consensus       157 ~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  233 (313)
T 3brb_A          157 ALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW  233 (313)
T ss_dssp             HHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred             HHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence              8999999999999999999999   566789999999998664432   12334567889999999988899999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       234 sl  235 (313)
T 3brb_A          234 AF  235 (313)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.97  E-value=8.3e-32  Score=193.00  Aligned_cols=138  Identities=17%  Similarity=0.257  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHcCCCcCccc---------------eeeeeee-CCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHH
Q 031828           11 SCLDCELNFLSSVNHPNIIR---------------LFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL   72 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~---------------l~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~   72 (152)
                      +.+.+|++++++++||||++               +++++.. ++..++||||+ +++|.+++...  ..+++..+..++
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~  165 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA  165 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence            56889999999999999988               5666665 67899999999 99999999876  679999999999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCc--eEEEeeccCccccCCCC--------ccccCCCCCCccccccccc
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~  140 (152)
                      .++  |+.|||+++++|+||||+||++.   ..+  .++|+|||+++.+....        ......||+.|+|||++.+
T Consensus       166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  242 (352)
T 2jii_A          166 CRLLDALEFLHENEYVHGNVTAENIFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG  242 (352)
T ss_dssp             HHHHHHHHHHHHTTCBCSCCCGGGEEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred             HHHHHHHHHHHhCCccCCCCCHHHEEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence            998  89999999999999999999994   444  89999999997654332        1234578999999999998


Q ss_pred             CCCCcccceeeC
Q 031828          141 QRYDEKVNFFVS  152 (152)
Q Consensus       141 ~~~~~~~Dvws~  152 (152)
                      ..++.++|||||
T Consensus       243 ~~~~~~~Di~sl  254 (352)
T 2jii_A          243 CGPSRRSDLQSL  254 (352)
T ss_dssp             CCCCHHHHHHHH
T ss_pred             CCCCchhhHHHH
Confidence            899999999996

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=3.2e-31  Score=184.47  Aligned_cols=141  Identities=23%  Similarity=0.411  Sum_probs=119.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+.+++.++||||+++++++..+ ..+++||++++++|.+++.... .+++..+..++.++  |+.+||+++
T Consensus        55 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  133 (281)
T 3cc6_A           55 DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN  133 (281)
T ss_dssp             HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4568899999999999999999999998754 5689999999999999997654 58999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.   ..+.++++|||+++......  ......+++.|+|||++.+..++.++|||||
T Consensus       134 i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  200 (281)
T 3cc6_A          134 CVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMF  200 (281)
T ss_dssp             CCCCCCSGGGEEEE---ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             cccCCCccceEEEC---CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHH
Confidence            99999999999994   56689999999997654432  1233456788999999998889999999996

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=2.1e-31  Score=189.83  Aligned_cols=147  Identities=27%  Similarity=0.374  Sum_probs=125.1

Q ss_pred             cchhhHhHHHHHHHHHHHHHc--CCCcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~--l~h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i   75 (152)
                      +|.++....+.+.+|.++++.  ++||||+++++++...+    ..+++|||+++++|.+++.+ ..+++..+..++.++
T Consensus        70 vK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i  148 (342)
T 1b6c_B           70 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALST  148 (342)
T ss_dssp             EEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred             EEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHH
Confidence            677777777888899999988  79999999999998775    79999999999999999975 468999999999998


Q ss_pred             --HHHHHH--------hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCccccccccc
Q 031828           76 --GLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        76 --~l~~lh--------~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~  140 (152)
                        |+.+||        +.+++|+||||+||++   +..+.+||+|||+++......     ......||+.|+|||++.+
T Consensus       149 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  225 (342)
T 1b6c_B          149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  225 (342)
T ss_dssp             HHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred             HHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence              899999        8899999999999999   566789999999997664433     2345578999999999986


Q ss_pred             C------CCCcccceeeC
Q 031828          141 Q------RYDEKVNFFVS  152 (152)
Q Consensus       141 ~------~~~~~~Dvws~  152 (152)
                      .      .++.++|||||
T Consensus       226 ~~~~~~~~~~~~~Di~sl  243 (342)
T 1b6c_B          226 SINMKHFESFKRADIYAM  243 (342)
T ss_dssp             CCCTTCHHHHHHHHHHHH
T ss_pred             cccccccccCCcccHHHH
Confidence            5      23468999996

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=1.9e-31  Score=189.53  Aligned_cols=141  Identities=25%  Similarity=0.372  Sum_probs=115.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+.+++.++||||+++++++..++ .+++++++.+++|.+++... ..+++..+..++.++  |+.|||+++
T Consensus        59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  137 (327)
T 3lzb_A           59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  137 (327)
T ss_dssp             CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            45678999999999999999999999998765 78899999999999999764 568999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.   ..+.+||+|||+++.......   .....+|+.|+|||++.+..++.++|||||
T Consensus       138 ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  205 (327)
T 3lzb_A          138 LVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY  205 (327)
T ss_dssp             CCCSCCCGGGEEEE---ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             CcCCCCCHHHEEEc---CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHH
Confidence            99999999999994   566899999999987644322   233446778999999999999999999996

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=2.2e-31  Score=195.67  Aligned_cols=150  Identities=29%  Similarity=0.520  Sum_probs=115.1

Q ss_pred             cchhhHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCH-------HHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-------QTARKFLQ   73 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~-------~~~~~~~~   73 (152)
                      +|++.....+.+.+|+++++++ +||||+++++++..++..|++||++. ++|.+++........       ..+..++.
T Consensus        44 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~  122 (434)
T 2rio_A           44 VKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR  122 (434)
T ss_dssp             EEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHH
T ss_pred             EEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHH
Confidence            5655555567788999999886 89999999999999999999999995 699999976543222       23456788


Q ss_pred             HH--HHHHHHhCCCeecCCCCCceEeecC----------CCCceEEEeeccCccccCCCC-----ccccCCCCCCccccc
Q 031828           74 QL--GLEILNSHHIIHRDLKPENILLSGL----------DDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPE  136 (152)
Q Consensus        74 ~i--~l~~lh~~~~~h~dl~~~nil~~~~----------~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE  136 (152)
                      ++  |+.|||+++++|+||||+||++...          .....+||+|||+++......     ......||+.|+|||
T Consensus       123 qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  202 (434)
T 2rio_A          123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE  202 (434)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHH
T ss_pred             HHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence            87  8999999999999999999999632          234589999999998765432     123467999999999


Q ss_pred             cccc-------CCCCcccceeeC
Q 031828          137 VLQF-------QRYDEKVNFFVS  152 (152)
Q Consensus       137 ~~~~-------~~~~~~~Dvws~  152 (152)
                      ++.+       ..++.++|||||
T Consensus       203 ~~~~~~~~~~~~~~~~~~DiwSl  225 (434)
T 2rio_A          203 LLEESNNLQTKRRLTRSIDIFSM  225 (434)
T ss_dssp             HHSCCCTTSCCCCCCTHHHHHHH
T ss_pred             HhccccccccccCcchhhhhHhH
Confidence            9976       568999999996

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=6.9e-31  Score=190.20  Aligned_cols=137  Identities=27%  Similarity=0.495  Sum_probs=117.0

Q ss_pred             HHHHHHHHHcCCCcCccceeeeeeeC--------------------------------------CeEEEEEeecCCCChH
Q 031828           13 LDCELNFLSSVNHPNIIRLFDAFQAE--------------------------------------NCIFLVVEFCAGGNLS   54 (152)
Q Consensus        13 ~~~E~~~l~~l~h~ni~~l~~~~~~~--------------------------------------~~~~lv~e~~~~~~l~   54 (152)
                      ..+|+++++.++||||+++++++...                                      ...++||||++ ++|.
T Consensus        47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~  125 (383)
T 3eb0_A           47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH  125 (383)
T ss_dssp             CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHH
T ss_pred             HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHH
Confidence            45799999999999999999998443                                      34899999996 5776


Q ss_pred             HHHH----hcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCC
Q 031828           55 SYIR----LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG  128 (152)
Q Consensus        55 ~~~~----~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  128 (152)
                      +.+.    ....+++..+..++.++  |+.|||+.+++|+||||+||++.  ...+.+||+|||+++............+
T Consensus       126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  203 (383)
T 3eb0_A          126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYIC  203 (383)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCC
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCccc
Confidence            6664    45679999999999998  89999999999999999999994  2467899999999987766666667788


Q ss_pred             CCCcccccccccCC-CCcccceeeC
Q 031828          129 SPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus       129 t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      |+.|+|||++.+.. ++.++|||||
T Consensus       204 t~~y~aPE~~~~~~~~~~~~Diwsl  228 (383)
T 3eb0_A          204 SRFYRAPELMLGATEYTPSIDLWSI  228 (383)
T ss_dssp             CSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred             CCCccCHHHhcCCCCCCcchhhhhH
Confidence            99999999998754 8999999995

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=1.9e-31  Score=190.51  Aligned_cols=138  Identities=20%  Similarity=0.396  Sum_probs=122.7

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHH------HHh--cCCCCHHHHHHHHHHH--HHHHH
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY------IRL--HGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~------~~~--~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      +.+.+|+++++.++||||+++++++..++..++||||+++++|.++      +..  ...+++..+..++.++  |+.+|
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999999999998      655  5669999999999998  89999


Q ss_pred             Hh-CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC-CCCc-ccceeeC
Q 031828           81 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDE-KVNFFVS  152 (152)
Q Consensus        81 h~-~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~-~~Dvws~  152 (152)
                      |+ .+++|+||+|+||++   +..+.++++|||.++..... ......+++.|+|||++.+. .++. ++|||||
T Consensus       168 H~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  238 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL  238 (348)
T ss_dssp             HHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHH
T ss_pred             hccCCEeecCCChHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHH
Confidence            99 999999999999999   56778999999999765443 34556789999999999987 5666 9999995

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.97  E-value=7.5e-31  Score=187.83  Aligned_cols=139  Identities=26%  Similarity=0.474  Sum_probs=117.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeee--------CCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHH
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~--------~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~   78 (152)
                      ...+.+|+.+++.++||||+++++++..        .+..++||||++ +++.+.+... ..+++..+..++.++  |+.
T Consensus        60 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~  138 (351)
T 3mi9_A           60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY  138 (351)
T ss_dssp             CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999977        346899999996 5777766543 569999999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-----CccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |||+++++|+||||+||++   +..+.+||+|||+++.+...     .......||+.|+|||++.+. .++.++|||||
T Consensus       139 ~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  215 (351)
T 3mi9_A          139 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA  215 (351)
T ss_dssp             HHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred             HHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence            9999999999999999999   56778999999999875422     223456789999999999764 58999999996

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=8.8e-32  Score=202.32  Aligned_cols=139  Identities=20%  Similarity=0.393  Sum_probs=120.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.|.+|+++|+.++|+||+++++++.. +..|+||||+.+++|.+++...  ..+++..+..++.++  ||.|||++++
T Consensus       306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  384 (535)
T 2h8h_A          306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  384 (535)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            5679999999999999999999999876 6789999999999999999743  458999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +....+||+|||+++.+....  ......++..|+|||++.+..++.++|||||
T Consensus       385 vHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSl  450 (535)
T 2h8h_A          385 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  450 (535)
T ss_dssp             CCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             eCCCCCHhhEEE---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHH
Confidence            999999999999   466789999999998654322  1223445778999999998899999999996

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=3.9e-31  Score=189.96  Aligned_cols=140  Identities=28%  Similarity=0.450  Sum_probs=110.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeee-----CCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ..+.+.+|++++++++||||+++++++..     ....|+||||+. ++|.+.+... ..+++..+..++.++  |+.||
T Consensus        72 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  150 (362)
T 3pg1_A           72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL  150 (362)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            34789999999999999999999999843     346899999996 6888877654 368999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+++++|+||||+||++   +..+.+||+|||+++............+|+.|+|||++.+ ..++.++|||||
T Consensus       151 H~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  220 (362)
T 3pg1_A          151 HEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSA  220 (362)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHH
T ss_pred             HHCcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhH
Confidence            99999999999999999   5667899999999986555555556778999999999987 668999999995

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.6e-31  Score=184.24  Aligned_cols=142  Identities=25%  Similarity=0.472  Sum_probs=122.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++++.++||||+++++++ ..+..+++||++++++|.+++... ..+++..+..++.++  |+.+||+.
T Consensus        51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  129 (287)
T 1u59_A           51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK  129 (287)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34577899999999999999999999999 456799999999999999998644 458999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++.   ..+.++|+|||+++.......    .....+|+.|+|||++.+..++.++|||||
T Consensus       130 ~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  199 (287)
T 1u59_A          130 NFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY  199 (287)
T ss_dssp             TEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred             CEeeCCCchheEEEc---CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHH
Confidence            999999999999994   566899999999987644322    223456788999999998889999999996

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=2.1e-31  Score=185.18  Aligned_cols=140  Identities=24%  Similarity=0.483  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|+++++.++||||+++++++. ++..+++||++++++|.+++....  .+++..+..++.++  |+.+||+++
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  129 (279)
T 1qpc_A           51 SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN  129 (279)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3578899999999999999999999986 456899999999999999986543  68999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.++++|||+++.......  .....+++.|+|||++.+..++.++|||||
T Consensus       130 i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  196 (279)
T 1qpc_A          130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  196 (279)
T ss_dssp             EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred             eeccCCCHhhEEE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHH
Confidence            9999999999999   5677899999999987654432  233456788999999998889999999996

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.97  E-value=3.3e-31  Score=185.20  Aligned_cols=142  Identities=27%  Similarity=0.455  Sum_probs=110.8

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++++.++||||++++++. ..+..+++|||+.+++|.+++.. ...+++..+..++.++  |+.+||+.
T Consensus        61 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~  139 (289)
T 3og7_A           61 PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK  139 (289)
T ss_dssp             HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            45568899999999999999999999965 45668999999999999999854 3458999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC---CccccCCCCCCcccccccc---cCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++.   ..+.++|+|||+++.....   .......||+.|+|||++.   ...++.++|||||
T Consensus       140 ~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl  211 (289)
T 3og7_A          140 SIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF  211 (289)
T ss_dssp             TCCCSCCCGGGEEEE---TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHH
T ss_pred             CcccccCccceEEEC---CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHH
Confidence            999999999999994   5678999999999765332   2234567899999999997   5568889999996

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=5.5e-31  Score=191.47  Aligned_cols=136  Identities=29%  Similarity=0.475  Sum_probs=114.3

Q ss_pred             HHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHH--HHHHHH
Q 031828           14 DCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus        14 ~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      .+|+++++.++||||+++++++...+      ..++||||++++ +...+.    ....+++..+..++.++  |+.|||
T Consensus        80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH  158 (394)
T 4e7w_A           80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH  158 (394)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            47999999999999999999985443      388999999654 433332    35679999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++.  ...+.+||+|||+++............+|+.|+|||++.+. .++.++|||||
T Consensus       159 ~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  228 (394)
T 4e7w_A          159 SIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWST  228 (394)
T ss_dssp             HTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence            99999999999999994  25678999999999887666556677889999999999765 48999999995

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.97  E-value=1.3e-30  Score=182.58  Aligned_cols=142  Identities=30%  Similarity=0.573  Sum_probs=115.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeee-------------CCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-------------ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQ   73 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-------------~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~   73 (152)
                      ...+.+.+|+.+++.++||||+++++++..             .+..+++|||+++++|.+++.... .+++..+..++.
T Consensus        44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~  123 (303)
T 1zy4_A           44 EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR  123 (303)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHH
Confidence            446788999999999999999999998854             356899999999999999998544 478888889999


Q ss_pred             HH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC---------------CccccCCCCCCccccc
Q 031828           74 QL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMAPE  136 (152)
Q Consensus        74 ~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~t~~y~aPE  136 (152)
                      ++  |+.+||+++++|+||||+||++   +..+.++++|||+++.....               .......||+.|+|||
T Consensus       124 qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  200 (303)
T 1zy4_A          124 QILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE  200 (303)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCHH
T ss_pred             HHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcc
Confidence            98  8999999999999999999999   56778999999999765321               1223456899999999


Q ss_pred             ccccC-CCCcccceeeC
Q 031828          137 VLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus       137 ~~~~~-~~~~~~Dvws~  152 (152)
                      ++.+. .++.++|||||
T Consensus       201 ~~~~~~~~~~~~Di~sl  217 (303)
T 1zy4_A          201 VLDGTGHYNEKIDMYSL  217 (303)
T ss_dssp             HHTSCSCCCTHHHHHHH
T ss_pred             cccCCCCCcchhhHHHH
Confidence            99865 58999999995

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=4.6e-31  Score=188.80  Aligned_cols=138  Identities=35%  Similarity=0.539  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      +.+.+|+++++.++||||+++++++..++..++||||++ ++|.+++.... .+++..+..++.++  |+.|||+++++|
T Consensus        57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  135 (346)
T 1ua2_A           57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  135 (346)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS-EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC-CCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Confidence            467899999999999999999999999999999999996 48888886543 58888899999998  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      +||||+||++   +..+.+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||
T Consensus       136 ~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  199 (346)
T 1ua2_A          136 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAV  199 (346)
T ss_dssp             CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred             CCCCHHHEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhH
Confidence            9999999999   566789999999998764433 34556789999999999764 48899999996

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=1.2e-31  Score=188.03  Aligned_cols=141  Identities=35%  Similarity=0.594  Sum_probs=111.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh--------cCCCCHHHHHHHHHHH--HHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ..+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++..        ...+++..+..++.++  |+.
T Consensus        56 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  135 (303)
T 2vwi_A           56 SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE  135 (303)
T ss_dssp             ----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHH
Confidence            456788999999999999999999999999999999999999999999874        3458999999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC------ccccCCCCCCccccccccc-CCCCcccceee
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFV  151 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws  151 (152)
                      +||+++++|+||+|+||++   +..+.++++|||++.......      ......||+.|+|||++.+ ..++.++||||
T Consensus       136 ~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s  212 (303)
T 2vwi_A          136 YLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS  212 (303)
T ss_dssp             HHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHH
T ss_pred             HHHhCCCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHH
Confidence            9999999999999999999   566789999999987654322      1234578999999999976 46899999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       213 l  213 (303)
T 2vwi_A          213 F  213 (303)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=2e-31  Score=187.92  Aligned_cols=142  Identities=31%  Similarity=0.483  Sum_probs=122.0

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeCC-eEEEEEeecCCCChHHHHHhcCC----------------CCHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR----------------VPEQTAR   69 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~~~----------------~~~~~~~   69 (152)
                      ...+.+.+|+.+++.+ +||||+++++++..++ ..+++|||+++++|.+++.....                +++..+.
T Consensus        72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (316)
T 2xir_A           72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  151 (316)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred             HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence            4456789999999999 7999999999987764 58999999999999999986554                7888999


Q ss_pred             HHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCC
Q 031828           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD  144 (152)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~  144 (152)
                      .++.++  |+.+||+++++|+||||+||++   +..+.+|++|||+++.......   .....+|+.|+|||++.+..++
T Consensus       152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (316)
T 2xir_A          152 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  228 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc
Confidence            999998  8999999999999999999999   4667899999999986544321   2344568899999999988999


Q ss_pred             cccceeeC
Q 031828          145 EKVNFFVS  152 (152)
Q Consensus       145 ~~~Dvws~  152 (152)
                      .++|||||
T Consensus       229 ~~~Di~sl  236 (316)
T 2xir_A          229 IQSDVWSF  236 (316)
T ss_dssp             HHHHHHHH
T ss_pred             chhHHHHH
Confidence            99999996

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=1.9e-31  Score=189.65  Aligned_cols=147  Identities=29%  Similarity=0.416  Sum_probs=116.8

Q ss_pred             cchhhHhHHHHHHHHHHHHH--cCCCcCccceeeeee-----eCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLS--SVNHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ   74 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~--~l~h~ni~~l~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~   74 (152)
                      +|+++....+.+..|.+++.  .++||||+++++.+.     ....+++||||+++++|.+++.... .++..+..++.+
T Consensus        41 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~q  119 (336)
T 3g2f_A           41 VKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHS  119 (336)
T ss_dssp             EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHH
T ss_pred             EEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHH
Confidence            56666555566666666654  489999999997543     2346799999999999999997654 488888889999


Q ss_pred             H--HHHHHHhC---------CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---------ccccCCCCCCccc
Q 031828           75 L--GLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMA  134 (152)
Q Consensus        75 i--~l~~lh~~---------~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~t~~y~a  134 (152)
                      +  |+.|||+.         +++|+||||+||++   +..+.+||+|||+++.+....         ......||+.|+|
T Consensus       120 i~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  196 (336)
T 3g2f_A          120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA  196 (336)
T ss_dssp             HHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCC
T ss_pred             HHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeC
Confidence            8  89999999         99999999999999   566789999999998664321         2234578999999


Q ss_pred             cccccc-------CCCCcccceeeC
Q 031828          135 PEVLQF-------QRYDEKVNFFVS  152 (152)
Q Consensus       135 PE~~~~-------~~~~~~~Dvws~  152 (152)
                      ||++.+       ..++.++|||||
T Consensus       197 PE~~~~~~~~~~~~~~~~~~Diwsl  221 (336)
T 3g2f_A          197 PEVLEGAVNLRDXESALKQVDMYAL  221 (336)
T ss_dssp             HHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred             chhhcCCcccccccccccccchHHH
Confidence            999986       456788999996

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=8.5e-31  Score=199.92  Aligned_cols=147  Identities=29%  Similarity=0.559  Sum_probs=128.7

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee------CCeEEEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHH-
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL-   75 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i-   75 (152)
                      +....+.+.+|+++++.++||||+++++++..      ++..++||||+++++|.+++....   .+++..+..++.++ 
T Consensus        52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl  131 (676)
T 3qa8_A           52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS  131 (676)
T ss_dssp             CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH
Confidence            44567889999999999999999999998765      667899999999999999998654   48888899999998 


Q ss_pred             -HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 -~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                       |+.|||+.+++|+||||+||++...+....++++|||+++............||+.|+|||++.+..++.++|||||
T Consensus       132 ~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSL  209 (676)
T 3qa8_A          132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF  209 (676)
T ss_dssp             HHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHH
T ss_pred             HHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHH
Confidence             89999999999999999999997544455699999999987766655566789999999999999899999999995

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.97  E-value=4.4e-31  Score=190.47  Aligned_cols=138  Identities=30%  Similarity=0.530  Sum_probs=106.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      ...+.+.+|+.+++.++||||+++++++...      +..|+++|++ +++|.+++.. ..+++..+..++.++  |+.|
T Consensus        70 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~  147 (367)
T 2fst_X           70 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKY  147 (367)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4567788999999999999999999998654      5679999998 7899988865 568999999999998  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      ||+.|++|+||||+||++   +..+.+||+|||+++....  ......+|++|+|||++.+ ..++.++|||||
T Consensus       148 LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  216 (367)
T 2fst_X          148 IHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  216 (367)
T ss_dssp             HHHTTCCCCCCCGGGEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHH
T ss_pred             HHHCCeeeCCCCHhhEEE---CCCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHH
Confidence            999999999999999999   5677899999999976433  2345678999999999987 578999999995

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.97  E-value=4.6e-31  Score=187.33  Aligned_cols=143  Identities=26%  Similarity=0.433  Sum_probs=121.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC--eEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ....+.+.+|+++++.++||||+++++++...+  ..++|||++++++|.+++.... .+++..+..++.++  |+.+||
T Consensus        83 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH  162 (326)
T 2w1i_A           83 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG  162 (326)
T ss_dssp             SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999999987654  6899999999999999998754 58999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++|+||||+||++.   ..+.++|+|||+++.......    .....++..|+|||++.+..++.++|||||
T Consensus       163 ~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  234 (326)
T 2w1i_A          163 TKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF  234 (326)
T ss_dssp             HTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             hCCEeccCCCcceEEEc---CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence            99999999999999994   566899999999987654422    223456778999999998889999999996

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=1.6e-31  Score=185.60  Aligned_cols=144  Identities=33%  Similarity=0.645  Sum_probs=120.8

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeee--eCCeEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHH--HH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQL--GL   77 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~--~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i--~l   77 (152)
                      +...++.+.+|+++++.++||||+++++++.  .++..+++|||+++++|.+++...    ..+++..++.++.++  |+
T Consensus        45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l  124 (279)
T 2w5a_A           45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  124 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999874  457899999999999999998653    238999999999998  89


Q ss_pred             HHHHhCC-----CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceee
Q 031828           78 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        78 ~~lh~~~-----~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                      .+||+.+     ++|+||+|+||++   +..+.+|++|||+++...... ......+++.|+|||++.+..++.++||||
T Consensus       125 ~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  201 (279)
T 2w5a_A          125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS  201 (279)
T ss_dssp             HHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred             HHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHH
Confidence            9999999     9999999999999   566789999999997654432 223456899999999999888999999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       202 l  202 (279)
T 2w5a_A          202 L  202 (279)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=8.8e-31  Score=184.63  Aligned_cols=145  Identities=36%  Similarity=0.578  Sum_probs=115.0

Q ss_pred             cchhh-HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCC---CCHHHHHHHHHHH--
Q 031828            2 LKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQL--   75 (152)
Q Consensus         2 ~k~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i--   75 (152)
                      +|.+. ....+.+.+|++++++++||||+++++++.+  ..++||||+++++|.+++.....   ++...+..++.++  
T Consensus        36 vK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~  113 (307)
T 2eva_A           36 IKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ  113 (307)
T ss_dssp             EEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHH
T ss_pred             EEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHH
Confidence            34443 3456789999999999999999999999874  47899999999999999986553   6788888898888  


Q ss_pred             HHHHHHh---CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNS---HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~---~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|||+   ++++|+||||+||++.  .....+|++|||++......  .....||+.|+|||++.+..++.++|||||
T Consensus       114 ~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  189 (307)
T 2eva_A          114 GVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSW  189 (307)
T ss_dssp             HHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHH
T ss_pred             HHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHH
Confidence            8999999   8999999999999995  22335899999999754332  234568999999999998889999999996

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=8.2e-31  Score=200.95  Aligned_cols=142  Identities=27%  Similarity=0.499  Sum_probs=119.5

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...++.+.+|+.+++.++||||+++++++. ++..|+||||+++++|.+++...+ .+++..+..++.++  |+.|||++
T Consensus       432 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  510 (656)
T 2j0j_A          432 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK  510 (656)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345678999999999999999999999985 466899999999999999997654 58999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++.   ..+.+||+|||+++.......  .....+|+.|+|||++.+..++.++|||||
T Consensus       511 givHrDikp~NILl~---~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  578 (656)
T 2j0j_A          511 RFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF  578 (656)
T ss_dssp             TCCCSCCSGGGEEEE---ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             CccccccchHhEEEe---CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHH
Confidence            999999999999994   567899999999987644332  223456788999999998899999999996

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.97  E-value=8.3e-31  Score=185.06  Aligned_cols=144  Identities=26%  Similarity=0.330  Sum_probs=120.6

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--   75 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--   75 (152)
                      +....+.+.+|+++++.++||||+++++++..    .+..++++||+.+++|.+++..    ...+++..+..++.++  
T Consensus        66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~  145 (317)
T 2buj_A           66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR  145 (317)
T ss_dssp             SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence            34567889999999999999999999999863    3478999999999999999875    4568999999999998  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----------cccCCCCCCcccccccccCC---
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----------AEKVCGSPLYMAPEVLQFQR---  142 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~---  142 (152)
                      |+.+||+++++|+||||+||++   +..+.++++|||+++.......          .....||+.|+|||++....   
T Consensus       146 ~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  222 (317)
T 2buj_A          146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV  222 (317)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred             HHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence            8999999999999999999999   5667899999999876432110          12345789999999997554   


Q ss_pred             CCcccceeeC
Q 031828          143 YDEKVNFFVS  152 (152)
Q Consensus       143 ~~~~~Dvws~  152 (152)
                      ++.++|||||
T Consensus       223 ~~~~~Di~sl  232 (317)
T 2buj_A          223 IDERTDVWSL  232 (317)
T ss_dssp             ECTHHHHHHH
T ss_pred             CCchhhHHHH
Confidence            6899999996

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=5.3e-32  Score=195.68  Aligned_cols=138  Identities=13%  Similarity=0.136  Sum_probs=113.7

Q ss_pred             hHHHHHHHHH---HHHHcCCCcCcccee-------eeeeeCC-----------------eEEEEEeecCCCChHHHHHhc
Q 031828            8 HLKSCLDCEL---NFLSSVNHPNIIRLF-------DAFQAEN-----------------CIFLVVEFCAGGNLSSYIRLH   60 (152)
Q Consensus         8 ~~~~~~~~E~---~~l~~l~h~ni~~l~-------~~~~~~~-----------------~~~lv~e~~~~~~l~~~~~~~   60 (152)
                      ...+.+.+|+   ++++.++||||++++       +++..++                 ..|++|||+ +|+|.+++...
T Consensus       115 ~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~  193 (377)
T 3byv_A          115 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL  193 (377)
T ss_dssp             THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc
Confidence            4568899999   556666899999998       5555443                 278999999 68999999865


Q ss_pred             CCCCH-------HHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCC
Q 031828           61 GRVPE-------QTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL  131 (152)
Q Consensus        61 ~~~~~-------~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~  131 (152)
                      +.+++       ..+..++.++  |+.|||+++++|+||||+||++   +..+.+||+|||+++...  ......+| +.
T Consensus       194 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~  267 (377)
T 3byv_A          194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RG  267 (377)
T ss_dssp             HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TT
T ss_pred             cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cC
Confidence            55554       7777888888  8999999999999999999999   566789999999997532  23445677 99


Q ss_pred             cccccccccC-----------CCCcccceeeC
Q 031828          132 YMAPEVLQFQ-----------RYDEKVNFFVS  152 (152)
Q Consensus       132 y~aPE~~~~~-----------~~~~~~Dvws~  152 (152)
                      |+|||++.+.           .++.++|||||
T Consensus       268 y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          268 FEPPELEARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             CCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             ccChhhhcccccccccccccccCChhhhHHHH
Confidence            9999999987           79999999996

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=1.8e-31  Score=185.48  Aligned_cols=146  Identities=25%  Similarity=0.471  Sum_probs=115.6

Q ss_pred             cchhhH-hHHHHHHHHHHHHHcCCCcCccceeeeeeeC-CeEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHH--
Q 031828            2 LKKLNK-HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQL--   75 (152)
Q Consensus         2 ~k~~~~-~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i--   75 (152)
                      +|.++. ...+.+.+|+++++.++||||+++++++... +..+++||++++++|.+++...+.  +++..+..++.++  
T Consensus        49 vK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~  128 (278)
T 1byg_A           49 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE  128 (278)
T ss_dssp             EEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHH
Confidence            344432 3467789999999999999999999987554 578999999999999999976543  7888899999998  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.+||+++++|+||||+||++   +..+.++++|||+++.....  .....+++.|+|||++.+..++.++|||||
T Consensus       129 ~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  200 (278)
T 1byg_A          129 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF  200 (278)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHH
Confidence            8999999999999999999999   56678999999998754332  233457889999999998889999999996

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.97  E-value=1.7e-30  Score=190.29  Aligned_cols=137  Identities=28%  Similarity=0.461  Sum_probs=114.1

Q ss_pred             HHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHH--HHHHH
Q 031828           13 LDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus        13 ~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ..+|+++++.++||||+++++++...      ...++||||++ +++.+.+.    ....+++..+..++.++  ||.||
T Consensus        94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L  172 (420)
T 1j1b_A           94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI  172 (420)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            45799999999999999999988532      24679999996 46666554    34669999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+++++|+||||+||++.  .....+||+|||+++.+..........+|+.|+|||++.+. .++.++|||||
T Consensus       173 H~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  243 (420)
T 1j1b_A          173 HSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSA  243 (420)
T ss_dssp             HTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHH
Confidence            999999999999999994  23457899999999877655555667889999999999765 68999999996

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=8.9e-31  Score=183.08  Aligned_cols=143  Identities=31%  Similarity=0.501  Sum_probs=120.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHH--HHHHHHh
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+.+|+.+++.++||||+++++++...+..+++||++++++|.+++....   .+++..+..++.++  |+.+||+
T Consensus        61 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  140 (295)
T 2clq_A           61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD  140 (295)
T ss_dssp             ---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh
Confidence            446788999999999999999999999999999999999999999999997653   35688888888888  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC--CCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~  152 (152)
                      .+++|+||+|+||++.  ...+.++|+|||+++...... ......|++.|+|||++.+..  ++.++|||||
T Consensus       141 ~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  211 (295)
T 2clq_A          141 NQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL  211 (295)
T ss_dssp             TTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHH
T ss_pred             CCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHH
Confidence            9999999999999995  236789999999998764432 234567899999999997654  7899999996

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.97  E-value=1.5e-30  Score=187.25  Aligned_cols=140  Identities=27%  Similarity=0.489  Sum_probs=118.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ...+.+.+|+++++.++||||+++++++...     ...++++|++. ++|.+++.. +.+++..+..++.++  |+.||
T Consensus        67 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~L  144 (364)
T 3qyz_A           67 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYI  144 (364)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHH
Confidence            4457788999999999999999999999655     36899999995 699998865 468999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      |+++++|+||||+||++   +..+.+||+|||+++......    .....+||+.|+|||++.+ ..++.++|||||
T Consensus       145 H~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  218 (364)
T 3qyz_A          145 HSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV  218 (364)
T ss_dssp             HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHH
T ss_pred             HHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHH
Confidence            99999999999999999   567789999999998654332    1245578999999998765 448999999995

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=3.8e-31  Score=185.58  Aligned_cols=142  Identities=29%  Similarity=0.541  Sum_probs=118.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+++++.++||||+++++++..++..+++||++++++|.+++.. ...+++..+..++.++  |+.+||+.+
T Consensus        58 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  137 (302)
T 2j7t_A           58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR  137 (302)
T ss_dssp             CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            3457888999999999999999999999999999999999999999998865 4569999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.++++|||++...... .......||+.|+|||++.     ...++.++|||||
T Consensus       138 i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl  208 (302)
T 2j7t_A          138 IIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL  208 (302)
T ss_dssp             CCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred             cccCCCCHHHEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence            9999999999999   56678999999987543211 1233457899999999983     5668899999996

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=3.9e-30  Score=179.36  Aligned_cols=138  Identities=30%  Similarity=0.501  Sum_probs=115.5

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC--C
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH--I   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~--~   85 (152)
                      +.+.+|+++++.++||||+++++++....  +++|||+++++|.+.+... ..+++..+..++.++  |+.|||+++  +
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i  145 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI  145 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence            67899999999999999999999997665  6999999999998888654 468999999999998  899999999  9


Q ss_pred             eecCCCCCceEeecCC--CCceEEEeeccCccccCCCCccccCCCCCCcccccccc--cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++...+  ....+|++|||+++....  ......||+.|+|||++.  ...++.++|||||
T Consensus       146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~sl  214 (287)
T 4f0f_A          146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSF  214 (287)
T ss_dssp             BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHH
T ss_pred             ecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHH
Confidence            9999999999994321  112399999999975333  344567899999999994  4457899999995

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=1e-30  Score=185.51  Aligned_cols=137  Identities=28%  Similarity=0.489  Sum_probs=113.3

Q ss_pred             HHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCeec
Q 031828           12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHIIHR   88 (152)
Q Consensus        12 ~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~h~   88 (152)
                      .+.+|+++++.++||||+++++++..++..++||||++ ++|.+++...+ .+++..+..++.++  |+.|||+.+++|+
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  124 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHR  124 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            44579999999999999999999999999999999996 68988887654 48999999999998  8999999999999


Q ss_pred             CCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           89 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        89 dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      ||||+||++   +..+.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||
T Consensus       125 Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  187 (324)
T 3mtl_A          125 DLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV  187 (324)
T ss_dssp             SCCGGGEEE---CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CcCHHHEEE---CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHH
Confidence            999999999   566789999999997654332 3345578999999999986 558999999995

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=1.3e-30  Score=182.27  Aligned_cols=143  Identities=18%  Similarity=0.219  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeee-eeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~-~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+.+|+.+++.++|++++..+.. ....+..+++|||+ +++|.+++.. ...+++..+..++.++  |+.|||+++
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  125 (296)
T 3uzp_A           47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN  125 (296)
T ss_dssp             SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34678999999999998876655544 46677889999999 9999999974 4569999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--------cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||+++..+..+.+||+|||+++.......        .....||+.|+|||++.+..++.++|||||
T Consensus       126 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  201 (296)
T 3uzp_A          126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL  201 (296)
T ss_dssp             EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHH
Confidence            99999999999995334567899999999987654322        245678999999999999899999999996

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=1.9e-30  Score=190.47  Aligned_cols=139  Identities=31%  Similarity=0.452  Sum_probs=119.2

Q ss_pred             hHHHHHHHHHHHHHcC------CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HH
Q 031828            8 HLKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GL   77 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l------~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l   77 (152)
                      ...+.+.+|+.+++.+      +|+||+++++++...+..+++||++ +++|.+++....  .+++..+..++.++  |+
T Consensus       135 ~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL  213 (429)
T 3kvw_A          135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL  213 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            3456788899988887      5679999999999999999999999 579999987654  48999999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCCCc--eEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .|||+.+++|+||||+||++.   ..+  .+||+|||+++....  ...+.++|+.|+|||++.+..++.++|||||
T Consensus       214 ~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  285 (429)
T 3kvw_A          214 DALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSL  285 (429)
T ss_dssp             HHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHH
T ss_pred             HHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhH
Confidence            999999999999999999994   333  399999999965432  3445688999999999999899999999996

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=9.7e-31  Score=182.58  Aligned_cols=141  Identities=28%  Similarity=0.420  Sum_probs=119.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.+.+|+++++.++||||+++++++..++ .++++|++++++|.+++... ..+++..+..++.++  |+.+||+++
T Consensus        63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  141 (291)
T 1u46_A           63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR  141 (291)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34678899999999999999999999998765 88999999999999999764 568999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++.   ..+.++++|||+++.......    .....+|+.|+|||++.+..++.++|||||
T Consensus       142 i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  210 (291)
T 1u46_A          142 FIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF  210 (291)
T ss_dssp             EECSCCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             cccCCCchheEEEc---CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHH
Confidence            99999999999994   566899999999987654332    223456778999999998889999999996

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.97  E-value=1.2e-30  Score=180.19  Aligned_cols=139  Identities=20%  Similarity=0.312  Sum_probs=119.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....+.+.+|+.+++.++||||+++++++..+  +..+++|||+++++|.+++....  .+++..+..++.++  |+.||
T Consensus        48 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  127 (271)
T 3kmu_A           48 TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL  127 (271)
T ss_dssp             HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            45567899999999999999999999999877  78899999999999999998765  48999999999998  89999


Q ss_pred             HhCC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCc---ccceeeC
Q 031828           81 NSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE---KVNFFVS  152 (152)
Q Consensus        81 h~~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~Dvws~  152 (152)
                      |+++  ++|+||||+||++   +..+.+++.|||++....    .....+|+.|+|||++.+..++.   ++|||||
T Consensus       128 H~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~sl  197 (271)
T 3kmu_A          128 HTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF  197 (271)
T ss_dssp             TTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHH
T ss_pred             hcCCCceecCCCccceEEE---cCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHH
Confidence            9999  9999999999999   566678888888764322    23456799999999998766554   7999996

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=3.3e-30  Score=179.82  Aligned_cols=139  Identities=27%  Similarity=0.413  Sum_probs=106.3

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      .+.+..+...++.++||||+++++++..++..+++|||++ ++|.+++..    ...+++..+..++.++  |+.|||++
T Consensus        50 ~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  128 (290)
T 3fme_A           50 KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK  128 (290)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence            4445556666888999999999999999999999999996 588777653    4679999999999998  89999998


Q ss_pred             -CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccc----ccCCCCcccceeeC
Q 031828           84 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVNFFVS  152 (152)
Q Consensus        84 -~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Dvws~  152 (152)
                       +++|+||||+||++   +..+.+||+|||+++............||+.|+|||++    ....++.++|||||
T Consensus       129 ~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~sl  199 (290)
T 3fme_A          129 LSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL  199 (290)
T ss_dssp             SCCCCCCCSGGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHH
T ss_pred             CCeecCCCCHHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHH
Confidence             99999999999999   56678999999999876655555566799999999996    45568999999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=1.2e-30  Score=200.84  Aligned_cols=135  Identities=26%  Similarity=0.469  Sum_probs=114.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCe-----EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~-----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ...+.+.+|++++++++||||+++++++...+.     .|+||||+++++|.+++..  .+++..+..++.++  |+.||
T Consensus       121 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~l  198 (681)
T 2pzi_A          121 EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYL  198 (681)
T ss_dssp             HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHH
Confidence            456778999999999999999999999987654     7999999999999988754  68999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+++++|+||||+||++.   . ..+||+|||+++.....   ....||+.|+|||++.+. ++.++|||||
T Consensus       199 H~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~sl  262 (681)
T 2pzi_A          199 HSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTV  262 (681)
T ss_dssp             HHTTEECCCCSGGGEEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHH
T ss_pred             HHCCCeecccChHHeEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhh
Confidence            999999999999999994   2 37999999999875443   456799999999999764 4889999996

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.97  E-value=2.2e-30  Score=183.85  Aligned_cols=142  Identities=27%  Similarity=0.477  Sum_probs=105.7

Q ss_pred             HhHHHHHHHHHHHHHcCC-CcCccceeeeee--------eCCeEEEEEeecCCCChHHHHHh---cCCCCHHHHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQQ   74 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~--------~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~   74 (152)
                      ....+.+.+|+.+++++. ||||+++++++.        ....+++++||+ +++|.+++..   .+.+++..+..++.+
T Consensus        66 ~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~q  144 (337)
T 3ll6_A           66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQ  144 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHH
Confidence            345677899999999996 999999999983        345689999999 5799888864   456999999999999


Q ss_pred             H--HHHHHHhCC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc-------------cccCCCCCCcccccc
Q 031828           75 L--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------------AEKVCGSPLYMAPEV  137 (152)
Q Consensus        75 i--~l~~lh~~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~t~~y~aPE~  137 (152)
                      +  |+.|||+++  ++|+||||+||++   +..+.+||+|||+++.......             .....+|+.|+|||+
T Consensus       145 i~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~  221 (337)
T 3ll6_A          145 TCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEI  221 (337)
T ss_dssp             HHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC-----------------------------
T ss_pred             HHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhh
Confidence            8  899999999  9999999999999   5667899999999986544321             124568999999999


Q ss_pred             c---ccCCCCcccceeeC
Q 031828          138 L---QFQRYDEKVNFFVS  152 (152)
Q Consensus       138 ~---~~~~~~~~~Dvws~  152 (152)
                      +   .+..++.++|||||
T Consensus       222 ~~~~~~~~~~~~~Dv~sl  239 (337)
T 3ll6_A          222 IDLYSNFPIGEKQDIWAL  239 (337)
T ss_dssp             --CCTTSCSSHHHHHHHH
T ss_pred             hhccccCCCChHHhHHHH
Confidence            8   45668899999996

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=5.7e-30  Score=181.74  Aligned_cols=142  Identities=24%  Similarity=0.390  Sum_probs=121.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcC------ccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HH
Q 031828            8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GL   77 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~n------i~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l   77 (152)
                      ...+.+.+|+++++.++|++      ++++++++..++..++|||++ +++|.+++...+  .+++..+..++.++  |+
T Consensus        53 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l  131 (339)
T 1z57_A           53 RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV  131 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence            44678899999999987665      999999999999999999999 899999998765  58899999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecCCC----------------CceEEEeeccCccccCCCCccccCCCCCCcccccccccC
Q 031828           78 EILNSHHIIHRDLKPENILLSGLDD----------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  141 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~~~----------------~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  141 (152)
                      .|||+++++|+||||+||++...+.                ...+|++|||+++....  ......||+.|+|||++.+.
T Consensus       132 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~  209 (339)
T 1z57_A          132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL  209 (339)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS
T ss_pred             HHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC
Confidence            9999999999999999999953211                45799999999976433  23456789999999999998


Q ss_pred             CCCcccceeeC
Q 031828          142 RYDEKVNFFVS  152 (152)
Q Consensus       142 ~~~~~~Dvws~  152 (152)
                      .++.++|||||
T Consensus       210 ~~~~~~Di~sl  220 (339)
T 1z57_A          210 GWSQPCDVWSI  220 (339)
T ss_dssp             CCCTHHHHHHH
T ss_pred             CCCcchhhHHH
Confidence            99999999996

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=5.5e-30  Score=181.37  Aligned_cols=138  Identities=36%  Similarity=0.554  Sum_probs=118.9

Q ss_pred             HHHHHHHHHHHcC---CCcCccceeeeee-----eCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHH
Q 031828           11 SCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLE   78 (152)
Q Consensus        11 ~~~~~E~~~l~~l---~h~ni~~l~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~   78 (152)
                      ..+.+|+.+++.+   +||||+++++++.     ..+..++++|++. ++|.+++....  .+++..+..++.++  |+.
T Consensus        56 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~  134 (326)
T 1blx_A           56 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD  134 (326)
T ss_dssp             CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence            4566788877766   8999999999987     4567899999996 69999997654  38999999999998  899


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||+.|++|+||||+||++   +..+.++|+|||+++............+|+.|+|||++.+..++.++|||||
T Consensus       135 ~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  205 (326)
T 1blx_A          135 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSV  205 (326)
T ss_dssp             HHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHHHCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHH
Confidence            9999999999999999999   5667899999999987654444556778999999999998889999999996

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.96  E-value=5e-30  Score=181.69  Aligned_cols=142  Identities=31%  Similarity=0.581  Sum_probs=114.8

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeee------CCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--H
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--G   76 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~   76 (152)
                      ...+.+.+|+.+++.+ +||||+++++++..      .+..+++|||+++++|.+++...  ..+++..+..++.++  |
T Consensus        62 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~  141 (326)
T 2x7f_A           62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG  141 (326)
T ss_dssp             STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence            3457889999999998 89999999999976      46799999999999999999764  468999999999998  8


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccc-----cCCCCccccee
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFF  150 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvw  150 (152)
                      +.+||+.+++|+||+|+||++   +..+.++|+|||++...... .......||+.|+|||++.     ...++.++|||
T Consensus       142 l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~  218 (326)
T 2x7f_A          142 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW  218 (326)
T ss_dssp             HHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred             HHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHH
Confidence            999999999999999999999   56778999999998765433 2234567899999999997     45688999999


Q ss_pred             eC
Q 031828          151 VS  152 (152)
Q Consensus       151 s~  152 (152)
                      ||
T Consensus       219 sl  220 (326)
T 2x7f_A          219 SL  220 (326)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=2.1e-30  Score=185.85  Aligned_cols=140  Identities=29%  Similarity=0.423  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCC-------eEEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHH--H
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQL--G   76 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-------~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i--~   76 (152)
                      .....+|++.++.++||||+++++++...+       ..+++|||+++ ++...+.    ....+++..+..++.++  |
T Consensus        63 ~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~a  141 (360)
T 3e3p_A           63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRS  141 (360)
T ss_dssp             CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence            456678888899999999999999986543       28899999965 5544433    45568899999999998  8


Q ss_pred             HHHHH--hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           77 LEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh--~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +.|+|  +.+++|+||||+||++.  ...+.+||+|||+++............||+.|+|||++.+.. ++.++|||||
T Consensus       142 l~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  218 (360)
T 3e3p_A          142 IGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSV  218 (360)
T ss_dssp             HHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence            99999  99999999999999994  236789999999998776665566678899999999997655 8999999996

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=5.5e-30  Score=182.98  Aligned_cols=142  Identities=22%  Similarity=0.377  Sum_probs=120.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcC------ccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HH
Q 031828            8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GL   77 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~n------i~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l   77 (152)
                      ...+.+.+|+.+++.++|++      ++.+.+++...+..+++||++ ++++.+.+....  .+++..+..++.++  |+
T Consensus        58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L  136 (355)
T 2eu9_A           58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL  136 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            45678889999999998766      889999999999999999999 677777776543  58999999999998  89


Q ss_pred             HHHHhCCCeecCCCCCceEeecC----------------CCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC
Q 031828           78 EILNSHHIIHRDLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ  141 (152)
Q Consensus        78 ~~lh~~~~~h~dl~~~nil~~~~----------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  141 (152)
                      .|||+++++|+||||+||++...                .....+||+|||+++....  ......||+.|+|||++.+.
T Consensus       137 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~  214 (355)
T 2eu9_A          137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL  214 (355)
T ss_dssp             HHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC
T ss_pred             HHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC
Confidence            99999999999999999999432                2456899999999976433  23456789999999999988


Q ss_pred             CCCcccceeeC
Q 031828          142 RYDEKVNFFVS  152 (152)
Q Consensus       142 ~~~~~~Dvws~  152 (152)
                      .++.++|||||
T Consensus       215 ~~~~~~Di~sl  225 (355)
T 2eu9_A          215 GWAQPCDVWSI  225 (355)
T ss_dssp             CCCTHHHHHHH
T ss_pred             CCCCccchHHH
Confidence            99999999996

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=1.5e-29  Score=178.40  Aligned_cols=142  Identities=27%  Similarity=0.556  Sum_probs=117.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeee--------------eCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------------AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL   72 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~--------------~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~   72 (152)
                      ....+.+.+|+++++.++||||+++++++.              ..+..+++|||+. ++|.+++.+ +.+++..+..++
T Consensus        49 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~  126 (320)
T 2i6l_A           49 PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFM  126 (320)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHH
Confidence            455678899999999999999999998873              3467899999996 699998864 568999999999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC----CccccCCCCCCccccccccc-CCCCc
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQF-QRYDE  145 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~  145 (152)
                      .++  |+.+||+++++|+||||+||++.  .....+||+|||+++.....    .......+++.|+|||.+.. ..++.
T Consensus       127 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (320)
T 2i6l_A          127 YQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK  204 (320)
T ss_dssp             HHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCH
T ss_pred             HHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCc
Confidence            998  89999999999999999999994  24568999999999865432    12234567899999999875 66899


Q ss_pred             ccceeeC
Q 031828          146 KVNFFVS  152 (152)
Q Consensus       146 ~~Dvws~  152 (152)
                      ++|||||
T Consensus       205 ~~Di~sl  211 (320)
T 2i6l_A          205 AIDMWAA  211 (320)
T ss_dssp             HHHHHHH
T ss_pred             hhhhHhH
Confidence            9999996

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=4.8e-30  Score=179.34  Aligned_cols=144  Identities=18%  Similarity=0.217  Sum_probs=119.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeee-eeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~-~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...+.+.+|+.+++.++|++++..+.. +..++..+++||++ +++|.+++.. ...+++..+..++.++  |+.|||++
T Consensus        46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  124 (296)
T 4hgt_A           46 TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK  124 (296)
T ss_dssp             --CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            344668899999999998877766554 46778899999999 9999999974 4569999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--------cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++|+||||+||++...+..+.+||+|||+++.......        .....||+.|+|||++.+..++.++|||||
T Consensus       125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  201 (296)
T 4hgt_A          125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL  201 (296)
T ss_dssp             TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHH
T ss_pred             CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHH
Confidence            999999999999994334566899999999987644321        235678999999999999899999999996

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=1.1e-29  Score=181.67  Aligned_cols=140  Identities=25%  Similarity=0.471  Sum_probs=117.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      .....+.+|+++++.++||||+++++++..+     +..++++|++. ++|.+++.. +.+++..+..++.++  |+.+|
T Consensus        51 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~L  128 (353)
T 2b9h_A           51 LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVL  128 (353)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHH
Confidence            4466788999999999999999999987654     67899999995 689988875 468999999999998  89999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----------ccccCCCCCCccccccccc-CCCCcccc
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------YAEKVCGSPLYMAPEVLQF-QRYDEKVN  148 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----------~~~~~~~t~~y~aPE~~~~-~~~~~~~D  148 (152)
                      |+++++|+||||+||++   +..+.+||+|||+++......           ......||+.|+|||++.. ..++.++|
T Consensus       129 H~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  205 (353)
T 2b9h_A          129 HGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD  205 (353)
T ss_dssp             HHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHH
T ss_pred             HHCCeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhh
Confidence            99999999999999999   567789999999998654321           1223578999999998765 66899999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      ||||
T Consensus       206 i~sl  209 (353)
T 2b9h_A          206 VWSC  209 (353)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.96  E-value=2.2e-30  Score=184.68  Aligned_cols=134  Identities=31%  Similarity=0.651  Sum_probs=97.8

Q ss_pred             HHHHcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHHhCCCeecC
Q 031828           18 NFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILNSHHIIHRD   89 (152)
Q Consensus        18 ~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh~~~~~h~d   89 (152)
                      ..++.++||||+++++++..    ++..++||||+++++|.+++....  .+++..+..++.++  |+.|||+++++|+|
T Consensus        74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~d  153 (336)
T 3fhr_A           74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD  153 (336)
T ss_dssp             HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            44677799999999999976    456899999999999999998654  58999999999998  89999999999999


Q ss_pred             CCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           90 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        90 l~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+||++...+....+||+|||+++..... ......+|+.|+|||++.+..++.++|||||
T Consensus       154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl  215 (336)
T 3fhr_A          154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL  215 (336)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHH
T ss_pred             CCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHH
Confidence            9999999965445667999999999765432 3345678999999999988889999999995

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=1e-29  Score=183.38  Aligned_cols=137  Identities=29%  Similarity=0.489  Sum_probs=114.4

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeE------EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      ...+.+.+|+.+++.++||||+++++++...+..      +++||++. ++|.+.+.  ..+++..+..++.++  |+.|
T Consensus        83 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~  159 (371)
T 4exu_A           83 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKY  159 (371)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHH
Confidence            4467888999999999999999999999877654      99999995 78887763  348999999999998  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      ||+++++|+||||+||++   +..+.+||+|||+++....  ......+|+.|+|||++.+ ..++.++|||||
T Consensus       160 LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (371)
T 4exu_A          160 IHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSV  228 (371)
T ss_dssp             HHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHH
T ss_pred             HHHCCCcCCCcCHHHeEE---CCCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHH
Confidence            999999999999999999   5677899999999975433  2345678999999999987 678999999996

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=177.28  Aligned_cols=140  Identities=30%  Similarity=0.532  Sum_probs=115.6

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeee--eCCeEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~--~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ..+.+.+|+++++.++||||+++++++.  ..+..+++|||+.++ +.+++..  ...+++..+..++.++  |+.+||+
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~  127 (305)
T 2wtk_C           49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS  127 (305)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999984  446789999999755 7777764  3458999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC---CccccCCCCCCcccccccccCC--CCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR--YDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dvws~  152 (152)
                      ++++|+||||+||++   +..+.++++|||++......   .......||+.|+|||++.+..  ++.++|||||
T Consensus       128 ~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~sl  199 (305)
T 2wtk_C          128 QGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSA  199 (305)
T ss_dssp             TTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHH
T ss_pred             CCeeecCCCcccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHH
Confidence            999999999999999   56678999999999875432   2234566899999999998644  4779999995

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.96  E-value=1.4e-29  Score=179.68  Aligned_cols=141  Identities=28%  Similarity=0.478  Sum_probs=99.6

Q ss_pred             hHHHHHHHHHH-HHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-----cCCCCHHHHHHHHHHH--HHHH
Q 031828            8 HLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         8 ~~~~~~~~E~~-~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      .....+..|.. +++.++||||+++++++..++..+++|||++ ++|.+++..     ...+++..+..++.++  |+.+
T Consensus        62 ~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~  140 (327)
T 3aln_A           62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH  140 (327)
T ss_dssp             HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHH
Confidence            34445556665 7788899999999999999999999999996 588777763     5668999999999998  8999


Q ss_pred             HHhC-CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccc----ccCCCCcccceeeC
Q 031828           80 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~-~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~~~~~Dvws~  152 (152)
                      ||+. +++|+||||+||++   +..+.+||+|||+++............||+.|+|||++    .+..++.++|||||
T Consensus       141 lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~sl  215 (327)
T 3aln_A          141 LKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSL  215 (327)
T ss_dssp             HHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC------------------------------CCSHHHHHHH
T ss_pred             HhccCCEeECCCCHHHEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHH
Confidence            9999 99999999999999   46678999999999876555444455789999999999    45668999999996

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.96  E-value=1.2e-29  Score=179.08  Aligned_cols=141  Identities=26%  Similarity=0.533  Sum_probs=117.2

Q ss_pred             HhHHHHHHHHHHHHHcCC--CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828            7 KHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ....+.+.+|+++++.++  |+||+++++++..++..+++|| +.+++|.+++.....+++..+..++.++  |+.|||+
T Consensus        67 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  145 (313)
T 3cek_A           67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ  145 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            445688999999999997  5999999999999999999999 5589999999988889999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCccccccccc-----------CCCCcccc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKVN  148 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-----------~~~~~~~D  148 (152)
                      ++++|+||||+||++.    .+.+||+|||+++......   ......||+.|+|||++.+           ..++.++|
T Consensus       146 ~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  221 (313)
T 3cek_A          146 HGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD  221 (313)
T ss_dssp             TTCCCCCCCGGGEEEE----TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHH
T ss_pred             CCceecCCCcccEEEE----CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHH
Confidence            9999999999999994    3689999999998654432   2235578999999999975           46888999


Q ss_pred             eeeC
Q 031828          149 FFVS  152 (152)
Q Consensus       149 vws~  152 (152)
                      ||||
T Consensus       222 i~sl  225 (313)
T 3cek_A          222 VWSL  225 (313)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9996

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=9.9e-30  Score=184.16  Aligned_cols=148  Identities=30%  Similarity=0.477  Sum_probs=119.7

Q ss_pred             cchhh--HhHHHHHHHHHHHHHcCC--------CcCccceeeeee----eCCeEEEEEeecCCCChHHHHHhc--CCCCH
Q 031828            2 LKKLN--KHLKSCLDCELNFLSSVN--------HPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLH--GRVPE   65 (152)
Q Consensus         2 ~k~~~--~~~~~~~~~E~~~l~~l~--------h~ni~~l~~~~~----~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~   65 (152)
                      +|++.  ....+.+.+|+.+++.++        |+||+++++++.    .....++|||++ ++++.+.+...  ..+++
T Consensus        67 vK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~  145 (397)
T 1wak_A           67 MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPL  145 (397)
T ss_dssp             EEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCH
T ss_pred             EEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCH
Confidence            44443  334678889999999985        788999999987    456799999999 66666666543  45899


Q ss_pred             HHHHHHHHHH--HHHHHHhC-CCeecCCCCCceEeecCC-----------------------------------------
Q 031828           66 QTARKFLQQL--GLEILNSH-HIIHRDLKPENILLSGLD-----------------------------------------  101 (152)
Q Consensus        66 ~~~~~~~~~i--~l~~lh~~-~~~h~dl~~~nil~~~~~-----------------------------------------  101 (152)
                      ..+..++.++  ||.|||++ +++|+||||+||++...+                                         
T Consensus       146 ~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (397)
T 1wak_A          146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPL  225 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccc
Confidence            9999999998  89999998 999999999999994211                                         


Q ss_pred             -----CCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828          102 -----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus       102 -----~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                           ....+||+|||+++.....  .....||+.|+|||++.+..++.++|||||
T Consensus       226 ~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  279 (397)
T 1wak_A          226 EPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWST  279 (397)
T ss_dssp             SGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHH
T ss_pred             ccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHH
Confidence                 1127999999999765432  345678999999999999899999999996

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=2.1e-30  Score=186.95  Aligned_cols=139  Identities=15%  Similarity=0.105  Sum_probs=98.9

Q ss_pred             hHHHHHHHHHHHHHcC--CCcCcccee-------eeeeeC-----------------CeEEEEEeecCCCChHHHHHhc-
Q 031828            8 HLKSCLDCELNFLSSV--NHPNIIRLF-------DAFQAE-----------------NCIFLVVEFCAGGNLSSYIRLH-   60 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l--~h~ni~~l~-------~~~~~~-----------------~~~~lv~e~~~~~~l~~~~~~~-   60 (152)
                      ...+.+.+|+.+++.+  +||||++++       +++..+                 ...|+||||++ ++|.+++... 
T Consensus       104 ~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~  182 (371)
T 3q60_A          104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD  182 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc
Confidence            4567788885444444  699988755       444333                 34899999997 8999999763 


Q ss_pred             CCCCHHHH------HHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCc
Q 031828           61 GRVPEQTA------RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY  132 (152)
Q Consensus        61 ~~~~~~~~------~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y  132 (152)
                      ..++....      ..++.++  |+.|||+++++|+||||+||++   +..+.+||+|||+++.....  .....+|+.|
T Consensus       183 ~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y  257 (371)
T 3q60_A          183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGTR--GPASSVPVTY  257 (371)
T ss_dssp             HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTCE--EEGGGSCGGG
T ss_pred             cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCCC--ccCccCCcCC
Confidence            23344444      5666777  8999999999999999999999   56778999999999865332  2244567999


Q ss_pred             cccccccc--CCCCcccceeeC
Q 031828          133 MAPEVLQF--QRYDEKVNFFVS  152 (152)
Q Consensus       133 ~aPE~~~~--~~~~~~~Dvws~  152 (152)
                      +|||++.+  ..++.++|||||
T Consensus       258 ~aPE~~~~~~~~~~~~~DiwSl  279 (371)
T 3q60_A          258 APREFLNASTATFTHALNAWQL  279 (371)
T ss_dssp             CCHHHHTCSEEECCHHHHHHHH
T ss_pred             cChhhccCCCCCcCccccHHHH
Confidence            99999987  679999999996

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.96  E-value=8.4e-30  Score=182.59  Aligned_cols=137  Identities=29%  Similarity=0.493  Sum_probs=113.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCe------EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~------~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      ...+.+.+|+.+++.++||||+++++++...+.      ++++||++. ++|.+++.  ..+++..+..++.++  |+.|
T Consensus        65 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~  141 (353)
T 3coi_A           65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKY  141 (353)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            446788899999999999999999999987653      599999995 68887764  358999999999998  8999


Q ss_pred             HHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           80 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      ||+++++|+||||+||++   +..+.+||+|||+++.....  .....+|+.|+|||++.+ ..++.++|||||
T Consensus       142 LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~sl  210 (353)
T 3coi_A          142 IHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSV  210 (353)
T ss_dssp             HHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHH
T ss_pred             HHHCCcccCCCCHHHEeE---CCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHH
Confidence            999999999999999999   56678999999999764332  345678999999999987 568999999996

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=5.8e-29  Score=184.89  Aligned_cols=142  Identities=18%  Similarity=0.206  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHcCCC-cCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+..|+++++.++| +++..+..++...+..+++|||+ +++|.+++.. ...+++..++.++.++  ||.|||++++
T Consensus        46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gI  124 (483)
T 3sv0_A           46 HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF  124 (483)
T ss_dssp             SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            4568899999999987 55556667777788999999999 9999999975 4569999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--------cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++...+..+.+||+|||+++.+.....        .....||+.|+|||++.+..++.++|||||
T Consensus       125 vHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSl  199 (483)
T 3sv0_A          125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESL  199 (483)
T ss_dssp             ECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             eecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHH
Confidence            9999999999995334567899999999987654321        225678999999999999999999999996

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=1.2e-30  Score=184.37  Aligned_cols=139  Identities=21%  Similarity=0.344  Sum_probs=116.1

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+.+|+.+++.++||||+++++++..++..++++||+++++|.+++...+ .+++..+..++.++  |+.+||+++++
T Consensus        73 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~  152 (319)
T 2y4i_B           73 LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL  152 (319)
T ss_dssp             CCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            4567789999999999999999999999999999999999999999997654 58899999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC------CccccCCCCCCccccccccc---------CCCCcccceee
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQF---------QRYDEKVNFFV  151 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~t~~y~aPE~~~~---------~~~~~~~Dvws  151 (152)
                      |+||||+||++.    .+.++++|||+++.....      .......|++.|+|||++..         ..++.++||||
T Consensus       153 H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~s  228 (319)
T 2y4i_B          153 HKDLKSKNVFYD----NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA  228 (319)
T ss_dssp             CCCCCSTTEEEC------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHH
T ss_pred             ccCCChhhEEEe----CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHH
Confidence            999999999993    458999999998654221      12234558899999999975         34788999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       229 l  229 (319)
T 2y4i_B          229 L  229 (319)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.96  E-value=5.4e-30  Score=180.63  Aligned_cols=140  Identities=29%  Similarity=0.436  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHHcC----CCcCccceeeeeeeCCeEEEEEee-cCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           10 KSCLDCELNFLSSV----NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~l~~l----~h~ni~~l~~~~~~~~~~~lv~e~-~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+|+.+++++    +|+||+++++++..++..++++|+ +.+++|.+++...+.+++..+..++.++  |+.|||+
T Consensus        78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~  157 (312)
T 2iwi_A           78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS  157 (312)
T ss_dssp             -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34556799999998    899999999999999999999999 7889999999988889999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCC-cccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dvws~  152 (152)
                      ++++|+||||+||++.  ...+.++++|||+++..... ......|++.|+|||++.+..+. .++|||||
T Consensus       158 ~~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl  225 (312)
T 2iwi_A          158 RGVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSL  225 (312)
T ss_dssp             HTEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHH
T ss_pred             CCeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHH
Confidence            9999999999999994  25678999999999866443 33456789999999999877765 58999995

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=8.5e-29  Score=179.18  Aligned_cols=141  Identities=35%  Similarity=0.460  Sum_probs=118.9

Q ss_pred             hHHHHHHHHHHHHHcCC-Cc-----CccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--HH
Q 031828            8 HLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--GL   77 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~-h~-----ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--~l   77 (152)
                      ...+.+..|+.+++.++ |+     +|+++++++..++..|+|||++. ++|.+++...  ..+++..+..++.++  |+
T Consensus        92 ~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al  170 (382)
T 2vx3_A           92 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL  170 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHH
Confidence            34567788999998885 44     49999999999999999999995 6999999765  358999999999998  89


Q ss_pred             HHHH--hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           78 EILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        78 ~~lh--~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      .|||  +.+++|+||||+||++.. +..+.+||+|||+++....  ......+|+.|+|||++.+..++.++|||||
T Consensus       171 ~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl  244 (382)
T 2vx3_A          171 LFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSL  244 (382)
T ss_dssp             HHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHH
Confidence            9999  568999999999999942 2356799999999986543  2345678999999999999899999999996

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.96  E-value=4.8e-29  Score=176.63  Aligned_cols=139  Identities=27%  Similarity=0.460  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHcCC--CcCccceeeeeeeCCeEEEEEeecCC-CChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      +.+.+|+.+++.++  |+||+++++++..++..++++|++.+ ++|.+++...+.+++..+..++.++  |+.|||+.++
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  170 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV  170 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            45678999999996  59999999999999999999999975 8999999988889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      +|+||||+||++.  ...+.+||+|||+++..... ......||+.|+|||++.+..+ +.++|||||
T Consensus       171 vH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  235 (320)
T 3a99_A          171 LHRDIKDENILID--LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL  235 (320)
T ss_dssp             ECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred             EeCCCCHHHEEEe--CCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhH
Confidence            9999999999994  25678999999999866443 3345678999999999987775 678999996

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=1.5e-28  Score=173.33  Aligned_cols=139  Identities=30%  Similarity=0.494  Sum_probs=105.8

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC-CC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH-HI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~-~~   85 (152)
                      .+.+..+..+++.++||||+++++++..++..+++||++ ++.+..+... ...+++..+..++.++  |+.|||+. ++
T Consensus        68 ~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i  146 (318)
T 2dyl_A           68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV  146 (318)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence            344555666788899999999999999999999999999 5566555543 4678999999999998  89999995 99


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++   +..+.+||+|||++.............+|+.|+|||++.     ...++.++|||||
T Consensus       147 ~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl  215 (318)
T 2dyl_A          147 IHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL  215 (318)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHH
T ss_pred             EeCCCCHHHEEE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhH
Confidence            999999999999   567789999999997765554455667899999999995     4568899999995

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=7.3e-29  Score=178.47  Aligned_cols=142  Identities=27%  Similarity=0.459  Sum_probs=120.2

Q ss_pred             hHHHHHHHHHHHHHcCC-----------CcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhc--CCCCHHHHHH
Q 031828            8 HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK   70 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~-----------h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~   70 (152)
                      ...+.+.+|+.++++++           |+||+++++++...+    ..+++||++ +++|.+++...  ..+++..+..
T Consensus        57 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~  135 (373)
T 1q8y_A           57 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ  135 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHH
T ss_pred             cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHH
Confidence            34677889999999886           889999999997654    789999999 89999999764  4489999999


Q ss_pred             HHHHH--HHHHHHhC-CCeecCCCCCceEeecC---CCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCC
Q 031828           71 FLQQL--GLEILNSH-HIIHRDLKPENILLSGL---DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD  144 (152)
Q Consensus        71 ~~~~i--~l~~lh~~-~~~h~dl~~~nil~~~~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  144 (152)
                      ++.++  |+.|||++ +++|+||||+||++...   .....+||+|||+++.....  .....+|+.|+|||++.+..++
T Consensus       136 i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~  213 (373)
T 1q8y_A          136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWG  213 (373)
T ss_dssp             HHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCC
Confidence            99998  89999998 99999999999999532   23447999999999765432  3445789999999999998899


Q ss_pred             cccceeeC
Q 031828          145 EKVNFFVS  152 (152)
Q Consensus       145 ~~~Dvws~  152 (152)
                      .++|||||
T Consensus       214 ~~~Di~sl  221 (373)
T 1q8y_A          214 CGADIWST  221 (373)
T ss_dssp             THHHHHHH
T ss_pred             chHhHHHH
Confidence            99999996

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.5e-29  Score=190.28  Aligned_cols=129  Identities=18%  Similarity=0.158  Sum_probs=109.5

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+++.+|++++++++||||+++..++..++..|+||||+++++|.+++..        ...++.++  |+.|||+++++|
T Consensus       383 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiH  454 (540)
T 3en9_A          383 KSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIH  454 (540)
T ss_dssp             HHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCcc
Confidence            56789999999999999999666666667778999999999999999865        45677777  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCc--------cccCCCCCCccccccccc--CCCCcccceee
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVNFFV  151 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~--~~~~~~~Dvws  151 (152)
                      +||||+||++.   .  .+||+|||+++.......        ..+.+||+.|+|||++..  ..|+..+|+||
T Consensus       455 rDiKp~NILl~---~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws  523 (540)
T 3en9_A          455 NDLTTSNFIFD---K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWE  523 (540)
T ss_dssp             TTCCTTSEEES---S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHH
T ss_pred             CCCCHHHEEEC---C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHH
Confidence            99999999993   3  899999999987654321        235679999999999987  66888899997

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=1.8e-25  Score=156.84  Aligned_cols=121  Identities=28%  Similarity=0.563  Sum_probs=102.5

Q ss_pred             HHHHHHHHHH-HcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--HHHHHH
Q 031828           11 SCLDCELNFL-SSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus        11 ~~~~~E~~~l-~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      ..+.+|+.++ +..+||||+++++++..    ++..++||||+++++|.+++....  .+++..+..++.++  |+.|||
T Consensus        55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH  134 (299)
T 3m2w_A           55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH  134 (299)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567899888 66699999999999976    678999999999999999998764  58999999999998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++++|+||||+||++........++++|||++....                     +..++.++|||||
T Consensus       135 ~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~Diwsl  184 (299)
T 3m2w_A          135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSL  184 (299)
T ss_dssp             HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHH
T ss_pred             hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHH
Confidence            9999999999999999643336789999999986432                     1346778898885

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.92  E-value=9e-25  Score=152.70  Aligned_cols=114  Identities=16%  Similarity=0.127  Sum_probs=96.1

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+++++.++||||+++++++..++..|+||||+++++|.+++++.  .....+..++.++  |+.|||++|+
T Consensus        73 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~gi  150 (286)
T 3uqc_A           73 DVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGV  150 (286)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCC
Confidence            34578999999999999999999999999999999999999999999998543  3555677888888  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +|+||||+||++.   ..+.+++++++                   |++|       ++.++|||||
T Consensus       151 vH~Dikp~NIll~---~~g~~kl~~~~-------------------~~~~-------~~~~~Di~sl  188 (286)
T 3uqc_A          151 ALSIDHPSRVRVS---IDGDVVLAYPA-------------------TMPD-------ANPQDDIRGI  188 (286)
T ss_dssp             CCCCCSGGGEEEE---TTSCEEECSCC-------------------CCTT-------CCHHHHHHHH
T ss_pred             ccCCCCcccEEEc---CCCCEEEEecc-------------------ccCC-------CCchhHHHHH
Confidence            9999999999994   56677776433                   3333       6788999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.91  E-value=2.3e-25  Score=162.82  Aligned_cols=136  Identities=15%  Similarity=0.102  Sum_probs=101.3

Q ss_pred             HHHHHHHHHHHHcCCC-cCcccee---------------------eeeee-----CCeEEEEEeecCCCChHHHHHh---
Q 031828           10 KSCLDCELNFLSSVNH-PNIIRLF---------------------DAFQA-----ENCIFLVVEFCAGGNLSSYIRL---   59 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h-~ni~~l~---------------------~~~~~-----~~~~~lv~e~~~~~~l~~~~~~---   59 (152)
                      .+.+++|+.+++.++| +|.....                     .++..     ....+++|+.+ +++|.++++.   
T Consensus       122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~  200 (413)
T 3dzo_A          122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS  200 (413)
T ss_dssp             CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc
Confidence            5778999999999987 3221111                     11111     12357777765 7899988841   


Q ss_pred             ----cCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcc
Q 031828           60 ----HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM  133 (152)
Q Consensus        60 ----~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~  133 (152)
                          ...+++.....++.|+  |+.|||+++++||||||+||++   +..+.+||+|||+++.....  ....+| +.|+
T Consensus       201 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~  274 (413)
T 3dzo_A          201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFA  274 (413)
T ss_dssp             HTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TTTC
T ss_pred             ccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-Ccee
Confidence                2236677788888888  8999999999999999999999   56677999999998764332  455677 9999


Q ss_pred             ccccc----------ccCCCCcccceeeC
Q 031828          134 APEVL----------QFQRYDEKVNFFVS  152 (152)
Q Consensus       134 aPE~~----------~~~~~~~~~Dvws~  152 (152)
                      |||++          ....++.++|||||
T Consensus       275 aPE~~~~~~~~~~~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          275 PPETTAERMLPFGQHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             CHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred             CchhhhccccccccccCcCCCchhhHHHH
Confidence            99999          55568899999996

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=2.1e-21  Score=135.49  Aligned_cols=116  Identities=17%  Similarity=0.213  Sum_probs=90.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+..+.+|+++++.++  | +++.+++.. +..|+||||+++++|.+ +..      .....++.++  |+.+||+.|++
T Consensus       147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~gii  215 (282)
T 1zar_A          147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIV  215 (282)
T ss_dssp             HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCE
Confidence            4677899999999999  5 666666544 45699999999999988 421      2233577777  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc----------CCCCcccceee
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----------QRYDEKVNFFV  151 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~----------~~~~~~~Dvws  151 (152)
                      |+||||.||++.    .+.++|+|||+++.            +..+.|||.+..          ..|+..+|+|+
T Consensus       216 HrDlkp~NILl~----~~~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          216 HGDLSQYNVLVS----EEGIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             CSCCSTTSEEEE----TTEEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             eCCCCHHHEEEE----CCcEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999999999993    67899999999864            345789998864          34566667664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.62  E-value=3.9e-16  Score=107.46  Aligned_cols=98  Identities=19%  Similarity=0.205  Sum_probs=72.1

Q ss_pred             HHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCC-C----ChHHHHHhcCCCCHHHHHHHHHHH--HHHHHH-h
Q 031828           11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-G----NLSSYIRLHGRVPEQTARKFLQQL--GLEILN-S   82 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh-~   82 (152)
                      ..+.+|+.+++.++|+++.....+..  +..++||||+++ |    +|.+....   .++..+..++.++  |+.+|| +
T Consensus       115 ~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~  189 (258)
T 1zth_A          115 IWTEKEFRNLERAKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQE  189 (258)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHH
Confidence            57889999999998886532222222  346899999942 3    66655322   2234556677777  899999 9


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY  118 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~  118 (152)
                      ++++|+||||.||++.   .  .++++|||+|....
T Consensus       190 ~givHrDlkp~NILl~---~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          190 AELVHADLSEYNIMYI---D--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SCEECSSCSTTSEEES---S--SEEECCCTTCEETT
T ss_pred             CCEEeCCCCHHHEEEc---C--cEEEEECcccccCC
Confidence            9999999999999993   3  89999999997643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.26  E-value=4.1e-12  Score=91.81  Aligned_cols=96  Identities=19%  Similarity=0.195  Sum_probs=62.7

Q ss_pred             HHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCC
Q 031828           14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLK   91 (152)
Q Consensus        14 ~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~   91 (152)
                      .+|...|.++.+.++.....+...  ..++||||++|.+|.++..    .+  ....++.++  ++.++|.+|++|+|||
T Consensus       161 ~kE~~nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~----~~--~~~~l~~qll~~l~~lH~~gIVHrDLK  232 (397)
T 4gyi_A          161 IKEFAFMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS----VP--DPASLYADLIALILRLAKHGLIHGDFN  232 (397)
T ss_dssp             HHHHHHHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC----CS--CHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             HHHHHHHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc----cH--HHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence            456666666654443322222222  2379999999888865432    12  223456676  8999999999999999


Q ss_pred             CCceEeecCCCC-------ceEEEeeccCcccc
Q 031828           92 PENILLSGLDDD-------VMLKIADFGLSCTL  117 (152)
Q Consensus        92 ~~nil~~~~~~~-------~~~kl~dfg~~~~~  117 (152)
                      |.|||+...+..       ..+.++||+.+...
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            999999642210       14789999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.17  E-value=4.6e-11  Score=81.95  Aligned_cols=99  Identities=17%  Similarity=0.192  Sum_probs=73.9

Q ss_pred             HHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh---
Q 031828            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS---   82 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~---   82 (152)
                      ....+.+|+.+++.+. +..+.++++++...+..|++||+++|.++.+.+.     +......++.++  ++..||+   
T Consensus        52 ~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~  126 (263)
T 3tm0_A           52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDI  126 (263)
T ss_dssp             STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCC
T ss_pred             CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCc
Confidence            3456899999999984 6778899999988899999999999988876521     111112344444  4777777   


Q ss_pred             --------------------------------------------------------CCCeecCCCCCceEeecCCCCceE
Q 031828           83 --------------------------------------------------------HHIIHRDLKPENILLSGLDDDVML  106 (152)
Q Consensus        83 --------------------------------------------------------~~~~h~dl~~~nil~~~~~~~~~~  106 (152)
                                                                              ..++|+|+++.||++.   ....+
T Consensus       127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~  203 (263)
T 3tm0_A          127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVS  203 (263)
T ss_dssp             TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEE
T ss_pred             ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEE
Confidence                                                                    3489999999999994   34456


Q ss_pred             EEeeccCcc
Q 031828          107 KIADFGLSC  115 (152)
Q Consensus       107 kl~dfg~~~  115 (152)
                      .++||+.+.
T Consensus       204 ~lIDwe~a~  212 (263)
T 3tm0_A          204 GFIDLGRSG  212 (263)
T ss_dssp             EECCCTTCE
T ss_pred             EEEEchhcc
Confidence            799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.95  E-value=1.1e-09  Score=74.62  Aligned_cols=45  Identities=18%  Similarity=0.136  Sum_probs=36.2

Q ss_pred             HHHHHHHHHHHHcCCCcC--ccceeeeeeeCCeEEEEEeecCCCChH
Q 031828           10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLS   54 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~n--i~~l~~~~~~~~~~~lv~e~~~~~~l~   54 (152)
                      ...+..|+.+++.+.+.+  +.+++++...++..+++||+++|.++.
T Consensus        57 ~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           57 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            356789999999985544  557888888778899999999988874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.87  E-value=5.5e-09  Score=74.77  Aligned_cols=104  Identities=14%  Similarity=0.319  Sum_probs=72.7

Q ss_pred             HHHHHHHHHHHHcCCC--cCccceeeeeeeC---CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh
Q 031828           10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      ...+.+|..+++.+..  ..+++++.++.+.   +..|++||+++|..+.+.  ....++......+..++  .+..||.
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~  157 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHT  157 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence            4578899999999974  5577888888766   458999999988776431  11234555555555555  4677775


Q ss_pred             ----------------------------------------------------------CCCeecCCCCCceEeecCCCCc
Q 031828           83 ----------------------------------------------------------HHIIHRDLKPENILLSGLDDDV  104 (152)
Q Consensus        83 ----------------------------------------------------------~~~~h~dl~~~nil~~~~~~~~  104 (152)
                                                                                ..++|+|+++.||++.... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~  236 (359)
T 3dxp_A          158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PR  236 (359)
T ss_dssp             SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SC
T ss_pred             CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-Cc
Confidence                                                                      3589999999999995211 13


Q ss_pred             eEEEeeccCccc
Q 031828          105 MLKIADFGLSCT  116 (152)
Q Consensus       105 ~~kl~dfg~~~~  116 (152)
                      .+.++||+.+..
T Consensus       237 v~~viDwe~a~~  248 (359)
T 3dxp_A          237 VLAVLDWELSTL  248 (359)
T ss_dssp             EEEECCCTTCEE
T ss_pred             EEEEECcccccc
Confidence            468999998853

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=2.5e-06  Score=58.44  Aligned_cols=56  Identities=11%  Similarity=0.065  Sum_probs=43.0

Q ss_pred             cchhhHhHHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI   57 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~   57 (152)
                      +|.........+.+|...|+.+. +--+.+++.++.+++..+++||+++|.++.+..
T Consensus        55 lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~  111 (272)
T 4gkh_A           55 LKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVL  111 (272)
T ss_dssp             EEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHH
T ss_pred             EEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccc
Confidence            45444555677889999998884 334678888998889999999999887776544

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.21  E-value=3.7e-06  Score=58.75  Aligned_cols=105  Identities=23%  Similarity=0.267  Sum_probs=63.1

Q ss_pred             HHHHHHHHHHHHHcC-CCcC--ccceeeeeeeCC---eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            9 LKSCLDCELNFLSSV-NHPN--IIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l-~h~n--i~~l~~~~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....+.+|..+++.+ .+..  +.+++......+   ..|+||++++|.++.....  ..++......+..++  .+..|
T Consensus        53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~L  130 (304)
T 3sg8_A           53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSEL  130 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHH
Confidence            457789999999887 4433  344554443333   3488999999887764221  112222222222222  12222


Q ss_pred             Hh----------------------------------------------------------CCCeecCCCCCceEeecCCC
Q 031828           81 NS----------------------------------------------------------HHIIHRDLKPENILLSGLDD  102 (152)
Q Consensus        81 h~----------------------------------------------------------~~~~h~dl~~~nil~~~~~~  102 (152)
                      |+                                                          ..++|+|+++.||++.+. .
T Consensus       131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~  209 (304)
T 3sg8_A          131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-K  209 (304)
T ss_dssp             HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-T
T ss_pred             HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-C
Confidence            21                                                          247999999999999521 1


Q ss_pred             CceEEEeeccCccc
Q 031828          103 DVMLKIADFGLSCT  116 (152)
Q Consensus       103 ~~~~kl~dfg~~~~  116 (152)
                      ...+.++||+.+..
T Consensus       210 ~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          210 NTICGIIDFGDAAI  223 (304)
T ss_dssp             TEEEEECCCTTCEE
T ss_pred             CCEEEEEeCCCCcc
Confidence            45678999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.05  E-value=6.8e-05  Score=52.47  Aligned_cols=47  Identities=17%  Similarity=0.077  Sum_probs=35.2

Q ss_pred             HHHHHHHHHHHHHcCCCc---Cccceeeeee-eCCeEEEEEeecCCCChHH
Q 031828            9 LKSCLDCELNFLSSVNHP---NIIRLFDAFQ-AENCIFLVVEFCAGGNLSS   55 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~---ni~~l~~~~~-~~~~~~lv~e~~~~~~l~~   55 (152)
                      ....+.+|.++|+.+.+.   .+.+.+.+.. ..+..+++|++++|..+..
T Consensus        52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE  102 (306)
T ss_dssp             HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence            457889999999999652   3556666664 4456789999999887765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.30  E-value=0.00024  Score=50.47  Aligned_cols=43  Identities=14%  Similarity=0.157  Sum_probs=31.4

Q ss_pred             HHHHHHHHHHHcCCC---cCccceeeeeeeC---CeEEEEEeecCCCCh
Q 031828           11 SCLDCELNFLSSVNH---PNIIRLFDAFQAE---NCIFLVVEFCAGGNL   53 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h---~ni~~l~~~~~~~---~~~~lv~e~~~~~~l   53 (152)
                      ..+.+|..+++.+..   ..+.+++.+....   +..+++||+++|..+
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence            467889999988843   3566788777654   356899999987554

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.24  E-value=0.0015  Score=45.83  Aligned_cols=30  Identities=20%  Similarity=0.357  Sum_probs=25.2

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      ..++|+|+++.||++.   ....+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~---~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLG---ENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEEC---GGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEe---CCCcEEEEehhhcc
Confidence            5699999999999983   34578999999874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.36  E-value=0.017  Score=41.62  Aligned_cols=29  Identities=28%  Similarity=0.389  Sum_probs=23.6

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      ..++|+|+.+.||++.   . ..++++||..+.
T Consensus       227 ~~L~HGDl~~~Nil~~---~-~~~~lID~e~a~  255 (397)
T 2olc_A          227 ETLIHGDLHTGSIFAS---E-HETKVIDPEFAF  255 (397)
T ss_dssp             CEEECSCCSGGGEEEC---S-SCEEECCCTTCE
T ss_pred             CceeeCCCCcCcEEEe---C-CCeEEEeCcccc
Confidence            4689999999999984   2 248899998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.71  E-value=0.026  Score=39.03  Aligned_cols=27  Identities=30%  Similarity=0.188  Sum_probs=22.6

Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      ++|+|+.+.|++.    ..+.+.++||..+.
T Consensus       175 l~HgDl~~~Nil~----~~~~~~lID~e~a~  201 (301)
T 3dxq_A          175 ACHCDPLCENFLD----TGERMWIVDWEYSG  201 (301)
T ss_dssp             EECSCCCGGGEEE----CSSCEEECCCTTCE
T ss_pred             eeccCCCcCCEEE----CCCCEEEEeccccc
Confidence            7999999999995    33467999998875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=93.70  E-value=0.03  Score=40.76  Aligned_cols=31  Identities=23%  Similarity=0.434  Sum_probs=25.0

Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      ...++|+|+++.||++.   .. .+.++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~---~~-~~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVT---QD-STQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEEC---SS-CEEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEe---CC-CCEEEeCccccc
Confidence            45699999999999994   33 389999998753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=93.35  E-value=0.18  Score=35.36  Aligned_cols=52  Identities=15%  Similarity=0.183  Sum_probs=40.4

Q ss_pred             cchhhHhHHHHHHHHHHHHHcCC---CcCccceeeeeeeCCeEEEEEeecCCCCh
Q 031828            2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNL   53 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l~---h~ni~~l~~~~~~~~~~~lv~e~~~~~~l   53 (152)
                      +|.........+..|...|+.+.   ...+++++.+....+..+++||++++..+
T Consensus        64 lK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           64 VKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            45444445677899999998884   35678888888878889999999988764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.90  E-value=0.036  Score=38.55  Aligned_cols=29  Identities=31%  Similarity=0.628  Sum_probs=23.4

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      +++|+|+.+.||++.   ....+.++||+.+.
T Consensus       188 ~liHgDl~~~Nil~~---~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          188 GVIHADLFQDNVFFL---GDELSGLIDFYFAC  216 (322)
T ss_dssp             EEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             ccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence            589999999999994   33445799998874

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=92.19  E-value=0.07  Score=37.37  Aligned_cols=34  Identities=21%  Similarity=0.273  Sum_probs=25.3

Q ss_pred             CCCeecCCCCCceEeecCCC-CceEEEeeccCccc
Q 031828           83 HHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCT  116 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~-~~~~kl~dfg~~~~  116 (152)
                      ..++|+|+.+.||++..... ...+.++||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            35899999999999942110 25789999998753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=90.63  E-value=0.12  Score=36.77  Aligned_cols=28  Identities=32%  Similarity=0.516  Sum_probs=22.6

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .++|+|+.+.||++.    ...+.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~----~~~~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINT----NKCLRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEEC----C-CEEECCCTTCE
T ss_pred             EEEeCCCCcccEEec----CCcEEEEEecCCC
Confidence            489999999999983    2348999998775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=89.98  E-value=0.13  Score=35.79  Aligned_cols=28  Identities=25%  Similarity=0.192  Sum_probs=23.3

Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      ..++|+|+++.||++.    . .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~----~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR----D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES----S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc----C-CCEEEECCCCC
Confidence            3479999999999983    2 78999998775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.99  E-value=0.21  Score=37.01  Aligned_cols=36  Identities=25%  Similarity=0.331  Sum_probs=24.5

Q ss_pred             HHHHHHHHcCCCcCc-cceeeeeeeCCeEEEEEeecCCCCh
Q 031828           14 DCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL   53 (152)
Q Consensus        14 ~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~~~~~l   53 (152)
                      ..|..+++.+...++ .++++.+.  +.  ++++|++|.++
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence            478888988865444 46777763  22  49999976443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=88.61  E-value=0.18  Score=35.55  Aligned_cols=30  Identities=20%  Similarity=0.396  Sum_probs=24.7

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT  116 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~  116 (152)
                      .++|+|+.+.|+++.   ....+.++||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVG---NEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence            589999999999983   345789999987753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=88.31  E-value=0.15  Score=37.33  Aligned_cols=38  Identities=16%  Similarity=0.225  Sum_probs=24.8

Q ss_pred             HHHHHHHHHHHcCCCcCc-cceeeeeeeCCeEEEEEeecCCCC
Q 031828           11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGN   52 (152)
Q Consensus        11 ~~~~~E~~~l~~l~h~ni-~~l~~~~~~~~~~~lv~e~~~~~~   52 (152)
                      +.+..|..+++.+...++ .++++.+.  +  .++++|++|.+
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~  158 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRP  158 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEE
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCcc
Confidence            456679998888843333 56676654  2  28899987633

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.89  E-value=0.28  Score=35.44  Aligned_cols=32  Identities=31%  Similarity=0.364  Sum_probs=25.2

Q ss_pred             CeecCCCCCceEeecC---CCCceEEEeeccCccc
Q 031828           85 IIHRDLKPENILLSGL---DDDVMLKIADFGLSCT  116 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~---~~~~~~kl~dfg~~~~  116 (152)
                      ++|+|+.+.||++.+.   +....+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999998532   2345799999998853

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=87.05  E-value=0.031  Score=41.52  Aligned_cols=29  Identities=10%  Similarity=0.037  Sum_probs=25.0

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeC
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE   38 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~   38 (152)
                      .+.|..|++.+.+++|+|++++.|+|...
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~  351 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTV  351 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence            56799999999999999999999999654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=86.40  E-value=0.29  Score=35.29  Aligned_cols=32  Identities=31%  Similarity=0.441  Sum_probs=24.4

Q ss_pred             CCeecCCCCCceEeecC-CCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGL-DDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~-~~~~~~kl~dfg~~~  115 (152)
                      .++|+|+.+.||++... +....+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            38999999999999632 113578999999885

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	152
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-39
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-39
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-37
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-37
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-34
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-34
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-34
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-34
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-32
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-31
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-30
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-30
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-30
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-30
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-30
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-29
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-29
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-29
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-28
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-27
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-27
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-27
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-26
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-26
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-25
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-25
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-25
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-23
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-23
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-21
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-18
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-10

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-40
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 12/157 (7%)

Query: 2   LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           LK L K       ++  L  E+   S + HPNI+RL+  F     ++L++E+   G +  
Sbjct: 36  LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            ++   +  EQ    ++ +L   L   +S  +IHRD+KPEN+L   L     LKIADFG 
Sbjct: 96  ELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGW 152

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           S    P +    +CG+  Y+ PE+++ + +DEKV+ +
Sbjct: 153 SVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 188

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (339), Expect = 3e-40
 Identities = 52/155 (33%), Positives = 88/155 (56%), Gaps = 6/155 (3%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K + K      +  ++ E+  L  + HPNI+ L D +++   ++L+++  +GG L   I
Sbjct: 39  IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98

Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
              G   E+ A + + Q+   ++ L+   I+HRDLKPEN+L   LD+D  + I+DFGLS 
Sbjct: 99  VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
              PG+     CG+P Y+APEVL  + Y + V+ +
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCW 193

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  134 bits (339), Expect = 1e-39
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 4/150 (2%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
            +   ++  K  +  E+  +S + HP ++ L DAF+ +N + ++ EF +GG L   +   
Sbjct: 58  FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           H ++ E  A ++++Q+  GL  ++ ++ +H DLKPENI+ +       LK+ DFGL+  L
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-TKRSNELKLIDFGLTAHL 176

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
            P    +   G+  + APEV + +      
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-39
 Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 7/150 (4%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +  ++   +++ +  EL  L   N P I+  + AF ++  I + +E   GG+L   ++  
Sbjct: 39  IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 98

Query: 61  GRVPEQTARKFLQQL--GLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           GR+PEQ   K    +  GL  L   H I+HRD+KP NIL   ++    +K+ DFG+S  L
Sbjct: 99  GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQL 155

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
              + A    G+  YM+PE LQ   Y  + 
Sbjct: 156 -IDSMANSFVGTRSYMSPERLQGTHYSVQS 184

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 8e-39
 Identities = 52/156 (33%), Positives = 89/156 (57%), Gaps = 12/156 (7%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
           +KL K  +     E   L  + HPNI+R +D++++    + CI LV E    G L +Y++
Sbjct: 45  RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 104

Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 114
               +  +  R + +Q+  GL+ L++    IIHRDLK +NI ++       +KI D GL+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162

Query: 115 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            TL   ++A+ V G+P +MAPE+ + ++YDE V+ +
Sbjct: 163 -TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVY 196

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  132 bits (332), Expect = 1e-38
 Identities = 42/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)

Query: 2   LKKLNKHL---KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
            K +N      K  +  E++ ++ ++HP +I L DAF+ +  + L++EF +GG L   I 
Sbjct: 59  AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118

Query: 59  LHG-RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
               ++ E     +++Q   GL+ ++ H I+H D+KPENI+         +KI DFGL+ 
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT 177

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
            L P    +    +  + APE++  +      + +
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 212

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 3e-38
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 17/160 (10%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +KK++   K   +       E+ FL  + HPN I+    +  E+  +LV+E+C G     
Sbjct: 45  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
                  + E            GL  L+SH++IHRD+K  NIL   L +  ++K+ DFG 
Sbjct: 105 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL---LSEPGLVKLGDFGS 161

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVNFF 150
           +  + P N      G+P +MAPEV+      +YD KV+ +
Sbjct: 162 ASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVW 198

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 6e-38
 Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 14/160 (8%)

Query: 2   LKKLNKHL------KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K           +  E + +S ++HP  ++L+  FQ +  ++  + +   G L  
Sbjct: 38  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           YIR  G   E   R +  ++   LE L+   IIHRDLKPENIL   L++D+ ++I DFG 
Sbjct: 98  YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGT 154

Query: 114 SCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +  L P +    A    G+  Y++PE+L  +   +  + +
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 194

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 3e-37
 Identities = 53/161 (32%), Positives = 86/161 (53%), Gaps = 15/161 (9%)

Query: 2   LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
            K ++   +  L+    E++ L+S +HPNI++L DAF  EN +++++EFCAGG + + + 
Sbjct: 42  AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101

Query: 58  RLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
            L   + E   +   +Q    L  L+ + IIHRDLK  NIL      D  +K+ADFG+S 
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNIL---FTLDGDIKLADFGVSA 158

Query: 116 TLY-PGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFF 150
                    +   G+P +MAPEV+       + YD K + +
Sbjct: 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 5e-37
 Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 8/149 (5%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +  K        +  E+     +NH N+++ +   +  N  +L +E+C+GG L   I   
Sbjct: 38  VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 97

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
             +PE  A++F  QL  G+  L+   I HRD+KPEN+L   LD+   LKI+DFGL+    
Sbjct: 98  IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFR 154

Query: 119 PGNYAE---KVCGSPLYMAPEVLQFQRYD 144
             N      K+CG+  Y+APE+L+ + + 
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFH 183

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 3e-36
 Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 13/155 (8%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LH 60
           +             E+  L    H NI+     +     + +V ++C G +L  ++  + 
Sbjct: 40  VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIE 98

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
            +          +Q   G++ L++  IIHRDLK  NI    L +D+ +KI DFGL+    
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIF---LHEDLTVKIGDFGLATVKS 155

Query: 119 PGNYAEK---VCGSPLYMAPEVLQFQR---YDEKV 147
             + + +   + GS L+MAPEV++ Q    Y  + 
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 8e-35
 Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 9/157 (5%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYI 57
           LK L    K+  + EL    +   P+I+R+ D ++       C+ +V+E   GG L S I
Sbjct: 42  LKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 100

Query: 58  RLHG--RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           +  G     E+ A + ++ +   ++ L+S +I HRD+KPEN+L +    + +LK+ DFG 
Sbjct: 101 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      N     C +P Y+APEVL  ++YD+  + +
Sbjct: 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 197

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-34
 Identities = 41/150 (27%), Positives = 76/150 (50%), Gaps = 7/150 (4%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
            +    +  K  +  E+  +    +PNI+   D++   + +++V+E+ AGG+L+  +   
Sbjct: 52  QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-E 110

Query: 61  GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 117
             + E       ++    LE L+S+ +IHRD+K +NIL   L  D  +K+ DFG    + 
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNIL---LGMDGSVKLTDFGFCAQIT 167

Query: 118 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
              +    + G+P +MAPEV+  + Y  KV
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-34
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 17/160 (10%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI-- 57
              + +  K  L  E+N L  + HPNI+R +D    +    +++V+E+C GG+L+S I  
Sbjct: 39  YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98

Query: 58  --RLHGRVPEQTARKFLQQL--GLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 108
             +    + E+   + + QL   L+         H ++HRDLKP N+    LD    +K+
Sbjct: 99  GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF---LDGKQNVKL 155

Query: 109 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKV 147
            DFGL+  L     +A+   G+P YM+PE +    Y+EK 
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKS 195

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 6e-34
 Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 6/151 (3%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
            K +         +  E++ L+   H NI+ L ++F++   + ++ EF +G ++   I  
Sbjct: 35  AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94

Query: 60  HG-RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
               + E+    ++ Q+   L+ L+SH+I H D++PENI+         +KI +FG +  
Sbjct: 95  SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQ 153

Query: 117 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 147
           L PG+    +  +P Y APEV Q        
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  117 bits (295), Expect = 7e-34
 Identities = 55/147 (37%), Positives = 83/147 (56%), Gaps = 6/147 (4%)

Query: 3   KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
            +  + L+     E++ L  V+ HPNII+L D ++     FLV +    G L  Y+    
Sbjct: 46  AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 105

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 119
            + E+  RK ++ L   +  L+  +I+HRDLKPENIL   LDDD+ +K+ DFG SC L P
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDP 162

Query: 120 GNYAEKVCGSPLYMAPEVLQFQRYDEK 146
           G    +VCG+P Y+APE+++    D  
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNH 189

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-32
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 11/155 (7%)

Query: 2   LKKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL 59
           +K +           E + ++ + H N+++L     + +  +++V E+ A G+L  Y+R 
Sbjct: 35  VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94

Query: 60  HGR--VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
            GR  +      KF   +   +E L  ++ +HRDL   N+L   + +D + K++DFGL+ 
Sbjct: 95  RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVL---VSEDNVAKVSDFGLTK 151

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                   +       + APE L+ +++  K + +
Sbjct: 152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVW 184

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 6e-32
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 10/156 (6%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IR 58
           +K + +   S  D   E   +  ++HP +++L+     +  I LV EF   G LS Y   
Sbjct: 34  IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT 93

Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
             G    +T       +  G+  L    +IHRDL   N L   + ++ ++K++DFG++  
Sbjct: 94  QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL---VGENQVIKVSDFGMTRF 150

Query: 117 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFF 150
           +    Y           + +PEV  F RY  K + +
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 8e-32
 Identities = 37/156 (23%), Positives = 73/156 (46%), Gaps = 10/156 (6%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K + +   S  +   E   + +++H  +++L+     +  IF++ E+ A G L +Y+R 
Sbjct: 33  IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 92

Query: 60  -HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
              R   Q   +  + +   +E L S   +HRDL   N L   ++D  ++K++DFGLS  
Sbjct: 93  MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRY 149

Query: 117 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFF 150
           +    Y           +  PEVL + ++  K + +
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 9e-32
 Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 10/154 (6%)

Query: 3   KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
           +  +  LK  L  E N +  +++P I+R+    +AE+   LV+E    G L+ Y++ +  
Sbjct: 45  EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH 103

Query: 63  VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 120
           V ++   + + Q+  G++ L   + +HRDL   N+L   L      KI+DFGLS  L   
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALRAD 160

Query: 121 NYAEK----VCGSPLYMAPEVLQFQRYDEKVNFF 150
               K          + APE + + ++  K + +
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-31
 Identities = 44/138 (31%), Positives = 81/138 (58%), Gaps = 3/138 (2%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E++ L  + HPN+I L + ++ +  + L++E  AGG L  ++     + E+ A +FL+Q+
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLY 132
             G+  L+S  I H DLKPENI+L   +     +KI DFGL+  +  GN  + + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 133 MAPEVLQFQRYDEKVNFF 150
           +APE++ ++    + + +
Sbjct: 183 VAPEIVNYEPLGLEADMW 200

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (280), Expect = 2e-31
 Identities = 57/157 (36%), Positives = 88/157 (56%), Gaps = 13/157 (8%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K +   L        E   LS V HP IIR++  FQ    IF+++++  GG L S
Sbjct: 34  MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
            +R   R P   A+ +  ++   LE L+S  II+RDLKPENIL   LD +  +KI DFG 
Sbjct: 94  LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGF 150

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +  +    Y   +CG+P Y+APEV+  + Y++ ++++
Sbjct: 151 AKYVPDVTY--TLCGTPDYIAPEVVSTKPYNKSIDWW 185

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 3e-31
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 13/159 (8%)

Query: 2   LKKLNKHLKSCLDCELNFL-------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
           +K L K +    D     +        +  HP +  +F  FQ +  +F V+E+  GG+L 
Sbjct: 32  IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91

Query: 55  SYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
            +I+   +     A  +  ++  GL+ L+S  I++RDLK +NIL   LD D  +KIADFG
Sbjct: 92  YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFG 148

Query: 113 LSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVNFF 150
           +      G+      CG+P Y+APE+L  Q+Y+  V+++
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWW 187

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  107 bits (269), Expect = 4e-30
 Identities = 36/162 (22%), Positives = 69/162 (42%), Gaps = 13/162 (8%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGG 51
           +K L   L            E    +++NHP I+ ++D  +AE       ++V+E+  G 
Sbjct: 37  VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDD-DVMLKI 108
            L   +   G +  + A + +      L   + + IIHRD+KP NI++S  +   VM   
Sbjct: 97  TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
               ++ +         V G+  Y++PE  +    D + + +
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 198

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 6e-30
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 11/154 (7%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           + +   K     +  E   +  +++P I+RL    QAE  + LV+E   GG L  ++   
Sbjct: 44  LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK 102

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
              +P     + L Q+  G++ L   + +HRDL   N+L   L +    KI+DFGLS  L
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKAL 159

Query: 118 YPGNYAEK----VCGSPLYMAPEVLQFQRYDEKV 147
              +              + APE + F+++  + 
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 6e-30
 Identities = 35/157 (22%), Positives = 68/157 (43%), Gaps = 12/157 (7%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L +   S      E N +  + H  ++RL+     +  I+++ E+   G+L  +++ 
Sbjct: 42  VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT 100

Query: 60  HGRVP--EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
              +            Q+  G+  +   + IHRDL+  NIL   + D +  KIADFGL+ 
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL---VSDTLSCKIADFGLAR 157

Query: 116 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFF 150
            +    Y  +        + APE + +  +  K + +
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 9e-30
 Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 32/179 (17%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           + +K +   +  L  EL  ++ + +H NI+ L  A      I+L+ E+C  G+L +Y+R 
Sbjct: 75  LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134

Query: 60  H-----------------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPEN 94
                                     +  +    F  Q+  G+E L     +HRDL   N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194

Query: 95  ILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVNFF 150
           +L   +    ++KI DFGL+  +   +             +MAPE L    Y  K + +
Sbjct: 195 VL---VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  107 bits (268), Expect = 9e-30
 Identities = 34/159 (21%), Positives = 70/159 (44%), Gaps = 12/159 (7%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
           +     +  +     E + +   +HPN+I L         + ++ EF   G+L S++R +
Sbjct: 62  LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121

Query: 61  -GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
            G+         L+ +  G++ L   + +HRDL   NIL   ++ +++ K++DFGLS  L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFL 178

Query: 118 YPGNYAEKV------CGSPLYMAPEVLQFQRYDEKVNFF 150
                               + APE +Q++++    + +
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVW 217

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  108 bits (270), Expect = 1e-29
 Identities = 43/138 (31%), Positives = 75/138 (54%), Gaps = 7/138 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
            L+ +S+ + P I+ +  AF   + +  +++   GG+L  ++  HG   E   R +  ++
Sbjct: 57  MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 133
             GLE +++  +++RDLKP NIL   LD+   ++I+D GL+C  +         G+  YM
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYM 172

Query: 134 APEVLQ-FQRYDEKVNFF 150
           APEVLQ    YD   ++F
Sbjct: 173 APEVLQKGVAYDSSADWF 190

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 4e-29
 Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 22/169 (13%)

Query: 1   MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           M +  +K        EL  L  + +HPNII L  A +    ++L +E+   GNL  ++R 
Sbjct: 45  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104

Query: 60  H----------------GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLD 101
                              +  Q    F   +  G++ L+    IHRDL   NIL   + 
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL---VG 161

Query: 102 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           ++ + KIADFGLS                 +MA E L +  Y    + +
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 210

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 6e-29
 Identities = 31/140 (22%), Positives = 54/140 (38%), Gaps = 8/140 (5%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
           E   ++SV++P++ RL           +      G  L         +  Q    +  Q+
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 76  --GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 130
             G+  L    ++HRDL   N+L   +     +KI DFGL+  L        AE      
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 131 LYMAPEVLQFQRYDEKVNFF 150
            +MA E +  + Y  + + +
Sbjct: 178 KWMALESILHRIYTHQSDVW 197

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  105 bits (262), Expect = 6e-29
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 11/157 (7%)

Query: 2   LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L +      +   E   +  + HPN+++L      E   +++ EF   GNL  Y+R 
Sbjct: 47  VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106

Query: 60  HGR--VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
             R  V          Q+   +E L   + IHRDL   N L   + ++ ++K+ADFGLS 
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSR 163

Query: 116 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVNFF 150
            +    Y           + APE L + ++  K + +
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 7e-29
 Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 8/136 (5%)

Query: 16  ELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFL 72
           E+  L  V+     +IRL D F+  +   L++E      +L  +I   G + E+ AR F 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116

Query: 73  QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 130
            Q+   +   ++  ++HRD+K ENIL+    +   LK+ DFG    L          G+ 
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA-LLKDTVYTDFDGTR 173

Query: 131 LYMAPEVLQFQRYDEK 146
           +Y  PE +++ RY  +
Sbjct: 174 VYSPPEWIRYHRYHGR 189

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-28
 Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 17/162 (10%)

Query: 2   LKKLNKHLKS------CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L   + S          E+N + S++H N+IRL+        + +V E    G+L  
Sbjct: 41  VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLD 99

Query: 56  YIRLH-GRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 112
            +R H G     T  ++  Q+  G+  L S   IHRDL   N+L   L    ++KI DFG
Sbjct: 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL---LATRDLVKIGDFG 156

Query: 113 LSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           L   L   +      E       + APE L+ + +    + +
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 198

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 3e-28
 Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 12/158 (7%)

Query: 2   LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L K +    D       E   L +  HP +  L  AFQ  + +  V+E+  GG L  
Sbjct: 35  MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           ++       E+ AR +  ++   LE L+S  +++RD+K EN++   LD D  +KI DFGL
Sbjct: 95  HLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGL 151

Query: 114 SCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                  G   +  CG+P Y+APEVL+   Y   V+++
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 3e-28
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 9/137 (6%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLHGRVPEQTARKFLQQ 74
           E   +   +HP+I++L      EN +++++E C  G L S+       +   +   +  Q
Sbjct: 58  EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSP 130
           L   L  L S   +HRD+   N+L   +  +  +K+ DFGLS  +    Y  A K     
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173

Query: 131 LYMAPEVLQFQRYDEKV 147
            +MAPE + F+R+    
Sbjct: 174 KWMAPESINFRRFTSAS 190

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  102 bits (255), Expect = 1e-27
 Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 11/152 (7%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIR 58
           +K L    K  +  E+  L ++   PNII L D  +        LV E     +     +
Sbjct: 65  VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124

Query: 59  LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 116
               + +   R ++ ++   L+  +S  I+HRD+KP N+++    +   L++ D+GL+  
Sbjct: 125 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEF 179

Query: 117 LYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKV 147
            +PG        S  +  PE+ + +Q YD  +
Sbjct: 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 211

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-27
 Identities = 33/154 (21%), Positives = 66/154 (42%), Gaps = 12/154 (7%)

Query: 2   LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K L     S      E   +  + H  +++L+     E  I++V E+ + G+L  +++ 
Sbjct: 46  IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG 104

Query: 60  HGRVP--EQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 115
                           Q+  G+  +   + +HRDL+  NIL   + ++++ K+ADFGL+ 
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL---VGENLVCKVADFGLAR 161

Query: 116 TLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKV 147
            +    Y   +       + APE   + R+  K 
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 2e-27
 Identities = 36/175 (20%), Positives = 62/175 (35%), Gaps = 29/175 (16%)

Query: 2   LKKLNKHLKSCL--DCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSS 55
           +K  +   +     + E+     + H NI+    A   +N     ++LV ++   G+L  
Sbjct: 31  VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 90

Query: 56  YIRLHGRVPEQTARKFLQQL---------GLEILNSHHIIHRDLKPENILLSGLDDDVML 106
           Y+  +    E   +  L             +       I HRDLK +NIL   +  +   
Sbjct: 91  YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTC 147

Query: 107 KIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ------FQRYDEKVNFF 150
            IAD GL+                  G+  YMAPEVL            ++ + +
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIY 202

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 5e-27
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 15/161 (9%)

Query: 2   LKKLNKHLKSCLD--------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL 53
           +KK+    +S            E+  L  ++HPNII L DAF  ++ I LV +F      
Sbjct: 28  IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE 87

Query: 54  SSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
                    +     + ++     GLE L+ H I+HRDLKP N+L   LD++ +LK+ADF
Sbjct: 88  VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADF 144

Query: 112 GLSCTLYPGNYAEK-VCGSPLYMAPEVLQ-FQRYDEKVNFF 150
           GL+ +    N A      +  Y APE+L   + Y   V+ +
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMW 185

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 2e-26
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 15/161 (9%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
           +KK+ +  K   + EL  +  ++H NI+RL   F      + E  + LV+++        
Sbjct: 50  IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108

Query: 56  ---YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 110
              Y R    +P    + ++ QL   L  ++S  I HRD+KP+N+LL    D  +LK+ D
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD 166

Query: 111 FGLSCTLYPGNYAEKVCGSPLYMAP-EVLQFQRYDEKVNFF 150
           FG +  L  G        S  Y AP  +     Y   ++ +
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVW 207

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 3e-26
 Identities = 33/168 (19%), Positives = 68/168 (40%), Gaps = 22/168 (13%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K +N+      +     E + +   N  +++RL           +++E    G+L SY+
Sbjct: 55  IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114

Query: 58  RLHGRV----------PEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVM 105
           R                     +   ++  G+  LN++  +HRDL   N +   + +D  
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFT 171

Query: 106 LKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
           +KI DFG++  +Y  +Y     K      +M+PE L+   +    + +
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 219

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 97.6 bits (242), Expect = 6e-26
 Identities = 37/182 (20%), Positives = 75/182 (41%), Gaps = 36/182 (19%)

Query: 2   LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
           +K L +   + +      E   ++  ++PNI++L         + L+ E+ A G+L+ ++
Sbjct: 48  VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 107

Query: 58  RLHGR------------------------VPEQTARKFLQQL--GLEILNSHHIIHRDLK 91
           R                            +         +Q+  G+  L+    +HRDL 
Sbjct: 108 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167

Query: 92  PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVN 148
             N L   + +++++KIADFGLS  +Y  +Y +          +M PE + + RY  + +
Sbjct: 168 TRNCL---VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224

Query: 149 FF 150
            +
Sbjct: 225 VW 226

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 8e-26
 Identities = 46/143 (32%), Positives = 68/143 (47%), Gaps = 11/143 (7%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTAR 69
            L  L +  HPN++RLFD         E  + LV E       +   ++    VP +T +
Sbjct: 60  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119

Query: 70  KFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 127
             + Q   GL+ L+SH ++HRDLKP+NIL   +     +K+ADFGL+           V 
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNIL---VTSSGQIKLADFGLARIYSFQMALTSVV 176

Query: 128 GSPLYMAPEVLQFQRYDEKVNFF 150
            +  Y APEVL    Y   V+ +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLW 199

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 9e-26
 Identities = 40/162 (24%), Positives = 69/162 (42%), Gaps = 16/162 (9%)

Query: 2   LKKLNKHLK----SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSY 56
           +K LN+       S    E   +   +HPN++ L     ++E    +V+ +   G+L ++
Sbjct: 60  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 57  IRLHGRVPEQTARKFL---QQLGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           IR     P              G++ L S   +HRDL   N +   LD+   +K+ADFGL
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM---LDEKFTVKVADFGL 176

Query: 114 SCTLYPGNYAEK-----VCGSPLYMAPEVLQFQRYDEKVNFF 150
           +  +Y   +              +MA E LQ Q++  K + +
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 97.6 bits (242), Expect = 1e-25
 Identities = 48/158 (30%), Positives = 89/158 (56%), Gaps = 13/158 (8%)

Query: 2   LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
           +K L+K     L        E   L +VN P +++L  +F+  + +++V+E+ AGG + S
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 56  YIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 113
           ++R  GR  E  AR +  Q+    E L+S  +I+RDLKPEN+L   +D    +++ DFG 
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGF 187

Query: 114 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
           +  +    +   +CG+P  +APE++  + Y++ V+++ 
Sbjct: 188 AKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDWWA 223

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 2e-25
 Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 27/159 (16%)

Query: 16  ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------------- 58
           EL  LS + NH NI+ L  A        ++ E+C  G+L +++R                
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 59  --LHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
                 +  +    F  Q+  G+  L S + IHRDL   NIL   L    + KI DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLA 192

Query: 115 CTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
             +   +             +MAPE +    Y  + + +
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 3e-25
 Identities = 34/160 (21%), Positives = 65/160 (40%), Gaps = 14/160 (8%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY- 56
           +K L        +     E   +   +H NIIRL         + ++ E+   G L  + 
Sbjct: 41  IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100

Query: 57  IRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 114
               G          L+ +  G++ L + + +HRDL   NIL   ++ +++ K++DFGLS
Sbjct: 101 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL---VNSNLVCKVSDFGLS 157

Query: 115 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVNFF 150
             L     A            + APE + ++++    + +
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVW 197

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 3e-25
 Identities = 36/165 (21%), Positives = 69/165 (41%), Gaps = 19/165 (11%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNL 53
           ++   +        E+  L  + H N++ L +  +         +  I+LV +FC     
Sbjct: 45  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104

Query: 54  SSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 111
                +  +      ++ +Q L  GL  ++ + I+HRD+K  N+L   +  D +LK+ADF
Sbjct: 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADF 161

Query: 112 GLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVNFF 150
           GL+           N       +  Y  PE+L  +R Y   ++ +
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 94.6 bits (234), Expect = 6e-25
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 7/153 (4%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L+K ++ + S    E++ L  + H NI++L+D    +  + LV E              G
Sbjct: 36  LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG 95

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 118
            +   TA+ FL QL  G+   +   ++HRDLKP+N+L   ++ +  LKIADFGL+     
Sbjct: 96  GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFGI 152

Query: 119 PGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVNFF 150
           P         +  Y AP+VL   ++Y   ++ +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 7e-25
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 14/141 (9%)

Query: 16  ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
           E+  L    H NII + D  +A          +V    G +L   ++    +       F
Sbjct: 56  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYF 114

Query: 72  LQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEK 125
           L Q+  GL+ ++S +++HRDLKP N+L   L+    LKI DFGL+    P +    +  +
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTE 171

Query: 126 VCGSPLYMAPEVLQFQRYDEK 146
              +  Y APE++   +   K
Sbjct: 172 YVATRWYRAPEIMLNSKGYTK 192

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 93.8 bits (232), Expect = 2e-24
 Identities = 28/158 (17%), Positives = 52/158 (32%), Gaps = 12/158 (7%)

Query: 2   LKKLNKHLKSC-LDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRL 59
           +K      K   L  E      +     I       AE +   +V+E         +   
Sbjct: 37  IKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
             +   +T      Q+   +E ++S + IHRD+KP+N L+       ++ I DFGL+   
Sbjct: 97  SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156

Query: 118 YPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKV 147
                         + + G+  Y +           + 
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 2e-24
 Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 7/146 (4%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLH 60
           L    + + S    E++ L  +NHPNI++L D    EN ++LV EF              
Sbjct: 37  LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL 96

Query: 61  GRVPEQTARKFLQQ--LGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 118
             +P    + +L Q   GL   +SH ++HRDLKP+N+L   ++ +  +K+ADFGL+    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLARAFG 153

Query: 119 -PGNYAEKVCGSPLYMAPEVLQFQRY 143
            P         +  Y APE+L   +Y
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKY 179

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 89.9 bits (222), Expect = 4e-23
 Identities = 22/160 (13%), Positives = 54/160 (33%), Gaps = 14/160 (8%)

Query: 2   LKKLNKHLKS-CLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
           +K   +   +  L  E      +     I  ++   Q      LV++             
Sbjct: 35  IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94

Query: 60  HGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSC 115
             +   +T     +Q+   ++ ++   +++RD+KP+N L+      +  M+ + DFG+  
Sbjct: 95  GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154

Query: 116 TLYPG--------NYAEKVCGSPLYMAPEVLQFQRYDEKV 147
                           + + G+  YM+      +    + 
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD 194

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.9 bits (222), Expect = 5e-23
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 29/172 (16%)

Query: 2   LKKLNKHL----KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
           +K L         S L  E+  +  +  H NII L  A   +  ++++VE+ + GNL  Y
Sbjct: 50  VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109

Query: 57  IRLHG----------------RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLS 98
           ++                   ++  +       Q+  G+E L S   IHRDL   N+L  
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL-- 167

Query: 99  GLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKV 147
            + +D ++KIADFGL+  ++  +Y +K         +MAPE L  + Y  + 
Sbjct: 168 -VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.9 bits (214), Expect = 5e-22
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 7/153 (4%)

Query: 2   LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
           L   ++ + S    E+  L  + H NI+RL D   ++  + LV EFC       +   +G
Sbjct: 37  LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96

Query: 62  RVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 118
            +  +  + FL QL  GL   +S +++HRDLKP+N+L   ++ +  LK+A+FGL+     
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGI 153

Query: 119 PGNYAEKVCGSPLYMAPEVL-QFQRYDEKVNFF 150
           P         +  Y  P+VL   + Y   ++ +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 9e-22
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 21/160 (13%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL +  +S L       EL  L  + H N+I L D F  +         +LV+ F   
Sbjct: 48  IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-- 105

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
           G     +  H ++ E   +  + Q+  GL  +++  IIHRDLKP N+    +++D  LKI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA---VNEDCELKI 162

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKV 147
            DFGL+      +       +  Y APEV L + RY + V
Sbjct: 163 LDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTV 200

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 2e-21
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 8/133 (6%)

Query: 16  ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
           E   L  +   P ++ L  AFQ E  + L++++  GG L +++    R  E   + ++ +
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137

Query: 75  L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKVCGSP 130
           +   LE L+   II+RD+K ENIL   LD +  + + DFGLS          A   CG+ 
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 131 LYMAPEVLQFQRY 143
            YMAP++++    
Sbjct: 195 EYMAPDIVRGGDS 207

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (208), Expect = 5e-21
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 30/176 (17%)

Query: 2   LKKLNKH-----LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSS 55
           +K L +       ++ +      +   +H N++ L  A  +    + ++VEFC  GNLS+
Sbjct: 48  VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107

Query: 56  YIRLHGR----------------VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILL 97
           Y+R                    +  +    +  Q+  G+E L S   IHRDL   NIL 
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL- 166

Query: 98  SGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVNFF 150
             L +  ++KI DFGL+  +Y      +         +MAPE +  + Y  + + +
Sbjct: 167 --LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.6 bits (208), Expect = 9e-21
 Identities = 48/163 (29%), Positives = 72/163 (44%), Gaps = 19/163 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
           +KKL++  ++         EL  +  VNH NII L + F  +        ++LV+E    
Sbjct: 47  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106

Query: 51  GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 108
                   +   +  +     L Q+  G++ L+S  IIHRDLKP NI    +  D  LKI
Sbjct: 107 NLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKI 160

Query: 109 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFV 151
            DFGL+ T            +  Y APEV+    Y E V+ + 
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 203

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.4 bits (192), Expect = 1e-18
 Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 19/162 (11%)

Query: 2   LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGG 51
           +KKL++  +S +       EL  L  + H N+I L D F       E     +V    G 
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107

Query: 52  NLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 109
           +L++ ++   ++ +   +  + Q+  GL+ ++S  IIHRDLKP N+    +++D  LKI 
Sbjct: 108 DLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKIL 163

Query: 110 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVNFF 150
           DFGL+   +  +       +  Y APE+ L +  Y++ V+ +
Sbjct: 164 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 67.4 bits (163), Expect = 1e-14
 Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 13/155 (8%)

Query: 7   KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGN---LSSYIRLHG 61
           K L+   D +     S+   +I++L D F     N + +V+ F   G           H 
Sbjct: 61  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120

Query: 62  RVPEQTARKFLQQL--GLEILNSHH-IIHRDLKPENILLSGLD---DDVMLKIADFGLSC 115
            +P    ++  +QL  GL+ ++    IIH D+KPEN+L+  +D   + + +KIAD G +C
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 116 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFF 150
                        +  Y +PEVL    +    + +
Sbjct: 181 WYDEHYT--NSIQTREYRSPEVLLGAPWGCGADIW 213

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 52.9 bits (126), Expect = 7e-10
 Identities = 15/101 (14%), Positives = 33/101 (32%), Gaps = 17/101 (16%)

Query: 19  FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--G 76
            L  +    + +++          +++E               RV  +   + L  +   
Sbjct: 67  ALQKLQGLAVPKVYAWEG----NAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115

Query: 77  LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 117
           +       I+H DL   N+L+     +  + I DF  S  +
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	152
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.92
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.79
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.74
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.59
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.64
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.73
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	87.34
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	85.05

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-42  Score=243.43  Aligned_cols=144  Identities=35%  Similarity=0.637  Sum_probs=115.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+|+.++||||+++++++.+++.+|+||||++|++|.+++.+.+.+++..+..++.|+  |+.|||+++++
T Consensus        50 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  129 (307)
T d1a06a_          50 KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV  129 (307)
T ss_dssp             -----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceee
Confidence            3567889999999999999999999999999999999999999999999988899999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||||+||++...+..+.+|++|||+++.........+.+||+.|+|||++.+..|+.++|||||
T Consensus       130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSl  195 (307)
T d1a06a_         130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI  195 (307)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHH
T ss_pred             eEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhh
Confidence            999999999996555677899999999987766666677889999999999999999999999996

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-42  Score=236.22  Aligned_cols=139  Identities=32%  Similarity=0.576  Sum_probs=128.2

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++||||+++++++.+++.+|+||||+++|+|.+++.+.+.+++..+..++.|+  |+.|||+++++|
T Consensus        50 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivH  129 (263)
T d2j4za1          50 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIH  129 (263)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            577899999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||||+||++   +..+.+||+|||+|+..... .....+||+.|+|||++.+..|+.++|||||
T Consensus       130 rDiKp~Nill---~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl  190 (263)
T d2j4za1         130 RDIKPENLLL---GSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSL  190 (263)
T ss_dssp             CCCCGGGEEE---CTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             eeecccccee---cCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCCCCCchhhhhhH
Confidence            9999999999   56678999999999765433 3456789999999999999999999999996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=237.11  Aligned_cols=141  Identities=30%  Similarity=0.544  Sum_probs=127.6

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..++.+.+|+++++.++||||+++++++.+++.+|+||||+++|+|.+++.+ +.+++..+..++.|+  |+.|||++|+
T Consensus        59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~i  137 (293)
T d1yhwa1          59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV  137 (293)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3467899999999999999999999999999999999999999999998765 469999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+|+.+.... .....+||+.|+|||++.++.|+.++|||||
T Consensus       138 iHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  202 (293)
T d1yhwa1         138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL  202 (293)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHH
T ss_pred             cccCCcHHHeEE---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehH
Confidence            999999999999   466789999999998765443 4566789999999999999999999999996

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=238.84  Aligned_cols=141  Identities=35%  Similarity=0.633  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++..++.+++..+..++.|+  |+.|||+++++
T Consensus        46 ~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~Ii  125 (271)
T d1nvra_          46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT  125 (271)
T ss_dssp             ---CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence            3467899999999999999999999999999999999999999999999888889999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      ||||||+||++   +..+.+||+|||+|+......   ...+.+||+.|+|||++.+..+ +.++|||||
T Consensus       126 HrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSl  192 (271)
T d1nvra_         126 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC  192 (271)
T ss_dssp             CSCCCGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHH
T ss_pred             cCcccHHHEEE---CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHh
Confidence            99999999999   466789999999998764432   2456789999999999998876 578999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-42  Score=242.76  Aligned_cols=142  Identities=33%  Similarity=0.567  Sum_probs=127.2

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHh-C
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNS-H   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~-~   83 (152)
                      ...++.+.+|+++|+.++||||++++++|.+++.+|+||||+++|+|.+++.+.+.+++..+..++.|+  |+.|||+ +
T Consensus        45 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~  124 (322)
T d1s9ja_          45 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH  124 (322)
T ss_dssp             TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            455678999999999999999999999999999999999999999999999988899999999999998  9999997 5


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++||||||+|||+   +..+.+||+|||+|+.+... ...+.+||+.|+|||++.+..|+.++|||||
T Consensus       125 ~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSl  189 (322)
T d1s9ja_         125 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSM  189 (322)
T ss_dssp             CCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHH
T ss_pred             CEEccccCHHHeeE---CCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHH
Confidence            99999999999999   56778999999999865332 3446789999999999999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-41  Score=231.04  Aligned_cols=143  Identities=34%  Similarity=0.655  Sum_probs=125.4

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEI   79 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~   79 (152)
                      +....+.+.+|+++|++++||||++++++++.    ++.+|+||||+++++|.+++.+.+.+++..+..++.|+  |+.|
T Consensus        48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y  127 (270)
T d1t4ha_          48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF  127 (270)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence            34557789999999999999999999999865    35689999999999999999988899999999999998  9999


Q ss_pred             HHhCC--CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           80 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        80 lh~~~--~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||+++  ++||||||+||++.  +..+.+||+|||+++... .....+.+||+.|+|||++.+ .++.++|||||
T Consensus       128 LH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSl  198 (270)
T d1t4ha_         128 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAF  198 (270)
T ss_dssp             HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred             HHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceecc-CCccCCcccCccccCHHHhCC-CCCCcCchhhH
Confidence            99998  99999999999994  345689999999997543 334557789999999999875 69999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-41  Score=238.14  Aligned_cols=141  Identities=32%  Similarity=0.495  Sum_probs=130.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+|+.++||||+++++++++++.+|+||||+++|+|.+++.+.+.+++..++.++.|+  |+.|||+++++
T Consensus        48 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ii  127 (337)
T d1o6la_          48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV  127 (337)
T ss_dssp             CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCcc
Confidence            4577889999999999999999999999999999999999999999999999999999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||||+||++   +.++.+||+|||+|+..... ....+.+||+.|+|||++.+.+|+.++|||||
T Consensus       128 HRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSl  191 (337)
T d1o6la_         128 YRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL  191 (337)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHH
T ss_pred             ccccCHHHeEe---cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccch
Confidence            99999999999   56789999999999876443 44567889999999999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=236.02  Aligned_cols=141  Identities=31%  Similarity=0.576  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+++|++++||||+++++++.+++.+|+||||+++|+|.+++...+.+++..+..++.|+  |+.|||+++++
T Consensus        51 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  130 (288)
T d1uu3a_          51 KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGII  130 (288)
T ss_dssp             CHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEE
Confidence            3567999999999999999999999999999999999999999999999988999999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||||+||++   +..+.+|++|||+|+.+....   ...+.+||+.|+|||++.+..|+.++|||||
T Consensus       131 HrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSl  196 (288)
T d1uu3a_         131 HRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL  196 (288)
T ss_dssp             CSCCSGGGEEE---CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred             cCcCCcccccc---CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehh
Confidence            99999999999   567789999999998764332   3456789999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.4e-41  Score=239.33  Aligned_cols=145  Identities=29%  Similarity=0.523  Sum_probs=131.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH-hcCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++|++++||||+++++++.+++.+|+||||+++|+|.+++. ..+.+++..+..++.|+  |+.|||++
T Consensus        64 ~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~  143 (350)
T d1koaa2          64 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN  143 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            3456789999999999999999999999999999999999999999999985 44569999999999998  99999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++||||||+||++.. +..+.+||+|||+++.+.......+..||+.|+|||++.+..|+.++|||||
T Consensus       144 ~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSl  211 (350)
T d1koaa2         144 NYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSV  211 (350)
T ss_dssp             TEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHH
T ss_pred             CCeeeeechhHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhh
Confidence            9999999999999952 2346899999999998777666777899999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=234.91  Aligned_cols=143  Identities=35%  Similarity=0.575  Sum_probs=125.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+++|++++||||+++++++.+++..|+||||+++|+|.+++.+ .+.+++..+..++.|+  |+.|||++
T Consensus        50 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~  129 (288)
T d2jfla1          50 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN  129 (288)
T ss_dssp             SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            35567889999999999999999999999999999999999999999998765 4569999999999998  99999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccc-----cCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dvws~  152 (152)
                      +++||||||+||++   +.++.+||+|||+|+..... ....+.+||+.|+|||++.     ...|+.++|||||
T Consensus       130 ~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSl  201 (288)
T d2jfla1         130 KIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL  201 (288)
T ss_dssp             TEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHH
T ss_pred             CEEEeecChhheeE---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHH
Confidence            99999999999999   56778999999999764332 2345678999999999984     4558999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-40  Score=230.49  Aligned_cols=143  Identities=31%  Similarity=0.603  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++|++++||||+++++++.+++.+|+||||+++|+|.+++.+.+.+++..+..++.|+  |+.|||+++++|
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivH  136 (293)
T d1jksa_          57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH  136 (293)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceee
Confidence            578999999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCceEeecCC-CCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||||+||++...+ ....+|++|||+++.........+..||+.|+|||++.+..++.++|||||
T Consensus       137 rDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSl  202 (293)
T d1jksa_         137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI  202 (293)
T ss_dssp             CCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             cccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhh
Confidence            99999999995322 223699999999988777666777889999999999999899999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-40  Score=231.28  Aligned_cols=139  Identities=32%  Similarity=0.544  Sum_probs=124.7

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+.+.+|+++|++++||||+++++++.+++..|+|||||.++++..+....+.+++..+..++.|+  |+.|||++++
T Consensus        57 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~i  136 (309)
T d1u5ra_          57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM  136 (309)
T ss_dssp             HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            44577899999999999999999999999999999999999999998888888889999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc---CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+++....   ....+||+.|+|||++.+   +.|+.++|||||
T Consensus       137 iHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSl  200 (309)
T d1u5ra_         137 IHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL  200 (309)
T ss_dssp             BCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHH
T ss_pred             eccCCCcceEEE---CCCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhH
Confidence            999999999999   4677899999999976533   345689999999999864   458999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.5e-40  Score=230.23  Aligned_cols=139  Identities=37%  Similarity=0.651  Sum_probs=128.0

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+.+.+|+.+++.++||||+++++++.+++..|+||||+.|+++.+++.....+++..+..++.|+  |+.|||+++++
T Consensus        47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ii  126 (316)
T d1fota_          47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII  126 (316)
T ss_dssp             CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred             HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEE
Confidence            3577899999999999999999999999999999999999999999999999999999999999998  89999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||||+||++   +..+.+||+|||+|+....  ...+.+||+.|+|||++.+..|+.++|||||
T Consensus       127 HrDiKp~NILl---~~~g~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSl  187 (316)
T d1fota_         127 YRDLKPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSF  187 (316)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHH
T ss_pred             ccccCchheeE---cCCCCEEEecCccceEecc--ccccccCcccccCHHHHcCCCCCchhhcccc
Confidence            99999999999   5677999999999987543  3446789999999999999999999999996

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.7e-40  Score=235.44  Aligned_cols=144  Identities=28%  Similarity=0.518  Sum_probs=130.3

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..++.+.+|+++|++++||||+++++++.+++.+|+|||||++|+|.+.+...+ .+++..+..++.|+  |+.|||++|
T Consensus        68 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~  147 (352)
T d1koba_          68 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS  147 (352)
T ss_dssp             HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            446788899999999999999999999999999999999999999998876544 59999999999998  999999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++||||||+|||+.. ...+.+||+|||+|+.+.......+..||+.|+|||++.+..|+.++|||||
T Consensus       148 iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  214 (352)
T d1koba_         148 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI  214 (352)
T ss_dssp             EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHH
T ss_pred             eeecccccccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHH
Confidence            999999999999942 2456899999999998877766777889999999999999999999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=229.21  Aligned_cols=144  Identities=33%  Similarity=0.647  Sum_probs=114.9

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee--CCeEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHH--HH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQL--GL   77 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i--~l   77 (152)
                      ++...+.+.+|++++++++||||+++++++.+  ++.+|+||||+++|+|.+++.+    ...+++..++.++.|+  |+
T Consensus        43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al  122 (269)
T d2java1          43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL  122 (269)
T ss_dssp             CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence            45567889999999999999999999999864  4568999999999999999853    4569999999999998  89


Q ss_pred             HHHHhCC-----CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCCCCcccceee
Q 031828           78 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        78 ~~lh~~~-----~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                      .|||+.+     ++||||||+||++   +..+.+||+|||+++.+.... ...+.+||+.|+|||++.+..|+.++||||
T Consensus       123 ~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS  199 (269)
T d2java1         123 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS  199 (269)
T ss_dssp             HHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHH
T ss_pred             HHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHh
Confidence            9999866     9999999999999   567789999999998765543 345678999999999999999999999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       200 l  200 (269)
T d2java1         200 L  200 (269)
T ss_dssp             H
T ss_pred             h
Confidence            6

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-40  Score=231.11  Aligned_cols=144  Identities=24%  Similarity=0.441  Sum_probs=117.8

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      +...+++|.+|+++|++++||||+++++++..++..++||||+++|+|.+++... +.+++..+..++.++  |+.|||+
T Consensus        67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  146 (299)
T d1jpaa_          67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD  146 (299)
T ss_dssp             CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            4456778999999999999999999999999999999999999999999988764 468999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCcc------ccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------EKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++||||||+|||+   +.++.+||+|||+++.+......      ....+|+.|+|||++.++.++.++|||||
T Consensus       147 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~  219 (299)
T d1jpaa_         147 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSY  219 (299)
T ss_dssp             TTCCCSCCCGGGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred             CCCccCccccceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccc
Confidence            999999999999999   56779999999999876543221      22457889999999999999999999996

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-40  Score=227.57  Aligned_cols=141  Identities=26%  Similarity=0.478  Sum_probs=116.4

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..++|.+|++++++++||||+++++++..++..++||||+++|+|.+++... ..+++.....++.|+  |+.|+|++++
T Consensus        43 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~i  122 (263)
T d1sm2a_          43 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV  122 (263)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccce
Confidence            3577999999999999999999999999999999999999999999998654 458899999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +.++.+||+|||+++.......  .....||+.|+|||++.+..|+.++|||||
T Consensus       123 iHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~  188 (263)
T d1sm2a_         123 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF  188 (263)
T ss_dssp             CCTTCSGGGEEE---CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHH
T ss_pred             eecccchhheee---cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcch
Confidence            999999999999   5677999999999987654432  234568999999999999999999999996

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-40  Score=228.32  Aligned_cols=141  Identities=28%  Similarity=0.474  Sum_probs=124.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+++|.+|+++|++++||||+++++++..+ ..++||||+++|+|.+++.+...+++..+..++.|+  |+.|||++++
T Consensus        50 ~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i  128 (277)
T d1xbba_          50 ALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF  128 (277)
T ss_dssp             HHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCc
Confidence            4467899999999999999999999999654 578999999999999999998899999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+|++|||+++.+.....    .....||+.|+|||++.+..++.++|||||
T Consensus       129 iHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~  196 (277)
T d1xbba_         129 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF  196 (277)
T ss_dssp             ECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             ccCCCcchhhcc---cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccc
Confidence            999999999999   4667899999999987654422    234568999999999999999999999996

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-40  Score=230.04  Aligned_cols=148  Identities=26%  Similarity=0.436  Sum_probs=128.1

Q ss_pred             cchhh--HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--
Q 031828            2 LKKLN--KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--   75 (152)
Q Consensus         2 ~k~~~--~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--   75 (152)
                      +|+++  ....++|.+|+++|+.++||||+++++++.+++..+++|||+++|+|.+++.+.  ..+++..+..++.|+  
T Consensus        47 vK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~  126 (287)
T d1opja_          47 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS  126 (287)
T ss_dssp             EEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHH
T ss_pred             EEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHH
Confidence            45443  234678999999999999999999999999999999999999999999998754  458999999999998  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|||+++++||||||+|||+   +..+.+||+|||+++.......  .....|++.|+|||++.++.|+.++|||||
T Consensus       127 gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~  202 (287)
T d1opja_         127 AMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF  202 (287)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             HHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhH
Confidence            8999999999999999999999   5677999999999987654432  233457889999999999999999999996

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-40  Score=231.87  Aligned_cols=149  Identities=31%  Similarity=0.567  Sum_probs=129.2

Q ss_pred             cchhhHhHHHHHHHHHHHHHc-CCCcCccceeeeeee----CCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSS-VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQ   74 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~-l~h~ni~~l~~~~~~----~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~   74 (152)
                      +|+++.  ...+.+|+.++.+ .+||||++++++|++    ++.+|+|||||+||+|.+++.+.+  .+++..+..++.|
T Consensus        42 iK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~q  119 (335)
T d2ozaa1          42 LKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS  119 (335)
T ss_dssp             EEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHH
T ss_pred             EEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHH
Confidence            455543  2457789998765 589999999999975    467899999999999999998643  5899999999999


Q ss_pred             H--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           75 L--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        75 i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +  |+.|||+++++||||||+||++......+.+|++|||+++...........+||+.|+|||++.+..|+.++|||||
T Consensus       120 i~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl  199 (335)
T d2ozaa1         120 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL  199 (335)
T ss_dssp             HHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred             HHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence            8  99999999999999999999996545567899999999988777767778899999999999999999999999996

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-39  Score=225.54  Aligned_cols=142  Identities=27%  Similarity=0.484  Sum_probs=124.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....++|.+|+++|++++||||+++++++.. +.+|+||||+++|+|.+++.. ...+++..+..++.|+  |+.|||++
T Consensus        50 ~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~  128 (285)
T d1u59a_          50 KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK  128 (285)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4557889999999999999999999999975 458999999999999999765 4569999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++||||||+||++.   ..+.+|++|||+++.+.....    .....||+.|+|||++.++.++.++|||||
T Consensus       129 ~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~  198 (285)
T d1u59a_         129 NFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSY  198 (285)
T ss_dssp             TEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred             CeecCcCchhheeec---cCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcc
Confidence            999999999999994   567899999999987655432    234568899999999999999999999996

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=224.76  Aligned_cols=143  Identities=27%  Similarity=0.468  Sum_probs=119.3

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      +....+.|.+|+++|++++||||+++++++. ++..++||||+++|+|.+++... ..+++..+..++.|+  |+.|||+
T Consensus        44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~  122 (276)
T d1uwha_          44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA  122 (276)
T ss_dssp             CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            3456788999999999999999999999875 45689999999999999999654 559999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC---CccccCCCCCCccccccccc---CCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~---~~~~~~~Dvws~  152 (152)
                      ++++||||||+|||+   +.++.+||+|||+|+.....   ....+..||+.|+|||++.+   ..|+.++|||||
T Consensus       123 ~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~  195 (276)
T d1uwha_         123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF  195 (276)
T ss_dssp             TTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHH
T ss_pred             CCEeccccCHHHEEE---cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhh
Confidence            999999999999999   46678999999999765432   23356789999999999964   348999999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-39  Score=229.22  Aligned_cols=138  Identities=32%  Similarity=0.574  Sum_probs=127.9

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++|+.++||||+++++++...+..+++||++.+|+|.+.+.+.+.+++..+..++.|+  ||.|||+++++|
T Consensus        85 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiH  164 (350)
T d1rdqe_          85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIY  164 (350)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            567889999999999999999999999999999999999999999999988899999999999998  999999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||||+|||+   +..+.+||+|||+|+.+...  ..+.+||+.|+|||++.+..|+.++|||||
T Consensus       165 RDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSl  224 (350)
T d1rdqe_         165 RDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWAL  224 (350)
T ss_dssp             CCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             CcCCHHHccc---CCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccch
Confidence            9999999999   56778999999999876443  446789999999999999999999999996

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=230.10  Aligned_cols=143  Identities=28%  Similarity=0.459  Sum_probs=123.9

Q ss_pred             HhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-----------------------C
Q 031828            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------------R   62 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-----------------------~   62 (152)
                      ....+.+.+|+.+|+++ +||||+++++++.+++..|+||||+++|+|.+++....                       .
T Consensus        81 ~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (325)
T d1rjba_          81 SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV  160 (325)
T ss_dssp             ---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred             HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCC
Confidence            44567889999999998 89999999999999999999999999999999997542                       3


Q ss_pred             CCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccc
Q 031828           63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEV  137 (152)
Q Consensus        63 ~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~  137 (152)
                      +++..+..++.|+  |+.|||+++++||||||+||++   +.++.+||+|||+|+.......   ..+..||+.|+|||+
T Consensus       161 l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  237 (325)
T d1rjba_         161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  237 (325)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHH
Confidence            7888899999998  8999999999999999999999   4677999999999987544432   235567999999999


Q ss_pred             cccCCCCcccceeeC
Q 031828          138 LQFQRYDEKVNFFVS  152 (152)
Q Consensus       138 ~~~~~~~~~~Dvws~  152 (152)
                      +.++.++.++|||||
T Consensus       238 l~~~~~~~~~DiwS~  252 (325)
T d1rjba_         238 LFEGIYTIKSDVWSY  252 (325)
T ss_dssp             HHHCCCCHHHHHHHH
T ss_pred             HcCCCCCcceeccch
Confidence            999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-39  Score=225.30  Aligned_cols=144  Identities=26%  Similarity=0.464  Sum_probs=129.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      .....+.+|+++|+.++||||+++++++++++.+|+|||||+|++|.+++...+ .+++..+..++.|+  |+.|||+.+
T Consensus        43 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~  122 (321)
T d1tkia_          43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN  122 (321)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            345678899999999999999999999999999999999999999999997655 69999999999998  999999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++||||||+||++.. +....+|++|||+++.........+..+|+.|+|||...+..|+.++|||||
T Consensus       123 iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSl  189 (321)
T d1tkia_         123 IGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL  189 (321)
T ss_dssp             EECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHH
T ss_pred             CCcccccccceeecC-CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccH
Confidence            999999999999952 2445899999999988766666677789999999999999999999999996

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=220.70  Aligned_cols=144  Identities=22%  Similarity=0.403  Sum_probs=120.3

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHh
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNS   82 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~   82 (152)
                      +...+.+|.+|++++++++||||+++++++..++..+++|||+.++++.+.+... ..+++..+..++.++  |+.|||+
T Consensus        49 ~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~  128 (283)
T d1mqba_          49 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN  128 (283)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc
Confidence            3455678999999999999999999999999999999999999999999887654 569999999999998  8999999


Q ss_pred             CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           83 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        83 ~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++++||||||+|||+   +.++.+||+|||+++.+....    ......||+.|+|||++.++.++.++|||||
T Consensus       129 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~  199 (283)
T d1mqba_         129 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF  199 (283)
T ss_dssp             TTCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred             cccccCccccceEEE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCccccccc
Confidence            999999999999999   567899999999998764432    1233567899999999999999999999996

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-39  Score=223.07  Aligned_cols=147  Identities=23%  Similarity=0.445  Sum_probs=125.3

Q ss_pred             cchhhH--hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHH--
Q 031828            2 LKKLNK--HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL--   75 (152)
Q Consensus         2 ~k~~~~--~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i--   75 (152)
                      +|+++.  ...+.|.+|++++++++||||+++++++.. +..++||||+++|+|.+++...  ..+++..+..++.++  
T Consensus        42 vK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~  120 (272)
T d1qpca_          42 VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE  120 (272)
T ss_dssp             EEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHH
T ss_pred             EEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHH
Confidence            454432  335779999999999999999999998854 5679999999999999877533  358999999999998  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|||+++++||||||+||++   +.++.+||+|||+|+.+....  ......||+.|+|||++.++.++.++|||||
T Consensus       121 gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~  196 (272)
T d1qpca_         121 GMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSF  196 (272)
T ss_dssp             HHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHH
T ss_pred             HHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhh
Confidence            8999999999999999999999   567899999999998775543  2345678999999999998899999999996

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.4e-38  Score=218.11  Aligned_cols=141  Identities=40%  Similarity=0.761  Sum_probs=128.8

Q ss_pred             HHHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .++++.+|+.++++++ ||||+++++++.+++.+|+||||+++++|.++++.++.+++..+..++.|+  |+.|||++++
T Consensus        52 ~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~i  131 (277)
T d1phka_          52 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNI  131 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence            4567889999999997 999999999999999999999999999999999999999999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc------CCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Dvws~  152 (152)
                      +||||||+||++   +.++.+||+|||+++.+..........||+.|+|||.+.+      ..++.++||||+
T Consensus       132 vHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diwsl  201 (277)
T d1phka_         132 VHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST  201 (277)
T ss_dssp             ECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHH
T ss_pred             cccccccceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEccc
Confidence            999999999999   5777899999999988776666667889999999999863      346889999995

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-38  Score=222.12  Aligned_cols=140  Identities=36%  Similarity=0.608  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHH-cCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828           10 KSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus        10 ~~~~~~E~~~l~-~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      .+.+..|..++. .++||||+++++++.+++.+|+||||+++|+|.+++...+.+++..+..++.++  |+.|||+++++
T Consensus        46 ~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~ii  125 (320)
T d1xjda_          46 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV  125 (320)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456677777665 689999999999999999999999999999999999998899999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ||||||+||++   +..+.+|++|||+++..... ......+||+.|+|||++.+..|+.++|||||
T Consensus       126 HrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  189 (320)
T d1xjda_         126 YRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSF  189 (320)
T ss_dssp             CCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHH
T ss_pred             eccCcccceee---cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhh
Confidence            99999999999   56778999999999875543 33456789999999999999999999999996

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-37  Score=222.93  Aligned_cols=134  Identities=32%  Similarity=0.570  Sum_probs=120.7

Q ss_pred             HHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCeecCCCC
Q 031828           15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIHRDLKP   92 (152)
Q Consensus        15 ~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~   92 (152)
                      .|+++++.++||||+++++++.+++.+|+||||+++++|.+++.+...+++..+..++.++  |+.|||+++++||||||
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP  135 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP  135 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeecc
Confidence            3477788889999999999999999999999999999999999998899999999999998  99999999999999999


Q ss_pred             CceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccceeeC
Q 031828           93 ENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNFFVS  152 (152)
Q Consensus        93 ~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dvws~  152 (152)
                      +|||+   +..+.+||+|||+|+.+... .....+||+.|+|||++.. ..|+.++|||||
T Consensus       136 ~NILl---~~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSl  192 (364)
T d1omwa3         136 ANILL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSL  192 (364)
T ss_dssp             GGEEE---CSSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHH
T ss_pred             ceeEE---cCCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHH
Confidence            99999   56778999999999866543 3456789999999999975 468999999996

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-38  Score=216.04  Aligned_cols=142  Identities=25%  Similarity=0.458  Sum_probs=125.8

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...+.|.+|+.++++++||||+++++++.+++.+++||||+++|++.+++.. ...+++..+..++.|+  |+.|||+.+
T Consensus        41 ~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  120 (258)
T d1k2pa_          41 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ  120 (258)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC
Confidence            3467899999999999999999999999999999999999999999998654 4568899999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc--cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++|+||||+||++   +..+.+||+|||+++.+.....  .....+|+.|+|||++.++.++.++|||||
T Consensus       121 iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~  187 (258)
T d1k2pa_         121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF  187 (258)
T ss_dssp             BCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             cccccccceeEEE---cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeeccc
Confidence            9999999999999   5677899999999986654432  334678999999999999999999999996

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.7e-38  Score=217.53  Aligned_cols=143  Identities=24%  Similarity=0.445  Sum_probs=118.9

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ....+.+.+|+++++.++||||+++++++..++    .+|+||||++|++|.+++...+.+++..+..++.|+  |+.||
T Consensus        48 ~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~l  127 (277)
T d1o6ya_          48 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS  127 (277)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            344678999999999999999999999997653    489999999999999999988899999999999998  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+++++||||||+||++   ......+++|||.+.......    ...+.+||+.|+|||++.+..++.++|||||
T Consensus       128 H~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSl  200 (277)
T d1o6ya_         128 HQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL  200 (277)
T ss_dssp             HHTTEECCCCSGGGEEE---ETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHH
T ss_pred             HhCCccCccccCccccc---CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccc
Confidence            99999999999999999   466789999999987543322    3456789999999999999899999999996

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-38  Score=220.03  Aligned_cols=140  Identities=33%  Similarity=0.466  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      .+.+.+|+++++.++||||+++++++..++.+|+||||+.++++..+......+++..+..++.|+  |+.|||+++++|
T Consensus        44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH  123 (299)
T d1ua2a_          44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  123 (299)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence            356889999999999999999999999999999999999888777776666779999999999998  999999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |||||+||++   +..+.+||+|||+++...... ...+.+||+.|+|||++... .|+.++|||||
T Consensus       124 rDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  187 (299)
T d1ua2a_         124 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAV  187 (299)
T ss_dssp             CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHH
T ss_pred             ccCCcceEEe---cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhc
Confidence            9999999999   577899999999998765443 34567899999999998755 57999999996

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-37  Score=218.46  Aligned_cols=143  Identities=29%  Similarity=0.456  Sum_probs=123.4

Q ss_pred             HhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----------------CCCCHHHHH
Q 031828            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR   69 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------------~~~~~~~~~   69 (152)
                      ...++.+.+|+++|+++ +||||+++++++..++..++||||+++|+|.+++..+                ..+++..+.
T Consensus        51 ~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  130 (309)
T d1fvra_          51 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL  130 (309)
T ss_dssp             ----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHH
T ss_pred             hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHH
Confidence            34567899999999998 7999999999999999999999999999999999644                458999999


Q ss_pred             HHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCccc
Q 031828           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV  147 (152)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  147 (152)
                      .++.|+  |+.|+|+++++||||||+|||+   +....+||+|||+++............||+.|+|||.+.++.++.++
T Consensus       131 ~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~s  207 (309)
T d1fvra_         131 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS  207 (309)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHH
T ss_pred             HHHHHHHHHHHhhhcCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccc
Confidence            999998  8999999999999999999999   56778999999999865554445566789999999999999999999


Q ss_pred             ceeeC
Q 031828          148 NFFVS  152 (152)
Q Consensus       148 Dvws~  152 (152)
                      |||||
T Consensus       208 DvwSf  212 (309)
T d1fvra_         208 DVWSY  212 (309)
T ss_dssp             HHHHH
T ss_pred             eeehh
Confidence            99996

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-37  Score=214.57  Aligned_cols=142  Identities=26%  Similarity=0.469  Sum_probs=113.7

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ...++.+.+|++++++++||||+++++++. ++.+|+||||+++|++.+++.. ...+++..+..++.|+  |+.|||++
T Consensus        49 ~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~  127 (273)
T d1mp8a_          49 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK  127 (273)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc
Confidence            455788999999999999999999999996 5678999999999999998764 4468999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++||||||+||++.   ..+.+|++|||+++......  ......||+.|+|||++.+..++.++|||||
T Consensus       128 ~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSl  195 (273)
T d1mp8a_         128 RFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF  195 (273)
T ss_dssp             TCCCSCCSGGGEEEE---ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHH
T ss_pred             Ceeccccchhheeec---CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccc
Confidence            999999999999994   56789999999998754432  2345568899999999999999999999996

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=215.79  Aligned_cols=147  Identities=20%  Similarity=0.383  Sum_probs=119.5

Q ss_pred             cchhhHh--HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHH--
Q 031828            2 LKKLNKH--LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQL--   75 (152)
Q Consensus         2 ~k~~~~~--~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i--   75 (152)
                      +|+++..  ..+.|.+|+++|++++||||+++++++.. +..++||||+++|++..++..  ...+++..+..++.++  
T Consensus        46 iK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~  124 (285)
T d1fmka3          46 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS  124 (285)
T ss_dssp             EEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHH
T ss_pred             EEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHH
Confidence            4554322  25779999999999999999999999854 567899999999999988853  3468999999999998  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|||+++++|+||||+||++   +.++.+||+|||+++.+....  ......||+.|+|||++..+.++.++|||||
T Consensus       125 gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~  200 (285)
T d1fmka3         125 GMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  200 (285)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcc
Confidence            8999999999999999999999   566789999999998764433  2344678999999999999999999999996

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-37  Score=215.26  Aligned_cols=142  Identities=25%  Similarity=0.367  Sum_probs=120.0

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHH--HHHHHHhC
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQL--GLEILNSH   83 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i--~l~~lh~~   83 (152)
                      ....+.+.+|+.++++++||||+++++++.++ ..+++++++.+++|.+.+... ..+++..+..++.|+  |+.|||++
T Consensus        52 ~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~  130 (317)
T d1xkka_          52 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR  130 (317)
T ss_dssp             -CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence            34567899999999999999999999999865 567788889899998887654 568999999999998  89999999


Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc---cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +++||||||+||++   +..+.+||+|||+++.......   .....||+.|+|||++.++.++.++|||||
T Consensus       131 ~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~  199 (317)
T d1xkka_         131 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY  199 (317)
T ss_dssp             TCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             CcccCcchhhccee---CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhH
Confidence            99999999999999   4567899999999987654432   234568999999999999999999999996

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-37  Score=213.66  Aligned_cols=143  Identities=24%  Similarity=0.478  Sum_probs=124.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC------------------------C
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------R   62 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------------------~   62 (152)
                      ...+++|.+|++++++++||||+++++++...+..++++|++++++|.+++....                        .
T Consensus        57 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (301)
T d1lufa_          57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP  136 (301)
T ss_dssp             HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred             hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCC
Confidence            3457789999999999999999999999999999999999999999999986432                        3


Q ss_pred             CCHHHHHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccc
Q 031828           63 VPEQTARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEV  137 (152)
Q Consensus        63 ~~~~~~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~  137 (152)
                      ++...+..++.++  |+.|||+.+++||||||+||++   +.++.+||+|||+|+.+.+..   ...+..+++.|+|||.
T Consensus       137 l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (301)
T d1lufa_         137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  213 (301)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence            7788899999998  8999999999999999999999   567889999999998664433   2345678899999999


Q ss_pred             cccCCCCcccceeeC
Q 031828          138 LQFQRYDEKVNFFVS  152 (152)
Q Consensus       138 ~~~~~~~~~~Dvws~  152 (152)
                      +.+..||.++|||||
T Consensus       214 ~~~~~~t~ksDVwS~  228 (301)
T d1lufa_         214 IFYNRYTTESDVWAY  228 (301)
T ss_dssp             HHHCCCCHHHHHHHH
T ss_pred             HccCCCChhhhhccc
Confidence            999999999999996

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=208.44  Aligned_cols=144  Identities=26%  Similarity=0.397  Sum_probs=124.4

Q ss_pred             hHhHHHHHHHHHHHHHcCCCcCccceeeeeee-CCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHH
Q 031828            6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILN   81 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh   81 (152)
                      +....++|.+|+++|++++||||+++++++.. ++..++||||+++++|.+++.... ..+...+..++.|+  |+.|+|
T Consensus        68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH  147 (311)
T d1r0pa_          68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA  147 (311)
T ss_dssp             CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc
Confidence            44567889999999999999999999999865 468999999999999999887544 46778888899998  899999


Q ss_pred             hCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           82 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        82 ~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +.+++||||||+|||+   +....+||+|||+++......     ......||+.|+|||.+..+.++.++|||||
T Consensus       148 ~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~Sf  220 (311)
T d1r0pa_         148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF  220 (311)
T ss_dssp             HTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             ccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhh
Confidence            9999999999999999   567789999999998764432     1233568899999999999999999999996

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-36  Score=210.27  Aligned_cols=142  Identities=31%  Similarity=0.478  Sum_probs=115.0

Q ss_pred             hHHHHHHHHHHHHHcC-CCcCccceeeeeeeC-CeEEEEEeecCCCChHHHHHhcC----------------CCCHHHHH
Q 031828            8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR   69 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~   69 (152)
                      ...+.+.+|..++.++ +|+||+.+++++..+ +.++++|||+++|+|.+++....                .+++..+.
T Consensus        58 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~  137 (299)
T d1ywna1          58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI  137 (299)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHH
Confidence            4456677888877776 789999999987654 56899999999999999996432                37888999


Q ss_pred             HHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCC
Q 031828           70 KFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYD  144 (152)
Q Consensus        70 ~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  144 (152)
                      .++.|+  |+.|||+++++||||||+||++   +..+.+||+|||+|+......   ......||+.|+|||++.++.++
T Consensus       138 ~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~  214 (299)
T d1ywna1         138 CYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence            999998  8999999999999999999999   567799999999998654432   23456789999999999999999


Q ss_pred             cccceeeC
Q 031828          145 EKVNFFVS  152 (152)
Q Consensus       145 ~~~Dvws~  152 (152)
                      .++|||||
T Consensus       215 ~~sDiwS~  222 (299)
T d1ywna1         215 IQSDVWSF  222 (299)
T ss_dssp             HHHHHHHH
T ss_pred             cccceeeh
Confidence            99999996

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-37  Score=209.36  Aligned_cols=146  Identities=23%  Similarity=0.450  Sum_probs=117.0

Q ss_pred             cchhh-HhHHHHHHHHHHHHHcCCCcCccceeeeeee-CCeEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHH--
Q 031828            2 LKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQL--   75 (152)
Q Consensus         2 ~k~~~-~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~-~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i--   75 (152)
                      +|+++ +...+++.+|++++++++||||+++++++.. ++.+|+||||+++|+|.+++...+  .+++..+..++.++  
T Consensus        35 vK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~  114 (262)
T d1byga_          35 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE  114 (262)
T ss_dssp             EEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHh
Confidence            45443 3446789999999999999999999998854 467899999999999999986543  48999999999998  


Q ss_pred             HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           76 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        76 ~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |+.|||+.+++|+||||+||++   +.++.+|++|||+++.....  .....+++.|+|||++.++.++.++|||||
T Consensus       115 al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSf  186 (262)
T d1byga_         115 AMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSF  186 (262)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHH
T ss_pred             hccccccCceeccccchHhhee---cCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhH
Confidence            8999999999999999999999   56788999999999764332  344567889999999999999999999996

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-36  Score=208.39  Aligned_cols=144  Identities=28%  Similarity=0.453  Sum_probs=126.7

Q ss_pred             hHhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC----------------CCCHHHH
Q 031828            6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA   68 (152)
Q Consensus         6 ~~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------------~~~~~~~   68 (152)
                      +......+.+|...+.++ +||||+++++++.+++..++||||+.+|+|.+++....                .+++..+
T Consensus        58 ~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~  137 (299)
T d1fgka_          58 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL  137 (299)
T ss_dssp             CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHH
T ss_pred             ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHH
Confidence            345567888999999888 89999999999999999999999999999999997543                4799999


Q ss_pred             HHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCC
Q 031828           69 RKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY  143 (152)
Q Consensus        69 ~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~  143 (152)
                      ..++.|+  |+.|||+++++||||||+|||+   +.++.+|++|||+++......   ......+++.|+|||.+.++.|
T Consensus       138 ~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y  214 (299)
T d1fgka_         138 VSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY  214 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC
Confidence            9999998  8999999999999999999999   567789999999998764432   2345678899999999999999


Q ss_pred             CcccceeeC
Q 031828          144 DEKVNFFVS  152 (152)
Q Consensus       144 ~~~~Dvws~  152 (152)
                      +.++|||||
T Consensus       215 ~~k~DiwS~  223 (299)
T d1fgka_         215 THQSDVWSF  223 (299)
T ss_dssp             CHHHHHHHH
T ss_pred             CchhhhHHh
Confidence            999999996

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-36  Score=208.03  Aligned_cols=140  Identities=33%  Similarity=0.567  Sum_probs=120.2

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHH--hcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+++.+|+++|++++||||+++++++.+++..|+||||+.+ ++.+++.  ....+++..+..++.|+  |+.|||+++
T Consensus        44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~  122 (298)
T d1gz8a_          44 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR  122 (298)
T ss_dssp             CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence            367889999999999999999999999999999999999964 4444443  34559999999999998  999999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCC-CccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      ++||||||+||++   +.+..+|++|||+|+..... .......||+.|+|||++.... ++.++|||||
T Consensus       123 IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSl  189 (298)
T d1gz8a_         123 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSL  189 (298)
T ss_dssp             CCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHH
T ss_pred             EEccccCchheee---cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCcccccccc
Confidence            9999999999999   56778999999999876543 3445668999999999988766 5789999996

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-36  Score=207.32  Aligned_cols=141  Identities=28%  Similarity=0.403  Sum_probs=119.5

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ...++|.+|+.+|++++||||+++++++.+ +..++||||++++++.+.+.. .+.+++..+..++.|+  |+.|||+++
T Consensus        53 ~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~  131 (273)
T d1u46a_          53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR  131 (273)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence            335789999999999999999999999975 467899999999999987764 4469999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCCc----cccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++||||||+||++.   ....+|++|||+++.+.....    .....+++.|+|||++.+..++.++|||||
T Consensus       132 iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~  200 (273)
T d1u46a_         132 FIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMF  200 (273)
T ss_dssp             EECSCCCGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred             EeeeeecHHHhccc---cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhh
Confidence            99999999999994   566899999999987644432    234457888999999999999999999996

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-36  Score=205.48  Aligned_cols=139  Identities=27%  Similarity=0.464  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHcCC--CcCccceeeeeeeCCeEEEEEeecCC-CChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        11 ~~~~~E~~~l~~l~--h~ni~~l~~~~~~~~~~~lv~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .++.+|+.++++++  ||||+++++++.+++..++|||++.+ +++.+++.++..+++..+..++.|+  |+.|||++++
T Consensus        52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~i  131 (273)
T d1xwsa_          52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV  131 (273)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            34678999999986  89999999999999999999999965 6888888888899999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCC-CcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dvws~  152 (152)
                      +||||||+||++.  ...+.+|++|||+|+.... ....+..||+.|+|||++.+..+ +.++|||||
T Consensus       132 iHrDiKp~NIll~--~~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSl  196 (273)
T d1xwsa_         132 LHRDIKDENILID--LNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL  196 (273)
T ss_dssp             ECSCCSGGGEEEE--TTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred             ccccCcccceEEe--cCCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccc
Confidence            9999999999995  2446899999999976433 34456789999999999988775 567899996

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=208.53  Aligned_cols=143  Identities=29%  Similarity=0.419  Sum_probs=125.9

Q ss_pred             HhHHHHHHHHHHHHHcC-CCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC------------------CCCHHH
Q 031828            7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQT   67 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l-~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~------------------~~~~~~   67 (152)
                      ......+.+|+.+++++ +||||+++++++.+++..+++|||+++++|.+++....                  .+++..
T Consensus        67 ~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~  146 (311)
T d1t46a_          67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED  146 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred             HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence            34567899999999999 79999999999999999999999999999999987543                  478889


Q ss_pred             HHHHHHHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCC
Q 031828           68 ARKFLQQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR  142 (152)
Q Consensus        68 ~~~~~~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~  142 (152)
                      +..++.|+  |+.|||+++++||||||+||++   +..+.++++|||.++......   .....+||+.|+|||++.++.
T Consensus       147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  223 (311)
T d1t46a_         147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV  223 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence            99999998  8999999999999999999999   467799999999998765432   234467899999999999999


Q ss_pred             CCcccceeeC
Q 031828          143 YDEKVNFFVS  152 (152)
Q Consensus       143 ~~~~~Dvws~  152 (152)
                      ++.++|||||
T Consensus       224 ~~~~~DIwS~  233 (311)
T d1t46a_         224 YTFESDVWSY  233 (311)
T ss_dssp             CCHHHHHHHH
T ss_pred             CCCcccccch
Confidence            9999999996

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2e-35  Score=208.57  Aligned_cols=146  Identities=25%  Similarity=0.414  Sum_probs=126.6

Q ss_pred             cchhhHhHHHHHHHHHHHHHcCC-CcCccceeeeeeeC--CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--H
Q 031828            2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--G   76 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~   76 (152)
                      +|+++....+++.+|+++|+.++ ||||+++++++...  ..+++||||+.+++|..+.   +.+++..+..++.|+  |
T Consensus        65 iK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~a  141 (328)
T d3bqca1          65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA  141 (328)
T ss_dssp             EEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHH
T ss_pred             EEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            57776666788999999999995 99999999999744  5699999999999987763   468999999999998  9


Q ss_pred             HHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           77 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        77 l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      |.|||++|++||||||+|||+.  .....+|++|||+|+...+.......++|+.|+|||.+.+.. ++.++||||+
T Consensus       142 L~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  216 (328)
T d3bqca1         142 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  216 (328)
T ss_dssp             HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhh
Confidence            9999999999999999999995  234579999999998877666667788999999999988654 7999999995

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-35  Score=204.85  Aligned_cols=147  Identities=27%  Similarity=0.348  Sum_probs=117.5

Q ss_pred             cchhhHhHHHHHHHHHH--HHHcCCCcCccceeeeeeeCC----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELN--FLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL   75 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~--~l~~l~h~ni~~l~~~~~~~~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i   75 (152)
                      +|.++.+....+..|.+  .++.++||||+++++++..++    .+|+||||+++|+|.+++++. .+++.....++.++
T Consensus        31 vK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~i  109 (303)
T d1vjya_          31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST  109 (303)
T ss_dssp             EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHH
T ss_pred             EEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHH
Confidence            56666555555555555  445789999999999997653    689999999999999999764 57888888888887


Q ss_pred             --HHHHHHh--------CCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC-----ccccCCCCCCccccccccc
Q 031828           76 --GLEILNS--------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF  140 (152)
Q Consensus        76 --~l~~lh~--------~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~  140 (152)
                        |+.|+|.        .+++||||||+||++   +.++.+||+|||+++......     ......||+.|+|||++.+
T Consensus       110 a~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  186 (303)
T d1vjya_         110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD  186 (303)
T ss_dssp             HHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccc
Confidence              8999996        589999999999999   567899999999998764432     2345679999999999876


Q ss_pred             CC------CCcccceeeC
Q 031828          141 QR------YDEKVNFFVS  152 (152)
Q Consensus       141 ~~------~~~~~Dvws~  152 (152)
                      ..      ++.++|||||
T Consensus       187 ~~~~~~~~~~~k~Di~S~  204 (303)
T d1vjya_         187 SINMKHFESFKRADIYAM  204 (303)
T ss_dssp             CSCTTCHHHHHHHHHHHH
T ss_pred             cccccCCCcCcchhhhhh
Confidence            42      6778999996

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-35  Score=204.11  Aligned_cols=143  Identities=21%  Similarity=0.370  Sum_probs=124.6

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhc----------CCCCHHHHHHHHHHH-
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQL-   75 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i-   75 (152)
                      ......|.+|++++++++||||+++++++..++..++||||+++|+|.+++...          ..++...+..++.++ 
T Consensus        64 ~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia  143 (308)
T d1p4oa_          64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA  143 (308)
T ss_dssp             HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHH
Confidence            345677899999999999999999999999999999999999999999988533          236778888899998 


Q ss_pred             -HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC---ccccCCCCCCcccccccccCCCCcccceee
Q 031828           76 -GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVNFFV  151 (152)
Q Consensus        76 -~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  151 (152)
                       |+.|||+++++||||||+|||+   +.+..+||+|||+++......   ......+|+.|+|||.+.++.++.++||||
T Consensus       144 ~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S  220 (308)
T d1p4oa_         144 DGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS  220 (308)
T ss_dssp             HHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHhhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCccccccc
Confidence             8999999999999999999999   577899999999998664432   234456899999999999999999999999


Q ss_pred             C
Q 031828          152 S  152 (152)
Q Consensus       152 ~  152 (152)
                      |
T Consensus       221 ~  221 (308)
T d1p4oa_         221 F  221 (308)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-35  Score=205.24  Aligned_cols=140  Identities=34%  Similarity=0.492  Sum_probs=118.1

Q ss_pred             HHHHHHHHHHHHcC---CCcCccceeeeeee-----CCeEEEEEeecCCCChHHHHH-hcCCCCHHHHHHHHHHH--HHH
Q 031828           10 KSCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus        10 ~~~~~~E~~~l~~l---~h~ni~~l~~~~~~-----~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ...+.+|+.+++.+   +||||+++++++..     ....++++|++.++++..... ....+++..+..++.|+  |+.
T Consensus        51 ~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~  130 (305)
T d1blxa_          51 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD  130 (305)
T ss_dssp             BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            34566788877665   89999999999853     346899999998776654443 34458999999999998  999


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||+++++||||||+|||+   +..+.+|++|||+++............||+.|+|||++.+..|+.++|||||
T Consensus       131 yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl  201 (305)
T d1blxa_         131 FLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSV  201 (305)
T ss_dssp             HHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred             HHHhCCEEecCCCccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhch
Confidence            9999999999999999999   5677899999999987665566678899999999999999999999999995

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.4e-35  Score=202.47  Aligned_cols=141  Identities=29%  Similarity=0.450  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCe
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHII   86 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~   86 (152)
                      ..+++.+|+.+|++++||||+++++++..++..+++++++.++.+..+....+.+++..+..++.|+  ||.|||+.+++
T Consensus        43 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~Iv  122 (286)
T d1ob3a_          43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL  122 (286)
T ss_dssp             CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEE
Confidence            3678999999999999999999999999999999999999877777777777889999999999998  99999999999


Q ss_pred             ecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           87 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        87 h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      ||||||+||++   +.++.+|++|||.+....... ......+++.|+|||.+.+.. ++.++|||||
T Consensus       123 HrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~Diwsl  187 (286)
T d1ob3a_         123 HRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSV  187 (286)
T ss_dssp             CSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHH
T ss_pred             ecCCCCceeeE---cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhc
Confidence            99999999999   567889999999998765443 344557899999999997654 6899999996

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=201.26  Aligned_cols=148  Identities=28%  Similarity=0.438  Sum_probs=118.8

Q ss_pred             cchhhHhHHHHHHHHHHHHHcCCCcCccceeeeeeeC------CeEEEEEeecCCCChHHHH---HhcCCCCHHHHHHHH
Q 031828            2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL   72 (152)
Q Consensus         2 ~k~~~~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~------~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~   72 (152)
                      +|++... .....+|+++|++++||||++++++|...      .++|+||||++++.+..+.   .....+++..++.++
T Consensus        50 iK~i~~~-~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~  128 (350)
T d1q5ka_          50 IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM  128 (350)
T ss_dssp             EEEEECC-SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHH
T ss_pred             EEEECcc-chHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHH
Confidence            4444322 23345799999999999999999998543      3589999999755333322   345569999999999


Q ss_pred             HHH--HHHHHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccccccccc-CCCCcccce
Q 031828           73 QQL--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVNF  149 (152)
Q Consensus        73 ~~i--~l~~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv  149 (152)
                      .|+  |+.|||++|++||||||+|||+.  .....+||+|||+++.+.......+..||+.|+|||.+.+ ..++.++||
T Consensus       129 ~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DI  206 (350)
T d1q5ka_         129 YQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV  206 (350)
T ss_dssp             HHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHH
T ss_pred             HHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceee
Confidence            998  99999999999999999999994  2334799999999988776666677889999999999875 468999999


Q ss_pred             eeC
Q 031828          150 FVS  152 (152)
Q Consensus       150 ws~  152 (152)
                      |||
T Consensus       207 wSl  209 (350)
T d1q5ka_         207 WSA  209 (350)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            995

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7e-34  Score=197.88  Aligned_cols=142  Identities=18%  Similarity=0.250  Sum_probs=122.0

Q ss_pred             HHHHHHHHHHHHcCCC-cCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828           10 KSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      .+.+++|+++++.++| +|++.+++++..++..++|||++ +++|.+++...+ .++...+..++.++  |+.+||++|+
T Consensus        44 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~gi  122 (293)
T d1csna_          44 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL  122 (293)
T ss_dssp             SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCc
Confidence            4567889999999976 89999999999999999999998 789999887654 58999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCC--CCceEEEeeccCccccCCCC--------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~--~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      +||||||+||+++...  ..+.+|++|||+|+......        ...+.+||+.|+|||++.+..++.++|||||
T Consensus       123 iHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSl  199 (293)
T d1csna_         123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEAL  199 (293)
T ss_dssp             ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             eeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHh
Confidence            9999999999996322  24679999999998754321        2345679999999999999999999999996

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=200.60  Aligned_cols=140  Identities=29%  Similarity=0.502  Sum_probs=117.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCC-----eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~-----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ...+.+.+|+++|+.++||||+++++++..+.     .+++++ ++.+++|.+++... .+++..+..++.|+  |+.||
T Consensus        48 ~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yL  125 (345)
T d1pmea_          48 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI  125 (345)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHH
Confidence            44667889999999999999999999997653     355555 45689999999654 68999999999998  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCC----ccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |+++++||||||+|||+   +..+.+||+|||+++......    .....+||+.|+|||++... .++.++||||+
T Consensus       126 H~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSl  199 (345)
T d1pmea_         126 HSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV  199 (345)
T ss_dssp             HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHH
T ss_pred             HHCCCcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhcc
Confidence            99999999999999999   567789999999997654432    23556789999999998654 57899999995

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-33  Score=194.46  Aligned_cols=143  Identities=18%  Similarity=0.208  Sum_probs=118.1

Q ss_pred             HHHHHHHHHHHHHcCCCcCcc-ceeeeeeeCCeEEEEEeecCCCChHHHHH-hcCCCCHHHHHHHHHHH--HHHHHHhCC
Q 031828            9 LKSCLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQL--GLEILNSHH   84 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~-~l~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i--~l~~lh~~~   84 (152)
                      ..+.+..|+++++.++|+|++ .+..++..++..++|||++ ++++.+.+. ..+.+++..+..++.|+  |+.|||+++
T Consensus        45 ~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  123 (299)
T d1ckia_          45 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN  123 (299)
T ss_dssp             TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence            345688999999999877655 5566677888999999999 566666554 45579999999999998  899999999


Q ss_pred             CeecCCCCCceEeecCCCCceEEEeeccCccccCCCC--------ccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           85 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        85 ~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      ++||||||+||++...+....++++|||+|+.+....        ...+..||+.|+|||++.+..++.++|||||
T Consensus       124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  199 (299)
T d1ckia_         124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESL  199 (299)
T ss_dssp             EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHH
T ss_pred             eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEec
Confidence            9999999999998654556689999999998764432        2345679999999999999999999999996

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=200.28  Aligned_cols=140  Identities=34%  Similarity=0.483  Sum_probs=110.4

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeee------CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ....+++.+|+.+++.++||||++++++|..      .++.|+||||+.+ ++.+.+  ...+++..++.++.|+  |+.
T Consensus        57 ~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~  133 (355)
T d2b1pa1          57 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIK  133 (355)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHH
Confidence            4456778999999999999999999999953      3688999999965 444444  3568999999999998  999


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCCCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws~  152 (152)
                      |||++|++||||||+||++   ..++.++++|||+++...........++|+.|+|||++.+..++.++||||+
T Consensus       134 ~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSl  204 (355)
T d2b1pa1         134 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV  204 (355)
T ss_dssp             HHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred             HhhhcccccccCCcccccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccc
Confidence            9999999999999999999   5677899999999987766666677789999999999999999999999995

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-33  Score=197.93  Aligned_cols=141  Identities=25%  Similarity=0.443  Sum_probs=118.5

Q ss_pred             HHHHHHHHHHHHHcCCCcCccceeeeeee--------CCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 031828            9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h~ni~~l~~~~~~--------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ...++.+|+++|++++||||+++++++..        ++.+|++||++.++.+.........+++..+..++.|+  |+.
T Consensus        52 ~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~  131 (318)
T d3blha1          52 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY  131 (318)
T ss_dssp             SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHH
Confidence            45678899999999999999999998854        34689999999777766665566679999999999998  999


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCC-----CccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |||+++++||||||+||++   +.++.+|++|||+++.+...     ....+.+||+.|+|||++.+. .++.++|||||
T Consensus       132 ~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl  208 (318)
T d3blha1         132 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA  208 (318)
T ss_dssp             HHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HhccCCEEecCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence            9999999999999999999   56778999999999765432     233456799999999999865 58999999996

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-33  Score=197.36  Aligned_cols=139  Identities=32%  Similarity=0.535  Sum_probs=119.6

Q ss_pred             HhHHHHHHHHHHHHHcCCCcCccceeeeeeeCC------eEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHH
Q 031828            7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLE   78 (152)
Q Consensus         7 ~~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~   78 (152)
                      ....+.+.+|+++|+.++||||++++++|...+      ++|+||||+ +.+|..+.+ ++.+++..++.++.|+  ||.
T Consensus        58 ~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~  135 (346)
T d1cm8a_          58 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLR  135 (346)
T ss_dssp             HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999997654      579999999 667777664 5679999999999998  999


Q ss_pred             HHHhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccC-CCCcccceeeC
Q 031828           79 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVNFFVS  152 (152)
Q Consensus        79 ~lh~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dvws~  152 (152)
                      |||++|++||||||+||++   +..+.+|++|||+|+....  ......||+.|+|||++.+. .++.++||||+
T Consensus       136 ~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl  205 (346)
T d1cm8a_         136 YIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSV  205 (346)
T ss_dssp             HHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred             HHHhCCCcccccCcchhhc---ccccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcc
Confidence            9999999999999999999   5778899999999986543  34567799999999999764 46899999995

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-34  Score=199.75  Aligned_cols=141  Identities=30%  Similarity=0.499  Sum_probs=124.2

Q ss_pred             HHHHHHHHHHHHHcCCC-cCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         9 ~~~~~~~E~~~l~~l~h-~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ..+.+.+|++++++++| |||+++++++.++...++++||+.+++|.+++...+.+++..+..++.|+  |+.|+|+.++
T Consensus        71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~i  150 (322)
T d1vzoa_          71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI  150 (322)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence            35678899999999976 89999999999999999999999999999999998899999999999998  9999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCC--CccccCCCCCCcccccccccC--CCCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQ--RYDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dvws~  152 (152)
                      +||||||+||++   +..+.+||+|||+++.+...  ....+..|++.|+|||.+.+.  .++.++|||||
T Consensus       151 vHrDiKp~Nill---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSl  218 (322)
T d1vzoa_         151 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL  218 (322)
T ss_dssp             CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred             EeccCCccceee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHH
Confidence            999999999999   56778999999999876443  234567899999999999764  36789999996

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-32  Score=191.62  Aligned_cols=142  Identities=29%  Similarity=0.488  Sum_probs=126.0

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCC
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHI   85 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~   85 (152)
                      ...+++.+|+.+++.++||||+++++++..+...+++++++.++++..+....+.+++..+..++.|+  |+.|||++++
T Consensus        43 ~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~I  122 (292)
T d1unla_          43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV  122 (292)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCE
Confidence            45688999999999999999999999999999999999999999999988888889999999999998  8999999999


Q ss_pred             eecCCCCCceEeecCCCCceEEEeeccCccccCCCC-ccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           86 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        86 ~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      +||||||+||++   .....+|++|||.++...... ......+++.|+|||++.... ++.++|||||
T Consensus       123 vHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSl  188 (292)
T d1unla_         123 LHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA  188 (292)
T ss_dssp             ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred             eeecccCccccc---ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhcccc
Confidence            999999999999   566789999999998765543 334445678899999998765 6899999996

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=190.47  Aligned_cols=139  Identities=28%  Similarity=0.473  Sum_probs=112.9

Q ss_pred             hHHHHHHHHHHHHHcCCCcCccceeeeeeeC-----CeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHH
Q 031828            8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEIL   80 (152)
Q Consensus         8 ~~~~~~~~E~~~l~~l~h~ni~~l~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~l   80 (152)
                      ...+++.+|+++|+.++|||++++++++...     ...+++++++.+++|.+++.. +.+++..+..++.|+  ||.||
T Consensus        59 ~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~L  137 (348)
T d2gfsa1          59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI  137 (348)
T ss_dssp             HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHH
Confidence            4456788999999999999999999998643     234555666779999998854 569999999999998  99999


Q ss_pred             HhCCCeecCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCcccccccccCC-CCcccceeeC
Q 031828           81 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVNFFVS  152 (152)
Q Consensus        81 h~~~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dvws~  152 (152)
                      |++|++||||||+||++   +..+.+|++|||++...  .....+..||+.|+|||...+.. ++.++|||||
T Consensus       138 H~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~--~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSl  205 (348)
T d2gfsa1         138 HSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV  205 (348)
T ss_dssp             HHTTCCCCCCCGGGEEE---CTTCCEEECCC----CC--TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred             HhCCCcccccCCccccc---cccccccccccchhccc--CcccccccccccccCchhhcCCccCCcccchhhh
Confidence            99999999999999999   56778999999998653  23345667889999999987655 6889999996

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.92  E-value=5.4e-26  Score=161.64  Aligned_cols=149  Identities=28%  Similarity=0.426  Sum_probs=112.5

Q ss_pred             cchhhH--hHHHHHHHHHHHHHcCC-----------CcCccceeeeeeeC--CeEEEEEeecCCCCh-HHHH--HhcCCC
Q 031828            2 LKKLNK--HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAE--NCIFLVVEFCAGGNL-SSYI--RLHGRV   63 (152)
Q Consensus         2 ~k~~~~--~~~~~~~~E~~~l~~l~-----------h~ni~~l~~~~~~~--~~~~lv~e~~~~~~l-~~~~--~~~~~~   63 (152)
                      +|+++.  ...+.+.+|+++++.++           |+||+++++++...  ...+++++++..+.. ....  .....+
T Consensus        43 vKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  122 (362)
T d1q8ya_          43 MKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI  122 (362)
T ss_dssp             EEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCC
T ss_pred             EEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCC
Confidence            455543  23577889999998875           47899999887543  566677776644433 2222  234568


Q ss_pred             CHHHHHHHHHHH--HHHHHHh-CCCeecCCCCCceEeecCCC---CceEEEeeccCccccCCCCccccCCCCCCcccccc
Q 031828           64 PEQTARKFLQQL--GLEILNS-HHIIHRDLKPENILLSGLDD---DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV  137 (152)
Q Consensus        64 ~~~~~~~~~~~i--~l~~lh~-~~~~h~dl~~~nil~~~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~aPE~  137 (152)
                      ++..+..++.++  |+.|||+ .+++||||||+||++...+.   ...++++|||.+.....  .....+||+.|+|||+
T Consensus       123 ~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~  200 (362)
T d1q8ya_         123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEV  200 (362)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhh
Confidence            999999999998  9999997 88999999999999953221   23589999999875433  3356679999999999


Q ss_pred             cccCCCCcccceeeC
Q 031828          138 LQFQRYDEKVNFFVS  152 (152)
Q Consensus       138 ~~~~~~~~~~Dvws~  152 (152)
                      +....++.++|+||+
T Consensus       201 ~~~~~~~~~~DiwSl  215 (362)
T d1q8ya_         201 LLGAPWGCGADIWST  215 (362)
T ss_dssp             HHTCCCCTHHHHHHH
T ss_pred             ccccCCCccccccch
Confidence            999999999999995

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.79  E-value=8.3e-20  Score=119.02  Aligned_cols=120  Identities=15%  Similarity=0.182  Sum_probs=85.6

Q ss_pred             HHHHHHHHHHHHcCCCcCccceeeeeeeCCeEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH--HHHHHHhCCCee
Q 031828           10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL--GLEILNSHHIIH   87 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i--~l~~lh~~~~~h   87 (152)
                      ......|...+.++.|++++..+++..    .+++||++++..+.+       ++......++.++  ++.+||.+|++|
T Consensus        58 ~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiH  126 (191)
T d1zara2          58 IRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVH  126 (191)
T ss_dssp             HHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEE
Confidence            455667899999999999998876542    379999997766543       2334445677777  899999999999


Q ss_pred             cCCCCCceEeecCCCCceEEEeeccCccccCCCCccccCCCCCCccc------ccccccCCCCcccceeeC
Q 031828           88 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA------PEVLQFQRYDEKVNFFVS  152 (152)
Q Consensus        88 ~dl~~~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~t~~y~a------PE~~~~~~~~~~~Dvws~  152 (152)
                      +||||+||++.    ...++++|||.|+....+...       .|..      .+.+ .+.|+.++|+||.
T Consensus       127 rDiKP~NILv~----~~~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~  185 (191)
T d1zara2         127 GDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSA  185 (191)
T ss_dssp             SCCSTTSEEEE----TTEEEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHH
T ss_pred             ccCChhheeee----CCCEEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHH
Confidence            99999999994    245899999998764322210       1111      1111 2568899999983

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.74  E-value=8.6e-05  Score=48.79  Aligned_cols=47  Identities=9%  Similarity=0.014  Sum_probs=35.5

Q ss_pred             HHHHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCChHHH
Q 031828           10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY   56 (152)
Q Consensus        10 ~~~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l~~~   56 (152)
                      ...+.+|..++..+. +--+.+++.+...++..+++|++++|.++...
T Consensus        53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence            345678888887763 44467888888888999999999988776543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.59  E-value=6.9e-05  Score=49.06  Aligned_cols=51  Identities=18%  Similarity=0.073  Sum_probs=36.3

Q ss_pred             chhhHhHHHHHHHHHHHHHcCCC--cCccceeeeeeeCCeEEEEEeecCCCCh
Q 031828            3 KKLNKHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNL   53 (152)
Q Consensus         3 k~~~~~~~~~~~~E~~~l~~l~h--~ni~~l~~~~~~~~~~~lv~e~~~~~~l   53 (152)
                      |.........+..|...++.+..  -.+.+++.+...++..+++|++++|.++
T Consensus        41 K~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          41 KTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             EEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            44444444567788888887743  3356778888888889999999987655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.64  E-value=0.0049  Score=42.92  Aligned_cols=28  Identities=29%  Similarity=0.398  Sum_probs=23.3

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      .++|+|+.|.||++.    ...++++|+..+.
T Consensus       224 ~LiHGDl~~gNIlv~----~~~~~vID~E~a~  251 (392)
T d2pula1         224 TLIHGDLHTGSIFAS----EHETKVIDPEFAF  251 (392)
T ss_dssp             EEECSCCCGGGEEEC----SSCEEECCCTTCE
T ss_pred             ceeccCCcCCceeEc----CCceEEechhhcc
Confidence            489999999999994    2358999998875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.73  E-value=0.0049  Score=41.32  Aligned_cols=29  Identities=31%  Similarity=0.628  Sum_probs=24.3

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      |++|+|+.+.|+++.   .....-++||+.+.
T Consensus       184 giIHgDl~~dNvl~~---~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFL---GDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcc---cccceeEecccccc
Confidence            699999999999994   45556899999885

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=87.34  E-value=0.099  Score=34.98  Aligned_cols=27  Identities=26%  Similarity=0.226  Sum_probs=21.5

Q ss_pred             CCeecCCCCCceEeecCCCCceEEEeeccCcc
Q 031828           84 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC  115 (152)
Q Consensus        84 ~~~h~dl~~~nil~~~~~~~~~~kl~dfg~~~  115 (152)
                      +++|+|+.+.||++.   . + ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~---~-~-~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWR---D-G-PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEES---S-S-EEECCCTTCC
T ss_pred             eeecCCCCcccEEEe---C-C-ceEEechhcc
Confidence            589999999999983   2 2 3579999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=85.05  E-value=0.16  Score=34.83  Aligned_cols=38  Identities=16%  Similarity=0.141  Sum_probs=25.2

Q ss_pred             HHHHHHHHHHcCC-CcCccceeeeeeeCCeEEEEEeecCCCCh
Q 031828           12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNL   53 (152)
Q Consensus        12 ~~~~E~~~l~~l~-h~ni~~l~~~~~~~~~~~lv~e~~~~~~l   53 (152)
                      +..+|..+++.+. +.-..++++++..    .+|++|++|..+
T Consensus        90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            3457888888874 4334577777742    478899876433